data_1cir_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1cir _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.471 ' O ' ' O ' ' B' ' 62' ' ' ARG . 1.4 p . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.618 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -131.53 -30.76 1.64 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.043 -1.036 . . . . 0.0 110.484 -179.646 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.647 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 5.8 m-90 51.44 46.29 3.49 Favored Pre-proline 0 C--N 1.296 -1.723 0 C-N-CA 118.088 -1.445 . . . . 0.0 108.237 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.647 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 32.8 Cg_endo -73.76 -33.86 6.01 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 N-CA-C 107.75 -1.673 . . . . 0.0 107.75 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.69 -11.13 59.82 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.535 HD23 ' HA ' ' A' ' 16' ' ' ALA . 63.4 tp -79.96 -5.05 54.96 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 121.394 -0.816 . . . . 0.0 109.586 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.614 ' CG2' ' CG2' ' B' ' 60' ' ' VAL . 42.5 t -53.75 149.2 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 120.994 -1.066 . . . . 0.0 110.466 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.466 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 58.42 11.68 10.58 Favored Glycine 0 N--CA 1.481 1.647 0 C-N-CA 120.194 -1.003 . . . . 0.0 110.644 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.535 ' CB ' HD11 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -91.49 -144.28 0.19 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.925 -1.338 . . . . 0.0 109.124 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' B' ' 55' ' ' ASP . 0.5 OUTLIER -145.54 157.1 44.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.035 -1.04 . . . . 0.0 109.961 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.472 HG12 HG22 ' A' ' 31' ' ' VAL . 93.0 t -48.68 -34.28 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.343 -0.848 . . . . 0.0 109.479 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.508 ' O ' ' CD ' ' A' ' 18' ' ' LYS . 7.8 mm-40 -44.6 -75.52 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.092 -1.005 . . . . 0.0 109.163 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.401 ' O ' HG22 ' A' ' 19' ' ' VAL . 1.9 tt0 -58.71 -32.34 69.08 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.687 -0.633 . . . . 0.0 109.959 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.535 ' HA ' HD23 ' A' ' 8' ' ' LEU . . . -62.45 -80.66 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.086 -1.009 . . . . 0.0 109.676 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.516 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -44.2 -39.94 4.75 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.872 -1.143 . . . . 0.0 108.942 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.526 ' HD2' ' N ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -51.53 -81.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.75 0.786 . . . . 0.0 111.085 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 15' ' ' GLU . 1.9 t -66.08 -49.27 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.809 -0.557 . . . . 0.0 110.472 -178.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.597 ' HA ' ' OD2' ' A' ' 23' ' ' ASP . 61.7 mt -45.8 -40.13 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 0.0 109.518 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.534 ' CD1' ' HG3' ' A' ' 28' ' ' GLN . 35.1 tp -38.84 -23.82 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.55 ' O ' ' N ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -135.37 -81.22 0.42 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 119.977 -1.702 . . . . 0.0 111.617 -178.83 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.597 ' OD2' ' HA ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER 37.77 -94.82 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.739 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.609 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -58.48 -163.76 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 176.214 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 37.4 Cg_endo -76.32 82.44 2.23 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 N-CA-C 108.666 -1.321 . . . . 0.0 108.666 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.533 ' CG ' ' C ' ' A' ' 25' ' ' PRO . 0.3 OUTLIER 56.88 52.22 9.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.65 -0.657 . . . . 0.0 111.009 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.526 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -88.82 112.05 22.77 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 177.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.534 ' HG3' ' CD1' ' A' ' 21' ' ' LEU . 0.6 OUTLIER -87.51 -166.62 1.63 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.012 -1.055 . . . . 0.0 110.721 -177.213 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.548 ' CG1' ' HB2' ' B' ' 49' ' ' LEU . 1.7 tt -149.86 144.23 17.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.477 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.49 ' O ' ' HB3' ' B' ' 49' ' ' LEU . 31.9 mt -89.39 115.27 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.752 -0.593 . . . . 0.0 109.985 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.472 HG22 HG12 ' A' ' 13' ' ' VAL . 8.0 p -89.91 109.59 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.545 -1.347 . . . . 0.0 109.906 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.642 ' CD1' ' CE1' ' B' ' 50' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 C-N-CA 119.087 -1.045 . . . . 0.0 110.411 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.516 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 8.0 ptp180 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.47 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.7 OUTLIER -42.5 145.59 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 119.403 -0.919 . . . . 0.0 108.896 179.795 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.526 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.1 p-10 -107.66 46.43 0.94 Allowed 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.918 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' ARG . . . . . 0.468 ' HG2' ' CG1' ' A' ' 30' ' ' ILE . 11.3 mtt180 -150.16 150.1 31.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.33 -0.856 . . . . 0.0 109.426 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.6 ' CG2' ' CG2' ' B' ' 63' ' ' VAL . 79.2 t -151.32 126.47 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.316 -0.865 . . . . 0.0 110.082 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -53.35 87.95 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.734 -1.229 . . . . 0.0 110.584 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.548 ' HB2' ' CG1' ' A' ' 29' ' ' ILE . 4.9 tp -91.29 87.26 6.41 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' PHE . . . . . 0.642 ' CE1' ' CD1' ' A' ' 32' ' ' LEU . 5.7 m-30 -72.59 148.44 44.9 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.458 HG13 ' CG2' ' A' ' 13' ' ' VAL . 34.8 m -122.4 166.53 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.711 -1.243 . . . . 0.0 109.872 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' B' ' 55' ' ' ASP . 1.5 p-10 -93.52 -151.34 0.3 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.57 -0.707 . . . . 0.0 109.25 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.503 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 0.1 OUTLIER -75.56 -46.5 31.6 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.236 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . 0.517 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 1.8 mm? -101.61 36.81 1.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.622 -0.674 . . . . 0.0 109.655 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.539 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.0 OUTLIER 52.77 67.11 1.04 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.192 -0.942 . . . . 0.0 109.583 -179.32 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . 0.565 ' O ' ' N ' ' B' ' 58' ' ' ALA . 29.0 t30 -119.97 86.02 2.49 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.502 HD11 HG22 ' B' ' 57' ' ' ILE . 4.6 mt -31.94 87.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 CA-C-O 121.637 0.732 . . . . 0.0 111.42 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -89.37 -4.63 57.98 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -125.91 133.24 51.94 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.614 ' CG2' ' CG2' ' A' ' 9' ' ' VAL . 93.8 t -90.76 131.21 38.27 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.042 -1.036 . . . . 0.0 111.068 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.58 ' CB ' HG12 ' B' ' 47' ' ' VAL . 37.3 Cg_endo -83.84 161.75 14.05 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.581 2.188 . . . . 0.0 108.813 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' ARG . . . . . 0.566 ' HD3' ' HA ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -140.58 -49.15 0.44 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.798 -1.189 . . . . 0.0 110.164 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.6 ' CG2' ' CG2' ' B' ' 47' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--N 1.295 -1.773 0 O-C-N 121.442 -0.786 . . . . 0.0 109.812 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.525 HG21 ' CD ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.592 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 3.8 mt-10 -148.45 -44.2 0.15 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.276 -0.89 . . . . 0.0 110.655 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.626 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 6.1 m-90 59.6 41.67 0.6 Allowed Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 121.157 -0.964 . . . . 0.0 109.788 -178.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 34.1 Cg_endo -73.31 -33.36 7.2 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 N-CA-C 107.204 -1.883 . . . . 0.0 107.204 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -70.3 -12.53 61.65 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.534 HD22 ' CD1' ' B' ' 57' ' ' ILE . 49.5 tp -83.69 -4.31 58.5 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 121.385 -0.822 . . . . 0.0 109.262 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.467 ' HA ' HG21 ' B' ' 60' ' ' VAL . 14.7 t -53.69 152.36 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.91 -1.119 . . . . 0.0 109.319 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.465 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 66.85 4.77 28.56 Favored Glycine 0 N--CA 1.481 1.635 0 C-N-CA 119.823 -1.18 . . . . 0.0 110.625 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 2.3 tptp -94.54 -146.88 0.26 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.778 -1.425 . . . . 0.0 109.627 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.491 ' CB ' ' OE2' ' A' ' 14' ' ' GLU . 33.2 m -144.8 169.16 18.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.104 -0.998 . . . . 0.0 109.998 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.452 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 88.4 t -54.21 -34.92 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.488 -0.758 . . . . 0.0 109.902 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.551 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 1.3 pm0 -44.07 -73.75 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.313 -0.867 . . . . 0.0 109.197 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.415 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -61.79 -31.02 71.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.257 -0.902 . . . . 0.0 109.61 179.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.524 ' HB2' ' CD2' ' B' ' 49' ' ' LEU . . . -61.39 -83.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.103 -0.998 . . . . 0.0 109.481 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -46.79 -41.53 15.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.78 -1.2 . . . . 0.0 108.768 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.551 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -44.57 -77.37 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.617 0.722 . . . . 0.0 110.185 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.505 ' O ' ' C ' ' A' ' 20' ' ' ILE . 1.9 t -72.91 -54.35 16.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.728 -0.608 . . . . 0.0 110.225 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.578 HG12 ' CE2' ' A' ' 5' ' ' TRP . 62.5 mt -33.92 -50.74 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.611 -0.681 . . . . 0.0 110.362 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 28' ' ' GLN . 9.6 tt -38.66 -53.88 1.59 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.512 -0.742 . . . . 0.0 110.638 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -123.79 21.22 9.2 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.963 -1.085 . . . . 0.0 111.172 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.424 ' OD2' ' CG1' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -56.66 -60.16 3.95 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 177.648 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.724 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 3.2 tttm -68.23 -153.87 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 104.37 -2.456 . . . . 0.0 104.37 175.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.724 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 27.7 Cg_endo -68.68 -45.81 2.13 Favored 'Trans proline' 0 C--N 1.319 -1.012 0 CA-C-N 121.15 1.446 . . . . 0.0 109.002 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.504 ' CG ' ' C ' ' A' ' 25' ' ' PRO . 1.7 mt-10 -166.34 52.33 0.09 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.62 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -90.22 117.32 28.88 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.176 -1.009 . . . . 0.0 109.33 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.498 ' HB2' ' O ' ' B' ' 45' ' ' ASP . 11.5 mt-30 -88.79 178.49 6.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.155 -0.965 . . . . 0.0 109.152 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.591 ' CD1' ' CG ' ' B' ' 61' ' ' PRO . 8.5 tt -148.75 138.85 16.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 C-N-CA 118.99 -1.084 . . . . 0.0 111.074 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.5 HG23 ' CD2' ' A' ' 32' ' ' LEU . 1.2 mt -91.24 164.24 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.476 ' N ' HG21 ' A' ' 30' ' ' ILE . 7.4 p -131.06 135.84 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.683 -1.261 . . . . 0.0 110.187 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.673 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 110.075 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.527 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.433 ' C ' ' O ' ' B' ' 43' ' ' ARG . 11.8 tt -44.88 160.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.938 -1.101 . . . . 0.0 108.037 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.62 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.7 p-10 -127.08 45.83 2.63 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 118.602 -1.239 . . . . 0.0 110.167 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' ARG . . . . . 0.5 ' NH1' ' HG3' ' B' ' 46' ' ' ARG . 0.0 OUTLIER -152.07 150.55 30.06 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.539 ' CG2' HG21 ' B' ' 63' ' ' VAL . 0.0 OUTLIER -151.4 168.62 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.95 -1.094 . . . . 0.0 109.355 -179.617 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.466 ' NH1' ' HG2' ' B' ' 48' ' ' ARG . 0.0 OUTLIER -97.54 93.8 6.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.969 -1.082 . . . . 0.0 109.333 179.686 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.524 ' CD2' ' HB2' ' A' ' 16' ' ' ALA . 0.9 OUTLIER -88.67 82.05 6.93 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.439 -0.904 . . . . 0.0 109.475 179.745 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' PHE . . . . . 0.521 ' HE1' ' CD1' ' A' ' 32' ' ' LEU . 2.9 m-30 -66.05 158.22 28.97 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 12.2 m -118.86 -174.98 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.799 -1.188 . . . . 0.0 109.295 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.502 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.5 OUTLIER -124.86 -154.3 0.61 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.029 -1.044 . . . . 0.0 110.08 -179.531 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.502 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 1.8 mtmp? -60.85 -57.39 12.86 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.606 -0.684 . . . . 0.0 109.653 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . 0.412 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.3 OUTLIER -99.58 44.58 1.02 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.331 -0.856 . . . . 0.0 109.741 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 48.7 63.72 1.99 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.072 -1.018 . . . . 0.0 109.162 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . 0.587 ' O ' ' N ' ' B' ' 58' ' ' ALA . 7.6 t30 -130.25 109.85 11.1 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.534 ' CD1' HD22 ' A' ' 8' ' ' LEU . 23.9 mt -34.34 86.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 121.485 0.659 . . . . 0.0 111.262 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . 0.587 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -89.13 -8.77 53.1 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.47 85.43 2.05 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.467 HG21 ' HA ' ' A' ' 9' ' ' VAL . 2.2 t -48.25 139.49 10.23 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.465 -0.772 . . . . 0.0 110.131 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.591 ' CG ' ' CD1' ' A' ' 29' ' ' ILE . 36.4 Cg_endo -81.21 168.96 16.42 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.856 2.371 . . . . 0.0 109.404 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' ARG . . . . . 0.532 ' HD2' ' CB ' ' A' ' 4' ' ' GLU . 0.5 OUTLIER -149.89 124.45 9.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.873 -1.142 . . . . 0.0 110.274 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.539 HG21 ' CG2' ' B' ' 47' ' ' VAL . 2.6 t . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.339 -0.85 . . . . 0.0 108.788 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.543 ' CG2' ' HD2' ' A' ' 24' ' ' LYS . 2.8 p . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.612 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 0.4 OUTLIER -125.5 -57.75 1.45 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.196 -0.94 . . . . 0.0 110.012 -179.118 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.617 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.0 m-90 70.3 39.78 0.18 Allowed Pre-proline 0 C--N 1.3 -1.561 0 O-C-N 121.765 -0.584 . . . . 0.0 110.827 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 33.1 Cg_endo -72.31 -30.18 13.14 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 N-CA-C 107.559 -1.746 . . . . 0.0 107.559 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.51 -17.66 64.75 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.302 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.559 ' CD1' HD11 ' B' ' 57' ' ' ILE . 0.0 OUTLIER -69.48 -23.02 63.58 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 122.254 1.026 . . . . 0.0 108.565 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.568 ' CG2' ' CG2' ' B' ' 60' ' ' VAL . 3.8 t -43.63 138.61 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-O 121.988 0.899 . . . . 0.0 110.88 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.533 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 86.5 -45.55 3.46 Favored Glycine 0 C--N 1.298 -1.581 0 C-N-CA 119.749 -1.215 . . . . 0.0 112.364 175.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.3 78.14 1.08 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 119.951 -1.911 . . . . 0.0 111.492 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.616 ' O ' ' CB ' ' A' ' 16' ' ' ALA . 0.9 OUTLIER -153.18 46.73 0.68 Allowed 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 118.315 -1.354 . . . . 0.0 111.345 179.486 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.408 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 23.9 t -77.28 -73.03 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 O-C-N 121.068 -1.02 . . . . 0.0 109.725 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.484 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 11.6 pt-20 -55.71 -38.25 69.47 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.443 ' HA ' ' HB3' ' A' ' 18' ' ' LYS . 4.3 tt0 -68.48 -32.72 72.9 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.616 ' CB ' ' O ' ' A' ' 12' ' ' SER . . . -62.69 -71.62 0.15 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.096 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.466 ' HA ' ' CG2' ' A' ' 29' ' ' ILE . 0.5 OUTLIER -50.56 -35.58 30.48 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.112 179.613 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.495 ' HG2' ' N ' ' A' ' 19' ' ' VAL . 2.6 ttmt -62.17 -90.29 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.576 0.703 . . . . 0.0 110.742 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.495 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 3.4 t -46.19 -48.32 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.639 -0.663 . . . . 0.0 110.371 -178.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.537 HG12 ' CE2' ' A' ' 5' ' ' TRP . 61.6 mt -50.43 -50.88 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.176 -0.953 . . . . 0.0 109.876 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 3.3 tt -35.13 -29.99 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.679 -0.638 . . . . 0.0 111.544 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.556 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -136.36 3.24 2.81 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 118.002 -1.479 . . . . 0.0 111.98 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' ' 24' ' ' LYS . 22.5 m-20 -54.12 147.17 13.33 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 177.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.688 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 21.9 mtpt 69.86 -147.0 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 104.425 -2.435 . . . . 0.0 104.425 -175.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.688 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 33.2 Cg_endo -75.42 -64.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.324 -0.745 0 CA-C-N 121.36 1.521 . . . . 0.0 108.814 178.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.556 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 26.9 mt-10 -161.06 64.66 0.29 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -88.78 117.53 27.84 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.494 ' CB ' ' O ' ' B' ' 45' ' ' ASP . 0.0 OUTLIER -88.19 175.76 7.56 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.182 -0.949 . . . . 0.0 109.7 -179.47 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.523 HD13 ' CB ' ' B' ' 61' ' ' PRO . 3.3 tt -143.12 147.11 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.225 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.433 HD12 HG22 ' A' ' 30' ' ' ILE . 4.2 mt -102.44 130.89 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.471 HG12 HD22 ' B' ' 49' ' ' LEU . 2.5 t -104.23 125.72 58.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 120.798 -1.189 . . . . 0.0 109.721 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.643 ' CD1' ' CE1' ' B' ' 50' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.542 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 120.881 0.372 . . . . 0.0 110.213 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.506 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.5 OUTLIER -46.96 145.45 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.706 -1.246 . . . . 0.0 108.108 179.187 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.583 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.0 OUTLIER -105.86 43.05 1.16 Allowed 'General case' 0 C--N 1.295 -1.763 0 O-C-N 120.914 -1.116 . . . . 0.0 109.829 -179.338 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' ARG . . . . . 0.437 ' HG2' ' N ' ' B' ' 47' ' ' VAL . 0.3 OUTLIER -151.02 155.05 38.23 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.366 -0.834 . . . . 0.0 109.477 179.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.555 ' CG2' HG22 ' B' ' 63' ' ' VAL . 15.4 t -150.29 173.42 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 109.456 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.444 ' HD3' ' HA ' ' B' ' 48' ' ' ARG . 20.4 mmt180 -101.59 66.51 1.08 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.982 -1.074 . . . . 0.0 109.942 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.512 ' HB2' ' CD1' ' A' ' 29' ' ' ILE . 3.8 tp -61.49 89.94 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.268 -0.973 . . . . 0.0 109.121 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' PHE . . . . . 0.643 ' CE1' ' CD1' ' A' ' 32' ' ' LEU . 7.3 m-30 -79.26 135.32 36.73 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -104.89 -174.94 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.79 -1.194 . . . . 0.0 109.147 179.383 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.533 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.0 OUTLIER -126.48 -162.84 1.18 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.252 -0.905 . . . . 0.0 109.729 -179.687 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.533 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 21.0 mtpt -46.6 -64.74 0.69 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.398 0.618 . . . . 0.0 109.919 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . 0.422 ' O ' ' C ' ' B' ' 55' ' ' ASP . 0.5 OUTLIER -95.38 52.28 1.38 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.793 -179.563 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.422 ' HA ' ' HB ' ' B' ' 51' ' ' VAL . 0.0 OUTLIER 42.72 57.52 3.51 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.351 -0.843 . . . . 0.0 109.654 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . 0.507 ' OD1' ' O ' ' A' ' 10' ' ' GLY . 0.5 OUTLIER -115.6 122.11 44.65 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.412 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.559 HD11 ' CD1' ' A' ' 8' ' ' LEU . 5.0 mt -60.69 89.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.293 -0.88 . . . . 0.0 110.196 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.72 -28.31 20.62 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . 0.408 ' OE1' ' CD2' ' B' ' 50' ' ' PHE . 4.5 tt0 -105.13 133.02 50.61 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.568 ' CG2' ' CG2' ' A' ' 9' ' ' VAL . 58.9 t -89.15 129.11 49.1 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 120.843 -1.161 . . . . 0.0 110.711 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.533 ' HB2' ' CG1' ' B' ' 47' ' ' VAL . 36.6 Cg_endo -82.64 160.54 16.67 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.632 2.222 . . . . 0.0 109.295 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' ARG . . . . . 0.473 ' N ' HG12 ' B' ' 47' ' ' VAL . 0.0 OUTLIER -150.03 143.14 24.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.906 -1.121 . . . . 0.0 110.062 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.555 HG22 ' CG2' ' B' ' 47' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.453 HG21 ' HE3' ' A' ' 24' ' ' LYS . 4.1 p . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.492 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.5 mt-10 -112.04 179.23 4.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.422 -0.799 . . . . 0.0 109.336 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.612 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 14.7 m-90 -150.78 47.3 0.44 Allowed Pre-proline 0 C--N 1.298 -1.658 0 O-C-N 121.52 -0.738 . . . . 0.0 109.79 178.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 31.3 Cg_endo -71.18 -25.72 21.95 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 N-CA-C 107.411 -1.803 . . . . 0.0 107.411 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -69.79 -20.32 63.47 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.496 ' CG ' ' HB3' ' A' ' 5' ' ' TRP . 11.4 mt -83.64 -4.01 58.22 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.496 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.583 ' CG2' ' CG2' ' B' ' 60' ' ' VAL . 22.7 t -55.41 147.78 3.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.106 -0.996 . . . . 0.0 109.833 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.427 ' C ' ' OD1' ' B' ' 56' ' ' ASN . . . 61.65 10.4 23.98 Favored Glycine 0 N--CA 1.481 1.668 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 2.1 tptp -96.12 -144.59 0.28 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.959 -1.318 . . . . 0.0 109.071 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.404 ' CA ' HG12 ' B' ' 57' ' ' ILE . 1.4 m -142.76 165.86 26.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.044 -1.035 . . . . 0.0 109.909 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.496 ' CG2' HG12 ' A' ' 31' ' ' VAL . 76.4 t -50.86 -40.1 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.434 -0.791 . . . . 0.0 109.443 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.536 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 56.7 mt-10 -43.8 -72.1 0.07 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.468 -0.77 . . . . 0.0 109.538 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.433 ' O ' HG22 ' A' ' 19' ' ' VAL . 5.2 tp10 -56.37 -34.62 66.83 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.081 -1.012 . . . . 0.0 109.734 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.494 ' HA ' HD11 ' A' ' 8' ' ' LEU . . . -63.44 -84.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 110.206 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.517 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -44.74 -34.25 2.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.947 -1.096 . . . . 0.0 109.044 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 6.0 ttmt -55.98 -82.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.542 0.687 . . . . 0.0 110.511 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 23' ' ' ASP . 2.0 t -64.28 -49.9 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.545 -0.722 . . . . 0.0 109.769 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.538 ' CG2' ' HB ' ' A' ' 29' ' ' ILE . 77.1 mt -42.54 -54.09 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.364 -0.835 . . . . 0.0 109.47 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 28' ' ' GLN . 4.9 tt -42.1 -45.81 4.08 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.263 -0.898 . . . . 0.0 110.223 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -143.61 54.58 1.33 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.992 -1.068 . . . . 0.0 110.624 -179.188 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.604 ' OD2' ' CZ2' ' A' ' 5' ' ' TRP . 35.0 p-10 -76.23 -28.9 57.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.859 -1.151 . . . . 0.0 108.768 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.734 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -130.72 -83.45 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.055 -1.028 . . . . 0.0 108.692 178.315 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.734 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 42.4 Cg_endo -88.68 -84.93 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.645 0 N-CA-C 108.144 -1.521 . . . . 0.0 108.144 177.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 10.2 mt-10 -162.06 56.3 0.24 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.587 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -88.69 118.12 28.14 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.084 -1.01 . . . . 0.0 109.125 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.506 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 1.8 mt-30 -88.19 178.35 6.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 0.0 109.373 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.538 ' HB ' ' CG2' ' A' ' 20' ' ' ILE . 5.9 tt -147.43 137.67 17.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 C-N-CA 119.204 -0.998 . . . . 0.0 111.011 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.535 ' CD1' ' HD2' ' B' ' 46' ' ' ARG . 8.3 mt -90.28 117.36 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.496 HG12 ' CG2' ' A' ' 13' ' ' VAL . 5.1 t -99.82 140.98 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.797 -1.189 . . . . 0.0 109.75 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.65 ' CD2' ' CE1' ' B' ' 50' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.264 -0.897 . . . . 0.0 109.536 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.583 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.091 0.472 . . . . 0.0 109.757 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.436 ' O ' HG23 ' B' ' 63' ' ' VAL . 0.7 OUTLIER -48.4 137.1 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.544 -1.347 . . . . 0.0 107.644 179.222 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.587 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 4.3 p-10 -89.62 48.3 1.58 Allowed 'General case' 0 C--N 1.292 -1.896 0 C-N-CA 119.076 -1.05 . . . . 0.0 109.396 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' ARG . . . . . 0.535 ' HD2' ' CD1' ' A' ' 30' ' ' ILE . 10.1 ttp180 -151.08 151.68 32.33 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.565 ' CG2' ' CG2' ' B' ' 63' ' ' VAL . 61.4 t -151.43 169.34 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.588 ' HB3' ' CE2' ' B' ' 50' ' ' PHE . 12.6 mmt-85 -100.18 84.46 2.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.631 -1.293 . . . . 0.0 110.709 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.558 ' CD1' HD11 ' B' ' 57' ' ' ILE . 4.2 tp -84.68 97.69 9.79 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 118.933 -1.107 . . . . 0.0 108.62 178.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' PHE . . . . . 0.65 ' CE1' ' CD2' ' A' ' 32' ' ' LEU . 52.4 m-85 -92.88 131.71 37.66 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 178.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 32' ' ' LEU . 12.9 m -89.08 178.04 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.619 -1.301 . . . . 0.0 110.349 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.511 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.8 OUTLIER -107.89 -151.72 0.47 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.354 -0.841 . . . . 0.0 109.775 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.511 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 1.2 mmtp -74.03 -48.47 29.86 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . 0.478 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.1 OUTLIER -98.99 38.19 1.42 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.39 -0.819 . . . . 0.0 109.503 179.534 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.0 OUTLIER 50.48 67.62 0.89 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.165 -0.96 . . . . 0.0 109.181 -179.413 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . 0.565 ' O ' ' N ' ' B' ' 58' ' ' ALA . 1.2 t30 -133.58 117.35 16.98 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.558 HD11 ' CD1' ' B' ' 49' ' ' LEU . 27.0 mm -46.88 87.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-O 121.384 0.612 . . . . 0.0 109.823 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -89.32 -25.46 21.62 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -105.01 129.42 53.46 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.583 ' CG2' ' CG2' ' A' ' 9' ' ' VAL . 85.3 t -82.56 126.35 73.82 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.054 -1.029 . . . . 0.0 109.989 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.536 ' CB ' HG13 ' B' ' 47' ' ' VAL . 37.0 Cg_endo -81.36 158.91 19.87 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 C-N-CA 122.403 2.068 . . . . 0.0 110.199 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' ARG . . . . . 0.48 ' N ' HG12 ' B' ' 47' ' ' VAL . 0.3 OUTLIER -150.91 130.62 13.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.054 -1.029 . . . . 0.0 109.839 179.411 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.565 ' CG2' ' CG2' ' B' ' 47' ' ' VAL . 1.1 t . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.308 -0.87 . . . . 0.0 108.901 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.474 ' OG1' ' CD ' ' A' ' 24' ' ' LYS . 2.1 m . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.72 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.7 mt-10 -102.4 -36.43 8.44 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.112 -0.993 . . . . 0.0 110.026 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.647 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 7.8 m-90 56.2 47.33 2.87 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 121.018 -1.051 . . . . 0.0 109.249 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.72 ' HD3' ' HB2' ' A' ' 4' ' ' GLU . 33.4 Cg_endo -74.99 -37.39 2.06 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 N-CA-C 106.789 -2.043 . . . . 0.0 106.789 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -8.62 50.07 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 114.524 -1.216 . . . . 0.0 107.797 177.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.488 HD22 ' CB ' ' A' ' 16' ' ' ALA . 13.2 tp -83.2 -2.03 54.51 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 121.289 -0.882 . . . . 0.0 109.198 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.575 ' CG2' ' CG2' ' B' ' 60' ' ' VAL . 17.7 t -57.18 149.54 4.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.021 -1.049 . . . . 0.0 109.459 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.56 8.67 21.27 Favored Glycine 0 N--CA 1.481 1.688 0 C-N-CA 119.858 -1.163 . . . . 0.0 110.309 178.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 17.0 tptt -91.1 -145.63 0.19 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.789 -1.418 . . . . 0.0 109.161 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' B' ' 55' ' ' ASP . 0.4 OUTLIER -145.71 160.88 41.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.029 -1.045 . . . . 0.0 109.894 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.537 HG21 ' CG1' ' B' ' 51' ' ' VAL . 53.7 t -51.89 -32.48 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.339 -0.851 . . . . 0.0 109.19 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.547 ' O ' ' CG ' ' A' ' 18' ' ' LYS . 5.4 mt-10 -43.05 -74.06 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.97 -37.37 79.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.559 -0.713 . . . . 0.0 109.993 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.488 ' CB ' HD22 ' A' ' 8' ' ' LEU . . . -59.44 -80.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 0.0 110.04 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.524 ' HA ' ' CG2' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -47.21 -32.86 4.8 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.469 -1.394 . . . . 0.0 109.347 -179.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.547 ' CG ' ' O ' ' A' ' 14' ' ' GLU . 16.1 mtpt -58.86 -85.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.753 0.787 . . . . 0.0 110.953 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.522 ' O ' ' N ' ' A' ' 23' ' ' ASP . 2.8 t -57.83 -41.33 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.592 -0.692 . . . . 0.0 110.08 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.608 HD13 ' CD1' ' A' ' 5' ' ' TRP . 0.3 OUTLIER -48.73 -52.31 9.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.352 -0.843 . . . . 0.0 109.16 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.461 ' C ' ' O ' ' A' ' 20' ' ' ILE . 0.7 OUTLIER -38.14 -40.86 0.54 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.685 -0.635 . . . . 0.0 110.125 -179.581 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -140.38 40.88 1.91 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.112 -0.993 . . . . 0.0 109.765 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 19' ' ' VAL . 18.8 p-10 -52.09 -42.93 63.63 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.336 -0.852 . . . . 0.0 109.493 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.736 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -130.75 -78.69 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.444 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.715 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.736 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 40.6 Cg_endo -87.57 -80.79 0.0 OUTLIER 'Trans proline' 0 C--O 1.214 -0.717 0 N-CA-C 107.78 -1.662 . . . . 0.0 107.78 177.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 22.4 mt-10 -161.96 62.08 0.24 Allowed 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.607 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -87.92 121.25 30.11 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.989 -1.069 . . . . 0.0 110.236 -178.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.405 ' HB3' ' O ' ' B' ' 45' ' ' ASP . 1.1 tp60 -88.59 176.15 7.25 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.057 -1.027 . . . . 0.0 108.242 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.588 ' HB ' ' CG2' ' A' ' 20' ' ' ILE . 9.4 tt -148.9 137.53 14.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 120.7 -1.25 . . . . 0.0 111.193 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.485 ' O ' ' HB3' ' B' ' 49' ' ' LEU . 0.8 OUTLIER -88.92 152.89 3.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.011 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.501 HG22 ' CG2' ' A' ' 13' ' ' VAL . 7.6 p -135.02 134.93 53.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 118.813 -1.155 . . . . 0.0 110.298 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.687 ' CD1' ' CE1' ' B' ' 50' ' ' PHE . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.44 -0.787 . . . . 0.0 109.283 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.533 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 2.0 ptt-85 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.534 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.3 OUTLIER -44.75 142.54 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.893 -1.129 . . . . 0.0 108.458 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.607 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.1 p-10 -102.1 48.67 0.87 Allowed 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.127 -1.029 . . . . 0.0 110.058 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' ARG . . . . . 0.409 ' C ' HG21 ' B' ' 47' ' ' VAL . 0.1 OUTLIER -150.71 146.34 26.38 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.533 HG21 ' CG2' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -150.47 143.7 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 120.968 -1.083 . . . . 0.0 109.317 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -78.67 88.05 4.58 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.99 -1.069 . . . . 0.0 110.796 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.519 ' HB2' HD12 ' A' ' 29' ' ' ILE . 2.1 tp -90.41 97.22 11.05 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.141 -1.024 . . . . 0.0 108.657 178.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' PHE . . . . . 0.687 ' CE1' ' CD1' ' A' ' 32' ' ' LEU . 16.6 m-85 -92.35 110.72 22.12 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.537 ' CG1' HG21 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -89.77 172.08 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.906 -1.121 . . . . 0.0 110.947 -178.856 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' B' ' 54' ' ' LEU . 0.7 OUTLIER -94.66 -153.04 0.37 Allowed 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.683 0.754 . . . . 0.0 109.715 -179.233 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.521 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 6.2 mttm -76.84 -47.42 21.46 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . 0.522 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.0 OUTLIER -95.83 39.69 1.13 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.577 -0.702 . . . . 0.0 109.488 179.553 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.0 OUTLIER 47.75 67.29 0.84 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.12 -0.987 . . . . 0.0 109.123 -179.756 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' B' ' 58' ' ' ALA . 17.8 t-20 -127.33 94.12 3.91 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.658 0.742 . . . . 0.0 109.011 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.472 HD11 ' HG ' ' A' ' 8' ' ' LEU . 4.5 mt -39.68 87.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.301 0.572 . . . . 0.0 111.066 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -89.48 -19.65 24.82 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -118.19 106.1 12.48 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.575 ' CG2' ' CG2' ' A' ' 9' ' ' VAL . 35.4 t -62.52 133.87 94.88 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.227 -0.921 . . . . 0.0 110.345 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.477 ' O ' ' HD3' ' B' ' 62' ' ' ARG . 36.2 Cg_endo -79.81 163.38 23.56 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 122.531 2.154 . . . . 0.0 109.398 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' ARG . . . . . 0.514 ' N ' HG13 ' B' ' 47' ' ' VAL . 0.0 OUTLIER -150.55 128.08 11.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.971 -1.081 . . . . 0.0 110.102 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.533 ' CG2' HG21 ' B' ' 47' ' ' VAL . 1.8 t . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.263 -0.898 . . . . 0.0 109.073 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.558 ' CG2' ' HE2' ' A' ' 24' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.332 0.587 . . . . 0.0 109.598 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.573 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 6.9 mt-10 -94.33 -44.56 7.88 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.264 -0.897 . . . . 0.0 109.999 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.62 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.5 m-90 64.19 41.83 0.36 Allowed Pre-proline 0 C--N 1.296 -1.724 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.109 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 34.4 Cg_endo -73.14 -30.46 10.6 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 N-CA-C 106.929 -1.989 . . . . 0.0 106.929 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.67 -13.88 62.25 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 177.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.497 HD12 HD11 ' B' ' 57' ' ' ILE . 0.0 OUTLIER -81.89 -5.6 58.4 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.534 HG21 ' CG2' ' B' ' 60' ' ' VAL . 25.2 t -53.29 151.94 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.0 -1.063 . . . . 0.0 109.745 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.488 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 62.83 7.27 15.19 Favored Glycine 0 N--CA 1.482 1.716 0 C-N-CA 119.982 -1.104 . . . . 0.0 110.422 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -93.55 -142.56 0.23 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.833 -1.392 . . . . 0.0 109.183 179.646 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -148.73 161.48 41.68 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.994 -1.066 . . . . 0.0 109.89 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.407 ' O ' ' C ' ' A' ' 14' ' ' GLU . 39.9 t -46.39 -35.82 2.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.415 -0.803 . . . . 0.0 109.048 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.538 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 1.5 mt-10 -44.84 -73.88 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.511 -0.743 . . . . 0.0 109.066 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.478 ' O ' HG22 ' A' ' 19' ' ' VAL . 1.9 tm-20 -55.92 -34.5 65.65 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.192 -0.942 . . . . 0.0 109.555 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.534 ' CB ' HD23 ' B' ' 49' ' ' LEU . . . -62.82 -85.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.088 -1.008 . . . . 0.0 110.166 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -42.87 -45.45 4.93 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.837 -1.165 . . . . 0.0 108.914 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 6.1 tptm -42.37 -76.13 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.573 0.702 . . . . 0.0 110.584 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.482 ' O ' ' C ' ' A' ' 20' ' ' ILE . 1.0 OUTLIER -78.16 -52.81 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.459 -0.776 . . . . 0.0 110.402 -178.39 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.532 HD11 ' CD1' ' A' ' 29' ' ' ILE . 60.1 mt -37.98 -34.72 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.394 -0.816 . . . . 0.0 110.004 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' ' 19' ' ' VAL . 2.4 tt -56.09 -52.98 62.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.081 -1.012 . . . . 0.0 110.357 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.405 ' HB2' HD21 ' A' ' 21' ' ' LEU . 0.4 OUTLIER -128.59 64.21 1.43 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.925 -1.109 . . . . 0.0 111.045 -178.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -84.42 -50.55 7.67 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.412 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.711 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 10.0 mtpp -101.05 -105.77 0.0 OUTLIER Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.711 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 37.2 Cg_endo -80.16 -70.98 0.01 OUTLIER 'Trans proline' 0 C--O 1.213 -0.738 0 CA-C-N 121.873 1.705 . . . . 0.0 108.059 177.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 25' ' ' PRO . 30.8 mt-10 -162.76 70.2 0.26 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.609 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -88.51 120.48 29.93 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.871 -1.143 . . . . 0.0 109.233 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.82 168.61 11.94 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.193 -0.942 . . . . 0.0 109.642 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.532 ' CD1' HD11 ' A' ' 20' ' ' ILE . 21.4 tt -146.91 140.34 19.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.351 -0.843 . . . . 0.0 109.944 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.531 ' CD1' ' HG2' ' B' ' 46' ' ' ARG . 1.7 mp -88.97 142.35 13.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.486 ' C ' ' CD2' ' A' ' 32' ' ' LEU . 4.0 p -105.82 133.04 51.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.47 -0.892 . . . . 0.0 109.491 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.675 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.565 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.57 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 2.5 ptt180 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.006 0.431 . . . . 0.0 110.296 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.517 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.3 OUTLIER -47.52 142.91 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.82 -1.175 . . . . 0.0 107.955 178.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.609 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.5 p-10 -102.39 44.43 1.01 Allowed 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.004 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' ARG . . . . . 0.531 ' HG2' ' CD1' ' A' ' 30' ' ' ILE . 0.8 OUTLIER -151.09 142.69 23.6 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 178.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.528 ' CG1' ' O ' ' B' ' 62' ' ' ARG . 0.0 OUTLIER -150.59 157.75 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.126 -0.984 . . . . 0.0 109.319 -179.296 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -92.98 100.96 13.31 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.72 -1.237 . . . . 0.0 110.328 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.534 HD23 ' CB ' ' A' ' 16' ' ' ALA . 0.8 OUTLIER -95.45 96.02 8.82 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.263 -0.975 . . . . 0.0 108.872 178.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' PHE . . . . . 0.633 ' CE1' HD11 ' A' ' 32' ' ' LEU . 24.6 m-85 -93.26 143.53 26.17 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.49 ' HB ' ' HA ' ' B' ' 55' ' ' ASP . 6.1 m -107.21 -151.57 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.769 -1.207 . . . . 0.0 110.858 -179.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.532 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.2 OUTLIER -141.92 -157.47 0.77 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.426 -0.796 . . . . 0.0 109.68 -179.478 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.532 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 2.8 mtmp? -57.42 -59.02 5.77 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.667 -0.646 . . . . 0.0 109.509 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . 0.428 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 6.7 tp -96.2 42.82 1.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.437 -0.789 . . . . 0.0 109.619 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.49 ' HA ' ' HB ' ' B' ' 51' ' ' VAL . 0.0 OUTLIER 49.2 62.7 2.47 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.101 -0.999 . . . . 0.0 109.567 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . 0.551 ' O ' ' N ' ' B' ' 58' ' ' ALA . 4.0 t30 -122.59 106.19 10.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.311 -0.868 . . . . 0.0 108.808 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.497 HD11 HD12 ' A' ' 8' ' ' LEU . 28.0 mt -42.06 89.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.496 0.665 . . . . 0.0 110.374 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.48 -17.82 29.54 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -114.92 135.39 54.26 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.534 ' CG2' HG21 ' A' ' 9' ' ' VAL . 71.1 t -88.05 128.05 55.23 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.014 -1.054 . . . . 0.0 110.542 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.486 ' O ' ' HD3' ' B' ' 62' ' ' ARG . 36.3 Cg_endo -79.76 158.36 24.69 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.317 2.012 . . . . 0.0 108.41 177.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' ARG . . . . . 0.528 ' CD ' ' HA ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -150.54 133.05 15.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.768 -1.208 . . . . 0.0 110.409 -179.612 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.485 HG23 ' HB2' ' A' ' 27' ' ' ALA . 2.1 t . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.458 ' O ' ' HG3' ' B' ' 62' ' ' ARG . 2.4 m . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.608 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 27.7 mt-10 -118.82 -40.8 2.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -0.903 . . . . 0.0 109.914 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.641 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 9.6 m-90 61.7 41.92 0.49 Allowed Pre-proline 0 C--N 1.299 -1.621 0 O-C-N 121.524 -0.735 . . . . 0.0 110.092 -178.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 32.6 Cg_endo -72.49 -30.34 12.44 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 N-CA-C 106.468 -2.166 . . . . 0.0 106.468 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -16.05 63.17 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.086 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.528 ' CD1' ' CD1' ' A' ' 5' ' ' TRP . 7.2 mt -81.5 -5.78 58.3 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 121.302 -0.874 . . . . 0.0 109.293 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.604 ' CG2' ' CG2' ' B' ' 60' ' ' VAL . 23.7 t -57.0 148.04 4.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.148 -0.97 . . . . 0.0 109.81 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.421 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 60.12 10.19 14.1 Favored Glycine 0 N--CA 1.48 1.578 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.472 178.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.49 ' HB3' HD11 ' B' ' 57' ' ' ILE . 0.1 OUTLIER -94.65 -145.43 0.26 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.925 -1.338 . . . . 0.0 109.068 179.693 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.465 ' O ' HD13 ' B' ' 57' ' ' ILE . 0.3 OUTLIER -141.85 161.17 38.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.991 -1.068 . . . . 0.0 110.075 -179.546 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.477 HG22 HG13 ' B' ' 51' ' ' VAL . 79.1 t -45.16 -38.5 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.195 -0.941 . . . . 0.0 109.207 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.542 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 2.4 mt-10 -44.41 -75.28 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.409 ' O ' HG22 ' A' ' 19' ' ' VAL . 1.9 tp10 -53.46 -32.69 51.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.165 -0.959 . . . . 0.0 109.623 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.505 ' CB ' HD13 ' B' ' 49' ' ' LEU . . . -62.58 -85.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 110.578 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.94 -29.45 4.78 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.757 -1.215 . . . . 0.0 109.271 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 16.6 tptm -56.78 -77.95 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.31 0.576 . . . . 0.0 110.749 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 15' ' ' GLU . 1.5 t -69.3 -43.49 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.353 -0.842 . . . . 0.0 109.849 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.609 HG12 ' CE2' ' A' ' 5' ' ' TRP . 63.5 mt -48.13 -55.32 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.896 . . . . 0.0 110.003 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.464 ' C ' ' O ' ' A' ' 20' ' ' ILE . 1.2 tt -36.04 -35.84 0.08 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.584 -0.697 . . . . 0.0 110.794 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 20' ' ' ILE . 1.0 OUTLIER -141.91 56.87 1.49 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.02 -1.05 . . . . 0.0 109.718 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.483 ' OD1' ' HB1' ' A' ' 27' ' ' ALA . 26.6 p-10 -70.66 -31.46 68.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.923 . . . . 0.0 109.015 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.707 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -133.84 -97.85 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.702 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.707 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 36.2 Cg_endo -78.63 -68.72 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.716 0 N-CA-C 107.422 -1.799 . . . . 0.0 107.422 176.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.515 ' CG ' ' O ' ' A' ' 25' ' ' PRO . 25.8 mt-10 -163.84 72.26 0.26 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.529 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -88.36 114.73 25.27 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.068 -1.02 . . . . 0.0 108.875 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.509 ' CB ' ' O ' ' B' ' 45' ' ' ASP . 0.0 OUTLIER -89.06 171.99 9.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.253 -0.904 . . . . 0.0 109.197 -179.6 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.531 ' CD1' ' HB2' ' B' ' 49' ' ' LEU . 14.9 tt -149.31 146.58 17.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.823 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.544 HD11 ' N ' ' A' ' 30' ' ' ILE . 1.2 mp -89.04 155.78 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.549 ' CG1' HD11 ' B' ' 49' ' ' LEU . 2.0 t -127.91 116.24 42.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 118.555 -1.258 . . . . 0.0 110.956 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.631 ' CD1' ' CE1' ' B' ' 50' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.576 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 6.6 ptt-85 . . . . . 0 N--CA 1.494 1.739 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.459 ' O ' HG23 ' B' ' 63' ' ' VAL . 0.9 OUTLIER -48.05 136.05 4.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 120.622 -1.299 . . . . 0.0 108.132 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -90.13 38.65 0.94 Allowed 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.446 -0.901 . . . . 0.0 110.282 -178.445 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' ARG . . . . . 0.417 ' HG3' HD12 ' A' ' 30' ' ' ILE . 0.9 OUTLIER -141.11 146.98 37.79 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.634 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.584 ' CG2' ' CG2' ' B' ' 63' ' ' VAL . 63.5 t -151.59 169.26 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.102 -0.999 . . . . 0.0 109.365 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.419 ' N ' ' CG1' ' B' ' 47' ' ' VAL . 17.0 mmt-85 -99.5 95.52 7.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.718 -1.239 . . . . 0.0 109.57 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.56 ' C ' ' CD2' ' B' ' 49' ' ' LEU . 0.1 OUTLIER -90.67 82.54 5.77 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 118.954 -1.098 . . . . 0.0 109.293 179.465 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' PHE . . . . . 0.631 ' CE1' ' CD1' ' A' ' 32' ' ' LEU . 6.5 m-30 -74.46 145.46 43.6 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.501 ' HB ' ' HA ' ' B' ' 55' ' ' ASP . 14.1 m -127.02 176.54 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.573 -1.329 . . . . 0.0 110.742 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.481 ' OD2' ' HG2' ' B' ' 53' ' ' LYS . 0.0 OUTLIER -111.58 -171.76 1.9 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.481 ' HG2' ' OD2' ' B' ' 52' ' ' ASP . 1.8 ptmt -51.95 -53.41 41.66 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.965 -1.084 . . . . 0.0 110.781 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . 0.406 ' C ' ' CG ' ' B' ' 55' ' ' ASP . 0.2 OUTLIER -88.96 38.08 0.87 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.964 -1.085 . . . . 0.0 108.797 179.706 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.501 ' HA ' ' HB ' ' B' ' 51' ' ' VAL . 0.0 OUTLIER 51.35 51.42 16.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.688 -0.632 . . . . 0.0 109.458 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . 0.514 ' O ' ' N ' ' B' ' 58' ' ' ALA . 30.5 t30 -101.06 112.43 24.89 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.376 -0.827 . . . . 0.0 109.552 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.49 HD11 ' HB3' ' A' ' 11' ' ' LYS . 43.5 mt -51.9 91.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.581 -0.699 . . . . 0.0 109.276 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.12 -23.78 23.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.578 -0.701 . . . . 0.0 109.11 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.53 126.33 54.87 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.604 ' CG2' ' CG2' ' A' ' 9' ' ' VAL . 42.2 t -78.67 129.87 72.65 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 120.971 -1.081 . . . . 0.0 109.925 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.541 ' HB2' HG12 ' B' ' 47' ' ' VAL . 36.7 Cg_endo -83.69 159.94 14.3 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.671 2.247 . . . . 0.0 111.189 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' ARG . . . . . 0.552 ' NH1' ' HB ' ' B' ' 60' ' ' VAL . 0.1 OUTLIER -147.23 146.05 29.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.261 179.036 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.584 ' CG2' ' CG2' ' B' ' 47' ' ' VAL . 1.2 t . . . . . 0 N--CA 1.495 1.775 0 O-C-N 121.011 -1.056 . . . . 0.0 109.34 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.427 HG21 ' CD ' ' A' ' 24' ' ' LYS . 59.5 p . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.518 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 4.6 mt-10 -100.78 174.6 5.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.539 -0.725 . . . . 0.0 109.146 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.624 ' CE2' HG12 ' A' ' 20' ' ' ILE . 17.9 m-90 -145.61 46.75 0.59 Allowed Pre-proline 0 C--N 1.298 -1.644 0 O-C-N 121.592 -0.693 . . . . 0.0 109.334 178.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 30.5 Cg_endo -70.31 -27.7 23.51 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 N-CA-C 107.796 -1.655 . . . . 0.0 107.796 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.43 -19.34 62.99 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.531 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -87.33 -3.34 59.03 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.62 ' CG2' ' CG2' ' B' ' 60' ' ' VAL . 41.0 t -53.41 150.34 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 120.929 -1.107 . . . . 0.0 110.016 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.519 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 68.54 0.45 17.62 Favored Glycine 0 N--CA 1.48 1.598 0 C-N-CA 120.092 -1.051 . . . . 0.0 111.032 177.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -93.55 -154.78 0.42 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.625 -1.515 . . . . 0.0 109.321 179.732 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.4 ' O ' HD12 ' B' ' 57' ' ' ILE . 0.6 OUTLIER -134.98 177.88 7.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.113 -0.992 . . . . 0.0 110.197 -179.464 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.49 ' HA ' HD13 ' B' ' 49' ' ' LEU . 54.0 t -52.98 -43.03 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.526 -0.734 . . . . 0.0 110.199 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.533 ' O ' ' CG ' ' A' ' 18' ' ' LYS . 3.9 mt-10 -41.88 -71.07 0.09 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.387 -0.82 . . . . 0.0 109.41 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -56.62 -36.83 69.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.594 -0.691 . . . . 0.0 110.052 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.555 ' CA ' HD13 ' A' ' 20' ' ' ILE . . . -62.21 -81.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.192 -0.943 . . . . 0.0 110.032 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -46.22 -29.98 1.81 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.655 -1.278 . . . . 0.0 109.168 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 14' ' ' GLU . 4.4 mmtt -62.33 -84.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.628 0.728 . . . . 0.0 110.678 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.2 t -56.53 -46.4 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.526 -0.734 . . . . 0.0 109.766 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.624 HG12 ' CE2' ' A' ' 5' ' ' TRP . 87.7 mt -49.44 -58.27 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.238 -0.914 . . . . 0.0 109.386 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 28' ' ' GLN . 3.3 tt -35.66 -33.97 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.693 -0.629 . . . . 0.0 110.796 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.8 OUTLIER -150.48 50.25 0.88 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.993 -1.067 . . . . 0.0 110.509 -179.631 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -73.48 -52.81 12.33 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.985 -1.072 . . . . 0.0 108.73 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.822 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.7 OUTLIER -102.38 -92.38 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.366 0 CA-C-O 117.451 -1.261 . . . . 0.0 108.058 178.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.822 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 39.5 Cg_endo -87.05 -74.14 0.0 OUTLIER 'Trans proline' 0 C--O 1.213 -0.727 0 CA-C-N 121.765 1.666 . . . . 0.0 108.229 177.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.509 ' CG ' ' O ' ' A' ' 25' ' ' PRO . 21.2 mt-10 -162.47 56.94 0.22 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.601 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -87.93 117.91 27.12 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.192 -0.943 . . . . 0.0 108.845 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 3.4 tt0 -88.4 -176.87 5.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.324 -0.86 . . . . 0.0 109.786 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.505 ' HA ' HG22 ' B' ' 47' ' ' VAL . 11.6 tt -145.8 145.57 20.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.766 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.529 HG21 ' N ' ' A' ' 31' ' ' VAL . 7.8 mm -91.41 145.5 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.529 ' N ' HG21 ' A' ' 30' ' ' ILE . 8.0 p -99.05 125.53 52.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 120.814 -1.179 . . . . 0.0 109.775 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.686 ' CD1' ' CE1' ' B' ' 50' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.46 0 O-C-N 121.035 -1.04 . . . . 0.0 110.182 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.566 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 7.8 ptt-85 . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.516 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.4 OUTLIER -47.52 144.55 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.573 -1.329 . . . . 0.0 108.256 179.518 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.601 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -103.41 44.57 1.01 Allowed 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 119.053 -1.059 . . . . 0.0 109.419 -179.528 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' ARG . . . . . 0.478 ' HG2' HG12 ' A' ' 30' ' ' ILE . 7.6 mtt180 -150.32 153.11 35.53 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.538 ' CG2' HG22 ' B' ' 63' ' ' VAL . 0.0 OUTLIER -150.94 -176.97 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.72 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.421 ' HD3' ' HA ' ' B' ' 48' ' ' ARG . 25.7 mmt180 -111.89 79.8 1.25 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.793 -1.192 . . . . 0.0 110.026 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.535 HD13 ' CB ' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -62.18 94.74 0.06 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.226 -0.921 . . . . 0.0 109.172 179.456 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' PHE . . . . . 0.686 ' CE1' ' CD1' ' A' ' 32' ' ' LEU . 1.6 m-30 -80.22 130.47 35.24 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 32' ' ' LEU . 4.4 m -113.52 -176.46 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.593 -1.317 . . . . 0.0 110.741 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.498 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 1.4 p-10 -116.24 -151.07 0.47 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.463 -0.773 . . . . 0.0 109.93 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.498 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 0.9 OUTLIER -70.88 -51.06 28.64 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.407 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . 0.481 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 1.5 tp -100.07 44.6 1.01 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.469 -0.769 . . . . 0.0 109.186 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.424 ' CG ' ' C ' ' B' ' 54' ' ' LEU . 0.0 OUTLIER 44.39 67.35 0.7 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.302 -0.874 . . . . 0.0 110.029 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . 0.573 ' O ' ' N ' ' B' ' 58' ' ' ALA . 11.7 t30 -127.4 92.53 3.52 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.517 HD11 HG22 ' B' ' 57' ' ' ILE . 13.6 mt -30.06 86.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-O 121.54 0.686 . . . . 0.0 111.157 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.11 -27.38 21.96 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . 0.488 ' HB3' ' CB ' ' B' ' 50' ' ' PHE . 32.5 tp60 -113.83 130.76 56.43 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.62 ' CG2' ' CG2' ' A' ' 9' ' ' VAL . 91.2 t -87.29 134.46 36.38 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 120.979 -1.075 . . . . 0.0 110.859 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.472 ' O ' ' HD3' ' B' ' 62' ' ' ARG . 36.8 Cg_endo -79.76 169.45 18.15 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.558 2.172 . . . . 0.0 109.148 178.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' ARG . . . . . 0.523 ' O ' ' CG1' ' B' ' 47' ' ' VAL . 0.2 OUTLIER -150.18 135.05 17.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.976 -1.078 . . . . 0.0 110.06 -179.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.538 HG22 ' CG2' ' B' ' 47' ' ' VAL . 2.3 t . . . . . 0 N--CA 1.489 1.483 0 O-C-N 121.328 -0.858 . . . . 0.0 109.316 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.532 ' CA ' ' HD3' ' A' ' 24' ' ' LYS . 18.6 p . . . . . 0 N--CA 1.493 1.681 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.473 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 0.6 OUTLIER -110.32 169.6 8.63 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.277 -0.89 . . . . 0.0 108.824 179.244 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.621 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 15.1 m-90 -150.1 45.05 0.34 Allowed Pre-proline 0 C--N 1.294 -1.826 0 O-C-N 121.57 -0.706 . . . . 0.0 109.26 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 31.2 Cg_endo -69.12 -31.19 23.89 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 N-CA-C 108.232 -1.488 . . . . 0.0 108.232 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -69.66 -19.61 63.6 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 177.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.583 ' HB3' ' HB3' ' A' ' 5' ' ' TRP . 14.8 tp -84.29 -9.08 58.78 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.493 0.663 . . . . 0.0 109.247 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.454 HG22 HG22 ' B' ' 60' ' ' VAL . 10.4 t -55.69 152.39 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 119.086 -1.045 . . . . 0.0 108.873 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.432 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 66.87 4.16 25.67 Favored Glycine 0 N--CA 1.48 1.61 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.229 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.556 ' HB3' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -95.76 -143.5 0.27 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.875 -1.368 . . . . 0.0 109.276 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.493 ' CB ' ' OE2' ' A' ' 14' ' ' GLU . 2.2 m -145.02 168.12 21.03 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.068 -1.02 . . . . 0.0 110.192 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.496 ' CG2' HG13 ' B' ' 51' ' ' VAL . 48.5 t -51.3 -38.6 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.571 -0.706 . . . . 0.0 109.875 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.55 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -42.52 -75.75 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.153 -179.615 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.34 -33.34 65.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.34 -0.85 . . . . 0.0 109.682 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.581 ' CB ' ' CD2' ' B' ' 49' ' ' LEU . . . -62.18 -85.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.404 -0.81 . . . . 0.0 110.439 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.523 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -46.75 -31.89 3.27 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.044 -1.035 . . . . 0.0 108.827 -179.331 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.55 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 5.3 tttp -56.41 -83.35 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.425 0 CA-C-O 121.323 0.582 . . . . 0.0 110.549 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 20' ' ' ILE . 2.4 t -62.53 -48.68 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.507 -0.746 . . . . 0.0 109.842 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.581 HG12 ' CE2' ' A' ' 5' ' ' TRP . 88.9 mt -43.83 -45.17 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.23 -0.919 . . . . 0.0 109.538 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.461 HD22 ' HB2' ' A' ' 22' ' ' GLN . 0.9 OUTLIER -49.26 -44.59 43.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.252 -0.905 . . . . 0.0 111.239 -179.247 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.461 ' HB2' HD22 ' A' ' 21' ' ' LEU . 4.0 mt-30 -137.03 41.17 2.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.693 -1.254 . . . . 0.0 111.413 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.496 ' OD1' ' O ' ' A' ' 20' ' ' ILE . 1.3 p-10 -67.89 -49.46 61.88 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.722 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 1.0 OUTLIER -94.6 -116.05 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.476 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.314 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.722 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 37.2 Cg_endo -80.79 -66.47 0.02 OUTLIER 'Trans proline' 0 C--O 1.215 -0.664 0 CA-C-N 122.327 1.867 . . . . 0.0 108.035 178.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.487 ' CG ' ' O ' ' A' ' 25' ' ' PRO . 18.8 mt-10 -161.29 60.45 0.28 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -88.25 116.71 26.65 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.034 -1.041 . . . . 0.0 108.197 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.463 ' O ' ' HA ' ' B' ' 46' ' ' ARG . 3.7 tt0 -88.24 176.49 7.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.066 -1.021 . . . . 0.0 110.105 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.548 ' CD1' ' HB2' ' B' ' 49' ' ' LEU . 19.1 tt -143.66 149.79 17.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 O-C-N 121.183 -0.948 . . . . 0.0 110.67 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.51 HG21 ' N ' ' A' ' 31' ' ' VAL . 4.1 mm -97.66 146.44 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.51 ' N ' HG21 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -110.51 134.33 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.565 -1.334 . . . . 0.0 110.269 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.649 ' CD1' ' CE1' ' B' ' 50' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.756 -0.59 . . . . 0.0 109.509 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.56 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.8 0 CA-C-O 121.084 0.469 . . . . 0.0 110.99 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.529 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.3 OUTLIER -50.69 139.92 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 120.274 -1.517 . . . . 0.0 107.438 178.351 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.562 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 2.8 p30 -95.35 45.75 1.1 Allowed 'General case' 0 C--N 1.294 -1.848 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.281 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' ARG . . . . . 0.509 ' HG2' ' N ' ' B' ' 47' ' ' VAL . 6.0 ttt180 -149.26 156.39 42.05 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.484 -0.76 . . . . 0.0 109.175 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.522 HG21 ' CG2' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -151.75 -173.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.547 ' HD2' ' CD2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -112.15 69.05 0.68 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.868 -1.145 . . . . 0.0 111.212 -179.187 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.581 ' CD2' ' CB ' ' A' ' 16' ' ' ALA . 1.9 tm? -56.49 94.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.005 -1.059 . . . . 0.0 108.253 178.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' PHE . . . . . 0.649 ' CE1' ' CD1' ' A' ' 32' ' ' LEU . 8.2 m-30 -86.25 143.78 27.76 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.496 HG13 ' CG2' ' A' ' 13' ' ' VAL . 15.3 m -122.4 -175.28 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.844 -1.16 . . . . 0.0 109.578 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.499 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.4 OUTLIER -126.91 -154.76 0.65 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.408 -0.808 . . . . 0.0 109.868 -179.69 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.499 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 8.7 mttt -63.45 -54.79 31.06 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.457 0.646 . . . . 0.0 109.262 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . 0.462 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 2.9 mm? -98.48 44.07 1.04 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.534 -0.729 . . . . 0.0 109.806 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' B' ' 55' ' ' ASP . 0.0 OUTLIER 48.32 64.17 1.77 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.248 -0.908 . . . . 0.0 109.65 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . 0.536 ' O ' ' N ' ' B' ' 58' ' ' ALA . 0.0 OUTLIER -124.77 98.74 5.84 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.434 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.476 HD12 ' HB3' ' A' ' 16' ' ' ALA . 32.1 mt -44.27 91.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 121.491 0.663 . . . . 0.0 109.822 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.3 -20.33 25.56 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -128.23 104.17 7.59 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.491 HG12 ' HB2' ' A' ' 5' ' ' TRP . 5.0 t -73.69 134.93 78.39 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.226 -0.921 . . . . 0.0 110.397 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.494 ' HG3' HD12 ' A' ' 29' ' ' ILE . 37.7 Cg_endo -84.04 -175.55 2.27 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 122.735 2.29 . . . . 0.0 109.677 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' ARG . . . . . 0.406 ' O ' ' CG1' ' B' ' 47' ' ' VAL . 0.1 OUTLIER -151.09 144.48 24.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.053 -1.029 . . . . 0.0 110.045 179.599 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.522 ' CG2' HG21 ' B' ' 47' ' ' VAL . 1.6 t . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.56 ' CG2' ' HD2' ' A' ' 24' ' ' LYS . 21.0 p . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.594 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -90.31 -35.93 14.97 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.547 -0.721 . . . . 0.0 109.824 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.621 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.5 m-90 58.49 41.54 0.66 Allowed Pre-proline 0 C--N 1.296 -1.737 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.467 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 33.7 Cg_endo -72.94 -34.05 6.99 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 N-CA-C 107.119 -1.916 . . . . 0.0 107.119 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -69.44 -9.72 54.87 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.336 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.597 ' O ' ' CD2' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -80.16 -8.42 59.41 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 121.299 -0.875 . . . . 0.0 109.106 -179.47 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.595 ' CG2' ' CG2' ' B' ' 60' ' ' VAL . 35.4 t -48.66 149.84 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 120.882 -1.136 . . . . 0.0 110.437 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.453 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 67.98 2.31 23.57 Favored Glycine 0 N--CA 1.484 1.888 0 C-N-CA 120.142 -1.028 . . . . 0.0 111.138 177.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.501 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -93.41 -149.44 0.27 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.745 -1.444 . . . . 0.0 109.601 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.61 164.39 29.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.109 -0.994 . . . . 0.0 110.325 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.488 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 48.1 t -52.23 -34.93 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.461 -0.775 . . . . 0.0 109.062 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.542 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -44.36 -66.56 0.37 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.307 -0.871 . . . . 0.0 109.095 179.787 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.457 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -62.76 -34.04 76.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.093 -1.004 . . . . 0.0 109.303 179.297 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.532 ' HB2' ' CD2' ' B' ' 49' ' ' LEU . . . -62.11 -82.85 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.125 -0.985 . . . . 0.0 109.604 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.468 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -44.02 -42.07 5.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.951 -1.093 . . . . 0.0 108.905 179.813 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -47.48 -78.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.588 0.708 . . . . 0.0 110.339 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.458 ' O ' ' OD1' ' A' ' 23' ' ' ASP . 1.6 t -71.14 -55.27 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.7 -0.625 . . . . 0.0 110.116 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.577 HG12 ' CE2' ' A' ' 5' ' ' TRP . 95.3 mt -39.53 -34.82 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.524 -0.735 . . . . 0.0 109.872 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.1 tp -48.12 -52.22 21.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.367 -0.833 . . . . 0.0 110.759 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.578 ' O ' ' N ' ' A' ' 24' ' ' LYS . 0.8 OUTLIER -112.32 -66.88 1.04 Allowed 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.672 -1.211 . . . . 0.0 111.492 -178.373 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.517 ' O ' ' O ' ' A' ' 24' ' ' LYS . 0.4 OUTLIER 38.78 -92.81 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.41 -0.806 . . . . 0.0 108.875 -179.022 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.728 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 2.8 mtpm? -64.27 -131.72 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.422 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 177.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.728 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 32.5 Cg_endo -74.67 -64.41 0.03 OUTLIER 'Trans proline' 0 C--O 1.215 -0.662 0 CA-C-N 122.084 1.78 . . . . 0.0 108.825 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.49 ' CG ' ' C ' ' A' ' 25' ' ' PRO . 9.7 mt-10 -162.17 70.49 0.31 Allowed 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -88.85 117.47 27.87 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.522 ' CB ' ' O ' ' B' ' 45' ' ' ASP . 1.1 tt0 -87.2 173.55 9.15 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.951 -1.093 . . . . 0.0 109.249 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.555 HD12 ' CB ' ' B' ' 61' ' ' PRO . 5.4 tt -150.06 128.58 2.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 C-N-CA 118.999 -1.08 . . . . 0.0 110.741 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.435 HG23 ' CD2' ' A' ' 32' ' ' LEU . 2.9 mm -88.74 141.67 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.469 HG22 ' CG2' ' A' ' 13' ' ' VAL . 11.8 p -113.94 131.29 66.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 120.84 -1.163 . . . . 0.0 110.217 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.652 ' CD1' ' CE1' ' B' ' 50' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.431 0 O-C-N 121.489 -0.757 . . . . 0.0 109.381 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.542 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 2.5 ptt180 . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.523 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.4 OUTLIER -43.03 141.93 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 119.148 -1.021 . . . . 0.0 108.567 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.554 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.6 p-10 -102.51 47.01 0.9 Allowed 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 119.188 -1.005 . . . . 0.0 109.819 -178.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' ARG . . . . . 0.432 ' O ' HG21 ' B' ' 47' ' ' VAL . 3.9 ttm180 -151.9 148.13 27.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.383 -0.823 . . . . 0.0 110.119 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.567 ' CG2' ' CG2' ' B' ' 63' ' ' VAL . 53.7 t -151.41 154.83 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.494 ' HB3' ' CE1' ' B' ' 50' ' ' PHE . 10.5 mmt180 -88.06 66.7 8.68 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.601 -1.312 . . . . 0.0 110.372 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.546 HD12 ' CD1' ' B' ' 57' ' ' ILE . 2.5 tp -60.79 90.11 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.089 -1.007 . . . . 0.0 109.383 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' PHE . . . . . 0.652 ' CE1' ' CD1' ' A' ' 32' ' ' LEU . 3.8 m-30 -76.26 156.06 33.83 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 32' ' ' LEU . 1.8 m -121.31 176.73 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.73 -1.232 . . . . 0.0 109.68 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.492 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.4 OUTLIER -109.22 -154.95 0.55 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.252 -0.905 . . . . 0.0 109.774 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.492 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 2.7 mtpt -67.8 -53.97 22.86 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.536 -0.728 . . . . 0.0 109.465 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' B' ' 54' ' ' LEU . 3.2 mm? -95.88 42.9 1.09 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 109.567 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' B' ' 55' ' ' ASP . 0.0 OUTLIER 48.14 65.01 1.43 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.156 -0.965 . . . . 0.0 109.28 -179.727 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' B' ' 58' ' ' ALA . 8.9 t30 -130.01 106.68 8.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.385 -0.822 . . . . 0.0 108.846 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.546 ' CD1' HD12 ' B' ' 49' ' ' LEU . 15.6 mm -39.61 90.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-O 121.646 0.736 . . . . 0.0 110.68 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.09 -27.12 22.15 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -111.79 136.15 51.45 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.595 ' CG2' ' CG2' ' A' ' 9' ' ' VAL . 43.1 t -90.01 127.93 51.81 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.837 -1.165 . . . . 0.0 110.609 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.555 ' CB ' HD12 ' A' ' 29' ' ' ILE . 36.5 Cg_endo -79.72 157.04 24.55 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.378 2.052 . . . . 0.0 109.215 177.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' ARG . . . . . 0.547 ' HD2' ' CA ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -146.12 142.98 29.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.838 -1.164 . . . . 0.0 110.588 -179.396 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.567 ' CG2' ' CG2' ' B' ' 47' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.787 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.521 ' CG2' ' HE3' ' A' ' 24' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.41 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.542 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 2.6 mp0 -89.78 167.43 12.87 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.349 -0.844 . . . . 0.0 109.361 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.62 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 20.9 m-90 -141.09 46.0 0.82 Allowed Pre-proline 0 C--N 1.294 -1.836 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 31.2 Cg_endo -69.6 -27.32 27.36 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 N-CA-C 108.21 -1.496 . . . . 0.0 108.21 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -69.66 -20.03 63.59 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.54 ' CD1' HD11 ' B' ' 57' ' ' ILE . 0.0 OUTLIER -82.27 -8.66 59.64 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.63 ' CG2' ' CG2' ' B' ' 60' ' ' VAL . 20.6 t -48.81 154.14 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.095 -1.003 . . . . 0.0 110.004 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.504 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 65.71 2.43 11.59 Favored Glycine 0 N--CA 1.482 1.717 0 C-N-CA 120.252 -0.975 . . . . 0.0 110.883 178.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -93.69 -143.7 0.23 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.709 -1.465 . . . . 0.0 109.393 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.438 ' HB3' ' CD ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -144.46 167.52 22.29 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.964 -1.085 . . . . 0.0 110.121 -179.701 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.545 ' CG2' HG12 ' A' ' 31' ' ' VAL . 71.6 t -50.82 -40.96 20.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.531 -0.731 . . . . 0.0 109.796 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.544 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -44.68 -69.02 0.15 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.502 -0.749 . . . . 0.0 109.352 -179.763 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.454 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -58.07 -31.13 66.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.176 -0.952 . . . . 0.0 109.415 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.557 ' CB ' HD12 ' B' ' 57' ' ' ILE . . . -64.9 -84.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.045 -1.034 . . . . 0.0 109.954 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.48 ' HG2' HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -45.2 -34.89 2.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.986 -1.071 . . . . 0.0 109.086 -179.556 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.544 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 20.5 tttp -55.02 -75.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.508 0.671 . . . . 0.0 111.334 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' A' ' 23' ' ' ASP . 1.5 t -70.28 -46.1 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.486 -0.759 . . . . 0.0 110.968 -177.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.589 HG12 ' CE2' ' A' ' 5' ' ' TRP . 2.6 mt -53.28 -50.55 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.02 -1.05 . . . . 0.0 109.871 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 20' ' ' ILE . 2.3 tt -39.4 -28.08 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.265 -0.897 . . . . 0.0 110.642 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.475 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -149.9 26.82 0.8 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.875 -1.14 . . . . 0.0 110.675 -179.714 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -54.49 -64.15 0.92 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.731 -1.23 . . . . 0.0 108.194 179.182 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.748 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 3.5 mtpm? -80.47 -117.58 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 106.841 -1.541 . . . . 0.0 106.841 178.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.748 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 36.7 Cg_endo -79.92 -64.2 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.69 0 CA-C-N 122.103 1.787 . . . . 0.0 108.612 178.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.473 ' CG ' ' O ' ' A' ' 25' ' ' PRO . 27.2 mt-10 -159.97 60.97 0.36 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.567 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -88.53 117.31 27.39 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.185 -1.006 . . . . 0.0 108.61 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.45 ' CB ' ' O ' ' B' ' 45' ' ' ASP . 1.7 tt0 -88.6 169.78 11.41 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.199 -0.938 . . . . 0.0 109.965 -178.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.525 ' CD1' ' HB2' ' B' ' 49' ' ' LEU . 19.8 tt -140.6 135.14 34.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.51 -0.743 . . . . 0.0 109.52 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.455 HD11 ' N ' ' A' ' 30' ' ' ILE . 1.2 mp -88.76 128.57 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.545 HG12 ' CG2' ' A' ' 13' ' ' VAL . 25.3 t -94.72 136.3 26.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 118.518 -1.273 . . . . 0.0 110.487 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.633 ' CD1' ' CE1' ' B' ' 50' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 O-C-N 121.689 -0.632 . . . . 0.0 109.347 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.512 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 5.6 ptt180 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.126 0.488 . . . . 0.0 109.907 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.551 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.5 OUTLIER -45.82 146.22 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.946 -1.096 . . . . 0.0 108.73 179.585 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.567 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -110.86 40.91 1.91 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.391 -0.924 . . . . 0.0 109.953 -179.74 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' ARG . . . . . 0.429 ' NH1' HG12 ' A' ' 30' ' ' ILE . 0.2 OUTLIER -150.23 144.56 25.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.42 -0.8 . . . . 0.0 108.994 179.192 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.534 ' CG1' ' O ' ' B' ' 62' ' ' ARG . 0.0 OUTLIER -151.16 164.77 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.087 -1.008 . . . . 0.0 108.857 -179.747 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.447 ' HG3' ' CD2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -91.9 89.42 7.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.745 -1.222 . . . . 0.0 110.46 -179.241 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.525 ' HB2' ' CD1' ' A' ' 29' ' ' ILE . 4.0 tp -78.87 91.32 4.76 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' PHE . . . . . 0.633 ' CE1' ' CD1' ' A' ' 32' ' ' LEU . 4.1 m-30 -77.54 179.74 6.34 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.536 ' CG1' ' HA ' ' B' ' 55' ' ' ASP . 0.0 OUTLIER -148.01 -173.58 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.865 -1.147 . . . . 0.0 109.515 179.514 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.54 ' OD2' ' CB ' ' B' ' 56' ' ' ASN . 5.5 p-10 -116.7 -146.43 0.4 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.316 -0.865 . . . . 0.0 109.253 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.531 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 8.7 mmtp -62.28 -55.62 26.54 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.241 -0.912 . . . . 0.0 110.131 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . 0.551 ' O ' ' CB ' ' B' ' 55' ' ' ASP . 2.4 mp -103.28 17.02 25.04 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.997 -1.065 . . . . 0.0 111.687 -178.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' B' ' 54' ' ' LEU . 0.2 OUTLIER 91.43 47.87 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.459 0 CA-C-O 122.583 1.182 . . . . 0.0 110.623 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' B' ' 58' ' ' ALA . 1.9 t-20 -106.56 97.36 7.16 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.97 -1.081 . . . . 0.0 108.3 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.557 HD12 ' CB ' ' A' ' 16' ' ' ALA . 43.8 mt -37.28 88.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 121.549 0.69 . . . . 0.0 110.914 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.95 -31.26 18.25 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -99.69 134.94 41.85 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.63 ' CG2' ' CG2' ' A' ' 9' ' ' VAL . 65.1 t -90.12 129.44 45.85 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.092 -1.005 . . . . 0.0 111.21 -178.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.49 ' CB ' HD13 ' A' ' 29' ' ' ILE . 36.3 Cg_endo -81.84 162.53 18.56 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.308 2.005 . . . . 0.0 108.928 177.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' ARG . . . . . 0.534 ' O ' ' CG1' ' B' ' 47' ' ' VAL . 0.0 OUTLIER -150.91 132.62 14.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.659 -1.275 . . . . 0.0 110.711 -179.69 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.483 HG21 ' CG2' ' B' ' 47' ' ' VAL . 2.2 t . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.468 -0.77 . . . . 0.0 109.044 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.507 HG23 ' NZ ' ' A' ' 24' ' ' LYS . 16.1 p . . . . . 0 N--CA 1.494 1.742 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.573 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 9.8 mp0 -104.15 -28.98 11.14 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.547 0.689 . . . . 0.0 109.151 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.625 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 8.7 m-90 53.12 42.22 1.15 Allowed Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 119.507 -0.877 . . . . 0.0 108.946 -177.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.625 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 35.1 Cg_endo -73.0 -34.83 5.96 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 N-CA-C 107.447 -1.79 . . . . 0.0 107.447 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.73 -12.0 61.29 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 32.1 tp -81.21 -6.0 58.37 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 121.49 -0.756 . . . . 0.0 109.31 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.49 HG11 ' N ' ' A' ' 10' ' ' GLY . 21.0 t -54.37 152.48 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 120.942 -1.099 . . . . 0.0 109.034 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.49 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 64.11 7.14 22.78 Favored Glycine 0 N--CA 1.48 1.601 0 C-N-CA 119.94 -1.124 . . . . 0.0 110.44 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 5.2 tptt -93.92 -141.26 0.23 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.825 -1.397 . . . . 0.0 109.441 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.532 ' CA ' HG13 ' B' ' 57' ' ' ILE . 48.4 m -149.89 167.17 27.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.939 -1.101 . . . . 0.0 110.454 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.462 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 97.1 t -50.35 -34.05 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.49 -0.756 . . . . 0.0 109.814 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 27.1 mt-10 -45.87 -77.94 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.384 -0.822 . . . . 0.0 109.065 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.69 -31.28 62.3 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.333 -0.854 . . . . 0.0 109.388 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.539 ' HB2' ' CD1' ' B' ' 49' ' ' LEU . . . -62.02 -85.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.44 -0.788 . . . . 0.0 110.616 -179.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.46 ' HG2' HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -48.26 -29.81 4.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.634 -1.291 . . . . 0.0 108.994 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -57.6 -82.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.413 0.625 . . . . 0.0 111.116 -179.445 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -64.8 -40.21 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.369 -0.832 . . . . 0.0 110.315 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.569 HG12 ' CE2' ' A' ' 5' ' ' TRP . 98.5 mt -51.8 -56.17 6.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.336 -0.852 . . . . 0.0 109.82 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.46 ' C ' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -36.88 -29.76 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.51 -0.743 . . . . 0.0 110.593 -179.521 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 20' ' ' ILE . 2.2 mt-30 -148.74 52.53 0.99 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.023 -1.048 . . . . 0.0 109.855 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.499 ' OD2' ' HA ' ' A' ' 3' ' ' THR . 3.8 t0 -53.32 -62.81 1.41 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.985 -1.072 . . . . 0.0 108.409 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.798 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -115.98 -66.8 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 120.748 -1.22 . . . . 0.0 109.201 178.537 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.798 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 42.2 Cg_endo -91.25 -82.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.324 -0.748 0 N-CA-C 108.135 -1.525 . . . . 0.0 108.135 178.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.486 ' CG ' ' C ' ' A' ' 25' ' ' PRO . 16.9 mt-10 -161.45 65.46 0.27 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -87.7 115.32 25.06 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.246 -0.982 . . . . 0.0 108.843 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.453 ' CB ' ' O ' ' B' ' 45' ' ' ASP . 1.8 tt0 -87.92 170.27 11.3 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.233 -0.917 . . . . 0.0 108.774 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.535 ' CD1' ' HB2' ' B' ' 49' ' ' LEU . 12.9 tt -142.3 133.17 24.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 118.719 -1.192 . . . . 0.0 110.576 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.1 mm -87.68 107.09 16.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.518 ' HA ' ' HB3' ' B' ' 49' ' ' LEU . 19.5 t -89.0 146.88 5.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.108 -0.995 . . . . 0.0 110.88 -178.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.652 ' CD1' ' CE1' ' B' ' 50' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--N 1.302 -1.457 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.527 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 120.745 0.307 . . . . 0.0 110.363 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.518 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.3 OUTLIER -46.06 139.56 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.648 -1.283 . . . . 0.0 108.356 179.504 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.525 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -99.4 44.86 1.01 Allowed 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.202 -0.936 . . . . 0.0 109.8 -178.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -149.65 145.59 26.82 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.596 ' CG2' ' CG2' ' B' ' 63' ' ' VAL . 60.9 t -151.8 169.35 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 109.779 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.422 ' HG3' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -99.12 95.26 6.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.726 -1.234 . . . . 0.0 109.849 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.539 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -88.21 84.0 6.92 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.015 -1.053 . . . . 0.0 109.277 179.265 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' PHE . . . . . 0.652 ' CE1' ' CD1' ' A' ' 32' ' ' LEU . 4.4 m-30 -72.43 138.09 46.89 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.499 ' CG2' ' O ' ' A' ' 32' ' ' LEU . 2.6 m -123.6 -171.18 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.676 -1.265 . . . . 0.0 110.231 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.569 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.0 OUTLIER -129.72 -168.13 1.91 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.893 0.854 . . . . 0.0 110.006 -179.221 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.569 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 13.8 mttm -43.6 -68.95 0.15 Allowed 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.331 0.586 . . . . 0.0 110.071 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . 0.404 ' CG ' ' O ' ' B' ' 54' ' ' LEU . 0.6 OUTLIER -89.96 47.2 1.43 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 0.0 109.742 -179.59 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 47.62 57.39 5.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.294 -0.879 . . . . 0.0 109.828 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . 0.549 ' O ' ' N ' ' B' ' 58' ' ' ALA . 7.0 t30 -106.42 96.42 6.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.139 -0.976 . . . . 0.0 109.055 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.532 HG13 ' CA ' ' A' ' 12' ' ' SER . 12.2 mt -42.79 91.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 121.5 0.667 . . . . 0.0 109.681 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -87.77 -17.43 31.64 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -129.23 96.9 4.43 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.479 HG22 ' CG2' ' A' ' 9' ' ' VAL . 1.6 t -56.54 137.02 77.0 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.32 -0.862 . . . . 0.0 109.952 -178.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.555 ' HB2' ' CG1' ' B' ' 47' ' ' VAL . 36.2 Cg_endo -80.93 160.15 21.09 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.846 2.364 . . . . 0.0 110.22 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' ARG . . . . . 0.534 ' HD2' ' CB ' ' A' ' 4' ' ' GLU . 0.8 OUTLIER -141.96 134.44 28.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.137 -0.977 . . . . 0.0 109.622 179.798 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.596 ' CG2' ' CG2' ' B' ' 47' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.209 -0.932 . . . . 0.0 108.996 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.531 ' CG2' ' HE2' ' A' ' 24' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.598 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 13.7 mt-10 -100.09 -43.14 6.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.323 -0.861 . . . . 0.0 110.289 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.645 ' CE2' HG12 ' A' ' 20' ' ' ILE . 6.7 m-90 61.21 42.47 0.56 Allowed Pre-proline 0 C--N 1.296 -1.717 0 C-N-CA 119.441 -0.904 . . . . 0.0 109.488 -178.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 32.7 Cg_endo -72.45 -34.07 7.98 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 N-CA-C 106.925 -1.99 . . . . 0.0 106.925 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -69.34 -12.76 61.93 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.521 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 21.9 tp -76.62 -6.4 51.87 Favored 'General case' 0 C--N 1.31 -1.138 0 O-C-N 121.506 -0.746 . . . . 0.0 109.462 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.589 ' CG2' ' CG2' ' B' ' 60' ' ' VAL . 18.3 t -59.7 149.34 6.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 120.81 -1.181 . . . . 0.0 108.482 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.442 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 63.42 7.2 18.37 Favored Glycine 0 C--N 1.296 -1.642 0 C-N-CA 119.578 -1.296 . . . . 0.0 110.379 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -99.63 -154.71 0.48 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.818 -1.401 . . . . 0.0 108.869 179.558 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -135.48 160.93 36.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.689 -1.257 . . . . 0.0 110.888 -179.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.502 HG23 ' CG2' ' A' ' 31' ' ' VAL . 28.1 t -52.89 -33.08 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.585 -0.697 . . . . 0.0 109.219 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.549 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 52.7 mm-40 -46.28 -67.69 0.26 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.154 -0.966 . . . . 0.0 108.556 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.466 ' O ' HG22 ' A' ' 19' ' ' VAL . 2.5 tp10 -61.62 -30.89 70.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.4 -0.813 . . . . 0.0 109.501 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.532 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -67.54 -82.18 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.177 -0.952 . . . . 0.0 109.751 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -44.36 -40.39 5.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.672 -1.267 . . . . 0.0 108.972 179.64 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.549 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 20.8 tttm -49.92 -72.1 0.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.611 -0.681 . . . . 0.0 110.368 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.516 ' O ' ' N ' ' A' ' 23' ' ' ASP . 2.8 t -72.24 -57.62 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.523 -0.736 . . . . 0.0 109.972 -179.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.645 HG12 ' CE2' ' A' ' 5' ' ' TRP . 5.9 mt -35.93 -53.86 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.588 -0.695 . . . . 0.0 110.211 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 2.3 tt -37.56 -52.87 1.2 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.615 -0.678 . . . . 0.0 110.003 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -128.56 32.58 4.8 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 109.968 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' VAL . 17.4 p-10 -50.67 -48.88 58.28 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.019 -1.05 . . . . 0.0 108.28 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.708 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 10.4 mtpp -107.24 -106.62 0.0 OUTLIER Pre-proline 0 CA--C 1.561 1.374 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.708 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 37.0 Cg_endo -79.98 -67.74 0.02 OUTLIER 'Trans proline' 0 C--O 1.215 -0.657 0 CA-C-N 121.93 1.725 . . . . 0.0 108.631 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.528 ' CG ' ' O ' ' A' ' 25' ' ' PRO . 27.1 mt-10 -162.02 64.09 0.24 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.577 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -88.86 116.64 27.28 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.022 -1.049 . . . . 0.0 108.916 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' B' ' 45' ' ' ASP . 0.1 OUTLIER -88.86 165.65 14.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.899 -1.126 . . . . 0.0 109.166 -179.54 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.582 ' HB ' ' CG2' ' A' ' 20' ' ' ILE . 3.3 tt -139.84 131.99 34.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.158 -0.963 . . . . 0.0 110.276 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.5 mm -88.59 117.95 33.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.502 ' CG2' HG23 ' A' ' 13' ' ' VAL . 2.5 p -95.93 136.56 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.149 -0.969 . . . . 0.0 109.675 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.68 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 O-C-N 121.237 -0.915 . . . . 0.0 109.562 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.547 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.057 0.456 . . . . 0.0 110.688 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.568 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.6 OUTLIER -49.22 145.55 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 120.574 -1.329 . . . . 0.0 108.208 178.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.577 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.3 p-10 -108.46 32.76 4.59 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.07 -1.019 . . . . 0.0 109.888 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' ARG . . . . . 0.501 ' O ' HG21 ' B' ' 47' ' ' VAL . 0.1 OUTLIER -150.57 143.63 24.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.436 -0.79 . . . . 0.0 109.007 179.349 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.536 ' HB ' ' CD1' ' A' ' 29' ' ' ILE . 1.8 t -149.44 166.43 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -0.908 . . . . 0.0 109.608 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.515 ' HG3' ' CE2' ' B' ' 50' ' ' PHE . 0.0 OUTLIER -95.5 75.56 3.3 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.742 -1.224 . . . . 0.0 110.21 -179.611 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.552 ' HB2' ' CD1' ' A' ' 29' ' ' ILE . 4.3 tp -76.72 92.97 3.59 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 118.818 -1.153 . . . . 0.0 108.282 178.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' PHE . . . . . 0.636 ' CZ ' ' CD1' ' A' ' 32' ' ' LEU . 17.8 m-85 -81.52 -177.02 6.34 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.455 HG11 ' O ' ' B' ' 50' ' ' PHE . 6.1 m -144.28 -175.64 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.648 -1.283 . . . . 0.0 110.5 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.533 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.4 OUTLIER -120.0 -154.8 0.59 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.481 -0.762 . . . . 0.0 109.813 -179.616 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.533 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 11.4 mtpt -63.94 -56.78 12.72 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.565 -0.709 . . . . 0.0 109.332 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . 0.523 ' CD2' ' O ' ' B' ' 54' ' ' LEU . 2.6 tt -97.12 41.87 1.1 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.395 -0.816 . . . . 0.0 109.461 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.405 ' CG ' ' C ' ' B' ' 54' ' ' LEU . 0.0 OUTLIER 49.65 65.06 1.52 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.206 -0.934 . . . . 0.0 109.181 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . 0.553 ' O ' ' N ' ' B' ' 58' ' ' ALA . 17.4 t-20 -123.94 96.44 4.95 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.38 -0.825 . . . . 0.0 108.996 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.53 ' CD1' ' HB1' ' A' ' 16' ' ' ALA . 4.2 mt -37.45 89.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-O 121.576 0.703 . . . . 0.0 110.88 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.23 -21.56 24.45 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.67 133.79 53.67 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.589 ' CG2' ' CG2' ' A' ' 9' ' ' VAL . 99.4 t -90.09 128.11 50.94 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 120.999 -1.063 . . . . 0.0 110.59 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.465 ' O ' ' HD3' ' B' ' 62' ' ' ARG . 37.2 Cg_endo -83.63 165.29 14.01 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.396 2.064 . . . . 0.0 109.43 178.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' ARG . . . . . 0.519 ' HG3' ' HA ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -148.86 141.15 24.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.168 -0.958 . . . . 0.0 109.749 179.559 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.479 HG21 HG21 ' B' ' 47' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.731 0 O-C-N 121.261 -0.899 . . . . 0.0 109.084 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.493 HG23 ' CE ' ' A' ' 24' ' ' LYS . 70.7 p . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.585 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 81.2 mt-10 -93.53 -35.46 12.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.336 -0.852 . . . . 0.0 109.958 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.625 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 6.5 m-90 58.34 40.79 0.58 Allowed Pre-proline 0 C--N 1.293 -1.879 0 O-C-N 120.836 -1.165 . . . . 0.0 109.863 -178.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.625 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 34.2 Cg_endo -73.32 -34.92 5.46 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 N-CA-C 107.08 -1.931 . . . . 0.0 107.08 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.9 -11.72 61.08 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 177.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.489 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 30.5 tp -79.1 -7.91 58.54 Favored 'General case' 0 C--N 1.309 -1.172 0 O-C-N 121.402 -0.811 . . . . 0.0 109.216 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.546 HG21 ' CG2' ' B' ' 60' ' ' VAL . 19.4 t -54.34 154.22 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 118.994 -1.082 . . . . 0.0 109.151 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.491 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 70.37 -0.43 25.29 Favored Glycine 0 C--N 1.297 -1.623 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.629 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -96.16 -151.76 0.36 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.665 -1.491 . . . . 0.0 109.584 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.507 ' CB ' ' OE2' ' A' ' 14' ' ' GLU . 1.2 m -139.53 172.8 12.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.138 -0.976 . . . . 0.0 110.535 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.465 HG23 HG22 ' A' ' 31' ' ' VAL . 99.2 t -54.72 -37.95 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.586 -0.696 . . . . 0.0 109.916 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 0.7 OUTLIER -44.05 -74.76 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -0.904 . . . . 0.0 108.855 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.26 -38.23 65.58 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.394 -0.816 . . . . 0.0 109.835 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.538 ' CA ' HD13 ' A' ' 20' ' ' ILE . . . -59.02 -83.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.237 -0.915 . . . . 0.0 110.308 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.561 ' HA ' ' CG2' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -46.62 -28.06 1.34 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.586 -1.321 . . . . 0.0 109.617 -179.596 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 10.2 mttt -63.35 -83.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.487 -0.758 . . . . 0.0 110.746 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' A' ' 23' ' ' ASP . 2.1 t -57.61 -42.34 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.6 -0.688 . . . . 0.0 109.472 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.576 HG12 ' CE2' ' A' ' 5' ' ' TRP . 69.0 mt -50.64 -53.75 11.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.293 -0.879 . . . . 0.0 108.919 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.514 ' CD1' ' OE1' ' A' ' 28' ' ' GLN . 9.1 tt -34.98 -36.45 0.05 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.788 -0.57 . . . . 0.0 110.642 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 20' ' ' ILE . 3.3 mt-30 -147.36 41.4 1.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.113 -0.992 . . . . 0.0 110.241 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.52 ' OD1' ' HG2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -57.86 -44.85 86.86 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.969 -1.082 . . . . 0.0 108.441 179.598 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.782 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -120.71 -88.49 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.241 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.782 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 38.8 Cg_endo -84.07 -81.47 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.655 0 N-CA-C 108.214 -1.494 . . . . 0.0 108.214 177.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.466 ' CG ' ' C ' ' A' ' 25' ' ' PRO . 13.9 mt-10 -158.79 57.83 0.43 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -87.67 117.03 26.21 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.178 -0.951 . . . . 0.0 109.303 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.514 ' OE1' ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -88.58 -175.15 4.84 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.129 -0.982 . . . . 0.0 109.549 -179.358 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.561 ' CG2' ' HA ' ' A' ' 17' ' ' LYS . 14.6 tt -147.62 140.59 19.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.452 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.522 HG21 ' N ' ' A' ' 31' ' ' VAL . 2.7 mm -87.51 146.55 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.522 ' N ' HG21 ' A' ' 30' ' ' ILE . 8.7 p -102.37 133.53 45.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 119.071 -1.051 . . . . 0.0 109.734 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.682 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.401 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.564 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.118 0.485 . . . . 0.0 109.78 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.494 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.3 OUTLIER -48.16 139.37 2.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 120.646 -1.284 . . . . 0.0 108.189 179.334 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.548 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -97.12 45.64 1.04 Allowed 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.331 -179.281 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' ARG . . . . . 0.493 ' O ' HG21 ' B' ' 47' ' ' VAL . 12.1 ttp180 -150.93 143.28 24.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.403 -0.811 . . . . 0.0 109.133 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.57 ' CG2' ' CG2' ' B' ' 63' ' ' VAL . 53.5 t -151.0 146.38 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.209 -0.932 . . . . 0.0 110.092 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.459 ' HB3' HD13 ' A' ' 32' ' ' LEU . 7.0 mmt180 -71.81 98.24 1.94 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.625 -1.297 . . . . 0.0 110.443 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.48 ' HB2' HG12 ' A' ' 29' ' ' ILE . 2.6 tp -84.79 88.37 7.38 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.131 -0.981 . . . . 0.0 108.842 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' PHE . . . . . 0.597 ' CE1' HD11 ' A' ' 32' ' ' LEU . 1.8 m-85 -70.13 178.66 2.68 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.417 ' HB ' ' HA ' ' B' ' 55' ' ' ASP . 6.3 m -139.82 -174.71 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.043 -1.035 . . . . 0.0 109.276 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.529 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.1 OUTLIER -135.94 -158.71 0.89 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.147 -0.97 . . . . 0.0 110.115 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.529 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 26.9 mtpt -43.66 -69.81 0.12 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.67 -0.644 . . . . 0.0 110.407 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . 0.422 ' C ' ' CG ' ' B' ' 55' ' ' ASP . 0.4 OUTLIER -97.23 52.81 1.15 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.274 -0.891 . . . . 0.0 110.106 -179.138 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.422 ' CG ' ' C ' ' B' ' 54' ' ' LEU . 0.0 OUTLIER 47.38 58.1 5.22 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.251 -0.906 . . . . 0.0 109.183 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . 0.565 ' O ' ' N ' ' B' ' 58' ' ' ALA . 36.5 t-20 -121.52 113.74 20.25 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.519 HD12 ' CB ' ' A' ' 16' ' ' ALA . 26.4 mt -35.51 88.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-O 121.518 0.675 . . . . 0.0 110.966 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -89.17 -20.92 23.63 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -109.99 137.99 46.99 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.558 ' CG1' ' O ' ' A' ' 4' ' ' GLU . 71.3 t -90.33 129.46 45.31 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.092 -1.005 . . . . 0.0 111.022 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.53 ' CB ' ' CG1' ' B' ' 47' ' ' VAL . 37.4 Cg_endo -83.46 164.18 14.57 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 122.617 2.212 . . . . 0.0 108.587 178.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -138.97 -43.98 0.47 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.255 -1.528 . . . . 0.0 110.809 -179.65 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.57 ' CG2' ' CG2' ' B' ' 47' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.293 -1.874 0 O-C-N 121.218 -0.926 . . . . 0.0 109.662 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.538 ' CG2' ' HE3' ' A' ' 24' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.562 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 3.9 mt-10 -92.69 -47.22 7.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.387 -0.821 . . . . 0.0 110.336 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.619 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 10.9 m-90 62.29 45.15 0.72 Allowed Pre-proline 0 C--N 1.297 -1.703 0 C-N-CA 119.611 -0.836 . . . . 0.0 108.935 -177.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 33.0 Cg_endo -71.68 -30.85 14.08 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 N-CA-C 107.169 -1.897 . . . . 0.0 107.169 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.29 -15.28 62.87 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.482 HD23 ' HA ' ' A' ' 16' ' ' ALA . 13.4 tp -80.48 -5.81 57.2 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.657 -0.652 . . . . 0.0 109.325 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.527 ' CG2' HG22 ' B' ' 60' ' ' VAL . 36.9 t -51.68 152.22 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.089 -1.007 . . . . 0.0 109.528 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.502 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 47.42 21.14 1.15 Allowed Glycine 0 N--CA 1.483 1.77 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.516 178.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -96.51 -141.81 0.28 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.862 -1.375 . . . . 0.0 109.143 179.631 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.432 ' N ' HG12 ' B' ' 57' ' ' ILE . 0.6 OUTLIER -146.41 159.42 43.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.911 -1.118 . . . . 0.0 110.008 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.485 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 29.8 t -48.15 -36.76 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.409 -0.807 . . . . 0.0 109.649 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.533 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 2.7 mt-10 -45.46 -75.41 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.408 -0.807 . . . . 0.0 109.193 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.88 -32.84 54.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.235 -0.915 . . . . 0.0 109.113 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.485 ' HB1' ' HA ' ' A' ' 13' ' ' VAL . . . -64.88 -88.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.404 -0.81 . . . . 0.0 110.309 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.511 ' HA ' ' CG2' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -43.06 -29.02 0.32 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.823 -1.173 . . . . 0.0 109.255 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 3.5 tttt -61.81 -82.89 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.735 -0.603 . . . . 0.0 110.182 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' A' ' 23' ' ' ASP . 3.2 t -59.98 -48.36 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.42 -0.8 . . . . 0.0 109.427 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.616 HG12 ' CE2' ' A' ' 5' ' ' TRP . 80.0 mt -48.17 -59.87 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.407 -0.808 . . . . 0.0 110.045 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.469 ' CB ' ' O ' ' A' ' 17' ' ' LYS . 1.0 OUTLIER -37.74 -33.24 0.07 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.502 -0.749 . . . . 0.0 110.531 -179.327 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -149.51 50.47 0.94 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.137 -0.977 . . . . 0.0 109.623 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -66.65 -40.88 88.87 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.176 -0.952 . . . . 0.0 108.639 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.691 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -124.01 -88.53 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.441 0 CA-C-O 117.962 -1.018 . . . . 0.0 108.271 178.078 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.691 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 37.8 Cg_endo -81.34 -79.66 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.659 0 N-CA-C 108.522 -1.376 . . . . 0.0 108.522 177.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.463 ' CG ' ' C ' ' A' ' 25' ' ' PRO . 14.5 mt-10 -160.99 66.0 0.3 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.565 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -87.56 116.09 25.44 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.123 -1.031 . . . . 0.0 108.9 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.49 ' CB ' ' O ' ' B' ' 45' ' ' ASP . 0.0 OUTLIER -88.46 161.39 17.05 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.436 -0.79 . . . . 0.0 108.995 -179.543 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.547 ' CD1' HD12 ' A' ' 20' ' ' ILE . 14.4 tt -137.73 136.46 45.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.062 -1.055 . . . . 0.0 110.507 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.513 HG21 ' N ' ' A' ' 31' ' ' VAL . 3.9 mm -88.89 155.17 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.513 ' N ' HG21 ' A' ' 30' ' ' ILE . 14.9 p -116.32 137.38 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.77 -1.206 . . . . 0.0 109.752 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.668 ' CD1' ' CE1' ' B' ' 50' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.182 -0.949 . . . . 0.0 110.374 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.583 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 2.0 ptp180 . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.532 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.5 OUTLIER -42.96 143.14 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.87 -1.144 . . . . 0.0 108.765 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.565 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.1 p-10 -100.99 39.49 1.39 Allowed 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.12 -178.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -150.79 140.81 22.04 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.83 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.614 ' CG2' ' CG2' ' B' ' 63' ' ' VAL . 96.5 t -151.52 152.13 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.999 -1.063 . . . . 0.0 110.323 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.532 ' HG3' ' CD2' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -78.38 105.2 9.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.083 -1.011 . . . . 0.0 110.139 -179.515 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.539 HD12 ' CD1' ' B' ' 57' ' ' ILE . 2.6 tp -93.27 86.27 5.26 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.304 -0.959 . . . . 0.0 108.505 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' PHE . . . . . 0.668 ' CE1' ' CD1' ' A' ' 32' ' ' LEU . 5.9 m-30 -69.72 133.28 47.32 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.521 ' HB ' ' HA ' ' B' ' 55' ' ' ASP . 0.0 OUTLIER -103.52 -170.54 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.856 -1.153 . . . . 0.0 109.722 179.747 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.527 ' OD2' ' CB ' ' B' ' 56' ' ' ASN . 2.7 p-10 -126.28 -149.72 0.42 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.519 -0.738 . . . . 0.0 109.055 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.519 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 34.4 mttm -56.86 -58.81 6.5 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.317 -0.864 . . . . 0.0 110.233 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . 0.561 ' O ' ' CB ' ' B' ' 55' ' ' ASP . 0.9 OUTLIER -101.24 15.99 26.97 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.086 -1.009 . . . . 0.0 111.682 -178.587 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' B' ' 54' ' ' LEU . 0.2 OUTLIER 91.71 48.97 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.603 0 CA-C-O 122.621 1.2 . . . . 0.0 110.183 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . 0.527 ' CB ' ' OD2' ' B' ' 52' ' ' ASP . 1.8 t-20 -105.92 123.77 48.51 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.893 -1.129 . . . . 0.0 109.49 179.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.539 ' CD1' HD12 ' B' ' 49' ' ' LEU . 4.3 mm -54.97 88.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.61 -0.681 . . . . 0.0 109.457 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.56 -21.5 24.04 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . 0.416 ' O ' ' C ' ' B' ' 60' ' ' VAL . 8.7 mp0 -125.22 85.14 2.36 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.552 ' CG1' ' O ' ' A' ' 4' ' ' GLU . 9.3 t -42.37 130.15 2.82 Favored Pre-proline 0 N--CA 1.487 1.41 0 O-C-N 121.284 -0.885 . . . . 0.0 110.501 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.558 ' HB2' ' CG1' ' B' ' 47' ' ' VAL . 36.8 Cg_endo -82.56 162.16 16.82 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 122.976 2.451 . . . . 0.0 110.276 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' ARG . . . . . 0.56 ' N ' HG12 ' B' ' 47' ' ' VAL . 0.1 OUTLIER -139.88 152.81 46.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.065 -1.022 . . . . 0.0 109.514 179.43 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.614 ' CG2' ' CG2' ' B' ' 47' ' ' VAL . 1.2 t . . . . . 0 N--CA 1.495 1.816 0 O-C-N 121.154 -0.966 . . . . 0.0 109.009 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.536 HG23 ' CD ' ' A' ' 24' ' ' LYS . 26.4 p . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.692 ' HB3' ' HD3' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -105.05 -178.06 3.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.332 -0.855 . . . . 0.0 110.164 -179.575 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.597 ' CD1' HD13 ' A' ' 20' ' ' ILE . 8.0 m-90 -161.65 48.85 0.25 Allowed Pre-proline 0 C--N 1.299 -1.621 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.19 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.692 ' HD3' ' HB3' ' A' ' 4' ' ' GLU . 30.6 Cg_endo -69.24 -25.82 30.63 Favored 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 121.956 1.77 . . . . 0.0 107.586 178.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -67.4 -25.32 65.88 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.585 ' HB2' ' HB3' ' A' ' 5' ' ' TRP . 0.3 OUTLIER -73.7 -17.08 61.17 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.448 0.642 . . . . 0.0 109.445 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.437 HG11 ' N ' ' A' ' 10' ' ' GLY . 37.1 t -49.92 149.6 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 C-N-CA 119.555 -0.858 . . . . 0.0 110.02 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.437 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 54.39 17.44 8.27 Favored Glycine 0 N--CA 1.48 1.584 0 C-N-CA 120.134 -1.031 . . . . 0.0 110.574 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.478 ' HB3' HD11 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -106.89 -143.87 0.38 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.0 -1.294 . . . . 0.0 109.398 179.717 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.491 ' CA ' HG12 ' B' ' 57' ' ' ILE . 0.5 OUTLIER -146.26 168.91 19.9 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.043 -1.035 . . . . 0.0 110.195 -179.465 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.437 ' O ' ' C ' ' A' ' 14' ' ' GLU . 84.9 t -55.45 -32.77 30.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.436 -0.79 . . . . 0.0 109.586 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.535 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 2.3 mt-10 -45.27 -71.29 0.08 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.135 -0.978 . . . . 0.0 108.837 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.442 ' HB3' HD23 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -60.28 -37.7 81.29 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.313 -0.867 . . . . 0.0 109.87 179.474 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.537 ' CB ' HD23 ' B' ' 49' ' ' LEU . . . -57.87 -79.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 110.028 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.529 ' HA ' ' CG2' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -50.75 -32.17 18.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.549 -1.344 . . . . 0.0 109.369 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -56.31 -82.5 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.494 0.664 . . . . 0.0 111.208 -179.192 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -61.69 -35.09 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.626 -0.671 . . . . 0.0 110.342 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.597 HD13 ' CD1' ' A' ' 5' ' ' TRP . 0.3 OUTLIER -53.28 -50.25 48.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 O-C-N 121.074 -1.016 . . . . 0.0 109.541 179.873 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.48 ' C ' ' O ' ' A' ' 20' ' ' ILE . 4.2 tt -35.45 -32.2 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.454 -0.779 . . . . 0.0 110.278 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 20' ' ' ILE . 1.9 tt0 -145.77 56.88 1.21 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.251 -0.905 . . . . 0.0 109.13 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.529 ' OD2' ' CG ' ' A' ' 24' ' ' LYS . 0.4 OUTLIER -65.41 -62.24 1.65 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.671 -0.643 . . . . 0.0 109.537 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.781 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -110.07 -80.95 0.01 OUTLIER Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.551 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.781 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 39.5 Cg_endo -87.92 -71.87 0.01 OUTLIER 'Trans proline' 0 C--O 1.213 -0.732 0 N-CA-C 107.377 -1.817 . . . . 0.0 107.377 176.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 25' ' ' PRO . 19.4 mt-10 -165.02 62.3 0.12 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.544 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -87.53 120.52 28.92 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.069 -1.019 . . . . 0.0 109.345 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.446 ' CB ' ' O ' ' B' ' 45' ' ' ASP . 0.6 OUTLIER -88.36 174.17 8.31 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.416 -0.803 . . . . 0.0 109.143 -179.52 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.543 ' HB ' ' CG2' ' A' ' 20' ' ' ILE . 18.5 tt -145.74 134.76 17.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.466 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.511 HG21 ' N ' ' A' ' 31' ' ' VAL . 4.8 mt -88.07 148.27 4.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.511 ' N ' HG21 ' A' ' 30' ' ' ILE . 5.8 p -117.07 133.23 64.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 118.811 -1.156 . . . . 0.0 110.858 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.663 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.533 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.57 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.488 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.3 OUTLIER -44.03 137.22 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.926 -1.109 . . . . 0.0 108.675 179.971 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.544 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -93.19 45.32 1.17 Allowed 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.419 -0.912 . . . . 0.0 109.689 -178.854 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' ARG . . . . . 0.48 ' HD2' ' CD1' ' A' ' 30' ' ' ILE . 14.1 ttp180 -148.04 144.83 28.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.314 -0.867 . . . . 0.0 109.112 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' B' ' 62' ' ' ARG . 0.0 OUTLIER -152.2 143.9 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.157 -0.964 . . . . 0.0 109.427 -179.267 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.45 ' HA ' ' HD3' ' B' ' 48' ' ' ARG . 3.3 mmt85 -77.33 115.43 17.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.701 -1.249 . . . . 0.0 109.632 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.548 HD12 ' CD1' ' B' ' 57' ' ' ILE . 1.6 tp -107.89 81.02 1.44 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.987 -1.071 . . . . 0.0 108.843 178.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' PHE . . . . . 0.631 ' CE1' ' CD1' ' A' ' 32' ' ' LEU . 4.1 m-30 -66.05 -159.86 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.473 ' HB ' ' HA ' ' B' ' 55' ' ' ASP . 24.1 m -150.42 -171.46 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.74 -1.225 . . . . 0.0 109.574 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.51 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 1.0 OUTLIER -122.66 -153.14 0.54 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.297 -0.877 . . . . 0.0 109.259 179.434 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.51 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 29.1 mtpt -61.18 -61.48 2.53 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.617 -0.677 . . . . 0.0 109.606 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . 0.415 ' O ' ' C ' ' B' ' 55' ' ' ASP . 3.0 tp -96.09 48.11 1.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.365 -0.834 . . . . 0.0 109.909 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.473 ' HA ' ' HB ' ' B' ' 51' ' ' VAL . 0.0 OUTLIER 45.58 65.31 1.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.061 -1.025 . . . . 0.0 109.28 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . 0.577 ' O ' ' N ' ' B' ' 58' ' ' ALA . 3.5 t30 -133.14 108.71 8.99 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.548 ' CD1' HD12 ' B' ' 49' ' ' LEU . 12.7 mm -32.41 86.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.67 0.748 . . . . 0.0 111.391 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . 0.577 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -90.99 -23.72 20.31 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.04 96.24 5.09 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 5' ' ' TRP . 3.2 t -57.89 137.44 83.42 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.459 -0.776 . . . . 0.0 110.17 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.471 ' HD2' HG11 ' B' ' 60' ' ' VAL . 35.0 Cg_endo -76.97 172.97 15.24 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 122.438 2.092 . . . . 0.0 109.927 178.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' ARG . . . . . 0.532 ' O ' ' CG1' ' B' ' 47' ' ' VAL . 0.0 OUTLIER -150.94 135.36 17.01 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.811 -1.181 . . . . 0.0 110.614 -179.601 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.532 ' CG2' HG21 ' B' ' 47' ' ' VAL . 4.6 t . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.353 -0.842 . . . . 0.0 108.857 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.539 ' CA ' ' HD3' ' A' ' 24' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.701 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.593 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 37.3 mt-10 -135.33 -40.58 0.73 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.502 -0.749 . . . . 0.0 109.349 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.642 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 6.9 m-90 62.63 40.55 0.37 Allowed Pre-proline 0 C--N 1.299 -1.59 0 O-C-N 121.545 -0.722 . . . . 0.0 109.946 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.642 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 34.7 Cg_endo -72.93 -33.75 7.37 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 N-CA-C 107.462 -1.784 . . . . 0.0 107.462 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -69.57 -10.75 59.47 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 177.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.537 HD13 ' CB ' ' A' ' 11' ' ' LYS . 11.7 tp -81.36 -1.92 47.27 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 121.556 -0.715 . . . . 0.0 109.445 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.531 ' CG2' HG22 ' B' ' 60' ' ' VAL . 24.1 t -54.71 151.28 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.101 -1.0 . . . . 0.0 109.482 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.497 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 64.07 6.18 18.16 Favored Glycine 0 N--CA 1.481 1.677 0 C-N-CA 120.042 -1.075 . . . . 0.0 110.5 178.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.537 ' CB ' HD13 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -93.13 -145.36 0.23 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.801 -1.411 . . . . 0.0 109.327 179.697 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.479 ' O ' HD13 ' B' ' 57' ' ' ILE . 2.1 m -150.47 179.56 8.05 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.062 -1.023 . . . . 0.0 110.373 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.509 ' HA ' HD23 ' B' ' 49' ' ' LEU . 57.1 t -60.45 -35.3 62.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.487 -0.758 . . . . 0.0 109.724 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.503 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 1.9 pm0 -47.02 -74.46 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.047 -1.033 . . . . 0.0 108.893 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.428 ' O ' HG22 ' A' ' 19' ' ' VAL . 21.0 tt0 -57.61 -31.38 66.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.219 -0.925 . . . . 0.0 110.084 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.476 ' CA ' HD13 ' A' ' 20' ' ' ILE . . . -66.6 -81.12 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.88 -1.137 . . . . 0.0 109.962 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -45.96 -30.43 1.79 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.758 -1.214 . . . . 0.0 109.056 -179.875 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.7 OUTLIER -63.46 -81.44 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.703 -0.623 . . . . 0.0 110.677 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.488 HG21 ' HD3' ' A' ' 18' ' ' LYS . 3.3 t -56.18 -50.04 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.204 -0.935 . . . . 0.0 109.613 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.545 ' O ' ' N ' ' A' ' 22' ' ' GLN . 61.8 mt -46.9 -59.49 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.389 -0.819 . . . . 0.0 109.928 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.501 ' C ' ' O ' ' A' ' 20' ' ' ILE . 17.4 tp -29.56 -37.74 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.056 0.455 . . . . 0.0 110.659 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.558 ' O ' ' N ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -133.43 -72.67 0.5 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.968 -1.082 . . . . 0.0 109.405 179.096 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 22' ' ' GLN . 7.6 t0 42.48 -94.84 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.718 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 3.0 mtmp? -66.62 -118.14 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.332 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.718 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 36.5 Cg_endo -79.77 -75.53 0.01 OUTLIER 'Trans proline' 0 C--O 1.214 -0.703 0 CA-C-N 122.309 1.86 . . . . 0.0 108.902 178.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 4.5 mt-10 -156.84 59.88 0.53 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.705 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -89.03 113.01 24.08 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.475 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.519 ' HB2' ' O ' ' B' ' 45' ' ' ASP . 1.8 mt-30 -87.95 172.21 9.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.065 -1.022 . . . . 0.0 109.175 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.536 ' CD1' ' HB ' ' B' ' 47' ' ' VAL . 9.4 tt -136.86 142.66 37.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.979 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.483 ' O ' HD22 ' A' ' 32' ' ' LEU . 26.9 mm -90.24 122.4 41.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.535 ' CG2' HD22 ' B' ' 49' ' ' LEU . 32.7 t -96.59 134.09 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.966 -1.084 . . . . 0.0 109.74 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.698 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.303 -1.441 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 -178.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.557 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 1.2 ptt180 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 120.912 0.387 . . . . 0.0 110.086 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.538 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.4 OUTLIER -47.3 144.89 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 120.732 -1.23 . . . . 0.0 107.821 178.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.705 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.7 p-10 -106.34 45.7 0.96 Allowed 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 118.798 -1.161 . . . . 0.0 110.243 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' ARG . . . . . 0.456 ' HG3' HG12 ' A' ' 30' ' ' ILE . 1.4 ttt-85 -152.17 153.07 33.12 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.565 HG21 ' CG2' ' B' ' 63' ' ' VAL . 0.1 OUTLIER -150.59 -172.83 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.098 -1.001 . . . . 0.0 108.56 179.591 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.474 ' HB3' ' CE2' ' B' ' 50' ' ' PHE . 11.8 mmt85 -119.4 72.25 0.9 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.682 -1.261 . . . . 0.0 110.265 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.535 HD22 ' CG2' ' A' ' 31' ' ' VAL . 3.2 tp -69.21 97.74 0.96 Allowed 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.008 -1.077 . . . . 0.0 108.178 178.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' PHE . . . . . 0.624 ' CZ ' HD13 ' A' ' 32' ' ' LEU . 18.1 m-85 -89.37 -162.93 0.92 Allowed 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.543 ' CG1' ' HA ' ' B' ' 55' ' ' ASP . 34.8 m -142.1 175.09 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.769 -1.207 . . . . 0.0 109.363 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.548 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.0 OUTLIER -127.44 -71.9 0.65 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.242 -0.911 . . . . 0.0 108.633 -179.884 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.548 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 17.9 mmtt -93.21 -75.21 0.5 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.898 -1.126 . . . . 0.0 108.535 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . 0.555 ' O ' ' CB ' ' B' ' 55' ' ' ASP . 0.1 OUTLIER -131.68 51.75 2.12 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 179.088 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.555 ' CB ' ' O ' ' B' ' 54' ' ' LEU . 0.2 OUTLIER 91.33 23.0 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.18 0.514 . . . . 0.0 109.703 -179.344 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . 0.575 ' O ' ' N ' ' B' ' 58' ' ' ALA . 62.4 t30 -88.83 91.87 8.99 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.479 HD13 ' O ' ' A' ' 12' ' ' SER . 9.4 mt -38.49 89.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-O 121.687 0.756 . . . . 0.0 110.779 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . 0.575 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.13 -25.65 22.87 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -118.2 103.51 9.91 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.559 ' CG1' ' O ' ' A' ' 4' ' ' GLU . 63.0 t -62.49 138.21 96.46 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.386 -0.821 . . . . 0.0 110.918 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.515 ' CB ' HD13 ' A' ' 29' ' ' ILE . 36.4 Cg_endo -80.44 170.54 15.85 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.736 2.291 . . . . 0.0 109.294 178.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' ARG . . . . . 0.547 ' CD ' ' HA ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -149.9 140.39 22.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.758 -1.214 . . . . 0.0 110.721 -179.512 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.565 ' CG2' HG21 ' B' ' 47' ' ' VAL . 1.4 t . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.543 -0.723 . . . . 0.0 109.166 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.487 ' CG2' ' O ' ' B' ' 63' ' ' VAL . 7.3 m . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.643 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 10.1 mm-40 -105.8 -24.34 12.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.086 -1.009 . . . . 0.0 110.527 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.641 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 6.9 m-90 48.24 46.98 4.12 Favored Pre-proline 0 C--N 1.297 -1.709 0 C-N-CA 118.774 -1.17 . . . . 0.0 108.888 -178.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.643 ' HD3' ' HB2' ' A' ' 4' ' ' GLU . 31.4 Cg_endo -73.88 -35.44 4.37 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 N-CA-C 106.581 -2.123 . . . . 0.0 106.581 -179.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.84 -12.24 61.47 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 114.318 -1.31 . . . . 0.0 107.666 176.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.483 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 19.1 tp -79.68 -7.05 58.34 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 121.476 -0.765 . . . . 0.0 109.454 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.542 ' CG2' HG22 ' B' ' 60' ' ' VAL . 15.3 t -54.85 151.86 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.965 -1.084 . . . . 0.0 108.951 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.503 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 57.1 13.72 9.68 Favored Glycine 0 N--CA 1.481 1.64 0 N-CA-C 110.209 -1.157 . . . . 0.0 110.209 178.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -94.56 -143.52 0.25 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.959 -1.318 . . . . 0.0 109.511 179.843 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.12 170.4 18.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.042 -1.036 . . . . 0.0 110.173 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.465 ' HA ' HD12 ' B' ' 49' ' ' LEU . 78.4 t -53.27 -42.22 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.336 -0.853 . . . . 0.0 109.655 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.528 ' O ' ' CG ' ' A' ' 18' ' ' LYS . 59.0 mm-40 -41.38 -71.64 0.08 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.409 ' HB3' ' CD1' ' A' ' 8' ' ' LEU . 0.6 OUTLIER -56.09 -38.69 71.04 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.452 -0.78 . . . . 0.0 109.612 179.619 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.493 ' O ' HD12 ' A' ' 20' ' ' ILE . . . -58.72 -83.85 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.383 -0.823 . . . . 0.0 109.862 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 17' ' ' LYS . 4.3 tptp -45.13 -29.99 1.04 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.563 -1.335 . . . . 0.0 109.39 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' A' ' 14' ' ' GLU . 4.3 mmtt -61.35 -86.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.66 0.743 . . . . 0.0 111.087 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.4 t -57.89 -38.9 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 121.494 0.664 . . . . 0.0 109.824 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.595 ' CD1' ' N ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -53.48 -51.75 38.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.438 -0.789 . . . . 0.0 109.725 -179.645 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 20' ' ' ILE . 45.3 tp -39.25 -23.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.399 -0.813 . . . . 0.0 111.9 -178.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -142.1 13.33 2.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.001 -1.687 . . . . 0.0 112.622 -179.242 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.487 ' OD1' ' HB1' ' A' ' 27' ' ' ALA . 1.2 p-10 -49.29 150.72 1.66 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.729 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.4 OUTLIER 52.81 -131.03 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 -178.809 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.729 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 36.9 Cg_endo -78.17 -83.03 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.635 0 CA-C-N 121.952 1.733 . . . . 0.0 109.346 178.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 3.1 mt-10 -144.69 71.01 1.29 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.417 -0.802 . . . . 0.0 109.046 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -89.03 118.71 28.95 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.006 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.445 ' O ' HG22 ' B' ' 47' ' ' VAL . 0.0 OUTLIER -88.01 -178.69 6.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.241 -0.912 . . . . 0.0 109.435 -179.313 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.55 HG12 ' HB2' ' B' ' 49' ' ' LEU . 14.0 tt -150.06 152.16 11.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 C-N-CA 119.02 -1.072 . . . . 0.0 111.112 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.3 mm -112.16 128.65 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.524 ' HA ' ' HB3' ' B' ' 49' ' ' LEU . 3.0 t -89.56 150.12 3.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 120.824 -1.173 . . . . 0.0 110.173 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.716 ' CD2' ' CD1' ' B' ' 50' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -178.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.575 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 120.865 0.364 . . . . 0.0 110.283 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.53 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.2 OUTLIER -45.79 140.17 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.856 -1.152 . . . . 0.0 108.363 179.388 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.9 OUTLIER -98.92 48.34 0.97 Allowed 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.031 -1.043 . . . . 0.0 109.624 -179.371 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' ARG . . . . . 0.438 ' C ' HG21 ' B' ' 47' ' ' VAL . 23.9 ttm180 -150.29 150.4 31.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.459 -0.775 . . . . 0.0 109.03 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.51 ' CG2' HG22 ' B' ' 63' ' ' VAL . 0.1 OUTLIER -151.36 -172.48 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.181 -0.949 . . . . 0.0 109.343 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 5.1 mmt85 -118.17 71.02 0.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.095 -1.003 . . . . 0.0 110.156 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.55 ' HB2' HG12 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -54.61 103.09 0.08 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.005 -1.059 . . . . 0.0 108.872 179.297 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' PHE . . . . . 0.716 ' CD1' ' CD2' ' A' ' 32' ' ' LEU . 2.2 m-85 -92.21 119.21 31.62 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.356 -0.84 . . . . 0.0 108.961 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 1.5 m -108.33 -175.45 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.12 -0.988 . . . . 0.0 109.536 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.545 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.0 OUTLIER -129.16 -161.97 1.16 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.291 -0.88 . . . . 0.0 109.619 -179.915 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.545 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 1.8 mttp -49.96 -61.79 1.94 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.589 -0.694 . . . . 0.0 109.934 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . 0.481 HD11 ' N ' ' B' ' 54' ' ' LEU . 7.6 mp -89.57 48.98 1.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.479 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 44.39 49.44 8.11 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.349 -0.844 . . . . 0.0 109.246 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . 0.469 ' HB3' ' CG ' ' B' ' 52' ' ' ASP . 4.9 t30 -107.11 111.17 23.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.31 -0.868 . . . . 0.0 108.873 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.472 HD13 ' HG ' ' A' ' 8' ' ' LEU . 12.5 mt -59.46 90.55 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 121.352 0.596 . . . . 0.0 110.21 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -87.94 -19.63 27.0 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . 0.51 ' HB2' ' CB ' ' B' ' 50' ' ' PHE . 1.1 mt-30 -123.12 82.27 1.98 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.542 HG22 ' CG2' ' A' ' 9' ' ' VAL . 20.2 t -49.72 137.47 18.21 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.533 -0.73 . . . . 0.0 110.655 -178.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.508 ' O ' ' HD3' ' B' ' 62' ' ' ARG . 36.5 Cg_endo -81.23 172.67 12.53 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 123.023 2.482 . . . . 0.0 110.205 179.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' ARG . . . . . 0.56 ' HG3' ' HA ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -149.53 129.4 13.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.229 -0.919 . . . . 0.0 110.009 179.915 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.51 HG22 ' CG2' ' B' ' 47' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.752 0 O-C-N 121.217 -0.927 . . . . 0.0 108.906 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.55 ' CG2' ' HD2' ' A' ' 24' ' ' LYS . 62.7 p . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.559 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -135.42 -47.73 0.7 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.183 -0.948 . . . . 0.0 109.83 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.627 ' CE2' HG12 ' A' ' 20' ' ' ILE . 9.3 m-90 58.64 44.96 1.2 Allowed Pre-proline 0 C--N 1.299 -1.604 0 C-N-CA 119.398 -0.921 . . . . 0.0 108.995 -178.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.622 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 33.5 Cg_endo -72.88 -32.09 9.41 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 N-CA-C 107.462 -1.784 . . . . 0.0 107.462 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.56 -12.2 60.97 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.495 ' HB2' ' HB3' ' A' ' 5' ' ' TRP . 2.7 tp -78.04 -4.32 46.57 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 121.507 -0.746 . . . . 0.0 109.594 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.532 HG21 ' CG2' ' B' ' 60' ' ' VAL . 24.7 t -52.43 152.39 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 C-N-CA 118.866 -1.133 . . . . 0.0 109.116 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.497 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 45.51 24.08 1.01 Allowed Glycine 0 N--CA 1.481 1.652 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 178.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 1.7 tptm -99.78 -138.93 0.32 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.984 -1.304 . . . . 0.0 109.249 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' B' ' 55' ' ' ASP . 0.3 OUTLIER -150.03 154.83 38.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.809 -1.182 . . . . 0.0 110.744 -179.53 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.539 ' HA ' ' HB2' ' A' ' 16' ' ' ALA . 54.9 t -52.41 -30.01 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 O-C-N 121.435 -0.79 . . . . 0.0 109.019 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.524 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 14.3 mt-10 -48.91 -74.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.466 -0.771 . . . . 0.0 109.107 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.33 -28.94 63.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.168 -0.958 . . . . 0.0 108.705 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.539 ' HB2' ' HA ' ' A' ' 13' ' ' VAL . . . -61.08 -86.74 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.4 -0.812 . . . . 0.0 109.959 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.485 ' HG2' HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -47.46 -35.14 8.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.564 -1.335 . . . . 0.0 108.99 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -49.46 -78.82 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.468 0.651 . . . . 0.0 110.869 -179.471 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.469 HG13 ' OD1' ' A' ' 23' ' ' ASP . 0.5 OUTLIER -72.76 -44.57 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.425 -0.797 . . . . 0.0 109.677 -178.833 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.627 HG12 ' CE2' ' A' ' 5' ' ' TRP . 67.2 mt -40.07 -52.91 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.544 -0.722 . . . . 0.0 109.511 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 28' ' ' GLN . 0.5 OUTLIER -38.73 -49.44 1.59 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.563 -0.711 . . . . 0.0 110.483 -179.658 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.459 ' HB2' HD21 ' A' ' 21' ' ' LEU . 1.1 mt-30 -135.06 44.51 2.6 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.099 -1.0 . . . . 0.0 110.506 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.555 ' HB3' ' CE ' ' A' ' 24' ' ' LYS . 4.6 t0 -66.33 -39.85 89.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.866 -1.146 . . . . 0.0 108.488 179.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.769 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -117.42 -99.51 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.444 0 CA-C-O 117.214 -1.374 . . . . 0.0 107.975 178.707 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.769 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 37.3 Cg_endo -82.15 -76.14 0.0 OUTLIER 'Trans proline' 0 C--O 1.213 -0.742 0 CA-C-N 122.374 1.884 . . . . 0.0 108.284 177.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 16.3 mt-10 -160.77 56.35 0.31 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.579 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -88.81 119.15 29.05 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.128 -0.983 . . . . 0.0 109.467 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' B' ' 45' ' ' ASP . 15.7 mt-30 -89.25 -178.35 5.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.224 -0.923 . . . . 0.0 109.326 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.536 HD13 ' CB ' ' B' ' 61' ' ' PRO . 3.6 tt -145.45 127.93 9.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.089 -1.007 . . . . 0.0 110.436 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.512 ' CD1' ' HD3' ' B' ' 46' ' ' ARG . 33.4 mt -89.0 111.31 22.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.478 HG23 HG23 ' A' ' 13' ' ' VAL . 7.0 p -89.72 146.59 5.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.136 -0.977 . . . . 0.0 110.123 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.688 ' CD1' ' CE1' ' B' ' 50' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.461 -0.775 . . . . 0.0 109.461 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.554 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.536 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.5 OUTLIER -43.17 145.87 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.99 -1.069 . . . . 0.0 108.262 179.488 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.579 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 2.2 p-10 -106.1 46.44 0.92 Allowed 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 118.962 -1.095 . . . . 0.0 110.756 -178.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' ARG . . . . . 0.512 ' HD3' ' CD1' ' A' ' 30' ' ' ILE . 2.3 ptp180 -150.94 153.01 34.43 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.22 -0.925 . . . . 0.0 109.244 178.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.597 ' CG2' ' CG2' ' B' ' 63' ' ' VAL . 31.1 t -150.93 161.66 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.421 -0.799 . . . . 0.0 109.162 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.447 ' HG3' ' CD2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -93.38 84.16 4.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.85 -1.156 . . . . 0.0 110.022 -179.453 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.533 HD23 ' CB ' ' A' ' 16' ' ' ALA . 2.5 tp -80.04 83.36 5.94 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 118.985 -1.086 . . . . 0.0 109.17 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' PHE . . . . . 0.688 ' CE1' ' CD1' ' A' ' 32' ' ' LEU . 3.8 m-30 -66.98 -162.88 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.528 ' CG1' ' HA ' ' B' ' 55' ' ' ASP . 10.1 m -149.44 160.9 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.834 -1.166 . . . . 0.0 108.702 178.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.55 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.0 OUTLIER -112.37 -70.61 0.8 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.939 -1.1 . . . . 0.0 108.796 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.55 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 9.9 mmmt -92.5 -75.91 0.48 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.848 -1.158 . . . . 0.0 108.49 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . 0.543 ' O ' ' CB ' ' B' ' 55' ' ' ASP . 0.1 OUTLIER -136.85 57.22 1.77 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.056 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' B' ' 54' ' ' LEU . 0.2 OUTLIER 91.51 24.13 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.421 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' B' ' 58' ' ' ALA . 31.8 t-20 -88.82 86.79 7.04 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.472 HD11 ' HG ' ' A' ' 8' ' ' LEU . 3.8 mt -37.33 89.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-O 121.511 0.672 . . . . 0.0 111.315 -178.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.81 -17.5 29.62 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' B' ' 60' ' ' VAL . 33.9 mt-30 -127.68 84.37 2.25 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.532 ' CG2' HG21 ' A' ' 9' ' ' VAL . 6.4 t -41.68 136.2 2.01 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.453 -0.779 . . . . 0.0 110.161 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.566 ' HB2' ' CG1' ' B' ' 47' ' ' VAL . 36.7 Cg_endo -81.95 166.79 16.7 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.751 2.301 . . . . 0.0 110.523 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' ARG . . . . . 0.512 ' N ' HG12 ' B' ' 47' ' ' VAL . 0.3 OUTLIER -142.72 152.85 42.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 109.285 179.416 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.597 ' CG2' ' CG2' ' B' ' 47' ' ' VAL . 1.2 t . . . . . 0 N--CA 1.493 1.711 0 O-C-N 121.229 -0.919 . . . . 0.0 109.486 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.486 HG21 ' HE3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.7 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.578 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 4.9 mt-10 -99.92 -48.41 4.68 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.993 -1.067 . . . . 0.0 110.878 -178.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.603 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 10.4 m-90 60.71 45.76 1.03 Allowed Pre-proline 0 C--N 1.297 -1.711 0 C-N-CA 119.067 -1.053 . . . . 0.0 108.386 -177.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 32.8 Cg_endo -72.31 -31.2 11.93 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 N-CA-C 107.057 -1.94 . . . . 0.0 107.057 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.21 -13.14 62.02 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.525 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.547 ' HB2' ' O ' ' A' ' 5' ' ' TRP . 0.3 OUTLIER -71.32 -11.57 60.98 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.204 -0.935 . . . . 0.0 108.987 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.526 HG22 ' CG2' ' B' ' 60' ' ' VAL . 24.4 t -55.9 145.1 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.087 -1.008 . . . . 0.0 109.82 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.477 ' HA2' ' OD1' ' B' ' 56' ' ' ASN . . . 59.23 13.65 22.22 Favored Glycine 0 N--CA 1.482 1.726 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.287 177.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.466 ' HB3' HD11 ' A' ' 8' ' ' LEU . 1.2 tptp -95.44 -147.11 0.28 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.133 -1.216 . . . . 0.0 109.178 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.84 155.96 44.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -0.917 . . . . 0.0 109.372 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.531 ' CG2' HG13 ' B' ' 51' ' ' VAL . 69.0 t -47.17 -37.18 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.834 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.516 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -44.81 -76.9 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.211 -0.931 . . . . 0.0 109.317 -179.864 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.423 ' O ' HG22 ' A' ' 19' ' ' VAL . 4.7 mp0 -54.76 -35.57 63.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.561 -0.712 . . . . 0.0 110.143 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.497 ' CB ' HD22 ' B' ' 49' ' ' LEU . . . -63.46 -83.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.827 . . . . 0.0 110.364 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.516 ' HA ' ' CG2' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -45.7 -27.52 0.83 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.142 -0.974 . . . . 0.0 108.884 -179.618 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.1 OUTLIER -67.46 -86.28 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.746 -0.596 . . . . 0.0 111.167 -179.029 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.503 ' O ' ' OD1' ' A' ' 23' ' ' ASP . 4.6 t -46.13 -42.77 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.15 -0.969 . . . . 0.0 109.455 -178.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.598 HG12 ' CE2' ' A' ' 5' ' ' TRP . 46.5 mt -56.63 -44.24 80.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.452 -0.78 . . . . 0.0 109.536 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 20' ' ' ILE . 4.2 tt -39.15 -25.82 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.222 -0.923 . . . . 0.0 110.588 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.548 ' O ' ' N ' ' A' ' 24' ' ' LYS . 0.6 OUTLIER -144.3 -67.99 0.32 Allowed 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.525 -1.359 . . . . 0.0 111.592 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.516 ' OD1' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER 39.54 -94.51 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.393 -0.817 . . . . 0.0 108.86 -178.549 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.735 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 10.6 mtpt -64.89 -118.95 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.435 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 178.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.735 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 36.5 Cg_endo -80.56 -73.21 0.01 OUTLIER 'Trans proline' 0 C--O 1.214 -0.71 0 CA-C-N 122.221 1.829 . . . . 0.0 109.006 178.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 5.5 mt-10 -159.29 60.63 0.4 Allowed 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.689 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -88.03 113.99 24.21 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.467 ' O ' HG22 ' B' ' 47' ' ' VAL . 0.2 OUTLIER -86.78 170.57 11.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.144 -0.973 . . . . 0.0 110.517 -177.711 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.557 ' HB ' ' CG2' ' A' ' 20' ' ' ILE . 19.2 tt -140.21 141.91 32.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.829 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.509 ' O ' ' HB3' ' B' ' 49' ' ' LEU . 1.0 OUTLIER -91.31 163.77 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 179.132 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.539 ' CG1' HD11 ' B' ' 49' ' ' LEU . 64.5 t -135.2 133.39 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.312 -1.492 . . . . 0.0 110.372 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.691 ' CD2' ' CE1' ' B' ' 50' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.503 -0.748 . . . . 0.0 109.113 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' ARG . . . . . 0.536 ' HD3' ' CG1' ' B' ' 63' ' ' VAL . 1.6 tpp180 . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.536 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.4 OUTLIER -52.64 142.74 4.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 179.185 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.689 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -96.54 50.21 1.13 Allowed 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.703 -1.248 . . . . 0.0 110.4 -178.738 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 28' ' ' GLN . 15.0 ttm180 -150.03 150.21 31.44 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.436 -0.79 . . . . 0.0 108.9 178.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.542 HG21 ' CG2' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -151.71 179.9 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.769 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.615 ' HB3' ' CE2' ' B' ' 50' ' ' PHE . 0.9 OUTLIER -107.38 85.21 2.09 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.905 -1.122 . . . . 0.0 111.62 -178.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.556 ' HB2' ' CD1' ' A' ' 29' ' ' ILE . 2.1 tm? -78.31 93.47 4.67 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' PHE . . . . . 0.691 ' CE1' ' CD2' ' A' ' 32' ' ' LEU . 50.4 m-85 -89.42 132.95 34.75 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.531 HG13 ' CG2' ' A' ' 13' ' ' VAL . 16.7 m -99.77 -169.31 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.842 -1.161 . . . . 0.0 109.538 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' B' ' 55' ' ' ASP . 3.6 p-10 -126.77 -148.89 0.4 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.209 -0.932 . . . . 0.0 109.119 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' LYS . . . . . 0.496 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 4.6 mmmm -76.5 -45.43 30.97 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' LEU . . . . . 0.507 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 1.4 mt -101.15 34.46 2.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.542 -0.724 . . . . 0.0 109.612 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' ASP . . . . . 0.536 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.0 OUTLIER 53.77 68.28 0.87 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.016 -1.052 . . . . 0.0 108.179 -178.787 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' B' ' 58' ' ' ALA . 47.1 t-20 -130.93 100.4 5.24 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.506 ' CD1' HD22 ' B' ' 49' ' ' LEU . 31.2 mm -40.67 88.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.495 0.664 . . . . 0.0 110.624 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -89.59 -18.46 26.52 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.5 108.33 14.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.48 -0.763 . . . . 0.0 108.998 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.555 ' CG1' ' O ' ' A' ' 4' ' ' GLU . 32.8 t -66.27 133.51 94.55 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.304 -0.872 . . . . 0.0 110.236 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.5 ' O ' ' HD3' ' B' ' 62' ' ' ARG . 36.5 Cg_endo -81.72 165.17 18.05 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.601 2.201 . . . . 0.0 110.496 179.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' ARG . . . . . 0.571 ' CD ' ' HA ' ' A' ' 4' ' ' GLU . 1.1 tpp180 -150.22 134.85 17.47 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.223 -0.923 . . . . 0.0 110.54 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.542 ' CG2' HG21 ' B' ' 47' ' ' VAL . 1.4 t . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.536 ' HB3' ' CB ' ' A' ' 23' ' ' ASP . 1.4 tppm? -71.55 111.7 7.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.119 -0.988 . . . . 0.0 109.379 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.471 ' O ' ' O ' ' B' ' 62' ' ' ARG . 1.4 p -136.3 6.99 3.08 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.345 -0.847 . . . . 0.0 109.342 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.618 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -131.53 -30.76 1.64 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.043 -1.036 . . . . 0.0 110.484 -179.646 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.647 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 5.8 m-90 51.44 46.29 3.49 Favored Pre-proline 0 C--N 1.296 -1.723 0 C-N-CA 118.088 -1.445 . . . . 0.0 108.237 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.647 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 32.8 Cg_endo -73.76 -33.86 6.01 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 N-CA-C 107.75 -1.673 . . . . 0.0 107.75 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.69 -11.13 59.82 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.535 HD23 ' HA ' ' A' ' 16' ' ' ALA . 63.4 tp -79.96 -5.05 54.96 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 121.394 -0.816 . . . . 0.0 109.586 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.614 ' CG2' ' CG2' ' B' ' 60' ' ' VAL . 42.5 t -53.75 149.2 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 120.994 -1.066 . . . . 0.0 110.466 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.466 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 58.42 11.68 10.58 Favored Glycine 0 N--CA 1.481 1.647 0 C-N-CA 120.194 -1.003 . . . . 0.0 110.644 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.535 ' CB ' HD11 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -91.49 -144.28 0.19 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.925 -1.338 . . . . 0.0 109.124 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' B' ' 55' ' ' ASP . 0.5 OUTLIER -145.54 157.1 44.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.035 -1.04 . . . . 0.0 109.961 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.472 HG12 HG22 ' A' ' 31' ' ' VAL . 93.0 t -48.68 -34.28 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.343 -0.848 . . . . 0.0 109.479 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.508 ' O ' ' CD ' ' A' ' 18' ' ' LYS . 7.8 mm-40 -44.6 -75.52 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.092 -1.005 . . . . 0.0 109.163 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.401 ' O ' HG22 ' A' ' 19' ' ' VAL . 1.9 tt0 -58.71 -32.34 69.08 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.687 -0.633 . . . . 0.0 109.959 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.535 ' HA ' HD23 ' A' ' 8' ' ' LEU . . . -62.45 -80.66 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.086 -1.009 . . . . 0.0 109.676 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.516 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -44.2 -39.94 4.75 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.872 -1.143 . . . . 0.0 108.942 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.526 ' HD2' ' N ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -51.53 -81.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.75 0.786 . . . . 0.0 111.085 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 15' ' ' GLU . 1.9 t -66.08 -49.27 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.809 -0.557 . . . . 0.0 110.472 -178.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.597 ' HA ' ' OD2' ' A' ' 23' ' ' ASP . 61.7 mt -45.8 -40.13 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 0.0 109.518 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.534 ' CD1' ' HG3' ' A' ' 28' ' ' GLN . 35.1 tp -38.84 -23.82 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.55 ' O ' ' N ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -135.37 -81.22 0.42 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 119.977 -1.702 . . . . 0.0 111.617 -178.83 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.597 ' OD2' ' HA ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER 37.77 -94.82 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.739 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.609 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -58.48 -163.76 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 176.214 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 37.4 Cg_endo -76.32 82.44 2.23 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 N-CA-C 108.666 -1.321 . . . . 0.0 108.666 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.533 ' CG ' ' C ' ' A' ' 25' ' ' PRO . 0.3 OUTLIER 56.88 52.22 9.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.65 -0.657 . . . . 0.0 111.009 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.526 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -88.82 112.05 22.77 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 177.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.534 ' HG3' ' CD1' ' A' ' 21' ' ' LEU . 0.6 OUTLIER -87.51 -166.62 1.63 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.012 -1.055 . . . . 0.0 110.721 -177.213 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.548 ' CG1' ' HB2' ' B' ' 49' ' ' LEU . 1.7 tt -149.86 144.23 17.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.477 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.49 ' O ' ' HB3' ' B' ' 49' ' ' LEU . 31.9 mt -89.39 115.27 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.752 -0.593 . . . . 0.0 109.985 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.472 HG22 HG12 ' A' ' 13' ' ' VAL . 8.0 p -89.91 109.59 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.545 -1.347 . . . . 0.0 109.906 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.642 ' CD1' ' CE1' ' B' ' 50' ' ' PHE . 0.5 OUTLIER -138.94 152.44 70.26 Favored Pre-proline 0 N--CA 1.492 1.626 0 C-N-CA 119.087 -1.045 . . . . 0.0 110.411 179.616 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.528 ' HA ' ' CG2' ' B' ' 51' ' ' VAL . 37.5 Cg_endo -81.33 55.43 5.6 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 123.063 2.509 . . . . 0.0 110.007 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.472 ' O ' ' O ' ' A' ' 35' ' ' GLY . 67.2 t 50.38 -91.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.336 -0.852 . . . . 0.0 109.416 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . 47.18 -174.75 0.01 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.15 -167.12 0.7 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -1.179 . . . . 0.0 109.188 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.519 ' O ' ' CG2' ' A' ' 37' ' ' ILE . 3.4 mp -112.4 65.33 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.169 -0.957 . . . . 0.0 109.334 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.481 ' O ' HG21 ' A' ' 39' ' ' THR . 66.4 t 58.53 81.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 0.0 109.765 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.481 HG21 ' O ' ' A' ' 38' ' ' VAL . 1.2 t . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 118.088 -0.958 . . . . 0.0 109.836 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . 0.6 ' CZ ' ' HA ' ' B' ' 44' ' ' ILE . 6.8 p90 -136.18 -148.12 0.28 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.159 -0.963 . . . . 0.0 109.856 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.516 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 8.0 ptp180 -89.39 51.66 2.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.896 . . . . 0.0 109.31 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.6 ' HA ' ' CZ ' ' B' ' 42' ' ' TYR . 0.7 OUTLIER -42.5 145.59 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 119.403 -0.919 . . . . 0.0 108.896 179.795 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.526 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.1 p-10 -107.66 46.43 0.94 Allowed 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.918 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . 0.468 ' HG2' ' CG1' ' A' ' 30' ' ' ILE . 11.3 mtt180 -150.16 150.1 31.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.33 -0.856 . . . . 0.0 109.426 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.6 ' CG2' ' CG2' ' B' ' 63' ' ' VAL . 79.2 t -151.32 126.47 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.316 -0.865 . . . . 0.0 110.082 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -53.35 87.95 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.734 -1.229 . . . . 0.0 110.584 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.548 ' HB2' ' CG1' ' A' ' 29' ' ' ILE . 4.9 tp -91.29 87.26 6.41 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' PHE . . . . . 0.642 ' CE1' ' CD1' ' A' ' 32' ' ' LEU . 5.7 m-30 -72.59 148.44 44.9 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.528 ' CG2' ' HA ' ' A' ' 33' ' ' PRO . 34.8 m -122.4 166.53 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.711 -1.243 . . . . 0.0 109.872 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' B' ' 55' ' ' ASP . 1.5 p-10 -93.52 -151.34 0.3 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.57 -0.707 . . . . 0.0 109.25 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.503 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 0.1 OUTLIER -75.56 -46.5 31.6 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.236 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . 0.517 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 1.8 mm? -101.61 36.81 1.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.622 -0.674 . . . . 0.0 109.655 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.539 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.0 OUTLIER 52.77 67.11 1.04 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.192 -0.942 . . . . 0.0 109.583 -179.32 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . 0.565 ' O ' ' N ' ' B' ' 58' ' ' ALA . 29.0 t30 -119.97 86.02 2.49 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.502 HD11 HG22 ' B' ' 57' ' ' ILE . 4.6 mt -31.94 87.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 CA-C-O 121.637 0.732 . . . . 0.0 111.42 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -89.37 -4.63 57.98 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -125.91 133.24 51.94 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.614 ' CG2' ' CG2' ' A' ' 9' ' ' VAL . 93.8 t -90.76 131.21 38.27 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.042 -1.036 . . . . 0.0 111.068 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.58 ' CB ' HG12 ' B' ' 47' ' ' VAL . 37.3 Cg_endo -83.84 161.75 14.05 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.581 2.188 . . . . 0.0 108.813 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . 0.566 ' HD3' ' HA ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -140.58 -49.15 0.44 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.798 -1.189 . . . . 0.0 110.164 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.6 ' CG2' ' CG2' ' B' ' 47' ' ' VAL . 0.8 OUTLIER 76.04 -3.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 O-C-N 121.442 -0.786 . . . . 0.0 109.812 179.508 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 CA-C-O 118.027 -1.429 . . . . 0.0 109.611 -179.925 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.412 ' O ' ' OG1' ' A' ' 3' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.53 ' CB ' ' HB3' ' A' ' 23' ' ' ASP . 1.8 mmpt? -52.81 98.87 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.328 -0.858 . . . . 0.0 109.461 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.525 HG21 ' CD ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -126.28 25.37 6.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.317 -0.864 . . . . 0.0 109.143 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.592 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 3.8 mt-10 -148.45 -44.2 0.15 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.276 -0.89 . . . . 0.0 110.655 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.626 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 6.1 m-90 59.6 41.67 0.6 Allowed Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 121.157 -0.964 . . . . 0.0 109.788 -178.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 34.1 Cg_endo -73.31 -33.36 7.2 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 N-CA-C 107.204 -1.883 . . . . 0.0 107.204 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -70.3 -12.53 61.65 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.534 HD22 ' CD1' ' B' ' 57' ' ' ILE . 49.5 tp -83.69 -4.31 58.5 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 121.385 -0.822 . . . . 0.0 109.262 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.467 ' HA ' HG21 ' B' ' 60' ' ' VAL . 14.7 t -53.69 152.36 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.91 -1.119 . . . . 0.0 109.319 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.465 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 66.85 4.77 28.56 Favored Glycine 0 N--CA 1.481 1.635 0 C-N-CA 119.823 -1.18 . . . . 0.0 110.625 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 2.3 tptp -94.54 -146.88 0.26 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.778 -1.425 . . . . 0.0 109.627 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.491 ' CB ' ' OE2' ' A' ' 14' ' ' GLU . 33.2 m -144.8 169.16 18.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.104 -0.998 . . . . 0.0 109.998 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.452 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 88.4 t -54.21 -34.92 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.488 -0.758 . . . . 0.0 109.902 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.551 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 1.3 pm0 -44.07 -73.75 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.313 -0.867 . . . . 0.0 109.197 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.415 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -61.79 -31.02 71.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.257 -0.902 . . . . 0.0 109.61 179.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.524 ' HB2' ' CD2' ' B' ' 49' ' ' LEU . . . -61.39 -83.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.103 -0.998 . . . . 0.0 109.481 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -46.79 -41.53 15.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.78 -1.2 . . . . 0.0 108.768 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.551 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -44.57 -77.37 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.617 0.722 . . . . 0.0 110.185 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.505 ' O ' ' C ' ' A' ' 20' ' ' ILE . 1.9 t -72.91 -54.35 16.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.728 -0.608 . . . . 0.0 110.225 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.578 HG12 ' CE2' ' A' ' 5' ' ' TRP . 62.5 mt -33.92 -50.74 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.611 -0.681 . . . . 0.0 110.362 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 28' ' ' GLN . 9.6 tt -38.66 -53.88 1.59 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.512 -0.742 . . . . 0.0 110.638 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -123.79 21.22 9.2 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.963 -1.085 . . . . 0.0 111.172 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.53 ' HB3' ' CB ' ' A' ' 2' ' ' LYS . 0.2 OUTLIER -56.66 -60.16 3.95 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 177.648 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.724 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 3.2 tttm -68.23 -153.87 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 104.37 -2.456 . . . . 0.0 104.37 175.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.724 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 27.7 Cg_endo -68.68 -45.81 2.13 Favored 'Trans proline' 0 C--N 1.319 -1.012 0 CA-C-N 121.15 1.446 . . . . 0.0 109.002 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.504 ' CG ' ' C ' ' A' ' 25' ' ' PRO . 1.7 mt-10 -166.34 52.33 0.09 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.62 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -90.22 117.32 28.88 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.176 -1.009 . . . . 0.0 109.33 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.498 ' HB2' ' O ' ' B' ' 45' ' ' ASP . 11.5 mt-30 -88.79 178.49 6.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.155 -0.965 . . . . 0.0 109.152 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.591 ' CD1' ' CG ' ' B' ' 61' ' ' PRO . 8.5 tt -148.75 138.85 16.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 C-N-CA 118.99 -1.084 . . . . 0.0 111.074 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.5 HG23 ' CD2' ' A' ' 32' ' ' LEU . 1.2 mt -91.24 164.24 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.476 ' N ' HG21 ' A' ' 30' ' ' ILE . 7.4 p -131.06 135.84 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.683 -1.261 . . . . 0.0 110.187 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.673 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -150.4 164.22 21.31 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 110.075 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.559 ' HA ' ' CG2' ' B' ' 51' ' ' VAL . 37.0 Cg_endo -80.33 139.57 13.16 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.192 1.928 . . . . 0.0 109.326 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.591 ' HA ' ' CD2' ' B' ' 50' ' ' PHE . 24.1 m -63.66 -10.35 6.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.188 -0.945 . . . . 0.0 109.97 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 34' ' ' VAL . . . -40.66 -84.71 0.01 OUTLIER Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.5 p -99.45 -167.7 1.51 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.267 -1.137 . . . . 0.0 109.827 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.565 ' O ' ' CD1' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -134.4 39.99 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.406 -0.809 . . . . 0.0 108.956 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.79 140.66 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.026 -1.046 . . . . 0.0 109.657 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.432 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . 0.436 ' OE2' ' HB ' ' B' ' 44' ' ' ILE . 8.3 pt-20 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.471 0.653 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . 0.413 ' HD1' ' N ' ' B' ' 43' ' ' ARG . 3.9 p90 -75.31 -148.72 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.527 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.4 OUTLIER -104.59 62.66 0.72 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.774 -1.204 . . . . 0.0 109.589 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.436 ' HB ' ' OE2' ' B' ' 41' ' ' GLU . 11.8 tt -44.88 160.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.938 -1.101 . . . . 0.0 108.037 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.62 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.7 p-10 -127.08 45.83 2.63 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 118.602 -1.239 . . . . 0.0 110.167 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . 0.5 ' NH1' ' HG3' ' B' ' 46' ' ' ARG . 0.0 OUTLIER -152.07 150.55 30.06 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.539 ' CG2' HG21 ' B' ' 63' ' ' VAL . 0.0 OUTLIER -151.4 168.62 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.95 -1.094 . . . . 0.0 109.355 -179.617 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.466 ' NH1' ' HG2' ' B' ' 48' ' ' ARG . 0.0 OUTLIER -97.54 93.8 6.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.969 -1.082 . . . . 0.0 109.333 179.686 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.524 ' CD2' ' HB2' ' A' ' 16' ' ' ALA . 0.9 OUTLIER -88.67 82.05 6.93 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.439 -0.904 . . . . 0.0 109.475 179.745 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' PHE . . . . . 0.591 ' CD2' ' HA ' ' A' ' 34' ' ' VAL . 2.9 m-30 -66.05 158.22 28.97 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.559 ' CG2' ' HA ' ' A' ' 33' ' ' PRO . 12.2 m -118.86 -174.98 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.799 -1.188 . . . . 0.0 109.295 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.502 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.5 OUTLIER -124.86 -154.3 0.61 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.029 -1.044 . . . . 0.0 110.08 -179.531 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.502 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 1.8 mtmp? -60.85 -57.39 12.86 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.606 -0.684 . . . . 0.0 109.653 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . 0.412 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.3 OUTLIER -99.58 44.58 1.02 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.331 -0.856 . . . . 0.0 109.741 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 48.7 63.72 1.99 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.072 -1.018 . . . . 0.0 109.162 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . 0.587 ' O ' ' N ' ' B' ' 58' ' ' ALA . 7.6 t30 -130.25 109.85 11.1 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.534 ' CD1' HD22 ' A' ' 8' ' ' LEU . 23.9 mt -34.34 86.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 121.485 0.659 . . . . 0.0 111.262 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . 0.587 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -89.13 -8.77 53.1 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.47 85.43 2.05 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.467 HG21 ' HA ' ' A' ' 9' ' ' VAL . 2.2 t -48.25 139.49 10.23 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.465 -0.772 . . . . 0.0 110.131 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.591 ' CG ' ' CD1' ' A' ' 29' ' ' ILE . 36.4 Cg_endo -81.21 168.96 16.42 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.856 2.371 . . . . 0.0 109.404 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . 0.532 ' HD2' ' CB ' ' A' ' 4' ' ' GLU . 0.5 OUTLIER -149.89 124.45 9.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.873 -1.142 . . . . 0.0 110.274 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.539 HG21 ' CG2' ' B' ' 47' ' ' VAL . 2.6 t -107.65 152.91 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.339 -0.85 . . . . 0.0 108.788 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 CA-C-O 117.965 -1.464 . . . . 0.0 109.56 179.869 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.481 ' HG2' ' HA ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.4 0.619 . . . . 0.0 109.54 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.487 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . 0.3 OUTLIER -89.1 79.57 7.17 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.304 -0.873 . . . . 0.0 109.465 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.543 ' CG2' ' HD2' ' A' ' 24' ' ' LYS . 2.8 p -108.03 8.09 28.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.284 -0.885 . . . . 0.0 109.503 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.612 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 0.4 OUTLIER -125.5 -57.75 1.45 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.196 -0.94 . . . . 0.0 110.012 -179.118 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.617 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.0 m-90 70.3 39.78 0.18 Allowed Pre-proline 0 C--N 1.3 -1.561 0 O-C-N 121.765 -0.584 . . . . 0.0 110.827 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 33.1 Cg_endo -72.31 -30.18 13.14 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 N-CA-C 107.559 -1.746 . . . . 0.0 107.559 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.51 -17.66 64.75 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.302 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.559 ' CD1' HD11 ' B' ' 57' ' ' ILE . 0.0 OUTLIER -69.48 -23.02 63.58 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 122.254 1.026 . . . . 0.0 108.565 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.568 ' CG2' ' CG2' ' B' ' 60' ' ' VAL . 3.8 t -43.63 138.61 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-O 121.988 0.899 . . . . 0.0 110.88 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.533 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 86.5 -45.55 3.46 Favored Glycine 0 C--N 1.298 -1.581 0 C-N-CA 119.749 -1.215 . . . . 0.0 112.364 175.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.3 78.14 1.08 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 119.951 -1.911 . . . . 0.0 111.492 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.616 ' O ' ' CB ' ' A' ' 16' ' ' ALA . 0.9 OUTLIER -153.18 46.73 0.68 Allowed 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 118.315 -1.354 . . . . 0.0 111.345 179.486 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.408 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 23.9 t -77.28 -73.03 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 O-C-N 121.068 -1.02 . . . . 0.0 109.725 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.484 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 11.6 pt-20 -55.71 -38.25 69.47 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.443 ' HA ' ' HB3' ' A' ' 18' ' ' LYS . 4.3 tt0 -68.48 -32.72 72.9 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.616 ' CB ' ' O ' ' A' ' 12' ' ' SER . . . -62.69 -71.62 0.15 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.096 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.466 ' HA ' ' CG2' ' A' ' 29' ' ' ILE . 0.5 OUTLIER -50.56 -35.58 30.48 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.112 179.613 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.495 ' HG2' ' N ' ' A' ' 19' ' ' VAL . 2.6 ttmt -62.17 -90.29 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.576 0.703 . . . . 0.0 110.742 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.495 ' N ' ' HG2' ' A' ' 18' ' ' LYS . 3.4 t -46.19 -48.32 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.639 -0.663 . . . . 0.0 110.371 -178.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.537 HG12 ' CE2' ' A' ' 5' ' ' TRP . 61.6 mt -50.43 -50.88 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.176 -0.953 . . . . 0.0 109.876 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 3.3 tt -35.13 -29.99 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.679 -0.638 . . . . 0.0 111.544 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.556 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -136.36 3.24 2.81 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 118.002 -1.479 . . . . 0.0 111.98 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' ' 24' ' ' LYS . 22.5 m-20 -54.12 147.17 13.33 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 177.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.688 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 21.9 mtpt 69.86 -147.0 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 104.425 -2.435 . . . . 0.0 104.425 -175.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.688 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 33.2 Cg_endo -75.42 -64.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.324 -0.745 0 CA-C-N 121.36 1.521 . . . . 0.0 108.814 178.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.556 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 26.9 mt-10 -161.06 64.66 0.29 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -88.78 117.53 27.84 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.494 ' CB ' ' O ' ' B' ' 45' ' ' ASP . 0.0 OUTLIER -88.19 175.76 7.56 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.182 -0.949 . . . . 0.0 109.7 -179.47 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.523 HD13 ' CB ' ' B' ' 61' ' ' PRO . 3.3 tt -143.12 147.11 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.225 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.433 HD12 HG22 ' A' ' 30' ' ' ILE . 4.2 mt -102.44 130.89 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.471 HG12 HD22 ' B' ' 49' ' ' LEU . 2.5 t -104.23 125.72 58.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 120.798 -1.189 . . . . 0.0 109.721 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.643 ' CD1' ' CE1' ' B' ' 50' ' ' PHE . 0.7 OUTLIER -138.5 165.45 32.76 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -179.293 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.572 ' HD2' ' HB2' ' A' ' 32' ' ' LEU . 39.4 Cg_endo -79.43 18.65 1.05 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.447 2.098 . . . . 0.0 111.399 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.555 ' CB ' ' O ' ' A' ' 33' ' ' PRO . 3.2 t 81.24 -71.37 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.438 -0.789 . . . . 0.0 108.953 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.506 ' O ' ' CG1' ' A' ' 37' ' ' ILE . . . -49.11 -65.12 2.88 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.478 ' HB ' ' HD2' ' A' ' 33' ' ' PRO . 75.0 m -33.14 120.68 0.37 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.677 -0.896 . . . . 0.0 111.492 -178.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.506 ' CG1' ' O ' ' A' ' 35' ' ' GLY . 3.0 mt -128.49 15.45 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.0 m -57.86 -175.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.497 -0.752 . . . . 0.0 109.946 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.3 p . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 117.896 -1.05 . . . . 0.0 109.509 -179.939 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . 0.497 ' CE2' ' HA ' ' B' ' 44' ' ' ILE . 10.6 p90 -127.36 -145.39 0.31 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.807 -1.183 . . . . 0.0 109.444 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.542 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER -114.91 67.33 0.69 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.139 -0.976 . . . . 0.0 110.213 -179.334 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.506 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.5 OUTLIER -46.96 145.45 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.706 -1.246 . . . . 0.0 108.108 179.187 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.583 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.0 OUTLIER -105.86 43.05 1.16 Allowed 'General case' 0 C--N 1.295 -1.763 0 O-C-N 120.914 -1.116 . . . . 0.0 109.829 -179.338 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . 0.437 ' HG2' ' N ' ' B' ' 47' ' ' VAL . 0.3 OUTLIER -151.02 155.05 38.23 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.366 -0.834 . . . . 0.0 109.477 179.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.555 ' CG2' HG22 ' B' ' 63' ' ' VAL . 15.4 t -150.29 173.42 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 109.456 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.444 ' HD3' ' HA ' ' B' ' 48' ' ' ARG . 20.4 mmt180 -101.59 66.51 1.08 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.982 -1.074 . . . . 0.0 109.942 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.512 ' HB2' ' CD1' ' A' ' 29' ' ' ILE . 3.8 tp -61.49 89.94 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.268 -0.973 . . . . 0.0 109.121 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' PHE . . . . . 0.643 ' CE1' ' CD1' ' A' ' 32' ' ' LEU . 7.3 m-30 -79.26 135.32 36.73 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.505 HG21 ' HA ' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -104.89 -174.94 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.79 -1.194 . . . . 0.0 109.147 179.383 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.533 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.0 OUTLIER -126.48 -162.84 1.18 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.252 -0.905 . . . . 0.0 109.729 -179.687 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.533 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 21.0 mtpt -46.6 -64.74 0.69 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.398 0.618 . . . . 0.0 109.919 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . 0.422 ' O ' ' C ' ' B' ' 55' ' ' ASP . 0.5 OUTLIER -95.38 52.28 1.38 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.793 -179.563 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.422 ' HA ' ' HB ' ' B' ' 51' ' ' VAL . 0.0 OUTLIER 42.72 57.52 3.51 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.351 -0.843 . . . . 0.0 109.654 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . 0.507 ' OD1' ' O ' ' A' ' 10' ' ' GLY . 0.5 OUTLIER -115.6 122.11 44.65 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.412 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.559 HD11 ' CD1' ' A' ' 8' ' ' LEU . 5.0 mt -60.69 89.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.293 -0.88 . . . . 0.0 110.196 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.72 -28.31 20.62 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . 0.408 ' OE1' ' CD2' ' B' ' 50' ' ' PHE . 4.5 tt0 -105.13 133.02 50.61 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.568 ' CG2' ' CG2' ' A' ' 9' ' ' VAL . 58.9 t -89.15 129.11 49.1 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 120.843 -1.161 . . . . 0.0 110.711 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.533 ' HB2' ' CG1' ' B' ' 47' ' ' VAL . 36.6 Cg_endo -82.64 160.54 16.67 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.632 2.222 . . . . 0.0 109.295 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . 0.473 ' N ' HG12 ' B' ' 47' ' ' VAL . 0.0 OUTLIER -150.03 143.14 24.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.906 -1.121 . . . . 0.0 110.062 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.555 HG22 ' CG2' ' B' ' 47' ' ' VAL . 0.9 OUTLIER -111.75 145.16 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.264 0 CA-C-O 117.975 -1.458 . . . . 0.0 109.642 179.895 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 mtm . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.517 ' O ' ' OD2' ' A' ' 23' ' ' ASP . 0.2 OUTLIER -90.18 83.03 5.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 110.231 -179.611 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.453 HG21 ' HE3' ' A' ' 24' ' ' LYS . 4.1 p -89.12 -16.53 31.24 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.935 -1.103 . . . . 0.0 108.548 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.492 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.5 mt-10 -112.04 179.23 4.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.422 -0.799 . . . . 0.0 109.336 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.612 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 14.7 m-90 -150.78 47.3 0.44 Allowed Pre-proline 0 C--N 1.298 -1.658 0 O-C-N 121.52 -0.738 . . . . 0.0 109.79 178.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 31.3 Cg_endo -71.18 -25.72 21.95 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 N-CA-C 107.411 -1.803 . . . . 0.0 107.411 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -69.79 -20.32 63.47 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.496 ' CG ' ' HB3' ' A' ' 5' ' ' TRP . 11.4 mt -83.64 -4.01 58.22 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.496 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.583 ' CG2' ' CG2' ' B' ' 60' ' ' VAL . 22.7 t -55.41 147.78 3.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.106 -0.996 . . . . 0.0 109.833 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.427 ' C ' ' OD1' ' B' ' 56' ' ' ASN . . . 61.65 10.4 23.98 Favored Glycine 0 N--CA 1.481 1.668 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 2.1 tptp -96.12 -144.59 0.28 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.959 -1.318 . . . . 0.0 109.071 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.404 ' CA ' HG12 ' B' ' 57' ' ' ILE . 1.4 m -142.76 165.86 26.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.044 -1.035 . . . . 0.0 109.909 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.496 ' CG2' HG12 ' A' ' 31' ' ' VAL . 76.4 t -50.86 -40.1 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.434 -0.791 . . . . 0.0 109.443 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.536 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 56.7 mt-10 -43.8 -72.1 0.07 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.468 -0.77 . . . . 0.0 109.538 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.433 ' O ' HG22 ' A' ' 19' ' ' VAL . 5.2 tp10 -56.37 -34.62 66.83 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.081 -1.012 . . . . 0.0 109.734 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.494 ' HA ' HD11 ' A' ' 8' ' ' LEU . . . -63.44 -84.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 110.206 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.517 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -44.74 -34.25 2.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.947 -1.096 . . . . 0.0 109.044 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 6.0 ttmt -55.98 -82.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.542 0.687 . . . . 0.0 110.511 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 23' ' ' ASP . 2.0 t -64.28 -49.9 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.545 -0.722 . . . . 0.0 109.769 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.538 ' CG2' ' HB ' ' A' ' 29' ' ' ILE . 77.1 mt -42.54 -54.09 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.364 -0.835 . . . . 0.0 109.47 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 28' ' ' GLN . 4.9 tt -42.1 -45.81 4.08 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.263 -0.898 . . . . 0.0 110.223 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -143.61 54.58 1.33 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.992 -1.068 . . . . 0.0 110.624 -179.188 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.604 ' OD2' ' CZ2' ' A' ' 5' ' ' TRP . 35.0 p-10 -76.23 -28.9 57.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.859 -1.151 . . . . 0.0 108.768 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.734 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -130.72 -83.45 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.055 -1.028 . . . . 0.0 108.692 178.315 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.734 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 42.4 Cg_endo -88.68 -84.93 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.645 0 N-CA-C 108.144 -1.521 . . . . 0.0 108.144 177.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 10.2 mt-10 -162.06 56.3 0.24 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.587 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -88.69 118.12 28.14 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.084 -1.01 . . . . 0.0 109.125 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.506 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 1.8 mt-30 -88.19 178.35 6.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 0.0 109.373 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.538 ' HB ' ' CG2' ' A' ' 20' ' ' ILE . 5.9 tt -147.43 137.67 17.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 C-N-CA 119.204 -0.998 . . . . 0.0 111.011 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.535 ' CD1' ' HD2' ' B' ' 46' ' ' ARG . 8.3 mt -90.28 117.36 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.496 HG12 ' CG2' ' A' ' 13' ' ' VAL . 5.1 t -99.82 140.98 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.797 -1.189 . . . . 0.0 109.75 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.65 ' CD2' ' CE1' ' B' ' 50' ' ' PHE . 0.5 OUTLIER -144.08 162.81 38.67 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.264 -0.897 . . . . 0.0 109.536 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.601 ' O ' ' HB ' ' A' ' 34' ' ' VAL . 37.0 Cg_endo -79.83 16.74 1.4 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.542 2.161 . . . . 0.0 111.592 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.601 ' HB ' ' O ' ' A' ' 33' ' ' PRO . 77.1 t 77.33 -70.04 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.972 -0.455 . . . . 0.0 110.236 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.54 ' C ' ' O ' ' A' ' 34' ' ' VAL . . . -18.07 -52.08 0.01 OUTLIER Glycine 0 N--CA 1.501 2.999 0 N-CA-C 112.11 -0.396 . . . . 0.0 112.11 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.512 ' N ' ' O ' ' A' ' 34' ' ' VAL . 34.7 m -46.15 -91.73 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.993 -1.298 . . . . 0.0 109.949 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.481 ' CG1' ' O ' ' A' ' 36' ' ' THR . 10.4 pt 40.44 87.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.684 -0.635 . . . . 0.0 109.912 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.479 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 18.5 t 71.0 -99.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.449 -0.782 . . . . 0.0 110.225 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.464 ' OXT' ' O ' ' A' ' 36' ' ' THR . 7.4 t . . . . . 0 N--CA 1.492 1.653 0 O-C-N 120.722 -1.236 . . . . 0.0 109.864 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . 0.426 ' O ' ' O ' ' B' ' 42' ' ' TYR . 1.2 mp0 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.251 0.548 . . . . 0.0 109.577 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . 0.426 ' O ' ' O ' ' B' ' 41' ' ' GLU . 49.0 p90 -59.15 -157.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.192 -0.942 . . . . 0.0 109.393 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.583 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER -149.76 67.32 0.99 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.113 -0.992 . . . . 0.0 109.757 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.436 ' O ' HG23 ' B' ' 63' ' ' VAL . 0.7 OUTLIER -48.4 137.1 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.544 -1.347 . . . . 0.0 107.644 179.222 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.587 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 4.3 p-10 -89.62 48.3 1.58 Allowed 'General case' 0 C--N 1.292 -1.896 0 C-N-CA 119.076 -1.05 . . . . 0.0 109.396 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . 0.535 ' HD2' ' CD1' ' A' ' 30' ' ' ILE . 10.1 ttp180 -151.08 151.68 32.33 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.565 ' CG2' ' CG2' ' B' ' 63' ' ' VAL . 61.4 t -151.43 169.34 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.588 ' HB3' ' CE2' ' B' ' 50' ' ' PHE . 12.6 mmt-85 -100.18 84.46 2.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.631 -1.293 . . . . 0.0 110.709 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.558 ' CD1' HD11 ' B' ' 57' ' ' ILE . 4.2 tp -84.68 97.69 9.79 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 118.933 -1.107 . . . . 0.0 108.62 178.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' PHE . . . . . 0.65 ' CE1' ' CD2' ' A' ' 32' ' ' LEU . 52.4 m-85 -92.88 131.71 37.66 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 178.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.556 ' CG2' ' HA ' ' A' ' 33' ' ' PRO . 12.9 m -89.08 178.04 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.619 -1.301 . . . . 0.0 110.349 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.511 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.8 OUTLIER -107.89 -151.72 0.47 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.354 -0.841 . . . . 0.0 109.775 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.511 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 1.2 mmtp -74.03 -48.47 29.86 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . 0.478 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.1 OUTLIER -98.99 38.19 1.42 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.39 -0.819 . . . . 0.0 109.503 179.534 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.0 OUTLIER 50.48 67.62 0.89 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.165 -0.96 . . . . 0.0 109.181 -179.413 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . 0.565 ' O ' ' N ' ' B' ' 58' ' ' ALA . 1.2 t30 -133.58 117.35 16.98 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.558 HD11 ' CD1' ' B' ' 49' ' ' LEU . 27.0 mm -46.88 87.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-O 121.384 0.612 . . . . 0.0 109.823 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -89.32 -25.46 21.62 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -105.01 129.42 53.46 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.583 ' CG2' ' CG2' ' A' ' 9' ' ' VAL . 85.3 t -82.56 126.35 73.82 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.054 -1.029 . . . . 0.0 109.989 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.536 ' CB ' HG13 ' B' ' 47' ' ' VAL . 37.0 Cg_endo -81.36 158.91 19.87 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 C-N-CA 122.403 2.068 . . . . 0.0 110.199 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . 0.48 ' N ' HG12 ' B' ' 47' ' ' VAL . 0.3 OUTLIER -150.91 130.62 13.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.054 -1.029 . . . . 0.0 109.839 179.411 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.565 ' CG2' ' CG2' ' B' ' 47' ' ' VAL . 1.1 t -106.18 124.58 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.308 -0.87 . . . . 0.0 108.901 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.881 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 mmt . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.42 ' HD3' ' HA ' ' A' ' 2' ' ' LYS . 3.3 mmtp -85.99 71.53 10.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.062 -1.024 . . . . 0.0 109.604 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.474 ' OG1' ' CD ' ' A' ' 24' ' ' LYS . 2.1 m -99.56 -15.74 18.52 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.382 -0.824 . . . . 0.0 109.475 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.72 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.7 mt-10 -102.4 -36.43 8.44 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.112 -0.993 . . . . 0.0 110.026 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.647 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 7.8 m-90 56.2 47.33 2.87 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 121.018 -1.051 . . . . 0.0 109.249 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.72 ' HD3' ' HB2' ' A' ' 4' ' ' GLU . 33.4 Cg_endo -74.99 -37.39 2.06 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 N-CA-C 106.789 -2.043 . . . . 0.0 106.789 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -8.62 50.07 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 114.524 -1.216 . . . . 0.0 107.797 177.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.488 HD22 ' CB ' ' A' ' 16' ' ' ALA . 13.2 tp -83.2 -2.03 54.51 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 121.289 -0.882 . . . . 0.0 109.198 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.575 ' CG2' ' CG2' ' B' ' 60' ' ' VAL . 17.7 t -57.18 149.54 4.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.021 -1.049 . . . . 0.0 109.459 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.56 8.67 21.27 Favored Glycine 0 N--CA 1.481 1.688 0 C-N-CA 119.858 -1.163 . . . . 0.0 110.309 178.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 17.0 tptt -91.1 -145.63 0.19 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.789 -1.418 . . . . 0.0 109.161 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' B' ' 55' ' ' ASP . 0.4 OUTLIER -145.71 160.88 41.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.029 -1.045 . . . . 0.0 109.894 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.537 HG21 ' CG1' ' B' ' 51' ' ' VAL . 53.7 t -51.89 -32.48 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.339 -0.851 . . . . 0.0 109.19 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.547 ' O ' ' CG ' ' A' ' 18' ' ' LYS . 5.4 mt-10 -43.05 -74.06 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.97 -37.37 79.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.559 -0.713 . . . . 0.0 109.993 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.488 ' CB ' HD22 ' A' ' 8' ' ' LEU . . . -59.44 -80.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 0.0 110.04 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.524 ' HA ' ' CG2' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -47.21 -32.86 4.8 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.469 -1.394 . . . . 0.0 109.347 -179.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.547 ' CG ' ' O ' ' A' ' 14' ' ' GLU . 16.1 mtpt -58.86 -85.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.753 0.787 . . . . 0.0 110.953 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.522 ' O ' ' N ' ' A' ' 23' ' ' ASP . 2.8 t -57.83 -41.33 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.592 -0.692 . . . . 0.0 110.08 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.608 HD13 ' CD1' ' A' ' 5' ' ' TRP . 0.3 OUTLIER -48.73 -52.31 9.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.352 -0.843 . . . . 0.0 109.16 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.461 ' C ' ' O ' ' A' ' 20' ' ' ILE . 0.7 OUTLIER -38.14 -40.86 0.54 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.685 -0.635 . . . . 0.0 110.125 -179.581 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -140.38 40.88 1.91 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.112 -0.993 . . . . 0.0 109.765 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 19' ' ' VAL . 18.8 p-10 -52.09 -42.93 63.63 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.336 -0.852 . . . . 0.0 109.493 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.736 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -130.75 -78.69 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.444 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.715 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.736 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 40.6 Cg_endo -87.57 -80.79 0.0 OUTLIER 'Trans proline' 0 C--O 1.214 -0.717 0 N-CA-C 107.78 -1.662 . . . . 0.0 107.78 177.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 22.4 mt-10 -161.96 62.08 0.24 Allowed 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.607 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -87.92 121.25 30.11 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.989 -1.069 . . . . 0.0 110.236 -178.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.405 ' HB3' ' O ' ' B' ' 45' ' ' ASP . 1.1 tp60 -88.59 176.15 7.25 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.057 -1.027 . . . . 0.0 108.242 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.588 ' HB ' ' CG2' ' A' ' 20' ' ' ILE . 9.4 tt -148.9 137.53 14.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 120.7 -1.25 . . . . 0.0 111.193 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.485 ' O ' ' HB3' ' B' ' 49' ' ' LEU . 0.8 OUTLIER -88.92 152.89 3.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.011 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.501 HG22 ' CG2' ' A' ' 13' ' ' VAL . 7.6 p -135.02 134.93 53.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 118.813 -1.155 . . . . 0.0 110.298 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.687 ' CD1' ' CE1' ' B' ' 50' ' ' PHE . 0.4 OUTLIER -150.68 149.97 27.14 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.44 -0.787 . . . . 0.0 109.283 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 35' ' ' GLY . 37.9 Cg_endo -78.24 58.62 6.71 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.735 2.29 . . . . 0.0 111.725 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.493 ' HA ' ' CD1' ' B' ' 50' ' ' PHE . 22.0 t 44.16 -93.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.119 -0.988 . . . . 0.0 109.402 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . 43.53 -149.85 0.64 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.7 t -95.36 157.67 15.79 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.31 -1.112 . . . . 0.0 109.38 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -66.85 -36.66 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.288 -0.883 . . . . 0.0 109.484 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.457 ' O ' ' OXT' ' A' ' 39' ' ' THR . 2.5 p -80.1 125.57 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.097 -1.002 . . . . 0.0 109.487 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.457 ' OXT' ' O ' ' A' ' 38' ' ' VAL . 23.3 m . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.322 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . 0.581 ' CE2' ' HA ' ' B' ' 44' ' ' ILE . 15.1 p90 -121.43 -158.13 0.75 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.868 -1.145 . . . . 0.0 109.345 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.533 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 2.0 ptt-85 -91.6 57.02 3.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 109.929 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.581 ' HA ' ' CE2' ' B' ' 42' ' ' TYR . 0.3 OUTLIER -44.75 142.54 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.893 -1.129 . . . . 0.0 108.458 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.607 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.1 p-10 -102.1 48.67 0.87 Allowed 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.127 -1.029 . . . . 0.0 110.058 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . 0.409 ' C ' HG21 ' B' ' 47' ' ' VAL . 0.1 OUTLIER -150.71 146.34 26.38 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.533 HG21 ' CG2' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -150.47 143.7 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 120.968 -1.083 . . . . 0.0 109.317 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -78.67 88.05 4.58 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.99 -1.069 . . . . 0.0 110.796 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.519 ' HB2' HD12 ' A' ' 29' ' ' ILE . 2.1 tp -90.41 97.22 11.05 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.141 -1.024 . . . . 0.0 108.657 178.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' PHE . . . . . 0.687 ' CE1' ' CD1' ' A' ' 32' ' ' LEU . 16.6 m-85 -92.35 110.72 22.12 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.537 ' CG1' HG21 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -89.77 172.08 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.906 -1.121 . . . . 0.0 110.947 -178.856 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' B' ' 54' ' ' LEU . 0.7 OUTLIER -94.66 -153.04 0.37 Allowed 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.683 0.754 . . . . 0.0 109.715 -179.233 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.521 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 6.2 mttm -76.84 -47.42 21.46 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . 0.522 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.0 OUTLIER -95.83 39.69 1.13 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.577 -0.702 . . . . 0.0 109.488 179.553 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.0 OUTLIER 47.75 67.29 0.84 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.12 -0.987 . . . . 0.0 109.123 -179.756 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' B' ' 58' ' ' ALA . 17.8 t-20 -127.33 94.12 3.91 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.658 0.742 . . . . 0.0 109.011 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.472 HD11 ' HG ' ' A' ' 8' ' ' LEU . 4.5 mt -39.68 87.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.301 0.572 . . . . 0.0 111.066 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -89.48 -19.65 24.82 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -118.19 106.1 12.48 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.575 ' CG2' ' CG2' ' A' ' 9' ' ' VAL . 35.4 t -62.52 133.87 94.88 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.227 -0.921 . . . . 0.0 110.345 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.477 ' O ' ' HD3' ' B' ' 62' ' ' ARG . 36.2 Cg_endo -79.81 163.38 23.56 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 122.531 2.154 . . . . 0.0 109.398 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . 0.514 ' N ' HG13 ' B' ' 47' ' ' VAL . 0.0 OUTLIER -150.55 128.08 11.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.971 -1.081 . . . . 0.0 110.102 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.533 ' CG2' HG21 ' B' ' 47' ' ' VAL . 1.8 t -106.37 151.34 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.263 -0.898 . . . . 0.0 109.073 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.901 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mtt . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.296 0.57 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 23' ' ' ASP . 16.7 mmtp -85.11 71.17 10.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.177 -0.952 . . . . 0.0 109.552 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.558 ' CG2' ' HE2' ' A' ' 24' ' ' LYS . 0.3 OUTLIER -101.23 -24.13 14.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.257 -0.902 . . . . 0.0 109.598 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.573 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 6.9 mt-10 -94.33 -44.56 7.88 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.264 -0.897 . . . . 0.0 109.999 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.62 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.5 m-90 64.19 41.83 0.36 Allowed Pre-proline 0 C--N 1.296 -1.724 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.109 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 34.4 Cg_endo -73.14 -30.46 10.6 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 N-CA-C 106.929 -1.989 . . . . 0.0 106.929 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.67 -13.88 62.25 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 177.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.497 HD12 HD11 ' B' ' 57' ' ' ILE . 0.0 OUTLIER -81.89 -5.6 58.4 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.534 HG21 ' CG2' ' B' ' 60' ' ' VAL . 25.2 t -53.29 151.94 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.0 -1.063 . . . . 0.0 109.745 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.488 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 62.83 7.27 15.19 Favored Glycine 0 N--CA 1.482 1.716 0 C-N-CA 119.982 -1.104 . . . . 0.0 110.422 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -93.55 -142.56 0.23 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.833 -1.392 . . . . 0.0 109.183 179.646 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -148.73 161.48 41.68 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.994 -1.066 . . . . 0.0 109.89 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.407 ' O ' ' C ' ' A' ' 14' ' ' GLU . 39.9 t -46.39 -35.82 2.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.415 -0.803 . . . . 0.0 109.048 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.538 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 1.5 mt-10 -44.84 -73.88 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.511 -0.743 . . . . 0.0 109.066 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.478 ' O ' HG22 ' A' ' 19' ' ' VAL . 1.9 tm-20 -55.92 -34.5 65.65 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.192 -0.942 . . . . 0.0 109.555 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.534 ' CB ' HD23 ' B' ' 49' ' ' LEU . . . -62.82 -85.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.088 -1.008 . . . . 0.0 110.166 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -42.87 -45.45 4.93 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.837 -1.165 . . . . 0.0 108.914 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 6.1 tptm -42.37 -76.13 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.573 0.702 . . . . 0.0 110.584 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.482 ' O ' ' C ' ' A' ' 20' ' ' ILE . 1.0 OUTLIER -78.16 -52.81 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.459 -0.776 . . . . 0.0 110.402 -178.39 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.532 HD11 ' CD1' ' A' ' 29' ' ' ILE . 60.1 mt -37.98 -34.72 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.394 -0.816 . . . . 0.0 110.004 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' ' 19' ' ' VAL . 2.4 tt -56.09 -52.98 62.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.081 -1.012 . . . . 0.0 110.357 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.405 ' HB2' HD21 ' A' ' 21' ' ' LEU . 0.4 OUTLIER -128.59 64.21 1.43 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.925 -1.109 . . . . 0.0 111.045 -178.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -84.42 -50.55 7.67 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.412 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.711 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 10.0 mtpp -101.05 -105.77 0.0 OUTLIER Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.711 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 37.2 Cg_endo -80.16 -70.98 0.01 OUTLIER 'Trans proline' 0 C--O 1.213 -0.738 0 CA-C-N 121.873 1.705 . . . . 0.0 108.059 177.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 25' ' ' PRO . 30.8 mt-10 -162.76 70.2 0.26 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.609 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -88.51 120.48 29.93 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.871 -1.143 . . . . 0.0 109.233 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.82 168.61 11.94 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.193 -0.942 . . . . 0.0 109.642 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.532 ' CD1' HD11 ' A' ' 20' ' ' ILE . 21.4 tt -146.91 140.34 19.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.351 -0.843 . . . . 0.0 109.944 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.531 ' CD1' ' HG2' ' B' ' 46' ' ' ARG . 1.7 mp -88.97 142.35 13.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.486 ' C ' ' CD2' ' A' ' 32' ' ' LEU . 4.0 p -105.82 133.04 51.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.47 -0.892 . . . . 0.0 109.491 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.675 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -150.73 166.18 15.69 Favored Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.238 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.529 ' O ' ' CG2' ' A' ' 34' ' ' VAL . 37.4 Cg_endo -78.9 -93.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.301 -1.945 0 C-N-CA 121.703 1.602 . . . . 0.0 111.284 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 33' ' ' PRO . 1.8 t -171.94 -35.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 120.803 -1.186 . . . . 0.0 109.012 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 34' ' ' VAL . . . -38.46 160.06 0.01 OUTLIER Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -48.65 104.2 0.06 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -1.14 . . . . 0.0 109.534 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.9 mt 50.16 -94.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.249 -0.907 . . . . 0.0 109.621 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.45 ' N ' ' O ' ' A' ' 36' ' ' THR . 18.7 m -141.31 167.9 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.013 -1.055 . . . . 0.0 109.679 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.424 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.711 0.767 . . . . 0.0 109.452 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . 0.431 ' O ' ' OXT' ' B' ' 64' ' ' GLY . 28.6 p90 -100.58 -153.53 0.45 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.57 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 2.5 ptt180 -109.57 66.83 0.64 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.711 -1.243 . . . . 0.0 110.296 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.517 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.3 OUTLIER -47.52 142.91 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.82 -1.175 . . . . 0.0 107.955 178.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.609 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.5 p-10 -102.39 44.43 1.01 Allowed 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.004 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . 0.531 ' HG2' ' CD1' ' A' ' 30' ' ' ILE . 0.8 OUTLIER -151.09 142.69 23.6 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 178.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.528 ' CG1' ' O ' ' B' ' 62' ' ' ARG . 0.0 OUTLIER -150.59 157.75 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.126 -0.984 . . . . 0.0 109.319 -179.296 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 3.1 mmt180 -92.98 100.96 13.31 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.72 -1.237 . . . . 0.0 110.328 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.534 HD23 ' CB ' ' A' ' 16' ' ' ALA . 0.8 OUTLIER -95.45 96.02 8.82 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.263 -0.975 . . . . 0.0 108.872 178.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' PHE . . . . . 0.633 ' CE1' HD11 ' A' ' 32' ' ' LEU . 24.6 m-85 -93.26 143.53 26.17 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.49 ' HB ' ' HA ' ' B' ' 55' ' ' ASP . 6.1 m -107.21 -151.57 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.769 -1.207 . . . . 0.0 110.858 -179.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.532 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.2 OUTLIER -141.92 -157.47 0.77 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.426 -0.796 . . . . 0.0 109.68 -179.478 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.532 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 2.8 mtmp? -57.42 -59.02 5.77 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.667 -0.646 . . . . 0.0 109.509 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . 0.428 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 6.7 tp -96.2 42.82 1.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.437 -0.789 . . . . 0.0 109.619 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.49 ' HA ' ' HB ' ' B' ' 51' ' ' VAL . 0.0 OUTLIER 49.2 62.7 2.47 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.101 -0.999 . . . . 0.0 109.567 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . 0.551 ' O ' ' N ' ' B' ' 58' ' ' ALA . 4.0 t30 -122.59 106.19 10.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.311 -0.868 . . . . 0.0 108.808 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.497 HD11 HD12 ' A' ' 8' ' ' LEU . 28.0 mt -42.06 89.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.496 0.665 . . . . 0.0 110.374 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.48 -17.82 29.54 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -114.92 135.39 54.26 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.534 ' CG2' HG21 ' A' ' 9' ' ' VAL . 71.1 t -88.05 128.05 55.23 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.014 -1.054 . . . . 0.0 110.542 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.486 ' O ' ' HD3' ' B' ' 62' ' ' ARG . 36.3 Cg_endo -79.76 158.36 24.69 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.317 2.012 . . . . 0.0 108.41 177.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . 0.528 ' CD ' ' HA ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -150.54 133.05 15.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.768 -1.208 . . . . 0.0 110.409 -179.612 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.485 HG23 ' HB2' ' A' ' 27' ' ' ALA . 2.1 t -109.06 -25.58 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . 0.509 ' N ' HG23 ' A' ' 3' ' ' THR . . . . . . . . 0 N--CA 1.491 2.348 0 CA-C-O 117.94 -1.478 . . . . 0.0 109.594 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mmt . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.509 ' HB3' ' HB2' ' A' ' 23' ' ' ASP . 3.2 tppt? -84.16 72.73 10.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.064 -1.023 . . . . 0.0 109.969 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.458 ' O ' ' HG3' ' B' ' 62' ' ' ARG . 2.4 m -109.67 6.84 24.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.147 -0.97 . . . . 0.0 109.05 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.608 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 27.7 mt-10 -118.82 -40.8 2.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -0.903 . . . . 0.0 109.914 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.641 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 9.6 m-90 61.7 41.92 0.49 Allowed Pre-proline 0 C--N 1.299 -1.621 0 O-C-N 121.524 -0.735 . . . . 0.0 110.092 -178.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 32.6 Cg_endo -72.49 -30.34 12.44 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 N-CA-C 106.468 -2.166 . . . . 0.0 106.468 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -16.05 63.17 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.086 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.528 ' CD1' ' CD1' ' A' ' 5' ' ' TRP . 7.2 mt -81.5 -5.78 58.3 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 121.302 -0.874 . . . . 0.0 109.293 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.604 ' CG2' ' CG2' ' B' ' 60' ' ' VAL . 23.7 t -57.0 148.04 4.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.148 -0.97 . . . . 0.0 109.81 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.421 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 60.12 10.19 14.1 Favored Glycine 0 N--CA 1.48 1.578 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.472 178.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.49 ' HB3' HD11 ' B' ' 57' ' ' ILE . 0.1 OUTLIER -94.65 -145.43 0.26 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.925 -1.338 . . . . 0.0 109.068 179.693 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.465 ' O ' HD13 ' B' ' 57' ' ' ILE . 0.3 OUTLIER -141.85 161.17 38.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.991 -1.068 . . . . 0.0 110.075 -179.546 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.477 HG22 HG13 ' B' ' 51' ' ' VAL . 79.1 t -45.16 -38.5 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.195 -0.941 . . . . 0.0 109.207 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.542 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 2.4 mt-10 -44.41 -75.28 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.409 ' O ' HG22 ' A' ' 19' ' ' VAL . 1.9 tp10 -53.46 -32.69 51.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.165 -0.959 . . . . 0.0 109.623 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.505 ' CB ' HD13 ' B' ' 49' ' ' LEU . . . -62.58 -85.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 110.578 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.94 -29.45 4.78 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.757 -1.215 . . . . 0.0 109.271 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 16.6 tptm -56.78 -77.95 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.31 0.576 . . . . 0.0 110.749 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 15' ' ' GLU . 1.5 t -69.3 -43.49 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.353 -0.842 . . . . 0.0 109.849 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.609 HG12 ' CE2' ' A' ' 5' ' ' TRP . 63.5 mt -48.13 -55.32 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.896 . . . . 0.0 110.003 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.464 ' C ' ' O ' ' A' ' 20' ' ' ILE . 1.2 tt -36.04 -35.84 0.08 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.584 -0.697 . . . . 0.0 110.794 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 20' ' ' ILE . 1.0 OUTLIER -141.91 56.87 1.49 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.02 -1.05 . . . . 0.0 109.718 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.509 ' HB2' ' HB3' ' A' ' 2' ' ' LYS . 26.6 p-10 -70.66 -31.46 68.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.923 . . . . 0.0 109.015 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.707 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -133.84 -97.85 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.702 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.707 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 36.2 Cg_endo -78.63 -68.72 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.716 0 N-CA-C 107.422 -1.799 . . . . 0.0 107.422 176.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.515 ' CG ' ' O ' ' A' ' 25' ' ' PRO . 25.8 mt-10 -163.84 72.26 0.26 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.529 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -88.36 114.73 25.27 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.068 -1.02 . . . . 0.0 108.875 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.509 ' CB ' ' O ' ' B' ' 45' ' ' ASP . 0.0 OUTLIER -89.06 171.99 9.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.253 -0.904 . . . . 0.0 109.197 -179.6 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.531 ' CD1' ' HB2' ' B' ' 49' ' ' LEU . 14.9 tt -149.31 146.58 17.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.823 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.544 HD11 ' N ' ' A' ' 30' ' ' ILE . 1.2 mp -89.04 155.78 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.549 ' CG1' HD11 ' B' ' 49' ' ' LEU . 2.0 t -127.91 116.24 42.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 118.555 -1.258 . . . . 0.0 110.956 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.644 ' HB2' ' HD2' ' A' ' 33' ' ' PRO . 0.7 OUTLIER -141.37 168.03 15.32 Favored Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.1 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.644 ' HD2' ' HB2' ' A' ' 32' ' ' LEU . 37.6 Cg_endo -75.58 -96.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 121.187 1.258 . . . . 0.0 109.328 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.513 ' CG1' ' O ' ' A' ' 33' ' ' PRO . 17.6 m -158.98 13.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 120.86 -1.15 . . . . 0.0 109.518 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -158.32 -79.94 0.03 OUTLIER Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.424 ' O ' ' CG ' ' A' ' 33' ' ' PRO . 7.9 p -95.95 144.47 26.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.376 -1.073 . . . . 0.0 109.593 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.491 ' C ' ' CG2' ' A' ' 38' ' ' VAL . 11.3 mt -74.36 99.08 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.236 -0.915 . . . . 0.0 109.404 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.491 ' CG2' ' C ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER 39.8 -97.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.496 -0.752 . . . . 0.0 109.822 -179.849 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.467 ' N ' ' O ' ' A' ' 37' ' ' ILE . 63.9 p . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.004 -1.06 . . . . 0.0 109.454 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.33 0.586 . . . . 0.0 109.581 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . 0.472 ' O ' ' HA2' ' B' ' 64' ' ' GLY . 2.1 t80 -167.45 135.77 2.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.862 . . . . 0.0 108.961 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.576 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 6.6 ptt-85 -122.58 55.14 1.17 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.233 -0.917 . . . . 0.0 109.607 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.459 ' O ' HG23 ' B' ' 63' ' ' VAL . 0.9 OUTLIER -48.05 136.05 4.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 120.622 -1.299 . . . . 0.0 108.132 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -90.13 38.65 0.94 Allowed 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.446 -0.901 . . . . 0.0 110.282 -178.445 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . 0.417 ' HG3' HD12 ' A' ' 30' ' ' ILE . 0.9 OUTLIER -141.11 146.98 37.79 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.634 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.584 ' CG2' ' CG2' ' B' ' 63' ' ' VAL . 63.5 t -151.59 169.26 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.102 -0.999 . . . . 0.0 109.365 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.419 ' N ' ' CG1' ' B' ' 47' ' ' VAL . 17.0 mmt-85 -99.5 95.52 7.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.718 -1.239 . . . . 0.0 109.57 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.56 ' C ' ' CD2' ' B' ' 49' ' ' LEU . 0.1 OUTLIER -90.67 82.54 5.77 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 118.954 -1.098 . . . . 0.0 109.293 179.465 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' PHE . . . . . 0.631 ' CE1' ' CD1' ' A' ' 32' ' ' LEU . 6.5 m-30 -74.46 145.46 43.6 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.528 ' CG2' ' HA ' ' A' ' 33' ' ' PRO . 14.1 m -127.02 176.54 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.573 -1.329 . . . . 0.0 110.742 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.481 ' OD2' ' HG2' ' B' ' 53' ' ' LYS . 0.0 OUTLIER -111.58 -171.76 1.9 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.481 ' HG2' ' OD2' ' B' ' 52' ' ' ASP . 1.8 ptmt -51.95 -53.41 41.66 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.965 -1.084 . . . . 0.0 110.781 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . 0.406 ' C ' ' CG ' ' B' ' 55' ' ' ASP . 0.2 OUTLIER -88.96 38.08 0.87 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.964 -1.085 . . . . 0.0 108.797 179.706 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.501 ' HA ' ' HB ' ' B' ' 51' ' ' VAL . 0.0 OUTLIER 51.35 51.42 16.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.688 -0.632 . . . . 0.0 109.458 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . 0.514 ' O ' ' N ' ' B' ' 58' ' ' ALA . 30.5 t30 -101.06 112.43 24.89 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.376 -0.827 . . . . 0.0 109.552 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.49 HD11 ' HB3' ' A' ' 11' ' ' LYS . 43.5 mt -51.9 91.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.581 -0.699 . . . . 0.0 109.276 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.12 -23.78 23.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.578 -0.701 . . . . 0.0 109.11 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.53 126.33 54.87 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.604 ' CG2' ' CG2' ' A' ' 9' ' ' VAL . 42.2 t -78.67 129.87 72.65 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 120.971 -1.081 . . . . 0.0 109.925 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.541 ' HB2' HG12 ' B' ' 47' ' ' VAL . 36.7 Cg_endo -83.69 159.94 14.3 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.671 2.247 . . . . 0.0 111.189 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . 0.552 ' NH1' ' HB ' ' B' ' 60' ' ' VAL . 0.1 OUTLIER -147.23 146.05 29.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.261 179.036 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.584 ' CG2' ' CG2' ' B' ' 47' ' ' VAL . 1.2 t -117.9 136.97 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.011 -1.056 . . . . 0.0 109.34 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' B' ' 42' ' ' TYR . . . . . . . . 0 N--CA 1.488 2.154 0 CA-C-O 117.922 -1.488 . . . . 0.0 109.518 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.521 ' O ' ' N ' ' A' ' 3' ' ' THR . 9.2 tmm? . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.114 0.483 . . . . 0.0 109.933 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.492 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -50.6 87.7 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.26 -0.9 . . . . 0.0 110.363 -179.57 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 1' ' ' MET . 59.5 p -94.48 -29.16 15.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.949 -1.094 . . . . 0.0 108.359 178.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.518 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 4.6 mt-10 -100.78 174.6 5.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.539 -0.725 . . . . 0.0 109.146 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.624 ' CE2' HG12 ' A' ' 20' ' ' ILE . 17.9 m-90 -145.61 46.75 0.59 Allowed Pre-proline 0 C--N 1.298 -1.644 0 O-C-N 121.592 -0.693 . . . . 0.0 109.334 178.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 30.5 Cg_endo -70.31 -27.7 23.51 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 N-CA-C 107.796 -1.655 . . . . 0.0 107.796 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.43 -19.34 62.99 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.531 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -87.33 -3.34 59.03 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.62 ' CG2' ' CG2' ' B' ' 60' ' ' VAL . 41.0 t -53.41 150.34 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 120.929 -1.107 . . . . 0.0 110.016 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.519 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 68.54 0.45 17.62 Favored Glycine 0 N--CA 1.48 1.598 0 C-N-CA 120.092 -1.051 . . . . 0.0 111.032 177.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -93.55 -154.78 0.42 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.625 -1.515 . . . . 0.0 109.321 179.732 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.4 ' O ' HD12 ' B' ' 57' ' ' ILE . 0.6 OUTLIER -134.98 177.88 7.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.113 -0.992 . . . . 0.0 110.197 -179.464 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.49 ' HA ' HD13 ' B' ' 49' ' ' LEU . 54.0 t -52.98 -43.03 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.526 -0.734 . . . . 0.0 110.199 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.533 ' O ' ' CG ' ' A' ' 18' ' ' LYS . 3.9 mt-10 -41.88 -71.07 0.09 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.387 -0.82 . . . . 0.0 109.41 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -56.62 -36.83 69.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.594 -0.691 . . . . 0.0 110.052 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.555 ' CA ' HD13 ' A' ' 20' ' ' ILE . . . -62.21 -81.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.192 -0.943 . . . . 0.0 110.032 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -46.22 -29.98 1.81 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.655 -1.278 . . . . 0.0 109.168 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 14' ' ' GLU . 4.4 mmtt -62.33 -84.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.628 0.728 . . . . 0.0 110.678 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.2 t -56.53 -46.4 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.526 -0.734 . . . . 0.0 109.766 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.624 HG12 ' CE2' ' A' ' 5' ' ' TRP . 87.7 mt -49.44 -58.27 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.238 -0.914 . . . . 0.0 109.386 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 28' ' ' GLN . 3.3 tt -35.66 -33.97 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.693 -0.629 . . . . 0.0 110.796 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.8 OUTLIER -150.48 50.25 0.88 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.993 -1.067 . . . . 0.0 110.509 -179.631 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.489 ' OD2' ' HD2' ' A' ' 2' ' ' LYS . 2.8 t0 -73.48 -52.81 12.33 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.985 -1.072 . . . . 0.0 108.73 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.822 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.7 OUTLIER -102.38 -92.38 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.366 0 CA-C-O 117.451 -1.261 . . . . 0.0 108.058 178.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.822 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 39.5 Cg_endo -87.05 -74.14 0.0 OUTLIER 'Trans proline' 0 C--O 1.213 -0.727 0 CA-C-N 121.765 1.666 . . . . 0.0 108.229 177.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.509 ' CG ' ' O ' ' A' ' 25' ' ' PRO . 21.2 mt-10 -162.47 56.94 0.22 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.601 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -87.93 117.91 27.12 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.192 -0.943 . . . . 0.0 108.845 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 3.4 tt0 -88.4 -176.87 5.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.324 -0.86 . . . . 0.0 109.786 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.505 ' HA ' HG22 ' B' ' 47' ' ' VAL . 11.6 tt -145.8 145.57 20.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.766 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.529 HG21 ' N ' ' A' ' 31' ' ' VAL . 7.8 mm -91.41 145.5 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.529 ' N ' HG21 ' A' ' 30' ' ' ILE . 8.0 p -99.05 125.53 52.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 120.814 -1.179 . . . . 0.0 109.775 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.686 ' CD1' ' CE1' ' B' ' 50' ' ' PHE . 0.5 OUTLIER -143.55 156.51 60.05 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.035 -1.04 . . . . 0.0 110.182 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.567 ' O ' ' O ' ' A' ' 34' ' ' VAL . 40.5 Cg_endo -81.27 42.22 1.3 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 123.014 2.476 . . . . 0.0 111.125 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.595 ' HA ' ' CG ' ' B' ' 50' ' ' PHE . 2.4 p 42.23 100.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.329 -0.857 . . . . 0.0 109.303 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -141.07 -85.69 0.1 OUTLIER Glycine 0 N--CA 1.487 2.091 0 C-N-CA 119.62 -1.276 . . . . 0.0 110.746 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.556 ' O ' ' CB ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -69.39 -78.65 0.07 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.159 -1.2 . . . . 0.0 110.739 -178.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.59 ' CG1' ' CE2' ' B' ' 50' ' ' PHE . 1.7 tt 86.33 122.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.428 ' O ' ' O ' ' A' ' 37' ' ' ILE . 71.1 t 57.23 106.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.156 -0.965 . . . . 0.0 109.409 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.363 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . 0.586 ' CE2' ' HA ' ' B' ' 44' ' ' ILE . 21.8 p90 -129.53 -158.85 0.92 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 109.845 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.566 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 7.8 ptt-85 -91.88 70.47 5.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.421 -0.799 . . . . 0.0 109.834 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.586 ' HA ' ' CE2' ' B' ' 42' ' ' TYR . 0.4 OUTLIER -47.52 144.55 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.573 -1.329 . . . . 0.0 108.256 179.518 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.601 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -103.41 44.57 1.01 Allowed 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 119.053 -1.059 . . . . 0.0 109.419 -179.528 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . 0.478 ' HG2' HG12 ' A' ' 30' ' ' ILE . 7.6 mtt180 -150.32 153.11 35.53 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.538 ' CG2' HG22 ' B' ' 63' ' ' VAL . 0.0 OUTLIER -150.94 -176.97 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.72 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.421 ' HD3' ' HA ' ' B' ' 48' ' ' ARG . 25.7 mmt180 -111.89 79.8 1.25 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.793 -1.192 . . . . 0.0 110.026 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.535 HD13 ' CB ' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -62.18 94.74 0.06 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.226 -0.921 . . . . 0.0 109.172 179.456 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' PHE . . . . . 0.686 ' CE1' ' CD1' ' A' ' 32' ' ' LEU . 1.6 m-30 -80.22 130.47 35.24 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.534 ' O ' ' CG1' ' A' ' 34' ' ' VAL . 4.4 m -113.52 -176.46 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.593 -1.317 . . . . 0.0 110.741 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.498 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 1.4 p-10 -116.24 -151.07 0.47 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.463 -0.773 . . . . 0.0 109.93 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.498 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 0.9 OUTLIER -70.88 -51.06 28.64 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.407 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . 0.481 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 1.5 tp -100.07 44.6 1.01 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.469 -0.769 . . . . 0.0 109.186 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.424 ' CG ' ' C ' ' B' ' 54' ' ' LEU . 0.0 OUTLIER 44.39 67.35 0.7 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.302 -0.874 . . . . 0.0 110.029 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . 0.573 ' O ' ' N ' ' B' ' 58' ' ' ALA . 11.7 t30 -127.4 92.53 3.52 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.517 HD11 HG22 ' B' ' 57' ' ' ILE . 13.6 mt -30.06 86.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-O 121.54 0.686 . . . . 0.0 111.157 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.11 -27.38 21.96 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . 0.488 ' HB3' ' CB ' ' B' ' 50' ' ' PHE . 32.5 tp60 -113.83 130.76 56.43 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.62 ' CG2' ' CG2' ' A' ' 9' ' ' VAL . 91.2 t -87.29 134.46 36.38 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 120.979 -1.075 . . . . 0.0 110.859 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.472 ' O ' ' HD3' ' B' ' 62' ' ' ARG . 36.8 Cg_endo -79.76 169.45 18.15 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.558 2.172 . . . . 0.0 109.148 178.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . 0.523 ' O ' ' CG1' ' B' ' 47' ' ' VAL . 0.2 OUTLIER -150.18 135.05 17.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.976 -1.078 . . . . 0.0 110.06 -179.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.538 HG22 ' CG2' ' B' ' 47' ' ' VAL . 2.3 t -109.12 150.26 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.328 -0.858 . . . . 0.0 109.316 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.911 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.476 ' HA ' ' HG2' ' A' ' 24' ' ' LYS . 7.1 ptt? . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.266 0.555 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.471 ' CD ' ' O ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -86.11 82.61 8.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.212 -0.93 . . . . 0.0 109.739 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.532 ' CA ' ' HD3' ' A' ' 24' ' ' LYS . 18.6 p -88.66 -12.79 41.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.172 -0.955 . . . . 0.0 109.053 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.473 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 0.6 OUTLIER -110.32 169.6 8.63 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.277 -0.89 . . . . 0.0 108.824 179.244 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.621 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 15.1 m-90 -150.1 45.05 0.34 Allowed Pre-proline 0 C--N 1.294 -1.826 0 O-C-N 121.57 -0.706 . . . . 0.0 109.26 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 31.2 Cg_endo -69.12 -31.19 23.89 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 N-CA-C 108.232 -1.488 . . . . 0.0 108.232 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -69.66 -19.61 63.6 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 177.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.583 ' HB3' ' HB3' ' A' ' 5' ' ' TRP . 14.8 tp -84.29 -9.08 58.78 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.493 0.663 . . . . 0.0 109.247 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.454 HG22 HG22 ' B' ' 60' ' ' VAL . 10.4 t -55.69 152.39 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 119.086 -1.045 . . . . 0.0 108.873 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.432 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 66.87 4.16 25.67 Favored Glycine 0 N--CA 1.48 1.61 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.229 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.556 ' HB3' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -95.76 -143.5 0.27 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.875 -1.368 . . . . 0.0 109.276 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.493 ' CB ' ' OE2' ' A' ' 14' ' ' GLU . 2.2 m -145.02 168.12 21.03 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.068 -1.02 . . . . 0.0 110.192 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.496 ' CG2' HG13 ' B' ' 51' ' ' VAL . 48.5 t -51.3 -38.6 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.571 -0.706 . . . . 0.0 109.875 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.55 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -42.52 -75.75 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.153 -179.615 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.34 -33.34 65.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.34 -0.85 . . . . 0.0 109.682 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.581 ' CB ' ' CD2' ' B' ' 49' ' ' LEU . . . -62.18 -85.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.404 -0.81 . . . . 0.0 110.439 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.523 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -46.75 -31.89 3.27 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.044 -1.035 . . . . 0.0 108.827 -179.331 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.55 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 5.3 tttp -56.41 -83.35 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.425 0 CA-C-O 121.323 0.582 . . . . 0.0 110.549 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 20' ' ' ILE . 2.4 t -62.53 -48.68 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.507 -0.746 . . . . 0.0 109.842 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.581 HG12 ' CE2' ' A' ' 5' ' ' TRP . 88.9 mt -43.83 -45.17 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.23 -0.919 . . . . 0.0 109.538 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.461 HD22 ' HB2' ' A' ' 22' ' ' GLN . 0.9 OUTLIER -49.26 -44.59 43.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.252 -0.905 . . . . 0.0 111.239 -179.247 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.461 ' HB2' HD22 ' A' ' 21' ' ' LEU . 4.0 mt-30 -137.03 41.17 2.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.693 -1.254 . . . . 0.0 111.413 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.496 ' OD1' ' O ' ' A' ' 20' ' ' ILE . 1.3 p-10 -67.89 -49.46 61.88 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.722 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 1.0 OUTLIER -94.6 -116.05 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.476 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.314 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.722 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 37.2 Cg_endo -80.79 -66.47 0.02 OUTLIER 'Trans proline' 0 C--O 1.215 -0.664 0 CA-C-N 122.327 1.867 . . . . 0.0 108.035 178.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.487 ' CG ' ' O ' ' A' ' 25' ' ' PRO . 18.8 mt-10 -161.29 60.45 0.28 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -88.25 116.71 26.65 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.034 -1.041 . . . . 0.0 108.197 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.463 ' O ' ' HA ' ' B' ' 46' ' ' ARG . 3.7 tt0 -88.24 176.49 7.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.066 -1.021 . . . . 0.0 110.105 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.548 ' CD1' ' HB2' ' B' ' 49' ' ' LEU . 19.1 tt -143.66 149.79 17.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 O-C-N 121.183 -0.948 . . . . 0.0 110.67 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.51 HG21 ' N ' ' A' ' 31' ' ' VAL . 4.1 mm -97.66 146.44 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.51 ' N ' HG21 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -110.51 134.33 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.565 -1.334 . . . . 0.0 110.269 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.649 ' CD1' ' CE1' ' B' ' 50' ' ' PHE . 0.6 OUTLIER -152.67 165.72 16.94 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.756 -0.59 . . . . 0.0 109.509 -179.716 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.574 ' HD2' ' HB2' ' A' ' 32' ' ' LEU . 38.3 Cg_endo -80.66 24.38 0.67 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.495 2.13 . . . . 0.0 110.804 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.565 ' CB ' ' O ' ' A' ' 33' ' ' PRO . 2.8 t 81.34 -71.72 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.416 -0.803 . . . . 0.0 109.147 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 34' ' ' VAL . . . -48.23 -104.52 0.01 OUTLIER Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.473 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 0.3 OUTLIER -77.17 160.93 28.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.141 -1.211 . . . . 0.0 109.394 -179.649 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.492 HG21 ' N ' ' A' ' 38' ' ' VAL . 9.6 tt -112.91 -39.69 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 0.0 109.409 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.492 ' N ' HG21 ' A' ' 37' ' ' ILE . 26.0 m -103.52 -22.33 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.287 -0.883 . . . . 0.0 109.553 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.486 HG21 ' O ' ' A' ' 38' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.823 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . 0.454 ' O ' ' HB3' ' B' ' 42' ' ' TYR . 6.8 mt-10 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . 0.608 ' CE2' ' HA ' ' B' ' 44' ' ' ILE . 4.0 t80 61.8 157.22 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.087 -1.008 . . . . 0.0 108.856 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.56 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER -96.38 70.45 2.69 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.188 -0.945 . . . . 0.0 110.99 -178.576 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.608 ' HA ' ' CE2' ' B' ' 42' ' ' TYR . 0.3 OUTLIER -50.69 139.92 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 120.274 -1.517 . . . . 0.0 107.438 178.351 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.562 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 2.8 p30 -95.35 45.75 1.1 Allowed 'General case' 0 C--N 1.294 -1.848 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.281 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . 0.509 ' HG2' ' N ' ' B' ' 47' ' ' VAL . 6.0 ttt180 -149.26 156.39 42.05 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.484 -0.76 . . . . 0.0 109.175 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.522 HG21 ' CG2' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -151.75 -173.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.547 ' HD2' ' CD2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -112.15 69.05 0.68 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.868 -1.145 . . . . 0.0 111.212 -179.187 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.581 ' CD2' ' CB ' ' A' ' 16' ' ' ALA . 1.9 tm? -56.49 94.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.005 -1.059 . . . . 0.0 108.253 178.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' PHE . . . . . 0.649 ' CE1' ' CD1' ' A' ' 32' ' ' LEU . 8.2 m-30 -86.25 143.78 27.76 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.496 HG13 ' CG2' ' A' ' 13' ' ' VAL . 15.3 m -122.4 -175.28 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.844 -1.16 . . . . 0.0 109.578 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.499 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.4 OUTLIER -126.91 -154.76 0.65 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.408 -0.808 . . . . 0.0 109.868 -179.69 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.499 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 8.7 mttt -63.45 -54.79 31.06 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.457 0.646 . . . . 0.0 109.262 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . 0.462 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 2.9 mm? -98.48 44.07 1.04 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.534 -0.729 . . . . 0.0 109.806 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' B' ' 55' ' ' ASP . 0.0 OUTLIER 48.32 64.17 1.77 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.248 -0.908 . . . . 0.0 109.65 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . 0.536 ' O ' ' N ' ' B' ' 58' ' ' ALA . 0.0 OUTLIER -124.77 98.74 5.84 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.434 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.476 HD12 ' HB3' ' A' ' 16' ' ' ALA . 32.1 mt -44.27 91.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 121.491 0.663 . . . . 0.0 109.822 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.3 -20.33 25.56 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -128.23 104.17 7.59 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.491 HG12 ' HB2' ' A' ' 5' ' ' TRP . 5.0 t -73.69 134.93 78.39 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.226 -0.921 . . . . 0.0 110.397 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.494 ' HG3' HD12 ' A' ' 29' ' ' ILE . 37.7 Cg_endo -84.04 -175.55 2.27 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 122.735 2.29 . . . . 0.0 109.677 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . 0.406 ' O ' ' CG1' ' B' ' 47' ' ' VAL . 0.1 OUTLIER -151.09 144.48 24.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.053 -1.029 . . . . 0.0 110.045 179.599 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.522 ' CG2' HG21 ' B' ' 47' ' ' VAL . 1.6 t -110.85 -26.28 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . 0.449 ' N ' ' HB ' ' A' ' 3' ' ' THR . . . . . . . . 0 N--CA 1.489 2.19 0 CA-C-O 118.008 -1.44 . . . . 0.0 109.515 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 mmt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.547 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -67.14 99.14 0.65 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.036 -1.04 . . . . 0.0 109.584 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.56 ' CG2' ' HD2' ' A' ' 24' ' ' LYS . 21.0 p -140.98 -41.12 0.39 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.92 . . . . 0.0 108.53 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.594 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -90.31 -35.93 14.97 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.547 -0.721 . . . . 0.0 109.824 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.621 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.5 m-90 58.49 41.54 0.66 Allowed Pre-proline 0 C--N 1.296 -1.737 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.467 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 33.7 Cg_endo -72.94 -34.05 6.99 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 N-CA-C 107.119 -1.916 . . . . 0.0 107.119 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -69.44 -9.72 54.87 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.336 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.597 ' O ' ' CD2' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -80.16 -8.42 59.41 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 121.299 -0.875 . . . . 0.0 109.106 -179.47 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.595 ' CG2' ' CG2' ' B' ' 60' ' ' VAL . 35.4 t -48.66 149.84 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 120.882 -1.136 . . . . 0.0 110.437 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.453 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 67.98 2.31 23.57 Favored Glycine 0 N--CA 1.484 1.888 0 C-N-CA 120.142 -1.028 . . . . 0.0 111.138 177.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.501 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -93.41 -149.44 0.27 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.745 -1.444 . . . . 0.0 109.601 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.61 164.39 29.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.109 -0.994 . . . . 0.0 110.325 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.488 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 48.1 t -52.23 -34.93 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.461 -0.775 . . . . 0.0 109.062 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.542 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -44.36 -66.56 0.37 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.307 -0.871 . . . . 0.0 109.095 179.787 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.457 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -62.76 -34.04 76.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.093 -1.004 . . . . 0.0 109.303 179.297 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.532 ' HB2' ' CD2' ' B' ' 49' ' ' LEU . . . -62.11 -82.85 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.125 -0.985 . . . . 0.0 109.604 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.468 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -44.02 -42.07 5.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.951 -1.093 . . . . 0.0 108.905 179.813 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -47.48 -78.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.588 0.708 . . . . 0.0 110.339 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.458 ' O ' ' OD1' ' A' ' 23' ' ' ASP . 1.6 t -71.14 -55.27 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.7 -0.625 . . . . 0.0 110.116 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.577 HG12 ' CE2' ' A' ' 5' ' ' TRP . 95.3 mt -39.53 -34.82 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.524 -0.735 . . . . 0.0 109.872 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.1 tp -48.12 -52.22 21.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.367 -0.833 . . . . 0.0 110.759 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.578 ' O ' ' N ' ' A' ' 24' ' ' LYS . 0.8 OUTLIER -112.32 -66.88 1.04 Allowed 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.672 -1.211 . . . . 0.0 111.492 -178.373 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.546 ' CB ' ' HB3' ' A' ' 2' ' ' LYS . 0.4 OUTLIER 38.78 -92.81 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.41 -0.806 . . . . 0.0 108.875 -179.022 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.728 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 2.8 mtpm? -64.27 -131.72 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.422 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 177.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.728 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 32.5 Cg_endo -74.67 -64.41 0.03 OUTLIER 'Trans proline' 0 C--O 1.215 -0.662 0 CA-C-N 122.084 1.78 . . . . 0.0 108.825 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.49 ' CG ' ' C ' ' A' ' 25' ' ' PRO . 9.7 mt-10 -162.17 70.49 0.31 Allowed 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -88.85 117.47 27.87 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.522 ' CB ' ' O ' ' B' ' 45' ' ' ASP . 1.1 tt0 -87.2 173.55 9.15 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.951 -1.093 . . . . 0.0 109.249 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.555 HD12 ' CB ' ' B' ' 61' ' ' PRO . 5.4 tt -150.06 128.58 2.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 C-N-CA 118.999 -1.08 . . . . 0.0 110.741 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.435 HG23 ' CD2' ' A' ' 32' ' ' LEU . 2.9 mm -88.74 141.67 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.469 HG22 ' CG2' ' A' ' 13' ' ' VAL . 11.8 p -113.94 131.29 66.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 120.84 -1.163 . . . . 0.0 110.217 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.652 ' CD1' ' CE1' ' B' ' 50' ' ' PHE . 0.2 OUTLIER -143.21 161.98 45.19 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.489 -0.757 . . . . 0.0 109.381 179.444 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 32' ' ' LEU . 36.1 Cg_endo -76.79 142.97 23.14 Favored 'Trans proline' 0 C--N 1.301 -1.936 0 C-N-CA 121.946 1.764 . . . . 0.0 108.528 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.487 ' O ' ' O ' ' A' ' 35' ' ' GLY . 17.3 m -67.45 -1.44 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.087 -1.008 . . . . 0.0 110.573 -178.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 34' ' ' VAL . . . -57.11 -157.02 0.01 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -44.74 147.81 0.59 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.091 -1.24 . . . . 0.0 109.94 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.476 HG23 ' CG2' ' A' ' 38' ' ' VAL . 2.8 mp -117.03 -87.49 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.331 -0.856 . . . . 0.0 109.634 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.476 ' CG2' HG23 ' A' ' 37' ' ' ILE . 3.7 t -94.12 -52.55 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.065 -1.022 . . . . 0.0 109.612 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.409 ' O ' ' OG1' ' A' ' 39' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.565 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.541 0.686 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . 0.496 ' CD1' ' N ' ' B' ' 42' ' ' TYR . 0.0 OUTLIER -71.18 -110.14 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.519 -0.738 . . . . 0.0 109.552 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.542 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 2.5 ptt180 -113.7 44.87 1.53 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.715 -1.241 . . . . 0.0 109.124 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.523 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.4 OUTLIER -43.03 141.93 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 119.148 -1.021 . . . . 0.0 108.567 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.554 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.6 p-10 -102.51 47.01 0.9 Allowed 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 119.188 -1.005 . . . . 0.0 109.819 -178.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . 0.432 ' O ' HG21 ' B' ' 47' ' ' VAL . 3.9 ttm180 -151.9 148.13 27.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.383 -0.823 . . . . 0.0 110.119 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.567 ' CG2' ' CG2' ' B' ' 63' ' ' VAL . 53.7 t -151.41 154.83 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.494 ' HB3' ' CE1' ' B' ' 50' ' ' PHE . 10.5 mmt180 -88.06 66.7 8.68 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.601 -1.312 . . . . 0.0 110.372 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.546 HD12 ' CD1' ' B' ' 57' ' ' ILE . 2.5 tp -60.79 90.11 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.089 -1.007 . . . . 0.0 109.383 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' PHE . . . . . 0.652 ' CE1' ' CD1' ' A' ' 32' ' ' LEU . 3.8 m-30 -76.26 156.06 33.83 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 32' ' ' LEU . 1.8 m -121.31 176.73 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.73 -1.232 . . . . 0.0 109.68 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.492 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.4 OUTLIER -109.22 -154.95 0.55 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.252 -0.905 . . . . 0.0 109.774 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.492 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 2.7 mtpt -67.8 -53.97 22.86 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.536 -0.728 . . . . 0.0 109.465 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' B' ' 54' ' ' LEU . 3.2 mm? -95.88 42.9 1.09 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 109.567 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' B' ' 55' ' ' ASP . 0.0 OUTLIER 48.14 65.01 1.43 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.156 -0.965 . . . . 0.0 109.28 -179.727 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' B' ' 58' ' ' ALA . 8.9 t30 -130.01 106.68 8.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.385 -0.822 . . . . 0.0 108.846 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.546 ' CD1' HD12 ' B' ' 49' ' ' LEU . 15.6 mm -39.61 90.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-O 121.646 0.736 . . . . 0.0 110.68 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.09 -27.12 22.15 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -111.79 136.15 51.45 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.595 ' CG2' ' CG2' ' A' ' 9' ' ' VAL . 43.1 t -90.01 127.93 51.81 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.837 -1.165 . . . . 0.0 110.609 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.555 ' CB ' HD12 ' A' ' 29' ' ' ILE . 36.5 Cg_endo -79.72 157.04 24.55 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.378 2.052 . . . . 0.0 109.215 177.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . 0.547 ' HD2' ' CA ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -146.12 142.98 29.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.838 -1.164 . . . . 0.0 110.588 -179.396 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.567 ' CG2' ' CG2' ' B' ' 47' ' ' VAL . 0.9 OUTLIER -129.05 114.1 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.446 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.379 0 CA-C-O 117.869 -1.517 . . . . 0.0 109.579 -179.886 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.554 ' N ' ' HG2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -80.85 90.89 5.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.64 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.521 ' CG2' ' HE3' ' A' ' 24' ' ' LYS . 0.9 OUTLIER -89.4 -46.53 8.66 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.109 -0.994 . . . . 0.0 108.782 179.544 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.542 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 2.6 mp0 -89.78 167.43 12.87 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.349 -0.844 . . . . 0.0 109.361 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.62 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 20.9 m-90 -141.09 46.0 0.82 Allowed Pre-proline 0 C--N 1.294 -1.836 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 31.2 Cg_endo -69.6 -27.32 27.36 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 N-CA-C 108.21 -1.496 . . . . 0.0 108.21 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -69.66 -20.03 63.59 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.54 ' CD1' HD11 ' B' ' 57' ' ' ILE . 0.0 OUTLIER -82.27 -8.66 59.64 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.63 ' CG2' ' CG2' ' B' ' 60' ' ' VAL . 20.6 t -48.81 154.14 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.095 -1.003 . . . . 0.0 110.004 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.504 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 65.71 2.43 11.59 Favored Glycine 0 N--CA 1.482 1.717 0 C-N-CA 120.252 -0.975 . . . . 0.0 110.883 178.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -93.69 -143.7 0.23 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.709 -1.465 . . . . 0.0 109.393 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.438 ' HB3' ' CD ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -144.46 167.52 22.29 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.964 -1.085 . . . . 0.0 110.121 -179.701 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.545 ' CG2' HG12 ' A' ' 31' ' ' VAL . 71.6 t -50.82 -40.96 20.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.531 -0.731 . . . . 0.0 109.796 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.544 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -44.68 -69.02 0.15 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.502 -0.749 . . . . 0.0 109.352 -179.763 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.454 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -58.07 -31.13 66.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.176 -0.952 . . . . 0.0 109.415 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.557 ' CB ' HD12 ' B' ' 57' ' ' ILE . . . -64.9 -84.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.045 -1.034 . . . . 0.0 109.954 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.48 ' HG2' HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -45.2 -34.89 2.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.986 -1.071 . . . . 0.0 109.086 -179.556 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.544 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 20.5 tttp -55.02 -75.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.508 0.671 . . . . 0.0 111.334 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' A' ' 23' ' ' ASP . 1.5 t -70.28 -46.1 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.486 -0.759 . . . . 0.0 110.968 -177.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.589 HG12 ' CE2' ' A' ' 5' ' ' TRP . 2.6 mt -53.28 -50.55 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.02 -1.05 . . . . 0.0 109.871 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 20' ' ' ILE . 2.3 tt -39.4 -28.08 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.265 -0.897 . . . . 0.0 110.642 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.475 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -149.9 26.82 0.8 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.875 -1.14 . . . . 0.0 110.675 -179.714 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -54.49 -64.15 0.92 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.731 -1.23 . . . . 0.0 108.194 179.182 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.748 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 3.5 mtpm? -80.47 -117.58 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 106.841 -1.541 . . . . 0.0 106.841 178.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.748 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 36.7 Cg_endo -79.92 -64.2 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.69 0 CA-C-N 122.103 1.787 . . . . 0.0 108.612 178.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.473 ' CG ' ' O ' ' A' ' 25' ' ' PRO . 27.2 mt-10 -159.97 60.97 0.36 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.567 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -88.53 117.31 27.39 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.185 -1.006 . . . . 0.0 108.61 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.45 ' CB ' ' O ' ' B' ' 45' ' ' ASP . 1.7 tt0 -88.6 169.78 11.41 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.199 -0.938 . . . . 0.0 109.965 -178.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.525 ' CD1' ' HB2' ' B' ' 49' ' ' LEU . 19.8 tt -140.6 135.14 34.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.51 -0.743 . . . . 0.0 109.52 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.455 HD11 ' N ' ' A' ' 30' ' ' ILE . 1.2 mp -88.76 128.57 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.545 HG12 ' CG2' ' A' ' 13' ' ' VAL . 25.3 t -94.72 136.3 26.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 118.518 -1.273 . . . . 0.0 110.487 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.633 ' CD1' ' CE1' ' B' ' 50' ' ' PHE . 0.8 OUTLIER -147.31 156.66 46.18 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.689 -0.632 . . . . 0.0 109.347 179.764 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.534 ' O ' ' N ' ' A' ' 35' ' ' GLY . 37.9 Cg_endo -81.71 60.63 7.67 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.779 2.32 . . . . 0.0 109.3 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.485 ' CG2' ' C ' ' A' ' 33' ' ' PRO . 0.1 OUTLIER 45.75 -90.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.532 -0.73 . . . . 0.0 109.442 -179.055 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . 42.36 -151.59 0.27 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.31 -148.02 0.27 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.214 -1.168 . . . . 0.0 109.174 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.459 ' O ' HG23 ' A' ' 39' ' ' THR . 0.9 OUTLIER -59.76 -172.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.15 -0.969 . . . . 0.0 109.117 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.528 ' O ' ' CG2' ' A' ' 39' ' ' THR . 7.3 p -42.54 -38.85 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.092 -1.005 . . . . 0.0 109.746 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.528 ' CG2' ' O ' ' A' ' 38' ' ' VAL . 9.0 t . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 118.085 -0.959 . . . . 0.0 109.745 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . 0.597 ' CE2' ' HA ' ' B' ' 44' ' ' ILE . 10.4 p90 -127.51 -162.58 1.18 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.917 . . . . 0.0 109.337 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.512 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 5.6 ptt180 -92.98 64.46 3.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.027 -1.046 . . . . 0.0 109.907 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.597 ' HA ' ' CE2' ' B' ' 42' ' ' TYR . 0.5 OUTLIER -45.82 146.22 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.946 -1.096 . . . . 0.0 108.73 179.585 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.567 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -110.86 40.91 1.91 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.391 -0.924 . . . . 0.0 109.953 -179.74 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . 0.429 ' NH1' HG12 ' A' ' 30' ' ' ILE . 0.2 OUTLIER -150.23 144.56 25.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.42 -0.8 . . . . 0.0 108.994 179.192 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.534 ' CG1' ' O ' ' B' ' 62' ' ' ARG . 0.0 OUTLIER -151.16 164.77 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.087 -1.008 . . . . 0.0 108.857 -179.747 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.447 ' HG3' ' CD2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -91.9 89.42 7.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.745 -1.222 . . . . 0.0 110.46 -179.241 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.525 ' HB2' ' CD1' ' A' ' 29' ' ' ILE . 4.0 tp -78.87 91.32 4.76 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' PHE . . . . . 0.633 ' CE1' ' CD1' ' A' ' 32' ' ' LEU . 4.1 m-30 -77.54 179.74 6.34 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.536 ' CG1' ' HA ' ' B' ' 55' ' ' ASP . 0.0 OUTLIER -148.01 -173.58 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.865 -1.147 . . . . 0.0 109.515 179.514 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.54 ' OD2' ' CB ' ' B' ' 56' ' ' ASN . 5.5 p-10 -116.7 -146.43 0.4 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.316 -0.865 . . . . 0.0 109.253 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.531 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 8.7 mmtp -62.28 -55.62 26.54 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.241 -0.912 . . . . 0.0 110.131 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . 0.551 ' O ' ' CB ' ' B' ' 55' ' ' ASP . 2.4 mp -103.28 17.02 25.04 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.997 -1.065 . . . . 0.0 111.687 -178.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' B' ' 54' ' ' LEU . 0.2 OUTLIER 91.43 47.87 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.459 0 CA-C-O 122.583 1.182 . . . . 0.0 110.623 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' B' ' 58' ' ' ALA . 1.9 t-20 -106.56 97.36 7.16 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.97 -1.081 . . . . 0.0 108.3 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.557 HD12 ' CB ' ' A' ' 16' ' ' ALA . 43.8 mt -37.28 88.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 121.549 0.69 . . . . 0.0 110.914 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.95 -31.26 18.25 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -99.69 134.94 41.85 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.63 ' CG2' ' CG2' ' A' ' 9' ' ' VAL . 65.1 t -90.12 129.44 45.85 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.092 -1.005 . . . . 0.0 111.21 -178.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.49 ' CB ' HD13 ' A' ' 29' ' ' ILE . 36.3 Cg_endo -81.84 162.53 18.56 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.308 2.005 . . . . 0.0 108.928 177.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . 0.534 ' O ' ' CG1' ' B' ' 47' ' ' VAL . 0.0 OUTLIER -150.91 132.62 14.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.659 -1.275 . . . . 0.0 110.711 -179.69 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.483 HG21 ' CG2' ' B' ' 47' ' ' VAL . 2.2 t -109.63 130.51 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.468 -0.77 . . . . 0.0 109.044 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.381 0 CA-C-O 117.952 -1.471 . . . . 0.0 109.717 179.74 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpp? . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.593 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -90.94 34.64 0.91 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.162 -0.961 . . . . 0.0 110.083 -179.845 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.507 HG23 ' NZ ' ' A' ' 24' ' ' LYS . 16.1 p -88.48 -20.45 25.13 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.573 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 9.8 mp0 -104.15 -28.98 11.14 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.547 0.689 . . . . 0.0 109.151 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.625 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 8.7 m-90 53.12 42.22 1.15 Allowed Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 119.507 -0.877 . . . . 0.0 108.946 -177.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.625 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 35.1 Cg_endo -73.0 -34.83 5.96 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 N-CA-C 107.447 -1.79 . . . . 0.0 107.447 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.73 -12.0 61.29 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 32.1 tp -81.21 -6.0 58.37 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 121.49 -0.756 . . . . 0.0 109.31 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.49 HG11 ' N ' ' A' ' 10' ' ' GLY . 21.0 t -54.37 152.48 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 120.942 -1.099 . . . . 0.0 109.034 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.49 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 64.11 7.14 22.78 Favored Glycine 0 N--CA 1.48 1.601 0 C-N-CA 119.94 -1.124 . . . . 0.0 110.44 178.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 5.2 tptt -93.92 -141.26 0.23 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.825 -1.397 . . . . 0.0 109.441 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.532 ' CA ' HG13 ' B' ' 57' ' ' ILE . 48.4 m -149.89 167.17 27.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.939 -1.101 . . . . 0.0 110.454 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.462 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 97.1 t -50.35 -34.05 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.49 -0.756 . . . . 0.0 109.814 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 27.1 mt-10 -45.87 -77.94 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.384 -0.822 . . . . 0.0 109.065 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.69 -31.28 62.3 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.333 -0.854 . . . . 0.0 109.388 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.539 ' HB2' ' CD1' ' B' ' 49' ' ' LEU . . . -62.02 -85.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.44 -0.788 . . . . 0.0 110.616 -179.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.46 ' HG2' HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -48.26 -29.81 4.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.634 -1.291 . . . . 0.0 108.994 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.503 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -57.6 -82.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.413 0.625 . . . . 0.0 111.116 -179.445 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -64.8 -40.21 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.369 -0.832 . . . . 0.0 110.315 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.569 HG12 ' CE2' ' A' ' 5' ' ' TRP . 98.5 mt -51.8 -56.17 6.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.336 -0.852 . . . . 0.0 109.82 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.46 ' C ' ' O ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -36.88 -29.76 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.51 -0.743 . . . . 0.0 110.593 -179.521 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 20' ' ' ILE . 2.2 mt-30 -148.74 52.53 0.99 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.023 -1.048 . . . . 0.0 109.855 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.499 ' OD2' ' HA ' ' A' ' 3' ' ' THR . 3.8 t0 -53.32 -62.81 1.41 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.985 -1.072 . . . . 0.0 108.409 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.798 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -115.98 -66.8 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 120.748 -1.22 . . . . 0.0 109.201 178.537 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.798 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 42.2 Cg_endo -91.25 -82.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.324 -0.748 0 N-CA-C 108.135 -1.525 . . . . 0.0 108.135 178.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.486 ' CG ' ' C ' ' A' ' 25' ' ' PRO . 16.9 mt-10 -161.45 65.46 0.27 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -87.7 115.32 25.06 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.246 -0.982 . . . . 0.0 108.843 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.453 ' CB ' ' O ' ' B' ' 45' ' ' ASP . 1.8 tt0 -87.92 170.27 11.3 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.233 -0.917 . . . . 0.0 108.774 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.535 ' CD1' ' HB2' ' B' ' 49' ' ' LEU . 12.9 tt -142.3 133.17 24.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 118.719 -1.192 . . . . 0.0 110.576 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.1 mm -87.68 107.09 16.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.518 ' HA ' ' HB3' ' B' ' 49' ' ' LEU . 19.5 t -89.0 146.88 5.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.108 -0.995 . . . . 0.0 110.88 -178.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.652 ' CD1' ' CE1' ' B' ' 50' ' ' PHE . 0.8 OUTLIER -150.33 164.91 18.8 Favored Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.547 ' HD2' ' HB2' ' A' ' 32' ' ' LEU . 36.4 Cg_endo -77.93 25.18 0.51 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.408 2.072 . . . . 0.0 111.558 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.535 ' CB ' ' O ' ' A' ' 33' ' ' PRO . 0.4 OUTLIER 79.72 -11.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.095 -1.003 . . . . 0.0 110.087 179.446 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 36' ' ' THR . . . -55.52 -177.99 0.24 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 35' ' ' GLY . 18.4 p -45.91 169.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -1.162 . . . . 0.0 109.234 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 pp -86.44 -8.36 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.207 -0.933 . . . . 0.0 109.438 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.482 ' O ' ' CG2' ' A' ' 38' ' ' VAL . 14.2 m -91.05 113.9 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.221 -0.924 . . . . 0.0 109.32 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.3 m . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.532 -179.955 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.187 0.518 . . . . 0.0 109.641 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . 0.43 ' O ' ' HA2' ' B' ' 64' ' ' GLY . 27.4 p90 -111.16 -147.4 0.42 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.187 -0.946 . . . . 0.0 109.461 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.527 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER -107.03 55.91 0.65 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.869 -1.144 . . . . 0.0 110.363 -179.151 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.518 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.3 OUTLIER -46.06 139.56 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.648 -1.283 . . . . 0.0 108.356 179.504 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.525 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -99.4 44.86 1.01 Allowed 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.202 -0.936 . . . . 0.0 109.8 -178.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -149.65 145.59 26.82 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.596 ' CG2' ' CG2' ' B' ' 63' ' ' VAL . 60.9 t -151.8 169.35 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 109.779 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.422 ' HG3' HD22 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -99.12 95.26 6.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.726 -1.234 . . . . 0.0 109.849 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.539 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -88.21 84.0 6.92 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.015 -1.053 . . . . 0.0 109.277 179.265 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' PHE . . . . . 0.652 ' CE1' ' CD1' ' A' ' 32' ' ' LEU . 4.4 m-30 -72.43 138.09 46.89 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.499 ' CG2' ' O ' ' A' ' 32' ' ' LEU . 2.6 m -123.6 -171.18 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.676 -1.265 . . . . 0.0 110.231 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.569 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.0 OUTLIER -129.72 -168.13 1.91 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.893 0.854 . . . . 0.0 110.006 -179.221 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.569 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 13.8 mttm -43.6 -68.95 0.15 Allowed 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.331 0.586 . . . . 0.0 110.071 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . 0.404 ' CG ' ' O ' ' B' ' 54' ' ' LEU . 0.6 OUTLIER -89.96 47.2 1.43 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 0.0 109.742 -179.59 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 47.62 57.39 5.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.294 -0.879 . . . . 0.0 109.828 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . 0.549 ' O ' ' N ' ' B' ' 58' ' ' ALA . 7.0 t30 -106.42 96.42 6.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.139 -0.976 . . . . 0.0 109.055 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.532 HG13 ' CA ' ' A' ' 12' ' ' SER . 12.2 mt -42.79 91.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 121.5 0.667 . . . . 0.0 109.681 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -87.77 -17.43 31.64 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -129.23 96.9 4.43 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.479 HG22 ' CG2' ' A' ' 9' ' ' VAL . 1.6 t -56.54 137.02 77.0 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.32 -0.862 . . . . 0.0 109.952 -178.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.555 ' HB2' ' CG1' ' B' ' 47' ' ' VAL . 36.2 Cg_endo -80.93 160.15 21.09 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.846 2.364 . . . . 0.0 110.22 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . 0.534 ' HD2' ' CB ' ' A' ' 4' ' ' GLU . 0.8 OUTLIER -141.96 134.44 28.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.137 -0.977 . . . . 0.0 109.622 179.798 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.596 ' CG2' ' CG2' ' B' ' 47' ' ' VAL . 1.0 OUTLIER -110.22 147.54 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.209 -0.932 . . . . 0.0 108.996 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' B' ' 42' ' ' TYR . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 mmt . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.511 ' O ' ' CE2' ' A' ' 5' ' ' TRP . 19.0 mmtm -90.01 43.22 1.13 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.161 -0.962 . . . . 0.0 109.786 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.531 ' CG2' ' HE2' ' A' ' 24' ' ' LYS . 0.2 OUTLIER -90.51 -16.3 29.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.152 -0.967 . . . . 0.0 109.406 179.816 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.598 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 13.7 mt-10 -100.09 -43.14 6.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.323 -0.861 . . . . 0.0 110.289 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.645 ' CE2' HG12 ' A' ' 20' ' ' ILE . 6.7 m-90 61.21 42.47 0.56 Allowed Pre-proline 0 C--N 1.296 -1.717 0 C-N-CA 119.441 -0.904 . . . . 0.0 109.488 -178.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 32.7 Cg_endo -72.45 -34.07 7.98 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 N-CA-C 106.925 -1.99 . . . . 0.0 106.925 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -69.34 -12.76 61.93 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.521 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 21.9 tp -76.62 -6.4 51.87 Favored 'General case' 0 C--N 1.31 -1.138 0 O-C-N 121.506 -0.746 . . . . 0.0 109.462 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.589 ' CG2' ' CG2' ' B' ' 60' ' ' VAL . 18.3 t -59.7 149.34 6.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 120.81 -1.181 . . . . 0.0 108.482 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.442 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 63.42 7.2 18.37 Favored Glycine 0 C--N 1.296 -1.642 0 C-N-CA 119.578 -1.296 . . . . 0.0 110.379 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -99.63 -154.71 0.48 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.818 -1.401 . . . . 0.0 108.869 179.558 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -135.48 160.93 36.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.689 -1.257 . . . . 0.0 110.888 -179.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.502 HG23 ' CG2' ' A' ' 31' ' ' VAL . 28.1 t -52.89 -33.08 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.585 -0.697 . . . . 0.0 109.219 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.549 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 52.7 mm-40 -46.28 -67.69 0.26 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.154 -0.966 . . . . 0.0 108.556 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.466 ' O ' HG22 ' A' ' 19' ' ' VAL . 2.5 tp10 -61.62 -30.89 70.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.4 -0.813 . . . . 0.0 109.501 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.532 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . . . -67.54 -82.18 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.177 -0.952 . . . . 0.0 109.751 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -44.36 -40.39 5.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.672 -1.267 . . . . 0.0 108.972 179.64 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.549 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 20.8 tttm -49.92 -72.1 0.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.611 -0.681 . . . . 0.0 110.368 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.516 ' O ' ' N ' ' A' ' 23' ' ' ASP . 2.8 t -72.24 -57.62 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.523 -0.736 . . . . 0.0 109.972 -179.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.645 HG12 ' CE2' ' A' ' 5' ' ' TRP . 5.9 mt -35.93 -53.86 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.588 -0.695 . . . . 0.0 110.211 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 2.3 tt -37.56 -52.87 1.2 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.615 -0.678 . . . . 0.0 110.003 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -128.56 32.58 4.8 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 109.968 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' VAL . 17.4 p-10 -50.67 -48.88 58.28 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.019 -1.05 . . . . 0.0 108.28 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.708 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 10.4 mtpp -107.24 -106.62 0.0 OUTLIER Pre-proline 0 CA--C 1.561 1.374 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.708 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 37.0 Cg_endo -79.98 -67.74 0.02 OUTLIER 'Trans proline' 0 C--O 1.215 -0.657 0 CA-C-N 121.93 1.725 . . . . 0.0 108.631 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.528 ' CG ' ' O ' ' A' ' 25' ' ' PRO . 27.1 mt-10 -162.02 64.09 0.24 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.577 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -88.86 116.64 27.28 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.022 -1.049 . . . . 0.0 108.916 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' B' ' 45' ' ' ASP . 0.1 OUTLIER -88.86 165.65 14.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.899 -1.126 . . . . 0.0 109.166 -179.54 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.582 ' HB ' ' CG2' ' A' ' 20' ' ' ILE . 3.3 tt -139.84 131.99 34.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.158 -0.963 . . . . 0.0 110.276 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.5 mm -88.59 117.95 33.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.502 ' CG2' HG23 ' A' ' 13' ' ' VAL . 2.5 p -95.93 136.56 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.149 -0.969 . . . . 0.0 109.675 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.68 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -143.06 149.58 49.55 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.237 -0.915 . . . . 0.0 109.562 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.548 ' HA ' ' CG2' ' B' ' 51' ' ' VAL . 37.7 Cg_endo -78.51 67.21 8.4 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.749 2.299 . . . . 0.0 111.197 -178.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.584 ' HA ' ' CD1' ' B' ' 50' ' ' PHE . 91.8 t 41.34 -96.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.455 -0.778 . . . . 0.0 109.094 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.612 ' O ' ' N ' ' A' ' 37' ' ' ILE . . . 40.51 95.22 0.01 OUTLIER Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.47 ' O ' ' C ' ' A' ' 37' ' ' ILE . 1.4 p -36.74 86.68 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.755 -0.85 . . . . 0.0 110.698 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.612 ' N ' ' O ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER 33.36 74.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.827 -0.545 . . . . 0.0 110.446 179.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.405 ' O ' ' OG1' ' A' ' 39' ' ' THR . 41.3 t -95.3 -68.11 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.164 -0.96 . . . . 0.0 109.216 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 38' ' ' VAL . 6.7 m . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.425 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' B' ' 42' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . 0.518 ' CE2' ' HA ' ' B' ' 44' ' ' ILE . 21.7 p90 -57.32 -158.63 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.3 -0.875 . . . . 0.0 109.649 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.547 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER -108.45 81.25 1.44 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.008 -1.057 . . . . 0.0 110.688 -178.983 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.568 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.6 OUTLIER -49.22 145.55 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 120.574 -1.329 . . . . 0.0 108.208 178.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.577 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.3 p-10 -108.46 32.76 4.59 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.07 -1.019 . . . . 0.0 109.888 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . 0.501 ' O ' HG21 ' B' ' 47' ' ' VAL . 0.1 OUTLIER -150.57 143.63 24.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.436 -0.79 . . . . 0.0 109.007 179.349 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.536 ' HB ' ' CD1' ' A' ' 29' ' ' ILE . 1.8 t -149.44 166.43 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -0.908 . . . . 0.0 109.608 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.515 ' HG3' ' CE2' ' B' ' 50' ' ' PHE . 0.0 OUTLIER -95.5 75.56 3.3 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.742 -1.224 . . . . 0.0 110.21 -179.611 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.552 ' HB2' ' CD1' ' A' ' 29' ' ' ILE . 4.3 tp -76.72 92.97 3.59 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 118.818 -1.153 . . . . 0.0 108.282 178.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' PHE . . . . . 0.636 ' CZ ' ' CD1' ' A' ' 32' ' ' LEU . 17.8 m-85 -81.52 -177.02 6.34 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.548 ' CG2' ' HA ' ' A' ' 33' ' ' PRO . 6.1 m -144.28 -175.64 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.648 -1.283 . . . . 0.0 110.5 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.533 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.4 OUTLIER -120.0 -154.8 0.59 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.481 -0.762 . . . . 0.0 109.813 -179.616 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.533 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 11.4 mtpt -63.94 -56.78 12.72 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.565 -0.709 . . . . 0.0 109.332 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . 0.523 ' CD2' ' O ' ' B' ' 54' ' ' LEU . 2.6 tt -97.12 41.87 1.1 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.395 -0.816 . . . . 0.0 109.461 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.405 ' CG ' ' C ' ' B' ' 54' ' ' LEU . 0.0 OUTLIER 49.65 65.06 1.52 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.206 -0.934 . . . . 0.0 109.181 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . 0.553 ' O ' ' N ' ' B' ' 58' ' ' ALA . 17.4 t-20 -123.94 96.44 4.95 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.38 -0.825 . . . . 0.0 108.996 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.53 ' CD1' ' HB1' ' A' ' 16' ' ' ALA . 4.2 mt -37.45 89.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-O 121.576 0.703 . . . . 0.0 110.88 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.23 -21.56 24.45 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.67 133.79 53.67 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.589 ' CG2' ' CG2' ' A' ' 9' ' ' VAL . 99.4 t -90.09 128.11 50.94 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 120.999 -1.063 . . . . 0.0 110.59 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.465 ' O ' ' HD3' ' B' ' 62' ' ' ARG . 37.2 Cg_endo -83.63 165.29 14.01 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.396 2.064 . . . . 0.0 109.43 178.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . 0.519 ' HG3' ' HA ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -148.86 141.15 24.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.168 -0.958 . . . . 0.0 109.749 179.559 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.479 HG21 HG21 ' B' ' 47' ' ' VAL . 0.9 OUTLIER -113.12 -18.37 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.261 -0.899 . . . . 0.0 109.084 -179.859 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.935 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.439 ' SD ' ' HB3' ' A' ' 24' ' ' LYS . 2.4 mmt . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.306 0.574 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.572 ' O ' ' CE2' ' A' ' 5' ' ' TRP . 4.1 mmtp -84.79 72.24 10.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.889 . . . . 0.0 109.562 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.493 HG23 ' CE ' ' A' ' 24' ' ' LYS . 70.7 p -88.99 -26.81 21.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 109.197 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.585 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 81.2 mt-10 -93.53 -35.46 12.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.336 -0.852 . . . . 0.0 109.958 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.625 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 6.5 m-90 58.34 40.79 0.58 Allowed Pre-proline 0 C--N 1.293 -1.879 0 O-C-N 120.836 -1.165 . . . . 0.0 109.863 -178.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.625 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 34.2 Cg_endo -73.32 -34.92 5.46 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 N-CA-C 107.08 -1.931 . . . . 0.0 107.08 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.9 -11.72 61.08 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 177.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.489 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 30.5 tp -79.1 -7.91 58.54 Favored 'General case' 0 C--N 1.309 -1.172 0 O-C-N 121.402 -0.811 . . . . 0.0 109.216 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.546 HG21 ' CG2' ' B' ' 60' ' ' VAL . 19.4 t -54.34 154.22 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 118.994 -1.082 . . . . 0.0 109.151 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.491 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 70.37 -0.43 25.29 Favored Glycine 0 C--N 1.297 -1.623 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.629 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -96.16 -151.76 0.36 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.665 -1.491 . . . . 0.0 109.584 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.507 ' CB ' ' OE2' ' A' ' 14' ' ' GLU . 1.2 m -139.53 172.8 12.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.138 -0.976 . . . . 0.0 110.535 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.465 HG23 HG22 ' A' ' 31' ' ' VAL . 99.2 t -54.72 -37.95 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.586 -0.696 . . . . 0.0 109.916 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 0.7 OUTLIER -44.05 -74.76 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -0.904 . . . . 0.0 108.855 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.26 -38.23 65.58 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.394 -0.816 . . . . 0.0 109.835 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.538 ' CA ' HD13 ' A' ' 20' ' ' ILE . . . -59.02 -83.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.237 -0.915 . . . . 0.0 110.308 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.561 ' HA ' ' CG2' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -46.62 -28.06 1.34 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.586 -1.321 . . . . 0.0 109.617 -179.596 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.511 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 10.2 mttt -63.35 -83.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.487 -0.758 . . . . 0.0 110.746 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' A' ' 23' ' ' ASP . 2.1 t -57.61 -42.34 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.6 -0.688 . . . . 0.0 109.472 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.576 HG12 ' CE2' ' A' ' 5' ' ' TRP . 69.0 mt -50.64 -53.75 11.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.293 -0.879 . . . . 0.0 108.919 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.514 ' CD1' ' OE1' ' A' ' 28' ' ' GLN . 9.1 tt -34.98 -36.45 0.05 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.788 -0.57 . . . . 0.0 110.642 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 20' ' ' ILE . 3.3 mt-30 -147.36 41.4 1.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.113 -0.992 . . . . 0.0 110.241 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.52 ' OD1' ' HG2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -57.86 -44.85 86.86 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.969 -1.082 . . . . 0.0 108.441 179.598 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.782 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -120.71 -88.49 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.241 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.782 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 38.8 Cg_endo -84.07 -81.47 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.655 0 N-CA-C 108.214 -1.494 . . . . 0.0 108.214 177.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.466 ' CG ' ' C ' ' A' ' 25' ' ' PRO . 13.9 mt-10 -158.79 57.83 0.43 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -87.67 117.03 26.21 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.178 -0.951 . . . . 0.0 109.303 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.514 ' OE1' ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -88.58 -175.15 4.84 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.129 -0.982 . . . . 0.0 109.549 -179.358 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.561 ' CG2' ' HA ' ' A' ' 17' ' ' LYS . 14.6 tt -147.62 140.59 19.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.452 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.522 HG21 ' N ' ' A' ' 31' ' ' VAL . 2.7 mm -87.51 146.55 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.522 ' N ' HG21 ' A' ' 30' ' ' ILE . 8.7 p -102.37 133.53 45.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 119.071 -1.051 . . . . 0.0 109.734 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.682 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -145.68 149.25 39.42 Favored Pre-proline 0 N--CA 1.487 1.401 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.534 ' HA ' ' CG2' ' B' ' 51' ' ' VAL . 36.8 Cg_endo -79.75 21.99 0.75 Allowed 'Trans proline' 0 C--N 1.302 -1.906 0 C-N-CA 122.229 1.953 . . . . 0.0 111.891 -179.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.576 HG21 ' CD2' ' B' ' 50' ' ' PHE . 0.4 OUTLIER 78.52 -6.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.989 -1.069 . . . . 0.0 109.891 179.325 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -121.09 -31.74 1.15 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.461 ' OG1' ' HD2' ' A' ' 33' ' ' PRO . 4.7 m -69.55 93.97 0.73 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.23 -1.159 . . . . 0.0 109.559 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.429 HG22 ' O ' ' A' ' 36' ' ' THR . 0.2 OUTLIER -157.77 24.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.244 -0.91 . . . . 0.0 109.478 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.3 t -127.82 111.81 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.259 -0.901 . . . . 0.0 109.452 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.482 179.885 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -118.65 -154.82 0.58 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.225 -0.922 . . . . 0.0 109.46 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.564 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER -122.72 76.94 1.39 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.105 -0.997 . . . . 0.0 109.78 -179.493 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.494 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.3 OUTLIER -48.16 139.37 2.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 120.646 -1.284 . . . . 0.0 108.189 179.334 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.548 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -97.12 45.64 1.04 Allowed 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.331 -179.281 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . 0.493 ' O ' HG21 ' B' ' 47' ' ' VAL . 12.1 ttp180 -150.93 143.28 24.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.403 -0.811 . . . . 0.0 109.133 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.57 ' CG2' ' CG2' ' B' ' 63' ' ' VAL . 53.5 t -151.0 146.38 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.209 -0.932 . . . . 0.0 110.092 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.459 ' HB3' HD13 ' A' ' 32' ' ' LEU . 7.0 mmt180 -71.81 98.24 1.94 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.625 -1.297 . . . . 0.0 110.443 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.48 ' HB2' HG12 ' A' ' 29' ' ' ILE . 2.6 tp -84.79 88.37 7.38 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.131 -0.981 . . . . 0.0 108.842 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' PHE . . . . . 0.597 ' CE1' HD11 ' A' ' 32' ' ' LEU . 1.8 m-85 -70.13 178.66 2.68 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.534 ' CG2' ' HA ' ' A' ' 33' ' ' PRO . 6.3 m -139.82 -174.71 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.043 -1.035 . . . . 0.0 109.276 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.529 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.1 OUTLIER -135.94 -158.71 0.89 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.147 -0.97 . . . . 0.0 110.115 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.529 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 26.9 mtpt -43.66 -69.81 0.12 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.67 -0.644 . . . . 0.0 110.407 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . 0.422 ' C ' ' CG ' ' B' ' 55' ' ' ASP . 0.4 OUTLIER -97.23 52.81 1.15 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.274 -0.891 . . . . 0.0 110.106 -179.138 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.422 ' CG ' ' C ' ' B' ' 54' ' ' LEU . 0.0 OUTLIER 47.38 58.1 5.22 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.251 -0.906 . . . . 0.0 109.183 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . 0.565 ' O ' ' N ' ' B' ' 58' ' ' ALA . 36.5 t-20 -121.52 113.74 20.25 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.519 HD12 ' CB ' ' A' ' 16' ' ' ALA . 26.4 mt -35.51 88.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-O 121.518 0.675 . . . . 0.0 110.966 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -89.17 -20.92 23.63 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -109.99 137.99 46.99 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.558 ' CG1' ' O ' ' A' ' 4' ' ' GLU . 71.3 t -90.33 129.46 45.31 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.092 -1.005 . . . . 0.0 111.022 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.53 ' CB ' ' CG1' ' B' ' 47' ' ' VAL . 37.4 Cg_endo -83.46 164.18 14.57 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 122.617 2.212 . . . . 0.0 108.587 178.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -138.97 -43.98 0.47 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.255 -1.528 . . . . 0.0 110.809 -179.65 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.57 ' CG2' ' CG2' ' B' ' 47' ' ' VAL . 0.5 OUTLIER 77.59 -4.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 O-C-N 121.218 -0.926 . . . . 0.0 109.662 179.677 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.85 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ptp . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.455 ' O ' ' CE2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -84.49 64.63 8.53 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.283 -0.886 . . . . 0.0 109.686 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.538 ' CG2' ' HE3' ' A' ' 24' ' ' LYS . 0.6 OUTLIER -89.88 -12.75 38.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.097 -1.002 . . . . 0.0 109.083 179.617 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.562 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 3.9 mt-10 -92.69 -47.22 7.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.387 -0.821 . . . . 0.0 110.336 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.619 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 10.9 m-90 62.29 45.15 0.72 Allowed Pre-proline 0 C--N 1.297 -1.703 0 C-N-CA 119.611 -0.836 . . . . 0.0 108.935 -177.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 33.0 Cg_endo -71.68 -30.85 14.08 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 N-CA-C 107.169 -1.897 . . . . 0.0 107.169 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.29 -15.28 62.87 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.482 HD23 ' HA ' ' A' ' 16' ' ' ALA . 13.4 tp -80.48 -5.81 57.2 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.657 -0.652 . . . . 0.0 109.325 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.527 ' CG2' HG22 ' B' ' 60' ' ' VAL . 36.9 t -51.68 152.22 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.089 -1.007 . . . . 0.0 109.528 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.502 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 47.42 21.14 1.15 Allowed Glycine 0 N--CA 1.483 1.77 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.516 178.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -96.51 -141.81 0.28 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.862 -1.375 . . . . 0.0 109.143 179.631 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.432 ' N ' HG12 ' B' ' 57' ' ' ILE . 0.6 OUTLIER -146.41 159.42 43.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.911 -1.118 . . . . 0.0 110.008 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.485 ' HA ' ' HB1' ' A' ' 16' ' ' ALA . 29.8 t -48.15 -36.76 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.409 -0.807 . . . . 0.0 109.649 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.533 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 2.7 mt-10 -45.46 -75.41 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.408 -0.807 . . . . 0.0 109.193 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.88 -32.84 54.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.235 -0.915 . . . . 0.0 109.113 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.485 ' HB1' ' HA ' ' A' ' 13' ' ' VAL . . . -64.88 -88.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.404 -0.81 . . . . 0.0 110.309 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.511 ' HA ' ' CG2' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -43.06 -29.02 0.32 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.823 -1.173 . . . . 0.0 109.255 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 3.5 tttt -61.81 -82.89 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.735 -0.603 . . . . 0.0 110.182 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' A' ' 23' ' ' ASP . 3.2 t -59.98 -48.36 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.42 -0.8 . . . . 0.0 109.427 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.616 HG12 ' CE2' ' A' ' 5' ' ' TRP . 80.0 mt -48.17 -59.87 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.407 -0.808 . . . . 0.0 110.045 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.469 ' CB ' ' O ' ' A' ' 17' ' ' LYS . 1.0 OUTLIER -37.74 -33.24 0.07 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.502 -0.749 . . . . 0.0 110.531 -179.327 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -149.51 50.47 0.94 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.137 -0.977 . . . . 0.0 109.623 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -66.65 -40.88 88.87 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.176 -0.952 . . . . 0.0 108.639 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.691 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -124.01 -88.53 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.441 0 CA-C-O 117.962 -1.018 . . . . 0.0 108.271 178.078 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.691 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 37.8 Cg_endo -81.34 -79.66 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.659 0 N-CA-C 108.522 -1.376 . . . . 0.0 108.522 177.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.463 ' CG ' ' C ' ' A' ' 25' ' ' PRO . 14.5 mt-10 -160.99 66.0 0.3 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.565 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -87.56 116.09 25.44 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.123 -1.031 . . . . 0.0 108.9 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.49 ' CB ' ' O ' ' B' ' 45' ' ' ASP . 0.0 OUTLIER -88.46 161.39 17.05 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.436 -0.79 . . . . 0.0 108.995 -179.543 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.547 ' CD1' HD12 ' A' ' 20' ' ' ILE . 14.4 tt -137.73 136.46 45.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.062 -1.055 . . . . 0.0 110.507 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.513 HG21 ' N ' ' A' ' 31' ' ' VAL . 3.9 mm -88.89 155.17 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.513 ' N ' HG21 ' A' ' 30' ' ' ILE . 14.9 p -116.32 137.38 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.77 -1.206 . . . . 0.0 109.752 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.668 ' CD1' ' CE1' ' B' ' 50' ' ' PHE . 0.9 OUTLIER -150.43 159.99 33.77 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.182 -0.949 . . . . 0.0 110.374 -179.705 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 32' ' ' LEU . 36.9 Cg_endo -81.18 45.67 2.05 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 123.086 2.524 . . . . 0.0 110.418 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.565 ' CA ' HD13 ' A' ' 32' ' ' LEU . 68.9 t 59.87 -90.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.296 -0.878 . . . . 0.0 109.132 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.482 ' N ' HG11 ' A' ' 34' ' ' VAL . . . 53.72 170.99 0.04 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.451 ' O ' ' CG2' ' A' ' 36' ' ' THR . 10.0 t -99.94 70.64 1.61 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.178 -1.19 . . . . 0.0 109.451 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.499 ' O ' ' CG2' ' A' ' 37' ' ' ILE . 48.4 mt 47.64 61.59 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.221 -0.925 . . . . 0.0 109.427 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.488 HG21 ' N ' ' A' ' 39' ' ' THR . 11.0 m -96.43 -153.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.917 . . . . 0.0 109.325 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.488 ' N ' HG21 ' A' ' 38' ' ' VAL . 38.3 p . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.467 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . 0.426 ' N ' ' OXT' ' B' ' 64' ' ' GLY . 5.8 mm-40 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.655 0.741 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . 0.41 ' HD1' ' N ' ' B' ' 43' ' ' ARG . 0.1 OUTLIER -98.72 -123.03 0.14 Allowed 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.583 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 2.0 ptp180 -131.06 56.12 1.81 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.422 -1.424 . . . . 0.0 109.357 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.532 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.5 OUTLIER -42.96 143.14 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.87 -1.144 . . . . 0.0 108.765 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.565 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.1 p-10 -100.99 39.49 1.39 Allowed 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.12 -178.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -150.79 140.81 22.04 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.83 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.614 ' CG2' ' CG2' ' B' ' 63' ' ' VAL . 96.5 t -151.52 152.13 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.999 -1.063 . . . . 0.0 110.323 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.532 ' HG3' ' CD2' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -78.38 105.2 9.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.083 -1.011 . . . . 0.0 110.139 -179.515 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.539 HD12 ' CD1' ' B' ' 57' ' ' ILE . 2.6 tp -93.27 86.27 5.26 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.304 -0.959 . . . . 0.0 108.505 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' PHE . . . . . 0.668 ' CE1' ' CD1' ' A' ' 32' ' ' LEU . 5.9 m-30 -69.72 133.28 47.32 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.521 ' HB ' ' HA ' ' B' ' 55' ' ' ASP . 0.0 OUTLIER -103.52 -170.54 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.856 -1.153 . . . . 0.0 109.722 179.747 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.527 ' OD2' ' CB ' ' B' ' 56' ' ' ASN . 2.7 p-10 -126.28 -149.72 0.42 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.519 -0.738 . . . . 0.0 109.055 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.519 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 34.4 mttm -56.86 -58.81 6.5 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.317 -0.864 . . . . 0.0 110.233 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . 0.561 ' O ' ' CB ' ' B' ' 55' ' ' ASP . 0.9 OUTLIER -101.24 15.99 26.97 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.086 -1.009 . . . . 0.0 111.682 -178.587 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' B' ' 54' ' ' LEU . 0.2 OUTLIER 91.71 48.97 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.603 0 CA-C-O 122.621 1.2 . . . . 0.0 110.183 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . 0.527 ' CB ' ' OD2' ' B' ' 52' ' ' ASP . 1.8 t-20 -105.92 123.77 48.51 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.893 -1.129 . . . . 0.0 109.49 179.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.539 ' CD1' HD12 ' B' ' 49' ' ' LEU . 4.3 mm -54.97 88.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.61 -0.681 . . . . 0.0 109.457 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.56 -21.5 24.04 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . 0.416 ' O ' ' C ' ' B' ' 60' ' ' VAL . 8.7 mp0 -125.22 85.14 2.36 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.552 ' CG1' ' O ' ' A' ' 4' ' ' GLU . 9.3 t -42.37 130.15 2.82 Favored Pre-proline 0 N--CA 1.487 1.41 0 O-C-N 121.284 -0.885 . . . . 0.0 110.501 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.558 ' HB2' ' CG1' ' B' ' 47' ' ' VAL . 36.8 Cg_endo -82.56 162.16 16.82 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 122.976 2.451 . . . . 0.0 110.276 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . 0.56 ' N ' HG12 ' B' ' 47' ' ' VAL . 0.1 OUTLIER -139.88 152.81 46.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.065 -1.022 . . . . 0.0 109.514 179.43 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.614 ' CG2' ' CG2' ' B' ' 47' ' ' VAL . 1.2 t -119.24 123.38 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.154 -0.966 . . . . 0.0 109.009 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . 0.426 ' OXT' ' N ' ' B' ' 41' ' ' GLU . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mtt . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -87.86 78.4 8.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 109.741 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.536 HG23 ' CD ' ' A' ' 24' ' ' LYS . 26.4 p -93.49 -14.7 26.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.064 -1.022 . . . . 0.0 108.997 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.692 ' HB3' ' HD3' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -105.05 -178.06 3.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.332 -0.855 . . . . 0.0 110.164 -179.575 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.597 ' CD1' HD13 ' A' ' 20' ' ' ILE . 8.0 m-90 -161.65 48.85 0.25 Allowed Pre-proline 0 C--N 1.299 -1.621 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.19 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.692 ' HD3' ' HB3' ' A' ' 4' ' ' GLU . 30.6 Cg_endo -69.24 -25.82 30.63 Favored 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 121.956 1.77 . . . . 0.0 107.586 178.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -67.4 -25.32 65.88 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.585 ' HB2' ' HB3' ' A' ' 5' ' ' TRP . 0.3 OUTLIER -73.7 -17.08 61.17 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.448 0.642 . . . . 0.0 109.445 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.437 HG11 ' N ' ' A' ' 10' ' ' GLY . 37.1 t -49.92 149.6 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 C-N-CA 119.555 -0.858 . . . . 0.0 110.02 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.437 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 54.39 17.44 8.27 Favored Glycine 0 N--CA 1.48 1.584 0 C-N-CA 120.134 -1.031 . . . . 0.0 110.574 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.478 ' HB3' HD11 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -106.89 -143.87 0.38 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.0 -1.294 . . . . 0.0 109.398 179.717 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.491 ' CA ' HG12 ' B' ' 57' ' ' ILE . 0.5 OUTLIER -146.26 168.91 19.9 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.043 -1.035 . . . . 0.0 110.195 -179.465 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.437 ' O ' ' C ' ' A' ' 14' ' ' GLU . 84.9 t -55.45 -32.77 30.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.436 -0.79 . . . . 0.0 109.586 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.535 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 2.3 mt-10 -45.27 -71.29 0.08 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.135 -0.978 . . . . 0.0 108.837 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.442 ' HB3' HD23 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -60.28 -37.7 81.29 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.313 -0.867 . . . . 0.0 109.87 179.474 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.537 ' CB ' HD23 ' B' ' 49' ' ' LEU . . . -57.87 -79.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 110.028 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.529 ' HA ' ' CG2' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -50.75 -32.17 18.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.549 -1.344 . . . . 0.0 109.369 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -56.31 -82.5 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.494 0.664 . . . . 0.0 111.208 -179.192 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -61.69 -35.09 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.626 -0.671 . . . . 0.0 110.342 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.597 HD13 ' CD1' ' A' ' 5' ' ' TRP . 0.3 OUTLIER -53.28 -50.25 48.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 O-C-N 121.074 -1.016 . . . . 0.0 109.541 179.873 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.48 ' C ' ' O ' ' A' ' 20' ' ' ILE . 4.2 tt -35.45 -32.2 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.454 -0.779 . . . . 0.0 110.278 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 20' ' ' ILE . 1.9 tt0 -145.77 56.88 1.21 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.251 -0.905 . . . . 0.0 109.13 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.529 ' OD2' ' CG ' ' A' ' 24' ' ' LYS . 0.4 OUTLIER -65.41 -62.24 1.65 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.671 -0.643 . . . . 0.0 109.537 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.781 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -110.07 -80.95 0.01 OUTLIER Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.551 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.781 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 39.5 Cg_endo -87.92 -71.87 0.01 OUTLIER 'Trans proline' 0 C--O 1.213 -0.732 0 N-CA-C 107.377 -1.817 . . . . 0.0 107.377 176.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 25' ' ' PRO . 19.4 mt-10 -165.02 62.3 0.12 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.544 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -87.53 120.52 28.92 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.069 -1.019 . . . . 0.0 109.345 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.446 ' CB ' ' O ' ' B' ' 45' ' ' ASP . 0.6 OUTLIER -88.36 174.17 8.31 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.416 -0.803 . . . . 0.0 109.143 -179.52 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.543 ' HB ' ' CG2' ' A' ' 20' ' ' ILE . 18.5 tt -145.74 134.76 17.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.466 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.511 HG21 ' N ' ' A' ' 31' ' ' VAL . 4.8 mt -88.07 148.27 4.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.511 ' N ' HG21 ' A' ' 30' ' ' ILE . 5.8 p -117.07 133.23 64.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 118.811 -1.156 . . . . 0.0 110.858 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.663 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -147.57 162.24 32.68 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.827 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.591 ' HD2' ' HB2' ' A' ' 32' ' ' LEU . 36.8 Cg_endo -74.03 -85.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 121.634 1.556 . . . . 0.0 110.823 -177.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.515 ' CG1' ' O ' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -175.13 -34.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.684 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -89.08 -90.24 1.18 Allowed Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.12 125.0 8.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.36 -1.082 . . . . 0.0 109.696 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.3 tt -81.66 163.85 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.0 109.115 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.0 p -76.88 174.09 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.197 -0.939 . . . . 0.0 109.304 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 73.2 p . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.526 -179.892 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . 0.438 ' O ' ' O ' ' B' ' 64' ' ' GLY . 0.1 OUTLIER -98.49 -122.29 0.14 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.875 . . . . 0.0 109.554 -179.724 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.57 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.5 OUTLIER -123.34 56.73 1.18 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.556 -1.34 . . . . 0.0 109.552 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.488 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.3 OUTLIER -44.03 137.22 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.926 -1.109 . . . . 0.0 108.675 179.971 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.544 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -93.19 45.32 1.17 Allowed 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.419 -0.912 . . . . 0.0 109.689 -178.854 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . 0.48 ' HD2' ' CD1' ' A' ' 30' ' ' ILE . 14.1 ttp180 -148.04 144.83 28.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.314 -0.867 . . . . 0.0 109.112 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' B' ' 62' ' ' ARG . 0.0 OUTLIER -152.2 143.9 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.157 -0.964 . . . . 0.0 109.427 -179.267 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.45 ' HA ' ' HD3' ' B' ' 48' ' ' ARG . 3.3 mmt85 -77.33 115.43 17.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.701 -1.249 . . . . 0.0 109.632 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.548 HD12 ' CD1' ' B' ' 57' ' ' ILE . 1.6 tp -107.89 81.02 1.44 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.987 -1.071 . . . . 0.0 108.843 178.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' PHE . . . . . 0.631 ' CE1' ' CD1' ' A' ' 32' ' ' LEU . 4.1 m-30 -66.05 -159.86 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.503 HG23 ' HA ' ' A' ' 33' ' ' PRO . 24.1 m -150.42 -171.46 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.74 -1.225 . . . . 0.0 109.574 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.51 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 1.0 OUTLIER -122.66 -153.14 0.54 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.297 -0.877 . . . . 0.0 109.259 179.434 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.51 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 29.1 mtpt -61.18 -61.48 2.53 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.617 -0.677 . . . . 0.0 109.606 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . 0.415 ' O ' ' C ' ' B' ' 55' ' ' ASP . 3.0 tp -96.09 48.11 1.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.365 -0.834 . . . . 0.0 109.909 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.473 ' HA ' ' HB ' ' B' ' 51' ' ' VAL . 0.0 OUTLIER 45.58 65.31 1.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.061 -1.025 . . . . 0.0 109.28 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . 0.577 ' O ' ' N ' ' B' ' 58' ' ' ALA . 3.5 t30 -133.14 108.71 8.99 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.548 ' CD1' HD12 ' B' ' 49' ' ' LEU . 12.7 mm -32.41 86.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.67 0.748 . . . . 0.0 111.391 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . 0.577 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -90.99 -23.72 20.31 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.04 96.24 5.09 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 5' ' ' TRP . 3.2 t -57.89 137.44 83.42 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.459 -0.776 . . . . 0.0 110.17 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.471 ' HD2' HG11 ' B' ' 60' ' ' VAL . 35.0 Cg_endo -76.97 172.97 15.24 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 122.438 2.092 . . . . 0.0 109.927 178.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . 0.532 ' O ' ' CG1' ' B' ' 47' ' ' VAL . 0.0 OUTLIER -150.94 135.36 17.01 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.811 -1.181 . . . . 0.0 110.614 -179.601 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.532 ' CG2' HG21 ' B' ' 47' ' ' VAL . 4.6 t -123.77 111.29 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.353 -0.842 . . . . 0.0 108.857 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' B' ' 42' ' ' TYR . . . . . . . . 0 N--CA 1.491 2.341 0 CA-C-O 117.93 -1.483 . . . . 0.0 109.729 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ttp . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.247 0.546 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.529 ' CB ' ' OD2' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -89.98 48.21 1.55 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.305 -0.872 . . . . 0.0 109.854 -179.799 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.539 ' CA ' ' HD3' ' A' ' 24' ' ' LYS . 0.2 OUTLIER -89.44 18.81 4.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.213 -0.929 . . . . 0.0 108.499 179.084 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.593 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 37.3 mt-10 -135.33 -40.58 0.73 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.502 -0.749 . . . . 0.0 109.349 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.642 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 6.9 m-90 62.63 40.55 0.37 Allowed Pre-proline 0 C--N 1.299 -1.59 0 O-C-N 121.545 -0.722 . . . . 0.0 109.946 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.642 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 34.7 Cg_endo -72.93 -33.75 7.37 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 N-CA-C 107.462 -1.784 . . . . 0.0 107.462 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -69.57 -10.75 59.47 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 177.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.537 HD13 ' CB ' ' A' ' 11' ' ' LYS . 11.7 tp -81.36 -1.92 47.27 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 121.556 -0.715 . . . . 0.0 109.445 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.531 ' CG2' HG22 ' B' ' 60' ' ' VAL . 24.1 t -54.71 151.28 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.101 -1.0 . . . . 0.0 109.482 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.497 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 64.07 6.18 18.16 Favored Glycine 0 N--CA 1.481 1.677 0 C-N-CA 120.042 -1.075 . . . . 0.0 110.5 178.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.537 ' CB ' HD13 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -93.13 -145.36 0.23 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.801 -1.411 . . . . 0.0 109.327 179.697 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.479 ' O ' HD13 ' B' ' 57' ' ' ILE . 2.1 m -150.47 179.56 8.05 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.062 -1.023 . . . . 0.0 110.373 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.509 ' HA ' HD23 ' B' ' 49' ' ' LEU . 57.1 t -60.45 -35.3 62.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.487 -0.758 . . . . 0.0 109.724 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.503 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 1.9 pm0 -47.02 -74.46 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.047 -1.033 . . . . 0.0 108.893 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.428 ' O ' HG22 ' A' ' 19' ' ' VAL . 21.0 tt0 -57.61 -31.38 66.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.219 -0.925 . . . . 0.0 110.084 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.476 ' CA ' HD13 ' A' ' 20' ' ' ILE . . . -66.6 -81.12 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.88 -1.137 . . . . 0.0 109.962 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -45.96 -30.43 1.79 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.758 -1.214 . . . . 0.0 109.056 -179.875 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.7 OUTLIER -63.46 -81.44 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.703 -0.623 . . . . 0.0 110.677 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.488 HG21 ' HD3' ' A' ' 18' ' ' LYS . 3.3 t -56.18 -50.04 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.204 -0.935 . . . . 0.0 109.613 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.545 ' O ' ' N ' ' A' ' 22' ' ' GLN . 61.8 mt -46.9 -59.49 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.389 -0.819 . . . . 0.0 109.928 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.501 ' C ' ' O ' ' A' ' 20' ' ' ILE . 17.4 tp -29.56 -37.74 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.056 0.455 . . . . 0.0 110.659 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.558 ' O ' ' N ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -133.43 -72.67 0.5 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.968 -1.082 . . . . 0.0 109.405 179.096 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.529 ' OD2' ' CB ' ' A' ' 2' ' ' LYS . 7.6 t0 42.48 -94.84 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.718 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 3.0 mtmp? -66.62 -118.14 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.332 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.718 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 36.5 Cg_endo -79.77 -75.53 0.01 OUTLIER 'Trans proline' 0 C--O 1.214 -0.703 0 CA-C-N 122.309 1.86 . . . . 0.0 108.902 178.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 4.5 mt-10 -156.84 59.88 0.53 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.705 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -89.03 113.01 24.08 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.475 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.519 ' HB2' ' O ' ' B' ' 45' ' ' ASP . 1.8 mt-30 -87.95 172.21 9.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.065 -1.022 . . . . 0.0 109.175 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.536 ' CD1' ' HB ' ' B' ' 47' ' ' VAL . 9.4 tt -136.86 142.66 37.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.979 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.483 ' O ' HD22 ' A' ' 32' ' ' LEU . 26.9 mm -90.24 122.4 41.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.535 ' CG2' HD22 ' B' ' 49' ' ' LEU . 32.7 t -96.59 134.09 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.966 -1.084 . . . . 0.0 109.74 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.698 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -148.38 170.93 6.9 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 -178.671 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.613 ' HD2' ' HB2' ' A' ' 32' ' ' LEU . 39.9 Cg_endo -75.91 -94.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.299 -2.035 0 O-C-N 123.414 1.218 . . . . 0.0 109.839 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.542 ' CG2' ' O ' ' A' ' 33' ' ' PRO . 54.8 t -164.74 103.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -152.42 -115.69 0.64 Allowed Glycine 0 N--CA 1.484 1.849 0 C-N-CA 119.251 -1.452 . . . . 0.0 110.256 -178.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 61.2 m -71.88 96.13 1.63 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.298 -1.119 . . . . 0.0 109.898 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.565 HG21 ' CZ ' ' B' ' 50' ' ' PHE . 9.7 pt -94.5 153.54 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.332 -0.855 . . . . 0.0 109.048 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.461 HG11 ' O ' ' A' ' 38' ' ' VAL . 6.0 t 66.61 10.07 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.923 . . . . 0.0 109.526 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.917 -1.04 . . . . 0.0 109.425 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . 0.577 ' O ' ' CG ' ' B' ' 42' ' ' TYR . 52.6 mt-10 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . 0.577 ' CG ' ' O ' ' B' ' 41' ' ' GLU . 46.3 p90 40.66 -151.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.649 -0.657 . . . . 0.0 109.408 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.557 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 1.2 ptt180 -123.91 73.15 1.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.841 -1.162 . . . . 0.0 110.086 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.538 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.4 OUTLIER -47.3 144.89 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 120.732 -1.23 . . . . 0.0 107.821 178.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.705 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.7 p-10 -106.34 45.7 0.96 Allowed 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 118.798 -1.161 . . . . 0.0 110.243 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . 0.456 ' HG3' HG12 ' A' ' 30' ' ' ILE . 1.4 ttt-85 -152.17 153.07 33.12 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.565 HG21 ' CG2' ' B' ' 63' ' ' VAL . 0.1 OUTLIER -150.59 -172.83 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.098 -1.001 . . . . 0.0 108.56 179.591 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.474 ' HB3' ' CE2' ' B' ' 50' ' ' PHE . 11.8 mmt85 -119.4 72.25 0.9 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.682 -1.261 . . . . 0.0 110.265 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.535 HD22 ' CG2' ' A' ' 31' ' ' VAL . 3.2 tp -69.21 97.74 0.96 Allowed 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.008 -1.077 . . . . 0.0 108.178 178.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' PHE . . . . . 0.624 ' CZ ' HD13 ' A' ' 32' ' ' LEU . 18.1 m-85 -89.37 -162.93 0.92 Allowed 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.543 ' CG1' ' HA ' ' B' ' 55' ' ' ASP . 34.8 m -142.1 175.09 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.769 -1.207 . . . . 0.0 109.363 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.548 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.0 OUTLIER -127.44 -71.9 0.65 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.242 -0.911 . . . . 0.0 108.633 -179.884 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.548 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 17.9 mmtt -93.21 -75.21 0.5 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.898 -1.126 . . . . 0.0 108.535 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . 0.555 ' O ' ' CB ' ' B' ' 55' ' ' ASP . 0.1 OUTLIER -131.68 51.75 2.12 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 179.088 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.555 ' CB ' ' O ' ' B' ' 54' ' ' LEU . 0.2 OUTLIER 91.33 23.0 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.18 0.514 . . . . 0.0 109.703 -179.344 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . 0.575 ' O ' ' N ' ' B' ' 58' ' ' ALA . 62.4 t30 -88.83 91.87 8.99 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.479 HD13 ' O ' ' A' ' 12' ' ' SER . 9.4 mt -38.49 89.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-O 121.687 0.756 . . . . 0.0 110.779 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . 0.575 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.13 -25.65 22.87 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -118.2 103.51 9.91 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.559 ' CG1' ' O ' ' A' ' 4' ' ' GLU . 63.0 t -62.49 138.21 96.46 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.386 -0.821 . . . . 0.0 110.918 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.515 ' CB ' HD13 ' A' ' 29' ' ' ILE . 36.4 Cg_endo -80.44 170.54 15.85 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.736 2.291 . . . . 0.0 109.294 178.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . 0.547 ' CD ' ' HA ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -149.9 140.39 22.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.758 -1.214 . . . . 0.0 110.721 -179.512 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.565 ' CG2' HG21 ' B' ' 47' ' ' VAL . 1.4 t -119.03 138.75 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.543 -0.723 . . . . 0.0 109.166 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 CA-C-O 117.967 -1.463 . . . . 0.0 109.668 -179.845 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 mmt . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.185 0.516 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.47 ' O ' ' CE2' ' A' ' 5' ' ' TRP . 38.1 mmtm -90.0 45.9 1.31 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.259 -0.901 . . . . 0.0 109.551 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.487 ' CG2' ' O ' ' B' ' 63' ' ' VAL . 7.3 m -92.06 -22.56 19.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.229 -0.919 . . . . 0.0 109.708 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.643 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 10.1 mm-40 -105.8 -24.34 12.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.086 -1.009 . . . . 0.0 110.527 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.641 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 6.9 m-90 48.24 46.98 4.12 Favored Pre-proline 0 C--N 1.297 -1.709 0 C-N-CA 118.774 -1.17 . . . . 0.0 108.888 -178.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.643 ' HD3' ' HB2' ' A' ' 4' ' ' GLU . 31.4 Cg_endo -73.88 -35.44 4.37 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 N-CA-C 106.581 -2.123 . . . . 0.0 106.581 -179.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.84 -12.24 61.47 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 114.318 -1.31 . . . . 0.0 107.666 176.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.483 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 19.1 tp -79.68 -7.05 58.34 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 121.476 -0.765 . . . . 0.0 109.454 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.542 ' CG2' HG22 ' B' ' 60' ' ' VAL . 15.3 t -54.85 151.86 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.965 -1.084 . . . . 0.0 108.951 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.503 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 57.1 13.72 9.68 Favored Glycine 0 N--CA 1.481 1.64 0 N-CA-C 110.209 -1.157 . . . . 0.0 110.209 178.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -94.56 -143.52 0.25 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.959 -1.318 . . . . 0.0 109.511 179.843 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.12 170.4 18.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.042 -1.036 . . . . 0.0 110.173 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.465 ' HA ' HD12 ' B' ' 49' ' ' LEU . 78.4 t -53.27 -42.22 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.336 -0.853 . . . . 0.0 109.655 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.528 ' O ' ' CG ' ' A' ' 18' ' ' LYS . 59.0 mm-40 -41.38 -71.64 0.08 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.409 ' HB3' ' CD1' ' A' ' 8' ' ' LEU . 0.6 OUTLIER -56.09 -38.69 71.04 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.452 -0.78 . . . . 0.0 109.612 179.619 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.493 ' O ' HD12 ' A' ' 20' ' ' ILE . . . -58.72 -83.85 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.383 -0.823 . . . . 0.0 109.862 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.439 ' O ' ' HG3' ' A' ' 17' ' ' LYS . 4.3 tptp -45.13 -29.99 1.04 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.563 -1.335 . . . . 0.0 109.39 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' A' ' 14' ' ' GLU . 4.3 mmtt -61.35 -86.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.66 0.743 . . . . 0.0 111.087 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.4 t -57.89 -38.9 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 121.494 0.664 . . . . 0.0 109.824 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.595 ' CD1' ' N ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -53.48 -51.75 38.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.438 -0.789 . . . . 0.0 109.725 -179.645 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 20' ' ' ILE . 45.3 tp -39.25 -23.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.399 -0.813 . . . . 0.0 111.9 -178.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -142.1 13.33 2.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.001 -1.687 . . . . 0.0 112.622 -179.242 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.487 ' OD1' ' HB1' ' A' ' 27' ' ' ALA . 1.2 p-10 -49.29 150.72 1.66 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.729 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.4 OUTLIER 52.81 -131.03 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 -178.809 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.729 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 36.9 Cg_endo -78.17 -83.03 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.635 0 CA-C-N 121.952 1.733 . . . . 0.0 109.346 178.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 3.1 mt-10 -144.69 71.01 1.29 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.417 -0.802 . . . . 0.0 109.046 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -89.03 118.71 28.95 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.006 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.445 ' O ' HG22 ' B' ' 47' ' ' VAL . 0.0 OUTLIER -88.01 -178.69 6.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.241 -0.912 . . . . 0.0 109.435 -179.313 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.55 HG12 ' HB2' ' B' ' 49' ' ' LEU . 14.0 tt -150.06 152.16 11.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 C-N-CA 119.02 -1.072 . . . . 0.0 111.112 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.3 mm -112.16 128.65 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.524 ' HA ' ' HB3' ' B' ' 49' ' ' LEU . 3.0 t -89.56 150.12 3.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 120.824 -1.173 . . . . 0.0 110.173 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.716 ' CD2' ' CD1' ' B' ' 50' ' ' PHE . 0.0 OUTLIER -130.93 166.21 29.21 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -178.38 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.552 ' N ' ' HG ' ' A' ' 32' ' ' LEU . 37.9 Cg_endo -81.77 34.87 0.56 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 123.008 2.472 . . . . 0.0 108.934 178.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.562 ' H ' HD22 ' A' ' 32' ' ' LEU . 0.3 OUTLIER 56.91 3.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 123.549 0.74 . . . . 0.0 111.627 -178.807 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.427 ' O ' HD13 ' A' ' 32' ' ' LEU . . . -152.22 -155.58 7.11 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.99 129.52 23.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -1.156 . . . . 0.0 109.664 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.526 ' O ' ' CD1' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -57.72 -22.15 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.329 179.874 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.436 ' N ' HG21 ' A' ' 37' ' ' ILE . 46.0 t -73.08 84.41 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.221 -0.924 . . . . 0.0 109.493 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.408 ' C ' ' O ' ' A' ' 38' ' ' VAL . 23.1 p . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.339 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . 0.573 ' CE2' ' HB ' ' B' ' 44' ' ' ILE . 11.2 p90 -124.98 -140.63 0.29 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.185 -0.947 . . . . 0.0 109.63 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.575 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.2 OUTLIER -130.71 54.97 1.86 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.748 -1.22 . . . . 0.0 110.283 -179.332 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.573 ' HB ' ' CE2' ' B' ' 42' ' ' TYR . 0.2 OUTLIER -45.79 140.17 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.856 -1.152 . . . . 0.0 108.363 179.388 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.9 OUTLIER -98.92 48.34 0.97 Allowed 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.031 -1.043 . . . . 0.0 109.624 -179.371 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . 0.438 ' C ' HG21 ' B' ' 47' ' ' VAL . 23.9 ttm180 -150.29 150.4 31.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.459 -0.775 . . . . 0.0 109.03 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.51 ' CG2' HG22 ' B' ' 63' ' ' VAL . 0.1 OUTLIER -151.36 -172.48 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.181 -0.949 . . . . 0.0 109.343 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 5.1 mmt85 -118.17 71.02 0.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.095 -1.003 . . . . 0.0 110.156 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.55 ' HB2' HG12 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -54.61 103.09 0.08 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.005 -1.059 . . . . 0.0 108.872 179.297 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' PHE . . . . . 0.716 ' CD1' ' CD2' ' A' ' 32' ' ' LEU . 2.2 m-85 -92.21 119.21 31.62 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.356 -0.84 . . . . 0.0 108.961 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.505 ' O ' ' CG2' ' A' ' 34' ' ' VAL . 1.5 m -108.33 -175.45 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.12 -0.988 . . . . 0.0 109.536 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.545 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.0 OUTLIER -129.16 -161.97 1.16 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.291 -0.88 . . . . 0.0 109.619 -179.915 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.545 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 1.8 mttp -49.96 -61.79 1.94 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.589 -0.694 . . . . 0.0 109.934 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . 0.481 HD11 ' N ' ' B' ' 54' ' ' LEU . 7.6 mp -89.57 48.98 1.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.479 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 44.39 49.44 8.11 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.349 -0.844 . . . . 0.0 109.246 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . 0.469 ' HB3' ' CG ' ' B' ' 52' ' ' ASP . 4.9 t30 -107.11 111.17 23.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.31 -0.868 . . . . 0.0 108.873 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.472 HD13 ' HG ' ' A' ' 8' ' ' LEU . 12.5 mt -59.46 90.55 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 121.352 0.596 . . . . 0.0 110.21 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -87.94 -19.63 27.0 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . 0.51 ' HB2' ' CB ' ' B' ' 50' ' ' PHE . 1.1 mt-30 -123.12 82.27 1.98 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.542 HG22 ' CG2' ' A' ' 9' ' ' VAL . 20.2 t -49.72 137.47 18.21 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.533 -0.73 . . . . 0.0 110.655 -178.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.508 ' O ' ' HD3' ' B' ' 62' ' ' ARG . 36.5 Cg_endo -81.23 172.67 12.53 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 123.023 2.482 . . . . 0.0 110.205 179.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . 0.56 ' HG3' ' HA ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -149.53 129.4 13.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.229 -0.919 . . . . 0.0 110.009 179.915 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.51 HG22 ' CG2' ' B' ' 47' ' ' VAL . 0.9 OUTLIER -97.56 119.06 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.217 -0.927 . . . . 0.0 108.906 179.442 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 CA-C-O 118.023 -1.431 . . . . 0.0 109.55 -179.979 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.6 mtp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.335 0.588 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.465 ' HB3' ' OD2' ' A' ' 23' ' ' ASP . 0.5 OUTLIER -86.05 45.61 1.24 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.335 -0.853 . . . . 0.0 109.492 -179.812 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.55 ' CG2' ' HD2' ' A' ' 24' ' ' LYS . 62.7 p -89.65 33.94 0.83 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.175 -0.953 . . . . 0.0 109.599 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.559 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -135.42 -47.73 0.7 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.183 -0.948 . . . . 0.0 109.83 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.627 ' CE2' HG12 ' A' ' 20' ' ' ILE . 9.3 m-90 58.64 44.96 1.2 Allowed Pre-proline 0 C--N 1.299 -1.604 0 C-N-CA 119.398 -0.921 . . . . 0.0 108.995 -178.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.622 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 33.5 Cg_endo -72.88 -32.09 9.41 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 N-CA-C 107.462 -1.784 . . . . 0.0 107.462 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.56 -12.2 60.97 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.495 ' HB2' ' HB3' ' A' ' 5' ' ' TRP . 2.7 tp -78.04 -4.32 46.57 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 121.507 -0.746 . . . . 0.0 109.594 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.532 HG21 ' CG2' ' B' ' 60' ' ' VAL . 24.7 t -52.43 152.39 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 C-N-CA 118.866 -1.133 . . . . 0.0 109.116 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.497 ' N ' HG11 ' A' ' 9' ' ' VAL . . . 45.51 24.08 1.01 Allowed Glycine 0 N--CA 1.481 1.652 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 178.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 1.7 tptm -99.78 -138.93 0.32 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.984 -1.304 . . . . 0.0 109.249 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' B' ' 55' ' ' ASP . 0.3 OUTLIER -150.03 154.83 38.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.809 -1.182 . . . . 0.0 110.744 -179.53 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.539 ' HA ' ' HB2' ' A' ' 16' ' ' ALA . 54.9 t -52.41 -30.01 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 O-C-N 121.435 -0.79 . . . . 0.0 109.019 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.524 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 14.3 mt-10 -48.91 -74.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.466 -0.771 . . . . 0.0 109.107 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -57.33 -28.94 63.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.168 -0.958 . . . . 0.0 108.705 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.539 ' HB2' ' HA ' ' A' ' 13' ' ' VAL . . . -61.08 -86.74 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.4 -0.812 . . . . 0.0 109.959 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.485 ' HG2' HG21 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -47.46 -35.14 8.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.564 -1.335 . . . . 0.0 108.99 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -49.46 -78.82 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.468 0.651 . . . . 0.0 110.869 -179.471 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.469 HG13 ' OD1' ' A' ' 23' ' ' ASP . 0.5 OUTLIER -72.76 -44.57 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.425 -0.797 . . . . 0.0 109.677 -178.833 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.627 HG12 ' CE2' ' A' ' 5' ' ' TRP . 67.2 mt -40.07 -52.91 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.544 -0.722 . . . . 0.0 109.511 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 28' ' ' GLN . 0.5 OUTLIER -38.73 -49.44 1.59 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.563 -0.711 . . . . 0.0 110.483 -179.658 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.459 ' HB2' HD21 ' A' ' 21' ' ' LEU . 1.1 mt-30 -135.06 44.51 2.6 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.099 -1.0 . . . . 0.0 110.506 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.555 ' HB3' ' CE ' ' A' ' 24' ' ' LYS . 4.6 t0 -66.33 -39.85 89.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.866 -1.146 . . . . 0.0 108.488 179.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.769 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -117.42 -99.51 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.444 0 CA-C-O 117.214 -1.374 . . . . 0.0 107.975 178.707 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.769 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 37.3 Cg_endo -82.15 -76.14 0.0 OUTLIER 'Trans proline' 0 C--O 1.213 -0.742 0 CA-C-N 122.374 1.884 . . . . 0.0 108.284 177.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 16.3 mt-10 -160.77 56.35 0.31 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.579 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -88.81 119.15 29.05 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.128 -0.983 . . . . 0.0 109.467 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' B' ' 45' ' ' ASP . 15.7 mt-30 -89.25 -178.35 5.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.224 -0.923 . . . . 0.0 109.326 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.536 HD13 ' CB ' ' B' ' 61' ' ' PRO . 3.6 tt -145.45 127.93 9.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.089 -1.007 . . . . 0.0 110.436 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.512 ' CD1' ' HD3' ' B' ' 46' ' ' ARG . 33.4 mt -89.0 111.31 22.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.478 HG23 HG23 ' A' ' 13' ' ' VAL . 7.0 p -89.72 146.59 5.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.136 -0.977 . . . . 0.0 110.123 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.688 ' CD1' ' CE1' ' B' ' 50' ' ' PHE . 0.7 OUTLIER -150.49 161.6 29.99 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.461 -0.775 . . . . 0.0 109.461 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.528 ' HD2' ' HB2' ' A' ' 32' ' ' LEU . 36.9 Cg_endo -78.63 35.5 0.55 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.538 2.159 . . . . 0.0 111.432 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.468 ' HB ' ' O ' ' A' ' 33' ' ' PRO . 4.6 t 73.47 -78.8 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.245 -0.909 . . . . 0.0 109.829 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.53 168.28 0.58 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 36' ' ' THR . 0.5 OUTLIER -88.69 39.22 0.91 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -1.165 . . . . 0.0 109.032 179.724 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 65.95 144.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.324 -0.86 . . . . 0.0 108.951 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.3 t -65.94 137.98 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.104 -0.997 . . . . 0.0 109.542 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.517 -179.88 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.704 0.764 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . 0.563 ' CE2' ' HA ' ' B' ' 44' ' ' ILE . 9.7 p90 -131.63 -152.22 0.49 Allowed 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.74 -0.6 . . . . 0.0 109.419 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.554 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER -92.72 52.94 1.95 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.154 -0.966 . . . . 0.0 109.597 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.563 ' HA ' ' CE2' ' B' ' 42' ' ' TYR . 0.5 OUTLIER -43.17 145.87 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.99 -1.069 . . . . 0.0 108.262 179.488 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.579 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 2.2 p-10 -106.1 46.44 0.92 Allowed 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 118.962 -1.095 . . . . 0.0 110.756 -178.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . 0.512 ' HD3' ' CD1' ' A' ' 30' ' ' ILE . 2.3 ptp180 -150.94 153.01 34.43 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.22 -0.925 . . . . 0.0 109.244 178.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.597 ' CG2' ' CG2' ' B' ' 63' ' ' VAL . 31.1 t -150.93 161.66 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.421 -0.799 . . . . 0.0 109.162 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.447 ' HG3' ' CD2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -93.38 84.16 4.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.85 -1.156 . . . . 0.0 110.022 -179.453 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.533 HD23 ' CB ' ' A' ' 16' ' ' ALA . 2.5 tp -80.04 83.36 5.94 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 118.985 -1.086 . . . . 0.0 109.17 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' PHE . . . . . 0.688 ' CE1' ' CD1' ' A' ' 32' ' ' LEU . 3.8 m-30 -66.98 -162.88 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.528 ' CG1' ' HA ' ' B' ' 55' ' ' ASP . 10.1 m -149.44 160.9 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.834 -1.166 . . . . 0.0 108.702 178.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.55 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.0 OUTLIER -112.37 -70.61 0.8 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.939 -1.1 . . . . 0.0 108.796 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.55 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 9.9 mmmt -92.5 -75.91 0.48 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.848 -1.158 . . . . 0.0 108.49 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . 0.543 ' O ' ' CB ' ' B' ' 55' ' ' ASP . 0.1 OUTLIER -136.85 57.22 1.77 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.056 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.543 ' CB ' ' O ' ' B' ' 54' ' ' LEU . 0.2 OUTLIER 91.51 24.13 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.421 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' B' ' 58' ' ' ALA . 31.8 t-20 -88.82 86.79 7.04 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.472 HD11 ' HG ' ' A' ' 8' ' ' LEU . 3.8 mt -37.33 89.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-O 121.511 0.672 . . . . 0.0 111.315 -178.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.81 -17.5 29.62 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' B' ' 60' ' ' VAL . 33.9 mt-30 -127.68 84.37 2.25 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.532 ' CG2' HG21 ' A' ' 9' ' ' VAL . 6.4 t -41.68 136.2 2.01 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.453 -0.779 . . . . 0.0 110.161 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.566 ' HB2' ' CG1' ' B' ' 47' ' ' VAL . 36.7 Cg_endo -81.95 166.79 16.7 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.751 2.301 . . . . 0.0 110.523 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . 0.512 ' N ' HG12 ' B' ' 47' ' ' VAL . 0.3 OUTLIER -142.72 152.85 42.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 109.285 179.416 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.597 ' CG2' ' CG2' ' B' ' 47' ' ' VAL . 1.2 t -116.9 124.73 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.229 -0.919 . . . . 0.0 109.486 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.217 0 CA-C-O 117.957 -1.468 . . . . 0.0 109.599 179.685 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 tmm? . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.312 0.577 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' A' ' 2' ' ' LYS . 6.0 mmtp -88.92 66.66 7.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.125 -0.984 . . . . 0.0 109.311 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.486 HG21 ' HE3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -103.3 -7.78 20.83 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.307 -0.871 . . . . 0.0 109.063 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.578 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 4.9 mt-10 -99.92 -48.41 4.68 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.993 -1.067 . . . . 0.0 110.878 -178.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.603 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 10.4 m-90 60.71 45.76 1.03 Allowed Pre-proline 0 C--N 1.297 -1.711 0 C-N-CA 119.067 -1.053 . . . . 0.0 108.386 -177.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 32.8 Cg_endo -72.31 -31.2 11.93 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 N-CA-C 107.057 -1.94 . . . . 0.0 107.057 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.21 -13.14 62.02 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.525 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.547 ' HB2' ' O ' ' A' ' 5' ' ' TRP . 0.3 OUTLIER -71.32 -11.57 60.98 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.204 -0.935 . . . . 0.0 108.987 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.526 HG22 ' CG2' ' B' ' 60' ' ' VAL . 24.4 t -55.9 145.1 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.087 -1.008 . . . . 0.0 109.82 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.477 ' HA2' ' OD1' ' B' ' 56' ' ' ASN . . . 59.23 13.65 22.22 Favored Glycine 0 N--CA 1.482 1.726 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.287 177.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.466 ' HB3' HD11 ' A' ' 8' ' ' LEU . 1.2 tptp -95.44 -147.11 0.28 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.133 -1.216 . . . . 0.0 109.178 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.84 155.96 44.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -0.917 . . . . 0.0 109.372 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.531 ' CG2' HG13 ' B' ' 51' ' ' VAL . 69.0 t -47.17 -37.18 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.834 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.516 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -44.81 -76.9 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.211 -0.931 . . . . 0.0 109.317 -179.864 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.423 ' O ' HG22 ' A' ' 19' ' ' VAL . 4.7 mp0 -54.76 -35.57 63.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.561 -0.712 . . . . 0.0 110.143 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.497 ' CB ' HD22 ' B' ' 49' ' ' LEU . . . -63.46 -83.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.827 . . . . 0.0 110.364 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.516 ' HA ' ' CG2' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -45.7 -27.52 0.83 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.142 -0.974 . . . . 0.0 108.884 -179.618 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.1 OUTLIER -67.46 -86.28 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.746 -0.596 . . . . 0.0 111.167 -179.029 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.503 ' O ' ' OD1' ' A' ' 23' ' ' ASP . 4.6 t -46.13 -42.77 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.15 -0.969 . . . . 0.0 109.455 -178.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.598 HG12 ' CE2' ' A' ' 5' ' ' TRP . 46.5 mt -56.63 -44.24 80.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.452 -0.78 . . . . 0.0 109.536 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 20' ' ' ILE . 4.2 tt -39.15 -25.82 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.222 -0.923 . . . . 0.0 110.588 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.548 ' O ' ' N ' ' A' ' 24' ' ' LYS . 0.6 OUTLIER -144.3 -67.99 0.32 Allowed 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.525 -1.359 . . . . 0.0 111.592 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.516 ' OD1' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER 39.54 -94.51 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.393 -0.817 . . . . 0.0 108.86 -178.549 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.735 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 10.6 mtpt -64.89 -118.95 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.435 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 178.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.735 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 36.5 Cg_endo -80.56 -73.21 0.01 OUTLIER 'Trans proline' 0 C--O 1.214 -0.71 0 CA-C-N 122.221 1.829 . . . . 0.0 109.006 178.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 5.5 mt-10 -159.29 60.63 0.4 Allowed 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.689 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -88.03 113.99 24.21 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.467 ' O ' HG22 ' B' ' 47' ' ' VAL . 0.2 OUTLIER -86.78 170.57 11.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.144 -0.973 . . . . 0.0 110.517 -177.711 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.557 ' HB ' ' CG2' ' A' ' 20' ' ' ILE . 19.2 tt -140.21 141.91 32.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.829 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.509 ' O ' ' HB3' ' B' ' 49' ' ' LEU . 1.0 OUTLIER -91.31 163.77 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 179.132 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.539 ' CG1' HD11 ' B' ' 49' ' ' LEU . 64.5 t -135.2 133.39 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.312 -1.492 . . . . 0.0 110.372 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.691 ' CD2' ' CE1' ' B' ' 50' ' ' PHE . 0.5 OUTLIER -132.19 159.53 71.8 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.503 -0.748 . . . . 0.0 109.113 178.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.533 ' O ' ' N ' ' A' ' 35' ' ' GLY . 37.4 Cg_endo -80.73 39.97 0.92 Allowed 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.513 2.142 . . . . 0.0 110.652 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.548 ' CG2' ' O ' ' B' ' 51' ' ' VAL . 14.9 t 50.06 -92.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.102 -0.999 . . . . 0.0 108.708 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . 52.19 -116.53 5.2 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.467 ' O ' HG21 ' A' ' 37' ' ' ILE . 53.4 m -91.2 -101.03 0.11 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.378 -1.072 . . . . 0.0 110.184 -179.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.54 HG21 ' CG2' ' A' ' 38' ' ' VAL . 1.5 tp 67.95 173.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.23 -0.919 . . . . 0.0 108.767 -179.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.54 ' CG2' HG21 ' A' ' 37' ' ' ILE . 6.4 t 78.86 -7.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.33 -0.856 . . . . 0.0 109.689 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.5 p . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.315 -179.941 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.284 0.564 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . 0.577 ' CE2' ' HA ' ' B' ' 44' ' ' ILE . 53.6 p90 -120.87 -155.72 0.64 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.41 -0.806 . . . . 0.0 109.341 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' ARG . . . . . 0.551 ' N ' ' CD2' ' B' ' 42' ' ' TYR . 1.6 tpp180 -88.91 75.53 8.04 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.389 -0.819 . . . . 0.0 109.158 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.577 ' HA ' ' CE2' ' B' ' 42' ' ' TYR . 0.4 OUTLIER -52.64 142.74 4.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 179.185 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.689 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -96.54 50.21 1.13 Allowed 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.703 -1.248 . . . . 0.0 110.4 -178.738 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 28' ' ' GLN . 15.0 ttm180 -150.03 150.21 31.44 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.436 -0.79 . . . . 0.0 108.9 178.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.542 HG21 ' CG2' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -151.71 179.9 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.769 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.615 ' HB3' ' CE2' ' B' ' 50' ' ' PHE . 0.9 OUTLIER -107.38 85.21 2.09 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.905 -1.122 . . . . 0.0 111.62 -178.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.556 ' HB2' ' CD1' ' A' ' 29' ' ' ILE . 2.1 tm? -78.31 93.47 4.67 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' PHE . . . . . 0.691 ' CE1' ' CD2' ' A' ' 32' ' ' LEU . 50.4 m-85 -89.42 132.95 34.75 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.548 ' O ' ' CG2' ' A' ' 34' ' ' VAL . 16.7 m -99.77 -169.31 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.842 -1.161 . . . . 0.0 109.538 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' B' ' 55' ' ' ASP . 3.6 p-10 -126.77 -148.89 0.4 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.209 -0.932 . . . . 0.0 109.119 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' LYS . . . . . 0.496 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 4.6 mmmm -76.5 -45.43 30.97 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' LEU . . . . . 0.507 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 1.4 mt -101.15 34.46 2.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.542 -0.724 . . . . 0.0 109.612 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . 0.536 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.0 OUTLIER 53.77 68.28 0.87 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.016 -1.052 . . . . 0.0 108.179 -178.787 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' B' ' 58' ' ' ALA . 47.1 t-20 -130.93 100.4 5.24 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.506 ' CD1' HD22 ' B' ' 49' ' ' LEU . 31.2 mm -40.67 88.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.495 0.664 . . . . 0.0 110.624 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -89.59 -18.46 26.52 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.5 108.33 14.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.48 -0.763 . . . . 0.0 108.998 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.555 ' CG1' ' O ' ' A' ' 4' ' ' GLU . 32.8 t -66.27 133.51 94.55 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.304 -0.872 . . . . 0.0 110.236 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.5 ' O ' ' HD3' ' B' ' 62' ' ' ARG . 36.5 Cg_endo -81.72 165.17 18.05 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.601 2.201 . . . . 0.0 110.496 179.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' ARG . . . . . 0.571 ' CD ' ' HA ' ' A' ' 4' ' ' GLU . 1.1 tpp180 -150.22 134.85 17.47 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.223 -0.923 . . . . 0.0 110.54 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.542 ' CG2' HG21 ' B' ' 47' ' ' VAL . 1.4 t -118.06 146.96 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 CA-C-O 117.959 -1.467 . . . . 0.0 109.626 179.912 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.697 HG22 ' HD2' ' A' ' 24' ' ' LYS . 1.4 p . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.592 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -131.53 -30.76 1.64 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.043 -1.036 . . . . 0.0 110.484 -179.646 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.668 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 5.8 m-90 51.44 46.29 3.49 Favored Pre-proline 0 C--N 1.296 -1.723 0 C-N-CA 118.088 -1.445 . . . . 0.0 108.237 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.668 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 32.8 Cg_endo -73.76 -33.86 6.01 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 N-CA-C 107.75 -1.673 . . . . 0.0 107.75 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.69 -11.13 59.82 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.761 HD21 ' HB2' ' A' ' 16' ' ' ALA . 63.4 tp -79.96 -5.05 54.96 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 121.394 -0.816 . . . . 0.0 109.586 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.666 HG22 ' CG2' ' B' ' 60' ' ' VAL . 42.5 t -53.75 149.2 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 120.994 -1.066 . . . . 0.0 110.466 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 58.42 11.68 10.58 Favored Glycine 0 N--CA 1.481 1.647 0 C-N-CA 120.194 -1.003 . . . . 0.0 110.644 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.612 ' CB ' HD12 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -91.49 -144.28 0.19 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.925 -1.338 . . . . 0.0 109.124 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.431 ' O ' HD11 ' B' ' 57' ' ' ILE . 0.5 OUTLIER -145.54 157.1 44.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.035 -1.04 . . . . 0.0 109.961 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.515 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 93.0 t -48.68 -34.28 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.343 -0.848 . . . . 0.0 109.479 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.508 ' O ' ' CD ' ' A' ' 18' ' ' LYS . 7.8 mm-40 -44.6 -75.52 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.092 -1.005 . . . . 0.0 109.163 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -58.71 -32.34 69.08 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.687 -0.633 . . . . 0.0 109.959 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.761 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -62.45 -80.66 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.086 -1.009 . . . . 0.0 109.676 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.514 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -44.2 -39.94 4.75 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.872 -1.143 . . . . 0.0 108.942 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.528 ' HD2' ' N ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -51.53 -81.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.75 0.786 . . . . 0.0 111.085 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.9 t -66.08 -49.27 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.809 -0.557 . . . . 0.0 110.472 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.966 HD13 HD13 ' A' ' 29' ' ' ILE . 61.7 mt -45.8 -40.13 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 0.0 109.518 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.56 ' CD1' ' HG3' ' A' ' 28' ' ' GLN . 35.1 tp -38.84 -23.82 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.55 ' O ' ' N ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -135.37 -81.22 0.42 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 119.977 -1.702 . . . . 0.0 111.617 -178.83 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.613 ' OD2' ' HA ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER 37.77 -94.82 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.739 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.697 ' HD2' HG22 ' A' ' 3' ' ' THR . 0.0 OUTLIER -58.48 -163.76 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 176.214 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.62 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 37.4 Cg_endo -76.32 82.44 2.23 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 N-CA-C 108.666 -1.321 . . . . 0.0 108.666 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.533 ' CG ' ' C ' ' A' ' 25' ' ' PRO . 0.3 OUTLIER 56.88 52.22 9.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.65 -0.657 . . . . 0.0 111.009 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.789 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -88.82 112.05 22.77 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 177.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.56 ' HG3' ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -87.51 -166.62 1.63 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.012 -1.055 . . . . 0.0 110.721 -177.213 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.966 HD13 HD13 ' A' ' 20' ' ' ILE . 1.7 tt -149.86 144.23 17.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.477 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.497 ' O ' ' HB3' ' B' ' 49' ' ' LEU . 31.9 mt -89.39 115.27 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.752 -0.593 . . . . 0.0 109.985 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.638 ' O ' HG13 ' A' ' 31' ' ' VAL . 8.0 p -89.91 109.59 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.545 -1.347 . . . . 0.0 109.906 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.105 HD11 ' CE1' ' B' ' 50' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 C-N-CA 119.087 -1.045 . . . . 0.0 110.411 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.516 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 8.0 ptp180 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.482 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.7 OUTLIER -42.5 145.59 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 119.403 -0.919 . . . . 0.0 108.896 179.795 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.568 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.1 p-10 -107.66 46.43 0.94 Allowed 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.918 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' ARG . . . . . 0.484 ' HG2' HG13 ' A' ' 30' ' ' ILE . 11.3 mtt180 -150.16 150.1 31.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.33 -0.856 . . . . 0.0 109.426 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 1.101 ' CG2' HG23 ' B' ' 63' ' ' VAL . 79.2 t -151.32 126.47 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.316 -0.865 . . . . 0.0 110.082 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -53.35 87.95 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.734 -1.229 . . . . 0.0 110.584 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.583 ' HB2' ' CG1' ' A' ' 29' ' ' ILE . 4.9 tp -91.29 87.26 6.41 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 50' ' ' PHE . . . . . 1.105 ' CE1' HD11 ' A' ' 32' ' ' LEU . 5.7 m-30 -72.59 148.44 44.9 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.467 ' HB ' ' HA ' ' B' ' 55' ' ' ASP . 34.8 m -122.4 166.53 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.711 -1.243 . . . . 0.0 109.872 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' B' ' 55' ' ' ASP . 1.5 p-10 -93.52 -151.34 0.3 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.57 -0.707 . . . . 0.0 109.25 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.503 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 0.1 OUTLIER -75.56 -46.5 31.6 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.236 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.517 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 1.8 mm? -101.61 36.81 1.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.622 -0.674 . . . . 0.0 109.655 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 55' ' ' ASP . . . . . 0.539 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.0 OUTLIER 52.77 67.11 1.04 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.192 -0.942 . . . . 0.0 109.583 -179.32 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 56' ' ' ASN . . . . . 0.565 ' O ' ' N ' ' B' ' 58' ' ' ALA . 29.0 t30 -119.97 86.02 2.49 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.56 HD12 ' HG ' ' A' ' 8' ' ' LEU . 4.6 mt -31.94 87.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 CA-C-O 121.637 0.732 . . . . 0.0 111.42 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 58' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -89.37 -4.63 57.98 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -125.91 133.24 51.94 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.666 ' CG2' HG22 ' A' ' 9' ' ' VAL . 93.8 t -90.76 131.21 38.27 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.042 -1.036 . . . . 0.0 111.068 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 61' ' ' PRO . . . . . 0.874 ' CB ' HG11 ' B' ' 47' ' ' VAL . 37.3 Cg_endo -83.84 161.75 14.05 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.581 2.188 . . . . 0.0 108.813 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 62' ' ' ARG . . . . . 0.563 ' HD3' ' HA ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -140.58 -49.15 0.44 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.798 -1.189 . . . . 0.0 110.164 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 1.101 HG23 ' CG2' ' B' ' 47' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--N 1.295 -1.773 0 O-C-N 121.442 -0.786 . . . . 0.0 109.812 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.603 HG23 ' HG3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.602 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 3.8 mt-10 -148.45 -44.2 0.15 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.276 -0.89 . . . . 0.0 110.655 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.647 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 6.1 m-90 59.6 41.67 0.6 Allowed Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 121.157 -0.964 . . . . 0.0 109.788 -178.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.647 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 34.1 Cg_endo -73.31 -33.36 7.2 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 N-CA-C 107.204 -1.883 . . . . 0.0 107.204 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -70.3 -12.53 61.65 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.621 ' HG ' HD12 ' B' ' 57' ' ' ILE . 49.5 tp -83.69 -4.31 58.5 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 121.385 -0.822 . . . . 0.0 109.262 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.562 HG23 HG21 ' B' ' 60' ' ' VAL . 14.7 t -53.69 152.36 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.91 -1.119 . . . . 0.0 109.319 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.426 ' C ' ' OD1' ' B' ' 56' ' ' ASN . . . 66.85 4.77 28.56 Favored Glycine 0 N--CA 1.481 1.635 0 C-N-CA 119.823 -1.18 . . . . 0.0 110.625 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 2.3 tptp -94.54 -146.88 0.26 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.778 -1.425 . . . . 0.0 109.627 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.491 ' CB ' ' OE2' ' A' ' 14' ' ' GLU . 33.2 m -144.8 169.16 18.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.104 -0.998 . . . . 0.0 109.998 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.635 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 88.4 t -54.21 -34.92 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.488 -0.758 . . . . 0.0 109.902 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.551 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 1.3 pm0 -44.07 -73.75 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.313 -0.867 . . . . 0.0 109.197 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.79 -31.02 71.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.257 -0.902 . . . . 0.0 109.61 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.813 ' HB2' HD11 ' B' ' 57' ' ' ILE . . . -61.39 -83.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.103 -0.998 . . . . 0.0 109.481 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.523 ' HG2' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -46.79 -41.53 15.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.78 -1.2 . . . . 0.0 108.768 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.551 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -44.57 -77.37 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.617 0.722 . . . . 0.0 110.185 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.703 HG12 ' CG ' ' A' ' 23' ' ' ASP . 1.9 t -72.91 -54.35 16.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.728 -0.608 . . . . 0.0 110.225 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.801 HD13 HD13 ' A' ' 29' ' ' ILE . 62.5 mt -33.92 -50.74 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.611 -0.681 . . . . 0.0 110.362 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.616 ' C ' HD23 ' A' ' 21' ' ' LEU . 9.6 tt -38.66 -53.88 1.59 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.512 -0.742 . . . . 0.0 110.638 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -123.79 21.22 9.2 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.963 -1.085 . . . . 0.0 111.172 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.703 ' CG ' HG12 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -56.66 -60.16 3.95 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 177.648 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.756 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 3.2 tttm -68.23 -153.87 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 104.37 -2.456 . . . . 0.0 104.37 175.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.756 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 27.7 Cg_endo -68.68 -45.81 2.13 Favored 'Trans proline' 0 C--N 1.319 -1.012 0 CA-C-N 121.15 1.446 . . . . 0.0 109.002 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 1.7 mt-10 -166.34 52.33 0.09 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.662 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -90.22 117.32 28.88 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.176 -1.009 . . . . 0.0 109.33 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 11.5 mt-30 -88.79 178.49 6.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.155 -0.965 . . . . 0.0 109.152 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.801 HD13 HD13 ' A' ' 20' ' ' ILE . 8.5 tt -148.75 138.85 16.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 C-N-CA 118.99 -1.084 . . . . 0.0 111.074 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.579 HD12 ' HG3' ' B' ' 46' ' ' ARG . 1.2 mt -91.24 164.24 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.814 ' C ' HD23 ' A' ' 32' ' ' LEU . 7.4 p -131.06 135.84 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.683 -1.261 . . . . 0.0 110.187 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.948 ' N ' HD23 ' A' ' 32' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 110.075 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.527 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.433 ' C ' ' O ' ' B' ' 43' ' ' ARG . 11.8 tt -44.88 160.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.938 -1.101 . . . . 0.0 108.037 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.662 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.7 p-10 -127.08 45.83 2.63 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 118.602 -1.239 . . . . 0.0 110.167 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' ARG . . . . . 0.579 ' HG3' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -152.07 150.55 30.06 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.947 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.63 HG22 ' CG2' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -151.4 168.62 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.95 -1.094 . . . . 0.0 109.355 -179.617 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.541 ' HG3' HD11 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -97.54 93.8 6.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.969 -1.082 . . . . 0.0 109.333 179.686 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.561 ' C ' HD12 ' B' ' 49' ' ' LEU . 0.9 OUTLIER -88.67 82.05 6.93 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.439 -0.904 . . . . 0.0 109.475 179.745 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 50' ' ' PHE . . . . . 0.629 ' HE1' HD11 ' A' ' 32' ' ' LEU . 2.9 m-30 -66.05 158.22 28.97 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 12.2 m -118.86 -174.98 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.799 -1.188 . . . . 0.0 109.295 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.502 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.5 OUTLIER -124.86 -154.3 0.61 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.029 -1.044 . . . . 0.0 110.08 -179.531 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.502 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 1.8 mtmp? -60.85 -57.39 12.86 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.606 -0.684 . . . . 0.0 109.653 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' B' ' 54' ' ' LEU . 0.3 OUTLIER -99.58 44.58 1.02 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.331 -0.856 . . . . 0.0 109.741 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 48.7 63.72 1.99 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.072 -1.018 . . . . 0.0 109.162 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 56' ' ' ASN . . . . . 0.587 ' O ' ' N ' ' B' ' 58' ' ' ALA . 7.6 t30 -130.25 109.85 11.1 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.813 HD11 ' HB2' ' A' ' 16' ' ' ALA . 23.9 mt -34.34 86.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 121.485 0.659 . . . . 0.0 111.262 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 58' ' ' ALA . . . . . 0.587 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -89.13 -8.77 53.1 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.47 85.43 2.05 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.562 HG21 HG23 ' A' ' 9' ' ' VAL . 2.2 t -48.25 139.49 10.23 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.465 -0.772 . . . . 0.0 110.131 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 61' ' ' PRO . . . . . 0.591 ' CG ' ' CD1' ' A' ' 29' ' ' ILE . 36.4 Cg_endo -81.21 168.96 16.42 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.856 2.371 . . . . 0.0 109.404 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 62' ' ' ARG . . . . . 0.544 ' HD2' ' CB ' ' A' ' 4' ' ' GLU . 0.5 OUTLIER -149.89 124.45 9.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.873 -1.142 . . . . 0.0 110.274 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.63 ' CG2' HG22 ' B' ' 47' ' ' VAL . 2.6 t . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.339 -0.85 . . . . 0.0 108.788 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.786 HG22 ' CD ' ' A' ' 24' ' ' LYS . 2.8 p . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.633 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 0.4 OUTLIER -125.5 -57.75 1.45 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.196 -0.94 . . . . 0.0 110.012 -179.118 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.789 ' O ' HD22 ' A' ' 8' ' ' LEU . 5.0 m-90 70.3 39.78 0.18 Allowed Pre-proline 0 C--N 1.3 -1.561 0 O-C-N 121.765 -0.584 . . . . 0.0 110.827 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.633 ' HD3' ' CB ' ' A' ' 4' ' ' GLU . 33.1 Cg_endo -72.31 -30.18 13.14 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 N-CA-C 107.559 -1.746 . . . . 0.0 107.559 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.51 -17.66 64.75 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.302 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.064 HD23 ' N ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -69.48 -23.02 63.58 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 122.254 1.026 . . . . 0.0 108.565 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.064 ' N ' HD23 ' A' ' 8' ' ' LEU . 3.8 t -43.63 138.61 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-O 121.988 0.899 . . . . 0.0 110.88 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.657 ' O ' ' ND2' ' B' ' 56' ' ' ASN . . . 86.5 -45.55 3.46 Favored Glycine 0 C--N 1.298 -1.581 0 C-N-CA 119.749 -1.215 . . . . 0.0 112.364 175.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.3 78.14 1.08 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 119.951 -1.911 . . . . 0.0 111.492 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.881 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 0.9 OUTLIER -153.18 46.73 0.68 Allowed 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 118.315 -1.354 . . . . 0.0 111.345 179.486 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.644 HG21 ' O ' ' B' ' 55' ' ' ASP . 23.9 t -77.28 -73.03 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 O-C-N 121.068 -1.02 . . . . 0.0 109.725 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.484 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 11.6 pt-20 -55.71 -38.25 69.47 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.452 ' HA ' ' HB3' ' A' ' 18' ' ' LYS . 4.3 tt0 -68.48 -32.72 72.9 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.881 ' HB2' ' O ' ' A' ' 12' ' ' SER . . . -62.69 -71.62 0.15 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.096 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.787 ' HE2' HD12 ' A' ' 21' ' ' LEU . 0.5 OUTLIER -50.56 -35.58 30.48 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.112 179.613 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.5 ' HG2' ' N ' ' A' ' 19' ' ' VAL . 2.6 ttmt -62.17 -90.29 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.576 0.703 . . . . 0.0 110.742 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.735 HG12 ' OD2' ' A' ' 23' ' ' ASP . 3.4 t -46.19 -48.32 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.639 -0.663 . . . . 0.0 110.371 -178.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.928 HD13 HD13 ' A' ' 29' ' ' ILE . 61.6 mt -50.43 -50.88 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.176 -0.953 . . . . 0.0 109.876 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.787 HD12 ' HE2' ' A' ' 17' ' ' LYS . 3.3 tt -35.13 -29.99 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.679 -0.638 . . . . 0.0 111.544 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.566 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 2.2 tt0 -136.36 3.24 2.81 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 118.002 -1.479 . . . . 0.0 111.98 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.735 ' OD2' HG12 ' A' ' 19' ' ' VAL . 22.5 m-20 -54.12 147.17 13.33 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 177.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.786 ' CD ' HG22 ' A' ' 3' ' ' THR . 21.9 mtpt 69.86 -147.0 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 104.425 -2.435 . . . . 0.0 104.425 -175.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.688 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 33.2 Cg_endo -75.42 -64.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.324 -0.745 0 CA-C-N 121.36 1.521 . . . . 0.0 108.814 178.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 26.9 mt-10 -161.06 64.66 0.29 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.789 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -88.78 117.53 27.84 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.494 ' CB ' ' O ' ' B' ' 45' ' ' ASP . 0.0 OUTLIER -88.19 175.76 7.56 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.182 -0.949 . . . . 0.0 109.7 -179.47 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.928 HD13 HD13 ' A' ' 20' ' ' ILE . 3.3 tt -143.12 147.11 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.225 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.501 HD12 ' HD2' ' B' ' 46' ' ' ARG . 4.2 mt -102.44 130.89 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.878 HG13 ' HG ' ' B' ' 49' ' ' LEU . 2.5 t -104.23 125.72 58.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 120.798 -1.189 . . . . 0.0 109.721 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.077 HD11 ' CE1' ' B' ' 50' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.542 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 120.881 0.372 . . . . 0.0 110.213 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.512 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.5 OUTLIER -46.96 145.45 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.706 -1.246 . . . . 0.0 108.108 179.187 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.62 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.0 OUTLIER -105.86 43.05 1.16 Allowed 'General case' 0 C--N 1.295 -1.763 0 O-C-N 120.914 -1.116 . . . . 0.0 109.829 -179.338 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 46' ' ' ARG . . . . . 0.501 ' HD2' HD12 ' A' ' 30' ' ' ILE . 0.3 OUTLIER -151.02 155.05 38.23 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.366 -0.834 . . . . 0.0 109.477 179.637 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.944 ' CG2' HG23 ' B' ' 63' ' ' VAL . 15.4 t -150.29 173.42 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 109.456 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.606 ' H ' HG12 ' B' ' 47' ' ' VAL . 20.4 mmt180 -101.59 66.51 1.08 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.982 -1.074 . . . . 0.0 109.942 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.878 ' HG ' HG13 ' A' ' 31' ' ' VAL . 3.8 tp -61.49 89.94 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.268 -0.973 . . . . 0.0 109.121 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 50' ' ' PHE . . . . . 1.077 ' CE1' HD11 ' A' ' 32' ' ' LEU . 7.3 m-30 -79.26 135.32 36.73 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.789 HG22 ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -104.89 -174.94 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.79 -1.194 . . . . 0.0 109.147 179.383 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.533 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.0 OUTLIER -126.48 -162.84 1.18 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.252 -0.905 . . . . 0.0 109.729 -179.687 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.533 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 21.0 mtpt -46.6 -64.74 0.69 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.398 0.618 . . . . 0.0 109.919 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.422 ' O ' ' C ' ' B' ' 55' ' ' ASP . 0.5 OUTLIER -95.38 52.28 1.38 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.793 -179.563 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 55' ' ' ASP . . . . . 0.644 ' O ' HG21 ' A' ' 13' ' ' VAL . 0.0 OUTLIER 42.72 57.52 3.51 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.351 -0.843 . . . . 0.0 109.654 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 56' ' ' ASN . . . . . 0.657 ' ND2' ' O ' ' A' ' 10' ' ' GLY . 8.1 t-20 -115.6 122.11 44.65 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.673 HD13 HD11 ' A' ' 8' ' ' LEU . 5.0 mt -60.69 89.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.293 -0.88 . . . . 0.0 110.196 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 58' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.72 -28.31 20.62 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 59' ' ' GLN . . . . . 0.454 ' HB3' ' HB2' ' B' ' 50' ' ' PHE . 4.5 tt0 -105.13 133.02 50.61 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.613 HG22 HG23 ' A' ' 9' ' ' VAL . 58.9 t -89.15 129.11 49.1 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 120.843 -1.161 . . . . 0.0 110.711 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 61' ' ' PRO . . . . . 0.794 ' HB2' HG11 ' B' ' 47' ' ' VAL . 36.6 Cg_endo -82.64 160.54 16.67 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.632 2.222 . . . . 0.0 109.295 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 62' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 3' ' ' THR . 0.0 OUTLIER -150.03 143.14 24.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.906 -1.121 . . . . 0.0 110.062 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.944 HG23 ' CG2' ' B' ' 47' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 24' ' ' LYS . 4.1 p . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.541 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.5 mt-10 -112.04 179.23 4.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.422 -0.799 . . . . 0.0 109.336 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.612 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 14.7 m-90 -150.78 47.3 0.44 Allowed Pre-proline 0 C--N 1.298 -1.658 0 O-C-N 121.52 -0.738 . . . . 0.0 109.79 178.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 31.3 Cg_endo -71.18 -25.72 21.95 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 N-CA-C 107.411 -1.803 . . . . 0.0 107.411 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -69.79 -20.32 63.47 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.507 HD13 ' HA ' ' A' ' 16' ' ' ALA . 11.4 mt -83.64 -4.01 58.22 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.496 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.583 ' CG2' ' CG2' ' B' ' 60' ' ' VAL . 22.7 t -55.41 147.78 3.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.106 -0.996 . . . . 0.0 109.833 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.427 ' C ' ' OD1' ' B' ' 56' ' ' ASN . . . 61.65 10.4 23.98 Favored Glycine 0 N--CA 1.481 1.668 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 2.1 tptp -96.12 -144.59 0.28 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.959 -1.318 . . . . 0.0 109.071 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.416 ' CA ' HG12 ' B' ' 57' ' ' ILE . 1.4 m -142.76 165.86 26.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.044 -1.035 . . . . 0.0 109.909 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.682 ' CG2' HG11 ' A' ' 31' ' ' VAL . 76.4 t -50.86 -40.1 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.434 -0.791 . . . . 0.0 109.443 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.536 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 56.7 mt-10 -43.8 -72.1 0.07 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.468 -0.77 . . . . 0.0 109.538 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -56.37 -34.62 66.83 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.081 -1.012 . . . . 0.0 109.734 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.607 ' C ' HD12 ' A' ' 20' ' ' ILE . . . -63.44 -84.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 110.206 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.577 ' HG2' HG23 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -44.74 -34.25 2.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.947 -1.096 . . . . 0.0 109.044 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 6.0 ttmt -55.98 -82.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.542 0.687 . . . . 0.0 110.511 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.484 HG12 ' HB3' ' A' ' 23' ' ' ASP . 2.0 t -64.28 -49.9 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.545 -0.722 . . . . 0.0 109.769 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.929 HD13 HD13 ' A' ' 29' ' ' ILE . 77.1 mt -42.54 -54.09 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.364 -0.835 . . . . 0.0 109.47 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 28' ' ' GLN . 4.9 tt -42.1 -45.81 4.08 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.263 -0.898 . . . . 0.0 110.223 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -143.61 54.58 1.33 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.992 -1.068 . . . . 0.0 110.624 -179.188 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.604 ' OD2' ' CZ2' ' A' ' 5' ' ' TRP . 35.0 p-10 -76.23 -28.9 57.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.859 -1.151 . . . . 0.0 108.768 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.779 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -130.72 -83.45 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.055 -1.028 . . . . 0.0 108.692 178.315 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.779 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 42.4 Cg_endo -88.68 -84.93 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.645 0 N-CA-C 108.144 -1.521 . . . . 0.0 108.144 177.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 10.2 mt-10 -162.06 56.3 0.24 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.989 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -88.69 118.12 28.14 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.084 -1.01 . . . . 0.0 109.125 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 1.8 mt-30 -88.19 178.35 6.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 0.0 109.373 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.929 HD13 HD13 ' A' ' 20' ' ' ILE . 5.9 tt -147.43 137.67 17.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 C-N-CA 119.204 -0.998 . . . . 0.0 111.011 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.565 HD11 ' HD2' ' B' ' 46' ' ' ARG . 8.3 mt -90.28 117.36 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.944 HG13 ' HG ' ' B' ' 49' ' ' LEU . 5.1 t -99.82 140.98 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.797 -1.189 . . . . 0.0 109.75 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.963 HD21 ' CE1' ' B' ' 50' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.264 -0.897 . . . . 0.0 109.536 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.583 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.091 0.472 . . . . 0.0 109.757 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.432 ' C ' ' O ' ' B' ' 43' ' ' ARG . 0.7 OUTLIER -48.4 137.1 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.544 -1.347 . . . . 0.0 107.644 179.222 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.647 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 4.3 p-10 -89.62 48.3 1.58 Allowed 'General case' 0 C--N 1.292 -1.896 0 C-N-CA 119.076 -1.05 . . . . 0.0 109.396 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' ARG . . . . . 0.565 ' HD2' HD11 ' A' ' 30' ' ' ILE . 10.1 ttp180 -151.08 151.68 32.33 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 1.119 ' CG2' HG23 ' B' ' 63' ' ' VAL . 61.4 t -151.43 169.34 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.592 ' HB3' ' CE2' ' B' ' 50' ' ' PHE . 12.6 mmt-85 -100.18 84.46 2.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.631 -1.293 . . . . 0.0 110.709 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.944 ' HG ' HG13 ' A' ' 31' ' ' VAL . 4.2 tp -84.68 97.69 9.79 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 118.933 -1.107 . . . . 0.0 108.62 178.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 50' ' ' PHE . . . . . 0.963 ' CE1' HD21 ' A' ' 32' ' ' LEU . 52.4 m-85 -92.88 131.71 37.66 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 178.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.907 HG22 ' O ' ' A' ' 32' ' ' LEU . 12.9 m -89.08 178.04 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.619 -1.301 . . . . 0.0 110.349 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.511 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.8 OUTLIER -107.89 -151.72 0.47 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.354 -0.841 . . . . 0.0 109.775 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.511 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 1.2 mmtp -74.03 -48.47 29.86 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.478 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.1 OUTLIER -98.99 38.19 1.42 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.39 -0.819 . . . . 0.0 109.503 179.534 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 55' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.0 OUTLIER 50.48 67.62 0.89 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.165 -0.96 . . . . 0.0 109.181 -179.413 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 56' ' ' ASN . . . . . 0.565 ' O ' ' N ' ' B' ' 58' ' ' ALA . 1.2 t30 -133.58 117.35 16.98 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.652 ' CD1' HD11 ' B' ' 49' ' ' LEU . 27.0 mm -46.88 87.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-O 121.384 0.612 . . . . 0.0 109.823 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 58' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -89.32 -25.46 21.62 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -105.01 129.42 53.46 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.583 ' CG2' ' CG2' ' A' ' 9' ' ' VAL . 85.3 t -82.56 126.35 73.82 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.054 -1.029 . . . . 0.0 109.989 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 61' ' ' PRO . . . . . 0.954 ' HB2' HG11 ' B' ' 47' ' ' VAL . 37.0 Cg_endo -81.36 158.91 19.87 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 C-N-CA 122.403 2.068 . . . . 0.0 110.199 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 62' ' ' ARG . . . . . 0.457 ' NE ' ' HB3' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -150.91 130.62 13.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.054 -1.029 . . . . 0.0 109.839 179.411 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 1.119 HG23 ' CG2' ' B' ' 47' ' ' VAL . 1.1 t . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.308 -0.87 . . . . 0.0 108.901 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.506 HG22 ' O ' ' B' ' 63' ' ' VAL . 2.1 m . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.716 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.7 mt-10 -102.4 -36.43 8.44 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.112 -0.993 . . . . 0.0 110.026 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.78 ' NE1' HD12 ' A' ' 20' ' ' ILE . 7.8 m-90 56.2 47.33 2.87 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 121.018 -1.051 . . . . 0.0 109.249 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.716 ' HD3' ' HB2' ' A' ' 4' ' ' GLU . 33.4 Cg_endo -74.99 -37.39 2.06 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 N-CA-C 106.789 -2.043 . . . . 0.0 106.789 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -8.62 50.07 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 114.524 -1.216 . . . . 0.0 107.797 177.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.565 ' HG ' HD12 ' B' ' 57' ' ' ILE . 13.2 tp -83.2 -2.03 54.51 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 121.289 -0.882 . . . . 0.0 109.198 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.659 HG22 HG23 ' B' ' 60' ' ' VAL . 17.7 t -57.18 149.54 4.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.021 -1.049 . . . . 0.0 109.459 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.56 8.67 21.27 Favored Glycine 0 N--CA 1.481 1.688 0 C-N-CA 119.858 -1.163 . . . . 0.0 110.309 178.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 17.0 tptt -91.1 -145.63 0.19 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.789 -1.418 . . . . 0.0 109.161 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' B' ' 55' ' ' ASP . 0.4 OUTLIER -145.71 160.88 41.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.029 -1.045 . . . . 0.0 109.894 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.859 HG23 HG11 ' B' ' 51' ' ' VAL . 53.7 t -51.89 -32.48 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.339 -0.851 . . . . 0.0 109.19 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.547 ' O ' ' CG ' ' A' ' 18' ' ' LYS . 5.4 mt-10 -43.05 -74.06 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.501 ' HB3' HD11 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -59.97 -37.37 79.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.559 -0.713 . . . . 0.0 109.993 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.604 ' HB3' ' HA ' ' A' ' 13' ' ' VAL . . . -59.44 -80.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 0.0 110.04 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.532 ' HA ' ' CG2' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -47.21 -32.86 4.8 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.469 -1.394 . . . . 0.0 109.347 -179.817 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.547 ' CG ' ' O ' ' A' ' 14' ' ' GLU . 16.1 mtpt -58.86 -85.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.753 0.787 . . . . 0.0 110.953 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.522 ' O ' ' N ' ' A' ' 23' ' ' ASP . 2.8 t -57.83 -41.33 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.592 -0.692 . . . . 0.0 110.08 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.956 HG21 ' HB ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER -48.73 -52.31 9.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.352 -0.843 . . . . 0.0 109.16 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.461 ' C ' ' O ' ' A' ' 20' ' ' ILE . 0.7 OUTLIER -38.14 -40.86 0.54 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.685 -0.635 . . . . 0.0 110.125 -179.581 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.402 ' HB2' HD23 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -140.38 40.88 1.91 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.112 -0.993 . . . . 0.0 109.765 179.906 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 19' ' ' VAL . 18.8 p-10 -52.09 -42.93 63.63 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.336 -0.852 . . . . 0.0 109.493 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.782 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -130.75 -78.69 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.444 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.715 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.782 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 40.6 Cg_endo -87.57 -80.79 0.0 OUTLIER 'Trans proline' 0 C--O 1.214 -0.717 0 N-CA-C 107.78 -1.662 . . . . 0.0 107.78 177.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 22.4 mt-10 -161.96 62.08 0.24 Allowed 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.765 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -87.92 121.25 30.11 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.989 -1.069 . . . . 0.0 110.236 -178.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.43 ' O ' HG23 ' B' ' 47' ' ' VAL . 1.1 tp60 -88.59 176.15 7.25 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.057 -1.027 . . . . 0.0 108.242 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.956 ' HB ' HG21 ' A' ' 20' ' ' ILE . 9.4 tt -148.9 137.53 14.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 120.7 -1.25 . . . . 0.0 111.193 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.503 ' O ' ' HB3' ' B' ' 49' ' ' LEU . 0.8 OUTLIER -88.92 152.89 3.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.011 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.705 HG21 HG21 ' A' ' 13' ' ' VAL . 7.6 p -135.02 134.93 53.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 118.813 -1.155 . . . . 0.0 110.298 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.886 ' N ' HD23 ' A' ' 32' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.44 -0.787 . . . . 0.0 109.283 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.533 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 2.0 ptt-85 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.544 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.3 OUTLIER -44.75 142.54 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.893 -1.129 . . . . 0.0 108.458 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.645 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.1 p-10 -102.1 48.67 0.87 Allowed 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.127 -1.029 . . . . 0.0 110.058 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.71 146.34 26.38 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.675 HG12 ' H ' ' B' ' 62' ' ' ARG . 0.0 OUTLIER -150.47 143.7 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 120.968 -1.083 . . . . 0.0 109.317 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -78.67 88.05 4.58 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.99 -1.069 . . . . 0.0 110.796 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.534 ' C ' HD12 ' B' ' 49' ' ' LEU . 2.1 tp -90.41 97.22 11.05 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.141 -1.024 . . . . 0.0 108.657 178.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 50' ' ' PHE . . . . . 0.843 ' CZ ' HD11 ' A' ' 32' ' ' LEU . 16.6 m-85 -92.35 110.72 22.12 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.859 HG11 HG23 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -89.77 172.08 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.906 -1.121 . . . . 0.0 110.947 -178.856 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' B' ' 54' ' ' LEU . 0.7 OUTLIER -94.66 -153.04 0.37 Allowed 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.683 0.754 . . . . 0.0 109.715 -179.233 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.521 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 6.2 mttm -76.84 -47.42 21.46 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.522 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.0 OUTLIER -95.83 39.69 1.13 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.577 -0.702 . . . . 0.0 109.488 179.553 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 55' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.0 OUTLIER 47.75 67.29 0.84 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.12 -0.987 . . . . 0.0 109.123 -179.756 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 56' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' B' ' 58' ' ' ALA . 17.8 t-20 -127.33 94.12 3.91 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.658 0.742 . . . . 0.0 109.011 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.575 HD11 ' HB2' ' A' ' 16' ' ' ALA . 4.5 mt -39.68 87.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.301 0.572 . . . . 0.0 111.066 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 58' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -89.48 -19.65 24.82 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -118.19 106.1 12.48 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.659 HG23 HG22 ' A' ' 9' ' ' VAL . 35.4 t -62.52 133.87 94.88 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.227 -0.921 . . . . 0.0 110.345 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 61' ' ' PRO . . . . . 0.586 ' CB ' HD11 ' A' ' 29' ' ' ILE . 36.2 Cg_endo -79.81 163.38 23.56 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 122.531 2.154 . . . . 0.0 109.398 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 62' ' ' ARG . . . . . 0.675 ' H ' HG12 ' B' ' 47' ' ' VAL . 0.0 OUTLIER -150.55 128.08 11.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.971 -1.081 . . . . 0.0 110.102 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.765 HG21 ' HB1' ' A' ' 27' ' ' ALA . 1.8 t . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.263 -0.898 . . . . 0.0 109.073 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.654 HG23 ' CD ' ' A' ' 24' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.332 0.587 . . . . 0.0 109.598 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.586 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 6.9 mt-10 -94.33 -44.56 7.88 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.264 -0.897 . . . . 0.0 109.999 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.62 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.5 m-90 64.19 41.83 0.36 Allowed Pre-proline 0 C--N 1.296 -1.724 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.109 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 34.4 Cg_endo -73.14 -30.46 10.6 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 N-CA-C 106.929 -1.989 . . . . 0.0 106.929 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.67 -13.88 62.25 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 177.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.03 HD21 HG21 ' B' ' 57' ' ' ILE . 0.0 OUTLIER -81.89 -5.6 58.4 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.509 ' CG2' ' CG2' ' B' ' 60' ' ' VAL . 25.2 t -53.29 151.94 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.0 -1.063 . . . . 0.0 109.745 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.422 ' HA2' ' OD1' ' B' ' 56' ' ' ASN . . . 62.83 7.27 15.19 Favored Glycine 0 N--CA 1.482 1.716 0 C-N-CA 119.982 -1.104 . . . . 0.0 110.422 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -93.55 -142.56 0.23 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.833 -1.392 . . . . 0.0 109.183 179.646 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -148.73 161.48 41.68 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.994 -1.066 . . . . 0.0 109.89 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.726 ' HA ' HD21 ' B' ' 49' ' ' LEU . 39.9 t -46.39 -35.82 2.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.415 -0.803 . . . . 0.0 109.048 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.538 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 1.5 mt-10 -44.84 -73.88 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.511 -0.743 . . . . 0.0 109.066 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.449 ' O ' HG23 ' A' ' 19' ' ' VAL . 1.9 tm-20 -55.92 -34.5 65.65 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.192 -0.942 . . . . 0.0 109.555 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.685 ' HB1' HD12 ' A' ' 20' ' ' ILE . . . -62.82 -85.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.088 -1.008 . . . . 0.0 110.166 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -42.87 -45.45 4.93 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.837 -1.165 . . . . 0.0 108.914 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 6.1 tptm -42.37 -76.13 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.573 0.702 . . . . 0.0 110.584 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.482 ' O ' ' C ' ' A' ' 20' ' ' ILE . 1.0 OUTLIER -78.16 -52.81 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.459 -0.776 . . . . 0.0 110.402 -178.39 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.685 HD12 ' HB1' ' A' ' 16' ' ' ALA . 60.1 mt -37.98 -34.72 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.394 -0.816 . . . . 0.0 110.004 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.726 HD23 ' HB2' ' A' ' 22' ' ' GLN . 2.4 tt -56.09 -52.98 62.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.081 -1.012 . . . . 0.0 110.357 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.726 ' HB2' HD23 ' A' ' 21' ' ' LEU . 3.4 mt-30 -128.59 64.21 1.43 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.925 -1.109 . . . . 0.0 111.045 -178.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -84.42 -50.55 7.67 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.412 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.711 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 10.0 mtpp -101.05 -105.77 0.0 OUTLIER Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.711 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 37.2 Cg_endo -80.16 -70.98 0.01 OUTLIER 'Trans proline' 0 C--O 1.213 -0.738 0 CA-C-N 121.873 1.705 . . . . 0.0 108.059 177.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 25' ' ' PRO . 30.8 mt-10 -162.76 70.2 0.26 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.765 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -88.51 120.48 29.93 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.871 -1.143 . . . . 0.0 109.233 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -89.82 168.61 11.94 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.193 -0.942 . . . . 0.0 109.642 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.528 ' HB ' HG21 ' A' ' 20' ' ' ILE . 21.4 tt -146.91 140.34 19.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.351 -0.843 . . . . 0.0 109.944 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 1.025 HG22 HD22 ' A' ' 32' ' ' LEU . 1.7 mp -88.97 142.35 13.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.914 ' C ' HD23 ' A' ' 32' ' ' LEU . 4.0 p -105.82 133.04 51.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.47 -0.892 . . . . 0.0 109.491 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.025 HD22 HG22 ' A' ' 30' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.565 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.57 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 2.5 ptt180 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.006 0.431 . . . . 0.0 110.296 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.525 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.3 OUTLIER -47.52 142.91 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.82 -1.175 . . . . 0.0 107.955 178.955 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.651 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.5 p-10 -102.39 44.43 1.01 Allowed 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.004 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' ARG . . . . . 0.64 ' HG2' HD13 ' A' ' 30' ' ' ILE . 0.8 OUTLIER -151.09 142.69 23.6 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 178.993 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.536 HG12 ' H ' ' B' ' 62' ' ' ARG . 0.0 OUTLIER -150.59 157.75 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.126 -0.984 . . . . 0.0 109.319 -179.296 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.602 ' HD2' HD11 ' A' ' 32' ' ' LEU . 3.1 mmt180 -92.98 100.96 13.31 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.72 -1.237 . . . . 0.0 110.328 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.726 HD21 ' HA ' ' A' ' 13' ' ' VAL . 0.8 OUTLIER -95.45 96.02 8.82 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.263 -0.975 . . . . 0.0 108.872 178.876 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 50' ' ' PHE . . . . . 0.951 ' CE1' HD12 ' A' ' 32' ' ' LEU . 24.6 m-85 -93.26 143.53 26.17 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.554 HG23 ' N ' ' B' ' 52' ' ' ASP . 6.1 m -107.21 -151.57 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.769 -1.207 . . . . 0.0 110.858 -179.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.554 ' N ' HG23 ' B' ' 51' ' ' VAL . 0.2 OUTLIER -141.92 -157.47 0.77 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.426 -0.796 . . . . 0.0 109.68 -179.478 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.532 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 2.8 mtmp? -57.42 -59.02 5.77 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.667 -0.646 . . . . 0.0 109.509 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.428 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 6.7 tp -96.2 42.82 1.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.437 -0.789 . . . . 0.0 109.619 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 55' ' ' ASP . . . . . 0.498 ' HA ' ' HB ' ' B' ' 51' ' ' VAL . 0.0 OUTLIER 49.2 62.7 2.47 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.101 -0.999 . . . . 0.0 109.567 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 56' ' ' ASN . . . . . 0.551 ' O ' ' N ' ' B' ' 58' ' ' ALA . 4.0 t30 -122.59 106.19 10.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.311 -0.868 . . . . 0.0 108.808 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 1.03 HG21 HD21 ' A' ' 8' ' ' LEU . 28.0 mt -42.06 89.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.496 0.665 . . . . 0.0 110.374 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 58' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.48 -17.82 29.54 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -114.92 135.39 54.26 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.509 ' CG2' ' CG2' ' A' ' 9' ' ' VAL . 71.1 t -88.05 128.05 55.23 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.014 -1.054 . . . . 0.0 110.542 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 61' ' ' PRO . . . . . 0.479 ' O ' ' HD3' ' B' ' 62' ' ' ARG . 36.3 Cg_endo -79.76 158.36 24.69 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.317 2.012 . . . . 0.0 108.41 177.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 62' ' ' ARG . . . . . 0.536 ' H ' HG12 ' B' ' 47' ' ' VAL . 0.0 OUTLIER -150.54 133.05 15.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.768 -1.208 . . . . 0.0 110.409 -179.612 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.765 HG21 ' HB1' ' A' ' 27' ' ' ALA . 2.1 t . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.469 ' O ' ' HG3' ' B' ' 62' ' ' ARG . 2.4 m . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.619 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 27.7 mt-10 -118.82 -40.8 2.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -0.903 . . . . 0.0 109.914 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.641 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 9.6 m-90 61.7 41.92 0.49 Allowed Pre-proline 0 C--N 1.299 -1.621 0 O-C-N 121.524 -0.735 . . . . 0.0 110.092 -178.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 32.6 Cg_endo -72.49 -30.34 12.44 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 N-CA-C 106.468 -2.166 . . . . 0.0 106.468 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -16.05 63.17 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.086 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.583 HD11 ' CD1' ' A' ' 5' ' ' TRP . 7.2 mt -81.5 -5.78 58.3 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 121.302 -0.874 . . . . 0.0 109.293 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.653 ' CG2' HG22 ' B' ' 60' ' ' VAL . 23.7 t -57.0 148.04 4.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.148 -0.97 . . . . 0.0 109.81 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.423 ' HA2' ' OD1' ' B' ' 56' ' ' ASN . . . 60.12 10.19 14.1 Favored Glycine 0 N--CA 1.48 1.578 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.472 178.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.765 ' HB3' HD12 ' B' ' 57' ' ' ILE . 0.1 OUTLIER -94.65 -145.43 0.26 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.925 -1.338 . . . . 0.0 109.068 179.693 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 13' ' ' VAL . 0.3 OUTLIER -141.85 161.17 38.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.991 -1.068 . . . . 0.0 110.075 -179.546 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.602 ' HA ' HD11 ' B' ' 49' ' ' LEU . 79.1 t -45.16 -38.5 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.195 -0.941 . . . . 0.0 109.207 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.542 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 2.4 mt-10 -44.41 -75.28 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.413 ' O ' HG23 ' A' ' 19' ' ' VAL . 1.9 tp10 -53.46 -32.69 51.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.165 -0.959 . . . . 0.0 109.623 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.835 ' C ' HD12 ' A' ' 20' ' ' ILE . . . -62.58 -85.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 110.578 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.94 -29.45 4.78 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.757 -1.215 . . . . 0.0 109.271 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 16.6 tptm -56.78 -77.95 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.31 0.576 . . . . 0.0 110.749 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 15' ' ' GLU . 1.5 t -69.3 -43.49 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.353 -0.842 . . . . 0.0 109.849 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.835 HD12 ' C ' ' A' ' 16' ' ' ALA . 63.5 mt -48.13 -55.32 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.896 . . . . 0.0 110.003 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.464 ' C ' ' O ' ' A' ' 20' ' ' ILE . 1.2 tt -36.04 -35.84 0.08 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.584 -0.697 . . . . 0.0 110.794 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 20' ' ' ILE . 2.8 mt-30 -141.91 56.87 1.49 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.02 -1.05 . . . . 0.0 109.718 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.495 ' OD2' ' HD3' ' A' ' 24' ' ' LYS . 26.6 p-10 -70.66 -31.46 68.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.923 . . . . 0.0 109.015 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.707 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -133.84 -97.85 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.702 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.707 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 36.2 Cg_endo -78.63 -68.72 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.716 0 N-CA-C 107.422 -1.799 . . . . 0.0 107.422 176.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.533 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 25.8 mt-10 -163.84 72.26 0.26 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 1.007 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -88.36 114.73 25.27 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.068 -1.02 . . . . 0.0 108.875 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.509 ' CB ' ' O ' ' B' ' 45' ' ' ASP . 0.0 OUTLIER -89.06 171.99 9.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.253 -0.904 . . . . 0.0 109.197 -179.6 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.775 HD13 HD13 ' A' ' 20' ' ' ILE . 14.9 tt -149.31 146.58 17.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.823 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.699 HG22 HD22 ' A' ' 32' ' ' LEU . 1.2 mp -89.04 155.78 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 1.035 HG13 HD13 ' B' ' 49' ' ' LEU . 2.0 t -127.91 116.24 42.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 118.555 -1.258 . . . . 0.0 110.956 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.942 HD11 ' CE1' ' B' ' 50' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.576 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 6.6 ptt-85 . . . . . 0 N--CA 1.494 1.739 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.575 ' O ' HG22 ' B' ' 63' ' ' VAL . 0.9 OUTLIER -48.05 136.05 4.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 120.622 -1.299 . . . . 0.0 108.132 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.564 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -90.13 38.65 0.94 Allowed 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.446 -0.901 . . . . 0.0 110.282 -178.445 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 46' ' ' ARG . . . . . 0.566 ' CG ' HD13 ' A' ' 30' ' ' ILE . 0.9 OUTLIER -141.11 146.98 37.79 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.634 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 1.106 ' CG2' HG23 ' B' ' 63' ' ' VAL . 63.5 t -151.59 169.26 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.102 -0.999 . . . . 0.0 109.365 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.6 ' N ' HG12 ' B' ' 47' ' ' VAL . 17.0 mmt-85 -99.5 95.52 7.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.718 -1.239 . . . . 0.0 109.57 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 1.035 HD13 HG13 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -90.67 82.54 5.77 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 118.954 -1.098 . . . . 0.0 109.293 179.465 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 50' ' ' PHE . . . . . 0.942 ' CE1' HD11 ' A' ' 32' ' ' LEU . 6.5 m-30 -74.46 145.46 43.6 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.513 ' HB ' ' HA ' ' B' ' 55' ' ' ASP . 14.1 m -127.02 176.54 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.573 -1.329 . . . . 0.0 110.742 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.489 ' OD2' ' HG2' ' B' ' 53' ' ' LYS . 0.0 OUTLIER -111.58 -171.76 1.9 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.489 ' HG2' ' OD2' ' B' ' 52' ' ' ASP . 1.8 ptmt -51.95 -53.41 41.66 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.965 -1.084 . . . . 0.0 110.781 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.406 ' C ' ' CG ' ' B' ' 55' ' ' ASP . 0.2 OUTLIER -88.96 38.08 0.87 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.964 -1.085 . . . . 0.0 108.797 179.706 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 55' ' ' ASP . . . . . 0.513 ' HA ' ' HB ' ' B' ' 51' ' ' VAL . 0.0 OUTLIER 51.35 51.42 16.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.688 -0.632 . . . . 0.0 109.458 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 56' ' ' ASN . . . . . 0.514 ' O ' ' N ' ' B' ' 58' ' ' ALA . 30.5 t30 -101.06 112.43 24.89 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.376 -0.827 . . . . 0.0 109.552 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.765 HD12 ' HB3' ' A' ' 11' ' ' LYS . 43.5 mt -51.9 91.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.581 -0.699 . . . . 0.0 109.276 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 58' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.12 -23.78 23.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.578 -0.701 . . . . 0.0 109.11 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.53 126.33 54.87 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.653 HG22 ' CG2' ' A' ' 9' ' ' VAL . 42.2 t -78.67 129.87 72.65 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 120.971 -1.081 . . . . 0.0 109.925 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 61' ' ' PRO . . . . . 0.887 ' HB2' HG11 ' B' ' 47' ' ' VAL . 36.7 Cg_endo -83.69 159.94 14.3 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.671 2.247 . . . . 0.0 111.189 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 62' ' ' ARG . . . . . 0.558 ' NH1' ' HB ' ' B' ' 60' ' ' VAL . 0.1 OUTLIER -147.23 146.05 29.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.261 179.036 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 1.106 HG23 ' CG2' ' B' ' 47' ' ' VAL . 1.2 t . . . . . 0 N--CA 1.495 1.775 0 O-C-N 121.011 -1.056 . . . . 0.0 109.34 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 59.5 p . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.551 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 4.6 mt-10 -100.78 174.6 5.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.539 -0.725 . . . . 0.0 109.146 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.643 ' CE2' HG12 ' A' ' 20' ' ' ILE . 17.9 m-90 -145.61 46.75 0.59 Allowed Pre-proline 0 C--N 1.298 -1.644 0 O-C-N 121.592 -0.693 . . . . 0.0 109.334 178.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.628 ' HA ' HG21 ' B' ' 60' ' ' VAL . 30.5 Cg_endo -70.31 -27.7 23.51 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 N-CA-C 107.796 -1.655 . . . . 0.0 107.796 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.43 -19.34 62.99 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.793 HD21 HG21 ' B' ' 57' ' ' ILE . 0.0 OUTLIER -87.33 -3.34 59.03 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.657 HG22 ' CG2' ' B' ' 60' ' ' VAL . 41.0 t -53.41 150.34 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 120.929 -1.107 . . . . 0.0 110.016 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.54 0.45 17.62 Favored Glycine 0 N--CA 1.48 1.598 0 C-N-CA 120.092 -1.051 . . . . 0.0 111.032 177.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -93.55 -154.78 0.42 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.625 -1.515 . . . . 0.0 109.321 179.732 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.458 ' O ' HD11 ' B' ' 57' ' ' ILE . 0.6 OUTLIER -134.98 177.88 7.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.113 -0.992 . . . . 0.0 110.197 -179.464 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.77 HG22 HD13 ' B' ' 49' ' ' LEU . 54.0 t -52.98 -43.03 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.526 -0.734 . . . . 0.0 110.199 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.533 ' O ' ' CG ' ' A' ' 18' ' ' LYS . 3.9 mt-10 -41.88 -71.07 0.09 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.387 -0.82 . . . . 0.0 109.41 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -56.62 -36.83 69.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.594 -0.691 . . . . 0.0 110.052 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.685 ' HB2' HD11 ' B' ' 57' ' ' ILE . . . -62.21 -81.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.192 -0.943 . . . . 0.0 110.032 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -46.22 -29.98 1.81 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.655 -1.278 . . . . 0.0 109.168 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 14' ' ' GLU . 4.4 mmtt -62.33 -84.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.628 0.728 . . . . 0.0 110.678 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.55 HG12 ' OD1' ' A' ' 23' ' ' ASP . 2.2 t -56.53 -46.4 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.526 -0.734 . . . . 0.0 109.766 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.943 HG21 ' HB ' ' A' ' 29' ' ' ILE . 87.7 mt -49.44 -58.27 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.238 -0.914 . . . . 0.0 109.386 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.61 HD23 ' HB2' ' A' ' 22' ' ' GLN . 3.3 tt -35.66 -33.97 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.693 -0.629 . . . . 0.0 110.796 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.61 ' HB2' HD23 ' A' ' 21' ' ' LEU . 0.8 OUTLIER -150.48 50.25 0.88 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.993 -1.067 . . . . 0.0 110.509 -179.631 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.55 ' OD1' HG12 ' A' ' 19' ' ' VAL . 2.8 t0 -73.48 -52.81 12.33 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.985 -1.072 . . . . 0.0 108.73 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.875 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.7 OUTLIER -102.38 -92.38 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.366 0 CA-C-O 117.451 -1.261 . . . . 0.0 108.058 178.837 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.875 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 39.5 Cg_endo -87.05 -74.14 0.0 OUTLIER 'Trans proline' 0 C--O 1.213 -0.727 0 CA-C-N 121.765 1.666 . . . . 0.0 108.229 177.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.509 ' CG ' ' O ' ' A' ' 25' ' ' PRO . 21.2 mt-10 -162.47 56.94 0.22 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.645 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -87.93 117.91 27.12 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.192 -0.943 . . . . 0.0 108.845 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.504 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 3.4 tt0 -88.4 -176.87 5.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.324 -0.86 . . . . 0.0 109.786 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.943 ' HB ' HG21 ' A' ' 20' ' ' ILE . 11.6 tt -145.8 145.57 20.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.766 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.486 HG12 ' HG2' ' B' ' 46' ' ' ARG . 7.8 mm -91.41 145.5 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.489 ' O ' HG13 ' A' ' 31' ' ' VAL . 8.0 p -99.05 125.53 52.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 120.814 -1.179 . . . . 0.0 109.775 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.073 HD11 ' CE1' ' B' ' 50' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.46 0 O-C-N 121.035 -1.04 . . . . 0.0 110.182 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.566 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 7.8 ptt-85 . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.524 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.4 OUTLIER -47.52 144.55 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.573 -1.329 . . . . 0.0 108.256 179.518 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.645 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -103.41 44.57 1.01 Allowed 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 119.053 -1.059 . . . . 0.0 109.419 -179.528 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 46' ' ' ARG . . . . . 0.486 ' HG2' HG12 ' A' ' 30' ' ' ILE . 7.6 mtt180 -150.32 153.11 35.53 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.673 HG22 ' CG2' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -150.94 -176.97 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.72 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.754 ' HD2' HD22 ' A' ' 32' ' ' LEU . 25.7 mmt180 -111.89 79.8 1.25 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.793 -1.192 . . . . 0.0 110.026 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.77 HD13 HG22 ' A' ' 13' ' ' VAL . 0.5 OUTLIER -62.18 94.74 0.06 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.226 -0.921 . . . . 0.0 109.172 179.456 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 50' ' ' PHE . . . . . 1.073 ' CE1' HD11 ' A' ' 32' ' ' LEU . 1.6 m-30 -80.22 130.47 35.24 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.762 HG22 ' O ' ' A' ' 32' ' ' LEU . 4.4 m -113.52 -176.46 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.593 -1.317 . . . . 0.0 110.741 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.498 ' OD2' ' HB3' ' B' ' 56' ' ' ASN . 1.4 p-10 -116.24 -151.07 0.47 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.463 -0.773 . . . . 0.0 109.93 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.498 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 0.9 OUTLIER -70.88 -51.06 28.64 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.407 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.481 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 1.5 tp -100.07 44.6 1.01 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.469 -0.769 . . . . 0.0 109.186 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 55' ' ' ASP . . . . . 0.424 ' CG ' ' C ' ' B' ' 54' ' ' LEU . 0.0 OUTLIER 44.39 67.35 0.7 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.302 -0.874 . . . . 0.0 110.029 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 56' ' ' ASN . . . . . 0.573 ' O ' ' N ' ' B' ' 58' ' ' ALA . 11.7 t30 -127.4 92.53 3.52 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.793 HG21 HD21 ' A' ' 8' ' ' LEU . 13.6 mt -30.06 86.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-O 121.54 0.686 . . . . 0.0 111.157 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 58' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.11 -27.38 21.96 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 59' ' ' GLN . . . . . 0.525 ' HB3' ' HB2' ' B' ' 50' ' ' PHE . 32.5 tp60 -113.83 130.76 56.43 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.657 ' CG2' HG22 ' A' ' 9' ' ' VAL . 91.2 t -87.29 134.46 36.38 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 120.979 -1.075 . . . . 0.0 110.859 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 61' ' ' PRO . . . . . 0.46 ' O ' ' HD3' ' B' ' 62' ' ' ARG . 36.8 Cg_endo -79.76 169.45 18.15 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.558 2.172 . . . . 0.0 109.148 178.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 62' ' ' ARG . . . . . 0.523 ' O ' ' CG1' ' B' ' 47' ' ' VAL . 0.2 OUTLIER -150.18 135.05 17.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.976 -1.078 . . . . 0.0 110.06 -179.801 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.673 ' CG2' HG22 ' B' ' 47' ' ' VAL . 2.3 t . . . . . 0 N--CA 1.489 1.483 0 O-C-N 121.328 -0.858 . . . . 0.0 109.316 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.778 HG22 ' CD ' ' A' ' 24' ' ' LYS . 18.6 p . . . . . 0 N--CA 1.493 1.681 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.526 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 0.6 OUTLIER -110.32 169.6 8.63 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.277 -0.89 . . . . 0.0 108.824 179.244 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.673 ' O ' HG21 ' B' ' 60' ' ' VAL . 15.1 m-90 -150.1 45.05 0.34 Allowed Pre-proline 0 C--N 1.294 -1.826 0 O-C-N 121.57 -0.706 . . . . 0.0 109.26 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 31.2 Cg_endo -69.12 -31.19 23.89 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 N-CA-C 108.232 -1.488 . . . . 0.0 108.232 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -69.66 -19.61 63.6 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 177.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.69 HD12 ' CB ' ' A' ' 11' ' ' LYS . 14.8 tp -84.29 -9.08 58.78 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.493 0.663 . . . . 0.0 109.247 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.479 HG23 HG21 ' B' ' 60' ' ' VAL . 10.4 t -55.69 152.39 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 119.086 -1.045 . . . . 0.0 108.873 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.87 4.16 25.67 Favored Glycine 0 N--CA 1.48 1.61 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.229 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.69 ' CB ' HD12 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -95.76 -143.5 0.27 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.875 -1.368 . . . . 0.0 109.276 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.493 ' CB ' ' OE2' ' A' ' 14' ' ' GLU . 2.2 m -145.02 168.12 21.03 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.068 -1.02 . . . . 0.0 110.192 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.604 HG22 HD11 ' B' ' 49' ' ' LEU . 48.5 t -51.3 -38.6 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.571 -0.706 . . . . 0.0 109.875 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.55 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -42.52 -75.75 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.153 -179.615 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.34 -33.34 65.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.34 -0.85 . . . . 0.0 109.682 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 1.042 ' HB2' HD11 ' B' ' 57' ' ' ILE . . . -62.18 -85.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.404 -0.81 . . . . 0.0 110.439 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.527 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -46.75 -31.89 3.27 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.044 -1.035 . . . . 0.0 108.827 -179.331 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.55 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 5.3 tttp -56.41 -83.35 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.425 0 CA-C-O 121.323 0.582 . . . . 0.0 110.549 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 20' ' ' ILE . 2.4 t -62.53 -48.68 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.507 -0.746 . . . . 0.0 109.842 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.775 HG21 ' HB ' ' A' ' 29' ' ' ILE . 88.9 mt -43.83 -45.17 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.23 -0.919 . . . . 0.0 109.538 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.511 HD23 ' HB2' ' A' ' 22' ' ' GLN . 0.9 OUTLIER -49.26 -44.59 43.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.252 -0.905 . . . . 0.0 111.239 -179.247 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.511 ' HB2' HD23 ' A' ' 21' ' ' LEU . 4.0 mt-30 -137.03 41.17 2.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.693 -1.254 . . . . 0.0 111.413 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.496 ' OD1' ' O ' ' A' ' 20' ' ' ILE . 1.3 p-10 -67.89 -49.46 61.88 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.778 ' CD ' HG22 ' A' ' 3' ' ' THR . 1.0 OUTLIER -94.6 -116.05 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.476 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.314 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.722 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 37.2 Cg_endo -80.79 -66.47 0.02 OUTLIER 'Trans proline' 0 C--O 1.215 -0.664 0 CA-C-N 122.327 1.867 . . . . 0.0 108.035 178.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 18.8 mt-10 -161.29 60.45 0.28 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.611 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -88.25 116.71 26.65 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.034 -1.041 . . . . 0.0 108.197 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.459 ' O ' ' HA ' ' B' ' 46' ' ' ARG . 3.7 tt0 -88.24 176.49 7.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.066 -1.021 . . . . 0.0 110.105 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.775 ' HB ' HG21 ' A' ' 20' ' ' ILE . 19.1 tt -143.66 149.79 17.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 O-C-N 121.183 -0.948 . . . . 0.0 110.67 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.527 HD13 ' HA ' ' A' ' 30' ' ' ILE . 4.1 mm -97.66 146.44 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.8 HG12 HD12 ' B' ' 49' ' ' LEU . 0.0 OUTLIER -110.51 134.33 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.565 -1.334 . . . . 0.0 110.269 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.111 HD11 ' CE1' ' B' ' 50' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.756 -0.59 . . . . 0.0 109.509 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.56 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.8 0 CA-C-O 121.084 0.469 . . . . 0.0 110.99 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.537 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.3 OUTLIER -50.69 139.92 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 120.274 -1.517 . . . . 0.0 107.438 178.351 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.611 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 2.8 p30 -95.35 45.75 1.1 Allowed 'General case' 0 C--N 1.294 -1.848 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.281 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' ARG . . . . . 0.541 ' HG2' ' N ' ' B' ' 47' ' ' VAL . 6.0 ttt180 -149.26 156.39 42.05 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.484 -0.76 . . . . 0.0 109.175 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.6 HG22 ' CG2' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -151.75 -173.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.612 ' HD2' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -112.15 69.05 0.68 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.868 -1.145 . . . . 0.0 111.212 -179.187 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.8 HD12 HG12 ' A' ' 31' ' ' VAL . 1.9 tm? -56.49 94.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.005 -1.059 . . . . 0.0 108.253 178.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 50' ' ' PHE . . . . . 1.111 ' CE1' HD11 ' A' ' 32' ' ' LEU . 8.2 m-30 -86.25 143.78 27.76 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.807 HG22 ' O ' ' A' ' 32' ' ' LEU . 15.3 m -122.4 -175.28 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.844 -1.16 . . . . 0.0 109.578 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.499 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.4 OUTLIER -126.91 -154.76 0.65 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.408 -0.808 . . . . 0.0 109.868 -179.69 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.499 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 8.7 mttt -63.45 -54.79 31.06 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.457 0.646 . . . . 0.0 109.262 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.504 HD13 ' HA ' ' B' ' 54' ' ' LEU . 2.9 mm? -98.48 44.07 1.04 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.534 -0.729 . . . . 0.0 109.806 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 55' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' B' ' 55' ' ' ASP . 0.0 OUTLIER 48.32 64.17 1.77 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.248 -0.908 . . . . 0.0 109.65 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 56' ' ' ASN . . . . . 0.536 ' O ' ' N ' ' B' ' 58' ' ' ALA . 0.1 OUTLIER -124.77 98.74 5.84 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.434 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 1.042 HD11 ' HB2' ' A' ' 16' ' ' ALA . 32.1 mt -44.27 91.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 121.491 0.663 . . . . 0.0 109.822 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 58' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.3 -20.33 25.56 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -128.23 104.17 7.59 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.673 HG21 ' O ' ' A' ' 5' ' ' TRP . 5.0 t -73.69 134.93 78.39 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.226 -0.921 . . . . 0.0 110.397 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 61' ' ' PRO . . . . . 0.714 ' HG3' HD11 ' A' ' 29' ' ' ILE . 37.7 Cg_endo -84.04 -175.55 2.27 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 122.735 2.29 . . . . 0.0 109.677 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 62' ' ' ARG . . . . . 0.406 ' O ' ' CG1' ' B' ' 47' ' ' VAL . 0.1 OUTLIER -151.09 144.48 24.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.053 -1.029 . . . . 0.0 110.045 179.599 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.6 ' CG2' HG22 ' B' ' 47' ' ' VAL . 1.6 t . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . 1.025 HG22 ' CD ' ' A' ' 24' ' ' LYS . 21.0 p . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.599 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -90.31 -35.93 14.97 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.547 -0.721 . . . . 0.0 109.824 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.995 ' O ' HD12 ' A' ' 8' ' ' LEU . 5.5 m-90 58.49 41.54 0.66 Allowed Pre-proline 0 C--N 1.296 -1.737 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.467 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.636 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 33.7 Cg_endo -72.94 -34.05 6.99 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 N-CA-C 107.119 -1.916 . . . . 0.0 107.119 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -69.44 -9.72 54.87 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.336 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.048 ' O ' HD22 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -80.16 -8.42 59.41 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 121.299 -0.875 . . . . 0.0 109.106 -179.47 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.906 ' N ' HD13 ' A' ' 8' ' ' LEU . 35.4 t -48.66 149.84 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 120.882 -1.136 . . . . 0.0 110.437 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.98 2.31 23.57 Favored Glycine 0 N--CA 1.484 1.888 0 C-N-CA 120.142 -1.028 . . . . 0.0 111.138 177.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -93.41 -149.44 0.27 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.745 -1.444 . . . . 0.0 109.601 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.61 164.39 29.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.109 -0.994 . . . . 0.0 110.325 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.726 HG21 HG21 ' A' ' 31' ' ' VAL . 48.1 t -52.23 -34.93 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.461 -0.775 . . . . 0.0 109.062 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.542 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -44.36 -66.56 0.37 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.307 -0.871 . . . . 0.0 109.095 179.787 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.43 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -62.76 -34.04 76.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.093 -1.004 . . . . 0.0 109.303 179.297 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.729 ' HB1' HD12 ' A' ' 20' ' ' ILE . . . -62.11 -82.85 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.125 -0.985 . . . . 0.0 109.604 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.533 ' HG2' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -44.02 -42.07 5.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.951 -1.093 . . . . 0.0 108.905 179.813 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -47.48 -78.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.588 0.708 . . . . 0.0 110.339 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.458 ' O ' ' OD1' ' A' ' 23' ' ' ASP . 1.6 t -71.14 -55.27 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.7 -0.625 . . . . 0.0 110.116 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.882 HD13 HD13 ' A' ' 29' ' ' ILE . 95.3 mt -39.53 -34.82 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.524 -0.735 . . . . 0.0 109.872 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.1 tp -48.12 -52.22 21.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.367 -0.833 . . . . 0.0 110.759 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.578 ' O ' ' N ' ' A' ' 24' ' ' LYS . 0.8 OUTLIER -112.32 -66.88 1.04 Allowed 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.672 -1.211 . . . . 0.0 111.492 -178.373 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.517 ' O ' ' O ' ' A' ' 24' ' ' LYS . 0.4 OUTLIER 38.78 -92.81 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.41 -0.806 . . . . 0.0 108.875 -179.022 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 1.025 ' CD ' HG22 ' A' ' 3' ' ' THR . 2.8 mtpm? -64.27 -131.72 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.422 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 177.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.728 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 32.5 Cg_endo -74.67 -64.41 0.03 OUTLIER 'Trans proline' 0 C--O 1.215 -0.662 0 CA-C-N 122.084 1.78 . . . . 0.0 108.825 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 9.7 mt-10 -162.17 70.49 0.31 Allowed 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.605 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -88.85 117.47 27.87 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.522 ' CB ' ' O ' ' B' ' 45' ' ' ASP . 1.1 tt0 -87.2 173.55 9.15 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.951 -1.093 . . . . 0.0 109.249 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.882 HD13 HD13 ' A' ' 20' ' ' ILE . 5.4 tt -150.06 128.58 2.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 C-N-CA 118.999 -1.08 . . . . 0.0 110.741 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.636 HG22 HD22 ' A' ' 32' ' ' LEU . 2.9 mm -88.74 141.67 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.726 HG21 HG21 ' A' ' 13' ' ' VAL . 11.8 p -113.94 131.29 66.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 120.84 -1.163 . . . . 0.0 110.217 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.945 ' N ' HD23 ' A' ' 32' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.431 0 O-C-N 121.489 -0.757 . . . . 0.0 109.381 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.542 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 2.5 ptt180 . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.532 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.4 OUTLIER -43.03 141.93 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 119.148 -1.021 . . . . 0.0 108.567 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.605 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.6 p-10 -102.51 47.01 0.9 Allowed 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 119.188 -1.005 . . . . 0.0 109.819 -178.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' ARG . . . . . 0.406 ' C ' HG23 ' B' ' 47' ' ' VAL . 3.9 ttm180 -151.9 148.13 27.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.383 -0.823 . . . . 0.0 110.119 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 1.052 ' CG2' HG23 ' B' ' 63' ' ' VAL . 53.7 t -151.41 154.83 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.643 HH11 HD13 ' A' ' 32' ' ' LEU . 10.5 mmt180 -88.06 66.7 8.68 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.601 -1.312 . . . . 0.0 110.372 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 1.065 HD11 HD12 ' B' ' 57' ' ' ILE . 2.5 tp -60.79 90.11 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.089 -1.007 . . . . 0.0 109.383 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 50' ' ' PHE . . . . . 0.778 ' HE1' HD11 ' A' ' 32' ' ' LEU . 3.8 m-30 -76.26 156.06 33.83 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 32' ' ' LEU . 1.8 m -121.31 176.73 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.73 -1.232 . . . . 0.0 109.68 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.492 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.4 OUTLIER -109.22 -154.95 0.55 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.252 -0.905 . . . . 0.0 109.774 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.646 ' HB2' HD22 ' B' ' 54' ' ' LEU . 2.7 mtpt -67.8 -53.97 22.86 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.536 -0.728 . . . . 0.0 109.465 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.763 HD22 ' N ' ' B' ' 54' ' ' LEU . 3.2 mm? -95.88 42.9 1.09 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 109.567 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 55' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' B' ' 55' ' ' ASP . 0.0 OUTLIER 48.14 65.01 1.43 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.156 -0.965 . . . . 0.0 109.28 -179.727 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 56' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' B' ' 58' ' ' ALA . 8.9 t30 -130.01 106.68 8.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.385 -0.822 . . . . 0.0 108.846 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 1.065 HD12 HD11 ' B' ' 49' ' ' LEU . 15.6 mm -39.61 90.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-O 121.646 0.736 . . . . 0.0 110.68 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 58' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.09 -27.12 22.15 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -111.79 136.15 51.45 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.626 HG23 HG22 ' A' ' 9' ' ' VAL . 43.1 t -90.01 127.93 51.81 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.837 -1.165 . . . . 0.0 110.609 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 61' ' ' PRO . . . . . 0.877 ' HB2' HG11 ' B' ' 47' ' ' VAL . 36.5 Cg_endo -79.72 157.04 24.55 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.378 2.052 . . . . 0.0 109.215 177.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 62' ' ' ARG . . . . . 0.561 ' HD2' ' CA ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -146.12 142.98 29.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.838 -1.164 . . . . 0.0 110.588 -179.396 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 1.052 HG23 ' CG2' ' B' ' 47' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.787 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.642 HG23 ' HE3' ' A' ' 24' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.41 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.575 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 2.6 mp0 -89.78 167.43 12.87 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.349 -0.844 . . . . 0.0 109.361 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.62 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 20.9 m-90 -141.09 46.0 0.82 Allowed Pre-proline 0 C--N 1.294 -1.836 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 31.2 Cg_endo -69.6 -27.32 27.36 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 N-CA-C 108.21 -1.496 . . . . 0.0 108.21 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -69.66 -20.03 63.59 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.896 HD21 HG21 ' B' ' 57' ' ' ILE . 0.0 OUTLIER -82.27 -8.66 59.64 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.82 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.63 ' CG2' ' CG2' ' B' ' 60' ' ' VAL . 20.6 t -48.81 154.14 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.095 -1.003 . . . . 0.0 110.004 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.425 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . 65.71 2.43 11.59 Favored Glycine 0 N--CA 1.482 1.717 0 C-N-CA 120.252 -0.975 . . . . 0.0 110.883 178.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -93.69 -143.7 0.23 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.709 -1.465 . . . . 0.0 109.393 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.458 ' HB3' ' CD ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -144.46 167.52 22.29 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.964 -1.085 . . . . 0.0 110.121 -179.701 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.587 HG22 HD21 ' B' ' 49' ' ' LEU . 71.6 t -50.82 -40.96 20.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.531 -0.731 . . . . 0.0 109.796 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.544 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -44.68 -69.02 0.15 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.502 -0.749 . . . . 0.0 109.352 -179.763 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.596 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -58.07 -31.13 66.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.176 -0.952 . . . . 0.0 109.415 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.867 ' HB2' HD11 ' B' ' 57' ' ' ILE . . . -64.9 -84.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.045 -1.034 . . . . 0.0 109.954 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -45.2 -34.89 2.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.986 -1.071 . . . . 0.0 109.086 -179.556 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.544 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 20.5 tttp -55.02 -75.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.508 0.671 . . . . 0.0 111.334 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 15' ' ' GLU . 1.5 t -70.28 -46.1 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.486 -0.759 . . . . 0.0 110.968 -177.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.795 HG21 ' HB ' ' A' ' 29' ' ' ILE . 2.6 mt -53.28 -50.55 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.02 -1.05 . . . . 0.0 109.871 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 28' ' ' GLN . 2.3 tt -39.4 -28.08 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.265 -0.897 . . . . 0.0 110.642 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.475 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -149.9 26.82 0.8 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.875 -1.14 . . . . 0.0 110.675 -179.714 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.55 ' OD2' HG12 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -54.49 -64.15 0.92 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.731 -1.23 . . . . 0.0 108.194 179.182 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.748 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 3.5 mtpm? -80.47 -117.58 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 106.841 -1.541 . . . . 0.0 106.841 178.326 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.748 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 36.7 Cg_endo -79.92 -64.2 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.69 0 CA-C-N 122.103 1.787 . . . . 0.0 108.612 178.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 27.2 mt-10 -159.97 60.97 0.36 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.603 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -88.53 117.31 27.39 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.185 -1.006 . . . . 0.0 108.61 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 1.7 tt0 -88.6 169.78 11.41 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.199 -0.938 . . . . 0.0 109.965 -178.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.795 ' HB ' HG21 ' A' ' 20' ' ' ILE . 19.8 tt -140.6 135.14 34.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.51 -0.743 . . . . 0.0 109.52 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.694 HD13 ' CG ' ' B' ' 46' ' ' ARG . 1.2 mp -88.76 128.57 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 1.043 HG22 HD23 ' B' ' 49' ' ' LEU . 25.3 t -94.72 136.3 26.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 118.518 -1.273 . . . . 0.0 110.487 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.07 HD11 ' CE1' ' B' ' 50' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 O-C-N 121.689 -0.632 . . . . 0.0 109.347 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.512 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 5.6 ptt180 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.126 0.488 . . . . 0.0 109.907 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.563 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.5 OUTLIER -45.82 146.22 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.946 -1.096 . . . . 0.0 108.73 179.585 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.603 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -110.86 40.91 1.91 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.391 -0.924 . . . . 0.0 109.953 -179.74 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 46' ' ' ARG . . . . . 0.694 ' CG ' HD13 ' A' ' 30' ' ' ILE . 0.2 OUTLIER -150.23 144.56 25.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.42 -0.8 . . . . 0.0 108.994 179.192 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.55 ' CG2' HG23 ' B' ' 63' ' ' VAL . 0.0 OUTLIER -151.16 164.77 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.087 -1.008 . . . . 0.0 108.857 -179.747 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.614 ' HG3' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -91.9 89.42 7.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.745 -1.222 . . . . 0.0 110.46 -179.241 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 1.043 HD23 HG22 ' A' ' 31' ' ' VAL . 4.0 tp -78.87 91.32 4.76 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 50' ' ' PHE . . . . . 1.07 ' CE1' HD11 ' A' ' 32' ' ' LEU . 4.1 m-30 -77.54 179.74 6.34 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -148.01 -173.58 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.865 -1.147 . . . . 0.0 109.515 179.514 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.54 ' OD2' ' CB ' ' B' ' 56' ' ' ASN . 5.5 p-10 -116.7 -146.43 0.4 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.316 -0.865 . . . . 0.0 109.253 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.531 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 8.7 mmtp -62.28 -55.62 26.54 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.241 -0.912 . . . . 0.0 110.131 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.551 ' O ' ' CB ' ' B' ' 55' ' ' ASP . 2.4 mp -103.28 17.02 25.04 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.997 -1.065 . . . . 0.0 111.687 -178.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 55' ' ' ASP . . . . . 0.552 ' HA ' ' CG1' ' B' ' 51' ' ' VAL . 0.2 OUTLIER 91.43 47.87 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.459 0 CA-C-O 122.583 1.182 . . . . 0.0 110.623 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 56' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' B' ' 58' ' ' ALA . 1.9 t-20 -106.56 97.36 7.16 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.97 -1.081 . . . . 0.0 108.3 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.896 HG21 HD21 ' A' ' 8' ' ' LEU . 43.8 mt -37.28 88.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 121.549 0.69 . . . . 0.0 110.914 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 58' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.95 -31.26 18.25 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -99.69 134.94 41.85 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.63 ' CG2' ' CG2' ' A' ' 9' ' ' VAL . 65.1 t -90.12 129.44 45.85 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.092 -1.005 . . . . 0.0 111.21 -178.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 61' ' ' PRO . . . . . 0.413 ' O ' ' CD ' ' B' ' 62' ' ' ARG . 36.3 Cg_endo -81.84 162.53 18.56 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.308 2.005 . . . . 0.0 108.928 177.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 62' ' ' ARG . . . . . 0.534 ' O ' ' CG1' ' B' ' 47' ' ' VAL . 0.0 OUTLIER -150.91 132.62 14.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.659 -1.275 . . . . 0.0 110.711 -179.69 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.598 HG21 ' HB1' ' A' ' 27' ' ' ALA . 2.2 t . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.468 -0.77 . . . . 0.0 109.044 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.788 HG22 ' HD2' ' A' ' 24' ' ' LYS . 16.1 p . . . . . 0 N--CA 1.494 1.742 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.572 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 9.8 mp0 -104.15 -28.98 11.14 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.547 0.689 . . . . 0.0 109.151 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.637 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 8.7 m-90 53.12 42.22 1.15 Allowed Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 119.507 -0.877 . . . . 0.0 108.946 -177.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.637 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 35.1 Cg_endo -73.0 -34.83 5.96 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 N-CA-C 107.447 -1.79 . . . . 0.0 107.447 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.73 -12.0 61.29 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.557 ' HG ' HD12 ' B' ' 57' ' ' ILE . 32.1 tp -81.21 -6.0 58.37 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 121.49 -0.756 . . . . 0.0 109.31 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.594 HG23 HG21 ' B' ' 60' ' ' VAL . 21.0 t -54.37 152.48 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 120.942 -1.099 . . . . 0.0 109.034 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.11 7.14 22.78 Favored Glycine 0 N--CA 1.48 1.601 0 C-N-CA 119.94 -1.124 . . . . 0.0 110.44 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.501 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 5.2 tptt -93.92 -141.26 0.23 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.825 -1.397 . . . . 0.0 109.441 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.545 ' CA ' HG13 ' B' ' 57' ' ' ILE . 48.4 m -149.89 167.17 27.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.939 -1.101 . . . . 0.0 110.454 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.619 ' CG2' HG11 ' B' ' 51' ' ' VAL . 97.1 t -50.35 -34.05 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.49 -0.756 . . . . 0.0 109.814 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.524 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 27.1 mt-10 -45.87 -77.94 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.384 -0.822 . . . . 0.0 109.065 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.407 ' CD ' ' HE2' ' A' ' 11' ' ' LYS . 0.6 OUTLIER -55.69 -31.28 62.3 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.333 -0.854 . . . . 0.0 109.388 179.802 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.722 ' HB2' HD11 ' B' ' 57' ' ' ILE . . . -62.02 -85.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.44 -0.788 . . . . 0.0 110.616 -179.344 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.491 ' HG2' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -48.26 -29.81 4.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.634 -1.291 . . . . 0.0 108.994 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -57.6 -82.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.413 0.625 . . . . 0.0 111.116 -179.445 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -64.8 -40.21 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.369 -0.832 . . . . 0.0 110.315 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.8 HG21 ' HB ' ' A' ' 29' ' ' ILE . 98.5 mt -51.8 -56.17 6.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.336 -0.852 . . . . 0.0 109.82 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.462 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 0.4 OUTLIER -36.88 -29.76 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.51 -0.743 . . . . 0.0 110.593 -179.521 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 20' ' ' ILE . 2.2 mt-30 -148.74 52.53 0.99 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.023 -1.048 . . . . 0.0 109.855 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.516 ' OD2' ' HA ' ' A' ' 3' ' ' THR . 3.8 t0 -53.32 -62.81 1.41 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.985 -1.072 . . . . 0.0 108.409 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.845 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -115.98 -66.8 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 120.748 -1.22 . . . . 0.0 109.201 178.537 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.845 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 42.2 Cg_endo -91.25 -82.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.324 -0.748 0 N-CA-C 108.135 -1.525 . . . . 0.0 108.135 178.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 16.9 mt-10 -161.45 65.46 0.27 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.926 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -87.7 115.32 25.06 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.246 -0.982 . . . . 0.0 108.843 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.453 ' CB ' ' O ' ' B' ' 45' ' ' ASP . 1.8 tt0 -87.92 170.27 11.3 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.233 -0.917 . . . . 0.0 108.774 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.8 ' HB ' HG21 ' A' ' 20' ' ' ILE . 12.9 tt -142.3 133.17 24.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 118.719 -1.192 . . . . 0.0 110.576 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.44 HD13 ' HA ' ' A' ' 30' ' ' ILE . 12.1 mm -87.68 107.09 16.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.541 ' HA ' ' HB3' ' B' ' 49' ' ' LEU . 19.5 t -89.0 146.88 5.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.108 -0.995 . . . . 0.0 110.88 -178.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.063 HD11 ' CE1' ' B' ' 50' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--N 1.302 -1.457 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.527 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 120.745 0.307 . . . . 0.0 110.363 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.521 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.3 OUTLIER -46.06 139.56 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.648 -1.283 . . . . 0.0 108.356 179.504 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.567 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -99.4 44.86 1.01 Allowed 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.202 -0.936 . . . . 0.0 109.8 -178.932 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 46' ' ' ARG . . . . . 0.431 ' C ' HG23 ' B' ' 47' ' ' VAL . 0.2 OUTLIER -149.65 145.59 26.82 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.401 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 1.149 ' CG2' HG23 ' B' ' 63' ' ' VAL . 60.9 t -151.8 169.35 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 109.779 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.605 ' N ' HG12 ' B' ' 47' ' ' VAL . 0.0 OUTLIER -99.12 95.26 6.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.726 -1.234 . . . . 0.0 109.849 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.653 HD11 ' CB ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -88.21 84.0 6.92 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.015 -1.053 . . . . 0.0 109.277 179.265 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 50' ' ' PHE . . . . . 1.063 ' CE1' HD11 ' A' ' 32' ' ' LEU . 4.4 m-30 -72.43 138.09 46.89 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.949 HG22 ' O ' ' A' ' 32' ' ' LEU . 2.6 m -123.6 -171.18 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.676 -1.265 . . . . 0.0 110.231 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.569 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.0 OUTLIER -129.72 -168.13 1.91 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.893 0.854 . . . . 0.0 110.006 -179.221 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.569 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 13.8 mttm -43.6 -68.95 0.15 Allowed 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.331 0.586 . . . . 0.0 110.071 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.404 ' CG ' ' O ' ' B' ' 54' ' ' LEU . 0.6 OUTLIER -89.96 47.2 1.43 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 0.0 109.742 -179.59 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 47.62 57.39 5.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.294 -0.879 . . . . 0.0 109.828 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 56' ' ' ASN . . . . . 0.549 ' O ' ' N ' ' B' ' 58' ' ' ALA . 7.0 t30 -106.42 96.42 6.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.139 -0.976 . . . . 0.0 109.055 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.722 HD11 ' HB2' ' A' ' 16' ' ' ALA . 12.2 mt -42.79 91.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 121.5 0.667 . . . . 0.0 109.681 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 58' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -87.77 -17.43 31.64 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -129.23 96.9 4.43 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.594 HG21 HG23 ' A' ' 9' ' ' VAL . 1.6 t -56.54 137.02 77.0 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.32 -0.862 . . . . 0.0 109.952 -178.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 61' ' ' PRO . . . . . 0.799 ' HB2' HG11 ' B' ' 47' ' ' VAL . 36.2 Cg_endo -80.93 160.15 21.09 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.846 2.364 . . . . 0.0 110.22 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 62' ' ' ARG . . . . . 0.554 ' HD2' ' CB ' ' A' ' 4' ' ' GLU . 0.8 OUTLIER -141.96 134.44 28.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.137 -0.977 . . . . 0.0 109.622 179.798 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 1.149 HG23 ' CG2' ' B' ' 47' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.209 -0.932 . . . . 0.0 108.996 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.644 HG23 ' CD ' ' A' ' 24' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.607 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 13.7 mt-10 -100.09 -43.14 6.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.323 -0.861 . . . . 0.0 110.289 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.681 ' CE2' HG12 ' A' ' 20' ' ' ILE . 6.7 m-90 61.21 42.47 0.56 Allowed Pre-proline 0 C--N 1.296 -1.717 0 C-N-CA 119.441 -0.904 . . . . 0.0 109.488 -178.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.635 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 32.7 Cg_endo -72.45 -34.07 7.98 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 N-CA-C 106.925 -1.99 . . . . 0.0 106.925 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -69.34 -12.76 61.93 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.988 HD21 ' HB2' ' A' ' 16' ' ' ALA . 21.9 tp -76.62 -6.4 51.87 Favored 'General case' 0 C--N 1.31 -1.138 0 O-C-N 121.506 -0.746 . . . . 0.0 109.462 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.649 HG23 ' CG2' ' B' ' 60' ' ' VAL . 18.3 t -59.7 149.34 6.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 120.81 -1.181 . . . . 0.0 108.482 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.42 7.2 18.37 Favored Glycine 0 C--N 1.296 -1.642 0 C-N-CA 119.578 -1.296 . . . . 0.0 110.379 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.542 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -99.63 -154.71 0.48 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.818 -1.401 . . . . 0.0 108.869 179.558 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.445 ' C ' HD11 ' B' ' 57' ' ' ILE . 0.5 OUTLIER -135.48 160.93 36.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.689 -1.257 . . . . 0.0 110.888 -179.124 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.658 HG13 HD23 ' B' ' 49' ' ' LEU . 28.1 t -52.89 -33.08 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.585 -0.697 . . . . 0.0 109.219 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.549 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 52.7 mm-40 -46.28 -67.69 0.26 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.154 -0.966 . . . . 0.0 108.556 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.414 ' O ' HG23 ' A' ' 19' ' ' VAL . 2.5 tp10 -61.62 -30.89 70.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.4 -0.813 . . . . 0.0 109.501 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.988 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -67.54 -82.18 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.177 -0.952 . . . . 0.0 109.751 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -44.36 -40.39 5.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.672 -1.267 . . . . 0.0 108.972 179.64 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.549 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 20.8 tttm -49.92 -72.1 0.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.611 -0.681 . . . . 0.0 110.368 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.516 ' O ' ' N ' ' A' ' 23' ' ' ASP . 2.8 t -72.24 -57.62 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.523 -0.736 . . . . 0.0 109.972 -179.08 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.944 HG21 ' HB ' ' A' ' 29' ' ' ILE . 5.9 mt -35.93 -53.86 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.588 -0.695 . . . . 0.0 110.211 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.499 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 2.3 tt -37.56 -52.87 1.2 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.615 -0.678 . . . . 0.0 110.003 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.419 ' HG3' ' HA ' ' A' ' 26' ' ' GLU . 1.4 mt-30 -128.56 32.58 4.8 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 109.968 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' VAL . 17.4 p-10 -50.67 -48.88 58.28 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.019 -1.05 . . . . 0.0 108.28 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.708 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 10.4 mtpp -107.24 -106.62 0.0 OUTLIER Pre-proline 0 CA--C 1.561 1.374 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.708 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 37.0 Cg_endo -79.98 -67.74 0.02 OUTLIER 'Trans proline' 0 C--O 1.215 -0.657 0 CA-C-N 121.93 1.725 . . . . 0.0 108.631 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.528 ' CG ' ' O ' ' A' ' 25' ' ' PRO . 27.1 mt-10 -162.02 64.09 0.24 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.789 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -88.86 116.64 27.28 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.022 -1.049 . . . . 0.0 108.916 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.475 ' HG3' ' OD2' ' B' ' 45' ' ' ASP . 0.1 OUTLIER -88.86 165.65 14.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.899 -1.126 . . . . 0.0 109.166 -179.54 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.944 ' HB ' HG21 ' A' ' 20' ' ' ILE . 3.3 tt -139.84 131.99 34.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.158 -0.963 . . . . 0.0 110.276 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.5 mm -88.59 117.95 33.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.478 HG21 HG21 ' A' ' 13' ' ' VAL . 2.5 p -95.93 136.56 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.149 -0.969 . . . . 0.0 109.675 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.954 ' N ' HD23 ' A' ' 32' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 O-C-N 121.237 -0.915 . . . . 0.0 109.562 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.547 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.057 0.456 . . . . 0.0 110.688 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.747 HG23 HG22 ' B' ' 63' ' ' VAL . 0.6 OUTLIER -49.22 145.55 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 120.574 -1.329 . . . . 0.0 108.208 178.939 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.609 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.3 p-10 -108.46 32.76 4.59 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.07 -1.019 . . . . 0.0 109.888 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 46' ' ' ARG . . . . . 0.41 ' C ' ' CG2' ' B' ' 47' ' ' VAL . 0.1 OUTLIER -150.57 143.63 24.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.436 -0.79 . . . . 0.0 109.007 179.349 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.869 ' CG2' HG23 ' B' ' 63' ' ' VAL . 1.8 t -149.44 166.43 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -0.908 . . . . 0.0 109.608 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.536 ' HG3' ' CE2' ' B' ' 50' ' ' PHE . 0.0 OUTLIER -95.5 75.56 3.3 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.742 -1.224 . . . . 0.0 110.21 -179.611 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.662 HD22 ' HB1' ' A' ' 16' ' ' ALA . 4.3 tp -76.72 92.97 3.59 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 118.818 -1.153 . . . . 0.0 108.282 178.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 50' ' ' PHE . . . . . 0.839 ' CZ ' HD11 ' A' ' 32' ' ' LEU . 17.8 m-85 -81.52 -177.02 6.34 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 6.1 m -144.28 -175.64 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.648 -1.283 . . . . 0.0 110.5 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.533 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.4 OUTLIER -120.0 -154.8 0.59 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.481 -0.762 . . . . 0.0 109.813 -179.616 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.533 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 11.4 mtpt -63.94 -56.78 12.72 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.565 -0.709 . . . . 0.0 109.332 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.64 ' O ' HD23 ' B' ' 54' ' ' LEU . 2.6 tt -97.12 41.87 1.1 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.395 -0.816 . . . . 0.0 109.461 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 55' ' ' ASP . . . . . 0.405 ' CG ' ' C ' ' B' ' 54' ' ' LEU . 0.0 OUTLIER 49.65 65.06 1.52 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.206 -0.934 . . . . 0.0 109.181 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 56' ' ' ASN . . . . . 0.553 ' O ' ' N ' ' B' ' 58' ' ' ALA . 17.4 t-20 -123.94 96.44 4.95 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.38 -0.825 . . . . 0.0 108.996 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.607 HD12 ' HG ' ' A' ' 8' ' ' LEU . 4.2 mt -37.45 89.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-O 121.576 0.703 . . . . 0.0 110.88 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 58' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.23 -21.56 24.45 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.67 133.79 53.67 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.649 ' CG2' HG23 ' A' ' 9' ' ' VAL . 99.4 t -90.09 128.11 50.94 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 120.999 -1.063 . . . . 0.0 110.59 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 61' ' ' PRO . . . . . 0.533 ' HB2' HG11 ' B' ' 47' ' ' VAL . 37.2 Cg_endo -83.63 165.29 14.01 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.396 2.064 . . . . 0.0 109.43 178.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 62' ' ' ARG . . . . . 0.541 ' HG3' ' HA ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -148.86 141.15 24.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.168 -0.958 . . . . 0.0 109.749 179.559 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.869 HG23 ' CG2' ' B' ' 47' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.731 0 O-C-N 121.261 -0.899 . . . . 0.0 109.084 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.537 HG22 ' CD ' ' A' ' 24' ' ' LYS . 70.7 p . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.589 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 81.2 mt-10 -93.53 -35.46 12.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.336 -0.852 . . . . 0.0 109.958 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.627 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 6.5 m-90 58.34 40.79 0.58 Allowed Pre-proline 0 C--N 1.293 -1.879 0 O-C-N 120.836 -1.165 . . . . 0.0 109.863 -178.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.627 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 34.2 Cg_endo -73.32 -34.92 5.46 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 N-CA-C 107.08 -1.931 . . . . 0.0 107.08 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.9 -11.72 61.08 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 177.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.558 HD21 ' HA ' ' A' ' 16' ' ' ALA . 30.5 tp -79.1 -7.91 58.54 Favored 'General case' 0 C--N 1.309 -1.172 0 O-C-N 121.402 -0.811 . . . . 0.0 109.216 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.613 HG23 ' CG2' ' B' ' 60' ' ' VAL . 19.4 t -54.34 154.22 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 118.994 -1.082 . . . . 0.0 109.151 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.438 ' C ' ' OD1' ' B' ' 56' ' ' ASN . . . 70.37 -0.43 25.29 Favored Glycine 0 C--N 1.297 -1.623 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.629 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -96.16 -151.76 0.36 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.665 -1.491 . . . . 0.0 109.584 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.507 ' CB ' ' OE2' ' A' ' 14' ' ' GLU . 1.2 m -139.53 172.8 12.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.138 -0.976 . . . . 0.0 110.535 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.676 ' HA ' HD21 ' B' ' 49' ' ' LEU . 99.2 t -54.72 -37.95 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.586 -0.696 . . . . 0.0 109.916 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.507 ' OE2' ' CB ' ' A' ' 12' ' ' SER . 0.7 OUTLIER -44.05 -74.76 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -0.904 . . . . 0.0 108.855 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.26 -38.23 65.58 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.394 -0.816 . . . . 0.0 109.835 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.835 ' HB2' HD11 ' B' ' 57' ' ' ILE . . . -59.02 -83.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.237 -0.915 . . . . 0.0 110.308 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.572 ' HA ' HG22 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -46.62 -28.06 1.34 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.586 -1.321 . . . . 0.0 109.617 -179.596 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 10.2 mttt -63.35 -83.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.487 -0.758 . . . . 0.0 110.746 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.468 ' H ' HG23 ' A' ' 19' ' ' VAL . 2.1 t -57.61 -42.34 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.6 -0.688 . . . . 0.0 109.472 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.885 HG21 ' HB ' ' A' ' 29' ' ' ILE . 69.0 mt -50.64 -53.75 11.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.293 -0.879 . . . . 0.0 108.919 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.531 HD12 ' OE1' ' A' ' 28' ' ' GLN . 9.1 tt -34.98 -36.45 0.05 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.788 -0.57 . . . . 0.0 110.642 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 20' ' ' ILE . 3.3 mt-30 -147.36 41.4 1.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.113 -0.992 . . . . 0.0 110.241 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.547 ' OD1' ' HG2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -57.86 -44.85 86.86 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.969 -1.082 . . . . 0.0 108.441 179.598 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.837 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -120.71 -88.49 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.241 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.837 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 38.8 Cg_endo -84.07 -81.47 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.655 0 N-CA-C 108.214 -1.494 . . . . 0.0 108.214 177.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 13.9 mt-10 -158.79 57.83 0.43 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 1.035 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -87.67 117.03 26.21 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.178 -0.951 . . . . 0.0 109.303 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.531 ' OE1' HD12 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -88.58 -175.15 4.84 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.129 -0.982 . . . . 0.0 109.549 -179.358 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.885 ' HB ' HG21 ' A' ' 20' ' ' ILE . 14.6 tt -147.62 140.59 19.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.452 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.706 HG22 HD22 ' A' ' 32' ' ' LEU . 2.7 mm -87.51 146.55 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.81 ' C ' HD23 ' A' ' 32' ' ' LEU . 8.7 p -102.37 133.53 45.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 119.071 -1.051 . . . . 0.0 109.734 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.966 ' N ' HD23 ' A' ' 32' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.401 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.564 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.118 0.485 . . . . 0.0 109.78 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.495 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.3 OUTLIER -48.16 139.37 2.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 120.646 -1.284 . . . . 0.0 108.189 179.334 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.593 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -97.12 45.64 1.04 Allowed 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.331 -179.281 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -150.93 143.28 24.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.403 -0.811 . . . . 0.0 109.133 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 1.097 HG23 HG23 ' B' ' 63' ' ' VAL . 53.5 t -151.0 146.38 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.209 -0.932 . . . . 0.0 110.092 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.509 ' HB3' HD11 ' A' ' 32' ' ' LEU . 7.0 mmt180 -71.81 98.24 1.94 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.625 -1.297 . . . . 0.0 110.443 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.846 ' N ' HD21 ' A' ' 32' ' ' LEU . 2.6 tp -84.79 88.37 7.38 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.131 -0.981 . . . . 0.0 108.842 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 50' ' ' PHE . . . . . 0.759 ' CE1' HD12 ' A' ' 32' ' ' LEU . 1.8 m-85 -70.13 178.66 2.68 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.43 ' HB ' ' HA ' ' B' ' 55' ' ' ASP . 6.3 m -139.82 -174.71 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.043 -1.035 . . . . 0.0 109.276 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.687 ' HB3' ' HB2' ' B' ' 58' ' ' ALA . 0.1 OUTLIER -135.94 -158.71 0.89 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.147 -0.97 . . . . 0.0 110.115 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.529 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 26.9 mtpt -43.66 -69.81 0.12 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.67 -0.644 . . . . 0.0 110.407 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.481 ' HA ' HD22 ' B' ' 54' ' ' LEU . 0.4 OUTLIER -97.23 52.81 1.15 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.274 -0.891 . . . . 0.0 110.106 -179.138 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 55' ' ' ASP . . . . . 0.43 ' HA ' ' HB ' ' B' ' 51' ' ' VAL . 0.0 OUTLIER 47.38 58.1 5.22 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.251 -0.906 . . . . 0.0 109.183 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 56' ' ' ASN . . . . . 0.565 ' O ' ' N ' ' B' ' 58' ' ' ALA . 36.5 t-20 -121.52 113.74 20.25 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.835 HD11 ' HB2' ' A' ' 16' ' ' ALA . 26.4 mt -35.51 88.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-O 121.518 0.675 . . . . 0.0 110.966 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 58' ' ' ALA . . . . . 0.687 ' HB2' ' HB3' ' B' ' 52' ' ' ASP . . . -89.17 -20.92 23.63 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 59' ' ' GLN . . . . . 0.415 ' NE2' ' CD2' ' B' ' 50' ' ' PHE . 0.0 OUTLIER -109.99 137.99 46.99 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.324 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.613 ' CG2' HG23 ' A' ' 9' ' ' VAL . 71.3 t -90.33 129.46 45.31 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.092 -1.005 . . . . 0.0 111.022 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 61' ' ' PRO . . . . . 0.837 ' CB ' HG11 ' B' ' 47' ' ' VAL . 37.4 Cg_endo -83.46 164.18 14.57 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 122.617 2.212 . . . . 0.0 108.587 178.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 62' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -138.97 -43.98 0.47 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.255 -1.528 . . . . 0.0 110.809 -179.65 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 1.097 HG23 HG23 ' B' ' 47' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.293 -1.874 0 O-C-N 121.218 -0.926 . . . . 0.0 109.662 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.706 HG22 ' CE ' ' A' ' 24' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.569 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 3.9 mt-10 -92.69 -47.22 7.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.387 -0.821 . . . . 0.0 110.336 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.632 ' CE2' HG12 ' A' ' 20' ' ' ILE . 10.9 m-90 62.29 45.15 0.72 Allowed Pre-proline 0 C--N 1.297 -1.703 0 C-N-CA 119.611 -0.836 . . . . 0.0 108.935 -177.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.629 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 33.0 Cg_endo -71.68 -30.85 14.08 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 N-CA-C 107.169 -1.897 . . . . 0.0 107.169 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.29 -15.28 62.87 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.731 HD21 ' HB2' ' A' ' 16' ' ' ALA . 13.4 tp -80.48 -5.81 57.2 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.657 -0.652 . . . . 0.0 109.325 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.551 HG23 HG21 ' B' ' 60' ' ' VAL . 36.9 t -51.68 152.22 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.089 -1.007 . . . . 0.0 109.528 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.459 ' HA2' ' OD1' ' B' ' 56' ' ' ASN . . . 47.42 21.14 1.15 Allowed Glycine 0 N--CA 1.483 1.77 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.516 178.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -96.51 -141.81 0.28 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.862 -1.375 . . . . 0.0 109.143 179.631 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.45 ' N ' HG12 ' B' ' 57' ' ' ILE . 0.6 OUTLIER -146.41 159.42 43.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.911 -1.118 . . . . 0.0 110.008 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.604 ' HA ' HD21 ' B' ' 49' ' ' LEU . 29.8 t -48.15 -36.76 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.409 -0.807 . . . . 0.0 109.649 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.533 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 2.7 mt-10 -45.46 -75.41 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.408 -0.807 . . . . 0.0 109.193 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.4 ' HB3' ' CD1' ' A' ' 8' ' ' LEU . 0.9 OUTLIER -53.88 -32.84 54.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.235 -0.915 . . . . 0.0 109.113 179.489 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.731 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -64.88 -88.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.404 -0.81 . . . . 0.0 110.309 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.52 ' HA ' ' CG2' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -43.06 -29.02 0.32 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.823 -1.173 . . . . 0.0 109.255 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 3.5 tttt -61.81 -82.89 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.735 -0.603 . . . . 0.0 110.182 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' A' ' 23' ' ' ASP . 3.2 t -59.98 -48.36 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.42 -0.8 . . . . 0.0 109.427 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.699 HG21 ' HB ' ' A' ' 29' ' ' ILE . 80.0 mt -48.17 -59.87 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.407 -0.808 . . . . 0.0 110.045 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 27' ' ' ALA . 1.0 OUTLIER -37.74 -33.24 0.07 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.502 -0.749 . . . . 0.0 110.531 -179.327 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.445 ' HB2' HD23 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -149.51 50.47 0.94 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.137 -0.977 . . . . 0.0 109.623 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -66.65 -40.88 88.87 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.176 -0.952 . . . . 0.0 108.639 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.73 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -124.01 -88.53 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.441 0 CA-C-O 117.962 -1.018 . . . . 0.0 108.271 178.078 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.73 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 37.8 Cg_endo -81.34 -79.66 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.659 0 N-CA-C 108.522 -1.376 . . . . 0.0 108.522 177.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 14.5 mt-10 -160.99 66.0 0.3 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.982 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -87.56 116.09 25.44 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.123 -1.031 . . . . 0.0 108.9 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.49 ' CB ' ' O ' ' B' ' 45' ' ' ASP . 0.0 OUTLIER -88.46 161.39 17.05 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.436 -0.79 . . . . 0.0 108.995 -179.543 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.699 ' HB ' HG21 ' A' ' 20' ' ' ILE . 14.4 tt -137.73 136.46 45.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.062 -1.055 . . . . 0.0 110.507 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.528 ' O ' ' HB3' ' B' ' 49' ' ' LEU . 3.9 mm -88.89 155.17 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.502 ' HA ' ' HB3' ' B' ' 49' ' ' LEU . 14.9 p -116.32 137.38 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.77 -1.206 . . . . 0.0 109.752 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.099 HD11 ' CE1' ' B' ' 50' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.182 -0.949 . . . . 0.0 110.374 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.583 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 2.0 ptp180 . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.539 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.5 OUTLIER -42.96 143.14 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.87 -1.144 . . . . 0.0 108.765 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.603 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.1 p-10 -100.99 39.49 1.39 Allowed 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.12 -178.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 46' ' ' ARG . . . . . 0.459 ' C ' HG23 ' B' ' 47' ' ' VAL . 0.0 OUTLIER -150.79 140.81 22.04 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.83 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 1.044 ' CG2' HG23 ' B' ' 63' ' ' VAL . 96.5 t -151.52 152.13 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.999 -1.063 . . . . 0.0 110.323 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.545 ' HG3' HD21 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -78.38 105.2 9.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.083 -1.011 . . . . 0.0 110.139 -179.515 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 1.043 HD11 HD12 ' B' ' 57' ' ' ILE . 2.6 tp -93.27 86.27 5.26 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.304 -0.959 . . . . 0.0 108.505 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 50' ' ' PHE . . . . . 1.099 ' CE1' HD11 ' A' ' 32' ' ' LEU . 5.9 m-30 -69.72 133.28 47.32 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.714 HG22 ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -103.52 -170.54 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.856 -1.153 . . . . 0.0 109.722 179.747 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.527 ' OD2' ' CB ' ' B' ' 56' ' ' ASN . 2.7 p-10 -126.28 -149.72 0.42 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.519 -0.738 . . . . 0.0 109.055 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.519 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 34.4 mttm -56.86 -58.81 6.5 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.317 -0.864 . . . . 0.0 110.233 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.817 ' O ' HD23 ' B' ' 54' ' ' LEU . 0.9 OUTLIER -101.24 15.99 26.97 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.086 -1.009 . . . . 0.0 111.682 -178.587 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 55' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' B' ' 54' ' ' LEU . 0.2 OUTLIER 91.71 48.97 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.603 0 CA-C-O 122.621 1.2 . . . . 0.0 110.183 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 56' ' ' ASN . . . . . 0.527 ' CB ' ' OD2' ' B' ' 52' ' ' ASP . 1.8 t-20 -105.92 123.77 48.51 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.893 -1.129 . . . . 0.0 109.49 179.102 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 1.043 HD12 HD11 ' B' ' 49' ' ' LEU . 4.3 mm -54.97 88.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.61 -0.681 . . . . 0.0 109.457 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 58' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.56 -21.5 24.04 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 59' ' ' GLN . . . . . 0.416 ' O ' ' C ' ' B' ' 60' ' ' VAL . 8.7 mp0 -125.22 85.14 2.36 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.552 ' CG1' ' O ' ' A' ' 4' ' ' GLU . 9.3 t -42.37 130.15 2.82 Favored Pre-proline 0 N--CA 1.487 1.41 0 O-C-N 121.284 -0.885 . . . . 0.0 110.501 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 61' ' ' PRO . . . . . 0.591 ' HB2' HG11 ' B' ' 47' ' ' VAL . 36.8 Cg_endo -82.56 162.16 16.82 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 122.976 2.451 . . . . 0.0 110.276 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 62' ' ' ARG . . . . . 0.553 ' N ' HG11 ' B' ' 47' ' ' VAL . 0.1 OUTLIER -139.88 152.81 46.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.065 -1.022 . . . . 0.0 109.514 179.43 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 1.044 HG23 ' CG2' ' B' ' 47' ' ' VAL . 1.2 t . . . . . 0 N--CA 1.495 1.816 0 O-C-N 121.154 -0.966 . . . . 0.0 109.009 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.921 HG22 ' CD ' ' A' ' 24' ' ' LYS . 26.4 p . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.735 ' HB3' ' HD3' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -105.05 -178.06 3.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.332 -0.855 . . . . 0.0 110.164 -179.575 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.643 ' NE1' HD12 ' A' ' 20' ' ' ILE . 8.0 m-90 -161.65 48.85 0.25 Allowed Pre-proline 0 C--N 1.299 -1.621 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.19 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.735 ' HD3' ' HB3' ' A' ' 4' ' ' GLU . 30.6 Cg_endo -69.24 -25.82 30.63 Favored 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 121.956 1.77 . . . . 0.0 107.586 178.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -67.4 -25.32 65.88 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.618 ' HB2' ' HB3' ' A' ' 5' ' ' TRP . 0.3 OUTLIER -73.7 -17.08 61.17 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.448 0.642 . . . . 0.0 109.445 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.545 HG23 HG21 ' B' ' 60' ' ' VAL . 37.1 t -49.92 149.6 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 C-N-CA 119.555 -0.858 . . . . 0.0 110.02 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.423 ' C ' ' OD1' ' B' ' 56' ' ' ASN . . . 54.39 17.44 8.27 Favored Glycine 0 N--CA 1.48 1.584 0 C-N-CA 120.134 -1.031 . . . . 0.0 110.574 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.566 ' HB3' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -106.89 -143.87 0.38 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.0 -1.294 . . . . 0.0 109.398 179.717 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.502 ' CA ' HG12 ' B' ' 57' ' ' ILE . 0.5 OUTLIER -146.26 168.91 19.9 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.043 -1.035 . . . . 0.0 110.195 -179.465 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.559 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 84.9 t -55.45 -32.77 30.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.436 -0.79 . . . . 0.0 109.586 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.535 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 2.3 mt-10 -45.27 -71.29 0.08 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.135 -0.978 . . . . 0.0 108.837 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.28 -37.7 81.29 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.313 -0.867 . . . . 0.0 109.87 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.663 ' HB1' HD22 ' B' ' 49' ' ' LEU . . . -57.87 -79.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 110.028 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.54 ' HA ' ' CG2' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -50.75 -32.17 18.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.549 -1.344 . . . . 0.0 109.369 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -56.31 -82.5 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.494 0.664 . . . . 0.0 111.208 -179.192 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.403 HG23 ' H ' ' A' ' 19' ' ' VAL . 2.1 t -61.69 -35.09 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.626 -0.671 . . . . 0.0 110.342 -178.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.999 HG21 ' HB ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER -53.28 -50.25 48.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 O-C-N 121.074 -1.016 . . . . 0.0 109.541 179.873 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.563 HD23 ' HB2' ' A' ' 22' ' ' GLN . 4.2 tt -35.45 -32.2 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.454 -0.779 . . . . 0.0 110.278 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.563 ' HB2' HD23 ' A' ' 21' ' ' LEU . 1.9 tt0 -145.77 56.88 1.21 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.251 -0.905 . . . . 0.0 109.13 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.609 ' OD1' ' HB3' ' A' ' 27' ' ' ALA . 0.4 OUTLIER -65.41 -62.24 1.65 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.671 -0.643 . . . . 0.0 109.537 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.921 ' CD ' HG22 ' A' ' 3' ' ' THR . 0.0 OUTLIER -110.07 -80.95 0.01 OUTLIER Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.551 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.828 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 39.5 Cg_endo -87.92 -71.87 0.01 OUTLIER 'Trans proline' 0 C--O 1.213 -0.732 0 N-CA-C 107.377 -1.817 . . . . 0.0 107.377 176.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.537 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 19.4 mt-10 -165.02 62.3 0.12 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.609 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -87.53 120.52 28.92 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.069 -1.019 . . . . 0.0 109.345 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.446 ' CB ' ' O ' ' B' ' 45' ' ' ASP . 0.6 OUTLIER -88.36 174.17 8.31 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.416 -0.803 . . . . 0.0 109.143 -179.52 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.999 ' HB ' HG21 ' A' ' 20' ' ' ILE . 18.5 tt -145.74 134.76 17.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.466 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.557 HD12 ' HD2' ' B' ' 46' ' ' ARG . 4.8 mt -88.07 148.27 4.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.438 HG21 HG21 ' A' ' 13' ' ' VAL . 5.8 p -117.07 133.23 64.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 118.811 -1.156 . . . . 0.0 110.858 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.916 HD11 ' HE1' ' B' ' 50' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.533 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.57 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.488 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.3 OUTLIER -44.03 137.22 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.926 -1.109 . . . . 0.0 108.675 179.971 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.587 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -93.19 45.32 1.17 Allowed 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.419 -0.912 . . . . 0.0 109.689 -178.854 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 46' ' ' ARG . . . . . 0.557 ' HD2' HD12 ' A' ' 30' ' ' ILE . 14.1 ttp180 -148.04 144.83 28.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.314 -0.867 . . . . 0.0 109.112 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.663 HG22 ' CG2' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -152.2 143.9 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.157 -0.964 . . . . 0.0 109.427 -179.267 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.452 ' HA ' ' HD3' ' B' ' 48' ' ' ARG . 3.3 mmt85 -77.33 115.43 17.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.701 -1.249 . . . . 0.0 109.632 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 1.064 HD11 HD12 ' B' ' 57' ' ' ILE . 1.6 tp -107.89 81.02 1.44 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.987 -1.071 . . . . 0.0 108.843 178.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 50' ' ' PHE . . . . . 0.916 ' HE1' HD11 ' A' ' 32' ' ' LEU . 4.1 m-30 -66.05 -159.86 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.488 ' HB ' ' HA ' ' B' ' 55' ' ' ASP . 24.1 m -150.42 -171.46 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.74 -1.225 . . . . 0.0 109.574 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.532 ' HB3' ' HB2' ' B' ' 58' ' ' ALA . 1.0 OUTLIER -122.66 -153.14 0.54 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.297 -0.877 . . . . 0.0 109.259 179.434 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.51 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 29.1 mtpt -61.18 -61.48 2.53 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.617 -0.677 . . . . 0.0 109.606 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.415 ' O ' ' C ' ' B' ' 55' ' ' ASP . 3.0 tp -96.09 48.11 1.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.365 -0.834 . . . . 0.0 109.909 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 55' ' ' ASP . . . . . 0.488 ' HA ' ' HB ' ' B' ' 51' ' ' VAL . 0.0 OUTLIER 45.58 65.31 1.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.061 -1.025 . . . . 0.0 109.28 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 56' ' ' ASN . . . . . 0.577 ' O ' ' N ' ' B' ' 58' ' ' ALA . 3.5 t30 -133.14 108.71 8.99 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 1.064 HD12 HD11 ' B' ' 49' ' ' LEU . 12.7 mm -32.41 86.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.67 0.748 . . . . 0.0 111.391 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 58' ' ' ALA . . . . . 0.577 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -90.99 -23.72 20.31 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.04 96.24 5.09 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.607 HG13 ' HB2' ' A' ' 5' ' ' TRP . 3.2 t -57.89 137.44 83.42 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.459 -0.776 . . . . 0.0 110.17 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 61' ' ' PRO . . . . . 0.457 ' HG3' HD11 ' A' ' 29' ' ' ILE . 35.0 Cg_endo -76.97 172.97 15.24 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 122.438 2.092 . . . . 0.0 109.927 178.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 62' ' ' ARG . . . . . 0.532 ' O ' ' CG1' ' B' ' 47' ' ' VAL . 0.0 OUTLIER -150.94 135.36 17.01 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.811 -1.181 . . . . 0.0 110.614 -179.601 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.663 ' CG2' HG22 ' B' ' 47' ' ' VAL . 4.6 t . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.353 -0.842 . . . . 0.0 108.857 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.838 HG22 ' O ' ' B' ' 63' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.701 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.594 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 37.3 mt-10 -135.33 -40.58 0.73 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.502 -0.749 . . . . 0.0 109.349 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.651 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 6.9 m-90 62.63 40.55 0.37 Allowed Pre-proline 0 C--N 1.299 -1.59 0 O-C-N 121.545 -0.722 . . . . 0.0 109.946 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.651 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 34.7 Cg_endo -72.93 -33.75 7.37 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 N-CA-C 107.462 -1.784 . . . . 0.0 107.462 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -69.57 -10.75 59.47 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 177.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.666 HD21 ' HA ' ' A' ' 16' ' ' ALA . 11.7 tp -81.36 -1.92 47.27 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 121.556 -0.715 . . . . 0.0 109.445 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.58 HG22 HG23 ' B' ' 60' ' ' VAL . 24.1 t -54.71 151.28 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.101 -1.0 . . . . 0.0 109.482 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.07 6.18 18.16 Favored Glycine 0 N--CA 1.481 1.677 0 C-N-CA 120.042 -1.075 . . . . 0.0 110.5 178.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -93.13 -145.36 0.23 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.801 -1.411 . . . . 0.0 109.327 179.697 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 m -150.47 179.56 8.05 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.062 -1.023 . . . . 0.0 110.373 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 1.027 HG22 HD21 ' B' ' 49' ' ' LEU . 57.1 t -60.45 -35.3 62.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.487 -0.758 . . . . 0.0 109.724 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 1.9 pm0 -47.02 -74.46 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.047 -1.033 . . . . 0.0 108.893 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.475 ' HB3' HD11 ' A' ' 8' ' ' LEU . 21.0 tt0 -57.61 -31.38 66.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.219 -0.925 . . . . 0.0 110.084 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.912 ' HB2' HD11 ' B' ' 57' ' ' ILE . . . -66.6 -81.12 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.88 -1.137 . . . . 0.0 109.962 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -45.96 -30.43 1.79 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.758 -1.214 . . . . 0.0 109.056 -179.875 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.7 OUTLIER -63.46 -81.44 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.703 -0.623 . . . . 0.0 110.677 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.761 HG12 ' HB2' ' A' ' 23' ' ' ASP . 3.3 t -56.18 -50.04 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.204 -0.935 . . . . 0.0 109.613 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.941 HG21 ' HB ' ' A' ' 29' ' ' ILE . 61.8 mt -46.9 -59.49 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.389 -0.819 . . . . 0.0 109.928 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.501 ' C ' ' O ' ' A' ' 20' ' ' ILE . 17.4 tp -29.56 -37.74 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.056 0.455 . . . . 0.0 110.659 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.558 ' O ' ' N ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -133.43 -72.67 0.5 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.968 -1.082 . . . . 0.0 109.405 179.096 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.761 ' HB2' HG12 ' A' ' 19' ' ' VAL . 7.6 t0 42.48 -94.84 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.718 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 3.0 mtmp? -66.62 -118.14 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.332 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.718 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 36.5 Cg_endo -79.77 -75.53 0.01 OUTLIER 'Trans proline' 0 C--O 1.214 -0.703 0 CA-C-N 122.309 1.86 . . . . 0.0 108.902 178.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 4.5 mt-10 -156.84 59.88 0.53 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.758 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -89.03 113.01 24.08 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.475 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.549 ' O ' HG23 ' B' ' 47' ' ' VAL . 1.8 mt-30 -87.95 172.21 9.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.065 -1.022 . . . . 0.0 109.175 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.941 ' HB ' HG21 ' A' ' 20' ' ' ILE . 9.4 tt -136.86 142.66 37.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.979 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.802 HG22 HD22 ' A' ' 32' ' ' LEU . 26.9 mm -90.24 122.4 41.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.94 HG22 HD23 ' B' ' 49' ' ' LEU . 32.7 t -96.59 134.09 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.966 -1.084 . . . . 0.0 109.74 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.961 ' N ' HD23 ' A' ' 32' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.303 -1.441 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 -178.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.557 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 1.2 ptt180 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 120.912 0.387 . . . . 0.0 110.086 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.543 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.4 OUTLIER -47.3 144.89 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 120.732 -1.23 . . . . 0.0 107.821 178.991 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.758 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.7 p-10 -106.34 45.7 0.96 Allowed 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 118.798 -1.161 . . . . 0.0 110.243 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 46' ' ' ARG . . . . . 0.483 ' HG3' HG12 ' A' ' 30' ' ' ILE . 1.4 ttt-85 -152.17 153.07 33.12 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.713 HG22 ' CG2' ' B' ' 63' ' ' VAL . 0.1 OUTLIER -150.59 -172.83 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.098 -1.001 . . . . 0.0 108.56 179.591 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.617 ' HD2' HD11 ' A' ' 32' ' ' LEU . 11.8 mmt85 -119.4 72.25 0.9 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.682 -1.261 . . . . 0.0 110.265 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 1.027 HD21 HG22 ' A' ' 13' ' ' VAL . 3.2 tp -69.21 97.74 0.96 Allowed 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.008 -1.077 . . . . 0.0 108.178 178.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 50' ' ' PHE . . . . . 0.831 ' CE1' HD12 ' A' ' 32' ' ' LEU . 18.1 m-85 -89.37 -162.93 0.92 Allowed 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.553 ' CG1' ' HA ' ' B' ' 55' ' ' ASP . 34.8 m -142.1 175.09 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.769 -1.207 . . . . 0.0 109.363 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.649 ' CB ' ' HB2' ' B' ' 58' ' ' ALA . 0.0 OUTLIER -127.44 -71.9 0.65 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.242 -0.911 . . . . 0.0 108.633 -179.884 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.548 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 17.9 mmtt -93.21 -75.21 0.5 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.898 -1.126 . . . . 0.0 108.535 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.555 ' O ' ' CB ' ' B' ' 55' ' ' ASP . 0.1 OUTLIER -131.68 51.75 2.12 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 179.088 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 55' ' ' ASP . . . . . 0.555 ' CB ' ' O ' ' B' ' 54' ' ' LEU . 0.2 OUTLIER 91.33 23.0 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.18 0.514 . . . . 0.0 109.703 -179.344 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 56' ' ' ASN . . . . . 0.575 ' O ' ' N ' ' B' ' 58' ' ' ALA . 62.4 t30 -88.83 91.87 8.99 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.912 HD11 ' HB2' ' A' ' 16' ' ' ALA . 9.4 mt -38.49 89.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-O 121.687 0.756 . . . . 0.0 110.779 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 58' ' ' ALA . . . . . 0.649 ' HB2' ' CB ' ' B' ' 52' ' ' ASP . . . -88.13 -25.65 22.87 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -118.2 103.51 9.91 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.581 HG13 ' HD2' ' B' ' 61' ' ' PRO . 63.0 t -62.49 138.21 96.46 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.386 -0.821 . . . . 0.0 110.918 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 61' ' ' PRO . . . . . 0.581 ' HD2' HG13 ' B' ' 60' ' ' VAL . 36.4 Cg_endo -80.44 170.54 15.85 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.736 2.291 . . . . 0.0 109.294 178.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 62' ' ' ARG . . . . . 0.545 ' CD ' ' HA ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -149.9 140.39 22.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.758 -1.214 . . . . 0.0 110.721 -179.512 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.838 ' O ' HG22 ' A' ' 3' ' ' THR . 1.4 t . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.543 -0.723 . . . . 0.0 109.166 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.504 HG23 ' HD2' ' A' ' 24' ' ' LYS . 7.3 m . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.648 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 10.1 mm-40 -105.8 -24.34 12.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.086 -1.009 . . . . 0.0 110.527 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.814 ' NE1' HD12 ' A' ' 20' ' ' ILE . 6.9 m-90 48.24 46.98 4.12 Favored Pre-proline 0 C--N 1.297 -1.709 0 C-N-CA 118.774 -1.17 . . . . 0.0 108.888 -178.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.66 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 31.4 Cg_endo -73.88 -35.44 4.37 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 N-CA-C 106.581 -2.123 . . . . 0.0 106.581 -179.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.84 -12.24 61.47 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 114.318 -1.31 . . . . 0.0 107.666 176.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.579 HD11 ' HB3' ' A' ' 15' ' ' GLU . 19.1 tp -79.68 -7.05 58.34 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 121.476 -0.765 . . . . 0.0 109.454 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.562 HG23 HG21 ' B' ' 60' ' ' VAL . 15.3 t -54.85 151.86 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.965 -1.084 . . . . 0.0 108.951 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.451 ' HA2' ' OD1' ' B' ' 56' ' ' ASN . . . 57.1 13.72 9.68 Favored Glycine 0 N--CA 1.481 1.64 0 N-CA-C 110.209 -1.157 . . . . 0.0 110.209 178.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -94.56 -143.52 0.25 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.959 -1.318 . . . . 0.0 109.511 179.843 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.12 170.4 18.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.042 -1.036 . . . . 0.0 110.173 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.551 ' HA ' HD11 ' B' ' 49' ' ' LEU . 78.4 t -53.27 -42.22 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.336 -0.853 . . . . 0.0 109.655 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.528 ' O ' ' CG ' ' A' ' 18' ' ' LYS . 59.0 mm-40 -41.38 -71.64 0.08 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.579 ' HB3' HD11 ' A' ' 8' ' ' LEU . 0.6 OUTLIER -56.09 -38.69 71.04 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.452 -0.78 . . . . 0.0 109.612 179.619 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.758 ' HB2' HD11 ' B' ' 57' ' ' ILE . . . -58.72 -83.85 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.383 -0.823 . . . . 0.0 109.862 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 17' ' ' LYS . 4.3 tptp -45.13 -29.99 1.04 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.563 -1.335 . . . . 0.0 109.39 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' A' ' 14' ' ' GLU . 4.3 mmtt -61.35 -86.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.66 0.743 . . . . 0.0 111.087 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 19' ' ' VAL . 2.4 t -57.89 -38.9 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 121.494 0.664 . . . . 0.0 109.824 -178.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.884 HG21 ' HB ' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -53.48 -51.75 38.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.438 -0.789 . . . . 0.0 109.725 -179.645 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 20' ' ' ILE . 45.3 tp -39.25 -23.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.399 -0.813 . . . . 0.0 111.9 -178.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -142.1 13.33 2.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.001 -1.687 . . . . 0.0 112.622 -179.242 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.967 ' OD1' ' HB3' ' A' ' 27' ' ' ALA . 1.2 p-10 -49.29 150.72 1.66 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.729 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.4 OUTLIER 52.81 -131.03 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 -178.809 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.729 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 36.9 Cg_endo -78.17 -83.03 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.635 0 CA-C-N 121.952 1.733 . . . . 0.0 109.346 178.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 3.1 mt-10 -144.69 71.01 1.29 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.417 -0.802 . . . . 0.0 109.046 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.967 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -89.03 118.71 28.95 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.006 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.518 ' O ' HG23 ' B' ' 47' ' ' VAL . 0.0 OUTLIER -88.01 -178.69 6.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.241 -0.912 . . . . 0.0 109.435 -179.313 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.884 ' HB ' HG21 ' A' ' 20' ' ' ILE . 14.0 tt -150.06 152.16 11.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 C-N-CA 119.02 -1.072 . . . . 0.0 111.112 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.424 ' HA ' HD13 ' A' ' 30' ' ' ILE . 16.3 mm -112.16 128.65 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.554 ' HA ' ' HB3' ' B' ' 49' ' ' LEU . 3.0 t -89.56 150.12 3.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 120.824 -1.173 . . . . 0.0 110.173 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.13 HD22 ' CD1' ' B' ' 50' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -178.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.575 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 120.865 0.364 . . . . 0.0 110.283 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.531 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.2 OUTLIER -45.79 140.17 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.856 -1.152 . . . . 0.0 108.363 179.388 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.624 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.9 OUTLIER -98.92 48.34 0.97 Allowed 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.031 -1.043 . . . . 0.0 109.624 -179.371 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -150.29 150.4 31.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.459 -0.775 . . . . 0.0 109.03 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.858 HG22 HG23 ' B' ' 63' ' ' VAL . 0.1 OUTLIER -151.36 -172.48 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.181 -0.949 . . . . 0.0 109.343 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 5.1 mmt85 -118.17 71.02 0.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.095 -1.003 . . . . 0.0 110.156 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.572 ' HB2' HG12 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -54.61 103.09 0.08 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.005 -1.059 . . . . 0.0 108.872 179.297 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 50' ' ' PHE . . . . . 1.13 ' CD1' HD22 ' A' ' 32' ' ' LEU . 2.2 m-85 -92.21 119.21 31.62 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.356 -0.84 . . . . 0.0 108.961 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.472 HG11 HG23 ' A' ' 13' ' ' VAL . 1.5 m -108.33 -175.45 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.12 -0.988 . . . . 0.0 109.536 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.545 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.0 OUTLIER -129.16 -161.97 1.16 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.291 -0.88 . . . . 0.0 109.619 -179.915 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.545 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 1.8 mttp -49.96 -61.79 1.94 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.589 -0.694 . . . . 0.0 109.934 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 7.6 mp -89.57 48.98 1.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.479 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 44.39 49.44 8.11 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.349 -0.844 . . . . 0.0 109.246 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 56' ' ' ASN . . . . . 0.484 ' HB3' ' CG ' ' B' ' 52' ' ' ASP . 4.9 t30 -107.11 111.17 23.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.31 -0.868 . . . . 0.0 108.873 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.758 HD11 ' HB2' ' A' ' 16' ' ' ALA . 12.5 mt -59.46 90.55 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 121.352 0.596 . . . . 0.0 110.21 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -87.94 -19.63 27.0 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 59' ' ' GLN . . . . . 0.529 ' HB2' ' CB ' ' B' ' 50' ' ' PHE . 1.1 mt-30 -123.12 82.27 1.98 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.567 HG11 ' O ' ' A' ' 5' ' ' TRP . 20.2 t -49.72 137.47 18.21 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.533 -0.73 . . . . 0.0 110.655 -178.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 61' ' ' PRO . . . . . 0.545 ' HG3' HD11 ' A' ' 29' ' ' ILE . 36.5 Cg_endo -81.23 172.67 12.53 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 123.023 2.482 . . . . 0.0 110.205 179.065 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 62' ' ' ARG . . . . . 0.577 ' HG3' ' HA ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -149.53 129.4 13.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.229 -0.919 . . . . 0.0 110.009 179.915 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.858 HG23 HG22 ' B' ' 47' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.752 0 O-C-N 121.217 -0.927 . . . . 0.0 108.906 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.552 ' CG2' ' HD2' ' A' ' 24' ' ' LYS . 62.7 p . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.565 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -135.42 -47.73 0.7 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.183 -0.948 . . . . 0.0 109.83 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.651 ' CE2' HG12 ' A' ' 20' ' ' ILE . 9.3 m-90 58.64 44.96 1.2 Allowed Pre-proline 0 C--N 1.299 -1.604 0 C-N-CA 119.398 -0.921 . . . . 0.0 108.995 -178.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.645 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 33.5 Cg_endo -72.88 -32.09 9.41 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 N-CA-C 107.462 -1.784 . . . . 0.0 107.462 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.56 -12.2 60.97 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.842 HD21 ' HA ' ' A' ' 16' ' ' ALA . 2.7 tp -78.04 -4.32 46.57 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 121.507 -0.746 . . . . 0.0 109.594 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.7 t -52.43 152.39 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 C-N-CA 118.866 -1.133 . . . . 0.0 109.116 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.461 ' HA2' ' OD1' ' B' ' 56' ' ' ASN . . . 45.51 24.08 1.01 Allowed Glycine 0 N--CA 1.481 1.652 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 178.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 1.7 tptm -99.78 -138.93 0.32 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.984 -1.304 . . . . 0.0 109.249 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' B' ' 55' ' ' ASP . 0.3 OUTLIER -150.03 154.83 38.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.809 -1.182 . . . . 0.0 110.744 -179.53 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.633 ' HA ' HD21 ' B' ' 49' ' ' LEU . 54.9 t -52.41 -30.01 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 O-C-N 121.435 -0.79 . . . . 0.0 109.019 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.524 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 14.3 mt-10 -48.91 -74.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.466 -0.771 . . . . 0.0 109.107 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.491 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.6 OUTLIER -57.33 -28.94 63.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.168 -0.958 . . . . 0.0 108.705 179.226 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.89 ' C ' HD12 ' A' ' 20' ' ' ILE . . . -61.08 -86.74 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.4 -0.812 . . . . 0.0 109.959 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.448 ' C ' ' HD2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -47.46 -35.14 8.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.564 -1.335 . . . . 0.0 108.99 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -49.46 -78.82 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.468 0.651 . . . . 0.0 110.869 -179.471 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 15' ' ' GLU . 0.5 OUTLIER -72.76 -44.57 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.425 -0.797 . . . . 0.0 109.677 -178.833 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.959 HG21 ' HB ' ' A' ' 29' ' ' ILE . 67.2 mt -40.07 -52.91 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.544 -0.722 . . . . 0.0 109.511 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 28' ' ' GLN . 0.5 OUTLIER -38.73 -49.44 1.59 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.563 -0.711 . . . . 0.0 110.483 -179.658 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.464 ' HB2' HD23 ' A' ' 21' ' ' LEU . 1.1 mt-30 -135.06 44.51 2.6 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.099 -1.0 . . . . 0.0 110.506 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.582 ' HB3' ' CE ' ' A' ' 24' ' ' LYS . 4.6 t0 -66.33 -39.85 89.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.866 -1.146 . . . . 0.0 108.488 179.143 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.824 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -117.42 -99.51 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.444 0 CA-C-O 117.214 -1.374 . . . . 0.0 107.975 178.707 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.824 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 37.3 Cg_endo -82.15 -76.14 0.0 OUTLIER 'Trans proline' 0 C--O 1.213 -0.742 0 CA-C-N 122.374 1.884 . . . . 0.0 108.284 177.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 16.3 mt-10 -160.77 56.35 0.31 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.903 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -88.81 119.15 29.05 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.128 -0.983 . . . . 0.0 109.467 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 15.7 mt-30 -89.25 -178.35 5.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.224 -0.923 . . . . 0.0 109.326 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.959 ' HB ' HG21 ' A' ' 20' ' ' ILE . 3.6 tt -145.45 127.93 9.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.089 -1.007 . . . . 0.0 110.436 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.823 HD12 ' HD3' ' B' ' 46' ' ' ARG . 33.4 mt -89.0 111.31 22.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.486 HG21 HG21 ' A' ' 13' ' ' VAL . 7.0 p -89.72 146.59 5.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.136 -0.977 . . . . 0.0 110.123 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.161 HD11 ' CE1' ' B' ' 50' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.461 -0.775 . . . . 0.0 109.461 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.554 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.545 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.5 OUTLIER -43.17 145.87 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.99 -1.069 . . . . 0.0 108.262 179.488 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.611 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 2.2 p-10 -106.1 46.44 0.92 Allowed 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 118.962 -1.095 . . . . 0.0 110.756 -178.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 46' ' ' ARG . . . . . 0.823 ' HD3' HD12 ' A' ' 30' ' ' ILE . 2.3 ptp180 -150.94 153.01 34.43 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.22 -0.925 . . . . 0.0 109.244 178.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 1.091 ' CG2' HG23 ' B' ' 63' ' ' VAL . 31.1 t -150.93 161.66 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.421 -0.799 . . . . 0.0 109.162 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.804 ' HG3' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -93.38 84.16 4.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.85 -1.156 . . . . 0.0 110.022 -179.453 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.633 HD21 ' HA ' ' A' ' 13' ' ' VAL . 2.5 tp -80.04 83.36 5.94 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 118.985 -1.086 . . . . 0.0 109.17 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 50' ' ' PHE . . . . . 1.161 ' CE1' HD11 ' A' ' 32' ' ' LEU . 3.8 m-30 -66.98 -162.88 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.715 HG12 ' HA ' ' B' ' 55' ' ' ASP . 10.1 m -149.44 160.9 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.834 -1.166 . . . . 0.0 108.702 178.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.715 ' CB ' ' HB2' ' B' ' 58' ' ' ALA . 0.0 OUTLIER -112.37 -70.61 0.8 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.939 -1.1 . . . . 0.0 108.796 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.55 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 9.9 mmmt -92.5 -75.91 0.48 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.848 -1.158 . . . . 0.0 108.49 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.543 ' O ' ' CB ' ' B' ' 55' ' ' ASP . 0.1 OUTLIER -136.85 57.22 1.77 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.056 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 55' ' ' ASP . . . . . 0.715 ' HA ' HG12 ' B' ' 51' ' ' VAL . 0.2 OUTLIER 91.51 24.13 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.421 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 56' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' B' ' 58' ' ' ALA . 31.8 t-20 -88.82 86.79 7.04 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.742 HD11 ' HB2' ' A' ' 16' ' ' ALA . 3.8 mt -37.33 89.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-O 121.511 0.672 . . . . 0.0 111.315 -178.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 58' ' ' ALA . . . . . 0.715 ' HB2' ' CB ' ' B' ' 52' ' ' ASP . . . -88.81 -17.5 29.62 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 59' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' B' ' 60' ' ' VAL . 33.9 mt-30 -127.68 84.37 2.25 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 4' ' ' GLU . 6.4 t -41.68 136.2 2.01 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.453 -0.779 . . . . 0.0 110.161 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 61' ' ' PRO . . . . . 0.806 ' HB2' HG11 ' B' ' 47' ' ' VAL . 36.7 Cg_endo -81.95 166.79 16.7 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.751 2.301 . . . . 0.0 110.523 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 62' ' ' ARG . . . . . 0.621 ' O ' HG13 ' B' ' 47' ' ' VAL . 0.3 OUTLIER -142.72 152.85 42.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 109.285 179.416 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 1.091 HG23 ' CG2' ' B' ' 47' ' ' VAL . 1.2 t . . . . . 0 N--CA 1.493 1.711 0 O-C-N 121.229 -0.919 . . . . 0.0 109.486 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.747 HG22 ' CE ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.7 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.58 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 4.9 mt-10 -99.92 -48.41 4.68 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.993 -1.067 . . . . 0.0 110.878 -178.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.619 ' CE2' HG12 ' A' ' 20' ' ' ILE . 10.4 m-90 60.71 45.76 1.03 Allowed Pre-proline 0 C--N 1.297 -1.711 0 C-N-CA 119.067 -1.053 . . . . 0.0 108.386 -177.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.662 ' HA ' HG21 ' B' ' 60' ' ' VAL . 32.8 Cg_endo -72.31 -31.2 11.93 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 N-CA-C 107.057 -1.94 . . . . 0.0 107.057 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.21 -13.14 62.02 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.525 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.577 HD23 ' HB3' ' A' ' 5' ' ' TRP . 0.3 OUTLIER -71.32 -11.57 60.98 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.204 -0.935 . . . . 0.0 108.987 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.741 HG23 ' CG2' ' B' ' 60' ' ' VAL . 24.4 t -55.9 145.1 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.087 -1.008 . . . . 0.0 109.82 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.474 ' HA2' ' OD1' ' B' ' 56' ' ' ASN . . . 59.23 13.65 22.22 Favored Glycine 0 N--CA 1.482 1.726 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.287 177.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 1.2 tptp -95.44 -147.11 0.28 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.133 -1.216 . . . . 0.0 109.178 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.84 155.96 44.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -0.917 . . . . 0.0 109.372 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.528 ' CG2' ' CG1' ' B' ' 51' ' ' VAL . 69.0 t -47.17 -37.18 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.834 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.516 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -44.81 -76.9 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.211 -0.931 . . . . 0.0 109.317 -179.864 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -54.76 -35.57 63.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.561 -0.712 . . . . 0.0 110.143 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.69 ' C ' HD12 ' A' ' 20' ' ' ILE . . . -63.46 -83.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.827 . . . . 0.0 110.364 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.655 ' HG2' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -45.7 -27.52 0.83 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.142 -0.974 . . . . 0.0 108.884 -179.618 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.1 OUTLIER -67.46 -86.28 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.746 -0.596 . . . . 0.0 111.167 -179.029 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.503 ' O ' ' OD1' ' A' ' 23' ' ' ASP . 4.6 t -46.13 -42.77 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.15 -0.969 . . . . 0.0 109.455 -178.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.995 HG21 ' HB ' ' A' ' 29' ' ' ILE . 46.5 mt -56.63 -44.24 80.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.452 -0.78 . . . . 0.0 109.536 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 20' ' ' ILE . 4.2 tt -39.15 -25.82 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.222 -0.923 . . . . 0.0 110.588 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.548 ' O ' ' N ' ' A' ' 24' ' ' LYS . 4.1 mt-30 -144.3 -67.99 0.32 Allowed 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.525 -1.359 . . . . 0.0 111.592 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.516 ' OD1' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER 39.54 -94.51 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.393 -0.817 . . . . 0.0 108.86 -178.549 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.747 ' CE ' HG22 ' A' ' 3' ' ' THR . 10.6 mtpt -64.89 -118.95 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.435 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 178.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.735 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 36.5 Cg_endo -80.56 -73.21 0.01 OUTLIER 'Trans proline' 0 C--O 1.214 -0.71 0 CA-C-N 122.221 1.829 . . . . 0.0 109.006 178.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 5.5 mt-10 -159.29 60.63 0.4 Allowed 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.749 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -88.03 113.99 24.21 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.566 ' O ' HG23 ' B' ' 47' ' ' VAL . 0.2 OUTLIER -86.78 170.57 11.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.144 -0.973 . . . . 0.0 110.517 -177.711 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.995 ' HB ' HG21 ' A' ' 20' ' ' ILE . 19.2 tt -140.21 141.91 32.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.829 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.531 ' O ' ' HB3' ' B' ' 49' ' ' LEU . 1.0 OUTLIER -91.31 163.77 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 179.132 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 1.04 HG13 HD12 ' B' ' 49' ' ' LEU . 64.5 t -135.2 133.39 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.312 -1.492 . . . . 0.0 110.372 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.036 HD21 ' CE1' ' B' ' 50' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.503 -0.748 . . . . 0.0 109.113 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 43' ' ' ARG . . . . . 0.569 ' HD3' ' CG1' ' B' ' 63' ' ' VAL . 1.6 tpp180 . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.541 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.4 OUTLIER -52.64 142.74 4.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 179.185 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.749 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -96.54 50.21 1.13 Allowed 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.703 -1.248 . . . . 0.0 110.4 -178.738 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 46' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 28' ' ' GLN . 15.0 ttm180 -150.03 150.21 31.44 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.436 -0.79 . . . . 0.0 108.9 178.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.668 HG22 ' CG2' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -151.71 179.9 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.769 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.618 ' HB3' ' CE2' ' B' ' 50' ' ' PHE . 0.9 OUTLIER -107.38 85.21 2.09 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.905 -1.122 . . . . 0.0 111.62 -178.924 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 1.04 HD12 HG13 ' A' ' 31' ' ' VAL . 2.1 tm? -78.31 93.47 4.67 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 50' ' ' PHE . . . . . 1.036 ' CE1' HD21 ' A' ' 32' ' ' LEU . 50.4 m-85 -89.42 132.95 34.75 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 32' ' ' LEU . 16.7 m -99.77 -169.31 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.842 -1.161 . . . . 0.0 109.538 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 52' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' B' ' 55' ' ' ASP . 3.6 p-10 -126.77 -148.89 0.4 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.209 -0.932 . . . . 0.0 109.119 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 53' ' ' LYS . . . . . 0.496 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 4.6 mmmm -76.5 -45.43 30.97 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.088 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 54' ' ' LEU . . . . . 0.507 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 1.4 mt -101.15 34.46 2.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.542 -0.724 . . . . 0.0 109.612 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 55' ' ' ASP . . . . . 0.536 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.0 OUTLIER 53.77 68.28 0.87 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.016 -1.052 . . . . 0.0 108.179 -178.787 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 56' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' B' ' 58' ' ' ALA . 47.1 t-20 -130.93 100.4 5.24 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.678 HD12 HD21 ' B' ' 49' ' ' LEU . 31.2 mm -40.67 88.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.495 0.664 . . . . 0.0 110.624 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 58' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -89.59 -18.46 26.52 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.5 108.33 14.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.48 -0.763 . . . . 0.0 108.998 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.741 ' CG2' HG23 ' A' ' 9' ' ' VAL . 32.8 t -66.27 133.51 94.55 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.304 -0.872 . . . . 0.0 110.236 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 61' ' ' PRO . . . . . 0.611 ' HB3' HD11 ' A' ' 29' ' ' ILE . 36.5 Cg_endo -81.72 165.17 18.05 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.601 2.201 . . . . 0.0 110.496 179.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 62' ' ' ARG . . . . . 0.567 ' CD ' ' HA ' ' A' ' 4' ' ' GLU . 1.1 tpp180 -150.22 134.85 17.47 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.223 -0.923 . . . . 0.0 110.54 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.668 ' CG2' HG22 ' B' ' 47' ' ' VAL . 1.4 t . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.544 ' O ' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.535 ' HB3' ' CB ' ' A' ' 23' ' ' ASP . 1.4 tppm? -71.55 111.7 7.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.119 -0.988 . . . . 0.0 109.379 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.697 HG22 ' HD2' ' A' ' 24' ' ' LYS . 1.4 p -136.3 6.99 3.08 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.345 -0.847 . . . . 0.0 109.342 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.592 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -131.53 -30.76 1.64 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.043 -1.036 . . . . 0.0 110.484 -179.646 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.668 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 5.8 m-90 51.44 46.29 3.49 Favored Pre-proline 0 C--N 1.296 -1.723 0 C-N-CA 118.088 -1.445 . . . . 0.0 108.237 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.668 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 32.8 Cg_endo -73.76 -33.86 6.01 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 N-CA-C 107.75 -1.673 . . . . 0.0 107.75 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.69 -11.13 59.82 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.761 HD21 ' HB2' ' A' ' 16' ' ' ALA . 63.4 tp -79.96 -5.05 54.96 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 121.394 -0.816 . . . . 0.0 109.586 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.666 HG22 ' CG2' ' B' ' 60' ' ' VAL . 42.5 t -53.75 149.2 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 120.994 -1.066 . . . . 0.0 110.466 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 58.42 11.68 10.58 Favored Glycine 0 N--CA 1.481 1.647 0 C-N-CA 120.194 -1.003 . . . . 0.0 110.644 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.612 ' CB ' HD12 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -91.49 -144.28 0.19 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.925 -1.338 . . . . 0.0 109.124 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.431 ' O ' HD11 ' B' ' 57' ' ' ILE . 0.5 OUTLIER -145.54 157.1 44.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.035 -1.04 . . . . 0.0 109.961 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.515 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 93.0 t -48.68 -34.28 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.343 -0.848 . . . . 0.0 109.479 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.508 ' O ' ' CD ' ' A' ' 18' ' ' LYS . 7.8 mm-40 -44.6 -75.52 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.092 -1.005 . . . . 0.0 109.163 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -58.71 -32.34 69.08 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.687 -0.633 . . . . 0.0 109.959 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.761 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -62.45 -80.66 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.086 -1.009 . . . . 0.0 109.676 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.514 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -44.2 -39.94 4.75 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.872 -1.143 . . . . 0.0 108.942 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.528 ' HD2' ' N ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -51.53 -81.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.75 0.786 . . . . 0.0 111.085 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.9 t -66.08 -49.27 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.809 -0.557 . . . . 0.0 110.472 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.966 HD13 HD13 ' A' ' 29' ' ' ILE . 61.7 mt -45.8 -40.13 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 0.0 109.518 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.56 ' CD1' ' HG3' ' A' ' 28' ' ' GLN . 35.1 tp -38.84 -23.82 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.55 ' O ' ' N ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -135.37 -81.22 0.42 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 119.977 -1.702 . . . . 0.0 111.617 -178.83 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.613 ' OD2' ' HA ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER 37.77 -94.82 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.739 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.697 ' HD2' HG22 ' A' ' 3' ' ' THR . 0.0 OUTLIER -58.48 -163.76 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 176.214 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.62 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 37.4 Cg_endo -76.32 82.44 2.23 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 N-CA-C 108.666 -1.321 . . . . 0.0 108.666 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.533 ' CG ' ' C ' ' A' ' 25' ' ' PRO . 0.3 OUTLIER 56.88 52.22 9.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.65 -0.657 . . . . 0.0 111.009 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.789 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -88.82 112.05 22.77 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 177.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.56 ' HG3' ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -87.51 -166.62 1.63 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.012 -1.055 . . . . 0.0 110.721 -177.213 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.966 HD13 HD13 ' A' ' 20' ' ' ILE . 1.7 tt -149.86 144.23 17.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.477 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.497 ' O ' ' HB3' ' B' ' 49' ' ' LEU . 31.9 mt -89.39 115.27 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.752 -0.593 . . . . 0.0 109.985 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.638 ' O ' HG13 ' A' ' 31' ' ' VAL . 8.0 p -89.91 109.59 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.545 -1.347 . . . . 0.0 109.906 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.105 HD11 ' CE1' ' B' ' 50' ' ' PHE . 0.5 OUTLIER -138.94 152.44 70.26 Favored Pre-proline 0 N--CA 1.492 1.626 0 C-N-CA 119.087 -1.045 . . . . 0.0 110.411 179.616 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.598 ' HA ' HG22 ' B' ' 51' ' ' VAL . 37.5 Cg_endo -81.33 55.43 5.6 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 123.063 2.509 . . . . 0.0 110.007 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.632 HG22 ' HB3' ' B' ' 50' ' ' PHE . 67.2 t 50.38 -91.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.336 -0.852 . . . . 0.0 109.416 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . 47.18 -174.75 0.01 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.15 -167.12 0.7 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -1.179 . . . . 0.0 109.188 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.784 HG22 ' O ' ' A' ' 37' ' ' ILE . 3.4 mp -112.4 65.33 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.169 -0.957 . . . . 0.0 109.334 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 38' ' ' VAL . 66.4 t 58.53 81.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 0.0 109.765 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.474 ' CG2' ' O ' ' A' ' 38' ' ' VAL . 1.2 t . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 118.088 -0.958 . . . . 0.0 109.836 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' TYR . . . . . 0.623 ' CZ ' ' HA ' ' B' ' 44' ' ' ILE . 6.8 p90 -136.18 -148.12 0.28 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.159 -0.963 . . . . 0.0 109.856 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.516 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 8.0 ptp180 -89.39 51.66 2.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.896 . . . . 0.0 109.31 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.623 ' HA ' ' CZ ' ' B' ' 42' ' ' TYR . 0.7 OUTLIER -42.5 145.59 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 119.403 -0.919 . . . . 0.0 108.896 179.795 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.568 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.1 p-10 -107.66 46.43 0.94 Allowed 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.918 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' ARG . . . . . 0.484 ' HG2' HG13 ' A' ' 30' ' ' ILE . 11.3 mtt180 -150.16 150.1 31.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.33 -0.856 . . . . 0.0 109.426 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 1.101 ' CG2' HG23 ' B' ' 63' ' ' VAL . 79.2 t -151.32 126.47 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.316 -0.865 . . . . 0.0 110.082 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -53.35 87.95 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.734 -1.229 . . . . 0.0 110.584 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.583 ' HB2' ' CG1' ' A' ' 29' ' ' ILE . 4.9 tp -91.29 87.26 6.41 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' PHE . . . . . 1.105 ' CE1' HD11 ' A' ' 32' ' ' LEU . 5.7 m-30 -72.59 148.44 44.9 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.598 HG22 ' HA ' ' A' ' 33' ' ' PRO . 34.8 m -122.4 166.53 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.711 -1.243 . . . . 0.0 109.872 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' B' ' 55' ' ' ASP . 1.5 p-10 -93.52 -151.34 0.3 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.57 -0.707 . . . . 0.0 109.25 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.503 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 0.1 OUTLIER -75.56 -46.5 31.6 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.236 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.517 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 1.8 mm? -101.61 36.81 1.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.622 -0.674 . . . . 0.0 109.655 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' ASP . . . . . 0.539 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.0 OUTLIER 52.77 67.11 1.04 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.192 -0.942 . . . . 0.0 109.583 -179.32 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 56' ' ' ASN . . . . . 0.565 ' O ' ' N ' ' B' ' 58' ' ' ALA . 29.0 t30 -119.97 86.02 2.49 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.56 HD12 ' HG ' ' A' ' 8' ' ' LEU . 4.6 mt -31.94 87.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 CA-C-O 121.637 0.732 . . . . 0.0 111.42 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -89.37 -4.63 57.98 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -125.91 133.24 51.94 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.666 ' CG2' HG22 ' A' ' 9' ' ' VAL . 93.8 t -90.76 131.21 38.27 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.042 -1.036 . . . . 0.0 111.068 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.874 ' CB ' HG11 ' B' ' 47' ' ' VAL . 37.3 Cg_endo -83.84 161.75 14.05 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.581 2.188 . . . . 0.0 108.813 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 62' ' ' ARG . . . . . 0.563 ' HD3' ' HA ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -140.58 -49.15 0.44 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.798 -1.189 . . . . 0.0 110.164 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 1.101 HG23 ' CG2' ' B' ' 47' ' ' VAL . 0.8 OUTLIER 76.04 -3.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 O-C-N 121.442 -0.786 . . . . 0.0 109.812 179.508 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 CA-C-O 118.027 -1.429 . . . . 0.0 109.611 -179.925 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.405 ' O ' ' OG1' ' A' ' 3' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.522 ' CB ' ' HB3' ' A' ' 23' ' ' ASP . 1.8 mmpt? -52.81 98.87 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.328 -0.858 . . . . 0.0 109.461 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.603 HG23 ' HG3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -126.28 25.37 6.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.317 -0.864 . . . . 0.0 109.143 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.602 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 3.8 mt-10 -148.45 -44.2 0.15 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.276 -0.89 . . . . 0.0 110.655 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.647 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 6.1 m-90 59.6 41.67 0.6 Allowed Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 121.157 -0.964 . . . . 0.0 109.788 -178.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.647 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 34.1 Cg_endo -73.31 -33.36 7.2 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 N-CA-C 107.204 -1.883 . . . . 0.0 107.204 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -70.3 -12.53 61.65 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.621 ' HG ' HD12 ' B' ' 57' ' ' ILE . 49.5 tp -83.69 -4.31 58.5 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 121.385 -0.822 . . . . 0.0 109.262 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.562 HG23 HG21 ' B' ' 60' ' ' VAL . 14.7 t -53.69 152.36 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.91 -1.119 . . . . 0.0 109.319 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.426 ' C ' ' OD1' ' B' ' 56' ' ' ASN . . . 66.85 4.77 28.56 Favored Glycine 0 N--CA 1.481 1.635 0 C-N-CA 119.823 -1.18 . . . . 0.0 110.625 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 2.3 tptp -94.54 -146.88 0.26 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.778 -1.425 . . . . 0.0 109.627 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.491 ' CB ' ' OE2' ' A' ' 14' ' ' GLU . 33.2 m -144.8 169.16 18.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.104 -0.998 . . . . 0.0 109.998 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.635 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 88.4 t -54.21 -34.92 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.488 -0.758 . . . . 0.0 109.902 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.551 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 1.3 pm0 -44.07 -73.75 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.313 -0.867 . . . . 0.0 109.197 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.79 -31.02 71.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.257 -0.902 . . . . 0.0 109.61 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.813 ' HB2' HD11 ' B' ' 57' ' ' ILE . . . -61.39 -83.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.103 -0.998 . . . . 0.0 109.481 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.523 ' HG2' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -46.79 -41.53 15.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.78 -1.2 . . . . 0.0 108.768 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.551 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -44.57 -77.37 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.617 0.722 . . . . 0.0 110.185 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.703 HG12 ' CG ' ' A' ' 23' ' ' ASP . 1.9 t -72.91 -54.35 16.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.728 -0.608 . . . . 0.0 110.225 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.801 HD13 HD13 ' A' ' 29' ' ' ILE . 62.5 mt -33.92 -50.74 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.611 -0.681 . . . . 0.0 110.362 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.616 ' C ' HD23 ' A' ' 21' ' ' LEU . 9.6 tt -38.66 -53.88 1.59 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.512 -0.742 . . . . 0.0 110.638 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -123.79 21.22 9.2 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.963 -1.085 . . . . 0.0 111.172 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.703 ' CG ' HG12 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -56.66 -60.16 3.95 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 177.648 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.756 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 3.2 tttm -68.23 -153.87 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 104.37 -2.456 . . . . 0.0 104.37 175.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.756 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 27.7 Cg_endo -68.68 -45.81 2.13 Favored 'Trans proline' 0 C--N 1.319 -1.012 0 CA-C-N 121.15 1.446 . . . . 0.0 109.002 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 1.7 mt-10 -166.34 52.33 0.09 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.662 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -90.22 117.32 28.88 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.176 -1.009 . . . . 0.0 109.33 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 11.5 mt-30 -88.79 178.49 6.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.155 -0.965 . . . . 0.0 109.152 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.801 HD13 HD13 ' A' ' 20' ' ' ILE . 8.5 tt -148.75 138.85 16.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 C-N-CA 118.99 -1.084 . . . . 0.0 111.074 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.579 HD12 ' HG3' ' B' ' 46' ' ' ARG . 1.2 mt -91.24 164.24 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.814 ' C ' HD23 ' A' ' 32' ' ' LEU . 7.4 p -131.06 135.84 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.683 -1.261 . . . . 0.0 110.187 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.948 ' N ' HD23 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -150.4 164.22 21.31 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 110.075 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.559 ' HA ' HG22 ' B' ' 51' ' ' VAL . 37.0 Cg_endo -80.33 139.57 13.16 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.192 1.928 . . . . 0.0 109.326 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.831 HG12 ' HB3' ' B' ' 50' ' ' PHE . 24.1 m -63.66 -10.35 6.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.188 -0.945 . . . . 0.0 109.97 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 34' ' ' VAL . . . -40.66 -84.71 0.01 OUTLIER Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.5 p -99.45 -167.7 1.51 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.267 -1.137 . . . . 0.0 109.827 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.791 HG23 ' O ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -134.4 39.99 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.406 -0.809 . . . . 0.0 108.956 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.79 140.66 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.026 -1.046 . . . . 0.0 109.657 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.432 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' GLU . . . . . 0.449 ' OE2' ' HB ' ' B' ' 44' ' ' ILE . 8.3 pt-20 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.471 0.653 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' TYR . . . . . 0.422 ' HD1' ' N ' ' B' ' 43' ' ' ARG . 3.9 p90 -75.31 -148.72 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.527 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.4 OUTLIER -104.59 62.66 0.72 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.774 -1.204 . . . . 0.0 109.589 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.449 ' HB ' ' OE2' ' B' ' 41' ' ' GLU . 11.8 tt -44.88 160.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.938 -1.101 . . . . 0.0 108.037 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.662 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.7 p-10 -127.08 45.83 2.63 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 118.602 -1.239 . . . . 0.0 110.167 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' ARG . . . . . 0.579 ' HG3' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -152.07 150.55 30.06 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.947 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.63 HG22 ' CG2' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -151.4 168.62 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.95 -1.094 . . . . 0.0 109.355 -179.617 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.541 ' HG3' HD11 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -97.54 93.8 6.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.969 -1.082 . . . . 0.0 109.333 179.686 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.561 ' C ' HD12 ' B' ' 49' ' ' LEU . 0.9 OUTLIER -88.67 82.05 6.93 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.439 -0.904 . . . . 0.0 109.475 179.745 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 50' ' ' PHE . . . . . 0.831 ' HB3' HG12 ' A' ' 34' ' ' VAL . 2.9 m-30 -66.05 158.22 28.97 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.726 ' O ' HG13 ' A' ' 34' ' ' VAL . 12.2 m -118.86 -174.98 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.799 -1.188 . . . . 0.0 109.295 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.502 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.5 OUTLIER -124.86 -154.3 0.61 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.029 -1.044 . . . . 0.0 110.08 -179.531 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.502 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 1.8 mtmp? -60.85 -57.39 12.86 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.606 -0.684 . . . . 0.0 109.653 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' B' ' 54' ' ' LEU . 0.3 OUTLIER -99.58 44.58 1.02 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.331 -0.856 . . . . 0.0 109.741 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 48.7 63.72 1.99 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.072 -1.018 . . . . 0.0 109.162 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 56' ' ' ASN . . . . . 0.587 ' O ' ' N ' ' B' ' 58' ' ' ALA . 7.6 t30 -130.25 109.85 11.1 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.813 HD11 ' HB2' ' A' ' 16' ' ' ALA . 23.9 mt -34.34 86.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 121.485 0.659 . . . . 0.0 111.262 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.587 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -89.13 -8.77 53.1 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.47 85.43 2.05 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.562 HG21 HG23 ' A' ' 9' ' ' VAL . 2.2 t -48.25 139.49 10.23 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.465 -0.772 . . . . 0.0 110.131 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.591 ' CG ' ' CD1' ' A' ' 29' ' ' ILE . 36.4 Cg_endo -81.21 168.96 16.42 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.856 2.371 . . . . 0.0 109.404 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 62' ' ' ARG . . . . . 0.544 ' HD2' ' CB ' ' A' ' 4' ' ' GLU . 0.5 OUTLIER -149.89 124.45 9.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.873 -1.142 . . . . 0.0 110.274 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.63 ' CG2' HG22 ' B' ' 47' ' ' VAL . 2.6 t -107.65 152.91 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.339 -0.85 . . . . 0.0 108.788 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 CA-C-O 117.965 -1.464 . . . . 0.0 109.56 179.869 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.449 ' HG2' ' HA ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.4 0.619 . . . . 0.0 109.54 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.506 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . 0.3 OUTLIER -89.1 79.57 7.17 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.304 -0.873 . . . . 0.0 109.465 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.786 HG22 ' CD ' ' A' ' 24' ' ' LYS . 2.8 p -108.03 8.09 28.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.284 -0.885 . . . . 0.0 109.503 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.633 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 0.4 OUTLIER -125.5 -57.75 1.45 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.196 -0.94 . . . . 0.0 110.012 -179.118 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.789 ' O ' HD22 ' A' ' 8' ' ' LEU . 5.0 m-90 70.3 39.78 0.18 Allowed Pre-proline 0 C--N 1.3 -1.561 0 O-C-N 121.765 -0.584 . . . . 0.0 110.827 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.633 ' HD3' ' CB ' ' A' ' 4' ' ' GLU . 33.1 Cg_endo -72.31 -30.18 13.14 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 N-CA-C 107.559 -1.746 . . . . 0.0 107.559 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.51 -17.66 64.75 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.302 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.064 HD23 ' N ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -69.48 -23.02 63.58 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 122.254 1.026 . . . . 0.0 108.565 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.064 ' N ' HD23 ' A' ' 8' ' ' LEU . 3.8 t -43.63 138.61 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-O 121.988 0.899 . . . . 0.0 110.88 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.657 ' O ' ' ND2' ' B' ' 56' ' ' ASN . . . 86.5 -45.55 3.46 Favored Glycine 0 C--N 1.298 -1.581 0 C-N-CA 119.749 -1.215 . . . . 0.0 112.364 175.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.3 78.14 1.08 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 119.951 -1.911 . . . . 0.0 111.492 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.881 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 0.9 OUTLIER -153.18 46.73 0.68 Allowed 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 118.315 -1.354 . . . . 0.0 111.345 179.486 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.644 HG21 ' O ' ' B' ' 55' ' ' ASP . 23.9 t -77.28 -73.03 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 O-C-N 121.068 -1.02 . . . . 0.0 109.725 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.484 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 11.6 pt-20 -55.71 -38.25 69.47 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.452 ' HA ' ' HB3' ' A' ' 18' ' ' LYS . 4.3 tt0 -68.48 -32.72 72.9 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.881 ' HB2' ' O ' ' A' ' 12' ' ' SER . . . -62.69 -71.62 0.15 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.096 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.787 ' HE2' HD12 ' A' ' 21' ' ' LEU . 0.5 OUTLIER -50.56 -35.58 30.48 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.112 179.613 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.5 ' HG2' ' N ' ' A' ' 19' ' ' VAL . 2.6 ttmt -62.17 -90.29 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.576 0.703 . . . . 0.0 110.742 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.735 HG12 ' OD2' ' A' ' 23' ' ' ASP . 3.4 t -46.19 -48.32 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.639 -0.663 . . . . 0.0 110.371 -178.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.928 HD13 HD13 ' A' ' 29' ' ' ILE . 61.6 mt -50.43 -50.88 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.176 -0.953 . . . . 0.0 109.876 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.787 HD12 ' HE2' ' A' ' 17' ' ' LYS . 3.3 tt -35.13 -29.99 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.679 -0.638 . . . . 0.0 111.544 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.566 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 2.2 tt0 -136.36 3.24 2.81 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 118.002 -1.479 . . . . 0.0 111.98 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.735 ' OD2' HG12 ' A' ' 19' ' ' VAL . 22.5 m-20 -54.12 147.17 13.33 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 177.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.786 ' CD ' HG22 ' A' ' 3' ' ' THR . 21.9 mtpt 69.86 -147.0 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 104.425 -2.435 . . . . 0.0 104.425 -175.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.688 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 33.2 Cg_endo -75.42 -64.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.324 -0.745 0 CA-C-N 121.36 1.521 . . . . 0.0 108.814 178.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 26.9 mt-10 -161.06 64.66 0.29 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.789 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -88.78 117.53 27.84 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.494 ' CB ' ' O ' ' B' ' 45' ' ' ASP . 0.0 OUTLIER -88.19 175.76 7.56 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.182 -0.949 . . . . 0.0 109.7 -179.47 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.928 HD13 HD13 ' A' ' 20' ' ' ILE . 3.3 tt -143.12 147.11 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.225 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.501 HD12 ' HD2' ' B' ' 46' ' ' ARG . 4.2 mt -102.44 130.89 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.878 HG13 ' HG ' ' B' ' 49' ' ' LEU . 2.5 t -104.23 125.72 58.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 120.798 -1.189 . . . . 0.0 109.721 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.077 HD11 ' CE1' ' B' ' 50' ' ' PHE . 0.7 OUTLIER -138.5 165.45 32.76 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -179.293 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.674 ' C ' HG23 ' A' ' 34' ' ' VAL . 39.4 Cg_endo -79.43 18.65 1.05 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.447 2.098 . . . . 0.0 111.399 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.674 HG23 ' C ' ' A' ' 33' ' ' PRO . 3.2 t 81.24 -71.37 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.438 -0.789 . . . . 0.0 108.953 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.506 ' O ' ' CG1' ' A' ' 37' ' ' ILE . . . -49.11 -65.12 2.88 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.49 ' HB ' ' HD2' ' A' ' 33' ' ' PRO . 75.0 m -33.14 120.68 0.37 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.677 -0.896 . . . . 0.0 111.492 -178.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.506 ' CG1' ' O ' ' A' ' 35' ' ' GLY . 3.0 mt -128.49 15.45 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.0 m -57.86 -175.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.497 -0.752 . . . . 0.0 109.946 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.3 p . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 117.896 -1.05 . . . . 0.0 109.509 -179.939 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 42' ' ' TYR . . . . . 0.725 ' OH ' HD12 ' B' ' 44' ' ' ILE . 10.6 p90 -127.36 -145.39 0.31 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.807 -1.183 . . . . 0.0 109.444 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.542 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER -114.91 67.33 0.69 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.139 -0.976 . . . . 0.0 110.213 -179.334 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.725 HD12 ' OH ' ' B' ' 42' ' ' TYR . 0.5 OUTLIER -46.96 145.45 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.706 -1.246 . . . . 0.0 108.108 179.187 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.62 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.0 OUTLIER -105.86 43.05 1.16 Allowed 'General case' 0 C--N 1.295 -1.763 0 O-C-N 120.914 -1.116 . . . . 0.0 109.829 -179.338 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 46' ' ' ARG . . . . . 0.501 ' HD2' HD12 ' A' ' 30' ' ' ILE . 0.3 OUTLIER -151.02 155.05 38.23 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.366 -0.834 . . . . 0.0 109.477 179.637 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.944 ' CG2' HG23 ' B' ' 63' ' ' VAL . 15.4 t -150.29 173.42 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 109.456 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.606 ' H ' HG12 ' B' ' 47' ' ' VAL . 20.4 mmt180 -101.59 66.51 1.08 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.982 -1.074 . . . . 0.0 109.942 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.878 ' HG ' HG13 ' A' ' 31' ' ' VAL . 3.8 tp -61.49 89.94 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.268 -0.973 . . . . 0.0 109.121 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' PHE . . . . . 1.077 ' CE1' HD11 ' A' ' 32' ' ' LEU . 7.3 m-30 -79.26 135.32 36.73 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.789 HG22 ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -104.89 -174.94 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.79 -1.194 . . . . 0.0 109.147 179.383 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.533 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.0 OUTLIER -126.48 -162.84 1.18 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.252 -0.905 . . . . 0.0 109.729 -179.687 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.533 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 21.0 mtpt -46.6 -64.74 0.69 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.398 0.618 . . . . 0.0 109.919 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.422 ' O ' ' C ' ' B' ' 55' ' ' ASP . 0.5 OUTLIER -95.38 52.28 1.38 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.793 -179.563 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 55' ' ' ASP . . . . . 0.644 ' O ' HG21 ' A' ' 13' ' ' VAL . 0.0 OUTLIER 42.72 57.52 3.51 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.351 -0.843 . . . . 0.0 109.654 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 56' ' ' ASN . . . . . 0.657 ' ND2' ' O ' ' A' ' 10' ' ' GLY . 8.1 t-20 -115.6 122.11 44.65 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.673 HD13 HD11 ' A' ' 8' ' ' LEU . 5.0 mt -60.69 89.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.293 -0.88 . . . . 0.0 110.196 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.72 -28.31 20.62 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 59' ' ' GLN . . . . . 0.454 ' HB3' ' HB2' ' B' ' 50' ' ' PHE . 4.5 tt0 -105.13 133.02 50.61 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.613 HG22 HG23 ' A' ' 9' ' ' VAL . 58.9 t -89.15 129.11 49.1 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 120.843 -1.161 . . . . 0.0 110.711 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.794 ' HB2' HG11 ' B' ' 47' ' ' VAL . 36.6 Cg_endo -82.64 160.54 16.67 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.632 2.222 . . . . 0.0 109.295 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 62' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 3' ' ' THR . 0.0 OUTLIER -150.03 143.14 24.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.906 -1.121 . . . . 0.0 110.062 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.944 HG23 ' CG2' ' B' ' 47' ' ' VAL . 0.9 OUTLIER -111.75 145.16 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.264 0 CA-C-O 117.975 -1.458 . . . . 0.0 109.642 179.895 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 mtm . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.517 ' O ' ' OD2' ' A' ' 23' ' ' ASP . 0.2 OUTLIER -90.18 83.03 5.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 110.231 -179.611 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 24' ' ' LYS . 4.1 p -89.12 -16.53 31.24 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.935 -1.103 . . . . 0.0 108.548 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.541 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.5 mt-10 -112.04 179.23 4.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.422 -0.799 . . . . 0.0 109.336 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.612 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 14.7 m-90 -150.78 47.3 0.44 Allowed Pre-proline 0 C--N 1.298 -1.658 0 O-C-N 121.52 -0.738 . . . . 0.0 109.79 178.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 31.3 Cg_endo -71.18 -25.72 21.95 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 N-CA-C 107.411 -1.803 . . . . 0.0 107.411 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -69.79 -20.32 63.47 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.507 HD13 ' HA ' ' A' ' 16' ' ' ALA . 11.4 mt -83.64 -4.01 58.22 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.496 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.583 ' CG2' ' CG2' ' B' ' 60' ' ' VAL . 22.7 t -55.41 147.78 3.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.106 -0.996 . . . . 0.0 109.833 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.427 ' C ' ' OD1' ' B' ' 56' ' ' ASN . . . 61.65 10.4 23.98 Favored Glycine 0 N--CA 1.481 1.668 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 2.1 tptp -96.12 -144.59 0.28 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.959 -1.318 . . . . 0.0 109.071 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.416 ' CA ' HG12 ' B' ' 57' ' ' ILE . 1.4 m -142.76 165.86 26.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.044 -1.035 . . . . 0.0 109.909 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.682 ' CG2' HG11 ' A' ' 31' ' ' VAL . 76.4 t -50.86 -40.1 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.434 -0.791 . . . . 0.0 109.443 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.536 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 56.7 mt-10 -43.8 -72.1 0.07 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.468 -0.77 . . . . 0.0 109.538 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -56.37 -34.62 66.83 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.081 -1.012 . . . . 0.0 109.734 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.607 ' C ' HD12 ' A' ' 20' ' ' ILE . . . -63.44 -84.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 110.206 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.577 ' HG2' HG23 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -44.74 -34.25 2.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.947 -1.096 . . . . 0.0 109.044 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 6.0 ttmt -55.98 -82.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.542 0.687 . . . . 0.0 110.511 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.484 HG12 ' HB3' ' A' ' 23' ' ' ASP . 2.0 t -64.28 -49.9 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.545 -0.722 . . . . 0.0 109.769 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.929 HD13 HD13 ' A' ' 29' ' ' ILE . 77.1 mt -42.54 -54.09 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.364 -0.835 . . . . 0.0 109.47 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 28' ' ' GLN . 4.9 tt -42.1 -45.81 4.08 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.263 -0.898 . . . . 0.0 110.223 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -143.61 54.58 1.33 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.992 -1.068 . . . . 0.0 110.624 -179.188 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.604 ' OD2' ' CZ2' ' A' ' 5' ' ' TRP . 35.0 p-10 -76.23 -28.9 57.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.859 -1.151 . . . . 0.0 108.768 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.779 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -130.72 -83.45 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.055 -1.028 . . . . 0.0 108.692 178.315 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.779 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 42.4 Cg_endo -88.68 -84.93 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.645 0 N-CA-C 108.144 -1.521 . . . . 0.0 108.144 177.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 10.2 mt-10 -162.06 56.3 0.24 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.989 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -88.69 118.12 28.14 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.084 -1.01 . . . . 0.0 109.125 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 1.8 mt-30 -88.19 178.35 6.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 0.0 109.373 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.929 HD13 HD13 ' A' ' 20' ' ' ILE . 5.9 tt -147.43 137.67 17.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 C-N-CA 119.204 -0.998 . . . . 0.0 111.011 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.565 HD11 ' HD2' ' B' ' 46' ' ' ARG . 8.3 mt -90.28 117.36 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.944 HG13 ' HG ' ' B' ' 49' ' ' LEU . 5.1 t -99.82 140.98 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.797 -1.189 . . . . 0.0 109.75 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.963 HD21 ' CE1' ' B' ' 50' ' ' PHE . 0.5 OUTLIER -144.08 162.81 38.67 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.264 -0.897 . . . . 0.0 109.536 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.619 ' O ' ' HB ' ' A' ' 34' ' ' VAL . 37.0 Cg_endo -79.83 16.74 1.4 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.542 2.161 . . . . 0.0 111.592 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.619 ' HB ' ' O ' ' A' ' 33' ' ' PRO . 77.1 t 77.33 -70.04 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.972 -0.455 . . . . 0.0 110.236 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.54 ' C ' ' O ' ' A' ' 34' ' ' VAL . . . -18.07 -52.08 0.01 OUTLIER Glycine 0 N--CA 1.501 2.999 0 N-CA-C 112.11 -0.396 . . . . 0.0 112.11 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.556 HG22 ' N ' ' A' ' 37' ' ' ILE . 34.7 m -46.15 -91.73 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.993 -1.298 . . . . 0.0 109.949 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.556 ' N ' HG22 ' A' ' 36' ' ' THR . 10.4 pt 40.44 87.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.684 -0.635 . . . . 0.0 109.912 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.482 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 18.5 t 71.0 -99.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.449 -0.782 . . . . 0.0 110.225 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.464 ' OXT' ' O ' ' A' ' 36' ' ' THR . 7.4 t . . . . . 0 N--CA 1.492 1.653 0 O-C-N 120.722 -1.236 . . . . 0.0 109.864 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' GLU . . . . . 0.426 ' O ' ' O ' ' B' ' 42' ' ' TYR . 1.2 mp0 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.251 0.548 . . . . 0.0 109.577 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' TYR . . . . . 0.426 ' O ' ' O ' ' B' ' 41' ' ' GLU . 49.0 p90 -59.15 -157.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.192 -0.942 . . . . 0.0 109.393 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.583 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER -149.76 67.32 0.99 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.113 -0.992 . . . . 0.0 109.757 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.432 ' C ' ' O ' ' B' ' 43' ' ' ARG . 0.7 OUTLIER -48.4 137.1 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.544 -1.347 . . . . 0.0 107.644 179.222 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.647 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 4.3 p-10 -89.62 48.3 1.58 Allowed 'General case' 0 C--N 1.292 -1.896 0 C-N-CA 119.076 -1.05 . . . . 0.0 109.396 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' ARG . . . . . 0.565 ' HD2' HD11 ' A' ' 30' ' ' ILE . 10.1 ttp180 -151.08 151.68 32.33 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 1.119 ' CG2' HG23 ' B' ' 63' ' ' VAL . 61.4 t -151.43 169.34 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.592 ' HB3' ' CE2' ' B' ' 50' ' ' PHE . 12.6 mmt-85 -100.18 84.46 2.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.631 -1.293 . . . . 0.0 110.709 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.944 ' HG ' HG13 ' A' ' 31' ' ' VAL . 4.2 tp -84.68 97.69 9.79 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 118.933 -1.107 . . . . 0.0 108.62 178.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 50' ' ' PHE . . . . . 0.963 ' CE1' HD21 ' A' ' 32' ' ' LEU . 52.4 m-85 -92.88 131.71 37.66 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 178.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.907 HG22 ' O ' ' A' ' 32' ' ' LEU . 12.9 m -89.08 178.04 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.619 -1.301 . . . . 0.0 110.349 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.511 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.8 OUTLIER -107.89 -151.72 0.47 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.354 -0.841 . . . . 0.0 109.775 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.511 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 1.2 mmtp -74.03 -48.47 29.86 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.478 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.1 OUTLIER -98.99 38.19 1.42 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.39 -0.819 . . . . 0.0 109.503 179.534 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 55' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.0 OUTLIER 50.48 67.62 0.89 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.165 -0.96 . . . . 0.0 109.181 -179.413 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 56' ' ' ASN . . . . . 0.565 ' O ' ' N ' ' B' ' 58' ' ' ALA . 1.2 t30 -133.58 117.35 16.98 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.652 ' CD1' HD11 ' B' ' 49' ' ' LEU . 27.0 mm -46.88 87.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-O 121.384 0.612 . . . . 0.0 109.823 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -89.32 -25.46 21.62 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -105.01 129.42 53.46 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.583 ' CG2' ' CG2' ' A' ' 9' ' ' VAL . 85.3 t -82.56 126.35 73.82 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.054 -1.029 . . . . 0.0 109.989 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.954 ' HB2' HG11 ' B' ' 47' ' ' VAL . 37.0 Cg_endo -81.36 158.91 19.87 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 C-N-CA 122.403 2.068 . . . . 0.0 110.199 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 62' ' ' ARG . . . . . 0.457 ' NE ' ' HB3' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -150.91 130.62 13.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.054 -1.029 . . . . 0.0 109.839 179.411 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 1.119 HG23 ' CG2' ' B' ' 47' ' ' VAL . 1.1 t -106.18 124.58 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.308 -0.87 . . . . 0.0 108.901 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.881 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 mmt . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.433 ' HD3' ' HA ' ' A' ' 2' ' ' LYS . 3.3 mmtp -85.99 71.53 10.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.062 -1.024 . . . . 0.0 109.604 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.506 HG22 ' O ' ' B' ' 63' ' ' VAL . 2.1 m -99.56 -15.74 18.52 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.382 -0.824 . . . . 0.0 109.475 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.716 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.7 mt-10 -102.4 -36.43 8.44 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.112 -0.993 . . . . 0.0 110.026 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.78 ' NE1' HD12 ' A' ' 20' ' ' ILE . 7.8 m-90 56.2 47.33 2.87 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 121.018 -1.051 . . . . 0.0 109.249 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.716 ' HD3' ' HB2' ' A' ' 4' ' ' GLU . 33.4 Cg_endo -74.99 -37.39 2.06 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 N-CA-C 106.789 -2.043 . . . . 0.0 106.789 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -8.62 50.07 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 114.524 -1.216 . . . . 0.0 107.797 177.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.565 ' HG ' HD12 ' B' ' 57' ' ' ILE . 13.2 tp -83.2 -2.03 54.51 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 121.289 -0.882 . . . . 0.0 109.198 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.659 HG22 HG23 ' B' ' 60' ' ' VAL . 17.7 t -57.18 149.54 4.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.021 -1.049 . . . . 0.0 109.459 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.56 8.67 21.27 Favored Glycine 0 N--CA 1.481 1.688 0 C-N-CA 119.858 -1.163 . . . . 0.0 110.309 178.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 17.0 tptt -91.1 -145.63 0.19 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.789 -1.418 . . . . 0.0 109.161 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' B' ' 55' ' ' ASP . 0.4 OUTLIER -145.71 160.88 41.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.029 -1.045 . . . . 0.0 109.894 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.859 HG23 HG11 ' B' ' 51' ' ' VAL . 53.7 t -51.89 -32.48 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.339 -0.851 . . . . 0.0 109.19 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.547 ' O ' ' CG ' ' A' ' 18' ' ' LYS . 5.4 mt-10 -43.05 -74.06 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.501 ' HB3' HD11 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -59.97 -37.37 79.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.559 -0.713 . . . . 0.0 109.993 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.604 ' HB3' ' HA ' ' A' ' 13' ' ' VAL . . . -59.44 -80.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 0.0 110.04 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.532 ' HA ' ' CG2' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -47.21 -32.86 4.8 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.469 -1.394 . . . . 0.0 109.347 -179.817 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.547 ' CG ' ' O ' ' A' ' 14' ' ' GLU . 16.1 mtpt -58.86 -85.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.753 0.787 . . . . 0.0 110.953 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.522 ' O ' ' N ' ' A' ' 23' ' ' ASP . 2.8 t -57.83 -41.33 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.592 -0.692 . . . . 0.0 110.08 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.956 HG21 ' HB ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER -48.73 -52.31 9.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.352 -0.843 . . . . 0.0 109.16 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.461 ' C ' ' O ' ' A' ' 20' ' ' ILE . 0.7 OUTLIER -38.14 -40.86 0.54 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.685 -0.635 . . . . 0.0 110.125 -179.581 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.402 ' HB2' HD23 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -140.38 40.88 1.91 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.112 -0.993 . . . . 0.0 109.765 179.906 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 19' ' ' VAL . 18.8 p-10 -52.09 -42.93 63.63 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.336 -0.852 . . . . 0.0 109.493 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.782 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -130.75 -78.69 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.444 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.715 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.782 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 40.6 Cg_endo -87.57 -80.79 0.0 OUTLIER 'Trans proline' 0 C--O 1.214 -0.717 0 N-CA-C 107.78 -1.662 . . . . 0.0 107.78 177.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 22.4 mt-10 -161.96 62.08 0.24 Allowed 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.765 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -87.92 121.25 30.11 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.989 -1.069 . . . . 0.0 110.236 -178.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.43 ' O ' HG23 ' B' ' 47' ' ' VAL . 1.1 tp60 -88.59 176.15 7.25 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.057 -1.027 . . . . 0.0 108.242 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.956 ' HB ' HG21 ' A' ' 20' ' ' ILE . 9.4 tt -148.9 137.53 14.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 120.7 -1.25 . . . . 0.0 111.193 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.503 ' O ' ' HB3' ' B' ' 49' ' ' LEU . 0.8 OUTLIER -88.92 152.89 3.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.011 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.705 HG21 HG21 ' A' ' 13' ' ' VAL . 7.6 p -135.02 134.93 53.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 118.813 -1.155 . . . . 0.0 110.298 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.886 ' N ' HD23 ' A' ' 32' ' ' LEU . 0.4 OUTLIER -150.68 149.97 27.14 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.44 -0.787 . . . . 0.0 109.283 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 35' ' ' GLY . 37.9 Cg_endo -78.24 58.62 6.71 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.735 2.29 . . . . 0.0 111.725 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.649 HG23 ' O ' ' B' ' 51' ' ' VAL . 22.0 t 44.16 -93.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.119 -0.988 . . . . 0.0 109.402 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . 43.53 -149.85 0.64 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.7 t -95.36 157.67 15.79 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.31 -1.112 . . . . 0.0 109.38 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.403 HG23 ' N ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -66.85 -36.66 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.288 -0.883 . . . . 0.0 109.484 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.457 ' O ' ' OXT' ' A' ' 39' ' ' THR . 2.5 p -80.1 125.57 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.097 -1.002 . . . . 0.0 109.487 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.457 ' OXT' ' O ' ' A' ' 38' ' ' VAL . 23.3 m . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.322 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 42' ' ' TYR . . . . . 0.605 ' CE2' ' HA ' ' B' ' 44' ' ' ILE . 15.1 p90 -121.43 -158.13 0.75 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.868 -1.145 . . . . 0.0 109.345 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.533 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 2.0 ptt-85 -91.6 57.02 3.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 109.929 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.605 ' HA ' ' CE2' ' B' ' 42' ' ' TYR . 0.3 OUTLIER -44.75 142.54 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.893 -1.129 . . . . 0.0 108.458 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.645 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.1 p-10 -102.1 48.67 0.87 Allowed 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.127 -1.029 . . . . 0.0 110.058 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.71 146.34 26.38 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.675 HG12 ' H ' ' B' ' 62' ' ' ARG . 0.0 OUTLIER -150.47 143.7 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 120.968 -1.083 . . . . 0.0 109.317 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -78.67 88.05 4.58 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.99 -1.069 . . . . 0.0 110.796 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.534 ' C ' HD12 ' B' ' 49' ' ' LEU . 2.1 tp -90.41 97.22 11.05 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.141 -1.024 . . . . 0.0 108.657 178.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 50' ' ' PHE . . . . . 0.843 ' CZ ' HD11 ' A' ' 32' ' ' LEU . 16.6 m-85 -92.35 110.72 22.12 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.859 HG11 HG23 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -89.77 172.08 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.906 -1.121 . . . . 0.0 110.947 -178.856 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' B' ' 54' ' ' LEU . 0.7 OUTLIER -94.66 -153.04 0.37 Allowed 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.683 0.754 . . . . 0.0 109.715 -179.233 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.521 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 6.2 mttm -76.84 -47.42 21.46 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.522 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.0 OUTLIER -95.83 39.69 1.13 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.577 -0.702 . . . . 0.0 109.488 179.553 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 55' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.0 OUTLIER 47.75 67.29 0.84 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.12 -0.987 . . . . 0.0 109.123 -179.756 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 56' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' B' ' 58' ' ' ALA . 17.8 t-20 -127.33 94.12 3.91 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.658 0.742 . . . . 0.0 109.011 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.575 HD11 ' HB2' ' A' ' 16' ' ' ALA . 4.5 mt -39.68 87.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.301 0.572 . . . . 0.0 111.066 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -89.48 -19.65 24.82 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -118.19 106.1 12.48 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.659 HG23 HG22 ' A' ' 9' ' ' VAL . 35.4 t -62.52 133.87 94.88 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.227 -0.921 . . . . 0.0 110.345 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.586 ' CB ' HD11 ' A' ' 29' ' ' ILE . 36.2 Cg_endo -79.81 163.38 23.56 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 122.531 2.154 . . . . 0.0 109.398 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 62' ' ' ARG . . . . . 0.675 ' H ' HG12 ' B' ' 47' ' ' VAL . 0.0 OUTLIER -150.55 128.08 11.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.971 -1.081 . . . . 0.0 110.102 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.765 HG21 ' HB1' ' A' ' 27' ' ' ALA . 1.8 t -106.37 151.34 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.263 -0.898 . . . . 0.0 109.073 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.901 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mtt . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.296 0.57 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.518 ' HB2' ' HB3' ' A' ' 23' ' ' ASP . 16.7 mmtp -85.11 71.17 10.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.177 -0.952 . . . . 0.0 109.552 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.654 HG23 ' CD ' ' A' ' 24' ' ' LYS . 0.3 OUTLIER -101.23 -24.13 14.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.257 -0.902 . . . . 0.0 109.598 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.586 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 6.9 mt-10 -94.33 -44.56 7.88 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.264 -0.897 . . . . 0.0 109.999 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.62 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.5 m-90 64.19 41.83 0.36 Allowed Pre-proline 0 C--N 1.296 -1.724 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.109 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 34.4 Cg_endo -73.14 -30.46 10.6 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 N-CA-C 106.929 -1.989 . . . . 0.0 106.929 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.67 -13.88 62.25 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 177.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.03 HD21 HG21 ' B' ' 57' ' ' ILE . 0.0 OUTLIER -81.89 -5.6 58.4 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.509 ' CG2' ' CG2' ' B' ' 60' ' ' VAL . 25.2 t -53.29 151.94 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.0 -1.063 . . . . 0.0 109.745 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.422 ' HA2' ' OD1' ' B' ' 56' ' ' ASN . . . 62.83 7.27 15.19 Favored Glycine 0 N--CA 1.482 1.716 0 C-N-CA 119.982 -1.104 . . . . 0.0 110.422 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -93.55 -142.56 0.23 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.833 -1.392 . . . . 0.0 109.183 179.646 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -148.73 161.48 41.68 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.994 -1.066 . . . . 0.0 109.89 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.726 ' HA ' HD21 ' B' ' 49' ' ' LEU . 39.9 t -46.39 -35.82 2.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.415 -0.803 . . . . 0.0 109.048 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.538 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 1.5 mt-10 -44.84 -73.88 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.511 -0.743 . . . . 0.0 109.066 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.449 ' O ' HG23 ' A' ' 19' ' ' VAL . 1.9 tm-20 -55.92 -34.5 65.65 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.192 -0.942 . . . . 0.0 109.555 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.685 ' HB1' HD12 ' A' ' 20' ' ' ILE . . . -62.82 -85.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.088 -1.008 . . . . 0.0 110.166 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -42.87 -45.45 4.93 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.837 -1.165 . . . . 0.0 108.914 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 6.1 tptm -42.37 -76.13 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.573 0.702 . . . . 0.0 110.584 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.482 ' O ' ' C ' ' A' ' 20' ' ' ILE . 1.0 OUTLIER -78.16 -52.81 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.459 -0.776 . . . . 0.0 110.402 -178.39 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.685 HD12 ' HB1' ' A' ' 16' ' ' ALA . 60.1 mt -37.98 -34.72 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.394 -0.816 . . . . 0.0 110.004 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.726 HD23 ' HB2' ' A' ' 22' ' ' GLN . 2.4 tt -56.09 -52.98 62.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.081 -1.012 . . . . 0.0 110.357 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.726 ' HB2' HD23 ' A' ' 21' ' ' LEU . 3.4 mt-30 -128.59 64.21 1.43 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.925 -1.109 . . . . 0.0 111.045 -178.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.518 ' HB3' ' HB2' ' A' ' 2' ' ' LYS . 0.3 OUTLIER -84.42 -50.55 7.67 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.412 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.711 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 10.0 mtpp -101.05 -105.77 0.0 OUTLIER Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.711 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 37.2 Cg_endo -80.16 -70.98 0.01 OUTLIER 'Trans proline' 0 C--O 1.213 -0.738 0 CA-C-N 121.873 1.705 . . . . 0.0 108.059 177.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 25' ' ' PRO . 30.8 mt-10 -162.76 70.2 0.26 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.765 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -88.51 120.48 29.93 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.871 -1.143 . . . . 0.0 109.233 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -89.82 168.61 11.94 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.193 -0.942 . . . . 0.0 109.642 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.528 ' HB ' HG21 ' A' ' 20' ' ' ILE . 21.4 tt -146.91 140.34 19.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.351 -0.843 . . . . 0.0 109.944 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 1.025 HG22 HD22 ' A' ' 32' ' ' LEU . 1.7 mp -88.97 142.35 13.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.914 ' C ' HD23 ' A' ' 32' ' ' LEU . 4.0 p -105.82 133.04 51.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.47 -0.892 . . . . 0.0 109.491 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.025 HD22 HG22 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -150.73 166.18 15.69 Favored Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.238 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.903 ' O ' HG23 ' A' ' 34' ' ' VAL . 37.4 Cg_endo -78.9 -93.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.301 -1.945 0 C-N-CA 121.703 1.602 . . . . 0.0 111.284 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.903 HG23 ' O ' ' A' ' 33' ' ' PRO . 1.8 t -171.94 -35.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 120.803 -1.186 . . . . 0.0 109.012 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 34' ' ' VAL . . . -38.46 160.06 0.01 OUTLIER Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -48.65 104.2 0.06 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -1.14 . . . . 0.0 109.534 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.561 HG22 HG13 ' A' ' 38' ' ' VAL . 3.9 mt 50.16 -94.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.249 -0.907 . . . . 0.0 109.621 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.561 HG13 HG22 ' A' ' 37' ' ' ILE . 18.7 m -141.31 167.9 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.013 -1.055 . . . . 0.0 109.679 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.424 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.711 0.767 . . . . 0.0 109.452 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' TYR . . . . . 0.431 ' O ' ' OXT' ' B' ' 64' ' ' GLY . 28.6 p90 -100.58 -153.53 0.45 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.57 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 2.5 ptt180 -109.57 66.83 0.64 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.711 -1.243 . . . . 0.0 110.296 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.525 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.3 OUTLIER -47.52 142.91 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.82 -1.175 . . . . 0.0 107.955 178.955 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.651 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.5 p-10 -102.39 44.43 1.01 Allowed 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.004 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' ARG . . . . . 0.64 ' HG2' HD13 ' A' ' 30' ' ' ILE . 0.8 OUTLIER -151.09 142.69 23.6 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 178.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.536 HG12 ' H ' ' B' ' 62' ' ' ARG . 0.0 OUTLIER -150.59 157.75 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.126 -0.984 . . . . 0.0 109.319 -179.296 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.602 ' HD2' HD11 ' A' ' 32' ' ' LEU . 3.1 mmt180 -92.98 100.96 13.31 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.72 -1.237 . . . . 0.0 110.328 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.726 HD21 ' HA ' ' A' ' 13' ' ' VAL . 0.8 OUTLIER -95.45 96.02 8.82 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.263 -0.975 . . . . 0.0 108.872 178.876 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 50' ' ' PHE . . . . . 0.951 ' CE1' HD12 ' A' ' 32' ' ' LEU . 24.6 m-85 -93.26 143.53 26.17 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.793 HG22 ' HA ' ' A' ' 33' ' ' PRO . 6.1 m -107.21 -151.57 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.769 -1.207 . . . . 0.0 110.858 -179.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.554 ' N ' HG23 ' B' ' 51' ' ' VAL . 0.2 OUTLIER -141.92 -157.47 0.77 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.426 -0.796 . . . . 0.0 109.68 -179.478 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.532 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 2.8 mtmp? -57.42 -59.02 5.77 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.667 -0.646 . . . . 0.0 109.509 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.428 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 6.7 tp -96.2 42.82 1.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.437 -0.789 . . . . 0.0 109.619 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 55' ' ' ASP . . . . . 0.498 ' HA ' ' HB ' ' B' ' 51' ' ' VAL . 0.0 OUTLIER 49.2 62.7 2.47 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.101 -0.999 . . . . 0.0 109.567 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 56' ' ' ASN . . . . . 0.551 ' O ' ' N ' ' B' ' 58' ' ' ALA . 4.0 t30 -122.59 106.19 10.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.311 -0.868 . . . . 0.0 108.808 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 1.03 HG21 HD21 ' A' ' 8' ' ' LEU . 28.0 mt -42.06 89.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.496 0.665 . . . . 0.0 110.374 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.48 -17.82 29.54 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -114.92 135.39 54.26 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.509 ' CG2' ' CG2' ' A' ' 9' ' ' VAL . 71.1 t -88.05 128.05 55.23 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.014 -1.054 . . . . 0.0 110.542 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.479 ' O ' ' HD3' ' B' ' 62' ' ' ARG . 36.3 Cg_endo -79.76 158.36 24.69 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.317 2.012 . . . . 0.0 108.41 177.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 62' ' ' ARG . . . . . 0.536 ' H ' HG12 ' B' ' 47' ' ' VAL . 0.0 OUTLIER -150.54 133.05 15.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.768 -1.208 . . . . 0.0 110.409 -179.612 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.765 HG21 ' HB1' ' A' ' 27' ' ' ALA . 2.1 t -109.06 -25.58 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 64' ' ' GLY . . . . . 0.511 ' O ' HG21 ' A' ' 3' ' ' THR . . . . . . . . 0 N--CA 1.491 2.348 0 CA-C-O 117.94 -1.478 . . . . 0.0 109.594 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mmt . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.514 ' HB3' ' HB2' ' A' ' 23' ' ' ASP . 3.2 tppt? -84.16 72.73 10.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.064 -1.023 . . . . 0.0 109.969 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.469 ' O ' ' HG3' ' B' ' 62' ' ' ARG . 2.4 m -109.67 6.84 24.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.147 -0.97 . . . . 0.0 109.05 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.619 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 27.7 mt-10 -118.82 -40.8 2.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -0.903 . . . . 0.0 109.914 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.641 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 9.6 m-90 61.7 41.92 0.49 Allowed Pre-proline 0 C--N 1.299 -1.621 0 O-C-N 121.524 -0.735 . . . . 0.0 110.092 -178.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 32.6 Cg_endo -72.49 -30.34 12.44 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 N-CA-C 106.468 -2.166 . . . . 0.0 106.468 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -16.05 63.17 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.086 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.583 HD11 ' CD1' ' A' ' 5' ' ' TRP . 7.2 mt -81.5 -5.78 58.3 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 121.302 -0.874 . . . . 0.0 109.293 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.653 ' CG2' HG22 ' B' ' 60' ' ' VAL . 23.7 t -57.0 148.04 4.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.148 -0.97 . . . . 0.0 109.81 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.423 ' HA2' ' OD1' ' B' ' 56' ' ' ASN . . . 60.12 10.19 14.1 Favored Glycine 0 N--CA 1.48 1.578 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.472 178.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.765 ' HB3' HD12 ' B' ' 57' ' ' ILE . 0.1 OUTLIER -94.65 -145.43 0.26 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.925 -1.338 . . . . 0.0 109.068 179.693 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 13' ' ' VAL . 0.3 OUTLIER -141.85 161.17 38.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.991 -1.068 . . . . 0.0 110.075 -179.546 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.602 ' HA ' HD11 ' B' ' 49' ' ' LEU . 79.1 t -45.16 -38.5 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.195 -0.941 . . . . 0.0 109.207 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.542 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 2.4 mt-10 -44.41 -75.28 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.413 ' O ' HG23 ' A' ' 19' ' ' VAL . 1.9 tp10 -53.46 -32.69 51.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.165 -0.959 . . . . 0.0 109.623 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.835 ' C ' HD12 ' A' ' 20' ' ' ILE . . . -62.58 -85.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 110.578 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.94 -29.45 4.78 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.757 -1.215 . . . . 0.0 109.271 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 16.6 tptm -56.78 -77.95 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.31 0.576 . . . . 0.0 110.749 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 15' ' ' GLU . 1.5 t -69.3 -43.49 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.353 -0.842 . . . . 0.0 109.849 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.835 HD12 ' C ' ' A' ' 16' ' ' ALA . 63.5 mt -48.13 -55.32 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.896 . . . . 0.0 110.003 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.464 ' C ' ' O ' ' A' ' 20' ' ' ILE . 1.2 tt -36.04 -35.84 0.08 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.584 -0.697 . . . . 0.0 110.794 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 20' ' ' ILE . 2.8 mt-30 -141.91 56.87 1.49 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.02 -1.05 . . . . 0.0 109.718 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.514 ' HB2' ' HB3' ' A' ' 2' ' ' LYS . 26.6 p-10 -70.66 -31.46 68.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.923 . . . . 0.0 109.015 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.707 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -133.84 -97.85 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.702 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.707 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 36.2 Cg_endo -78.63 -68.72 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.716 0 N-CA-C 107.422 -1.799 . . . . 0.0 107.422 176.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.533 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 25.8 mt-10 -163.84 72.26 0.26 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 1.007 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -88.36 114.73 25.27 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.068 -1.02 . . . . 0.0 108.875 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.509 ' CB ' ' O ' ' B' ' 45' ' ' ASP . 0.0 OUTLIER -89.06 171.99 9.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.253 -0.904 . . . . 0.0 109.197 -179.6 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.775 HD13 HD13 ' A' ' 20' ' ' ILE . 14.9 tt -149.31 146.58 17.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.823 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.699 HG22 HD22 ' A' ' 32' ' ' LEU . 1.2 mp -89.04 155.78 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 1.035 HG13 HD13 ' B' ' 49' ' ' LEU . 2.0 t -127.91 116.24 42.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 118.555 -1.258 . . . . 0.0 110.956 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.942 HD11 ' CE1' ' B' ' 50' ' ' PHE . 0.7 OUTLIER -141.37 168.03 15.32 Favored Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.1 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.684 ' HD2' ' HB2' ' A' ' 32' ' ' LEU . 37.6 Cg_endo -75.58 -96.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 121.187 1.258 . . . . 0.0 109.328 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.567 HG13 ' O ' ' A' ' 33' ' ' PRO . 17.6 m -158.98 13.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 120.86 -1.15 . . . . 0.0 109.518 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -158.32 -79.94 0.03 OUTLIER Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.424 ' O ' ' CG ' ' A' ' 33' ' ' PRO . 7.9 p -95.95 144.47 26.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.376 -1.073 . . . . 0.0 109.593 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.556 ' O ' HG23 ' A' ' 38' ' ' VAL . 11.3 mt -74.36 99.08 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.236 -0.915 . . . . 0.0 109.404 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER 39.8 -97.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.496 -0.752 . . . . 0.0 109.822 -179.849 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.467 ' N ' ' O ' ' A' ' 37' ' ' ILE . 63.9 p . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.004 -1.06 . . . . 0.0 109.454 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.33 0.586 . . . . 0.0 109.581 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' TYR . . . . . 0.498 ' O ' ' HA2' ' B' ' 64' ' ' GLY . 2.1 t80 -167.45 135.77 2.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.862 . . . . 0.0 108.961 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.576 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 6.6 ptt-85 -122.58 55.14 1.17 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.233 -0.917 . . . . 0.0 109.607 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.606 HG22 ' H ' ' B' ' 64' ' ' GLY . 0.9 OUTLIER -48.05 136.05 4.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 120.622 -1.299 . . . . 0.0 108.132 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.564 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -90.13 38.65 0.94 Allowed 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.446 -0.901 . . . . 0.0 110.282 -178.445 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 46' ' ' ARG . . . . . 0.566 ' CG ' HD13 ' A' ' 30' ' ' ILE . 0.9 OUTLIER -141.11 146.98 37.79 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.634 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 1.106 ' CG2' HG23 ' B' ' 63' ' ' VAL . 63.5 t -151.59 169.26 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.102 -0.999 . . . . 0.0 109.365 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.6 ' N ' HG12 ' B' ' 47' ' ' VAL . 17.0 mmt-85 -99.5 95.52 7.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.718 -1.239 . . . . 0.0 109.57 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 1.035 HD13 HG13 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -90.67 82.54 5.77 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 118.954 -1.098 . . . . 0.0 109.293 179.465 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 50' ' ' PHE . . . . . 0.942 ' CE1' HD11 ' A' ' 32' ' ' LEU . 6.5 m-30 -74.46 145.46 43.6 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.513 ' HB ' ' HA ' ' B' ' 55' ' ' ASP . 14.1 m -127.02 176.54 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.573 -1.329 . . . . 0.0 110.742 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.489 ' OD2' ' HG2' ' B' ' 53' ' ' LYS . 0.0 OUTLIER -111.58 -171.76 1.9 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.489 ' HG2' ' OD2' ' B' ' 52' ' ' ASP . 1.8 ptmt -51.95 -53.41 41.66 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.965 -1.084 . . . . 0.0 110.781 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.406 ' C ' ' CG ' ' B' ' 55' ' ' ASP . 0.2 OUTLIER -88.96 38.08 0.87 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.964 -1.085 . . . . 0.0 108.797 179.706 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 55' ' ' ASP . . . . . 0.513 ' HA ' ' HB ' ' B' ' 51' ' ' VAL . 0.0 OUTLIER 51.35 51.42 16.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.688 -0.632 . . . . 0.0 109.458 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 56' ' ' ASN . . . . . 0.514 ' O ' ' N ' ' B' ' 58' ' ' ALA . 30.5 t30 -101.06 112.43 24.89 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.376 -0.827 . . . . 0.0 109.552 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.765 HD12 ' HB3' ' A' ' 11' ' ' LYS . 43.5 mt -51.9 91.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.581 -0.699 . . . . 0.0 109.276 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.12 -23.78 23.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.578 -0.701 . . . . 0.0 109.11 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.53 126.33 54.87 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.653 HG22 ' CG2' ' A' ' 9' ' ' VAL . 42.2 t -78.67 129.87 72.65 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 120.971 -1.081 . . . . 0.0 109.925 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.887 ' HB2' HG11 ' B' ' 47' ' ' VAL . 36.7 Cg_endo -83.69 159.94 14.3 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.671 2.247 . . . . 0.0 111.189 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 62' ' ' ARG . . . . . 0.558 ' NH1' ' HB ' ' B' ' 60' ' ' VAL . 0.1 OUTLIER -147.23 146.05 29.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.261 179.036 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 1.106 HG23 ' CG2' ' B' ' 47' ' ' VAL . 1.2 t -117.9 136.97 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.011 -1.056 . . . . 0.0 109.34 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 64' ' ' GLY . . . . . 0.606 ' H ' HG22 ' B' ' 44' ' ' ILE . . . . . . . . 0 N--CA 1.488 2.154 0 CA-C-O 117.922 -1.488 . . . . 0.0 109.518 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.578 ' O ' HG23 ' A' ' 3' ' ' THR . 9.2 tmm? . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.114 0.483 . . . . 0.0 109.933 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.493 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -50.6 87.7 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.26 -0.9 . . . . 0.0 110.363 -179.57 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 1' ' ' MET . 59.5 p -94.48 -29.16 15.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.949 -1.094 . . . . 0.0 108.359 178.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.551 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 4.6 mt-10 -100.78 174.6 5.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.539 -0.725 . . . . 0.0 109.146 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.643 ' CE2' HG12 ' A' ' 20' ' ' ILE . 17.9 m-90 -145.61 46.75 0.59 Allowed Pre-proline 0 C--N 1.298 -1.644 0 O-C-N 121.592 -0.693 . . . . 0.0 109.334 178.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.628 ' HA ' HG21 ' B' ' 60' ' ' VAL . 30.5 Cg_endo -70.31 -27.7 23.51 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 N-CA-C 107.796 -1.655 . . . . 0.0 107.796 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.43 -19.34 62.99 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.793 HD21 HG21 ' B' ' 57' ' ' ILE . 0.0 OUTLIER -87.33 -3.34 59.03 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.657 HG22 ' CG2' ' B' ' 60' ' ' VAL . 41.0 t -53.41 150.34 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 120.929 -1.107 . . . . 0.0 110.016 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.54 0.45 17.62 Favored Glycine 0 N--CA 1.48 1.598 0 C-N-CA 120.092 -1.051 . . . . 0.0 111.032 177.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -93.55 -154.78 0.42 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.625 -1.515 . . . . 0.0 109.321 179.732 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.458 ' O ' HD11 ' B' ' 57' ' ' ILE . 0.6 OUTLIER -134.98 177.88 7.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.113 -0.992 . . . . 0.0 110.197 -179.464 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.77 HG22 HD13 ' B' ' 49' ' ' LEU . 54.0 t -52.98 -43.03 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.526 -0.734 . . . . 0.0 110.199 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.533 ' O ' ' CG ' ' A' ' 18' ' ' LYS . 3.9 mt-10 -41.88 -71.07 0.09 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.387 -0.82 . . . . 0.0 109.41 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -56.62 -36.83 69.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.594 -0.691 . . . . 0.0 110.052 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.685 ' HB2' HD11 ' B' ' 57' ' ' ILE . . . -62.21 -81.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.192 -0.943 . . . . 0.0 110.032 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -46.22 -29.98 1.81 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.655 -1.278 . . . . 0.0 109.168 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 14' ' ' GLU . 4.4 mmtt -62.33 -84.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.628 0.728 . . . . 0.0 110.678 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.55 HG12 ' OD1' ' A' ' 23' ' ' ASP . 2.2 t -56.53 -46.4 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.526 -0.734 . . . . 0.0 109.766 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.943 HG21 ' HB ' ' A' ' 29' ' ' ILE . 87.7 mt -49.44 -58.27 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.238 -0.914 . . . . 0.0 109.386 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.61 HD23 ' HB2' ' A' ' 22' ' ' GLN . 3.3 tt -35.66 -33.97 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.693 -0.629 . . . . 0.0 110.796 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.61 ' HB2' HD23 ' A' ' 21' ' ' LEU . 0.8 OUTLIER -150.48 50.25 0.88 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.993 -1.067 . . . . 0.0 110.509 -179.631 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.55 ' OD1' HG12 ' A' ' 19' ' ' VAL . 2.8 t0 -73.48 -52.81 12.33 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.985 -1.072 . . . . 0.0 108.73 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.875 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.7 OUTLIER -102.38 -92.38 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.366 0 CA-C-O 117.451 -1.261 . . . . 0.0 108.058 178.837 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.875 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 39.5 Cg_endo -87.05 -74.14 0.0 OUTLIER 'Trans proline' 0 C--O 1.213 -0.727 0 CA-C-N 121.765 1.666 . . . . 0.0 108.229 177.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.509 ' CG ' ' O ' ' A' ' 25' ' ' PRO . 21.2 mt-10 -162.47 56.94 0.22 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.645 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -87.93 117.91 27.12 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.192 -0.943 . . . . 0.0 108.845 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.504 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 3.4 tt0 -88.4 -176.87 5.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.324 -0.86 . . . . 0.0 109.786 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.943 ' HB ' HG21 ' A' ' 20' ' ' ILE . 11.6 tt -145.8 145.57 20.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.766 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.486 HG12 ' HG2' ' B' ' 46' ' ' ARG . 7.8 mm -91.41 145.5 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.489 ' O ' HG13 ' A' ' 31' ' ' VAL . 8.0 p -99.05 125.53 52.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 120.814 -1.179 . . . . 0.0 109.775 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.073 HD11 ' CE1' ' B' ' 50' ' ' PHE . 0.5 OUTLIER -143.55 156.51 60.05 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.035 -1.04 . . . . 0.0 110.182 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.571 ' HA ' ' CG2' ' B' ' 51' ' ' VAL . 40.5 Cg_endo -81.27 42.22 1.3 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 123.014 2.476 . . . . 0.0 111.125 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.784 HG23 ' CD2' ' B' ' 50' ' ' PHE . 2.4 p 42.23 100.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.329 -0.857 . . . . 0.0 109.303 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -141.07 -85.69 0.1 OUTLIER Glycine 0 N--CA 1.487 2.091 0 C-N-CA 119.62 -1.276 . . . . 0.0 110.746 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.58 ' O ' HG22 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -69.39 -78.65 0.07 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.159 -1.2 . . . . 0.0 110.739 -178.836 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.619 HD12 ' CE2' ' B' ' 50' ' ' PHE . 1.7 tt 86.33 122.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.428 ' O ' ' O ' ' A' ' 37' ' ' ILE . 71.1 t 57.23 106.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.156 -0.965 . . . . 0.0 109.409 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.363 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 42' ' ' TYR . . . . . 0.603 ' CE2' ' HA ' ' B' ' 44' ' ' ILE . 21.8 p90 -129.53 -158.85 0.92 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 109.845 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.566 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 7.8 ptt-85 -91.88 70.47 5.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.421 -0.799 . . . . 0.0 109.834 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.603 ' HA ' ' CE2' ' B' ' 42' ' ' TYR . 0.4 OUTLIER -47.52 144.55 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.573 -1.329 . . . . 0.0 108.256 179.518 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.645 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -103.41 44.57 1.01 Allowed 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 119.053 -1.059 . . . . 0.0 109.419 -179.528 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 46' ' ' ARG . . . . . 0.486 ' HG2' HG12 ' A' ' 30' ' ' ILE . 7.6 mtt180 -150.32 153.11 35.53 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.673 HG22 ' CG2' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -150.94 -176.97 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.72 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.754 ' HD2' HD22 ' A' ' 32' ' ' LEU . 25.7 mmt180 -111.89 79.8 1.25 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.793 -1.192 . . . . 0.0 110.026 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.77 HD13 HG22 ' A' ' 13' ' ' VAL . 0.5 OUTLIER -62.18 94.74 0.06 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.226 -0.921 . . . . 0.0 109.172 179.456 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 50' ' ' PHE . . . . . 1.073 ' CE1' HD11 ' A' ' 32' ' ' LEU . 1.6 m-30 -80.22 130.47 35.24 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.762 HG22 ' O ' ' A' ' 32' ' ' LEU . 4.4 m -113.52 -176.46 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.593 -1.317 . . . . 0.0 110.741 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.498 ' OD2' ' HB3' ' B' ' 56' ' ' ASN . 1.4 p-10 -116.24 -151.07 0.47 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.463 -0.773 . . . . 0.0 109.93 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.498 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 0.9 OUTLIER -70.88 -51.06 28.64 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.407 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.481 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 1.5 tp -100.07 44.6 1.01 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.469 -0.769 . . . . 0.0 109.186 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 55' ' ' ASP . . . . . 0.424 ' CG ' ' C ' ' B' ' 54' ' ' LEU . 0.0 OUTLIER 44.39 67.35 0.7 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.302 -0.874 . . . . 0.0 110.029 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 56' ' ' ASN . . . . . 0.573 ' O ' ' N ' ' B' ' 58' ' ' ALA . 11.7 t30 -127.4 92.53 3.52 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.793 HG21 HD21 ' A' ' 8' ' ' LEU . 13.6 mt -30.06 86.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-O 121.54 0.686 . . . . 0.0 111.157 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.11 -27.38 21.96 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 59' ' ' GLN . . . . . 0.525 ' HB3' ' HB2' ' B' ' 50' ' ' PHE . 32.5 tp60 -113.83 130.76 56.43 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.657 ' CG2' HG22 ' A' ' 9' ' ' VAL . 91.2 t -87.29 134.46 36.38 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 120.979 -1.075 . . . . 0.0 110.859 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.46 ' O ' ' HD3' ' B' ' 62' ' ' ARG . 36.8 Cg_endo -79.76 169.45 18.15 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.558 2.172 . . . . 0.0 109.148 178.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 62' ' ' ARG . . . . . 0.523 ' O ' ' CG1' ' B' ' 47' ' ' VAL . 0.2 OUTLIER -150.18 135.05 17.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.976 -1.078 . . . . 0.0 110.06 -179.801 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.673 ' CG2' HG22 ' B' ' 47' ' ' VAL . 2.3 t -109.12 150.26 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.328 -0.858 . . . . 0.0 109.316 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.911 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.491 ' HA ' ' HG2' ' A' ' 24' ' ' LYS . 7.1 ptt? . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.266 0.555 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.509 ' HB3' ' HB2' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -86.11 82.61 8.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.212 -0.93 . . . . 0.0 109.739 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.778 HG22 ' CD ' ' A' ' 24' ' ' LYS . 18.6 p -88.66 -12.79 41.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.172 -0.955 . . . . 0.0 109.053 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.526 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 0.6 OUTLIER -110.32 169.6 8.63 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.277 -0.89 . . . . 0.0 108.824 179.244 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.673 ' O ' HG21 ' B' ' 60' ' ' VAL . 15.1 m-90 -150.1 45.05 0.34 Allowed Pre-proline 0 C--N 1.294 -1.826 0 O-C-N 121.57 -0.706 . . . . 0.0 109.26 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 31.2 Cg_endo -69.12 -31.19 23.89 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 N-CA-C 108.232 -1.488 . . . . 0.0 108.232 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -69.66 -19.61 63.6 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 177.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.69 HD12 ' CB ' ' A' ' 11' ' ' LYS . 14.8 tp -84.29 -9.08 58.78 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.493 0.663 . . . . 0.0 109.247 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.479 HG23 HG21 ' B' ' 60' ' ' VAL . 10.4 t -55.69 152.39 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 119.086 -1.045 . . . . 0.0 108.873 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.87 4.16 25.67 Favored Glycine 0 N--CA 1.48 1.61 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.229 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.69 ' CB ' HD12 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -95.76 -143.5 0.27 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.875 -1.368 . . . . 0.0 109.276 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.493 ' CB ' ' OE2' ' A' ' 14' ' ' GLU . 2.2 m -145.02 168.12 21.03 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.068 -1.02 . . . . 0.0 110.192 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.604 HG22 HD11 ' B' ' 49' ' ' LEU . 48.5 t -51.3 -38.6 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.571 -0.706 . . . . 0.0 109.875 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.55 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -42.52 -75.75 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.153 -179.615 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.34 -33.34 65.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.34 -0.85 . . . . 0.0 109.682 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 1.042 ' HB2' HD11 ' B' ' 57' ' ' ILE . . . -62.18 -85.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.404 -0.81 . . . . 0.0 110.439 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.527 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -46.75 -31.89 3.27 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.044 -1.035 . . . . 0.0 108.827 -179.331 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.55 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 5.3 tttp -56.41 -83.35 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.425 0 CA-C-O 121.323 0.582 . . . . 0.0 110.549 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 20' ' ' ILE . 2.4 t -62.53 -48.68 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.507 -0.746 . . . . 0.0 109.842 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.775 HG21 ' HB ' ' A' ' 29' ' ' ILE . 88.9 mt -43.83 -45.17 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.23 -0.919 . . . . 0.0 109.538 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.511 HD23 ' HB2' ' A' ' 22' ' ' GLN . 0.9 OUTLIER -49.26 -44.59 43.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.252 -0.905 . . . . 0.0 111.239 -179.247 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.511 ' HB2' HD23 ' A' ' 21' ' ' LEU . 4.0 mt-30 -137.03 41.17 2.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.693 -1.254 . . . . 0.0 111.413 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.509 ' HB2' ' HB3' ' A' ' 2' ' ' LYS . 1.3 p-10 -67.89 -49.46 61.88 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.778 ' CD ' HG22 ' A' ' 3' ' ' THR . 1.0 OUTLIER -94.6 -116.05 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.476 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.314 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.722 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 37.2 Cg_endo -80.79 -66.47 0.02 OUTLIER 'Trans proline' 0 C--O 1.215 -0.664 0 CA-C-N 122.327 1.867 . . . . 0.0 108.035 178.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 18.8 mt-10 -161.29 60.45 0.28 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.611 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -88.25 116.71 26.65 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.034 -1.041 . . . . 0.0 108.197 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.459 ' O ' ' HA ' ' B' ' 46' ' ' ARG . 3.7 tt0 -88.24 176.49 7.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.066 -1.021 . . . . 0.0 110.105 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.775 ' HB ' HG21 ' A' ' 20' ' ' ILE . 19.1 tt -143.66 149.79 17.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 O-C-N 121.183 -0.948 . . . . 0.0 110.67 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.826 HG21 HD11 ' A' ' 37' ' ' ILE . 4.1 mm -97.66 146.44 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.8 HG12 HD12 ' B' ' 49' ' ' LEU . 0.0 OUTLIER -110.51 134.33 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.565 -1.334 . . . . 0.0 110.269 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.111 HD11 ' CE1' ' B' ' 50' ' ' PHE . 0.6 OUTLIER -152.67 165.72 16.94 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.756 -0.59 . . . . 0.0 109.509 -179.716 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.693 ' C ' HG23 ' A' ' 34' ' ' VAL . 38.3 Cg_endo -80.66 24.38 0.67 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.495 2.13 . . . . 0.0 110.804 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.693 HG23 ' C ' ' A' ' 33' ' ' PRO . 2.8 t 81.34 -71.72 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.416 -0.803 . . . . 0.0 109.147 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 34' ' ' VAL . . . -48.23 -104.52 0.01 OUTLIER Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.47 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 0.3 OUTLIER -77.17 160.93 28.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.141 -1.211 . . . . 0.0 109.394 -179.649 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.826 HD11 HG21 ' A' ' 30' ' ' ILE . 9.6 tt -112.91 -39.69 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 0.0 109.409 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.826 HG13 HG23 ' A' ' 37' ' ' ILE . 26.0 m -103.52 -22.33 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.287 -0.883 . . . . 0.0 109.553 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.476 ' CG2' ' O ' ' A' ' 38' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.823 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' B' ' 42' ' ' TYR . 6.8 mt-10 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' TYR . . . . . 0.645 ' CE2' ' HA ' ' B' ' 44' ' ' ILE . 4.0 t80 61.8 157.22 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.087 -1.008 . . . . 0.0 108.856 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.56 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER -96.38 70.45 2.69 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.188 -0.945 . . . . 0.0 110.99 -178.576 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.645 ' HA ' ' CE2' ' B' ' 42' ' ' TYR . 0.3 OUTLIER -50.69 139.92 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 120.274 -1.517 . . . . 0.0 107.438 178.351 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.611 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 2.8 p30 -95.35 45.75 1.1 Allowed 'General case' 0 C--N 1.294 -1.848 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.281 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' ARG . . . . . 0.541 ' HG2' ' N ' ' B' ' 47' ' ' VAL . 6.0 ttt180 -149.26 156.39 42.05 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.484 -0.76 . . . . 0.0 109.175 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.6 HG22 ' CG2' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -151.75 -173.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.612 ' HD2' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -112.15 69.05 0.68 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.868 -1.145 . . . . 0.0 111.212 -179.187 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.8 HD12 HG12 ' A' ' 31' ' ' VAL . 1.9 tm? -56.49 94.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.005 -1.059 . . . . 0.0 108.253 178.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 50' ' ' PHE . . . . . 1.111 ' CE1' HD11 ' A' ' 32' ' ' LEU . 8.2 m-30 -86.25 143.78 27.76 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.807 HG22 ' O ' ' A' ' 32' ' ' LEU . 15.3 m -122.4 -175.28 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.844 -1.16 . . . . 0.0 109.578 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.499 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.4 OUTLIER -126.91 -154.76 0.65 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.408 -0.808 . . . . 0.0 109.868 -179.69 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.499 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 8.7 mttt -63.45 -54.79 31.06 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.457 0.646 . . . . 0.0 109.262 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.504 HD13 ' HA ' ' B' ' 54' ' ' LEU . 2.9 mm? -98.48 44.07 1.04 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.534 -0.729 . . . . 0.0 109.806 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 55' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' B' ' 55' ' ' ASP . 0.0 OUTLIER 48.32 64.17 1.77 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.248 -0.908 . . . . 0.0 109.65 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 56' ' ' ASN . . . . . 0.536 ' O ' ' N ' ' B' ' 58' ' ' ALA . 0.1 OUTLIER -124.77 98.74 5.84 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.434 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 1.042 HD11 ' HB2' ' A' ' 16' ' ' ALA . 32.1 mt -44.27 91.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 121.491 0.663 . . . . 0.0 109.822 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.3 -20.33 25.56 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -128.23 104.17 7.59 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.673 HG21 ' O ' ' A' ' 5' ' ' TRP . 5.0 t -73.69 134.93 78.39 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.226 -0.921 . . . . 0.0 110.397 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.714 ' HG3' HD11 ' A' ' 29' ' ' ILE . 37.7 Cg_endo -84.04 -175.55 2.27 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 122.735 2.29 . . . . 0.0 109.677 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 62' ' ' ARG . . . . . 0.406 ' O ' ' CG1' ' B' ' 47' ' ' VAL . 0.1 OUTLIER -151.09 144.48 24.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.053 -1.029 . . . . 0.0 110.045 179.599 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.6 ' CG2' HG22 ' B' ' 47' ' ' VAL . 1.6 t -110.85 -26.28 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 64' ' ' GLY . . . . . 0.46 ' N ' ' HB ' ' A' ' 3' ' ' THR . . . . . . . . 0 N--CA 1.489 2.19 0 CA-C-O 118.008 -1.44 . . . . 0.0 109.515 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 mmt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.568 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -67.14 99.14 0.65 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.036 -1.04 . . . . 0.0 109.584 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . 1.025 HG22 ' CD ' ' A' ' 24' ' ' LYS . 21.0 p -140.98 -41.12 0.39 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.92 . . . . 0.0 108.53 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.599 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -90.31 -35.93 14.97 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.547 -0.721 . . . . 0.0 109.824 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.995 ' O ' HD12 ' A' ' 8' ' ' LEU . 5.5 m-90 58.49 41.54 0.66 Allowed Pre-proline 0 C--N 1.296 -1.737 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.467 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.636 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 33.7 Cg_endo -72.94 -34.05 6.99 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 N-CA-C 107.119 -1.916 . . . . 0.0 107.119 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -69.44 -9.72 54.87 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.336 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.048 ' O ' HD22 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -80.16 -8.42 59.41 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 121.299 -0.875 . . . . 0.0 109.106 -179.47 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.906 ' N ' HD13 ' A' ' 8' ' ' LEU . 35.4 t -48.66 149.84 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 120.882 -1.136 . . . . 0.0 110.437 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.98 2.31 23.57 Favored Glycine 0 N--CA 1.484 1.888 0 C-N-CA 120.142 -1.028 . . . . 0.0 111.138 177.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -93.41 -149.44 0.27 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.745 -1.444 . . . . 0.0 109.601 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.61 164.39 29.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.109 -0.994 . . . . 0.0 110.325 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.726 HG21 HG21 ' A' ' 31' ' ' VAL . 48.1 t -52.23 -34.93 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.461 -0.775 . . . . 0.0 109.062 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.542 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -44.36 -66.56 0.37 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.307 -0.871 . . . . 0.0 109.095 179.787 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.43 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -62.76 -34.04 76.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.093 -1.004 . . . . 0.0 109.303 179.297 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.729 ' HB1' HD12 ' A' ' 20' ' ' ILE . . . -62.11 -82.85 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.125 -0.985 . . . . 0.0 109.604 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.533 ' HG2' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -44.02 -42.07 5.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.951 -1.093 . . . . 0.0 108.905 179.813 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -47.48 -78.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.588 0.708 . . . . 0.0 110.339 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.458 ' O ' ' OD1' ' A' ' 23' ' ' ASP . 1.6 t -71.14 -55.27 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.7 -0.625 . . . . 0.0 110.116 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.882 HD13 HD13 ' A' ' 29' ' ' ILE . 95.3 mt -39.53 -34.82 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.524 -0.735 . . . . 0.0 109.872 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.1 tp -48.12 -52.22 21.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.367 -0.833 . . . . 0.0 110.759 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.578 ' O ' ' N ' ' A' ' 24' ' ' LYS . 0.8 OUTLIER -112.32 -66.88 1.04 Allowed 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.672 -1.211 . . . . 0.0 111.492 -178.373 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.559 ' CB ' ' HB3' ' A' ' 2' ' ' LYS . 0.4 OUTLIER 38.78 -92.81 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.41 -0.806 . . . . 0.0 108.875 -179.022 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 1.025 ' CD ' HG22 ' A' ' 3' ' ' THR . 2.8 mtpm? -64.27 -131.72 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.422 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 177.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.728 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 32.5 Cg_endo -74.67 -64.41 0.03 OUTLIER 'Trans proline' 0 C--O 1.215 -0.662 0 CA-C-N 122.084 1.78 . . . . 0.0 108.825 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 9.7 mt-10 -162.17 70.49 0.31 Allowed 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.605 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -88.85 117.47 27.87 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.522 ' CB ' ' O ' ' B' ' 45' ' ' ASP . 1.1 tt0 -87.2 173.55 9.15 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.951 -1.093 . . . . 0.0 109.249 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.882 HD13 HD13 ' A' ' 20' ' ' ILE . 5.4 tt -150.06 128.58 2.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 C-N-CA 118.999 -1.08 . . . . 0.0 110.741 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.636 HG22 HD22 ' A' ' 32' ' ' LEU . 2.9 mm -88.74 141.67 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.726 HG21 HG21 ' A' ' 13' ' ' VAL . 11.8 p -113.94 131.29 66.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 120.84 -1.163 . . . . 0.0 110.217 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.945 ' N ' HD23 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -143.21 161.98 45.19 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.489 -0.757 . . . . 0.0 109.381 179.444 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.498 ' HD2' ' HB2' ' A' ' 32' ' ' LEU . 36.1 Cg_endo -76.79 142.97 23.14 Favored 'Trans proline' 0 C--N 1.301 -1.936 0 C-N-CA 121.946 1.764 . . . . 0.0 108.528 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.838 HG13 ' O ' ' B' ' 51' ' ' VAL . 17.3 m -67.45 -1.44 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.087 -1.008 . . . . 0.0 110.573 -178.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 34' ' ' VAL . . . -57.11 -157.02 0.01 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -44.74 147.81 0.59 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.091 -1.24 . . . . 0.0 109.94 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.543 HG22 HG23 ' A' ' 38' ' ' VAL . 2.8 mp -117.03 -87.49 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.331 -0.856 . . . . 0.0 109.634 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.543 HG23 HG22 ' A' ' 37' ' ' ILE . 3.7 t -94.12 -52.55 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.065 -1.022 . . . . 0.0 109.612 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.409 ' O ' ' OG1' ' A' ' 39' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.565 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.541 0.686 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 42' ' ' TYR . . . . . 0.496 ' CD1' ' N ' ' B' ' 42' ' ' TYR . 0.0 OUTLIER -71.18 -110.14 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.519 -0.738 . . . . 0.0 109.552 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.542 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 2.5 ptt180 -113.7 44.87 1.53 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.715 -1.241 . . . . 0.0 109.124 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.532 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.4 OUTLIER -43.03 141.93 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 119.148 -1.021 . . . . 0.0 108.567 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.605 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.6 p-10 -102.51 47.01 0.9 Allowed 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 119.188 -1.005 . . . . 0.0 109.819 -178.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' ARG . . . . . 0.406 ' C ' HG23 ' B' ' 47' ' ' VAL . 3.9 ttm180 -151.9 148.13 27.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.383 -0.823 . . . . 0.0 110.119 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 1.052 ' CG2' HG23 ' B' ' 63' ' ' VAL . 53.7 t -151.41 154.83 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.643 HH11 HD13 ' A' ' 32' ' ' LEU . 10.5 mmt180 -88.06 66.7 8.68 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.601 -1.312 . . . . 0.0 110.372 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 1.065 HD11 HD12 ' B' ' 57' ' ' ILE . 2.5 tp -60.79 90.11 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.089 -1.007 . . . . 0.0 109.383 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 50' ' ' PHE . . . . . 0.778 ' HE1' HD11 ' A' ' 32' ' ' LEU . 3.8 m-30 -76.26 156.06 33.83 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.838 ' O ' HG13 ' A' ' 34' ' ' VAL . 1.8 m -121.31 176.73 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.73 -1.232 . . . . 0.0 109.68 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.492 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.4 OUTLIER -109.22 -154.95 0.55 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.252 -0.905 . . . . 0.0 109.774 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.646 ' HB2' HD22 ' B' ' 54' ' ' LEU . 2.7 mtpt -67.8 -53.97 22.86 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.536 -0.728 . . . . 0.0 109.465 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.763 HD22 ' N ' ' B' ' 54' ' ' LEU . 3.2 mm? -95.88 42.9 1.09 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 109.567 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 55' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' B' ' 55' ' ' ASP . 0.0 OUTLIER 48.14 65.01 1.43 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.156 -0.965 . . . . 0.0 109.28 -179.727 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 56' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' B' ' 58' ' ' ALA . 8.9 t30 -130.01 106.68 8.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.385 -0.822 . . . . 0.0 108.846 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 1.065 HD12 HD11 ' B' ' 49' ' ' LEU . 15.6 mm -39.61 90.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-O 121.646 0.736 . . . . 0.0 110.68 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.09 -27.12 22.15 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -111.79 136.15 51.45 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.626 HG23 HG22 ' A' ' 9' ' ' VAL . 43.1 t -90.01 127.93 51.81 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.837 -1.165 . . . . 0.0 110.609 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.877 ' HB2' HG11 ' B' ' 47' ' ' VAL . 36.5 Cg_endo -79.72 157.04 24.55 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.378 2.052 . . . . 0.0 109.215 177.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 62' ' ' ARG . . . . . 0.561 ' HD2' ' CA ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -146.12 142.98 29.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.838 -1.164 . . . . 0.0 110.588 -179.396 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 1.052 HG23 ' CG2' ' B' ' 47' ' ' VAL . 0.9 OUTLIER -129.05 114.1 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.446 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.379 0 CA-C-O 117.869 -1.517 . . . . 0.0 109.579 -179.886 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.581 ' N ' ' HG2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -80.85 90.89 5.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.64 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.642 HG23 ' HE3' ' A' ' 24' ' ' LYS . 0.9 OUTLIER -89.4 -46.53 8.66 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.109 -0.994 . . . . 0.0 108.782 179.544 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.575 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 2.6 mp0 -89.78 167.43 12.87 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.349 -0.844 . . . . 0.0 109.361 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.62 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 20.9 m-90 -141.09 46.0 0.82 Allowed Pre-proline 0 C--N 1.294 -1.836 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 31.2 Cg_endo -69.6 -27.32 27.36 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 N-CA-C 108.21 -1.496 . . . . 0.0 108.21 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -69.66 -20.03 63.59 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.896 HD21 HG21 ' B' ' 57' ' ' ILE . 0.0 OUTLIER -82.27 -8.66 59.64 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.82 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.63 ' CG2' ' CG2' ' B' ' 60' ' ' VAL . 20.6 t -48.81 154.14 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.095 -1.003 . . . . 0.0 110.004 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.425 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . 65.71 2.43 11.59 Favored Glycine 0 N--CA 1.482 1.717 0 C-N-CA 120.252 -0.975 . . . . 0.0 110.883 178.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -93.69 -143.7 0.23 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.709 -1.465 . . . . 0.0 109.393 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.458 ' HB3' ' CD ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -144.46 167.52 22.29 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.964 -1.085 . . . . 0.0 110.121 -179.701 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.587 HG22 HD21 ' B' ' 49' ' ' LEU . 71.6 t -50.82 -40.96 20.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.531 -0.731 . . . . 0.0 109.796 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.544 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -44.68 -69.02 0.15 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.502 -0.749 . . . . 0.0 109.352 -179.763 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.596 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -58.07 -31.13 66.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.176 -0.952 . . . . 0.0 109.415 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.867 ' HB2' HD11 ' B' ' 57' ' ' ILE . . . -64.9 -84.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.045 -1.034 . . . . 0.0 109.954 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -45.2 -34.89 2.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.986 -1.071 . . . . 0.0 109.086 -179.556 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.544 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 20.5 tttp -55.02 -75.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.508 0.671 . . . . 0.0 111.334 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 15' ' ' GLU . 1.5 t -70.28 -46.1 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.486 -0.759 . . . . 0.0 110.968 -177.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.795 HG21 ' HB ' ' A' ' 29' ' ' ILE . 2.6 mt -53.28 -50.55 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.02 -1.05 . . . . 0.0 109.871 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 28' ' ' GLN . 2.3 tt -39.4 -28.08 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.265 -0.897 . . . . 0.0 110.642 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.475 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -149.9 26.82 0.8 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.875 -1.14 . . . . 0.0 110.675 -179.714 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.55 ' OD2' HG12 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -54.49 -64.15 0.92 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.731 -1.23 . . . . 0.0 108.194 179.182 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.748 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 3.5 mtpm? -80.47 -117.58 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 106.841 -1.541 . . . . 0.0 106.841 178.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.748 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 36.7 Cg_endo -79.92 -64.2 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.69 0 CA-C-N 122.103 1.787 . . . . 0.0 108.612 178.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 27.2 mt-10 -159.97 60.97 0.36 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.603 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -88.53 117.31 27.39 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.185 -1.006 . . . . 0.0 108.61 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 1.7 tt0 -88.6 169.78 11.41 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.199 -0.938 . . . . 0.0 109.965 -178.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.795 ' HB ' HG21 ' A' ' 20' ' ' ILE . 19.8 tt -140.6 135.14 34.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.51 -0.743 . . . . 0.0 109.52 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.694 HD13 ' CG ' ' B' ' 46' ' ' ARG . 1.2 mp -88.76 128.57 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 1.043 HG22 HD23 ' B' ' 49' ' ' LEU . 25.3 t -94.72 136.3 26.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 118.518 -1.273 . . . . 0.0 110.487 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.07 HD11 ' CE1' ' B' ' 50' ' ' PHE . 0.8 OUTLIER -147.31 156.66 46.18 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.689 -0.632 . . . . 0.0 109.347 179.764 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.566 ' O ' HG23 ' A' ' 34' ' ' VAL . 37.9 Cg_endo -81.71 60.63 7.67 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.779 2.32 . . . . 0.0 109.3 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 33' ' ' PRO . 0.1 OUTLIER 45.75 -90.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.532 -0.73 . . . . 0.0 109.442 -179.055 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . 42.36 -151.59 0.27 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.31 -148.02 0.27 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.214 -1.168 . . . . 0.0 109.174 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.68 HG23 ' H ' ' A' ' 39' ' ' THR . 0.9 OUTLIER -59.76 -172.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.15 -0.969 . . . . 0.0 109.117 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.529 ' O ' HG22 ' A' ' 39' ' ' THR . 7.3 p -42.54 -38.85 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.092 -1.005 . . . . 0.0 109.746 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.68 ' H ' HG23 ' A' ' 37' ' ' ILE . 9.0 t . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 118.085 -0.959 . . . . 0.0 109.745 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 42' ' ' TYR . . . . . 0.62 ' CE2' ' HA ' ' B' ' 44' ' ' ILE . 10.4 p90 -127.51 -162.58 1.18 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.917 . . . . 0.0 109.337 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.512 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 5.6 ptt180 -92.98 64.46 3.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.027 -1.046 . . . . 0.0 109.907 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.62 ' HA ' ' CE2' ' B' ' 42' ' ' TYR . 0.5 OUTLIER -45.82 146.22 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.946 -1.096 . . . . 0.0 108.73 179.585 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.603 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -110.86 40.91 1.91 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.391 -0.924 . . . . 0.0 109.953 -179.74 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 46' ' ' ARG . . . . . 0.694 ' CG ' HD13 ' A' ' 30' ' ' ILE . 0.2 OUTLIER -150.23 144.56 25.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.42 -0.8 . . . . 0.0 108.994 179.192 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.55 ' CG2' HG23 ' B' ' 63' ' ' VAL . 0.0 OUTLIER -151.16 164.77 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.087 -1.008 . . . . 0.0 108.857 -179.747 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.614 ' HG3' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -91.9 89.42 7.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.745 -1.222 . . . . 0.0 110.46 -179.241 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 1.043 HD23 HG22 ' A' ' 31' ' ' VAL . 4.0 tp -78.87 91.32 4.76 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 50' ' ' PHE . . . . . 1.07 ' CE1' HD11 ' A' ' 32' ' ' LEU . 4.1 m-30 -77.54 179.74 6.34 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -148.01 -173.58 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.865 -1.147 . . . . 0.0 109.515 179.514 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.54 ' OD2' ' CB ' ' B' ' 56' ' ' ASN . 5.5 p-10 -116.7 -146.43 0.4 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.316 -0.865 . . . . 0.0 109.253 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.531 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 8.7 mmtp -62.28 -55.62 26.54 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.241 -0.912 . . . . 0.0 110.131 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.551 ' O ' ' CB ' ' B' ' 55' ' ' ASP . 2.4 mp -103.28 17.02 25.04 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.997 -1.065 . . . . 0.0 111.687 -178.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 55' ' ' ASP . . . . . 0.552 ' HA ' ' CG1' ' B' ' 51' ' ' VAL . 0.2 OUTLIER 91.43 47.87 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.459 0 CA-C-O 122.583 1.182 . . . . 0.0 110.623 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 56' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' B' ' 58' ' ' ALA . 1.9 t-20 -106.56 97.36 7.16 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.97 -1.081 . . . . 0.0 108.3 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.896 HG21 HD21 ' A' ' 8' ' ' LEU . 43.8 mt -37.28 88.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 121.549 0.69 . . . . 0.0 110.914 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.95 -31.26 18.25 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -99.69 134.94 41.85 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.63 ' CG2' ' CG2' ' A' ' 9' ' ' VAL . 65.1 t -90.12 129.44 45.85 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.092 -1.005 . . . . 0.0 111.21 -178.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.413 ' O ' ' CD ' ' B' ' 62' ' ' ARG . 36.3 Cg_endo -81.84 162.53 18.56 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.308 2.005 . . . . 0.0 108.928 177.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 62' ' ' ARG . . . . . 0.534 ' O ' ' CG1' ' B' ' 47' ' ' VAL . 0.0 OUTLIER -150.91 132.62 14.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.659 -1.275 . . . . 0.0 110.711 -179.69 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.598 HG21 ' HB1' ' A' ' 27' ' ' ALA . 2.2 t -109.63 130.51 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.468 -0.77 . . . . 0.0 109.044 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.381 0 CA-C-O 117.952 -1.471 . . . . 0.0 109.717 179.74 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpp? . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.622 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -90.94 34.64 0.91 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.162 -0.961 . . . . 0.0 110.083 -179.845 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.788 HG22 ' HD2' ' A' ' 24' ' ' LYS . 16.1 p -88.48 -20.45 25.13 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.572 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 9.8 mp0 -104.15 -28.98 11.14 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.547 0.689 . . . . 0.0 109.151 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.637 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 8.7 m-90 53.12 42.22 1.15 Allowed Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 119.507 -0.877 . . . . 0.0 108.946 -177.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.637 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 35.1 Cg_endo -73.0 -34.83 5.96 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 N-CA-C 107.447 -1.79 . . . . 0.0 107.447 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.73 -12.0 61.29 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.557 ' HG ' HD12 ' B' ' 57' ' ' ILE . 32.1 tp -81.21 -6.0 58.37 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 121.49 -0.756 . . . . 0.0 109.31 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.594 HG23 HG21 ' B' ' 60' ' ' VAL . 21.0 t -54.37 152.48 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 120.942 -1.099 . . . . 0.0 109.034 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.11 7.14 22.78 Favored Glycine 0 N--CA 1.48 1.601 0 C-N-CA 119.94 -1.124 . . . . 0.0 110.44 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.501 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 5.2 tptt -93.92 -141.26 0.23 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.825 -1.397 . . . . 0.0 109.441 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.545 ' CA ' HG13 ' B' ' 57' ' ' ILE . 48.4 m -149.89 167.17 27.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.939 -1.101 . . . . 0.0 110.454 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.619 ' CG2' HG11 ' B' ' 51' ' ' VAL . 97.1 t -50.35 -34.05 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.49 -0.756 . . . . 0.0 109.814 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.524 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 27.1 mt-10 -45.87 -77.94 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.384 -0.822 . . . . 0.0 109.065 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.407 ' CD ' ' HE2' ' A' ' 11' ' ' LYS . 0.6 OUTLIER -55.69 -31.28 62.3 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.333 -0.854 . . . . 0.0 109.388 179.802 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.722 ' HB2' HD11 ' B' ' 57' ' ' ILE . . . -62.02 -85.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.44 -0.788 . . . . 0.0 110.616 -179.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.491 ' HG2' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -48.26 -29.81 4.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.634 -1.291 . . . . 0.0 108.994 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -57.6 -82.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.413 0.625 . . . . 0.0 111.116 -179.445 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -64.8 -40.21 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.369 -0.832 . . . . 0.0 110.315 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.8 HG21 ' HB ' ' A' ' 29' ' ' ILE . 98.5 mt -51.8 -56.17 6.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.336 -0.852 . . . . 0.0 109.82 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.462 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 0.4 OUTLIER -36.88 -29.76 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.51 -0.743 . . . . 0.0 110.593 -179.521 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 20' ' ' ILE . 2.2 mt-30 -148.74 52.53 0.99 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.023 -1.048 . . . . 0.0 109.855 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.516 ' OD2' ' HA ' ' A' ' 3' ' ' THR . 3.8 t0 -53.32 -62.81 1.41 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.985 -1.072 . . . . 0.0 108.409 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.845 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -115.98 -66.8 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 120.748 -1.22 . . . . 0.0 109.201 178.537 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.845 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 42.2 Cg_endo -91.25 -82.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.324 -0.748 0 N-CA-C 108.135 -1.525 . . . . 0.0 108.135 178.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 16.9 mt-10 -161.45 65.46 0.27 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.926 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -87.7 115.32 25.06 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.246 -0.982 . . . . 0.0 108.843 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.453 ' CB ' ' O ' ' B' ' 45' ' ' ASP . 1.8 tt0 -87.92 170.27 11.3 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.233 -0.917 . . . . 0.0 108.774 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.8 ' HB ' HG21 ' A' ' 20' ' ' ILE . 12.9 tt -142.3 133.17 24.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 118.719 -1.192 . . . . 0.0 110.576 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.44 HD13 ' HA ' ' A' ' 30' ' ' ILE . 12.1 mm -87.68 107.09 16.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.541 ' HA ' ' HB3' ' B' ' 49' ' ' LEU . 19.5 t -89.0 146.88 5.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.108 -0.995 . . . . 0.0 110.88 -178.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.063 HD11 ' CE1' ' B' ' 50' ' ' PHE . 0.8 OUTLIER -150.33 164.91 18.8 Favored Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.634 ' HA ' HG23 ' B' ' 51' ' ' VAL . 36.4 Cg_endo -77.93 25.18 0.51 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.408 2.072 . . . . 0.0 111.558 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.796 HG23 ' HB3' ' B' ' 50' ' ' PHE . 0.4 OUTLIER 79.72 -11.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.095 -1.003 . . . . 0.0 110.087 179.446 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 36' ' ' THR . . . -55.52 -177.99 0.24 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 35' ' ' GLY . 18.4 p -45.91 169.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -1.162 . . . . 0.0 109.234 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 pp -86.44 -8.36 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.207 -0.933 . . . . 0.0 109.438 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 38' ' ' VAL . 14.2 m -91.05 113.9 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.221 -0.924 . . . . 0.0 109.32 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.541 ' OXT' HG22 ' A' ' 39' ' ' THR . 10.3 m . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.532 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.187 0.518 . . . . 0.0 109.641 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 42' ' ' TYR . . . . . 0.443 ' O ' ' HA2' ' B' ' 64' ' ' GLY . 27.4 p90 -111.16 -147.4 0.42 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.187 -0.946 . . . . 0.0 109.461 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.527 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER -107.03 55.91 0.65 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.869 -1.144 . . . . 0.0 110.363 -179.151 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.521 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.3 OUTLIER -46.06 139.56 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.648 -1.283 . . . . 0.0 108.356 179.504 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.567 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -99.4 44.86 1.01 Allowed 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.202 -0.936 . . . . 0.0 109.8 -178.932 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 46' ' ' ARG . . . . . 0.431 ' C ' HG23 ' B' ' 47' ' ' VAL . 0.2 OUTLIER -149.65 145.59 26.82 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.401 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 1.149 ' CG2' HG23 ' B' ' 63' ' ' VAL . 60.9 t -151.8 169.35 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 109.779 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.605 ' N ' HG12 ' B' ' 47' ' ' VAL . 0.0 OUTLIER -99.12 95.26 6.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.726 -1.234 . . . . 0.0 109.849 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.653 HD11 ' CB ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -88.21 84.0 6.92 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.015 -1.053 . . . . 0.0 109.277 179.265 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 50' ' ' PHE . . . . . 1.063 ' CE1' HD11 ' A' ' 32' ' ' LEU . 4.4 m-30 -72.43 138.09 46.89 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.949 HG22 ' O ' ' A' ' 32' ' ' LEU . 2.6 m -123.6 -171.18 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.676 -1.265 . . . . 0.0 110.231 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.569 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.0 OUTLIER -129.72 -168.13 1.91 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.893 0.854 . . . . 0.0 110.006 -179.221 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.569 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 13.8 mttm -43.6 -68.95 0.15 Allowed 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.331 0.586 . . . . 0.0 110.071 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.404 ' CG ' ' O ' ' B' ' 54' ' ' LEU . 0.6 OUTLIER -89.96 47.2 1.43 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 0.0 109.742 -179.59 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 47.62 57.39 5.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.294 -0.879 . . . . 0.0 109.828 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 56' ' ' ASN . . . . . 0.549 ' O ' ' N ' ' B' ' 58' ' ' ALA . 7.0 t30 -106.42 96.42 6.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.139 -0.976 . . . . 0.0 109.055 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.722 HD11 ' HB2' ' A' ' 16' ' ' ALA . 12.2 mt -42.79 91.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 121.5 0.667 . . . . 0.0 109.681 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -87.77 -17.43 31.64 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -129.23 96.9 4.43 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.594 HG21 HG23 ' A' ' 9' ' ' VAL . 1.6 t -56.54 137.02 77.0 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.32 -0.862 . . . . 0.0 109.952 -178.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.799 ' HB2' HG11 ' B' ' 47' ' ' VAL . 36.2 Cg_endo -80.93 160.15 21.09 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.846 2.364 . . . . 0.0 110.22 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 62' ' ' ARG . . . . . 0.554 ' HD2' ' CB ' ' A' ' 4' ' ' GLU . 0.8 OUTLIER -141.96 134.44 28.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.137 -0.977 . . . . 0.0 109.622 179.798 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 1.149 HG23 ' CG2' ' B' ' 47' ' ' VAL . 1.0 OUTLIER -110.22 147.54 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.209 -0.932 . . . . 0.0 108.996 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 64' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' B' ' 42' ' ' TYR . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 mmt . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.511 ' O ' ' CE2' ' A' ' 5' ' ' TRP . 19.0 mmtm -90.01 43.22 1.13 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.161 -0.962 . . . . 0.0 109.786 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.644 HG23 ' CD ' ' A' ' 24' ' ' LYS . 0.2 OUTLIER -90.51 -16.3 29.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.152 -0.967 . . . . 0.0 109.406 179.816 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.607 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 13.7 mt-10 -100.09 -43.14 6.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.323 -0.861 . . . . 0.0 110.289 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.681 ' CE2' HG12 ' A' ' 20' ' ' ILE . 6.7 m-90 61.21 42.47 0.56 Allowed Pre-proline 0 C--N 1.296 -1.717 0 C-N-CA 119.441 -0.904 . . . . 0.0 109.488 -178.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.635 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 32.7 Cg_endo -72.45 -34.07 7.98 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 N-CA-C 106.925 -1.99 . . . . 0.0 106.925 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -69.34 -12.76 61.93 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.988 HD21 ' HB2' ' A' ' 16' ' ' ALA . 21.9 tp -76.62 -6.4 51.87 Favored 'General case' 0 C--N 1.31 -1.138 0 O-C-N 121.506 -0.746 . . . . 0.0 109.462 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.649 HG23 ' CG2' ' B' ' 60' ' ' VAL . 18.3 t -59.7 149.34 6.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 120.81 -1.181 . . . . 0.0 108.482 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.42 7.2 18.37 Favored Glycine 0 C--N 1.296 -1.642 0 C-N-CA 119.578 -1.296 . . . . 0.0 110.379 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.542 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -99.63 -154.71 0.48 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.818 -1.401 . . . . 0.0 108.869 179.558 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.445 ' C ' HD11 ' B' ' 57' ' ' ILE . 0.5 OUTLIER -135.48 160.93 36.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.689 -1.257 . . . . 0.0 110.888 -179.124 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.658 HG13 HD23 ' B' ' 49' ' ' LEU . 28.1 t -52.89 -33.08 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.585 -0.697 . . . . 0.0 109.219 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.549 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 52.7 mm-40 -46.28 -67.69 0.26 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.154 -0.966 . . . . 0.0 108.556 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.414 ' O ' HG23 ' A' ' 19' ' ' VAL . 2.5 tp10 -61.62 -30.89 70.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.4 -0.813 . . . . 0.0 109.501 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.988 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -67.54 -82.18 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.177 -0.952 . . . . 0.0 109.751 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -44.36 -40.39 5.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.672 -1.267 . . . . 0.0 108.972 179.64 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.549 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 20.8 tttm -49.92 -72.1 0.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.611 -0.681 . . . . 0.0 110.368 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.516 ' O ' ' N ' ' A' ' 23' ' ' ASP . 2.8 t -72.24 -57.62 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.523 -0.736 . . . . 0.0 109.972 -179.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.944 HG21 ' HB ' ' A' ' 29' ' ' ILE . 5.9 mt -35.93 -53.86 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.588 -0.695 . . . . 0.0 110.211 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.499 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 2.3 tt -37.56 -52.87 1.2 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.615 -0.678 . . . . 0.0 110.003 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.419 ' HG3' ' HA ' ' A' ' 26' ' ' GLU . 1.4 mt-30 -128.56 32.58 4.8 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 109.968 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' VAL . 17.4 p-10 -50.67 -48.88 58.28 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.019 -1.05 . . . . 0.0 108.28 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.708 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 10.4 mtpp -107.24 -106.62 0.0 OUTLIER Pre-proline 0 CA--C 1.561 1.374 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.708 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 37.0 Cg_endo -79.98 -67.74 0.02 OUTLIER 'Trans proline' 0 C--O 1.215 -0.657 0 CA-C-N 121.93 1.725 . . . . 0.0 108.631 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.528 ' CG ' ' O ' ' A' ' 25' ' ' PRO . 27.1 mt-10 -162.02 64.09 0.24 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.789 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -88.86 116.64 27.28 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.022 -1.049 . . . . 0.0 108.916 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.475 ' HG3' ' OD2' ' B' ' 45' ' ' ASP . 0.1 OUTLIER -88.86 165.65 14.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.899 -1.126 . . . . 0.0 109.166 -179.54 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.944 ' HB ' HG21 ' A' ' 20' ' ' ILE . 3.3 tt -139.84 131.99 34.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.158 -0.963 . . . . 0.0 110.276 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.5 mm -88.59 117.95 33.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.478 HG21 HG21 ' A' ' 13' ' ' VAL . 2.5 p -95.93 136.56 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.149 -0.969 . . . . 0.0 109.675 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.954 ' N ' HD23 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -143.06 149.58 49.55 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.237 -0.915 . . . . 0.0 109.562 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.568 ' HA ' ' CG2' ' B' ' 51' ' ' VAL . 37.7 Cg_endo -78.51 67.21 8.4 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.749 2.299 . . . . 0.0 111.197 -178.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.586 ' HA ' ' CD1' ' B' ' 50' ' ' PHE . 91.8 t 41.34 -96.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.455 -0.778 . . . . 0.0 109.094 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.612 ' O ' ' N ' ' A' ' 37' ' ' ILE . . . 40.51 95.22 0.01 OUTLIER Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.47 ' O ' ' C ' ' A' ' 37' ' ' ILE . 1.4 p -36.74 86.68 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.755 -0.85 . . . . 0.0 110.698 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.612 ' N ' ' O ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER 33.36 74.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.827 -0.545 . . . . 0.0 110.446 179.764 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.3 t -95.3 -68.11 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.164 -0.96 . . . . 0.0 109.216 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 39' ' ' THR . 6.7 m . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.425 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 41' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' B' ' 42' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 42' ' ' TYR . . . . . 0.594 ' OH ' HD12 ' B' ' 44' ' ' ILE . 21.7 p90 -57.32 -158.63 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.3 -0.875 . . . . 0.0 109.649 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.547 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER -108.45 81.25 1.44 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.008 -1.057 . . . . 0.0 110.688 -178.983 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.747 HG23 HG22 ' B' ' 63' ' ' VAL . 0.6 OUTLIER -49.22 145.55 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 120.574 -1.329 . . . . 0.0 108.208 178.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.609 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.3 p-10 -108.46 32.76 4.59 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.07 -1.019 . . . . 0.0 109.888 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 46' ' ' ARG . . . . . 0.41 ' C ' ' CG2' ' B' ' 47' ' ' VAL . 0.1 OUTLIER -150.57 143.63 24.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.436 -0.79 . . . . 0.0 109.007 179.349 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.869 ' CG2' HG23 ' B' ' 63' ' ' VAL . 1.8 t -149.44 166.43 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -0.908 . . . . 0.0 109.608 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.536 ' HG3' ' CE2' ' B' ' 50' ' ' PHE . 0.0 OUTLIER -95.5 75.56 3.3 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.742 -1.224 . . . . 0.0 110.21 -179.611 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.662 HD22 ' HB1' ' A' ' 16' ' ' ALA . 4.3 tp -76.72 92.97 3.59 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 118.818 -1.153 . . . . 0.0 108.282 178.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 50' ' ' PHE . . . . . 0.839 ' CZ ' HD11 ' A' ' 32' ' ' LEU . 17.8 m-85 -81.52 -177.02 6.34 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.568 ' CG2' ' HA ' ' A' ' 33' ' ' PRO . 6.1 m -144.28 -175.64 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.648 -1.283 . . . . 0.0 110.5 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.533 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.4 OUTLIER -120.0 -154.8 0.59 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.481 -0.762 . . . . 0.0 109.813 -179.616 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.533 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 11.4 mtpt -63.94 -56.78 12.72 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.565 -0.709 . . . . 0.0 109.332 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.64 ' O ' HD23 ' B' ' 54' ' ' LEU . 2.6 tt -97.12 41.87 1.1 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.395 -0.816 . . . . 0.0 109.461 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 55' ' ' ASP . . . . . 0.405 ' CG ' ' C ' ' B' ' 54' ' ' LEU . 0.0 OUTLIER 49.65 65.06 1.52 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.206 -0.934 . . . . 0.0 109.181 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 56' ' ' ASN . . . . . 0.553 ' O ' ' N ' ' B' ' 58' ' ' ALA . 17.4 t-20 -123.94 96.44 4.95 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.38 -0.825 . . . . 0.0 108.996 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.607 HD12 ' HG ' ' A' ' 8' ' ' LEU . 4.2 mt -37.45 89.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-O 121.576 0.703 . . . . 0.0 110.88 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.23 -21.56 24.45 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.67 133.79 53.67 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.649 ' CG2' HG23 ' A' ' 9' ' ' VAL . 99.4 t -90.09 128.11 50.94 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 120.999 -1.063 . . . . 0.0 110.59 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.533 ' HB2' HG11 ' B' ' 47' ' ' VAL . 37.2 Cg_endo -83.63 165.29 14.01 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.396 2.064 . . . . 0.0 109.43 178.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 62' ' ' ARG . . . . . 0.541 ' HG3' ' HA ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -148.86 141.15 24.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.168 -0.958 . . . . 0.0 109.749 179.559 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.869 HG23 ' CG2' ' B' ' 47' ' ' VAL . 0.9 OUTLIER -113.12 -18.37 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.261 -0.899 . . . . 0.0 109.084 -179.859 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.935 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.455 ' SD ' ' HB3' ' A' ' 24' ' ' LYS . 2.4 mmt . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.306 0.574 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.572 ' O ' ' CE2' ' A' ' 5' ' ' TRP . 4.1 mmtp -84.79 72.24 10.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.889 . . . . 0.0 109.562 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.537 HG22 ' CD ' ' A' ' 24' ' ' LYS . 70.7 p -88.99 -26.81 21.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 109.197 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.589 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 81.2 mt-10 -93.53 -35.46 12.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.336 -0.852 . . . . 0.0 109.958 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.627 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 6.5 m-90 58.34 40.79 0.58 Allowed Pre-proline 0 C--N 1.293 -1.879 0 O-C-N 120.836 -1.165 . . . . 0.0 109.863 -178.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.627 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 34.2 Cg_endo -73.32 -34.92 5.46 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 N-CA-C 107.08 -1.931 . . . . 0.0 107.08 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.9 -11.72 61.08 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 177.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.558 HD21 ' HA ' ' A' ' 16' ' ' ALA . 30.5 tp -79.1 -7.91 58.54 Favored 'General case' 0 C--N 1.309 -1.172 0 O-C-N 121.402 -0.811 . . . . 0.0 109.216 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.613 HG23 ' CG2' ' B' ' 60' ' ' VAL . 19.4 t -54.34 154.22 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 118.994 -1.082 . . . . 0.0 109.151 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.438 ' C ' ' OD1' ' B' ' 56' ' ' ASN . . . 70.37 -0.43 25.29 Favored Glycine 0 C--N 1.297 -1.623 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.629 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -96.16 -151.76 0.36 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.665 -1.491 . . . . 0.0 109.584 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.507 ' CB ' ' OE2' ' A' ' 14' ' ' GLU . 1.2 m -139.53 172.8 12.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.138 -0.976 . . . . 0.0 110.535 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.676 ' HA ' HD21 ' B' ' 49' ' ' LEU . 99.2 t -54.72 -37.95 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.586 -0.696 . . . . 0.0 109.916 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.507 ' OE2' ' CB ' ' A' ' 12' ' ' SER . 0.7 OUTLIER -44.05 -74.76 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -0.904 . . . . 0.0 108.855 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.26 -38.23 65.58 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.394 -0.816 . . . . 0.0 109.835 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.835 ' HB2' HD11 ' B' ' 57' ' ' ILE . . . -59.02 -83.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.237 -0.915 . . . . 0.0 110.308 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.572 ' HA ' HG22 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -46.62 -28.06 1.34 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.586 -1.321 . . . . 0.0 109.617 -179.596 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 10.2 mttt -63.35 -83.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.487 -0.758 . . . . 0.0 110.746 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.468 ' H ' HG23 ' A' ' 19' ' ' VAL . 2.1 t -57.61 -42.34 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.6 -0.688 . . . . 0.0 109.472 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.885 HG21 ' HB ' ' A' ' 29' ' ' ILE . 69.0 mt -50.64 -53.75 11.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.293 -0.879 . . . . 0.0 108.919 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.531 HD12 ' OE1' ' A' ' 28' ' ' GLN . 9.1 tt -34.98 -36.45 0.05 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.788 -0.57 . . . . 0.0 110.642 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 20' ' ' ILE . 3.3 mt-30 -147.36 41.4 1.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.113 -0.992 . . . . 0.0 110.241 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.547 ' OD1' ' HG2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -57.86 -44.85 86.86 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.969 -1.082 . . . . 0.0 108.441 179.598 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.837 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -120.71 -88.49 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.241 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.837 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 38.8 Cg_endo -84.07 -81.47 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.655 0 N-CA-C 108.214 -1.494 . . . . 0.0 108.214 177.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 13.9 mt-10 -158.79 57.83 0.43 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 1.035 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -87.67 117.03 26.21 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.178 -0.951 . . . . 0.0 109.303 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.531 ' OE1' HD12 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -88.58 -175.15 4.84 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.129 -0.982 . . . . 0.0 109.549 -179.358 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.885 ' HB ' HG21 ' A' ' 20' ' ' ILE . 14.6 tt -147.62 140.59 19.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.452 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.706 HG22 HD22 ' A' ' 32' ' ' LEU . 2.7 mm -87.51 146.55 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.81 ' C ' HD23 ' A' ' 32' ' ' LEU . 8.7 p -102.37 133.53 45.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 119.071 -1.051 . . . . 0.0 109.734 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.966 ' N ' HD23 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -145.68 149.25 39.42 Favored Pre-proline 0 N--CA 1.487 1.401 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.688 ' O ' HG12 ' A' ' 34' ' ' VAL . 36.8 Cg_endo -79.75 21.99 0.75 Allowed 'Trans proline' 0 C--N 1.302 -1.906 0 C-N-CA 122.229 1.953 . . . . 0.0 111.891 -179.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.688 HG12 ' O ' ' A' ' 33' ' ' PRO . 0.4 OUTLIER 78.52 -6.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.989 -1.069 . . . . 0.0 109.891 179.325 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -121.09 -31.74 1.15 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 37' ' ' ILE . 4.7 m -69.55 93.97 0.73 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.23 -1.159 . . . . 0.0 109.559 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.475 HG23 ' O ' ' A' ' 36' ' ' THR . 0.2 OUTLIER -157.77 24.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.244 -0.91 . . . . 0.0 109.478 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.3 t -127.82 111.81 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.259 -0.901 . . . . 0.0 109.452 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.482 179.885 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -118.65 -154.82 0.58 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.225 -0.922 . . . . 0.0 109.46 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.564 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER -122.72 76.94 1.39 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.105 -0.997 . . . . 0.0 109.78 -179.493 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.495 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.3 OUTLIER -48.16 139.37 2.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 120.646 -1.284 . . . . 0.0 108.189 179.334 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.593 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -97.12 45.64 1.04 Allowed 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.331 -179.281 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -150.93 143.28 24.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.403 -0.811 . . . . 0.0 109.133 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 1.097 HG23 HG23 ' B' ' 63' ' ' VAL . 53.5 t -151.0 146.38 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.209 -0.932 . . . . 0.0 110.092 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.509 ' HB3' HD11 ' A' ' 32' ' ' LEU . 7.0 mmt180 -71.81 98.24 1.94 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.625 -1.297 . . . . 0.0 110.443 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.846 ' N ' HD21 ' A' ' 32' ' ' LEU . 2.6 tp -84.79 88.37 7.38 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.131 -0.981 . . . . 0.0 108.842 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 50' ' ' PHE . . . . . 0.759 ' CE1' HD12 ' A' ' 32' ' ' LEU . 1.8 m-85 -70.13 178.66 2.68 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.672 HG21 ' HA ' ' A' ' 33' ' ' PRO . 6.3 m -139.82 -174.71 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.043 -1.035 . . . . 0.0 109.276 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.687 ' HB3' ' HB2' ' B' ' 58' ' ' ALA . 0.1 OUTLIER -135.94 -158.71 0.89 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.147 -0.97 . . . . 0.0 110.115 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.529 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 26.9 mtpt -43.66 -69.81 0.12 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.67 -0.644 . . . . 0.0 110.407 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.481 ' HA ' HD22 ' B' ' 54' ' ' LEU . 0.4 OUTLIER -97.23 52.81 1.15 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.274 -0.891 . . . . 0.0 110.106 -179.138 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 55' ' ' ASP . . . . . 0.43 ' HA ' ' HB ' ' B' ' 51' ' ' VAL . 0.0 OUTLIER 47.38 58.1 5.22 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.251 -0.906 . . . . 0.0 109.183 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 56' ' ' ASN . . . . . 0.565 ' O ' ' N ' ' B' ' 58' ' ' ALA . 36.5 t-20 -121.52 113.74 20.25 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.835 HD11 ' HB2' ' A' ' 16' ' ' ALA . 26.4 mt -35.51 88.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-O 121.518 0.675 . . . . 0.0 110.966 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.687 ' HB2' ' HB3' ' B' ' 52' ' ' ASP . . . -89.17 -20.92 23.63 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 59' ' ' GLN . . . . . 0.415 ' NE2' ' CD2' ' B' ' 50' ' ' PHE . 0.0 OUTLIER -109.99 137.99 46.99 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.324 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.613 ' CG2' HG23 ' A' ' 9' ' ' VAL . 71.3 t -90.33 129.46 45.31 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.092 -1.005 . . . . 0.0 111.022 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.837 ' CB ' HG11 ' B' ' 47' ' ' VAL . 37.4 Cg_endo -83.46 164.18 14.57 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 122.617 2.212 . . . . 0.0 108.587 178.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 62' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -138.97 -43.98 0.47 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.255 -1.528 . . . . 0.0 110.809 -179.65 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 1.097 HG23 HG23 ' B' ' 47' ' ' VAL . 0.5 OUTLIER 77.59 -4.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 O-C-N 121.218 -0.926 . . . . 0.0 109.662 179.677 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.85 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ptp . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.455 ' O ' ' CE2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -84.49 64.63 8.53 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.283 -0.886 . . . . 0.0 109.686 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.706 HG22 ' CE ' ' A' ' 24' ' ' LYS . 0.6 OUTLIER -89.88 -12.75 38.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.097 -1.002 . . . . 0.0 109.083 179.617 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.569 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 3.9 mt-10 -92.69 -47.22 7.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.387 -0.821 . . . . 0.0 110.336 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.632 ' CE2' HG12 ' A' ' 20' ' ' ILE . 10.9 m-90 62.29 45.15 0.72 Allowed Pre-proline 0 C--N 1.297 -1.703 0 C-N-CA 119.611 -0.836 . . . . 0.0 108.935 -177.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.629 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 33.0 Cg_endo -71.68 -30.85 14.08 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 N-CA-C 107.169 -1.897 . . . . 0.0 107.169 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.29 -15.28 62.87 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.731 HD21 ' HB2' ' A' ' 16' ' ' ALA . 13.4 tp -80.48 -5.81 57.2 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.657 -0.652 . . . . 0.0 109.325 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.551 HG23 HG21 ' B' ' 60' ' ' VAL . 36.9 t -51.68 152.22 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.089 -1.007 . . . . 0.0 109.528 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.459 ' HA2' ' OD1' ' B' ' 56' ' ' ASN . . . 47.42 21.14 1.15 Allowed Glycine 0 N--CA 1.483 1.77 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.516 178.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -96.51 -141.81 0.28 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.862 -1.375 . . . . 0.0 109.143 179.631 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.45 ' N ' HG12 ' B' ' 57' ' ' ILE . 0.6 OUTLIER -146.41 159.42 43.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.911 -1.118 . . . . 0.0 110.008 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.604 ' HA ' HD21 ' B' ' 49' ' ' LEU . 29.8 t -48.15 -36.76 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.409 -0.807 . . . . 0.0 109.649 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.533 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 2.7 mt-10 -45.46 -75.41 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.408 -0.807 . . . . 0.0 109.193 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.4 ' HB3' ' CD1' ' A' ' 8' ' ' LEU . 0.9 OUTLIER -53.88 -32.84 54.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.235 -0.915 . . . . 0.0 109.113 179.489 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.731 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -64.88 -88.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.404 -0.81 . . . . 0.0 110.309 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.52 ' HA ' ' CG2' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -43.06 -29.02 0.32 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.823 -1.173 . . . . 0.0 109.255 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 3.5 tttt -61.81 -82.89 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.735 -0.603 . . . . 0.0 110.182 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' A' ' 23' ' ' ASP . 3.2 t -59.98 -48.36 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.42 -0.8 . . . . 0.0 109.427 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.699 HG21 ' HB ' ' A' ' 29' ' ' ILE . 80.0 mt -48.17 -59.87 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.407 -0.808 . . . . 0.0 110.045 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 27' ' ' ALA . 1.0 OUTLIER -37.74 -33.24 0.07 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.502 -0.749 . . . . 0.0 110.531 -179.327 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.445 ' HB2' HD23 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -149.51 50.47 0.94 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.137 -0.977 . . . . 0.0 109.623 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -66.65 -40.88 88.87 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.176 -0.952 . . . . 0.0 108.639 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.73 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -124.01 -88.53 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.441 0 CA-C-O 117.962 -1.018 . . . . 0.0 108.271 178.078 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.73 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 37.8 Cg_endo -81.34 -79.66 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.659 0 N-CA-C 108.522 -1.376 . . . . 0.0 108.522 177.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 14.5 mt-10 -160.99 66.0 0.3 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.982 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -87.56 116.09 25.44 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.123 -1.031 . . . . 0.0 108.9 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.49 ' CB ' ' O ' ' B' ' 45' ' ' ASP . 0.0 OUTLIER -88.46 161.39 17.05 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.436 -0.79 . . . . 0.0 108.995 -179.543 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.699 ' HB ' HG21 ' A' ' 20' ' ' ILE . 14.4 tt -137.73 136.46 45.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.062 -1.055 . . . . 0.0 110.507 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.528 ' O ' ' HB3' ' B' ' 49' ' ' LEU . 3.9 mm -88.89 155.17 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.502 ' HA ' ' HB3' ' B' ' 49' ' ' LEU . 14.9 p -116.32 137.38 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.77 -1.206 . . . . 0.0 109.752 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.099 HD11 ' CE1' ' B' ' 50' ' ' PHE . 0.9 OUTLIER -150.43 159.99 33.77 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.182 -0.949 . . . . 0.0 110.374 -179.705 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.555 ' HA ' HG23 ' B' ' 51' ' ' VAL . 36.9 Cg_endo -81.18 45.67 2.05 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 123.086 2.524 . . . . 0.0 110.418 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.649 ' N ' HD12 ' A' ' 32' ' ' LEU . 68.9 t 59.87 -90.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.296 -0.878 . . . . 0.0 109.132 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.474 ' N ' HG12 ' A' ' 34' ' ' VAL . . . 53.72 170.99 0.04 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.681 HG23 ' O ' ' A' ' 36' ' ' THR . 10.0 t -99.94 70.64 1.61 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.178 -1.19 . . . . 0.0 109.451 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.756 HG22 ' O ' ' A' ' 37' ' ' ILE . 48.4 mt 47.64 61.59 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.221 -0.925 . . . . 0.0 109.427 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.725 HG23 HG23 ' A' ' 39' ' ' THR . 11.0 m -96.43 -153.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.917 . . . . 0.0 109.325 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.725 HG23 HG23 ' A' ' 38' ' ' VAL . 38.3 p . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.467 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 41' ' ' GLU . . . . . 0.426 ' N ' ' OXT' ' B' ' 64' ' ' GLY . 5.8 mm-40 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.655 0.741 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 42' ' ' TYR . . . . . 0.417 ' HD1' ' N ' ' B' ' 43' ' ' ARG . 0.1 OUTLIER -98.72 -123.03 0.14 Allowed 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.583 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 2.0 ptp180 -131.06 56.12 1.81 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.422 -1.424 . . . . 0.0 109.357 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.539 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.5 OUTLIER -42.96 143.14 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.87 -1.144 . . . . 0.0 108.765 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.603 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.1 p-10 -100.99 39.49 1.39 Allowed 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.12 -178.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 46' ' ' ARG . . . . . 0.459 ' C ' HG23 ' B' ' 47' ' ' VAL . 0.0 OUTLIER -150.79 140.81 22.04 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.83 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 1.044 ' CG2' HG23 ' B' ' 63' ' ' VAL . 96.5 t -151.52 152.13 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.999 -1.063 . . . . 0.0 110.323 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.545 ' HG3' HD21 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -78.38 105.2 9.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.083 -1.011 . . . . 0.0 110.139 -179.515 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 1.043 HD11 HD12 ' B' ' 57' ' ' ILE . 2.6 tp -93.27 86.27 5.26 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.304 -0.959 . . . . 0.0 108.505 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 50' ' ' PHE . . . . . 1.099 ' CE1' HD11 ' A' ' 32' ' ' LEU . 5.9 m-30 -69.72 133.28 47.32 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.714 HG22 ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -103.52 -170.54 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.856 -1.153 . . . . 0.0 109.722 179.747 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.527 ' OD2' ' CB ' ' B' ' 56' ' ' ASN . 2.7 p-10 -126.28 -149.72 0.42 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.519 -0.738 . . . . 0.0 109.055 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.519 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 34.4 mttm -56.86 -58.81 6.5 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.317 -0.864 . . . . 0.0 110.233 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.817 ' O ' HD23 ' B' ' 54' ' ' LEU . 0.9 OUTLIER -101.24 15.99 26.97 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.086 -1.009 . . . . 0.0 111.682 -178.587 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 55' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' B' ' 54' ' ' LEU . 0.2 OUTLIER 91.71 48.97 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.603 0 CA-C-O 122.621 1.2 . . . . 0.0 110.183 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 56' ' ' ASN . . . . . 0.527 ' CB ' ' OD2' ' B' ' 52' ' ' ASP . 1.8 t-20 -105.92 123.77 48.51 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.893 -1.129 . . . . 0.0 109.49 179.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 1.043 HD12 HD11 ' B' ' 49' ' ' LEU . 4.3 mm -54.97 88.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.61 -0.681 . . . . 0.0 109.457 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.56 -21.5 24.04 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 59' ' ' GLN . . . . . 0.416 ' O ' ' C ' ' B' ' 60' ' ' VAL . 8.7 mp0 -125.22 85.14 2.36 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.552 ' CG1' ' O ' ' A' ' 4' ' ' GLU . 9.3 t -42.37 130.15 2.82 Favored Pre-proline 0 N--CA 1.487 1.41 0 O-C-N 121.284 -0.885 . . . . 0.0 110.501 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.591 ' HB2' HG11 ' B' ' 47' ' ' VAL . 36.8 Cg_endo -82.56 162.16 16.82 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 122.976 2.451 . . . . 0.0 110.276 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 62' ' ' ARG . . . . . 0.553 ' N ' HG11 ' B' ' 47' ' ' VAL . 0.1 OUTLIER -139.88 152.81 46.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.065 -1.022 . . . . 0.0 109.514 179.43 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 1.044 HG23 ' CG2' ' B' ' 47' ' ' VAL . 1.2 t -119.24 123.38 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.154 -0.966 . . . . 0.0 109.009 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 64' ' ' GLY . . . . . 0.426 ' OXT' ' N ' ' B' ' 41' ' ' GLU . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mtt . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.502 ' O ' ' HB2' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -87.86 78.4 8.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 109.741 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.921 HG22 ' CD ' ' A' ' 24' ' ' LYS . 26.4 p -93.49 -14.7 26.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.064 -1.022 . . . . 0.0 108.997 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.735 ' HB3' ' HD3' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -105.05 -178.06 3.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.332 -0.855 . . . . 0.0 110.164 -179.575 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.643 ' NE1' HD12 ' A' ' 20' ' ' ILE . 8.0 m-90 -161.65 48.85 0.25 Allowed Pre-proline 0 C--N 1.299 -1.621 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.19 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.735 ' HD3' ' HB3' ' A' ' 4' ' ' GLU . 30.6 Cg_endo -69.24 -25.82 30.63 Favored 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 121.956 1.77 . . . . 0.0 107.586 178.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -67.4 -25.32 65.88 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.618 ' HB2' ' HB3' ' A' ' 5' ' ' TRP . 0.3 OUTLIER -73.7 -17.08 61.17 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.448 0.642 . . . . 0.0 109.445 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.545 HG23 HG21 ' B' ' 60' ' ' VAL . 37.1 t -49.92 149.6 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 C-N-CA 119.555 -0.858 . . . . 0.0 110.02 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.423 ' C ' ' OD1' ' B' ' 56' ' ' ASN . . . 54.39 17.44 8.27 Favored Glycine 0 N--CA 1.48 1.584 0 C-N-CA 120.134 -1.031 . . . . 0.0 110.574 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.566 ' HB3' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -106.89 -143.87 0.38 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.0 -1.294 . . . . 0.0 109.398 179.717 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.502 ' CA ' HG12 ' B' ' 57' ' ' ILE . 0.5 OUTLIER -146.26 168.91 19.9 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.043 -1.035 . . . . 0.0 110.195 -179.465 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.559 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 84.9 t -55.45 -32.77 30.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.436 -0.79 . . . . 0.0 109.586 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.535 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 2.3 mt-10 -45.27 -71.29 0.08 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.135 -0.978 . . . . 0.0 108.837 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.28 -37.7 81.29 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.313 -0.867 . . . . 0.0 109.87 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.663 ' HB1' HD22 ' B' ' 49' ' ' LEU . . . -57.87 -79.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 110.028 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.54 ' HA ' ' CG2' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -50.75 -32.17 18.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.549 -1.344 . . . . 0.0 109.369 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -56.31 -82.5 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.494 0.664 . . . . 0.0 111.208 -179.192 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.403 HG23 ' H ' ' A' ' 19' ' ' VAL . 2.1 t -61.69 -35.09 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.626 -0.671 . . . . 0.0 110.342 -178.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.999 HG21 ' HB ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER -53.28 -50.25 48.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 O-C-N 121.074 -1.016 . . . . 0.0 109.541 179.873 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.563 HD23 ' HB2' ' A' ' 22' ' ' GLN . 4.2 tt -35.45 -32.2 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.454 -0.779 . . . . 0.0 110.278 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.563 ' HB2' HD23 ' A' ' 21' ' ' LEU . 1.9 tt0 -145.77 56.88 1.21 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.251 -0.905 . . . . 0.0 109.13 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.609 ' OD1' ' HB3' ' A' ' 27' ' ' ALA . 0.4 OUTLIER -65.41 -62.24 1.65 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.671 -0.643 . . . . 0.0 109.537 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.921 ' CD ' HG22 ' A' ' 3' ' ' THR . 0.0 OUTLIER -110.07 -80.95 0.01 OUTLIER Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.551 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.828 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 39.5 Cg_endo -87.92 -71.87 0.01 OUTLIER 'Trans proline' 0 C--O 1.213 -0.732 0 N-CA-C 107.377 -1.817 . . . . 0.0 107.377 176.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.537 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 19.4 mt-10 -165.02 62.3 0.12 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.609 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -87.53 120.52 28.92 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.069 -1.019 . . . . 0.0 109.345 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.446 ' CB ' ' O ' ' B' ' 45' ' ' ASP . 0.6 OUTLIER -88.36 174.17 8.31 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.416 -0.803 . . . . 0.0 109.143 -179.52 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.999 ' HB ' HG21 ' A' ' 20' ' ' ILE . 18.5 tt -145.74 134.76 17.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.466 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.557 HD12 ' HD2' ' B' ' 46' ' ' ARG . 4.8 mt -88.07 148.27 4.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.438 HG21 HG21 ' A' ' 13' ' ' VAL . 5.8 p -117.07 133.23 64.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 118.811 -1.156 . . . . 0.0 110.858 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.916 HD11 ' HE1' ' B' ' 50' ' ' PHE . 0.2 OUTLIER -147.57 162.24 32.68 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.827 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.897 ' O ' HG13 ' A' ' 34' ' ' VAL . 36.8 Cg_endo -74.03 -85.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 121.634 1.556 . . . . 0.0 110.823 -177.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.897 HG13 ' O ' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -175.13 -34.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.684 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -89.08 -90.24 1.18 Allowed Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.451 HG22 ' H ' ' A' ' 36' ' ' THR . 0.0 OUTLIER -48.12 125.0 8.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.36 -1.082 . . . . 0.0 109.696 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.3 tt -81.66 163.85 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.0 109.115 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.536 HG22 ' H ' ' A' ' 39' ' ' THR . 2.0 p -76.88 174.09 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.197 -0.939 . . . . 0.0 109.304 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.536 ' H ' HG22 ' A' ' 38' ' ' VAL . 73.2 p . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.526 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 42' ' ' TYR . . . . . 0.438 ' O ' ' O ' ' B' ' 64' ' ' GLY . 0.1 OUTLIER -98.49 -122.29 0.14 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.875 . . . . 0.0 109.554 -179.724 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.57 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.5 OUTLIER -123.34 56.73 1.18 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.556 -1.34 . . . . 0.0 109.552 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.488 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.3 OUTLIER -44.03 137.22 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.926 -1.109 . . . . 0.0 108.675 179.971 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.587 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -93.19 45.32 1.17 Allowed 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.419 -0.912 . . . . 0.0 109.689 -178.854 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 46' ' ' ARG . . . . . 0.557 ' HD2' HD12 ' A' ' 30' ' ' ILE . 14.1 ttp180 -148.04 144.83 28.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.314 -0.867 . . . . 0.0 109.112 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.663 HG22 ' CG2' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -152.2 143.9 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.157 -0.964 . . . . 0.0 109.427 -179.267 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.452 ' HA ' ' HD3' ' B' ' 48' ' ' ARG . 3.3 mmt85 -77.33 115.43 17.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.701 -1.249 . . . . 0.0 109.632 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 1.064 HD11 HD12 ' B' ' 57' ' ' ILE . 1.6 tp -107.89 81.02 1.44 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.987 -1.071 . . . . 0.0 108.843 178.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 50' ' ' PHE . . . . . 0.916 ' HE1' HD11 ' A' ' 32' ' ' LEU . 4.1 m-30 -66.05 -159.86 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.575 HG22 ' HA ' ' A' ' 33' ' ' PRO . 24.1 m -150.42 -171.46 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.74 -1.225 . . . . 0.0 109.574 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.532 ' HB3' ' HB2' ' B' ' 58' ' ' ALA . 1.0 OUTLIER -122.66 -153.14 0.54 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.297 -0.877 . . . . 0.0 109.259 179.434 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.51 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 29.1 mtpt -61.18 -61.48 2.53 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.617 -0.677 . . . . 0.0 109.606 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.415 ' O ' ' C ' ' B' ' 55' ' ' ASP . 3.0 tp -96.09 48.11 1.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.365 -0.834 . . . . 0.0 109.909 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 55' ' ' ASP . . . . . 0.488 ' HA ' ' HB ' ' B' ' 51' ' ' VAL . 0.0 OUTLIER 45.58 65.31 1.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.061 -1.025 . . . . 0.0 109.28 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 56' ' ' ASN . . . . . 0.577 ' O ' ' N ' ' B' ' 58' ' ' ALA . 3.5 t30 -133.14 108.71 8.99 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 1.064 HD12 HD11 ' B' ' 49' ' ' LEU . 12.7 mm -32.41 86.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.67 0.748 . . . . 0.0 111.391 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.577 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -90.99 -23.72 20.31 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.04 96.24 5.09 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.607 HG13 ' HB2' ' A' ' 5' ' ' TRP . 3.2 t -57.89 137.44 83.42 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.459 -0.776 . . . . 0.0 110.17 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.457 ' HG3' HD11 ' A' ' 29' ' ' ILE . 35.0 Cg_endo -76.97 172.97 15.24 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 122.438 2.092 . . . . 0.0 109.927 178.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 62' ' ' ARG . . . . . 0.532 ' O ' ' CG1' ' B' ' 47' ' ' VAL . 0.0 OUTLIER -150.94 135.36 17.01 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.811 -1.181 . . . . 0.0 110.614 -179.601 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.663 ' CG2' HG22 ' B' ' 47' ' ' VAL . 4.6 t -123.77 111.29 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.353 -0.842 . . . . 0.0 108.857 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 64' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' B' ' 42' ' ' TYR . . . . . . . . 0 N--CA 1.491 2.341 0 CA-C-O 117.93 -1.483 . . . . 0.0 109.729 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ttp . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.247 0.546 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.529 ' CB ' ' OD2' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -89.98 48.21 1.55 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.305 -0.872 . . . . 0.0 109.854 -179.799 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.838 HG22 ' O ' ' B' ' 63' ' ' VAL . 0.2 OUTLIER -89.44 18.81 4.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.213 -0.929 . . . . 0.0 108.499 179.084 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.594 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 37.3 mt-10 -135.33 -40.58 0.73 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.502 -0.749 . . . . 0.0 109.349 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.651 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 6.9 m-90 62.63 40.55 0.37 Allowed Pre-proline 0 C--N 1.299 -1.59 0 O-C-N 121.545 -0.722 . . . . 0.0 109.946 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.651 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 34.7 Cg_endo -72.93 -33.75 7.37 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 N-CA-C 107.462 -1.784 . . . . 0.0 107.462 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -69.57 -10.75 59.47 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 177.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.666 HD21 ' HA ' ' A' ' 16' ' ' ALA . 11.7 tp -81.36 -1.92 47.27 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 121.556 -0.715 . . . . 0.0 109.445 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.58 HG22 HG23 ' B' ' 60' ' ' VAL . 24.1 t -54.71 151.28 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.101 -1.0 . . . . 0.0 109.482 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.07 6.18 18.16 Favored Glycine 0 N--CA 1.481 1.677 0 C-N-CA 120.042 -1.075 . . . . 0.0 110.5 178.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -93.13 -145.36 0.23 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.801 -1.411 . . . . 0.0 109.327 179.697 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 m -150.47 179.56 8.05 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.062 -1.023 . . . . 0.0 110.373 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 1.027 HG22 HD21 ' B' ' 49' ' ' LEU . 57.1 t -60.45 -35.3 62.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.487 -0.758 . . . . 0.0 109.724 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 1.9 pm0 -47.02 -74.46 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.047 -1.033 . . . . 0.0 108.893 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.475 ' HB3' HD11 ' A' ' 8' ' ' LEU . 21.0 tt0 -57.61 -31.38 66.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.219 -0.925 . . . . 0.0 110.084 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.912 ' HB2' HD11 ' B' ' 57' ' ' ILE . . . -66.6 -81.12 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.88 -1.137 . . . . 0.0 109.962 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -45.96 -30.43 1.79 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.758 -1.214 . . . . 0.0 109.056 -179.875 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.7 OUTLIER -63.46 -81.44 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.703 -0.623 . . . . 0.0 110.677 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.761 HG12 ' HB2' ' A' ' 23' ' ' ASP . 3.3 t -56.18 -50.04 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.204 -0.935 . . . . 0.0 109.613 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.941 HG21 ' HB ' ' A' ' 29' ' ' ILE . 61.8 mt -46.9 -59.49 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.389 -0.819 . . . . 0.0 109.928 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.501 ' C ' ' O ' ' A' ' 20' ' ' ILE . 17.4 tp -29.56 -37.74 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.056 0.455 . . . . 0.0 110.659 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.558 ' O ' ' N ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -133.43 -72.67 0.5 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.968 -1.082 . . . . 0.0 109.405 179.096 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.761 ' HB2' HG12 ' A' ' 19' ' ' VAL . 7.6 t0 42.48 -94.84 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.718 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 3.0 mtmp? -66.62 -118.14 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.332 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.718 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 36.5 Cg_endo -79.77 -75.53 0.01 OUTLIER 'Trans proline' 0 C--O 1.214 -0.703 0 CA-C-N 122.309 1.86 . . . . 0.0 108.902 178.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 4.5 mt-10 -156.84 59.88 0.53 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.758 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -89.03 113.01 24.08 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.475 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.549 ' O ' HG23 ' B' ' 47' ' ' VAL . 1.8 mt-30 -87.95 172.21 9.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.065 -1.022 . . . . 0.0 109.175 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.941 ' HB ' HG21 ' A' ' 20' ' ' ILE . 9.4 tt -136.86 142.66 37.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.979 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.802 HG22 HD22 ' A' ' 32' ' ' LEU . 26.9 mm -90.24 122.4 41.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.94 HG22 HD23 ' B' ' 49' ' ' LEU . 32.7 t -96.59 134.09 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.966 -1.084 . . . . 0.0 109.74 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.961 ' N ' HD23 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -148.38 170.93 6.9 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 -178.671 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.699 ' O ' HG23 ' A' ' 34' ' ' VAL . 39.9 Cg_endo -75.91 -94.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.299 -2.035 0 O-C-N 123.414 1.218 . . . . 0.0 109.839 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 33' ' ' PRO . 54.8 t -164.74 103.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -152.42 -115.69 0.64 Allowed Glycine 0 N--CA 1.484 1.849 0 C-N-CA 119.251 -1.452 . . . . 0.0 110.256 -178.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 61.2 m -71.88 96.13 1.63 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.298 -1.119 . . . . 0.0 109.898 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.813 HG22 ' CE2' ' B' ' 50' ' ' PHE . 9.7 pt -94.5 153.54 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.332 -0.855 . . . . 0.0 109.048 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 38' ' ' VAL . 6.0 t 66.61 10.07 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.923 . . . . 0.0 109.526 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.917 -1.04 . . . . 0.0 109.425 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 41' ' ' GLU . . . . . 0.577 ' O ' ' CG ' ' B' ' 42' ' ' TYR . 52.6 mt-10 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 42' ' ' TYR . . . . . 0.577 ' CG ' ' O ' ' B' ' 41' ' ' GLU . 46.3 p90 40.66 -151.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.649 -0.657 . . . . 0.0 109.408 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.557 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 1.2 ptt180 -123.91 73.15 1.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.841 -1.162 . . . . 0.0 110.086 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.543 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.4 OUTLIER -47.3 144.89 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 120.732 -1.23 . . . . 0.0 107.821 178.991 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.758 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.7 p-10 -106.34 45.7 0.96 Allowed 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 118.798 -1.161 . . . . 0.0 110.243 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 46' ' ' ARG . . . . . 0.483 ' HG3' HG12 ' A' ' 30' ' ' ILE . 1.4 ttt-85 -152.17 153.07 33.12 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.713 HG22 ' CG2' ' B' ' 63' ' ' VAL . 0.1 OUTLIER -150.59 -172.83 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.098 -1.001 . . . . 0.0 108.56 179.591 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.617 ' HD2' HD11 ' A' ' 32' ' ' LEU . 11.8 mmt85 -119.4 72.25 0.9 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.682 -1.261 . . . . 0.0 110.265 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 1.027 HD21 HG22 ' A' ' 13' ' ' VAL . 3.2 tp -69.21 97.74 0.96 Allowed 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.008 -1.077 . . . . 0.0 108.178 178.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 50' ' ' PHE . . . . . 0.831 ' CE1' HD12 ' A' ' 32' ' ' LEU . 18.1 m-85 -89.37 -162.93 0.92 Allowed 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 33' ' ' PRO . 34.8 m -142.1 175.09 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.769 -1.207 . . . . 0.0 109.363 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.649 ' CB ' ' HB2' ' B' ' 58' ' ' ALA . 0.0 OUTLIER -127.44 -71.9 0.65 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.242 -0.911 . . . . 0.0 108.633 -179.884 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.548 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 17.9 mmtt -93.21 -75.21 0.5 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.898 -1.126 . . . . 0.0 108.535 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.555 ' O ' ' CB ' ' B' ' 55' ' ' ASP . 0.1 OUTLIER -131.68 51.75 2.12 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 179.088 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 55' ' ' ASP . . . . . 0.555 ' CB ' ' O ' ' B' ' 54' ' ' LEU . 0.2 OUTLIER 91.33 23.0 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.18 0.514 . . . . 0.0 109.703 -179.344 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 56' ' ' ASN . . . . . 0.575 ' O ' ' N ' ' B' ' 58' ' ' ALA . 62.4 t30 -88.83 91.87 8.99 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.912 HD11 ' HB2' ' A' ' 16' ' ' ALA . 9.4 mt -38.49 89.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-O 121.687 0.756 . . . . 0.0 110.779 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.649 ' HB2' ' CB ' ' B' ' 52' ' ' ASP . . . -88.13 -25.65 22.87 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -118.2 103.51 9.91 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.581 HG13 ' HD2' ' B' ' 61' ' ' PRO . 63.0 t -62.49 138.21 96.46 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.386 -0.821 . . . . 0.0 110.918 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.581 ' HD2' HG13 ' B' ' 60' ' ' VAL . 36.4 Cg_endo -80.44 170.54 15.85 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.736 2.291 . . . . 0.0 109.294 178.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 62' ' ' ARG . . . . . 0.545 ' CD ' ' HA ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -149.9 140.39 22.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.758 -1.214 . . . . 0.0 110.721 -179.512 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.838 ' O ' HG22 ' A' ' 3' ' ' THR . 1.4 t -119.03 138.75 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.543 -0.723 . . . . 0.0 109.166 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 CA-C-O 117.967 -1.463 . . . . 0.0 109.668 -179.845 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 mmt . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.185 0.516 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.47 ' O ' ' CE2' ' A' ' 5' ' ' TRP . 38.1 mmtm -90.0 45.9 1.31 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.259 -0.901 . . . . 0.0 109.551 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.504 HG23 ' HD2' ' A' ' 24' ' ' LYS . 7.3 m -92.06 -22.56 19.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.229 -0.919 . . . . 0.0 109.708 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.648 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 10.1 mm-40 -105.8 -24.34 12.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.086 -1.009 . . . . 0.0 110.527 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.814 ' NE1' HD12 ' A' ' 20' ' ' ILE . 6.9 m-90 48.24 46.98 4.12 Favored Pre-proline 0 C--N 1.297 -1.709 0 C-N-CA 118.774 -1.17 . . . . 0.0 108.888 -178.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.66 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 31.4 Cg_endo -73.88 -35.44 4.37 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 N-CA-C 106.581 -2.123 . . . . 0.0 106.581 -179.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.84 -12.24 61.47 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 114.318 -1.31 . . . . 0.0 107.666 176.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.579 HD11 ' HB3' ' A' ' 15' ' ' GLU . 19.1 tp -79.68 -7.05 58.34 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 121.476 -0.765 . . . . 0.0 109.454 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.562 HG23 HG21 ' B' ' 60' ' ' VAL . 15.3 t -54.85 151.86 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.965 -1.084 . . . . 0.0 108.951 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.451 ' HA2' ' OD1' ' B' ' 56' ' ' ASN . . . 57.1 13.72 9.68 Favored Glycine 0 N--CA 1.481 1.64 0 N-CA-C 110.209 -1.157 . . . . 0.0 110.209 178.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -94.56 -143.52 0.25 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.959 -1.318 . . . . 0.0 109.511 179.843 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.12 170.4 18.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.042 -1.036 . . . . 0.0 110.173 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.551 ' HA ' HD11 ' B' ' 49' ' ' LEU . 78.4 t -53.27 -42.22 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.336 -0.853 . . . . 0.0 109.655 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.528 ' O ' ' CG ' ' A' ' 18' ' ' LYS . 59.0 mm-40 -41.38 -71.64 0.08 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.579 ' HB3' HD11 ' A' ' 8' ' ' LEU . 0.6 OUTLIER -56.09 -38.69 71.04 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.452 -0.78 . . . . 0.0 109.612 179.619 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.758 ' HB2' HD11 ' B' ' 57' ' ' ILE . . . -58.72 -83.85 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.383 -0.823 . . . . 0.0 109.862 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 17' ' ' LYS . 4.3 tptp -45.13 -29.99 1.04 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.563 -1.335 . . . . 0.0 109.39 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' A' ' 14' ' ' GLU . 4.3 mmtt -61.35 -86.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.66 0.743 . . . . 0.0 111.087 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 19' ' ' VAL . 2.4 t -57.89 -38.9 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 121.494 0.664 . . . . 0.0 109.824 -178.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.884 HG21 ' HB ' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -53.48 -51.75 38.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.438 -0.789 . . . . 0.0 109.725 -179.645 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 20' ' ' ILE . 45.3 tp -39.25 -23.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.399 -0.813 . . . . 0.0 111.9 -178.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -142.1 13.33 2.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.001 -1.687 . . . . 0.0 112.622 -179.242 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.967 ' OD1' ' HB3' ' A' ' 27' ' ' ALA . 1.2 p-10 -49.29 150.72 1.66 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.729 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.4 OUTLIER 52.81 -131.03 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 -178.809 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.729 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 36.9 Cg_endo -78.17 -83.03 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.635 0 CA-C-N 121.952 1.733 . . . . 0.0 109.346 178.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 3.1 mt-10 -144.69 71.01 1.29 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.417 -0.802 . . . . 0.0 109.046 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.967 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -89.03 118.71 28.95 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.006 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.518 ' O ' HG23 ' B' ' 47' ' ' VAL . 0.0 OUTLIER -88.01 -178.69 6.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.241 -0.912 . . . . 0.0 109.435 -179.313 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.884 ' HB ' HG21 ' A' ' 20' ' ' ILE . 14.0 tt -150.06 152.16 11.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 C-N-CA 119.02 -1.072 . . . . 0.0 111.112 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.424 ' HA ' HD13 ' A' ' 30' ' ' ILE . 16.3 mm -112.16 128.65 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.554 ' HA ' ' HB3' ' B' ' 49' ' ' LEU . 3.0 t -89.56 150.12 3.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 120.824 -1.173 . . . . 0.0 110.173 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.13 HD22 ' CD1' ' B' ' 50' ' ' PHE . 0.0 OUTLIER -130.93 166.21 29.21 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -178.38 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.71 ' O ' HG12 ' A' ' 34' ' ' VAL . 37.9 Cg_endo -81.77 34.87 0.56 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 123.008 2.472 . . . . 0.0 108.934 178.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.966 ' HA ' HD21 ' A' ' 32' ' ' LEU . 0.3 OUTLIER 56.91 3.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 123.549 0.74 . . . . 0.0 111.627 -178.807 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -152.22 -155.58 7.11 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.99 129.52 23.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -1.156 . . . . 0.0 109.664 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.991 ' O ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -57.72 -22.15 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.329 179.874 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' A' ' 39' ' ' THR . 46.0 t -73.08 84.41 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.221 -0.924 . . . . 0.0 109.493 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.408 ' C ' ' O ' ' A' ' 38' ' ' VAL . 23.1 p . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.339 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 42' ' ' TYR . . . . . 0.577 ' CE2' ' HB ' ' B' ' 44' ' ' ILE . 11.2 p90 -124.98 -140.63 0.29 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.185 -0.947 . . . . 0.0 109.63 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.575 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.2 OUTLIER -130.71 54.97 1.86 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.748 -1.22 . . . . 0.0 110.283 -179.332 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.577 ' HB ' ' CE2' ' B' ' 42' ' ' TYR . 0.2 OUTLIER -45.79 140.17 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.856 -1.152 . . . . 0.0 108.363 179.388 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.624 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.9 OUTLIER -98.92 48.34 0.97 Allowed 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.031 -1.043 . . . . 0.0 109.624 -179.371 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -150.29 150.4 31.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.459 -0.775 . . . . 0.0 109.03 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.858 HG22 HG23 ' B' ' 63' ' ' VAL . 0.1 OUTLIER -151.36 -172.48 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.181 -0.949 . . . . 0.0 109.343 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 5.1 mmt85 -118.17 71.02 0.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.095 -1.003 . . . . 0.0 110.156 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.572 ' HB2' HG12 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -54.61 103.09 0.08 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.005 -1.059 . . . . 0.0 108.872 179.297 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 50' ' ' PHE . . . . . 1.13 ' CD1' HD22 ' A' ' 32' ' ' LEU . 2.2 m-85 -92.21 119.21 31.62 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.356 -0.84 . . . . 0.0 108.961 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.505 ' O ' ' CG2' ' A' ' 34' ' ' VAL . 1.5 m -108.33 -175.45 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.12 -0.988 . . . . 0.0 109.536 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.545 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.0 OUTLIER -129.16 -161.97 1.16 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.291 -0.88 . . . . 0.0 109.619 -179.915 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.545 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 1.8 mttp -49.96 -61.79 1.94 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.589 -0.694 . . . . 0.0 109.934 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 7.6 mp -89.57 48.98 1.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.479 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 44.39 49.44 8.11 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.349 -0.844 . . . . 0.0 109.246 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 56' ' ' ASN . . . . . 0.484 ' HB3' ' CG ' ' B' ' 52' ' ' ASP . 4.9 t30 -107.11 111.17 23.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.31 -0.868 . . . . 0.0 108.873 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.758 HD11 ' HB2' ' A' ' 16' ' ' ALA . 12.5 mt -59.46 90.55 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 121.352 0.596 . . . . 0.0 110.21 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -87.94 -19.63 27.0 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 59' ' ' GLN . . . . . 0.529 ' HB2' ' CB ' ' B' ' 50' ' ' PHE . 1.1 mt-30 -123.12 82.27 1.98 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.567 HG11 ' O ' ' A' ' 5' ' ' TRP . 20.2 t -49.72 137.47 18.21 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.533 -0.73 . . . . 0.0 110.655 -178.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.545 ' HG3' HD11 ' A' ' 29' ' ' ILE . 36.5 Cg_endo -81.23 172.67 12.53 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 123.023 2.482 . . . . 0.0 110.205 179.065 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 62' ' ' ARG . . . . . 0.577 ' HG3' ' HA ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -149.53 129.4 13.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.229 -0.919 . . . . 0.0 110.009 179.915 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.858 HG23 HG22 ' B' ' 47' ' ' VAL . 0.9 OUTLIER -97.56 119.06 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.217 -0.927 . . . . 0.0 108.906 179.442 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 64' ' ' GLY . . . . . 0.418 ' OXT' HG22 ' B' ' 44' ' ' ILE . . . . . . . . 0 N--CA 1.491 2.339 0 CA-C-O 118.023 -1.431 . . . . 0.0 109.55 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.6 mtp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.335 0.588 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.47 ' HB3' ' OD2' ' A' ' 23' ' ' ASP . 0.5 OUTLIER -86.05 45.61 1.24 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.335 -0.853 . . . . 0.0 109.492 -179.812 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.552 ' CG2' ' HD2' ' A' ' 24' ' ' LYS . 62.7 p -89.65 33.94 0.83 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.175 -0.953 . . . . 0.0 109.599 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.565 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -135.42 -47.73 0.7 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.183 -0.948 . . . . 0.0 109.83 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.651 ' CE2' HG12 ' A' ' 20' ' ' ILE . 9.3 m-90 58.64 44.96 1.2 Allowed Pre-proline 0 C--N 1.299 -1.604 0 C-N-CA 119.398 -0.921 . . . . 0.0 108.995 -178.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.645 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 33.5 Cg_endo -72.88 -32.09 9.41 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 N-CA-C 107.462 -1.784 . . . . 0.0 107.462 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.56 -12.2 60.97 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.842 HD21 ' HA ' ' A' ' 16' ' ' ALA . 2.7 tp -78.04 -4.32 46.57 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 121.507 -0.746 . . . . 0.0 109.594 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.7 t -52.43 152.39 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 C-N-CA 118.866 -1.133 . . . . 0.0 109.116 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.461 ' HA2' ' OD1' ' B' ' 56' ' ' ASN . . . 45.51 24.08 1.01 Allowed Glycine 0 N--CA 1.481 1.652 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 178.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 1.7 tptm -99.78 -138.93 0.32 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.984 -1.304 . . . . 0.0 109.249 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' B' ' 55' ' ' ASP . 0.3 OUTLIER -150.03 154.83 38.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.809 -1.182 . . . . 0.0 110.744 -179.53 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.633 ' HA ' HD21 ' B' ' 49' ' ' LEU . 54.9 t -52.41 -30.01 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 O-C-N 121.435 -0.79 . . . . 0.0 109.019 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.524 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 14.3 mt-10 -48.91 -74.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.466 -0.771 . . . . 0.0 109.107 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.491 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.6 OUTLIER -57.33 -28.94 63.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.168 -0.958 . . . . 0.0 108.705 179.226 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.89 ' C ' HD12 ' A' ' 20' ' ' ILE . . . -61.08 -86.74 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.4 -0.812 . . . . 0.0 109.959 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.448 ' C ' ' HD2' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -47.46 -35.14 8.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.564 -1.335 . . . . 0.0 108.99 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -49.46 -78.82 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.468 0.651 . . . . 0.0 110.869 -179.471 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 15' ' ' GLU . 0.5 OUTLIER -72.76 -44.57 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.425 -0.797 . . . . 0.0 109.677 -178.833 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.959 HG21 ' HB ' ' A' ' 29' ' ' ILE . 67.2 mt -40.07 -52.91 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.544 -0.722 . . . . 0.0 109.511 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 28' ' ' GLN . 0.5 OUTLIER -38.73 -49.44 1.59 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.563 -0.711 . . . . 0.0 110.483 -179.658 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.464 ' HB2' HD23 ' A' ' 21' ' ' LEU . 1.1 mt-30 -135.06 44.51 2.6 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.099 -1.0 . . . . 0.0 110.506 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.582 ' HB3' ' CE ' ' A' ' 24' ' ' LYS . 4.6 t0 -66.33 -39.85 89.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.866 -1.146 . . . . 0.0 108.488 179.143 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.824 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -117.42 -99.51 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.444 0 CA-C-O 117.214 -1.374 . . . . 0.0 107.975 178.707 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.824 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 37.3 Cg_endo -82.15 -76.14 0.0 OUTLIER 'Trans proline' 0 C--O 1.213 -0.742 0 CA-C-N 122.374 1.884 . . . . 0.0 108.284 177.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 16.3 mt-10 -160.77 56.35 0.31 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.903 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -88.81 119.15 29.05 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.128 -0.983 . . . . 0.0 109.467 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 15.7 mt-30 -89.25 -178.35 5.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.224 -0.923 . . . . 0.0 109.326 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.959 ' HB ' HG21 ' A' ' 20' ' ' ILE . 3.6 tt -145.45 127.93 9.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.089 -1.007 . . . . 0.0 110.436 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.823 HD12 ' HD3' ' B' ' 46' ' ' ARG . 33.4 mt -89.0 111.31 22.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.486 HG21 HG21 ' A' ' 13' ' ' VAL . 7.0 p -89.72 146.59 5.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.136 -0.977 . . . . 0.0 110.123 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.161 HD11 ' CE1' ' B' ' 50' ' ' PHE . 0.7 OUTLIER -150.49 161.6 29.99 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.461 -0.775 . . . . 0.0 109.461 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.557 ' HD2' ' HB2' ' A' ' 32' ' ' LEU . 36.9 Cg_endo -78.63 35.5 0.55 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.538 2.159 . . . . 0.0 111.432 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' A' ' 33' ' ' PRO . 4.6 t 73.47 -78.8 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.245 -0.909 . . . . 0.0 109.829 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.53 168.28 0.58 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.437 ' O ' ' OG1' ' A' ' 36' ' ' THR . 0.5 OUTLIER -88.69 39.22 0.91 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -1.165 . . . . 0.0 109.032 179.724 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 65.95 144.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.324 -0.86 . . . . 0.0 108.951 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.3 t -65.94 137.98 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.104 -0.997 . . . . 0.0 109.542 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.517 -179.88 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.704 0.764 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 42' ' ' TYR . . . . . 0.581 ' CE2' ' HA ' ' B' ' 44' ' ' ILE . 9.7 p90 -131.63 -152.22 0.49 Allowed 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.74 -0.6 . . . . 0.0 109.419 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.554 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER -92.72 52.94 1.95 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.154 -0.966 . . . . 0.0 109.597 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.581 ' HA ' ' CE2' ' B' ' 42' ' ' TYR . 0.5 OUTLIER -43.17 145.87 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.99 -1.069 . . . . 0.0 108.262 179.488 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.611 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 2.2 p-10 -106.1 46.44 0.92 Allowed 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 118.962 -1.095 . . . . 0.0 110.756 -178.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 46' ' ' ARG . . . . . 0.823 ' HD3' HD12 ' A' ' 30' ' ' ILE . 2.3 ptp180 -150.94 153.01 34.43 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.22 -0.925 . . . . 0.0 109.244 178.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 1.091 ' CG2' HG23 ' B' ' 63' ' ' VAL . 31.1 t -150.93 161.66 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.421 -0.799 . . . . 0.0 109.162 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.804 ' HG3' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -93.38 84.16 4.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.85 -1.156 . . . . 0.0 110.022 -179.453 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.633 HD21 ' HA ' ' A' ' 13' ' ' VAL . 2.5 tp -80.04 83.36 5.94 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 118.985 -1.086 . . . . 0.0 109.17 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 50' ' ' PHE . . . . . 1.161 ' CE1' HD11 ' A' ' 32' ' ' LEU . 3.8 m-30 -66.98 -162.88 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.715 HG12 ' HA ' ' B' ' 55' ' ' ASP . 10.1 m -149.44 160.9 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.834 -1.166 . . . . 0.0 108.702 178.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.715 ' CB ' ' HB2' ' B' ' 58' ' ' ALA . 0.0 OUTLIER -112.37 -70.61 0.8 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.939 -1.1 . . . . 0.0 108.796 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.55 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 9.9 mmmt -92.5 -75.91 0.48 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.848 -1.158 . . . . 0.0 108.49 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.543 ' O ' ' CB ' ' B' ' 55' ' ' ASP . 0.1 OUTLIER -136.85 57.22 1.77 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.056 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 55' ' ' ASP . . . . . 0.715 ' HA ' HG12 ' B' ' 51' ' ' VAL . 0.2 OUTLIER 91.51 24.13 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.421 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 56' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' B' ' 58' ' ' ALA . 31.8 t-20 -88.82 86.79 7.04 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.742 HD11 ' HB2' ' A' ' 16' ' ' ALA . 3.8 mt -37.33 89.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-O 121.511 0.672 . . . . 0.0 111.315 -178.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.715 ' HB2' ' CB ' ' B' ' 52' ' ' ASP . . . -88.81 -17.5 29.62 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 59' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' B' ' 60' ' ' VAL . 33.9 mt-30 -127.68 84.37 2.25 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 4' ' ' GLU . 6.4 t -41.68 136.2 2.01 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.453 -0.779 . . . . 0.0 110.161 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.806 ' HB2' HG11 ' B' ' 47' ' ' VAL . 36.7 Cg_endo -81.95 166.79 16.7 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.751 2.301 . . . . 0.0 110.523 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 62' ' ' ARG . . . . . 0.621 ' O ' HG13 ' B' ' 47' ' ' VAL . 0.3 OUTLIER -142.72 152.85 42.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 109.285 179.416 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 1.091 HG23 ' CG2' ' B' ' 47' ' ' VAL . 1.2 t -116.9 124.73 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.229 -0.919 . . . . 0.0 109.486 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.217 0 CA-C-O 117.957 -1.468 . . . . 0.0 109.599 179.685 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.406 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 1.5 tmm? . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.312 0.577 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.431 ' HD3' ' HA ' ' A' ' 2' ' ' LYS . 6.0 mmtp -88.92 66.66 7.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.125 -0.984 . . . . 0.0 109.311 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.747 HG22 ' CE ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -103.3 -7.78 20.83 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.307 -0.871 . . . . 0.0 109.063 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.58 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 4.9 mt-10 -99.92 -48.41 4.68 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.993 -1.067 . . . . 0.0 110.878 -178.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.619 ' CE2' HG12 ' A' ' 20' ' ' ILE . 10.4 m-90 60.71 45.76 1.03 Allowed Pre-proline 0 C--N 1.297 -1.711 0 C-N-CA 119.067 -1.053 . . . . 0.0 108.386 -177.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.662 ' HA ' HG21 ' B' ' 60' ' ' VAL . 32.8 Cg_endo -72.31 -31.2 11.93 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 N-CA-C 107.057 -1.94 . . . . 0.0 107.057 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.21 -13.14 62.02 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.525 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.577 HD23 ' HB3' ' A' ' 5' ' ' TRP . 0.3 OUTLIER -71.32 -11.57 60.98 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.204 -0.935 . . . . 0.0 108.987 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.741 HG23 ' CG2' ' B' ' 60' ' ' VAL . 24.4 t -55.9 145.1 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.087 -1.008 . . . . 0.0 109.82 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.474 ' HA2' ' OD1' ' B' ' 56' ' ' ASN . . . 59.23 13.65 22.22 Favored Glycine 0 N--CA 1.482 1.726 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.287 177.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 1.2 tptp -95.44 -147.11 0.28 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.133 -1.216 . . . . 0.0 109.178 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.84 155.96 44.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -0.917 . . . . 0.0 109.372 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.528 ' CG2' ' CG1' ' B' ' 51' ' ' VAL . 69.0 t -47.17 -37.18 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.834 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.516 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -44.81 -76.9 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.211 -0.931 . . . . 0.0 109.317 -179.864 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -54.76 -35.57 63.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.561 -0.712 . . . . 0.0 110.143 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.69 ' C ' HD12 ' A' ' 20' ' ' ILE . . . -63.46 -83.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.827 . . . . 0.0 110.364 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.655 ' HG2' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -45.7 -27.52 0.83 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.142 -0.974 . . . . 0.0 108.884 -179.618 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.1 OUTLIER -67.46 -86.28 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.746 -0.596 . . . . 0.0 111.167 -179.029 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.503 ' O ' ' OD1' ' A' ' 23' ' ' ASP . 4.6 t -46.13 -42.77 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.15 -0.969 . . . . 0.0 109.455 -178.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.995 HG21 ' HB ' ' A' ' 29' ' ' ILE . 46.5 mt -56.63 -44.24 80.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.452 -0.78 . . . . 0.0 109.536 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 20' ' ' ILE . 4.2 tt -39.15 -25.82 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.222 -0.923 . . . . 0.0 110.588 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.548 ' O ' ' N ' ' A' ' 24' ' ' LYS . 4.1 mt-30 -144.3 -67.99 0.32 Allowed 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.525 -1.359 . . . . 0.0 111.592 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.516 ' OD1' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER 39.54 -94.51 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.393 -0.817 . . . . 0.0 108.86 -178.549 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.747 ' CE ' HG22 ' A' ' 3' ' ' THR . 10.6 mtpt -64.89 -118.95 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.435 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 178.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.735 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 36.5 Cg_endo -80.56 -73.21 0.01 OUTLIER 'Trans proline' 0 C--O 1.214 -0.71 0 CA-C-N 122.221 1.829 . . . . 0.0 109.006 178.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 5.5 mt-10 -159.29 60.63 0.4 Allowed 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.749 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -88.03 113.99 24.21 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.566 ' O ' HG23 ' B' ' 47' ' ' VAL . 0.2 OUTLIER -86.78 170.57 11.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.144 -0.973 . . . . 0.0 110.517 -177.711 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.995 ' HB ' HG21 ' A' ' 20' ' ' ILE . 19.2 tt -140.21 141.91 32.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.829 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.531 ' O ' ' HB3' ' B' ' 49' ' ' LEU . 1.0 OUTLIER -91.31 163.77 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 179.132 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 1.04 HG13 HD12 ' B' ' 49' ' ' LEU . 64.5 t -135.2 133.39 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.312 -1.492 . . . . 0.0 110.372 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.036 HD21 ' CE1' ' B' ' 50' ' ' PHE . 0.5 OUTLIER -132.19 159.53 71.8 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.503 -0.748 . . . . 0.0 109.113 178.998 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.541 ' HA ' ' CG2' ' B' ' 51' ' ' VAL . 37.4 Cg_endo -80.73 39.97 0.92 Allowed 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.513 2.142 . . . . 0.0 110.652 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.783 HG12 ' N ' ' A' ' 35' ' ' GLY . 14.9 t 50.06 -92.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.102 -0.999 . . . . 0.0 108.708 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.783 ' N ' HG12 ' A' ' 34' ' ' VAL . . . 52.19 -116.53 5.2 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.637 ' O ' HG22 ' A' ' 37' ' ' ILE . 53.4 m -91.2 -101.03 0.11 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.378 -1.072 . . . . 0.0 110.184 -179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.786 ' CG2' HG23 ' A' ' 38' ' ' VAL . 1.5 tp 67.95 173.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.23 -0.919 . . . . 0.0 108.767 -179.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.786 HG23 ' CG2' ' A' ' 37' ' ' ILE . 6.4 t 78.86 -7.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.33 -0.856 . . . . 0.0 109.689 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 38' ' ' VAL . 19.5 p . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.315 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.284 0.564 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 42' ' ' TYR . . . . . 0.579 ' CE2' ' HA ' ' B' ' 44' ' ' ILE . 53.6 p90 -120.87 -155.72 0.64 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.41 -0.806 . . . . 0.0 109.341 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 43' ' ' ARG . . . . . 0.569 ' HD3' ' CG1' ' B' ' 63' ' ' VAL . 1.6 tpp180 -88.91 75.53 8.04 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.389 -0.819 . . . . 0.0 109.158 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.579 ' HA ' ' CE2' ' B' ' 42' ' ' TYR . 0.4 OUTLIER -52.64 142.74 4.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 179.185 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.749 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -96.54 50.21 1.13 Allowed 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.703 -1.248 . . . . 0.0 110.4 -178.738 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 46' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 28' ' ' GLN . 15.0 ttm180 -150.03 150.21 31.44 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.436 -0.79 . . . . 0.0 108.9 178.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.668 HG22 ' CG2' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -151.71 179.9 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.769 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.618 ' HB3' ' CE2' ' B' ' 50' ' ' PHE . 0.9 OUTLIER -107.38 85.21 2.09 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.905 -1.122 . . . . 0.0 111.62 -178.924 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 1.04 HD12 HG13 ' A' ' 31' ' ' VAL . 2.1 tm? -78.31 93.47 4.67 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 50' ' ' PHE . . . . . 1.036 ' CE1' HD21 ' A' ' 32' ' ' LEU . 50.4 m-85 -89.42 132.95 34.75 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 32' ' ' LEU . 16.7 m -99.77 -169.31 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.842 -1.161 . . . . 0.0 109.538 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 52' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' B' ' 55' ' ' ASP . 3.6 p-10 -126.77 -148.89 0.4 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.209 -0.932 . . . . 0.0 109.119 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 53' ' ' LYS . . . . . 0.496 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 4.6 mmmm -76.5 -45.43 30.97 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 54' ' ' LEU . . . . . 0.507 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 1.4 mt -101.15 34.46 2.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.542 -0.724 . . . . 0.0 109.612 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 55' ' ' ASP . . . . . 0.536 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.0 OUTLIER 53.77 68.28 0.87 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.016 -1.052 . . . . 0.0 108.179 -178.787 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 56' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' B' ' 58' ' ' ALA . 47.1 t-20 -130.93 100.4 5.24 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.678 HD12 HD21 ' B' ' 49' ' ' LEU . 31.2 mm -40.67 88.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.495 0.664 . . . . 0.0 110.624 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 58' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -89.59 -18.46 26.52 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.5 108.33 14.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.48 -0.763 . . . . 0.0 108.998 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.741 ' CG2' HG23 ' A' ' 9' ' ' VAL . 32.8 t -66.27 133.51 94.55 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.304 -0.872 . . . . 0.0 110.236 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.611 ' HB3' HD11 ' A' ' 29' ' ' ILE . 36.5 Cg_endo -81.72 165.17 18.05 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.601 2.201 . . . . 0.0 110.496 179.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 62' ' ' ARG . . . . . 0.567 ' CD ' ' HA ' ' A' ' 4' ' ' GLU . 1.1 tpp180 -150.22 134.85 17.47 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.223 -0.923 . . . . 0.0 110.54 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.668 ' CG2' HG22 ' B' ' 47' ' ' VAL . 1.4 t -118.06 146.96 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 CA-C-O 117.959 -1.467 . . . . 0.0 109.626 179.912 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.697 HG22 ' HD2' ' A' ' 24' ' ' LYS . 1.4 p . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.592 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -131.53 -30.76 1.64 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.043 -1.036 . . . . 0.0 110.484 -179.646 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.668 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 5.8 m-90 51.44 46.29 3.49 Favored Pre-proline 0 C--N 1.296 -1.723 0 C-N-CA 118.088 -1.445 . . . . 0.0 108.237 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.668 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 32.8 Cg_endo -73.76 -33.86 6.01 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 N-CA-C 107.75 -1.673 . . . . 0.0 107.75 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.69 -11.13 59.82 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.761 HD21 ' HB2' ' A' ' 16' ' ' ALA . 63.4 tp -79.96 -5.05 54.96 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 121.394 -0.816 . . . . 0.0 109.586 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.666 HG22 ' CG2' ' B' ' 60' ' ' VAL . 42.5 t -53.75 149.2 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 120.994 -1.066 . . . . 0.0 110.466 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 58.42 11.68 10.58 Favored Glycine 0 N--CA 1.481 1.647 0 C-N-CA 120.194 -1.003 . . . . 0.0 110.644 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.612 ' CB ' HD12 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -91.49 -144.28 0.19 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.925 -1.338 . . . . 0.0 109.124 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.431 ' O ' HD11 ' B' ' 57' ' ' ILE . 0.5 OUTLIER -145.54 157.1 44.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.035 -1.04 . . . . 0.0 109.961 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.515 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 93.0 t -48.68 -34.28 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.343 -0.848 . . . . 0.0 109.479 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.508 ' O ' ' CD ' ' A' ' 18' ' ' LYS . 7.8 mm-40 -44.6 -75.52 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.092 -1.005 . . . . 0.0 109.163 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -58.71 -32.34 69.08 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.687 -0.633 . . . . 0.0 109.959 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.761 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -62.45 -80.66 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.086 -1.009 . . . . 0.0 109.676 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.514 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -44.2 -39.94 4.75 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.872 -1.143 . . . . 0.0 108.942 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.528 ' N ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -51.53 -81.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.75 0.786 . . . . 0.0 111.085 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.9 t -66.08 -49.27 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.809 -0.557 . . . . 0.0 110.472 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.966 HD13 HD13 ' A' ' 29' ' ' ILE . 61.7 mt -45.8 -40.13 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 0.0 109.518 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.56 ' CD1' ' HG3' ' A' ' 28' ' ' GLN . 35.1 tp -38.84 -23.82 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.55 ' O ' ' N ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -135.37 -81.22 0.42 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 119.977 -1.702 . . . . 0.0 111.617 -178.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.613 ' OD2' ' HA ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER 37.77 -94.82 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.739 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.697 ' HD2' HG22 ' A' ' 3' ' ' THR . 0.0 OUTLIER -58.48 -163.76 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 176.214 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.62 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 37.4 Cg_endo -76.32 82.44 2.23 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 N-CA-C 108.666 -1.321 . . . . 0.0 108.666 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.533 ' CG ' ' C ' ' A' ' 25' ' ' PRO . 0.3 OUTLIER 56.88 52.22 9.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.65 -0.657 . . . . 0.0 111.009 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.789 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -88.82 112.05 22.77 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 177.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.56 ' HG3' ' CD1' ' A' ' 21' ' ' LEU . 0.6 OUTLIER -87.51 -166.62 1.63 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.012 -1.055 . . . . 0.0 110.721 -177.213 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.966 HD13 HD13 ' A' ' 20' ' ' ILE . 1.7 tt -149.86 144.23 17.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.477 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.497 ' O ' ' HB3' ' B' ' 49' ' ' LEU . 31.9 mt -89.39 115.27 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.752 -0.593 . . . . 0.0 109.985 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.638 HG13 ' O ' ' A' ' 31' ' ' VAL . 8.0 p -89.91 109.59 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.545 -1.347 . . . . 0.0 109.906 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.105 HD11 ' CE1' ' B' ' 50' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 C-N-CA 119.087 -1.045 . . . . 0.0 110.411 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.516 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 8.0 ptp180 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.482 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.7 OUTLIER -42.5 145.59 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 119.403 -0.919 . . . . 0.0 108.896 179.795 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.568 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.1 p-10 -107.66 46.43 0.94 Allowed 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.918 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' ARG . . . . . 0.484 ' HG2' HG13 ' A' ' 30' ' ' ILE . 11.3 mtt180 -150.16 150.1 31.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.33 -0.856 . . . . 0.0 109.426 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 1.101 ' CG2' HG23 ' B' ' 63' ' ' VAL . 79.2 t -151.32 126.47 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.316 -0.865 . . . . 0.0 110.082 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -53.35 87.95 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.734 -1.229 . . . . 0.0 110.584 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.583 ' HB2' ' CG1' ' A' ' 29' ' ' ILE . 4.9 tp -91.29 87.26 6.41 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' PHE . . . . . 1.105 ' CE1' HD11 ' A' ' 32' ' ' LEU . 5.7 m-30 -72.59 148.44 44.9 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.467 ' HB ' ' HA ' ' B' ' 55' ' ' ASP . 34.8 m -122.4 166.53 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.711 -1.243 . . . . 0.0 109.872 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' B' ' 55' ' ' ASP . 1.5 p-10 -93.52 -151.34 0.3 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.57 -0.707 . . . . 0.0 109.25 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.503 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 0.1 OUTLIER -75.56 -46.5 31.6 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.236 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.517 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 1.8 mm? -101.61 36.81 1.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.622 -0.674 . . . . 0.0 109.655 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . 0.539 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.0 OUTLIER 52.77 67.11 1.04 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.192 -0.942 . . . . 0.0 109.583 -179.32 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . 0.565 ' O ' ' N ' ' B' ' 58' ' ' ALA . 29.0 t30 -119.97 86.02 2.49 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.56 HD12 ' HG ' ' A' ' 8' ' ' LEU . 4.6 mt -31.94 87.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 CA-C-O 121.637 0.732 . . . . 0.0 111.42 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -89.37 -4.63 57.98 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -125.91 133.24 51.94 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.666 ' CG2' HG22 ' A' ' 9' ' ' VAL . 93.8 t -90.76 131.21 38.27 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.042 -1.036 . . . . 0.0 111.068 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . 0.874 ' CB ' HG11 ' B' ' 47' ' ' VAL . 37.3 Cg_endo -83.84 161.75 14.05 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.581 2.188 . . . . 0.0 108.813 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' ARG . . . . . 0.563 ' HD3' ' HA ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -140.58 -49.15 0.44 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.798 -1.189 . . . . 0.0 110.164 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 1.101 HG23 ' CG2' ' B' ' 47' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--N 1.295 -1.773 0 O-C-N 121.442 -0.786 . . . . 0.0 109.812 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.603 HG23 ' HG3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.602 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 3.8 mt-10 -148.45 -44.2 0.15 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.276 -0.89 . . . . 0.0 110.655 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.647 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 6.1 m-90 59.6 41.67 0.6 Allowed Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 121.157 -0.964 . . . . 0.0 109.788 -178.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.647 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 34.1 Cg_endo -73.31 -33.36 7.2 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 N-CA-C 107.204 -1.883 . . . . 0.0 107.204 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -70.3 -12.53 61.65 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.621 ' HG ' HD12 ' B' ' 57' ' ' ILE . 49.5 tp -83.69 -4.31 58.5 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 121.385 -0.822 . . . . 0.0 109.262 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.562 HG23 HG21 ' B' ' 60' ' ' VAL . 14.7 t -53.69 152.36 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.91 -1.119 . . . . 0.0 109.319 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.426 ' C ' ' OD1' ' B' ' 56' ' ' ASN . . . 66.85 4.77 28.56 Favored Glycine 0 N--CA 1.481 1.635 0 C-N-CA 119.823 -1.18 . . . . 0.0 110.625 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 2.3 tptp -94.54 -146.88 0.26 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.778 -1.425 . . . . 0.0 109.627 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.491 ' CB ' ' OE2' ' A' ' 14' ' ' GLU . 33.2 m -144.8 169.16 18.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.104 -0.998 . . . . 0.0 109.998 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.635 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 88.4 t -54.21 -34.92 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.488 -0.758 . . . . 0.0 109.902 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.551 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 1.3 pm0 -44.07 -73.75 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.313 -0.867 . . . . 0.0 109.197 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.79 -31.02 71.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.257 -0.902 . . . . 0.0 109.61 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.813 ' HB2' HD11 ' B' ' 57' ' ' ILE . . . -61.39 -83.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.103 -0.998 . . . . 0.0 109.481 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.523 ' HG2' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -46.79 -41.53 15.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.78 -1.2 . . . . 0.0 108.768 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.551 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -44.57 -77.37 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.617 0.722 . . . . 0.0 110.185 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.703 HG12 ' CG ' ' A' ' 23' ' ' ASP . 1.9 t -72.91 -54.35 16.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.728 -0.608 . . . . 0.0 110.225 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.801 HD13 HD13 ' A' ' 29' ' ' ILE . 62.5 mt -33.92 -50.74 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.611 -0.681 . . . . 0.0 110.362 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.616 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.6 tt -38.66 -53.88 1.59 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.512 -0.742 . . . . 0.0 110.638 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -123.79 21.22 9.2 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.963 -1.085 . . . . 0.0 111.172 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.703 ' CG ' HG12 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -56.66 -60.16 3.95 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 177.648 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.756 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 3.2 tttm -68.23 -153.87 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 104.37 -2.456 . . . . 0.0 104.37 175.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.756 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 27.7 Cg_endo -68.68 -45.81 2.13 Favored 'Trans proline' 0 C--N 1.319 -1.012 0 CA-C-N 121.15 1.446 . . . . 0.0 109.002 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 1.7 mt-10 -166.34 52.33 0.09 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.662 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -90.22 117.32 28.88 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.176 -1.009 . . . . 0.0 109.33 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 11.5 mt-30 -88.79 178.49 6.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.155 -0.965 . . . . 0.0 109.152 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.801 HD13 HD13 ' A' ' 20' ' ' ILE . 8.5 tt -148.75 138.85 16.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 C-N-CA 118.99 -1.084 . . . . 0.0 111.074 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.579 HD12 ' HG3' ' B' ' 46' ' ' ARG . 1.2 mt -91.24 164.24 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.814 ' C ' HD23 ' A' ' 32' ' ' LEU . 7.4 p -131.06 135.84 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.683 -1.261 . . . . 0.0 110.187 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.948 HD23 ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 110.075 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.527 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.433 ' C ' ' O ' ' B' ' 43' ' ' ARG . 11.8 tt -44.88 160.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.938 -1.101 . . . . 0.0 108.037 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.662 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.7 p-10 -127.08 45.83 2.63 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 118.602 -1.239 . . . . 0.0 110.167 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' ARG . . . . . 0.579 ' HG3' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -152.07 150.55 30.06 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.63 HG22 ' CG2' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -151.4 168.62 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.95 -1.094 . . . . 0.0 109.355 -179.617 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.541 ' HG3' HD11 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -97.54 93.8 6.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.969 -1.082 . . . . 0.0 109.333 179.686 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.561 ' C ' HD12 ' B' ' 49' ' ' LEU . 0.9 OUTLIER -88.67 82.05 6.93 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.439 -0.904 . . . . 0.0 109.475 179.745 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' PHE . . . . . 0.629 ' HE1' HD11 ' A' ' 32' ' ' LEU . 2.9 m-30 -66.05 158.22 28.97 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 12.2 m -118.86 -174.98 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.799 -1.188 . . . . 0.0 109.295 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.502 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.5 OUTLIER -124.86 -154.3 0.61 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.029 -1.044 . . . . 0.0 110.08 -179.531 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.502 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 1.8 mtmp? -60.85 -57.39 12.86 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.606 -0.684 . . . . 0.0 109.653 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.43 ' HA ' HD13 ' B' ' 54' ' ' LEU . 0.3 OUTLIER -99.58 44.58 1.02 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.331 -0.856 . . . . 0.0 109.741 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 48.7 63.72 1.99 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.072 -1.018 . . . . 0.0 109.162 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . 0.587 ' O ' ' N ' ' B' ' 58' ' ' ALA . 7.6 t30 -130.25 109.85 11.1 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.813 HD11 ' HB2' ' A' ' 16' ' ' ALA . 23.9 mt -34.34 86.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 121.485 0.659 . . . . 0.0 111.262 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . 0.587 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -89.13 -8.77 53.1 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.47 85.43 2.05 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.562 HG21 HG23 ' A' ' 9' ' ' VAL . 2.2 t -48.25 139.49 10.23 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.465 -0.772 . . . . 0.0 110.131 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . 0.591 ' CG ' ' CD1' ' A' ' 29' ' ' ILE . 36.4 Cg_endo -81.21 168.96 16.42 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.856 2.371 . . . . 0.0 109.404 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' ARG . . . . . 0.544 ' HD2' ' CB ' ' A' ' 4' ' ' GLU . 0.5 OUTLIER -149.89 124.45 9.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.873 -1.142 . . . . 0.0 110.274 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.63 ' CG2' HG22 ' B' ' 47' ' ' VAL . 2.6 t . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.339 -0.85 . . . . 0.0 108.788 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.786 HG22 ' CD ' ' A' ' 24' ' ' LYS . 2.8 p . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.633 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 0.4 OUTLIER -125.5 -57.75 1.45 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.196 -0.94 . . . . 0.0 110.012 -179.118 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.789 ' O ' HD22 ' A' ' 8' ' ' LEU . 5.0 m-90 70.3 39.78 0.18 Allowed Pre-proline 0 C--N 1.3 -1.561 0 O-C-N 121.765 -0.584 . . . . 0.0 110.827 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.633 ' HD3' ' CB ' ' A' ' 4' ' ' GLU . 33.1 Cg_endo -72.31 -30.18 13.14 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 N-CA-C 107.559 -1.746 . . . . 0.0 107.559 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.51 -17.66 64.75 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.302 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.064 HD23 ' N ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -69.48 -23.02 63.58 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 122.254 1.026 . . . . 0.0 108.565 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.064 ' N ' HD23 ' A' ' 8' ' ' LEU . 3.8 t -43.63 138.61 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-O 121.988 0.899 . . . . 0.0 110.88 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.507 ' O ' ' OD1' ' B' ' 56' ' ' ASN . . . 86.5 -45.55 3.46 Favored Glycine 0 C--N 1.298 -1.581 0 C-N-CA 119.749 -1.215 . . . . 0.0 112.364 175.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.3 78.14 1.08 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 119.951 -1.911 . . . . 0.0 111.492 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.881 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 0.9 OUTLIER -153.18 46.73 0.68 Allowed 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 118.315 -1.354 . . . . 0.0 111.345 179.486 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.644 HG21 ' O ' ' B' ' 55' ' ' ASP . 23.9 t -77.28 -73.03 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 O-C-N 121.068 -1.02 . . . . 0.0 109.725 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.484 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 11.6 pt-20 -55.71 -38.25 69.47 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.452 ' HA ' ' HB3' ' A' ' 18' ' ' LYS . 4.3 tt0 -68.48 -32.72 72.9 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.881 ' HB2' ' O ' ' A' ' 12' ' ' SER . . . -62.69 -71.62 0.15 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.096 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.787 ' HE2' HD12 ' A' ' 21' ' ' LEU . 0.5 OUTLIER -50.56 -35.58 30.48 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.112 179.613 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.5 ' HG2' ' N ' ' A' ' 19' ' ' VAL . 2.6 ttmt -62.17 -90.29 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.576 0.703 . . . . 0.0 110.742 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.735 HG12 ' OD2' ' A' ' 23' ' ' ASP . 3.4 t -46.19 -48.32 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.639 -0.663 . . . . 0.0 110.371 -178.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.928 HD13 HD13 ' A' ' 29' ' ' ILE . 61.6 mt -50.43 -50.88 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.176 -0.953 . . . . 0.0 109.876 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.787 HD12 ' HE2' ' A' ' 17' ' ' LYS . 3.3 tt -35.13 -29.99 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.679 -0.638 . . . . 0.0 111.544 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.566 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -136.36 3.24 2.81 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 118.002 -1.479 . . . . 0.0 111.98 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.735 ' OD2' HG12 ' A' ' 19' ' ' VAL . 22.5 m-20 -54.12 147.17 13.33 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 177.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.786 ' CD ' HG22 ' A' ' 3' ' ' THR . 21.9 mtpt 69.86 -147.0 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 104.425 -2.435 . . . . 0.0 104.425 -175.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.688 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 33.2 Cg_endo -75.42 -64.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.324 -0.745 0 CA-C-N 121.36 1.521 . . . . 0.0 108.814 178.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 26.9 mt-10 -161.06 64.66 0.29 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.789 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -88.78 117.53 27.84 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.494 ' CB ' ' O ' ' B' ' 45' ' ' ASP . 0.0 OUTLIER -88.19 175.76 7.56 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.182 -0.949 . . . . 0.0 109.7 -179.47 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.928 HD13 HD13 ' A' ' 20' ' ' ILE . 3.3 tt -143.12 147.11 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.225 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.501 HD12 ' HD2' ' B' ' 46' ' ' ARG . 4.2 mt -102.44 130.89 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.878 HG13 ' HG ' ' B' ' 49' ' ' LEU . 2.5 t -104.23 125.72 58.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 120.798 -1.189 . . . . 0.0 109.721 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.077 HD11 ' CE1' ' B' ' 50' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.542 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 120.881 0.372 . . . . 0.0 110.213 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.512 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.5 OUTLIER -46.96 145.45 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.706 -1.246 . . . . 0.0 108.108 179.187 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.62 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.0 OUTLIER -105.86 43.05 1.16 Allowed 'General case' 0 C--N 1.295 -1.763 0 O-C-N 120.914 -1.116 . . . . 0.0 109.829 -179.338 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' ARG . . . . . 0.501 ' HD2' HD12 ' A' ' 30' ' ' ILE . 0.3 OUTLIER -151.02 155.05 38.23 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.366 -0.834 . . . . 0.0 109.477 179.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.944 ' CG2' HG23 ' B' ' 63' ' ' VAL . 15.4 t -150.29 173.42 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 109.456 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.606 ' H ' HG12 ' B' ' 47' ' ' VAL . 20.4 mmt180 -101.59 66.51 1.08 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.982 -1.074 . . . . 0.0 109.942 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.878 ' HG ' HG13 ' A' ' 31' ' ' VAL . 3.8 tp -61.49 89.94 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.268 -0.973 . . . . 0.0 109.121 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' PHE . . . . . 1.077 ' CE1' HD11 ' A' ' 32' ' ' LEU . 7.3 m-30 -79.26 135.32 36.73 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.789 HG22 ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -104.89 -174.94 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.79 -1.194 . . . . 0.0 109.147 179.383 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.533 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.0 OUTLIER -126.48 -162.84 1.18 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.252 -0.905 . . . . 0.0 109.729 -179.687 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.533 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 21.0 mtpt -46.6 -64.74 0.69 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.398 0.618 . . . . 0.0 109.919 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.422 ' O ' ' C ' ' B' ' 55' ' ' ASP . 0.5 OUTLIER -95.38 52.28 1.38 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.793 -179.563 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . 0.644 ' O ' HG21 ' A' ' 13' ' ' VAL . 0.0 OUTLIER 42.72 57.52 3.51 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.351 -0.843 . . . . 0.0 109.654 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . 0.507 ' OD1' ' O ' ' A' ' 10' ' ' GLY . 0.5 OUTLIER -115.6 122.11 44.65 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.412 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.673 HD13 HD11 ' A' ' 8' ' ' LEU . 5.0 mt -60.69 89.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.293 -0.88 . . . . 0.0 110.196 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.72 -28.31 20.62 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . 0.454 ' HB3' ' HB2' ' B' ' 50' ' ' PHE . 4.5 tt0 -105.13 133.02 50.61 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.613 HG22 HG23 ' A' ' 9' ' ' VAL . 58.9 t -89.15 129.11 49.1 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 120.843 -1.161 . . . . 0.0 110.711 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . 0.794 ' HB2' HG11 ' B' ' 47' ' ' VAL . 36.6 Cg_endo -82.64 160.54 16.67 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.632 2.222 . . . . 0.0 109.295 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 3' ' ' THR . 0.0 OUTLIER -150.03 143.14 24.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.906 -1.121 . . . . 0.0 110.062 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.944 HG23 ' CG2' ' B' ' 47' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 24' ' ' LYS . 4.1 p . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.541 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.5 mt-10 -112.04 179.23 4.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.422 -0.799 . . . . 0.0 109.336 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.612 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 14.7 m-90 -150.78 47.3 0.44 Allowed Pre-proline 0 C--N 1.298 -1.658 0 O-C-N 121.52 -0.738 . . . . 0.0 109.79 178.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 31.3 Cg_endo -71.18 -25.72 21.95 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 N-CA-C 107.411 -1.803 . . . . 0.0 107.411 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -69.79 -20.32 63.47 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.507 HD13 ' HA ' ' A' ' 16' ' ' ALA . 11.4 mt -83.64 -4.01 58.22 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.496 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.583 ' CG2' ' CG2' ' B' ' 60' ' ' VAL . 22.7 t -55.41 147.78 3.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.106 -0.996 . . . . 0.0 109.833 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.427 ' C ' ' OD1' ' B' ' 56' ' ' ASN . . . 61.65 10.4 23.98 Favored Glycine 0 N--CA 1.481 1.668 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 2.1 tptp -96.12 -144.59 0.28 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.959 -1.318 . . . . 0.0 109.071 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.416 ' CA ' HG12 ' B' ' 57' ' ' ILE . 1.4 m -142.76 165.86 26.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.044 -1.035 . . . . 0.0 109.909 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.682 ' CG2' HG11 ' A' ' 31' ' ' VAL . 76.4 t -50.86 -40.1 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.434 -0.791 . . . . 0.0 109.443 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.536 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 56.7 mt-10 -43.8 -72.1 0.07 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.468 -0.77 . . . . 0.0 109.538 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -56.37 -34.62 66.83 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.081 -1.012 . . . . 0.0 109.734 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.607 ' C ' HD12 ' A' ' 20' ' ' ILE . . . -63.44 -84.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 110.206 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.577 ' HG2' HG23 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -44.74 -34.25 2.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.947 -1.096 . . . . 0.0 109.044 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 6.0 ttmt -55.98 -82.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.542 0.687 . . . . 0.0 110.511 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.484 HG12 ' HB3' ' A' ' 23' ' ' ASP . 2.0 t -64.28 -49.9 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.545 -0.722 . . . . 0.0 109.769 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.929 HD13 HD13 ' A' ' 29' ' ' ILE . 77.1 mt -42.54 -54.09 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.364 -0.835 . . . . 0.0 109.47 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 28' ' ' GLN . 4.9 tt -42.1 -45.81 4.08 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.263 -0.898 . . . . 0.0 110.223 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -143.61 54.58 1.33 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.992 -1.068 . . . . 0.0 110.624 -179.188 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.604 ' OD2' ' CZ2' ' A' ' 5' ' ' TRP . 35.0 p-10 -76.23 -28.9 57.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.859 -1.151 . . . . 0.0 108.768 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.779 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -130.72 -83.45 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.055 -1.028 . . . . 0.0 108.692 178.315 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.779 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 42.4 Cg_endo -88.68 -84.93 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.645 0 N-CA-C 108.144 -1.521 . . . . 0.0 108.144 177.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 10.2 mt-10 -162.06 56.3 0.24 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.989 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -88.69 118.12 28.14 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.084 -1.01 . . . . 0.0 109.125 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 1.8 mt-30 -88.19 178.35 6.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 0.0 109.373 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.929 HD13 HD13 ' A' ' 20' ' ' ILE . 5.9 tt -147.43 137.67 17.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 C-N-CA 119.204 -0.998 . . . . 0.0 111.011 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.565 HD11 ' HD2' ' B' ' 46' ' ' ARG . 8.3 mt -90.28 117.36 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.944 HG13 ' HG ' ' B' ' 49' ' ' LEU . 5.1 t -99.82 140.98 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.797 -1.189 . . . . 0.0 109.75 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.963 HD21 ' CE1' ' B' ' 50' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.264 -0.897 . . . . 0.0 109.536 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.583 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.091 0.472 . . . . 0.0 109.757 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.432 ' C ' ' O ' ' B' ' 43' ' ' ARG . 0.7 OUTLIER -48.4 137.1 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.544 -1.347 . . . . 0.0 107.644 179.222 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.647 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 4.3 p-10 -89.62 48.3 1.58 Allowed 'General case' 0 C--N 1.292 -1.896 0 C-N-CA 119.076 -1.05 . . . . 0.0 109.396 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' ARG . . . . . 0.565 ' HD2' HD11 ' A' ' 30' ' ' ILE . 10.1 ttp180 -151.08 151.68 32.33 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 1.119 ' CG2' HG23 ' B' ' 63' ' ' VAL . 61.4 t -151.43 169.34 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.592 ' HB3' ' CE2' ' B' ' 50' ' ' PHE . 12.6 mmt-85 -100.18 84.46 2.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.631 -1.293 . . . . 0.0 110.709 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.944 ' HG ' HG13 ' A' ' 31' ' ' VAL . 4.2 tp -84.68 97.69 9.79 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 118.933 -1.107 . . . . 0.0 108.62 178.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' PHE . . . . . 0.963 ' CE1' HD21 ' A' ' 32' ' ' LEU . 52.4 m-85 -92.88 131.71 37.66 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 178.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.907 HG22 ' O ' ' A' ' 32' ' ' LEU . 12.9 m -89.08 178.04 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.619 -1.301 . . . . 0.0 110.349 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.511 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.8 OUTLIER -107.89 -151.72 0.47 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.354 -0.841 . . . . 0.0 109.775 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.511 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 1.2 mmtp -74.03 -48.47 29.86 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.478 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.1 OUTLIER -98.99 38.19 1.42 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.39 -0.819 . . . . 0.0 109.503 179.534 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.0 OUTLIER 50.48 67.62 0.89 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.165 -0.96 . . . . 0.0 109.181 -179.413 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . 0.565 ' O ' ' N ' ' B' ' 58' ' ' ALA . 1.2 t30 -133.58 117.35 16.98 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.652 ' CD1' HD11 ' B' ' 49' ' ' LEU . 27.0 mm -46.88 87.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-O 121.384 0.612 . . . . 0.0 109.823 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -89.32 -25.46 21.62 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -105.01 129.42 53.46 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.583 ' CG2' ' CG2' ' A' ' 9' ' ' VAL . 85.3 t -82.56 126.35 73.82 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.054 -1.029 . . . . 0.0 109.989 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . 0.954 ' HB2' HG11 ' B' ' 47' ' ' VAL . 37.0 Cg_endo -81.36 158.91 19.87 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 C-N-CA 122.403 2.068 . . . . 0.0 110.199 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' ARG . . . . . 0.457 ' NE ' ' HB3' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -150.91 130.62 13.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.054 -1.029 . . . . 0.0 109.839 179.411 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 1.119 HG23 ' CG2' ' B' ' 47' ' ' VAL . 1.1 t . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.308 -0.87 . . . . 0.0 108.901 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.506 HG22 ' O ' ' B' ' 63' ' ' VAL . 2.1 m . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.716 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.7 mt-10 -102.4 -36.43 8.44 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.112 -0.993 . . . . 0.0 110.026 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.78 ' NE1' HD12 ' A' ' 20' ' ' ILE . 7.8 m-90 56.2 47.33 2.87 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 121.018 -1.051 . . . . 0.0 109.249 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.716 ' HD3' ' HB2' ' A' ' 4' ' ' GLU . 33.4 Cg_endo -74.99 -37.39 2.06 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 N-CA-C 106.789 -2.043 . . . . 0.0 106.789 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -8.62 50.07 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 114.524 -1.216 . . . . 0.0 107.797 177.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.565 ' HG ' HD12 ' B' ' 57' ' ' ILE . 13.2 tp -83.2 -2.03 54.51 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 121.289 -0.882 . . . . 0.0 109.198 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.659 HG22 HG23 ' B' ' 60' ' ' VAL . 17.7 t -57.18 149.54 4.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.021 -1.049 . . . . 0.0 109.459 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.56 8.67 21.27 Favored Glycine 0 N--CA 1.481 1.688 0 C-N-CA 119.858 -1.163 . . . . 0.0 110.309 178.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 17.0 tptt -91.1 -145.63 0.19 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.789 -1.418 . . . . 0.0 109.161 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' B' ' 55' ' ' ASP . 0.4 OUTLIER -145.71 160.88 41.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.029 -1.045 . . . . 0.0 109.894 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.859 HG23 HG11 ' B' ' 51' ' ' VAL . 53.7 t -51.89 -32.48 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.339 -0.851 . . . . 0.0 109.19 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.547 ' O ' ' CG ' ' A' ' 18' ' ' LYS . 5.4 mt-10 -43.05 -74.06 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.501 ' HB3' HD11 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -59.97 -37.37 79.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.559 -0.713 . . . . 0.0 109.993 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.604 ' HB3' ' HA ' ' A' ' 13' ' ' VAL . . . -59.44 -80.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 0.0 110.04 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.532 ' HA ' ' CG2' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -47.21 -32.86 4.8 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.469 -1.394 . . . . 0.0 109.347 -179.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.547 ' CG ' ' O ' ' A' ' 14' ' ' GLU . 16.1 mtpt -58.86 -85.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.753 0.787 . . . . 0.0 110.953 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.522 ' O ' ' N ' ' A' ' 23' ' ' ASP . 2.8 t -57.83 -41.33 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.592 -0.692 . . . . 0.0 110.08 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.956 HG21 ' HB ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER -48.73 -52.31 9.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.352 -0.843 . . . . 0.0 109.16 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.461 ' C ' ' O ' ' A' ' 20' ' ' ILE . 0.7 OUTLIER -38.14 -40.86 0.54 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.685 -0.635 . . . . 0.0 110.125 -179.581 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.402 ' HB2' HD23 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -140.38 40.88 1.91 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.112 -0.993 . . . . 0.0 109.765 179.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 19' ' ' VAL . 18.8 p-10 -52.09 -42.93 63.63 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.336 -0.852 . . . . 0.0 109.493 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.782 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -130.75 -78.69 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.444 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.715 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.782 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 40.6 Cg_endo -87.57 -80.79 0.0 OUTLIER 'Trans proline' 0 C--O 1.214 -0.717 0 N-CA-C 107.78 -1.662 . . . . 0.0 107.78 177.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 22.4 mt-10 -161.96 62.08 0.24 Allowed 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.765 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -87.92 121.25 30.11 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.989 -1.069 . . . . 0.0 110.236 -178.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.43 ' O ' HG23 ' B' ' 47' ' ' VAL . 1.1 tp60 -88.59 176.15 7.25 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.057 -1.027 . . . . 0.0 108.242 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.956 ' HB ' HG21 ' A' ' 20' ' ' ILE . 9.4 tt -148.9 137.53 14.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 120.7 -1.25 . . . . 0.0 111.193 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.503 ' O ' ' HB3' ' B' ' 49' ' ' LEU . 0.8 OUTLIER -88.92 152.89 3.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.011 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.705 HG21 HG21 ' A' ' 13' ' ' VAL . 7.6 p -135.02 134.93 53.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 118.813 -1.155 . . . . 0.0 110.298 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.886 HD23 ' N ' ' A' ' 32' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.44 -0.787 . . . . 0.0 109.283 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.533 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 2.0 ptt-85 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.544 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.3 OUTLIER -44.75 142.54 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.893 -1.129 . . . . 0.0 108.458 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.645 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.1 p-10 -102.1 48.67 0.87 Allowed 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.127 -1.029 . . . . 0.0 110.058 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.71 146.34 26.38 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.675 HG12 ' H ' ' B' ' 62' ' ' ARG . 0.0 OUTLIER -150.47 143.7 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 120.968 -1.083 . . . . 0.0 109.317 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -78.67 88.05 4.58 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.99 -1.069 . . . . 0.0 110.796 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.534 ' C ' HD12 ' B' ' 49' ' ' LEU . 2.1 tp -90.41 97.22 11.05 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.141 -1.024 . . . . 0.0 108.657 178.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' PHE . . . . . 0.843 ' CZ ' HD11 ' A' ' 32' ' ' LEU . 16.6 m-85 -92.35 110.72 22.12 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.859 HG11 HG23 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -89.77 172.08 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.906 -1.121 . . . . 0.0 110.947 -178.856 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' B' ' 54' ' ' LEU . 0.7 OUTLIER -94.66 -153.04 0.37 Allowed 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.683 0.754 . . . . 0.0 109.715 -179.233 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.521 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 6.2 mttm -76.84 -47.42 21.46 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.522 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.0 OUTLIER -95.83 39.69 1.13 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.577 -0.702 . . . . 0.0 109.488 179.553 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.0 OUTLIER 47.75 67.29 0.84 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.12 -0.987 . . . . 0.0 109.123 -179.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' B' ' 58' ' ' ALA . 17.8 t-20 -127.33 94.12 3.91 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.658 0.742 . . . . 0.0 109.011 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.575 HD11 ' HB2' ' A' ' 16' ' ' ALA . 4.5 mt -39.68 87.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.301 0.572 . . . . 0.0 111.066 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -89.48 -19.65 24.82 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -118.19 106.1 12.48 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.659 HG23 HG22 ' A' ' 9' ' ' VAL . 35.4 t -62.52 133.87 94.88 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.227 -0.921 . . . . 0.0 110.345 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . 0.586 ' CB ' HD11 ' A' ' 29' ' ' ILE . 36.2 Cg_endo -79.81 163.38 23.56 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 122.531 2.154 . . . . 0.0 109.398 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' ARG . . . . . 0.675 ' H ' HG12 ' B' ' 47' ' ' VAL . 0.0 OUTLIER -150.55 128.08 11.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.971 -1.081 . . . . 0.0 110.102 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.765 HG21 ' HB1' ' A' ' 27' ' ' ALA . 1.8 t . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.263 -0.898 . . . . 0.0 109.073 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.654 HG23 ' CD ' ' A' ' 24' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.332 0.587 . . . . 0.0 109.598 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.586 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 6.9 mt-10 -94.33 -44.56 7.88 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.264 -0.897 . . . . 0.0 109.999 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.62 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.5 m-90 64.19 41.83 0.36 Allowed Pre-proline 0 C--N 1.296 -1.724 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.109 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 34.4 Cg_endo -73.14 -30.46 10.6 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 N-CA-C 106.929 -1.989 . . . . 0.0 106.929 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.67 -13.88 62.25 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 177.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.03 HD21 HG21 ' B' ' 57' ' ' ILE . 0.0 OUTLIER -81.89 -5.6 58.4 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.509 ' CG2' ' CG2' ' B' ' 60' ' ' VAL . 25.2 t -53.29 151.94 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.0 -1.063 . . . . 0.0 109.745 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.422 ' HA2' ' OD1' ' B' ' 56' ' ' ASN . . . 62.83 7.27 15.19 Favored Glycine 0 N--CA 1.482 1.716 0 C-N-CA 119.982 -1.104 . . . . 0.0 110.422 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -93.55 -142.56 0.23 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.833 -1.392 . . . . 0.0 109.183 179.646 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -148.73 161.48 41.68 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.994 -1.066 . . . . 0.0 109.89 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.726 ' HA ' HD21 ' B' ' 49' ' ' LEU . 39.9 t -46.39 -35.82 2.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.415 -0.803 . . . . 0.0 109.048 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.538 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 1.5 mt-10 -44.84 -73.88 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.511 -0.743 . . . . 0.0 109.066 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.449 ' O ' HG23 ' A' ' 19' ' ' VAL . 1.9 tm-20 -55.92 -34.5 65.65 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.192 -0.942 . . . . 0.0 109.555 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.685 ' HB1' HD12 ' A' ' 20' ' ' ILE . . . -62.82 -85.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.088 -1.008 . . . . 0.0 110.166 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -42.87 -45.45 4.93 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.837 -1.165 . . . . 0.0 108.914 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 6.1 tptm -42.37 -76.13 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.573 0.702 . . . . 0.0 110.584 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.482 ' O ' ' C ' ' A' ' 20' ' ' ILE . 1.0 OUTLIER -78.16 -52.81 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.459 -0.776 . . . . 0.0 110.402 -178.39 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.685 HD12 ' HB1' ' A' ' 16' ' ' ALA . 60.1 mt -37.98 -34.72 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.394 -0.816 . . . . 0.0 110.004 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.726 HD23 ' HB2' ' A' ' 22' ' ' GLN . 2.4 tt -56.09 -52.98 62.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.081 -1.012 . . . . 0.0 110.357 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.726 ' HB2' HD23 ' A' ' 21' ' ' LEU . 0.4 OUTLIER -128.59 64.21 1.43 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.925 -1.109 . . . . 0.0 111.045 -178.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -84.42 -50.55 7.67 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.412 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.711 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 10.0 mtpp -101.05 -105.77 0.0 OUTLIER Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.711 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 37.2 Cg_endo -80.16 -70.98 0.01 OUTLIER 'Trans proline' 0 C--O 1.213 -0.738 0 CA-C-N 121.873 1.705 . . . . 0.0 108.059 177.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 25' ' ' PRO . 30.8 mt-10 -162.76 70.2 0.26 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.765 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -88.51 120.48 29.93 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.871 -1.143 . . . . 0.0 109.233 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.82 168.61 11.94 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.193 -0.942 . . . . 0.0 109.642 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.528 ' HB ' HG21 ' A' ' 20' ' ' ILE . 21.4 tt -146.91 140.34 19.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.351 -0.843 . . . . 0.0 109.944 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 1.025 HG22 HD22 ' A' ' 32' ' ' LEU . 1.7 mp -88.97 142.35 13.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.914 ' C ' HD23 ' A' ' 32' ' ' LEU . 4.0 p -105.82 133.04 51.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.47 -0.892 . . . . 0.0 109.491 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.025 HD22 HG22 ' A' ' 30' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.565 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.57 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 2.5 ptt180 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.006 0.431 . . . . 0.0 110.296 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.525 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.3 OUTLIER -47.52 142.91 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.82 -1.175 . . . . 0.0 107.955 178.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.651 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.5 p-10 -102.39 44.43 1.01 Allowed 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.004 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' ARG . . . . . 0.64 ' HG2' HD13 ' A' ' 30' ' ' ILE . 0.8 OUTLIER -151.09 142.69 23.6 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 178.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.536 HG12 ' H ' ' B' ' 62' ' ' ARG . 0.0 OUTLIER -150.59 157.75 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.126 -0.984 . . . . 0.0 109.319 -179.296 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.602 ' HD2' HD11 ' A' ' 32' ' ' LEU . 3.1 mmt180 -92.98 100.96 13.31 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.72 -1.237 . . . . 0.0 110.328 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.726 HD21 ' HA ' ' A' ' 13' ' ' VAL . 0.8 OUTLIER -95.45 96.02 8.82 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.263 -0.975 . . . . 0.0 108.872 178.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' PHE . . . . . 0.951 ' CE1' HD12 ' A' ' 32' ' ' LEU . 24.6 m-85 -93.26 143.53 26.17 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.554 HG23 ' N ' ' B' ' 52' ' ' ASP . 6.1 m -107.21 -151.57 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.769 -1.207 . . . . 0.0 110.858 -179.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.554 ' N ' HG23 ' B' ' 51' ' ' VAL . 0.2 OUTLIER -141.92 -157.47 0.77 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.426 -0.796 . . . . 0.0 109.68 -179.478 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.532 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 2.8 mtmp? -57.42 -59.02 5.77 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.667 -0.646 . . . . 0.0 109.509 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.428 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 6.7 tp -96.2 42.82 1.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.437 -0.789 . . . . 0.0 109.619 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . 0.498 ' HA ' ' HB ' ' B' ' 51' ' ' VAL . 0.0 OUTLIER 49.2 62.7 2.47 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.101 -0.999 . . . . 0.0 109.567 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . 0.551 ' O ' ' N ' ' B' ' 58' ' ' ALA . 4.0 t30 -122.59 106.19 10.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.311 -0.868 . . . . 0.0 108.808 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 1.03 HG21 HD21 ' A' ' 8' ' ' LEU . 28.0 mt -42.06 89.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.496 0.665 . . . . 0.0 110.374 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.48 -17.82 29.54 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -114.92 135.39 54.26 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.509 ' CG2' ' CG2' ' A' ' 9' ' ' VAL . 71.1 t -88.05 128.05 55.23 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.014 -1.054 . . . . 0.0 110.542 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . 0.479 ' O ' ' HD3' ' B' ' 62' ' ' ARG . 36.3 Cg_endo -79.76 158.36 24.69 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.317 2.012 . . . . 0.0 108.41 177.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' ARG . . . . . 0.536 ' H ' HG12 ' B' ' 47' ' ' VAL . 0.0 OUTLIER -150.54 133.05 15.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.768 -1.208 . . . . 0.0 110.409 -179.612 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.765 HG21 ' HB1' ' A' ' 27' ' ' ALA . 2.1 t . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.469 ' O ' ' HG3' ' B' ' 62' ' ' ARG . 2.4 m . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.619 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 27.7 mt-10 -118.82 -40.8 2.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -0.903 . . . . 0.0 109.914 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.641 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 9.6 m-90 61.7 41.92 0.49 Allowed Pre-proline 0 C--N 1.299 -1.621 0 O-C-N 121.524 -0.735 . . . . 0.0 110.092 -178.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 32.6 Cg_endo -72.49 -30.34 12.44 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 N-CA-C 106.468 -2.166 . . . . 0.0 106.468 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -16.05 63.17 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.086 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.583 HD11 ' CD1' ' A' ' 5' ' ' TRP . 7.2 mt -81.5 -5.78 58.3 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 121.302 -0.874 . . . . 0.0 109.293 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.653 ' CG2' HG22 ' B' ' 60' ' ' VAL . 23.7 t -57.0 148.04 4.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.148 -0.97 . . . . 0.0 109.81 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.423 ' HA2' ' OD1' ' B' ' 56' ' ' ASN . . . 60.12 10.19 14.1 Favored Glycine 0 N--CA 1.48 1.578 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.472 178.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.765 ' HB3' HD12 ' B' ' 57' ' ' ILE . 0.1 OUTLIER -94.65 -145.43 0.26 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.925 -1.338 . . . . 0.0 109.068 179.693 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 13' ' ' VAL . 0.3 OUTLIER -141.85 161.17 38.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.991 -1.068 . . . . 0.0 110.075 -179.546 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.602 ' HA ' HD11 ' B' ' 49' ' ' LEU . 79.1 t -45.16 -38.5 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.195 -0.941 . . . . 0.0 109.207 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.542 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 2.4 mt-10 -44.41 -75.28 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.413 ' O ' HG23 ' A' ' 19' ' ' VAL . 1.9 tp10 -53.46 -32.69 51.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.165 -0.959 . . . . 0.0 109.623 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.835 ' C ' HD12 ' A' ' 20' ' ' ILE . . . -62.58 -85.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 110.578 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.94 -29.45 4.78 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.757 -1.215 . . . . 0.0 109.271 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 16.6 tptm -56.78 -77.95 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.31 0.576 . . . . 0.0 110.749 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 15' ' ' GLU . 1.5 t -69.3 -43.49 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.353 -0.842 . . . . 0.0 109.849 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.835 HD12 ' C ' ' A' ' 16' ' ' ALA . 63.5 mt -48.13 -55.32 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.896 . . . . 0.0 110.003 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.464 ' C ' ' O ' ' A' ' 20' ' ' ILE . 1.2 tt -36.04 -35.84 0.08 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.584 -0.697 . . . . 0.0 110.794 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 20' ' ' ILE . 1.0 OUTLIER -141.91 56.87 1.49 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.02 -1.05 . . . . 0.0 109.718 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.495 ' OD2' ' HD3' ' A' ' 24' ' ' LYS . 26.6 p-10 -70.66 -31.46 68.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.923 . . . . 0.0 109.015 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.707 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -133.84 -97.85 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.702 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.707 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 36.2 Cg_endo -78.63 -68.72 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.716 0 N-CA-C 107.422 -1.799 . . . . 0.0 107.422 176.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.533 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 25.8 mt-10 -163.84 72.26 0.26 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 1.007 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -88.36 114.73 25.27 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.068 -1.02 . . . . 0.0 108.875 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.509 ' CB ' ' O ' ' B' ' 45' ' ' ASP . 0.0 OUTLIER -89.06 171.99 9.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.253 -0.904 . . . . 0.0 109.197 -179.6 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.775 HD13 HD13 ' A' ' 20' ' ' ILE . 14.9 tt -149.31 146.58 17.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.823 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.699 HG22 HD22 ' A' ' 32' ' ' LEU . 1.2 mp -89.04 155.78 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 1.035 HG13 HD13 ' B' ' 49' ' ' LEU . 2.0 t -127.91 116.24 42.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 118.555 -1.258 . . . . 0.0 110.956 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.942 HD11 ' CE1' ' B' ' 50' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.576 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 6.6 ptt-85 . . . . . 0 N--CA 1.494 1.739 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.575 ' O ' HG22 ' B' ' 63' ' ' VAL . 0.9 OUTLIER -48.05 136.05 4.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 120.622 -1.299 . . . . 0.0 108.132 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.564 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -90.13 38.65 0.94 Allowed 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.446 -0.901 . . . . 0.0 110.282 -178.445 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' ARG . . . . . 0.566 ' CG ' HD13 ' A' ' 30' ' ' ILE . 0.9 OUTLIER -141.11 146.98 37.79 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.634 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 1.106 ' CG2' HG23 ' B' ' 63' ' ' VAL . 63.5 t -151.59 169.26 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.102 -0.999 . . . . 0.0 109.365 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.6 ' N ' HG12 ' B' ' 47' ' ' VAL . 17.0 mmt-85 -99.5 95.52 7.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.718 -1.239 . . . . 0.0 109.57 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 1.035 HD13 HG13 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -90.67 82.54 5.77 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 118.954 -1.098 . . . . 0.0 109.293 179.465 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' PHE . . . . . 0.942 ' CE1' HD11 ' A' ' 32' ' ' LEU . 6.5 m-30 -74.46 145.46 43.6 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.513 ' HB ' ' HA ' ' B' ' 55' ' ' ASP . 14.1 m -127.02 176.54 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.573 -1.329 . . . . 0.0 110.742 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.489 ' OD2' ' HG2' ' B' ' 53' ' ' LYS . 0.0 OUTLIER -111.58 -171.76 1.9 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.489 ' HG2' ' OD2' ' B' ' 52' ' ' ASP . 1.8 ptmt -51.95 -53.41 41.66 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.965 -1.084 . . . . 0.0 110.781 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.406 ' C ' ' CG ' ' B' ' 55' ' ' ASP . 0.2 OUTLIER -88.96 38.08 0.87 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.964 -1.085 . . . . 0.0 108.797 179.706 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . 0.513 ' HA ' ' HB ' ' B' ' 51' ' ' VAL . 0.0 OUTLIER 51.35 51.42 16.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.688 -0.632 . . . . 0.0 109.458 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . 0.514 ' O ' ' N ' ' B' ' 58' ' ' ALA . 30.5 t30 -101.06 112.43 24.89 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.376 -0.827 . . . . 0.0 109.552 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.765 HD12 ' HB3' ' A' ' 11' ' ' LYS . 43.5 mt -51.9 91.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.581 -0.699 . . . . 0.0 109.276 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.12 -23.78 23.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.578 -0.701 . . . . 0.0 109.11 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.53 126.33 54.87 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.653 HG22 ' CG2' ' A' ' 9' ' ' VAL . 42.2 t -78.67 129.87 72.65 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 120.971 -1.081 . . . . 0.0 109.925 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . 0.887 ' HB2' HG11 ' B' ' 47' ' ' VAL . 36.7 Cg_endo -83.69 159.94 14.3 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.671 2.247 . . . . 0.0 111.189 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' ARG . . . . . 0.558 ' NH1' ' HB ' ' B' ' 60' ' ' VAL . 0.1 OUTLIER -147.23 146.05 29.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.261 179.036 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 1.106 HG23 ' CG2' ' B' ' 47' ' ' VAL . 1.2 t . . . . . 0 N--CA 1.495 1.775 0 O-C-N 121.011 -1.056 . . . . 0.0 109.34 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 59.5 p . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.551 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 4.6 mt-10 -100.78 174.6 5.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.539 -0.725 . . . . 0.0 109.146 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.643 ' CE2' HG12 ' A' ' 20' ' ' ILE . 17.9 m-90 -145.61 46.75 0.59 Allowed Pre-proline 0 C--N 1.298 -1.644 0 O-C-N 121.592 -0.693 . . . . 0.0 109.334 178.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.628 ' HA ' HG21 ' B' ' 60' ' ' VAL . 30.5 Cg_endo -70.31 -27.7 23.51 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 N-CA-C 107.796 -1.655 . . . . 0.0 107.796 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.43 -19.34 62.99 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.793 HD21 HG21 ' B' ' 57' ' ' ILE . 0.0 OUTLIER -87.33 -3.34 59.03 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.657 HG22 ' CG2' ' B' ' 60' ' ' VAL . 41.0 t -53.41 150.34 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 120.929 -1.107 . . . . 0.0 110.016 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.54 0.45 17.62 Favored Glycine 0 N--CA 1.48 1.598 0 C-N-CA 120.092 -1.051 . . . . 0.0 111.032 177.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -93.55 -154.78 0.42 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.625 -1.515 . . . . 0.0 109.321 179.732 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.458 ' O ' HD11 ' B' ' 57' ' ' ILE . 0.6 OUTLIER -134.98 177.88 7.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.113 -0.992 . . . . 0.0 110.197 -179.464 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.77 HG22 HD13 ' B' ' 49' ' ' LEU . 54.0 t -52.98 -43.03 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.526 -0.734 . . . . 0.0 110.199 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.533 ' O ' ' CG ' ' A' ' 18' ' ' LYS . 3.9 mt-10 -41.88 -71.07 0.09 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.387 -0.82 . . . . 0.0 109.41 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -56.62 -36.83 69.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.594 -0.691 . . . . 0.0 110.052 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.685 ' HB2' HD11 ' B' ' 57' ' ' ILE . . . -62.21 -81.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.192 -0.943 . . . . 0.0 110.032 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -46.22 -29.98 1.81 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.655 -1.278 . . . . 0.0 109.168 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 14' ' ' GLU . 4.4 mmtt -62.33 -84.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.628 0.728 . . . . 0.0 110.678 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.55 HG12 ' OD1' ' A' ' 23' ' ' ASP . 2.2 t -56.53 -46.4 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.526 -0.734 . . . . 0.0 109.766 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.943 HG21 ' HB ' ' A' ' 29' ' ' ILE . 87.7 mt -49.44 -58.27 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.238 -0.914 . . . . 0.0 109.386 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.61 HD23 ' HB2' ' A' ' 22' ' ' GLN . 3.3 tt -35.66 -33.97 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.693 -0.629 . . . . 0.0 110.796 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.61 ' HB2' HD23 ' A' ' 21' ' ' LEU . 0.8 OUTLIER -150.48 50.25 0.88 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.993 -1.067 . . . . 0.0 110.509 -179.631 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.55 ' OD1' HG12 ' A' ' 19' ' ' VAL . 2.8 t0 -73.48 -52.81 12.33 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.985 -1.072 . . . . 0.0 108.73 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.875 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.7 OUTLIER -102.38 -92.38 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.366 0 CA-C-O 117.451 -1.261 . . . . 0.0 108.058 178.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.875 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 39.5 Cg_endo -87.05 -74.14 0.0 OUTLIER 'Trans proline' 0 C--O 1.213 -0.727 0 CA-C-N 121.765 1.666 . . . . 0.0 108.229 177.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.509 ' CG ' ' O ' ' A' ' 25' ' ' PRO . 21.2 mt-10 -162.47 56.94 0.22 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.645 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -87.93 117.91 27.12 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.192 -0.943 . . . . 0.0 108.845 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.504 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 3.4 tt0 -88.4 -176.87 5.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.324 -0.86 . . . . 0.0 109.786 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.943 ' HB ' HG21 ' A' ' 20' ' ' ILE . 11.6 tt -145.8 145.57 20.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.766 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.486 HG12 ' HG2' ' B' ' 46' ' ' ARG . 7.8 mm -91.41 145.5 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 31' ' ' VAL . 8.0 p -99.05 125.53 52.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 120.814 -1.179 . . . . 0.0 109.775 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.073 HD11 ' CE1' ' B' ' 50' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.46 0 O-C-N 121.035 -1.04 . . . . 0.0 110.182 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.566 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 7.8 ptt-85 . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.524 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.4 OUTLIER -47.52 144.55 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.573 -1.329 . . . . 0.0 108.256 179.518 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.645 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -103.41 44.57 1.01 Allowed 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 119.053 -1.059 . . . . 0.0 109.419 -179.528 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' ARG . . . . . 0.486 ' HG2' HG12 ' A' ' 30' ' ' ILE . 7.6 mtt180 -150.32 153.11 35.53 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.673 HG22 ' CG2' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -150.94 -176.97 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.72 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.754 ' HD2' HD22 ' A' ' 32' ' ' LEU . 25.7 mmt180 -111.89 79.8 1.25 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.793 -1.192 . . . . 0.0 110.026 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.77 HD13 HG22 ' A' ' 13' ' ' VAL . 0.5 OUTLIER -62.18 94.74 0.06 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.226 -0.921 . . . . 0.0 109.172 179.456 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' PHE . . . . . 1.073 ' CE1' HD11 ' A' ' 32' ' ' LEU . 1.6 m-30 -80.22 130.47 35.24 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.762 HG22 ' O ' ' A' ' 32' ' ' LEU . 4.4 m -113.52 -176.46 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.593 -1.317 . . . . 0.0 110.741 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.498 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 1.4 p-10 -116.24 -151.07 0.47 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.463 -0.773 . . . . 0.0 109.93 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.498 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 0.9 OUTLIER -70.88 -51.06 28.64 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.407 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.481 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 1.5 tp -100.07 44.6 1.01 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.469 -0.769 . . . . 0.0 109.186 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . 0.424 ' CG ' ' C ' ' B' ' 54' ' ' LEU . 0.0 OUTLIER 44.39 67.35 0.7 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.302 -0.874 . . . . 0.0 110.029 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . 0.573 ' O ' ' N ' ' B' ' 58' ' ' ALA . 11.7 t30 -127.4 92.53 3.52 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.793 HG21 HD21 ' A' ' 8' ' ' LEU . 13.6 mt -30.06 86.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-O 121.54 0.686 . . . . 0.0 111.157 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.11 -27.38 21.96 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . 0.525 ' HB3' ' HB2' ' B' ' 50' ' ' PHE . 32.5 tp60 -113.83 130.76 56.43 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.657 ' CG2' HG22 ' A' ' 9' ' ' VAL . 91.2 t -87.29 134.46 36.38 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 120.979 -1.075 . . . . 0.0 110.859 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . 0.46 ' O ' ' HD3' ' B' ' 62' ' ' ARG . 36.8 Cg_endo -79.76 169.45 18.15 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.558 2.172 . . . . 0.0 109.148 178.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' ARG . . . . . 0.523 ' O ' ' CG1' ' B' ' 47' ' ' VAL . 0.2 OUTLIER -150.18 135.05 17.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.976 -1.078 . . . . 0.0 110.06 -179.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.673 ' CG2' HG22 ' B' ' 47' ' ' VAL . 2.3 t . . . . . 0 N--CA 1.489 1.483 0 O-C-N 121.328 -0.858 . . . . 0.0 109.316 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.778 HG22 ' CD ' ' A' ' 24' ' ' LYS . 18.6 p . . . . . 0 N--CA 1.493 1.681 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.526 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 0.6 OUTLIER -110.32 169.6 8.63 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.277 -0.89 . . . . 0.0 108.824 179.244 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.673 ' O ' HG21 ' B' ' 60' ' ' VAL . 15.1 m-90 -150.1 45.05 0.34 Allowed Pre-proline 0 C--N 1.294 -1.826 0 O-C-N 121.57 -0.706 . . . . 0.0 109.26 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 31.2 Cg_endo -69.12 -31.19 23.89 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 N-CA-C 108.232 -1.488 . . . . 0.0 108.232 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -69.66 -19.61 63.6 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 177.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.69 HD12 ' CB ' ' A' ' 11' ' ' LYS . 14.8 tp -84.29 -9.08 58.78 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.493 0.663 . . . . 0.0 109.247 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.479 HG23 HG21 ' B' ' 60' ' ' VAL . 10.4 t -55.69 152.39 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 119.086 -1.045 . . . . 0.0 108.873 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.87 4.16 25.67 Favored Glycine 0 N--CA 1.48 1.61 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.229 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.69 ' CB ' HD12 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -95.76 -143.5 0.27 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.875 -1.368 . . . . 0.0 109.276 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.493 ' CB ' ' OE2' ' A' ' 14' ' ' GLU . 2.2 m -145.02 168.12 21.03 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.068 -1.02 . . . . 0.0 110.192 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.604 HG22 HD11 ' B' ' 49' ' ' LEU . 48.5 t -51.3 -38.6 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.571 -0.706 . . . . 0.0 109.875 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.55 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -42.52 -75.75 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.153 -179.615 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.34 -33.34 65.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.34 -0.85 . . . . 0.0 109.682 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 1.042 ' HB2' HD11 ' B' ' 57' ' ' ILE . . . -62.18 -85.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.404 -0.81 . . . . 0.0 110.439 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.527 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -46.75 -31.89 3.27 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.044 -1.035 . . . . 0.0 108.827 -179.331 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.55 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 5.3 tttp -56.41 -83.35 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.425 0 CA-C-O 121.323 0.582 . . . . 0.0 110.549 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 20' ' ' ILE . 2.4 t -62.53 -48.68 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.507 -0.746 . . . . 0.0 109.842 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.775 HG21 ' HB ' ' A' ' 29' ' ' ILE . 88.9 mt -43.83 -45.17 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.23 -0.919 . . . . 0.0 109.538 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.511 HD23 ' HB2' ' A' ' 22' ' ' GLN . 0.9 OUTLIER -49.26 -44.59 43.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.252 -0.905 . . . . 0.0 111.239 -179.247 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.511 ' HB2' HD23 ' A' ' 21' ' ' LEU . 4.0 mt-30 -137.03 41.17 2.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.693 -1.254 . . . . 0.0 111.413 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.496 ' OD1' ' O ' ' A' ' 20' ' ' ILE . 1.3 p-10 -67.89 -49.46 61.88 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.778 ' CD ' HG22 ' A' ' 3' ' ' THR . 1.0 OUTLIER -94.6 -116.05 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.476 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.314 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.722 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 37.2 Cg_endo -80.79 -66.47 0.02 OUTLIER 'Trans proline' 0 C--O 1.215 -0.664 0 CA-C-N 122.327 1.867 . . . . 0.0 108.035 178.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 18.8 mt-10 -161.29 60.45 0.28 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.611 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -88.25 116.71 26.65 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.034 -1.041 . . . . 0.0 108.197 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.459 ' O ' ' HA ' ' B' ' 46' ' ' ARG . 3.7 tt0 -88.24 176.49 7.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.066 -1.021 . . . . 0.0 110.105 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.775 ' HB ' HG21 ' A' ' 20' ' ' ILE . 19.1 tt -143.66 149.79 17.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 O-C-N 121.183 -0.948 . . . . 0.0 110.67 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.527 ' HA ' HD13 ' A' ' 30' ' ' ILE . 4.1 mm -97.66 146.44 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.8 HG12 HD12 ' B' ' 49' ' ' LEU . 0.0 OUTLIER -110.51 134.33 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.565 -1.334 . . . . 0.0 110.269 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.111 HD11 ' CE1' ' B' ' 50' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.756 -0.59 . . . . 0.0 109.509 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.56 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.8 0 CA-C-O 121.084 0.469 . . . . 0.0 110.99 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.537 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.3 OUTLIER -50.69 139.92 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 120.274 -1.517 . . . . 0.0 107.438 178.351 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.611 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 2.8 p30 -95.35 45.75 1.1 Allowed 'General case' 0 C--N 1.294 -1.848 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.281 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' ARG . . . . . 0.541 ' HG2' ' N ' ' B' ' 47' ' ' VAL . 6.0 ttt180 -149.26 156.39 42.05 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.484 -0.76 . . . . 0.0 109.175 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.6 HG22 ' CG2' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -151.75 -173.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.612 ' HD2' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -112.15 69.05 0.68 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.868 -1.145 . . . . 0.0 111.212 -179.187 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.8 HD12 HG12 ' A' ' 31' ' ' VAL . 1.9 tm? -56.49 94.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.005 -1.059 . . . . 0.0 108.253 178.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' PHE . . . . . 1.111 ' CE1' HD11 ' A' ' 32' ' ' LEU . 8.2 m-30 -86.25 143.78 27.76 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.807 HG22 ' O ' ' A' ' 32' ' ' LEU . 15.3 m -122.4 -175.28 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.844 -1.16 . . . . 0.0 109.578 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.499 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.4 OUTLIER -126.91 -154.76 0.65 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.408 -0.808 . . . . 0.0 109.868 -179.69 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.499 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 8.7 mttt -63.45 -54.79 31.06 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.457 0.646 . . . . 0.0 109.262 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.504 ' HA ' HD13 ' B' ' 54' ' ' LEU . 2.9 mm? -98.48 44.07 1.04 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.534 -0.729 . . . . 0.0 109.806 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' B' ' 55' ' ' ASP . 0.0 OUTLIER 48.32 64.17 1.77 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.248 -0.908 . . . . 0.0 109.65 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . 0.536 ' O ' ' N ' ' B' ' 58' ' ' ALA . 0.0 OUTLIER -124.77 98.74 5.84 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.434 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 1.042 HD11 ' HB2' ' A' ' 16' ' ' ALA . 32.1 mt -44.27 91.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 121.491 0.663 . . . . 0.0 109.822 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.3 -20.33 25.56 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -128.23 104.17 7.59 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.673 HG21 ' O ' ' A' ' 5' ' ' TRP . 5.0 t -73.69 134.93 78.39 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.226 -0.921 . . . . 0.0 110.397 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . 0.714 ' HG3' HD11 ' A' ' 29' ' ' ILE . 37.7 Cg_endo -84.04 -175.55 2.27 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 122.735 2.29 . . . . 0.0 109.677 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' ARG . . . . . 0.406 ' O ' ' CG1' ' B' ' 47' ' ' VAL . 0.1 OUTLIER -151.09 144.48 24.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.053 -1.029 . . . . 0.0 110.045 179.599 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.6 ' CG2' HG22 ' B' ' 47' ' ' VAL . 1.6 t . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 1.025 HG22 ' CD ' ' A' ' 24' ' ' LYS . 21.0 p . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.599 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -90.31 -35.93 14.97 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.547 -0.721 . . . . 0.0 109.824 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.995 ' O ' HD12 ' A' ' 8' ' ' LEU . 5.5 m-90 58.49 41.54 0.66 Allowed Pre-proline 0 C--N 1.296 -1.737 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.467 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.636 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 33.7 Cg_endo -72.94 -34.05 6.99 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 N-CA-C 107.119 -1.916 . . . . 0.0 107.119 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -69.44 -9.72 54.87 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.336 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.048 ' O ' HD22 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -80.16 -8.42 59.41 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 121.299 -0.875 . . . . 0.0 109.106 -179.47 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.906 ' N ' HD13 ' A' ' 8' ' ' LEU . 35.4 t -48.66 149.84 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 120.882 -1.136 . . . . 0.0 110.437 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.98 2.31 23.57 Favored Glycine 0 N--CA 1.484 1.888 0 C-N-CA 120.142 -1.028 . . . . 0.0 111.138 177.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -93.41 -149.44 0.27 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.745 -1.444 . . . . 0.0 109.601 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.61 164.39 29.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.109 -0.994 . . . . 0.0 110.325 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.726 HG21 HG21 ' A' ' 31' ' ' VAL . 48.1 t -52.23 -34.93 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.461 -0.775 . . . . 0.0 109.062 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.542 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -44.36 -66.56 0.37 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.307 -0.871 . . . . 0.0 109.095 179.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.43 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -62.76 -34.04 76.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.093 -1.004 . . . . 0.0 109.303 179.297 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.729 ' HB1' HD12 ' A' ' 20' ' ' ILE . . . -62.11 -82.85 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.125 -0.985 . . . . 0.0 109.604 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.533 ' HG2' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -44.02 -42.07 5.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.951 -1.093 . . . . 0.0 108.905 179.813 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -47.48 -78.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.588 0.708 . . . . 0.0 110.339 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.458 ' O ' ' OD1' ' A' ' 23' ' ' ASP . 1.6 t -71.14 -55.27 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.7 -0.625 . . . . 0.0 110.116 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.882 HD13 HD13 ' A' ' 29' ' ' ILE . 95.3 mt -39.53 -34.82 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.524 -0.735 . . . . 0.0 109.872 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.1 tp -48.12 -52.22 21.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.367 -0.833 . . . . 0.0 110.759 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.578 ' O ' ' N ' ' A' ' 24' ' ' LYS . 0.8 OUTLIER -112.32 -66.88 1.04 Allowed 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.672 -1.211 . . . . 0.0 111.492 -178.373 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.517 ' O ' ' O ' ' A' ' 24' ' ' LYS . 0.4 OUTLIER 38.78 -92.81 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.41 -0.806 . . . . 0.0 108.875 -179.022 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 1.025 ' CD ' HG22 ' A' ' 3' ' ' THR . 2.8 mtpm? -64.27 -131.72 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.422 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 177.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.728 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 32.5 Cg_endo -74.67 -64.41 0.03 OUTLIER 'Trans proline' 0 C--O 1.215 -0.662 0 CA-C-N 122.084 1.78 . . . . 0.0 108.825 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 9.7 mt-10 -162.17 70.49 0.31 Allowed 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.605 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -88.85 117.47 27.87 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.522 ' CB ' ' O ' ' B' ' 45' ' ' ASP . 1.1 tt0 -87.2 173.55 9.15 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.951 -1.093 . . . . 0.0 109.249 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.882 HD13 HD13 ' A' ' 20' ' ' ILE . 5.4 tt -150.06 128.58 2.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 C-N-CA 118.999 -1.08 . . . . 0.0 110.741 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.636 HG22 HD22 ' A' ' 32' ' ' LEU . 2.9 mm -88.74 141.67 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.726 HG21 HG21 ' A' ' 13' ' ' VAL . 11.8 p -113.94 131.29 66.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 120.84 -1.163 . . . . 0.0 110.217 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.945 HD23 ' N ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.431 0 O-C-N 121.489 -0.757 . . . . 0.0 109.381 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.542 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 2.5 ptt180 . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.532 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.4 OUTLIER -43.03 141.93 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 119.148 -1.021 . . . . 0.0 108.567 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.605 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.6 p-10 -102.51 47.01 0.9 Allowed 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 119.188 -1.005 . . . . 0.0 109.819 -178.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' ARG . . . . . 0.406 ' C ' HG23 ' B' ' 47' ' ' VAL . 3.9 ttm180 -151.9 148.13 27.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.383 -0.823 . . . . 0.0 110.119 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 1.052 ' CG2' HG23 ' B' ' 63' ' ' VAL . 53.7 t -151.41 154.83 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.643 HH11 HD13 ' A' ' 32' ' ' LEU . 10.5 mmt180 -88.06 66.7 8.68 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.601 -1.312 . . . . 0.0 110.372 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 1.065 HD11 HD12 ' B' ' 57' ' ' ILE . 2.5 tp -60.79 90.11 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.089 -1.007 . . . . 0.0 109.383 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' PHE . . . . . 0.778 ' HE1' HD11 ' A' ' 32' ' ' LEU . 3.8 m-30 -76.26 156.06 33.83 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 32' ' ' LEU . 1.8 m -121.31 176.73 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.73 -1.232 . . . . 0.0 109.68 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.492 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.4 OUTLIER -109.22 -154.95 0.55 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.252 -0.905 . . . . 0.0 109.774 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.646 ' HB2' HD22 ' B' ' 54' ' ' LEU . 2.7 mtpt -67.8 -53.97 22.86 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.536 -0.728 . . . . 0.0 109.465 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.763 ' N ' HD22 ' B' ' 54' ' ' LEU . 3.2 mm? -95.88 42.9 1.09 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 109.567 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' B' ' 55' ' ' ASP . 0.0 OUTLIER 48.14 65.01 1.43 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.156 -0.965 . . . . 0.0 109.28 -179.727 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' B' ' 58' ' ' ALA . 8.9 t30 -130.01 106.68 8.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.385 -0.822 . . . . 0.0 108.846 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 1.065 HD12 HD11 ' B' ' 49' ' ' LEU . 15.6 mm -39.61 90.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-O 121.646 0.736 . . . . 0.0 110.68 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.09 -27.12 22.15 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -111.79 136.15 51.45 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.626 HG23 HG22 ' A' ' 9' ' ' VAL . 43.1 t -90.01 127.93 51.81 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.837 -1.165 . . . . 0.0 110.609 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . 0.877 ' HB2' HG11 ' B' ' 47' ' ' VAL . 36.5 Cg_endo -79.72 157.04 24.55 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.378 2.052 . . . . 0.0 109.215 177.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' ARG . . . . . 0.561 ' HD2' ' CA ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -146.12 142.98 29.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.838 -1.164 . . . . 0.0 110.588 -179.396 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 1.052 HG23 ' CG2' ' B' ' 47' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.787 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.642 HG23 ' HE3' ' A' ' 24' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.41 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.575 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 2.6 mp0 -89.78 167.43 12.87 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.349 -0.844 . . . . 0.0 109.361 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.62 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 20.9 m-90 -141.09 46.0 0.82 Allowed Pre-proline 0 C--N 1.294 -1.836 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 31.2 Cg_endo -69.6 -27.32 27.36 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 N-CA-C 108.21 -1.496 . . . . 0.0 108.21 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -69.66 -20.03 63.59 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.896 HD21 HG21 ' B' ' 57' ' ' ILE . 0.0 OUTLIER -82.27 -8.66 59.64 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.63 ' CG2' ' CG2' ' B' ' 60' ' ' VAL . 20.6 t -48.81 154.14 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.095 -1.003 . . . . 0.0 110.004 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.425 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . 65.71 2.43 11.59 Favored Glycine 0 N--CA 1.482 1.717 0 C-N-CA 120.252 -0.975 . . . . 0.0 110.883 178.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -93.69 -143.7 0.23 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.709 -1.465 . . . . 0.0 109.393 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.458 ' HB3' ' CD ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -144.46 167.52 22.29 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.964 -1.085 . . . . 0.0 110.121 -179.701 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.587 HG22 HD21 ' B' ' 49' ' ' LEU . 71.6 t -50.82 -40.96 20.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.531 -0.731 . . . . 0.0 109.796 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.544 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -44.68 -69.02 0.15 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.502 -0.749 . . . . 0.0 109.352 -179.763 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.596 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -58.07 -31.13 66.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.176 -0.952 . . . . 0.0 109.415 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.867 ' HB2' HD11 ' B' ' 57' ' ' ILE . . . -64.9 -84.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.045 -1.034 . . . . 0.0 109.954 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -45.2 -34.89 2.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.986 -1.071 . . . . 0.0 109.086 -179.556 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.544 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 20.5 tttp -55.02 -75.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.508 0.671 . . . . 0.0 111.334 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 15' ' ' GLU . 1.5 t -70.28 -46.1 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.486 -0.759 . . . . 0.0 110.968 -177.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.795 HG21 ' HB ' ' A' ' 29' ' ' ILE . 2.6 mt -53.28 -50.55 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.02 -1.05 . . . . 0.0 109.871 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 28' ' ' GLN . 2.3 tt -39.4 -28.08 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.265 -0.897 . . . . 0.0 110.642 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.475 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -149.9 26.82 0.8 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.875 -1.14 . . . . 0.0 110.675 -179.714 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.55 ' OD2' HG12 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -54.49 -64.15 0.92 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.731 -1.23 . . . . 0.0 108.194 179.182 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.748 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 3.5 mtpm? -80.47 -117.58 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 106.841 -1.541 . . . . 0.0 106.841 178.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.748 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 36.7 Cg_endo -79.92 -64.2 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.69 0 CA-C-N 122.103 1.787 . . . . 0.0 108.612 178.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 27.2 mt-10 -159.97 60.97 0.36 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.603 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -88.53 117.31 27.39 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.185 -1.006 . . . . 0.0 108.61 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 1.7 tt0 -88.6 169.78 11.41 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.199 -0.938 . . . . 0.0 109.965 -178.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.795 ' HB ' HG21 ' A' ' 20' ' ' ILE . 19.8 tt -140.6 135.14 34.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.51 -0.743 . . . . 0.0 109.52 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.694 HD13 ' CG ' ' B' ' 46' ' ' ARG . 1.2 mp -88.76 128.57 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 1.043 HG22 HD23 ' B' ' 49' ' ' LEU . 25.3 t -94.72 136.3 26.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 118.518 -1.273 . . . . 0.0 110.487 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.07 HD11 ' CE1' ' B' ' 50' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 O-C-N 121.689 -0.632 . . . . 0.0 109.347 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.512 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 5.6 ptt180 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.126 0.488 . . . . 0.0 109.907 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.563 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.5 OUTLIER -45.82 146.22 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.946 -1.096 . . . . 0.0 108.73 179.585 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.603 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -110.86 40.91 1.91 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.391 -0.924 . . . . 0.0 109.953 -179.74 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' ARG . . . . . 0.694 ' CG ' HD13 ' A' ' 30' ' ' ILE . 0.2 OUTLIER -150.23 144.56 25.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.42 -0.8 . . . . 0.0 108.994 179.192 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.55 ' CG2' HG23 ' B' ' 63' ' ' VAL . 0.0 OUTLIER -151.16 164.77 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.087 -1.008 . . . . 0.0 108.857 -179.747 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.614 ' HG3' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -91.9 89.42 7.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.745 -1.222 . . . . 0.0 110.46 -179.241 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 1.043 HD23 HG22 ' A' ' 31' ' ' VAL . 4.0 tp -78.87 91.32 4.76 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' PHE . . . . . 1.07 ' CE1' HD11 ' A' ' 32' ' ' LEU . 4.1 m-30 -77.54 179.74 6.34 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -148.01 -173.58 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.865 -1.147 . . . . 0.0 109.515 179.514 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.54 ' OD2' ' CB ' ' B' ' 56' ' ' ASN . 5.5 p-10 -116.7 -146.43 0.4 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.316 -0.865 . . . . 0.0 109.253 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.531 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 8.7 mmtp -62.28 -55.62 26.54 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.241 -0.912 . . . . 0.0 110.131 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.551 ' O ' ' CB ' ' B' ' 55' ' ' ASP . 2.4 mp -103.28 17.02 25.04 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.997 -1.065 . . . . 0.0 111.687 -178.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . 0.552 ' HA ' ' CG1' ' B' ' 51' ' ' VAL . 0.2 OUTLIER 91.43 47.87 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.459 0 CA-C-O 122.583 1.182 . . . . 0.0 110.623 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' B' ' 58' ' ' ALA . 1.9 t-20 -106.56 97.36 7.16 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.97 -1.081 . . . . 0.0 108.3 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.896 HG21 HD21 ' A' ' 8' ' ' LEU . 43.8 mt -37.28 88.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 121.549 0.69 . . . . 0.0 110.914 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.95 -31.26 18.25 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -99.69 134.94 41.85 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.63 ' CG2' ' CG2' ' A' ' 9' ' ' VAL . 65.1 t -90.12 129.44 45.85 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.092 -1.005 . . . . 0.0 111.21 -178.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . 0.413 ' O ' ' CD ' ' B' ' 62' ' ' ARG . 36.3 Cg_endo -81.84 162.53 18.56 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.308 2.005 . . . . 0.0 108.928 177.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' ARG . . . . . 0.534 ' O ' ' CG1' ' B' ' 47' ' ' VAL . 0.0 OUTLIER -150.91 132.62 14.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.659 -1.275 . . . . 0.0 110.711 -179.69 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.598 HG21 ' HB1' ' A' ' 27' ' ' ALA . 2.2 t . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.468 -0.77 . . . . 0.0 109.044 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.788 HG22 ' HD2' ' A' ' 24' ' ' LYS . 16.1 p . . . . . 0 N--CA 1.494 1.742 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.572 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 9.8 mp0 -104.15 -28.98 11.14 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.547 0.689 . . . . 0.0 109.151 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.637 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 8.7 m-90 53.12 42.22 1.15 Allowed Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 119.507 -0.877 . . . . 0.0 108.946 -177.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.637 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 35.1 Cg_endo -73.0 -34.83 5.96 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 N-CA-C 107.447 -1.79 . . . . 0.0 107.447 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.73 -12.0 61.29 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.557 ' HG ' HD12 ' B' ' 57' ' ' ILE . 32.1 tp -81.21 -6.0 58.37 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 121.49 -0.756 . . . . 0.0 109.31 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.594 HG23 HG21 ' B' ' 60' ' ' VAL . 21.0 t -54.37 152.48 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 120.942 -1.099 . . . . 0.0 109.034 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.11 7.14 22.78 Favored Glycine 0 N--CA 1.48 1.601 0 C-N-CA 119.94 -1.124 . . . . 0.0 110.44 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.501 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 5.2 tptt -93.92 -141.26 0.23 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.825 -1.397 . . . . 0.0 109.441 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.545 ' CA ' HG13 ' B' ' 57' ' ' ILE . 48.4 m -149.89 167.17 27.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.939 -1.101 . . . . 0.0 110.454 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.619 ' CG2' HG11 ' B' ' 51' ' ' VAL . 97.1 t -50.35 -34.05 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.49 -0.756 . . . . 0.0 109.814 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.524 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 27.1 mt-10 -45.87 -77.94 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.384 -0.822 . . . . 0.0 109.065 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.407 ' CD ' ' HE2' ' A' ' 11' ' ' LYS . 0.6 OUTLIER -55.69 -31.28 62.3 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.333 -0.854 . . . . 0.0 109.388 179.802 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.722 ' HB2' HD11 ' B' ' 57' ' ' ILE . . . -62.02 -85.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.44 -0.788 . . . . 0.0 110.616 -179.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.491 ' HG2' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -48.26 -29.81 4.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.634 -1.291 . . . . 0.0 108.994 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -57.6 -82.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.413 0.625 . . . . 0.0 111.116 -179.445 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -64.8 -40.21 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.369 -0.832 . . . . 0.0 110.315 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.8 HG21 ' HB ' ' A' ' 29' ' ' ILE . 98.5 mt -51.8 -56.17 6.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.336 -0.852 . . . . 0.0 109.82 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 21' ' ' LEU . 0.4 OUTLIER -36.88 -29.76 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.51 -0.743 . . . . 0.0 110.593 -179.521 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 20' ' ' ILE . 2.2 mt-30 -148.74 52.53 0.99 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.023 -1.048 . . . . 0.0 109.855 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.516 ' OD2' ' HA ' ' A' ' 3' ' ' THR . 3.8 t0 -53.32 -62.81 1.41 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.985 -1.072 . . . . 0.0 108.409 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.845 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -115.98 -66.8 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 120.748 -1.22 . . . . 0.0 109.201 178.537 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.845 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 42.2 Cg_endo -91.25 -82.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.324 -0.748 0 N-CA-C 108.135 -1.525 . . . . 0.0 108.135 178.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 16.9 mt-10 -161.45 65.46 0.27 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.926 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -87.7 115.32 25.06 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.246 -0.982 . . . . 0.0 108.843 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.453 ' CB ' ' O ' ' B' ' 45' ' ' ASP . 1.8 tt0 -87.92 170.27 11.3 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.233 -0.917 . . . . 0.0 108.774 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.8 ' HB ' HG21 ' A' ' 20' ' ' ILE . 12.9 tt -142.3 133.17 24.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 118.719 -1.192 . . . . 0.0 110.576 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.44 ' HA ' HD13 ' A' ' 30' ' ' ILE . 12.1 mm -87.68 107.09 16.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.541 ' HA ' ' HB3' ' B' ' 49' ' ' LEU . 19.5 t -89.0 146.88 5.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.108 -0.995 . . . . 0.0 110.88 -178.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.063 HD11 ' CE1' ' B' ' 50' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--N 1.302 -1.457 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.527 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 120.745 0.307 . . . . 0.0 110.363 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.521 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.3 OUTLIER -46.06 139.56 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.648 -1.283 . . . . 0.0 108.356 179.504 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.567 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -99.4 44.86 1.01 Allowed 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.202 -0.936 . . . . 0.0 109.8 -178.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' ARG . . . . . 0.431 ' C ' HG23 ' B' ' 47' ' ' VAL . 0.2 OUTLIER -149.65 145.59 26.82 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.401 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 1.149 ' CG2' HG23 ' B' ' 63' ' ' VAL . 60.9 t -151.8 169.35 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 109.779 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.605 ' N ' HG12 ' B' ' 47' ' ' VAL . 0.0 OUTLIER -99.12 95.26 6.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.726 -1.234 . . . . 0.0 109.849 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.653 HD11 ' CB ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -88.21 84.0 6.92 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.015 -1.053 . . . . 0.0 109.277 179.265 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' PHE . . . . . 1.063 ' CE1' HD11 ' A' ' 32' ' ' LEU . 4.4 m-30 -72.43 138.09 46.89 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.949 HG22 ' O ' ' A' ' 32' ' ' LEU . 2.6 m -123.6 -171.18 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.676 -1.265 . . . . 0.0 110.231 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.569 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.0 OUTLIER -129.72 -168.13 1.91 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.893 0.854 . . . . 0.0 110.006 -179.221 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.569 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 13.8 mttm -43.6 -68.95 0.15 Allowed 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.331 0.586 . . . . 0.0 110.071 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.404 ' CG ' ' O ' ' B' ' 54' ' ' LEU . 0.6 OUTLIER -89.96 47.2 1.43 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 0.0 109.742 -179.59 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 47.62 57.39 5.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.294 -0.879 . . . . 0.0 109.828 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . 0.549 ' O ' ' N ' ' B' ' 58' ' ' ALA . 7.0 t30 -106.42 96.42 6.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.139 -0.976 . . . . 0.0 109.055 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.722 HD11 ' HB2' ' A' ' 16' ' ' ALA . 12.2 mt -42.79 91.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 121.5 0.667 . . . . 0.0 109.681 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -87.77 -17.43 31.64 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -129.23 96.9 4.43 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.594 HG21 HG23 ' A' ' 9' ' ' VAL . 1.6 t -56.54 137.02 77.0 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.32 -0.862 . . . . 0.0 109.952 -178.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . 0.799 ' HB2' HG11 ' B' ' 47' ' ' VAL . 36.2 Cg_endo -80.93 160.15 21.09 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.846 2.364 . . . . 0.0 110.22 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' ARG . . . . . 0.554 ' HD2' ' CB ' ' A' ' 4' ' ' GLU . 0.8 OUTLIER -141.96 134.44 28.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.137 -0.977 . . . . 0.0 109.622 179.798 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 1.149 HG23 ' CG2' ' B' ' 47' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.209 -0.932 . . . . 0.0 108.996 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.644 HG23 ' CD ' ' A' ' 24' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.607 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 13.7 mt-10 -100.09 -43.14 6.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.323 -0.861 . . . . 0.0 110.289 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.681 ' CE2' HG12 ' A' ' 20' ' ' ILE . 6.7 m-90 61.21 42.47 0.56 Allowed Pre-proline 0 C--N 1.296 -1.717 0 C-N-CA 119.441 -0.904 . . . . 0.0 109.488 -178.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.635 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 32.7 Cg_endo -72.45 -34.07 7.98 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 N-CA-C 106.925 -1.99 . . . . 0.0 106.925 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -69.34 -12.76 61.93 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.988 HD21 ' HB2' ' A' ' 16' ' ' ALA . 21.9 tp -76.62 -6.4 51.87 Favored 'General case' 0 C--N 1.31 -1.138 0 O-C-N 121.506 -0.746 . . . . 0.0 109.462 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.649 HG23 ' CG2' ' B' ' 60' ' ' VAL . 18.3 t -59.7 149.34 6.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 120.81 -1.181 . . . . 0.0 108.482 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.42 7.2 18.37 Favored Glycine 0 C--N 1.296 -1.642 0 C-N-CA 119.578 -1.296 . . . . 0.0 110.379 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.542 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -99.63 -154.71 0.48 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.818 -1.401 . . . . 0.0 108.869 179.558 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.445 ' C ' HD11 ' B' ' 57' ' ' ILE . 0.5 OUTLIER -135.48 160.93 36.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.689 -1.257 . . . . 0.0 110.888 -179.124 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.658 HG13 HD23 ' B' ' 49' ' ' LEU . 28.1 t -52.89 -33.08 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.585 -0.697 . . . . 0.0 109.219 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.549 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 52.7 mm-40 -46.28 -67.69 0.26 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.154 -0.966 . . . . 0.0 108.556 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.414 ' O ' HG23 ' A' ' 19' ' ' VAL . 2.5 tp10 -61.62 -30.89 70.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.4 -0.813 . . . . 0.0 109.501 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.988 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -67.54 -82.18 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.177 -0.952 . . . . 0.0 109.751 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -44.36 -40.39 5.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.672 -1.267 . . . . 0.0 108.972 179.64 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.549 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 20.8 tttm -49.92 -72.1 0.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.611 -0.681 . . . . 0.0 110.368 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.516 ' O ' ' N ' ' A' ' 23' ' ' ASP . 2.8 t -72.24 -57.62 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.523 -0.736 . . . . 0.0 109.972 -179.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.944 HG21 ' HB ' ' A' ' 29' ' ' ILE . 5.9 mt -35.93 -53.86 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.588 -0.695 . . . . 0.0 110.211 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.499 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 2.3 tt -37.56 -52.87 1.2 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.615 -0.678 . . . . 0.0 110.003 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.419 ' HG3' ' HA ' ' A' ' 26' ' ' GLU . 1.4 mt-30 -128.56 32.58 4.8 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 109.968 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' VAL . 17.4 p-10 -50.67 -48.88 58.28 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.019 -1.05 . . . . 0.0 108.28 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.708 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 10.4 mtpp -107.24 -106.62 0.0 OUTLIER Pre-proline 0 CA--C 1.561 1.374 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.708 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 37.0 Cg_endo -79.98 -67.74 0.02 OUTLIER 'Trans proline' 0 C--O 1.215 -0.657 0 CA-C-N 121.93 1.725 . . . . 0.0 108.631 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.528 ' CG ' ' O ' ' A' ' 25' ' ' PRO . 27.1 mt-10 -162.02 64.09 0.24 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.789 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -88.86 116.64 27.28 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.022 -1.049 . . . . 0.0 108.916 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.475 ' HG3' ' OD2' ' B' ' 45' ' ' ASP . 0.1 OUTLIER -88.86 165.65 14.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.899 -1.126 . . . . 0.0 109.166 -179.54 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.944 ' HB ' HG21 ' A' ' 20' ' ' ILE . 3.3 tt -139.84 131.99 34.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.158 -0.963 . . . . 0.0 110.276 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.5 mm -88.59 117.95 33.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.478 HG21 HG21 ' A' ' 13' ' ' VAL . 2.5 p -95.93 136.56 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.149 -0.969 . . . . 0.0 109.675 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.954 HD23 ' N ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 O-C-N 121.237 -0.915 . . . . 0.0 109.562 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.547 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.057 0.456 . . . . 0.0 110.688 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.747 HG23 HG22 ' B' ' 63' ' ' VAL . 0.6 OUTLIER -49.22 145.55 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 120.574 -1.329 . . . . 0.0 108.208 178.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.609 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.3 p-10 -108.46 32.76 4.59 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.07 -1.019 . . . . 0.0 109.888 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' ARG . . . . . 0.41 ' C ' ' CG2' ' B' ' 47' ' ' VAL . 0.1 OUTLIER -150.57 143.63 24.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.436 -0.79 . . . . 0.0 109.007 179.349 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.869 ' CG2' HG23 ' B' ' 63' ' ' VAL . 1.8 t -149.44 166.43 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -0.908 . . . . 0.0 109.608 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.536 ' HG3' ' CE2' ' B' ' 50' ' ' PHE . 0.0 OUTLIER -95.5 75.56 3.3 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.742 -1.224 . . . . 0.0 110.21 -179.611 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.662 HD22 ' HB1' ' A' ' 16' ' ' ALA . 4.3 tp -76.72 92.97 3.59 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 118.818 -1.153 . . . . 0.0 108.282 178.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' PHE . . . . . 0.839 ' CZ ' HD11 ' A' ' 32' ' ' LEU . 17.8 m-85 -81.52 -177.02 6.34 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . . . . . . . . . 6.1 m -144.28 -175.64 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.648 -1.283 . . . . 0.0 110.5 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.533 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.4 OUTLIER -120.0 -154.8 0.59 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.481 -0.762 . . . . 0.0 109.813 -179.616 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.533 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 11.4 mtpt -63.94 -56.78 12.72 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.565 -0.709 . . . . 0.0 109.332 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.64 HD23 ' O ' ' B' ' 54' ' ' LEU . 2.6 tt -97.12 41.87 1.1 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.395 -0.816 . . . . 0.0 109.461 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . 0.405 ' CG ' ' C ' ' B' ' 54' ' ' LEU . 0.0 OUTLIER 49.65 65.06 1.52 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.206 -0.934 . . . . 0.0 109.181 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . 0.553 ' O ' ' N ' ' B' ' 58' ' ' ALA . 17.4 t-20 -123.94 96.44 4.95 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.38 -0.825 . . . . 0.0 108.996 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.607 HD12 ' HG ' ' A' ' 8' ' ' LEU . 4.2 mt -37.45 89.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-O 121.576 0.703 . . . . 0.0 110.88 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.23 -21.56 24.45 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.67 133.79 53.67 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.649 ' CG2' HG23 ' A' ' 9' ' ' VAL . 99.4 t -90.09 128.11 50.94 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 120.999 -1.063 . . . . 0.0 110.59 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . 0.533 ' HB2' HG11 ' B' ' 47' ' ' VAL . 37.2 Cg_endo -83.63 165.29 14.01 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.396 2.064 . . . . 0.0 109.43 178.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' ARG . . . . . 0.541 ' HG3' ' HA ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -148.86 141.15 24.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.168 -0.958 . . . . 0.0 109.749 179.559 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.869 HG23 ' CG2' ' B' ' 47' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.731 0 O-C-N 121.261 -0.899 . . . . 0.0 109.084 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.537 HG22 ' CD ' ' A' ' 24' ' ' LYS . 70.7 p . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.589 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 81.2 mt-10 -93.53 -35.46 12.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.336 -0.852 . . . . 0.0 109.958 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.627 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 6.5 m-90 58.34 40.79 0.58 Allowed Pre-proline 0 C--N 1.293 -1.879 0 O-C-N 120.836 -1.165 . . . . 0.0 109.863 -178.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.627 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 34.2 Cg_endo -73.32 -34.92 5.46 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 N-CA-C 107.08 -1.931 . . . . 0.0 107.08 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.9 -11.72 61.08 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 177.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.558 HD21 ' HA ' ' A' ' 16' ' ' ALA . 30.5 tp -79.1 -7.91 58.54 Favored 'General case' 0 C--N 1.309 -1.172 0 O-C-N 121.402 -0.811 . . . . 0.0 109.216 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.613 HG23 ' CG2' ' B' ' 60' ' ' VAL . 19.4 t -54.34 154.22 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 118.994 -1.082 . . . . 0.0 109.151 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.438 ' C ' ' OD1' ' B' ' 56' ' ' ASN . . . 70.37 -0.43 25.29 Favored Glycine 0 C--N 1.297 -1.623 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.629 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -96.16 -151.76 0.36 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.665 -1.491 . . . . 0.0 109.584 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.507 ' CB ' ' OE2' ' A' ' 14' ' ' GLU . 1.2 m -139.53 172.8 12.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.138 -0.976 . . . . 0.0 110.535 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.676 ' HA ' HD21 ' B' ' 49' ' ' LEU . 99.2 t -54.72 -37.95 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.586 -0.696 . . . . 0.0 109.916 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.507 ' OE2' ' CB ' ' A' ' 12' ' ' SER . 0.7 OUTLIER -44.05 -74.76 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -0.904 . . . . 0.0 108.855 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.26 -38.23 65.58 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.394 -0.816 . . . . 0.0 109.835 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.835 ' HB2' HD11 ' B' ' 57' ' ' ILE . . . -59.02 -83.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.237 -0.915 . . . . 0.0 110.308 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.572 ' HA ' HG22 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -46.62 -28.06 1.34 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.586 -1.321 . . . . 0.0 109.617 -179.596 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 10.2 mttt -63.35 -83.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.487 -0.758 . . . . 0.0 110.746 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.468 HG23 ' H ' ' A' ' 19' ' ' VAL . 2.1 t -57.61 -42.34 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.6 -0.688 . . . . 0.0 109.472 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.885 HG21 ' HB ' ' A' ' 29' ' ' ILE . 69.0 mt -50.64 -53.75 11.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.293 -0.879 . . . . 0.0 108.919 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.531 HD12 ' OE1' ' A' ' 28' ' ' GLN . 9.1 tt -34.98 -36.45 0.05 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.788 -0.57 . . . . 0.0 110.642 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 20' ' ' ILE . 3.3 mt-30 -147.36 41.4 1.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.113 -0.992 . . . . 0.0 110.241 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.547 ' OD1' ' HG2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -57.86 -44.85 86.86 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.969 -1.082 . . . . 0.0 108.441 179.598 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.837 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -120.71 -88.49 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.241 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.837 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 38.8 Cg_endo -84.07 -81.47 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.655 0 N-CA-C 108.214 -1.494 . . . . 0.0 108.214 177.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 13.9 mt-10 -158.79 57.83 0.43 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 1.035 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -87.67 117.03 26.21 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.178 -0.951 . . . . 0.0 109.303 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.531 ' OE1' HD12 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -88.58 -175.15 4.84 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.129 -0.982 . . . . 0.0 109.549 -179.358 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.885 ' HB ' HG21 ' A' ' 20' ' ' ILE . 14.6 tt -147.62 140.59 19.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.452 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.706 HG22 HD22 ' A' ' 32' ' ' LEU . 2.7 mm -87.51 146.55 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.81 ' C ' HD23 ' A' ' 32' ' ' LEU . 8.7 p -102.37 133.53 45.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 119.071 -1.051 . . . . 0.0 109.734 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.966 HD23 ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.401 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.564 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.118 0.485 . . . . 0.0 109.78 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.495 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.3 OUTLIER -48.16 139.37 2.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 120.646 -1.284 . . . . 0.0 108.189 179.334 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.593 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -97.12 45.64 1.04 Allowed 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.331 -179.281 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -150.93 143.28 24.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.403 -0.811 . . . . 0.0 109.133 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 1.097 HG23 HG23 ' B' ' 63' ' ' VAL . 53.5 t -151.0 146.38 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.209 -0.932 . . . . 0.0 110.092 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.509 ' HB3' HD11 ' A' ' 32' ' ' LEU . 7.0 mmt180 -71.81 98.24 1.94 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.625 -1.297 . . . . 0.0 110.443 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.846 ' N ' HD21 ' A' ' 32' ' ' LEU . 2.6 tp -84.79 88.37 7.38 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.131 -0.981 . . . . 0.0 108.842 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' PHE . . . . . 0.759 ' CE1' HD12 ' A' ' 32' ' ' LEU . 1.8 m-85 -70.13 178.66 2.68 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.43 ' HB ' ' HA ' ' B' ' 55' ' ' ASP . 6.3 m -139.82 -174.71 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.043 -1.035 . . . . 0.0 109.276 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.687 ' HB3' ' HB2' ' B' ' 58' ' ' ALA . 0.1 OUTLIER -135.94 -158.71 0.89 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.147 -0.97 . . . . 0.0 110.115 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.529 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 26.9 mtpt -43.66 -69.81 0.12 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.67 -0.644 . . . . 0.0 110.407 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.481 ' HA ' HD22 ' B' ' 54' ' ' LEU . 0.4 OUTLIER -97.23 52.81 1.15 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.274 -0.891 . . . . 0.0 110.106 -179.138 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . 0.43 ' HA ' ' HB ' ' B' ' 51' ' ' VAL . 0.0 OUTLIER 47.38 58.1 5.22 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.251 -0.906 . . . . 0.0 109.183 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . 0.565 ' O ' ' N ' ' B' ' 58' ' ' ALA . 36.5 t-20 -121.52 113.74 20.25 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.835 HD11 ' HB2' ' A' ' 16' ' ' ALA . 26.4 mt -35.51 88.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-O 121.518 0.675 . . . . 0.0 110.966 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . 0.687 ' HB2' ' HB3' ' B' ' 52' ' ' ASP . . . -89.17 -20.92 23.63 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -109.99 137.99 46.99 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.613 ' CG2' HG23 ' A' ' 9' ' ' VAL . 71.3 t -90.33 129.46 45.31 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.092 -1.005 . . . . 0.0 111.022 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . 0.837 ' CB ' HG11 ' B' ' 47' ' ' VAL . 37.4 Cg_endo -83.46 164.18 14.57 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 122.617 2.212 . . . . 0.0 108.587 178.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -138.97 -43.98 0.47 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.255 -1.528 . . . . 0.0 110.809 -179.65 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 1.097 HG23 HG23 ' B' ' 47' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.293 -1.874 0 O-C-N 121.218 -0.926 . . . . 0.0 109.662 179.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.706 HG22 ' CE ' ' A' ' 24' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.569 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 3.9 mt-10 -92.69 -47.22 7.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.387 -0.821 . . . . 0.0 110.336 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.632 ' CE2' HG12 ' A' ' 20' ' ' ILE . 10.9 m-90 62.29 45.15 0.72 Allowed Pre-proline 0 C--N 1.297 -1.703 0 C-N-CA 119.611 -0.836 . . . . 0.0 108.935 -177.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.629 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 33.0 Cg_endo -71.68 -30.85 14.08 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 N-CA-C 107.169 -1.897 . . . . 0.0 107.169 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.29 -15.28 62.87 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.731 HD21 ' HB2' ' A' ' 16' ' ' ALA . 13.4 tp -80.48 -5.81 57.2 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.657 -0.652 . . . . 0.0 109.325 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.551 HG23 HG21 ' B' ' 60' ' ' VAL . 36.9 t -51.68 152.22 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.089 -1.007 . . . . 0.0 109.528 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.459 ' HA2' ' OD1' ' B' ' 56' ' ' ASN . . . 47.42 21.14 1.15 Allowed Glycine 0 N--CA 1.483 1.77 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.516 178.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -96.51 -141.81 0.28 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.862 -1.375 . . . . 0.0 109.143 179.631 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.45 ' N ' HG12 ' B' ' 57' ' ' ILE . 0.6 OUTLIER -146.41 159.42 43.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.911 -1.118 . . . . 0.0 110.008 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.604 ' HA ' HD21 ' B' ' 49' ' ' LEU . 29.8 t -48.15 -36.76 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.409 -0.807 . . . . 0.0 109.649 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.533 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 2.7 mt-10 -45.46 -75.41 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.408 -0.807 . . . . 0.0 109.193 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.4 ' HB3' ' CD1' ' A' ' 8' ' ' LEU . 0.9 OUTLIER -53.88 -32.84 54.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.235 -0.915 . . . . 0.0 109.113 179.489 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.731 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -64.88 -88.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.404 -0.81 . . . . 0.0 110.309 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.52 ' HA ' ' CG2' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -43.06 -29.02 0.32 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.823 -1.173 . . . . 0.0 109.255 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 3.5 tttt -61.81 -82.89 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.735 -0.603 . . . . 0.0 110.182 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' A' ' 23' ' ' ASP . 3.2 t -59.98 -48.36 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.42 -0.8 . . . . 0.0 109.427 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.699 HG21 ' HB ' ' A' ' 29' ' ' ILE . 80.0 mt -48.17 -59.87 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.407 -0.808 . . . . 0.0 110.045 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 27' ' ' ALA . 1.0 OUTLIER -37.74 -33.24 0.07 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.502 -0.749 . . . . 0.0 110.531 -179.327 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.445 ' HB2' HD23 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -149.51 50.47 0.94 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.137 -0.977 . . . . 0.0 109.623 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -66.65 -40.88 88.87 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.176 -0.952 . . . . 0.0 108.639 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.73 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -124.01 -88.53 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.441 0 CA-C-O 117.962 -1.018 . . . . 0.0 108.271 178.078 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.73 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 37.8 Cg_endo -81.34 -79.66 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.659 0 N-CA-C 108.522 -1.376 . . . . 0.0 108.522 177.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 14.5 mt-10 -160.99 66.0 0.3 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.982 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -87.56 116.09 25.44 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.123 -1.031 . . . . 0.0 108.9 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.49 ' CB ' ' O ' ' B' ' 45' ' ' ASP . 0.0 OUTLIER -88.46 161.39 17.05 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.436 -0.79 . . . . 0.0 108.995 -179.543 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.699 ' HB ' HG21 ' A' ' 20' ' ' ILE . 14.4 tt -137.73 136.46 45.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.062 -1.055 . . . . 0.0 110.507 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.528 ' O ' ' HB3' ' B' ' 49' ' ' LEU . 3.9 mm -88.89 155.17 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.502 ' HA ' ' HB3' ' B' ' 49' ' ' LEU . 14.9 p -116.32 137.38 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.77 -1.206 . . . . 0.0 109.752 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.099 HD11 ' CE1' ' B' ' 50' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.182 -0.949 . . . . 0.0 110.374 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.583 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 2.0 ptp180 . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.539 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.5 OUTLIER -42.96 143.14 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.87 -1.144 . . . . 0.0 108.765 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.603 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.1 p-10 -100.99 39.49 1.39 Allowed 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.12 -178.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' ARG . . . . . 0.459 ' C ' HG23 ' B' ' 47' ' ' VAL . 0.0 OUTLIER -150.79 140.81 22.04 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 1.044 ' CG2' HG23 ' B' ' 63' ' ' VAL . 96.5 t -151.52 152.13 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.999 -1.063 . . . . 0.0 110.323 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.545 ' HG3' HD21 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -78.38 105.2 9.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.083 -1.011 . . . . 0.0 110.139 -179.515 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 1.043 HD11 HD12 ' B' ' 57' ' ' ILE . 2.6 tp -93.27 86.27 5.26 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.304 -0.959 . . . . 0.0 108.505 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' PHE . . . . . 1.099 ' CE1' HD11 ' A' ' 32' ' ' LEU . 5.9 m-30 -69.72 133.28 47.32 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.714 HG22 ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -103.52 -170.54 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.856 -1.153 . . . . 0.0 109.722 179.747 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.527 ' OD2' ' CB ' ' B' ' 56' ' ' ASN . 2.7 p-10 -126.28 -149.72 0.42 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.519 -0.738 . . . . 0.0 109.055 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.519 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 34.4 mttm -56.86 -58.81 6.5 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.317 -0.864 . . . . 0.0 110.233 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.817 HD23 ' O ' ' B' ' 54' ' ' LEU . 0.9 OUTLIER -101.24 15.99 26.97 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.086 -1.009 . . . . 0.0 111.682 -178.587 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' B' ' 54' ' ' LEU . 0.2 OUTLIER 91.71 48.97 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.603 0 CA-C-O 122.621 1.2 . . . . 0.0 110.183 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . 0.527 ' CB ' ' OD2' ' B' ' 52' ' ' ASP . 1.8 t-20 -105.92 123.77 48.51 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.893 -1.129 . . . . 0.0 109.49 179.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 1.043 HD12 HD11 ' B' ' 49' ' ' LEU . 4.3 mm -54.97 88.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.61 -0.681 . . . . 0.0 109.457 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.56 -21.5 24.04 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . 0.416 ' O ' ' C ' ' B' ' 60' ' ' VAL . 8.7 mp0 -125.22 85.14 2.36 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.552 ' CG1' ' O ' ' A' ' 4' ' ' GLU . 9.3 t -42.37 130.15 2.82 Favored Pre-proline 0 N--CA 1.487 1.41 0 O-C-N 121.284 -0.885 . . . . 0.0 110.501 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . 0.591 ' HB2' HG11 ' B' ' 47' ' ' VAL . 36.8 Cg_endo -82.56 162.16 16.82 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 122.976 2.451 . . . . 0.0 110.276 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' ARG . . . . . 0.553 ' N ' HG11 ' B' ' 47' ' ' VAL . 0.1 OUTLIER -139.88 152.81 46.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.065 -1.022 . . . . 0.0 109.514 179.43 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 1.044 HG23 ' CG2' ' B' ' 47' ' ' VAL . 1.2 t . . . . . 0 N--CA 1.495 1.816 0 O-C-N 121.154 -0.966 . . . . 0.0 109.009 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.921 HG22 ' CD ' ' A' ' 24' ' ' LYS . 26.4 p . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.735 ' HB3' ' HD3' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -105.05 -178.06 3.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.332 -0.855 . . . . 0.0 110.164 -179.575 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.643 ' NE1' HD12 ' A' ' 20' ' ' ILE . 8.0 m-90 -161.65 48.85 0.25 Allowed Pre-proline 0 C--N 1.299 -1.621 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.19 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.735 ' HD3' ' HB3' ' A' ' 4' ' ' GLU . 30.6 Cg_endo -69.24 -25.82 30.63 Favored 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 121.956 1.77 . . . . 0.0 107.586 178.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -67.4 -25.32 65.88 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.618 ' HB2' ' HB3' ' A' ' 5' ' ' TRP . 0.3 OUTLIER -73.7 -17.08 61.17 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.448 0.642 . . . . 0.0 109.445 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.545 HG23 HG21 ' B' ' 60' ' ' VAL . 37.1 t -49.92 149.6 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 C-N-CA 119.555 -0.858 . . . . 0.0 110.02 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.423 ' C ' ' OD1' ' B' ' 56' ' ' ASN . . . 54.39 17.44 8.27 Favored Glycine 0 N--CA 1.48 1.584 0 C-N-CA 120.134 -1.031 . . . . 0.0 110.574 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.566 ' HB3' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -106.89 -143.87 0.38 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.0 -1.294 . . . . 0.0 109.398 179.717 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.502 ' CA ' HG12 ' B' ' 57' ' ' ILE . 0.5 OUTLIER -146.26 168.91 19.9 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.043 -1.035 . . . . 0.0 110.195 -179.465 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.559 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 84.9 t -55.45 -32.77 30.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.436 -0.79 . . . . 0.0 109.586 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.535 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 2.3 mt-10 -45.27 -71.29 0.08 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.135 -0.978 . . . . 0.0 108.837 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.28 -37.7 81.29 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.313 -0.867 . . . . 0.0 109.87 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.663 ' HB1' HD22 ' B' ' 49' ' ' LEU . . . -57.87 -79.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 110.028 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.54 ' HA ' ' CG2' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -50.75 -32.17 18.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.549 -1.344 . . . . 0.0 109.369 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -56.31 -82.5 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.494 0.664 . . . . 0.0 111.208 -179.192 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.403 HG23 ' H ' ' A' ' 19' ' ' VAL . 2.1 t -61.69 -35.09 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.626 -0.671 . . . . 0.0 110.342 -178.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.999 HG21 ' HB ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER -53.28 -50.25 48.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 O-C-N 121.074 -1.016 . . . . 0.0 109.541 179.873 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.563 HD23 ' HB2' ' A' ' 22' ' ' GLN . 4.2 tt -35.45 -32.2 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.454 -0.779 . . . . 0.0 110.278 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.563 ' HB2' HD23 ' A' ' 21' ' ' LEU . 1.9 tt0 -145.77 56.88 1.21 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.251 -0.905 . . . . 0.0 109.13 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.609 ' OD1' ' HB3' ' A' ' 27' ' ' ALA . 0.4 OUTLIER -65.41 -62.24 1.65 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.671 -0.643 . . . . 0.0 109.537 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.921 ' CD ' HG22 ' A' ' 3' ' ' THR . 0.0 OUTLIER -110.07 -80.95 0.01 OUTLIER Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.551 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.828 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 39.5 Cg_endo -87.92 -71.87 0.01 OUTLIER 'Trans proline' 0 C--O 1.213 -0.732 0 N-CA-C 107.377 -1.817 . . . . 0.0 107.377 176.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.537 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 19.4 mt-10 -165.02 62.3 0.12 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.609 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -87.53 120.52 28.92 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.069 -1.019 . . . . 0.0 109.345 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.446 ' CB ' ' O ' ' B' ' 45' ' ' ASP . 0.6 OUTLIER -88.36 174.17 8.31 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.416 -0.803 . . . . 0.0 109.143 -179.52 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.999 ' HB ' HG21 ' A' ' 20' ' ' ILE . 18.5 tt -145.74 134.76 17.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.466 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.557 HD12 ' HD2' ' B' ' 46' ' ' ARG . 4.8 mt -88.07 148.27 4.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.438 HG21 HG21 ' A' ' 13' ' ' VAL . 5.8 p -117.07 133.23 64.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 118.811 -1.156 . . . . 0.0 110.858 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.916 HD11 ' HE1' ' B' ' 50' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.533 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.57 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.488 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.3 OUTLIER -44.03 137.22 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.926 -1.109 . . . . 0.0 108.675 179.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.587 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -93.19 45.32 1.17 Allowed 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.419 -0.912 . . . . 0.0 109.689 -178.854 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' ARG . . . . . 0.557 ' HD2' HD12 ' A' ' 30' ' ' ILE . 14.1 ttp180 -148.04 144.83 28.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.314 -0.867 . . . . 0.0 109.112 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.663 HG22 ' CG2' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -152.2 143.9 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.157 -0.964 . . . . 0.0 109.427 -179.267 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.452 ' HD3' ' HA ' ' B' ' 48' ' ' ARG . 3.3 mmt85 -77.33 115.43 17.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.701 -1.249 . . . . 0.0 109.632 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 1.064 HD11 HD12 ' B' ' 57' ' ' ILE . 1.6 tp -107.89 81.02 1.44 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.987 -1.071 . . . . 0.0 108.843 178.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' PHE . . . . . 0.916 ' HE1' HD11 ' A' ' 32' ' ' LEU . 4.1 m-30 -66.05 -159.86 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.488 ' HB ' ' HA ' ' B' ' 55' ' ' ASP . 24.1 m -150.42 -171.46 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.74 -1.225 . . . . 0.0 109.574 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.532 ' HB3' ' HB2' ' B' ' 58' ' ' ALA . 1.0 OUTLIER -122.66 -153.14 0.54 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.297 -0.877 . . . . 0.0 109.259 179.434 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.51 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 29.1 mtpt -61.18 -61.48 2.53 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.617 -0.677 . . . . 0.0 109.606 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.415 ' O ' ' C ' ' B' ' 55' ' ' ASP . 3.0 tp -96.09 48.11 1.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.365 -0.834 . . . . 0.0 109.909 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . 0.488 ' HA ' ' HB ' ' B' ' 51' ' ' VAL . 0.0 OUTLIER 45.58 65.31 1.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.061 -1.025 . . . . 0.0 109.28 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . 0.577 ' O ' ' N ' ' B' ' 58' ' ' ALA . 3.5 t30 -133.14 108.71 8.99 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 1.064 HD12 HD11 ' B' ' 49' ' ' LEU . 12.7 mm -32.41 86.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.67 0.748 . . . . 0.0 111.391 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . 0.577 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -90.99 -23.72 20.31 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.04 96.24 5.09 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.607 HG13 ' HB2' ' A' ' 5' ' ' TRP . 3.2 t -57.89 137.44 83.42 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.459 -0.776 . . . . 0.0 110.17 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . 0.457 ' HG3' HD11 ' A' ' 29' ' ' ILE . 35.0 Cg_endo -76.97 172.97 15.24 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 122.438 2.092 . . . . 0.0 109.927 178.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' ARG . . . . . 0.532 ' O ' ' CG1' ' B' ' 47' ' ' VAL . 0.0 OUTLIER -150.94 135.36 17.01 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.811 -1.181 . . . . 0.0 110.614 -179.601 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.663 ' CG2' HG22 ' B' ' 47' ' ' VAL . 4.6 t . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.353 -0.842 . . . . 0.0 108.857 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.838 HG22 ' O ' ' B' ' 63' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.701 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.594 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 37.3 mt-10 -135.33 -40.58 0.73 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.502 -0.749 . . . . 0.0 109.349 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.651 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 6.9 m-90 62.63 40.55 0.37 Allowed Pre-proline 0 C--N 1.299 -1.59 0 O-C-N 121.545 -0.722 . . . . 0.0 109.946 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.651 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 34.7 Cg_endo -72.93 -33.75 7.37 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 N-CA-C 107.462 -1.784 . . . . 0.0 107.462 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -69.57 -10.75 59.47 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 177.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.666 HD21 ' HA ' ' A' ' 16' ' ' ALA . 11.7 tp -81.36 -1.92 47.27 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 121.556 -0.715 . . . . 0.0 109.445 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.58 HG22 HG23 ' B' ' 60' ' ' VAL . 24.1 t -54.71 151.28 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.101 -1.0 . . . . 0.0 109.482 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.07 6.18 18.16 Favored Glycine 0 N--CA 1.481 1.677 0 C-N-CA 120.042 -1.075 . . . . 0.0 110.5 178.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -93.13 -145.36 0.23 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.801 -1.411 . . . . 0.0 109.327 179.697 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 m -150.47 179.56 8.05 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.062 -1.023 . . . . 0.0 110.373 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 1.027 HG22 HD21 ' B' ' 49' ' ' LEU . 57.1 t -60.45 -35.3 62.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.487 -0.758 . . . . 0.0 109.724 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 1.9 pm0 -47.02 -74.46 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.047 -1.033 . . . . 0.0 108.893 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.475 ' HB3' HD11 ' A' ' 8' ' ' LEU . 21.0 tt0 -57.61 -31.38 66.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.219 -0.925 . . . . 0.0 110.084 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.912 ' HB2' HD11 ' B' ' 57' ' ' ILE . . . -66.6 -81.12 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.88 -1.137 . . . . 0.0 109.962 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -45.96 -30.43 1.79 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.758 -1.214 . . . . 0.0 109.056 -179.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.7 OUTLIER -63.46 -81.44 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.703 -0.623 . . . . 0.0 110.677 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.761 HG12 ' HB2' ' A' ' 23' ' ' ASP . 3.3 t -56.18 -50.04 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.204 -0.935 . . . . 0.0 109.613 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.941 HG21 ' HB ' ' A' ' 29' ' ' ILE . 61.8 mt -46.9 -59.49 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.389 -0.819 . . . . 0.0 109.928 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.501 ' C ' ' O ' ' A' ' 20' ' ' ILE . 17.4 tp -29.56 -37.74 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.056 0.455 . . . . 0.0 110.659 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.558 ' O ' ' N ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -133.43 -72.67 0.5 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.968 -1.082 . . . . 0.0 109.405 179.096 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.761 ' HB2' HG12 ' A' ' 19' ' ' VAL . 7.6 t0 42.48 -94.84 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.718 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 3.0 mtmp? -66.62 -118.14 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.332 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.718 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 36.5 Cg_endo -79.77 -75.53 0.01 OUTLIER 'Trans proline' 0 C--O 1.214 -0.703 0 CA-C-N 122.309 1.86 . . . . 0.0 108.902 178.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 4.5 mt-10 -156.84 59.88 0.53 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.758 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -89.03 113.01 24.08 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.475 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.549 ' O ' HG23 ' B' ' 47' ' ' VAL . 1.8 mt-30 -87.95 172.21 9.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.065 -1.022 . . . . 0.0 109.175 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.941 ' HB ' HG21 ' A' ' 20' ' ' ILE . 9.4 tt -136.86 142.66 37.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.979 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.802 HG22 HD22 ' A' ' 32' ' ' LEU . 26.9 mm -90.24 122.4 41.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.94 HG22 HD23 ' B' ' 49' ' ' LEU . 32.7 t -96.59 134.09 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.966 -1.084 . . . . 0.0 109.74 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.961 HD23 ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.303 -1.441 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 -178.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.557 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 1.2 ptt180 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 120.912 0.387 . . . . 0.0 110.086 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.543 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.4 OUTLIER -47.3 144.89 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 120.732 -1.23 . . . . 0.0 107.821 178.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.758 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.7 p-10 -106.34 45.7 0.96 Allowed 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 118.798 -1.161 . . . . 0.0 110.243 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' ARG . . . . . 0.483 ' HG3' HG12 ' A' ' 30' ' ' ILE . 1.4 ttt-85 -152.17 153.07 33.12 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.713 HG22 ' CG2' ' B' ' 63' ' ' VAL . 0.1 OUTLIER -150.59 -172.83 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.098 -1.001 . . . . 0.0 108.56 179.591 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.617 ' HD2' HD11 ' A' ' 32' ' ' LEU . 11.8 mmt85 -119.4 72.25 0.9 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.682 -1.261 . . . . 0.0 110.265 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 1.027 HD21 HG22 ' A' ' 13' ' ' VAL . 3.2 tp -69.21 97.74 0.96 Allowed 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.008 -1.077 . . . . 0.0 108.178 178.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' PHE . . . . . 0.831 ' CE1' HD12 ' A' ' 32' ' ' LEU . 18.1 m-85 -89.37 -162.93 0.92 Allowed 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.553 ' CG1' ' HA ' ' B' ' 55' ' ' ASP . 34.8 m -142.1 175.09 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.769 -1.207 . . . . 0.0 109.363 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.649 ' CB ' ' HB2' ' B' ' 58' ' ' ALA . 0.0 OUTLIER -127.44 -71.9 0.65 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.242 -0.911 . . . . 0.0 108.633 -179.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.548 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 17.9 mmtt -93.21 -75.21 0.5 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.898 -1.126 . . . . 0.0 108.535 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.555 ' O ' ' CB ' ' B' ' 55' ' ' ASP . 0.1 OUTLIER -131.68 51.75 2.12 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 179.088 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . 0.555 ' CB ' ' O ' ' B' ' 54' ' ' LEU . 0.2 OUTLIER 91.33 23.0 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.18 0.514 . . . . 0.0 109.703 -179.344 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . 0.575 ' O ' ' N ' ' B' ' 58' ' ' ALA . 62.4 t30 -88.83 91.87 8.99 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.912 HD11 ' HB2' ' A' ' 16' ' ' ALA . 9.4 mt -38.49 89.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-O 121.687 0.756 . . . . 0.0 110.779 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . 0.649 ' HB2' ' CB ' ' B' ' 52' ' ' ASP . . . -88.13 -25.65 22.87 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -118.2 103.51 9.91 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.581 HG13 ' HD2' ' B' ' 61' ' ' PRO . 63.0 t -62.49 138.21 96.46 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.386 -0.821 . . . . 0.0 110.918 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . 0.581 ' HD2' HG13 ' B' ' 60' ' ' VAL . 36.4 Cg_endo -80.44 170.54 15.85 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.736 2.291 . . . . 0.0 109.294 178.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' ARG . . . . . 0.545 ' CD ' ' HA ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -149.9 140.39 22.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.758 -1.214 . . . . 0.0 110.721 -179.512 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.838 ' O ' HG22 ' A' ' 3' ' ' THR . 1.4 t . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.543 -0.723 . . . . 0.0 109.166 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.504 HG23 ' HD2' ' A' ' 24' ' ' LYS . 7.3 m . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.648 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 10.1 mm-40 -105.8 -24.34 12.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.086 -1.009 . . . . 0.0 110.527 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.814 ' NE1' HD12 ' A' ' 20' ' ' ILE . 6.9 m-90 48.24 46.98 4.12 Favored Pre-proline 0 C--N 1.297 -1.709 0 C-N-CA 118.774 -1.17 . . . . 0.0 108.888 -178.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.66 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 31.4 Cg_endo -73.88 -35.44 4.37 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 N-CA-C 106.581 -2.123 . . . . 0.0 106.581 -179.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.84 -12.24 61.47 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 114.318 -1.31 . . . . 0.0 107.666 176.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.579 HD11 ' HB3' ' A' ' 15' ' ' GLU . 19.1 tp -79.68 -7.05 58.34 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 121.476 -0.765 . . . . 0.0 109.454 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.562 HG23 HG21 ' B' ' 60' ' ' VAL . 15.3 t -54.85 151.86 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.965 -1.084 . . . . 0.0 108.951 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.451 ' HA2' ' OD1' ' B' ' 56' ' ' ASN . . . 57.1 13.72 9.68 Favored Glycine 0 N--CA 1.481 1.64 0 N-CA-C 110.209 -1.157 . . . . 0.0 110.209 178.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -94.56 -143.52 0.25 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.959 -1.318 . . . . 0.0 109.511 179.843 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.12 170.4 18.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.042 -1.036 . . . . 0.0 110.173 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.551 ' HA ' HD11 ' B' ' 49' ' ' LEU . 78.4 t -53.27 -42.22 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.336 -0.853 . . . . 0.0 109.655 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.528 ' O ' ' CG ' ' A' ' 18' ' ' LYS . 59.0 mm-40 -41.38 -71.64 0.08 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.579 ' HB3' HD11 ' A' ' 8' ' ' LEU . 0.6 OUTLIER -56.09 -38.69 71.04 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.452 -0.78 . . . . 0.0 109.612 179.619 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.758 ' HB2' HD11 ' B' ' 57' ' ' ILE . . . -58.72 -83.85 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.383 -0.823 . . . . 0.0 109.862 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 17' ' ' LYS . 4.3 tptp -45.13 -29.99 1.04 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.563 -1.335 . . . . 0.0 109.39 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' A' ' 14' ' ' GLU . 4.3 mmtt -61.35 -86.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.66 0.743 . . . . 0.0 111.087 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 19' ' ' VAL . 2.4 t -57.89 -38.9 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 121.494 0.664 . . . . 0.0 109.824 -178.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.884 HG21 ' HB ' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -53.48 -51.75 38.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.438 -0.789 . . . . 0.0 109.725 -179.645 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 20' ' ' ILE . 45.3 tp -39.25 -23.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.399 -0.813 . . . . 0.0 111.9 -178.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -142.1 13.33 2.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.001 -1.687 . . . . 0.0 112.622 -179.242 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.967 ' OD1' ' HB3' ' A' ' 27' ' ' ALA . 1.2 p-10 -49.29 150.72 1.66 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.729 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.4 OUTLIER 52.81 -131.03 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 -178.809 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.729 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 36.9 Cg_endo -78.17 -83.03 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.635 0 CA-C-N 121.952 1.733 . . . . 0.0 109.346 178.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 3.1 mt-10 -144.69 71.01 1.29 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.417 -0.802 . . . . 0.0 109.046 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.967 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -89.03 118.71 28.95 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.006 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.518 ' O ' HG23 ' B' ' 47' ' ' VAL . 0.0 OUTLIER -88.01 -178.69 6.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.241 -0.912 . . . . 0.0 109.435 -179.313 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.884 ' HB ' HG21 ' A' ' 20' ' ' ILE . 14.0 tt -150.06 152.16 11.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 C-N-CA 119.02 -1.072 . . . . 0.0 111.112 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.424 ' HA ' HD13 ' A' ' 30' ' ' ILE . 16.3 mm -112.16 128.65 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.554 ' HA ' ' HB3' ' B' ' 49' ' ' LEU . 3.0 t -89.56 150.12 3.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 120.824 -1.173 . . . . 0.0 110.173 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.13 HD22 ' CD1' ' B' ' 50' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -178.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.575 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 120.865 0.364 . . . . 0.0 110.283 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.531 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.2 OUTLIER -45.79 140.17 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.856 -1.152 . . . . 0.0 108.363 179.388 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.624 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.9 OUTLIER -98.92 48.34 0.97 Allowed 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.031 -1.043 . . . . 0.0 109.624 -179.371 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -150.29 150.4 31.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.459 -0.775 . . . . 0.0 109.03 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.858 HG22 HG23 ' B' ' 63' ' ' VAL . 0.1 OUTLIER -151.36 -172.48 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.181 -0.949 . . . . 0.0 109.343 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 5.1 mmt85 -118.17 71.02 0.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.095 -1.003 . . . . 0.0 110.156 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.572 ' HB2' HG12 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -54.61 103.09 0.08 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.005 -1.059 . . . . 0.0 108.872 179.297 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' PHE . . . . . 1.13 ' CD1' HD22 ' A' ' 32' ' ' LEU . 2.2 m-85 -92.21 119.21 31.62 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.356 -0.84 . . . . 0.0 108.961 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.472 HG11 HG23 ' A' ' 13' ' ' VAL . 1.5 m -108.33 -175.45 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.12 -0.988 . . . . 0.0 109.536 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.545 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.0 OUTLIER -129.16 -161.97 1.16 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.291 -0.88 . . . . 0.0 109.619 -179.915 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.545 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 1.8 mttp -49.96 -61.79 1.94 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.589 -0.694 . . . . 0.0 109.934 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 7.6 mp -89.57 48.98 1.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.479 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 44.39 49.44 8.11 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.349 -0.844 . . . . 0.0 109.246 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . 0.484 ' HB3' ' CG ' ' B' ' 52' ' ' ASP . 4.9 t30 -107.11 111.17 23.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.31 -0.868 . . . . 0.0 108.873 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.758 HD11 ' HB2' ' A' ' 16' ' ' ALA . 12.5 mt -59.46 90.55 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 121.352 0.596 . . . . 0.0 110.21 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -87.94 -19.63 27.0 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . 0.529 ' HB2' ' CB ' ' B' ' 50' ' ' PHE . 1.1 mt-30 -123.12 82.27 1.98 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.567 HG11 ' O ' ' A' ' 5' ' ' TRP . 20.2 t -49.72 137.47 18.21 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.533 -0.73 . . . . 0.0 110.655 -178.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . 0.545 ' HG3' HD11 ' A' ' 29' ' ' ILE . 36.5 Cg_endo -81.23 172.67 12.53 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 123.023 2.482 . . . . 0.0 110.205 179.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' ARG . . . . . 0.577 ' HG3' ' HA ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -149.53 129.4 13.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.229 -0.919 . . . . 0.0 110.009 179.915 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.858 HG23 HG22 ' B' ' 47' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.752 0 O-C-N 121.217 -0.927 . . . . 0.0 108.906 179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.552 ' CG2' ' HD2' ' A' ' 24' ' ' LYS . 62.7 p . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.565 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -135.42 -47.73 0.7 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.183 -0.948 . . . . 0.0 109.83 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.651 ' CE2' HG12 ' A' ' 20' ' ' ILE . 9.3 m-90 58.64 44.96 1.2 Allowed Pre-proline 0 C--N 1.299 -1.604 0 C-N-CA 119.398 -0.921 . . . . 0.0 108.995 -178.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.645 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 33.5 Cg_endo -72.88 -32.09 9.41 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 N-CA-C 107.462 -1.784 . . . . 0.0 107.462 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.56 -12.2 60.97 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.842 HD21 ' HA ' ' A' ' 16' ' ' ALA . 2.7 tp -78.04 -4.32 46.57 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 121.507 -0.746 . . . . 0.0 109.594 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.7 t -52.43 152.39 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 C-N-CA 118.866 -1.133 . . . . 0.0 109.116 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.461 ' HA2' ' OD1' ' B' ' 56' ' ' ASN . . . 45.51 24.08 1.01 Allowed Glycine 0 N--CA 1.481 1.652 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 178.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 1.7 tptm -99.78 -138.93 0.32 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.984 -1.304 . . . . 0.0 109.249 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' B' ' 55' ' ' ASP . 0.3 OUTLIER -150.03 154.83 38.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.809 -1.182 . . . . 0.0 110.744 -179.53 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.633 ' HA ' HD21 ' B' ' 49' ' ' LEU . 54.9 t -52.41 -30.01 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 O-C-N 121.435 -0.79 . . . . 0.0 109.019 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.524 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 14.3 mt-10 -48.91 -74.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.466 -0.771 . . . . 0.0 109.107 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.491 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.6 OUTLIER -57.33 -28.94 63.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.168 -0.958 . . . . 0.0 108.705 179.226 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.89 ' C ' HD12 ' A' ' 20' ' ' ILE . . . -61.08 -86.74 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.4 -0.812 . . . . 0.0 109.959 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.448 ' HD2' ' C ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -47.46 -35.14 8.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.564 -1.335 . . . . 0.0 108.99 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -49.46 -78.82 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.468 0.651 . . . . 0.0 110.869 -179.471 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 15' ' ' GLU . 0.5 OUTLIER -72.76 -44.57 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.425 -0.797 . . . . 0.0 109.677 -178.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.959 HG21 ' HB ' ' A' ' 29' ' ' ILE . 67.2 mt -40.07 -52.91 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.544 -0.722 . . . . 0.0 109.511 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 28' ' ' GLN . 0.5 OUTLIER -38.73 -49.44 1.59 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.563 -0.711 . . . . 0.0 110.483 -179.658 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.464 ' HB2' HD23 ' A' ' 21' ' ' LEU . 1.1 mt-30 -135.06 44.51 2.6 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.099 -1.0 . . . . 0.0 110.506 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.582 ' HB3' ' CE ' ' A' ' 24' ' ' LYS . 4.6 t0 -66.33 -39.85 89.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.866 -1.146 . . . . 0.0 108.488 179.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.824 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -117.42 -99.51 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.444 0 CA-C-O 117.214 -1.374 . . . . 0.0 107.975 178.707 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.824 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 37.3 Cg_endo -82.15 -76.14 0.0 OUTLIER 'Trans proline' 0 C--O 1.213 -0.742 0 CA-C-N 122.374 1.884 . . . . 0.0 108.284 177.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 16.3 mt-10 -160.77 56.35 0.31 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.903 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -88.81 119.15 29.05 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.128 -0.983 . . . . 0.0 109.467 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 15.7 mt-30 -89.25 -178.35 5.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.224 -0.923 . . . . 0.0 109.326 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.959 ' HB ' HG21 ' A' ' 20' ' ' ILE . 3.6 tt -145.45 127.93 9.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.089 -1.007 . . . . 0.0 110.436 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.823 HD12 ' HD3' ' B' ' 46' ' ' ARG . 33.4 mt -89.0 111.31 22.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.486 HG21 HG21 ' A' ' 13' ' ' VAL . 7.0 p -89.72 146.59 5.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.136 -0.977 . . . . 0.0 110.123 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.161 HD11 ' CE1' ' B' ' 50' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.461 -0.775 . . . . 0.0 109.461 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.554 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.545 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.5 OUTLIER -43.17 145.87 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.99 -1.069 . . . . 0.0 108.262 179.488 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.611 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 2.2 p-10 -106.1 46.44 0.92 Allowed 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 118.962 -1.095 . . . . 0.0 110.756 -178.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' ARG . . . . . 0.823 ' HD3' HD12 ' A' ' 30' ' ' ILE . 2.3 ptp180 -150.94 153.01 34.43 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.22 -0.925 . . . . 0.0 109.244 178.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 1.091 ' CG2' HG23 ' B' ' 63' ' ' VAL . 31.1 t -150.93 161.66 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.421 -0.799 . . . . 0.0 109.162 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.804 ' HG3' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -93.38 84.16 4.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.85 -1.156 . . . . 0.0 110.022 -179.453 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.633 HD21 ' HA ' ' A' ' 13' ' ' VAL . 2.5 tp -80.04 83.36 5.94 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 118.985 -1.086 . . . . 0.0 109.17 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' PHE . . . . . 1.161 ' CE1' HD11 ' A' ' 32' ' ' LEU . 3.8 m-30 -66.98 -162.88 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.715 HG12 ' HA ' ' B' ' 55' ' ' ASP . 10.1 m -149.44 160.9 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.834 -1.166 . . . . 0.0 108.702 178.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.715 ' CB ' ' HB2' ' B' ' 58' ' ' ALA . 0.0 OUTLIER -112.37 -70.61 0.8 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.939 -1.1 . . . . 0.0 108.796 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.55 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 9.9 mmmt -92.5 -75.91 0.48 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.848 -1.158 . . . . 0.0 108.49 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.543 ' O ' ' CB ' ' B' ' 55' ' ' ASP . 0.1 OUTLIER -136.85 57.22 1.77 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.056 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . 0.715 ' HA ' HG12 ' B' ' 51' ' ' VAL . 0.2 OUTLIER 91.51 24.13 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.421 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' B' ' 58' ' ' ALA . 31.8 t-20 -88.82 86.79 7.04 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.742 HD11 ' HB2' ' A' ' 16' ' ' ALA . 3.8 mt -37.33 89.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-O 121.511 0.672 . . . . 0.0 111.315 -178.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . 0.715 ' HB2' ' CB ' ' B' ' 52' ' ' ASP . . . -88.81 -17.5 29.62 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' B' ' 60' ' ' VAL . 33.9 mt-30 -127.68 84.37 2.25 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 4' ' ' GLU . 6.4 t -41.68 136.2 2.01 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.453 -0.779 . . . . 0.0 110.161 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . 0.806 ' HB2' HG11 ' B' ' 47' ' ' VAL . 36.7 Cg_endo -81.95 166.79 16.7 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.751 2.301 . . . . 0.0 110.523 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' ARG . . . . . 0.621 ' O ' HG13 ' B' ' 47' ' ' VAL . 0.3 OUTLIER -142.72 152.85 42.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 109.285 179.416 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 1.091 HG23 ' CG2' ' B' ' 47' ' ' VAL . 1.2 t . . . . . 0 N--CA 1.493 1.711 0 O-C-N 121.229 -0.919 . . . . 0.0 109.486 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.747 HG22 ' CE ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.7 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.58 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 4.9 mt-10 -99.92 -48.41 4.68 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.993 -1.067 . . . . 0.0 110.878 -178.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.619 ' CE2' HG12 ' A' ' 20' ' ' ILE . 10.4 m-90 60.71 45.76 1.03 Allowed Pre-proline 0 C--N 1.297 -1.711 0 C-N-CA 119.067 -1.053 . . . . 0.0 108.386 -177.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.662 ' HA ' HG21 ' B' ' 60' ' ' VAL . 32.8 Cg_endo -72.31 -31.2 11.93 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 N-CA-C 107.057 -1.94 . . . . 0.0 107.057 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.21 -13.14 62.02 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.525 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.577 HD23 ' HB3' ' A' ' 5' ' ' TRP . 0.3 OUTLIER -71.32 -11.57 60.98 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.204 -0.935 . . . . 0.0 108.987 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.741 HG23 ' CG2' ' B' ' 60' ' ' VAL . 24.4 t -55.9 145.1 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.087 -1.008 . . . . 0.0 109.82 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.474 ' HA2' ' OD1' ' B' ' 56' ' ' ASN . . . 59.23 13.65 22.22 Favored Glycine 0 N--CA 1.482 1.726 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.287 177.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 1.2 tptp -95.44 -147.11 0.28 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.133 -1.216 . . . . 0.0 109.178 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.84 155.96 44.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -0.917 . . . . 0.0 109.372 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.528 ' CG2' ' CG1' ' B' ' 51' ' ' VAL . 69.0 t -47.17 -37.18 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.834 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.516 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -44.81 -76.9 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.211 -0.931 . . . . 0.0 109.317 -179.864 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -54.76 -35.57 63.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.561 -0.712 . . . . 0.0 110.143 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.69 ' C ' HD12 ' A' ' 20' ' ' ILE . . . -63.46 -83.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.827 . . . . 0.0 110.364 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.655 ' HG2' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -45.7 -27.52 0.83 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.142 -0.974 . . . . 0.0 108.884 -179.618 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.1 OUTLIER -67.46 -86.28 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.746 -0.596 . . . . 0.0 111.167 -179.029 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.503 ' O ' ' OD1' ' A' ' 23' ' ' ASP . 4.6 t -46.13 -42.77 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.15 -0.969 . . . . 0.0 109.455 -178.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.995 HG21 ' HB ' ' A' ' 29' ' ' ILE . 46.5 mt -56.63 -44.24 80.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.452 -0.78 . . . . 0.0 109.536 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 20' ' ' ILE . 4.2 tt -39.15 -25.82 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.222 -0.923 . . . . 0.0 110.588 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.548 ' O ' ' N ' ' A' ' 24' ' ' LYS . 0.6 OUTLIER -144.3 -67.99 0.32 Allowed 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.525 -1.359 . . . . 0.0 111.592 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.516 ' OD1' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER 39.54 -94.51 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.393 -0.817 . . . . 0.0 108.86 -178.549 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.747 ' CE ' HG22 ' A' ' 3' ' ' THR . 10.6 mtpt -64.89 -118.95 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.435 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 178.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.735 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 36.5 Cg_endo -80.56 -73.21 0.01 OUTLIER 'Trans proline' 0 C--O 1.214 -0.71 0 CA-C-N 122.221 1.829 . . . . 0.0 109.006 178.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 5.5 mt-10 -159.29 60.63 0.4 Allowed 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.749 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -88.03 113.99 24.21 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.566 ' O ' HG23 ' B' ' 47' ' ' VAL . 0.2 OUTLIER -86.78 170.57 11.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.144 -0.973 . . . . 0.0 110.517 -177.711 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.995 ' HB ' HG21 ' A' ' 20' ' ' ILE . 19.2 tt -140.21 141.91 32.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.829 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.531 ' O ' ' HB3' ' B' ' 49' ' ' LEU . 1.0 OUTLIER -91.31 163.77 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 179.132 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 1.04 HG13 HD12 ' B' ' 49' ' ' LEU . 64.5 t -135.2 133.39 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.312 -1.492 . . . . 0.0 110.372 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.036 HD21 ' CE1' ' B' ' 50' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.503 -0.748 . . . . 0.0 109.113 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' ARG . . . . . 0.569 ' HD3' ' CG1' ' B' ' 63' ' ' VAL . 1.6 tpp180 . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.541 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.4 OUTLIER -52.64 142.74 4.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 179.185 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.749 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -96.54 50.21 1.13 Allowed 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.703 -1.248 . . . . 0.0 110.4 -178.738 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 28' ' ' GLN . 15.0 ttm180 -150.03 150.21 31.44 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.436 -0.79 . . . . 0.0 108.9 178.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.668 HG22 ' CG2' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -151.71 179.9 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.769 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.618 ' HB3' ' CE2' ' B' ' 50' ' ' PHE . 0.9 OUTLIER -107.38 85.21 2.09 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.905 -1.122 . . . . 0.0 111.62 -178.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 1.04 HD12 HG13 ' A' ' 31' ' ' VAL . 2.1 tm? -78.31 93.47 4.67 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' PHE . . . . . 1.036 ' CE1' HD21 ' A' ' 32' ' ' LEU . 50.4 m-85 -89.42 132.95 34.75 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 32' ' ' LEU . 16.7 m -99.77 -169.31 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.842 -1.161 . . . . 0.0 109.538 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' B' ' 55' ' ' ASP . 3.6 p-10 -126.77 -148.89 0.4 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.209 -0.932 . . . . 0.0 109.119 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' LYS . . . . . 0.496 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 4.6 mmmm -76.5 -45.43 30.97 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' LEU . . . . . 0.507 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 1.4 mt -101.15 34.46 2.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.542 -0.724 . . . . 0.0 109.612 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' ASP . . . . . 0.536 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.0 OUTLIER 53.77 68.28 0.87 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.016 -1.052 . . . . 0.0 108.179 -178.787 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' B' ' 58' ' ' ALA . 47.1 t-20 -130.93 100.4 5.24 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.678 HD12 HD21 ' B' ' 49' ' ' LEU . 31.2 mm -40.67 88.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.495 0.664 . . . . 0.0 110.624 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -89.59 -18.46 26.52 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.5 108.33 14.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.48 -0.763 . . . . 0.0 108.998 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.741 ' CG2' HG23 ' A' ' 9' ' ' VAL . 32.8 t -66.27 133.51 94.55 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.304 -0.872 . . . . 0.0 110.236 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . 0.611 ' HB3' HD11 ' A' ' 29' ' ' ILE . 36.5 Cg_endo -81.72 165.17 18.05 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.601 2.201 . . . . 0.0 110.496 179.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' ARG . . . . . 0.567 ' CD ' ' HA ' ' A' ' 4' ' ' GLU . 1.1 tpp180 -150.22 134.85 17.47 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.223 -0.923 . . . . 0.0 110.54 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.668 ' CG2' HG22 ' B' ' 47' ' ' VAL . 1.4 t . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.544 ' O ' HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.535 ' HB3' ' CB ' ' A' ' 23' ' ' ASP . 1.4 tppm? -71.55 111.7 7.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.119 -0.988 . . . . 0.0 109.379 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.697 HG22 ' HD2' ' A' ' 24' ' ' LYS . 1.4 p -136.3 6.99 3.08 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.345 -0.847 . . . . 0.0 109.342 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.592 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -131.53 -30.76 1.64 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.043 -1.036 . . . . 0.0 110.484 -179.646 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.668 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 5.8 m-90 51.44 46.29 3.49 Favored Pre-proline 0 C--N 1.296 -1.723 0 C-N-CA 118.088 -1.445 . . . . 0.0 108.237 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.668 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 32.8 Cg_endo -73.76 -33.86 6.01 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 N-CA-C 107.75 -1.673 . . . . 0.0 107.75 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.69 -11.13 59.82 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.761 HD21 ' HB2' ' A' ' 16' ' ' ALA . 63.4 tp -79.96 -5.05 54.96 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 121.394 -0.816 . . . . 0.0 109.586 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.666 HG22 ' CG2' ' B' ' 60' ' ' VAL . 42.5 t -53.75 149.2 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 120.994 -1.066 . . . . 0.0 110.466 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 58.42 11.68 10.58 Favored Glycine 0 N--CA 1.481 1.647 0 C-N-CA 120.194 -1.003 . . . . 0.0 110.644 178.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.612 ' CB ' HD12 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -91.49 -144.28 0.19 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.925 -1.338 . . . . 0.0 109.124 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.431 ' O ' HD11 ' B' ' 57' ' ' ILE . 0.5 OUTLIER -145.54 157.1 44.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.035 -1.04 . . . . 0.0 109.961 -179.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.515 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 93.0 t -48.68 -34.28 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.343 -0.848 . . . . 0.0 109.479 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.508 ' O ' ' CD ' ' A' ' 18' ' ' LYS . 7.8 mm-40 -44.6 -75.52 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.092 -1.005 . . . . 0.0 109.163 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -58.71 -32.34 69.08 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.687 -0.633 . . . . 0.0 109.959 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.761 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -62.45 -80.66 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.086 -1.009 . . . . 0.0 109.676 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.514 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -44.2 -39.94 4.75 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.872 -1.143 . . . . 0.0 108.942 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.528 ' N ' ' HD2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -51.53 -81.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.75 0.786 . . . . 0.0 111.085 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.9 t -66.08 -49.27 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.809 -0.557 . . . . 0.0 110.472 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.966 HD13 HD13 ' A' ' 29' ' ' ILE . 61.7 mt -45.8 -40.13 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 0.0 109.518 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.56 ' CD1' ' HG3' ' A' ' 28' ' ' GLN . 35.1 tp -38.84 -23.82 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.55 ' O ' ' N ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -135.37 -81.22 0.42 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 119.977 -1.702 . . . . 0.0 111.617 -178.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.613 ' OD2' ' HA ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER 37.77 -94.82 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.739 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.697 ' HD2' HG22 ' A' ' 3' ' ' THR . 0.0 OUTLIER -58.48 -163.76 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 176.214 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.62 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 37.4 Cg_endo -76.32 82.44 2.23 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 N-CA-C 108.666 -1.321 . . . . 0.0 108.666 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.533 ' CG ' ' C ' ' A' ' 25' ' ' PRO . 0.3 OUTLIER 56.88 52.22 9.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.65 -0.657 . . . . 0.0 111.009 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.789 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -88.82 112.05 22.77 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 177.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.56 ' HG3' ' CD1' ' A' ' 21' ' ' LEU . 0.6 OUTLIER -87.51 -166.62 1.63 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.012 -1.055 . . . . 0.0 110.721 -177.213 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.966 HD13 HD13 ' A' ' 20' ' ' ILE . 1.7 tt -149.86 144.23 17.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.477 -179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.497 ' O ' ' HB3' ' B' ' 49' ' ' LEU . 31.9 mt -89.39 115.27 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.752 -0.593 . . . . 0.0 109.985 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.638 HG13 ' O ' ' A' ' 31' ' ' VAL . 8.0 p -89.91 109.59 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.545 -1.347 . . . . 0.0 109.906 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.105 HD11 ' CE1' ' B' ' 50' ' ' PHE . 0.5 OUTLIER -138.94 152.44 70.26 Favored Pre-proline 0 N--CA 1.492 1.626 0 C-N-CA 119.087 -1.045 . . . . 0.0 110.411 179.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.598 ' HA ' HG22 ' B' ' 51' ' ' VAL . 37.5 Cg_endo -81.33 55.43 5.6 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 123.063 2.509 . . . . 0.0 110.007 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.632 HG22 ' HB3' ' B' ' 50' ' ' PHE . 67.2 t 50.38 -91.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.336 -0.852 . . . . 0.0 109.416 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . 47.18 -174.75 0.01 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.15 -167.12 0.7 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -1.179 . . . . 0.0 109.188 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.784 ' O ' HG22 ' A' ' 37' ' ' ILE . 3.4 mp -112.4 65.33 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.169 -0.957 . . . . 0.0 109.334 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.504 ' O ' HG12 ' A' ' 38' ' ' VAL . 66.4 t 58.53 81.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 0.0 109.765 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.474 ' CG2' ' O ' ' A' ' 38' ' ' VAL . 1.2 t . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 118.088 -0.958 . . . . 0.0 109.836 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . 0.623 ' CZ ' ' HA ' ' B' ' 44' ' ' ILE . 6.8 p90 -136.18 -148.12 0.28 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.159 -0.963 . . . . 0.0 109.856 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.516 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 8.0 ptp180 -89.39 51.66 2.17 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.896 . . . . 0.0 109.31 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.623 ' HA ' ' CZ ' ' B' ' 42' ' ' TYR . 0.7 OUTLIER -42.5 145.59 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 119.403 -0.919 . . . . 0.0 108.896 179.795 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.568 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.1 p-10 -107.66 46.43 0.94 Allowed 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.918 -178.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . 0.484 ' HG2' HG13 ' A' ' 30' ' ' ILE . 11.3 mtt180 -150.16 150.1 31.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.33 -0.856 . . . . 0.0 109.426 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 1.101 ' CG2' HG23 ' B' ' 63' ' ' VAL . 79.2 t -151.32 126.47 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.316 -0.865 . . . . 0.0 110.082 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -53.35 87.95 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.734 -1.229 . . . . 0.0 110.584 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.583 ' HB2' ' CG1' ' A' ' 29' ' ' ILE . 4.9 tp -91.29 87.26 6.41 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' PHE . . . . . 1.105 ' CE1' HD11 ' A' ' 32' ' ' LEU . 5.7 m-30 -72.59 148.44 44.9 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.598 HG22 ' HA ' ' A' ' 33' ' ' PRO . 34.8 m -122.4 166.53 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.711 -1.243 . . . . 0.0 109.872 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' B' ' 55' ' ' ASP . 1.5 p-10 -93.52 -151.34 0.3 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.57 -0.707 . . . . 0.0 109.25 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.503 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 0.1 OUTLIER -75.56 -46.5 31.6 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.236 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.517 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 1.8 mm? -101.61 36.81 1.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.622 -0.674 . . . . 0.0 109.655 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . 0.539 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.0 OUTLIER 52.77 67.11 1.04 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.192 -0.942 . . . . 0.0 109.583 -179.32 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . 0.565 ' O ' ' N ' ' B' ' 58' ' ' ALA . 29.0 t30 -119.97 86.02 2.49 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.56 HD12 ' HG ' ' A' ' 8' ' ' LEU . 4.6 mt -31.94 87.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 CA-C-O 121.637 0.732 . . . . 0.0 111.42 -179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -89.37 -4.63 57.98 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -125.91 133.24 51.94 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.666 ' CG2' HG22 ' A' ' 9' ' ' VAL . 93.8 t -90.76 131.21 38.27 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.042 -1.036 . . . . 0.0 111.068 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.874 ' CB ' HG11 ' B' ' 47' ' ' VAL . 37.3 Cg_endo -83.84 161.75 14.05 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.581 2.188 . . . . 0.0 108.813 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . 0.563 ' HD3' ' HA ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -140.58 -49.15 0.44 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.798 -1.189 . . . . 0.0 110.164 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 1.101 HG23 ' CG2' ' B' ' 47' ' ' VAL . 0.8 OUTLIER 76.04 -3.14 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 O-C-N 121.442 -0.786 . . . . 0.0 109.812 179.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 CA-C-O 118.027 -1.429 . . . . 0.0 109.611 -179.925 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.405 ' O ' ' OG1' ' A' ' 3' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.522 ' CB ' ' HB3' ' A' ' 23' ' ' ASP . 1.8 mmpt? -52.81 98.87 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.328 -0.858 . . . . 0.0 109.461 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.603 HG23 ' HG3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -126.28 25.37 6.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.317 -0.864 . . . . 0.0 109.143 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.602 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 3.8 mt-10 -148.45 -44.2 0.15 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.276 -0.89 . . . . 0.0 110.655 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.647 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 6.1 m-90 59.6 41.67 0.6 Allowed Pre-proline 0 C--N 1.301 -1.507 0 O-C-N 121.157 -0.964 . . . . 0.0 109.788 -178.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.647 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 34.1 Cg_endo -73.31 -33.36 7.2 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 N-CA-C 107.204 -1.883 . . . . 0.0 107.204 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -70.3 -12.53 61.65 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.621 ' HG ' HD12 ' B' ' 57' ' ' ILE . 49.5 tp -83.69 -4.31 58.5 Favored 'General case' 0 C--N 1.308 -1.202 0 O-C-N 121.385 -0.822 . . . . 0.0 109.262 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.562 HG23 HG21 ' B' ' 60' ' ' VAL . 14.7 t -53.69 152.36 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.91 -1.119 . . . . 0.0 109.319 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.426 ' C ' ' OD1' ' B' ' 56' ' ' ASN . . . 66.85 4.77 28.56 Favored Glycine 0 N--CA 1.481 1.635 0 C-N-CA 119.823 -1.18 . . . . 0.0 110.625 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 2.3 tptp -94.54 -146.88 0.26 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.778 -1.425 . . . . 0.0 109.627 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.491 ' CB ' ' OE2' ' A' ' 14' ' ' GLU . 33.2 m -144.8 169.16 18.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.104 -0.998 . . . . 0.0 109.998 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.635 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 88.4 t -54.21 -34.92 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.488 -0.758 . . . . 0.0 109.902 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.551 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 1.3 pm0 -44.07 -73.75 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.313 -0.867 . . . . 0.0 109.197 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.79 -31.02 71.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.257 -0.902 . . . . 0.0 109.61 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.813 ' HB2' HD11 ' B' ' 57' ' ' ILE . . . -61.39 -83.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.103 -0.998 . . . . 0.0 109.481 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.523 ' HG2' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -46.79 -41.53 15.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.78 -1.2 . . . . 0.0 108.768 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.551 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -44.57 -77.37 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.617 0.722 . . . . 0.0 110.185 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.703 HG12 ' CG ' ' A' ' 23' ' ' ASP . 1.9 t -72.91 -54.35 16.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.728 -0.608 . . . . 0.0 110.225 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.801 HD13 HD13 ' A' ' 29' ' ' ILE . 62.5 mt -33.92 -50.74 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.611 -0.681 . . . . 0.0 110.362 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.616 HD23 ' C ' ' A' ' 21' ' ' LEU . 9.6 tt -38.66 -53.88 1.59 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.512 -0.742 . . . . 0.0 110.638 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -123.79 21.22 9.2 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.963 -1.085 . . . . 0.0 111.172 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.703 ' CG ' HG12 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -56.66 -60.16 3.95 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 177.648 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.756 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 3.2 tttm -68.23 -153.87 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.566 0 N-CA-C 104.37 -2.456 . . . . 0.0 104.37 175.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.756 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 27.7 Cg_endo -68.68 -45.81 2.13 Favored 'Trans proline' 0 C--N 1.319 -1.012 0 CA-C-N 121.15 1.446 . . . . 0.0 109.002 178.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 1.7 mt-10 -166.34 52.33 0.09 Allowed 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.662 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -90.22 117.32 28.88 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.176 -1.009 . . . . 0.0 109.33 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 11.5 mt-30 -88.79 178.49 6.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.155 -0.965 . . . . 0.0 109.152 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.801 HD13 HD13 ' A' ' 20' ' ' ILE . 8.5 tt -148.75 138.85 16.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 C-N-CA 118.99 -1.084 . . . . 0.0 111.074 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.579 HD12 ' HG3' ' B' ' 46' ' ' ARG . 1.2 mt -91.24 164.24 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.814 ' C ' HD23 ' A' ' 32' ' ' LEU . 7.4 p -131.06 135.84 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.683 -1.261 . . . . 0.0 110.187 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.948 HD23 ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -150.4 164.22 21.31 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 110.075 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.559 ' HA ' HG22 ' B' ' 51' ' ' VAL . 37.0 Cg_endo -80.33 139.57 13.16 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.192 1.928 . . . . 0.0 109.326 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.831 HG12 ' HB3' ' B' ' 50' ' ' PHE . 24.1 m -63.66 -10.35 6.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.188 -0.945 . . . . 0.0 109.97 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 34' ' ' VAL . . . -40.66 -84.71 0.01 OUTLIER Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.5 p -99.45 -167.7 1.51 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.267 -1.137 . . . . 0.0 109.827 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.791 HG23 ' O ' ' A' ' 37' ' ' ILE . 0.2 OUTLIER -134.4 39.99 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.406 -0.809 . . . . 0.0 108.956 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.79 140.66 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.026 -1.046 . . . . 0.0 109.657 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.432 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . 0.449 ' OE2' ' HB ' ' B' ' 44' ' ' ILE . 8.3 pt-20 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.471 0.653 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . 0.422 ' HD1' ' N ' ' B' ' 43' ' ' ARG . 3.9 p90 -75.31 -148.72 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.527 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.4 OUTLIER -104.59 62.66 0.72 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.774 -1.204 . . . . 0.0 109.589 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.449 ' HB ' ' OE2' ' B' ' 41' ' ' GLU . 11.8 tt -44.88 160.13 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.938 -1.101 . . . . 0.0 108.037 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.662 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.7 p-10 -127.08 45.83 2.63 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 118.602 -1.239 . . . . 0.0 110.167 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . 0.579 ' HG3' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -152.07 150.55 30.06 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.63 HG22 ' CG2' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -151.4 168.62 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.95 -1.094 . . . . 0.0 109.355 -179.617 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.541 ' HG3' HD11 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -97.54 93.8 6.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.969 -1.082 . . . . 0.0 109.333 179.686 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.561 ' C ' HD12 ' B' ' 49' ' ' LEU . 0.9 OUTLIER -88.67 82.05 6.93 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.439 -0.904 . . . . 0.0 109.475 179.745 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' PHE . . . . . 0.831 ' HB3' HG12 ' A' ' 34' ' ' VAL . 2.9 m-30 -66.05 158.22 28.97 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.726 ' O ' HG13 ' A' ' 34' ' ' VAL . 12.2 m -118.86 -174.98 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.799 -1.188 . . . . 0.0 109.295 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.502 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.5 OUTLIER -124.86 -154.3 0.61 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.029 -1.044 . . . . 0.0 110.08 -179.531 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.502 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 1.8 mtmp? -60.85 -57.39 12.86 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.606 -0.684 . . . . 0.0 109.653 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.43 ' HA ' HD13 ' B' ' 54' ' ' LEU . 0.3 OUTLIER -99.58 44.58 1.02 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.331 -0.856 . . . . 0.0 109.741 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 48.7 63.72 1.99 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.072 -1.018 . . . . 0.0 109.162 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . 0.587 ' O ' ' N ' ' B' ' 58' ' ' ALA . 7.6 t30 -130.25 109.85 11.1 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.813 HD11 ' HB2' ' A' ' 16' ' ' ALA . 23.9 mt -34.34 86.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 121.485 0.659 . . . . 0.0 111.262 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.587 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -89.13 -8.77 53.1 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.47 85.43 2.05 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.562 HG21 HG23 ' A' ' 9' ' ' VAL . 2.2 t -48.25 139.49 10.23 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.465 -0.772 . . . . 0.0 110.131 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.591 ' CG ' ' CD1' ' A' ' 29' ' ' ILE . 36.4 Cg_endo -81.21 168.96 16.42 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.856 2.371 . . . . 0.0 109.404 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . 0.544 ' HD2' ' CB ' ' A' ' 4' ' ' GLU . 0.5 OUTLIER -149.89 124.45 9.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.873 -1.142 . . . . 0.0 110.274 -179.722 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.63 ' CG2' HG22 ' B' ' 47' ' ' VAL . 2.6 t -107.65 152.91 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.339 -0.85 . . . . 0.0 108.788 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 CA-C-O 117.965 -1.464 . . . . 0.0 109.56 179.869 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.449 ' HG2' ' HA ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.4 0.619 . . . . 0.0 109.54 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.506 ' HB2' ' OD1' ' A' ' 23' ' ' ASP . 0.3 OUTLIER -89.1 79.57 7.17 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.304 -0.873 . . . . 0.0 109.465 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.786 HG22 ' CD ' ' A' ' 24' ' ' LYS . 2.8 p -108.03 8.09 28.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.284 -0.885 . . . . 0.0 109.503 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.633 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 0.4 OUTLIER -125.5 -57.75 1.45 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.196 -0.94 . . . . 0.0 110.012 -179.118 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.789 ' O ' HD22 ' A' ' 8' ' ' LEU . 5.0 m-90 70.3 39.78 0.18 Allowed Pre-proline 0 C--N 1.3 -1.561 0 O-C-N 121.765 -0.584 . . . . 0.0 110.827 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.633 ' HD3' ' CB ' ' A' ' 4' ' ' GLU . 33.1 Cg_endo -72.31 -30.18 13.14 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 N-CA-C 107.559 -1.746 . . . . 0.0 107.559 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.51 -17.66 64.75 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-N 114.977 -1.01 . . . . 0.0 108.302 177.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.064 HD23 ' N ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -69.48 -23.02 63.58 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 122.254 1.026 . . . . 0.0 108.565 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.064 ' N ' HD23 ' A' ' 8' ' ' LEU . 3.8 t -43.63 138.61 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-O 121.988 0.899 . . . . 0.0 110.88 -178.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.507 ' O ' ' OD1' ' B' ' 56' ' ' ASN . . . 86.5 -45.55 3.46 Favored Glycine 0 C--N 1.298 -1.581 0 C-N-CA 119.749 -1.215 . . . . 0.0 112.364 175.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.3 78.14 1.08 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 119.951 -1.911 . . . . 0.0 111.492 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.881 ' O ' ' HB2' ' A' ' 16' ' ' ALA . 0.9 OUTLIER -153.18 46.73 0.68 Allowed 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 118.315 -1.354 . . . . 0.0 111.345 179.486 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.644 HG21 ' O ' ' B' ' 55' ' ' ASP . 23.9 t -77.28 -73.03 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 O-C-N 121.068 -1.02 . . . . 0.0 109.725 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.484 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 11.6 pt-20 -55.71 -38.25 69.47 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.452 ' HA ' ' HB3' ' A' ' 18' ' ' LYS . 4.3 tt0 -68.48 -32.72 72.9 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.881 ' HB2' ' O ' ' A' ' 12' ' ' SER . . . -62.69 -71.62 0.15 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.635 -0.826 . . . . 0.0 109.096 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.787 ' HE2' HD12 ' A' ' 21' ' ' LEU . 0.5 OUTLIER -50.56 -35.58 30.48 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.112 179.613 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.5 ' HG2' ' N ' ' A' ' 19' ' ' VAL . 2.6 ttmt -62.17 -90.29 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.576 0.703 . . . . 0.0 110.742 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.735 HG12 ' OD2' ' A' ' 23' ' ' ASP . 3.4 t -46.19 -48.32 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.639 -0.663 . . . . 0.0 110.371 -178.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.928 HD13 HD13 ' A' ' 29' ' ' ILE . 61.6 mt -50.43 -50.88 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.176 -0.953 . . . . 0.0 109.876 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.787 HD12 ' HE2' ' A' ' 17' ' ' LYS . 3.3 tt -35.13 -29.99 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.679 -0.638 . . . . 0.0 111.544 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.566 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -136.36 3.24 2.81 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 118.002 -1.479 . . . . 0.0 111.98 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.735 ' OD2' HG12 ' A' ' 19' ' ' VAL . 22.5 m-20 -54.12 147.17 13.33 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 177.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.786 ' CD ' HG22 ' A' ' 3' ' ' THR . 21.9 mtpt 69.86 -147.0 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 104.425 -2.435 . . . . 0.0 104.425 -175.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.688 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 33.2 Cg_endo -75.42 -64.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.324 -0.745 0 CA-C-N 121.36 1.521 . . . . 0.0 108.814 178.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 26.9 mt-10 -161.06 64.66 0.29 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.789 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -88.78 117.53 27.84 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.494 ' CB ' ' O ' ' B' ' 45' ' ' ASP . 0.0 OUTLIER -88.19 175.76 7.56 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.182 -0.949 . . . . 0.0 109.7 -179.47 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.928 HD13 HD13 ' A' ' 20' ' ' ILE . 3.3 tt -143.12 147.11 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.225 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.501 HD12 ' HD2' ' B' ' 46' ' ' ARG . 4.2 mt -102.44 130.89 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.878 HG13 ' HG ' ' B' ' 49' ' ' LEU . 2.5 t -104.23 125.72 58.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 120.798 -1.189 . . . . 0.0 109.721 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.077 HD11 ' CE1' ' B' ' 50' ' ' PHE . 0.7 OUTLIER -138.5 165.45 32.76 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 -179.293 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.674 ' C ' HG23 ' A' ' 34' ' ' VAL . 39.4 Cg_endo -79.43 18.65 1.05 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.447 2.098 . . . . 0.0 111.399 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.674 HG23 ' C ' ' A' ' 33' ' ' PRO . 3.2 t 81.24 -71.37 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.438 -0.789 . . . . 0.0 108.953 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.506 ' O ' ' CG1' ' A' ' 37' ' ' ILE . . . -49.11 -65.12 2.88 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.49 ' HB ' ' HD2' ' A' ' 33' ' ' PRO . 75.0 m -33.14 120.68 0.37 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.677 -0.896 . . . . 0.0 111.492 -178.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.506 ' CG1' ' O ' ' A' ' 35' ' ' GLY . 3.0 mt -128.49 15.45 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.0 m -57.86 -175.8 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.497 -0.752 . . . . 0.0 109.946 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.3 p . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 117.896 -1.05 . . . . 0.0 109.509 -179.939 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . 0.725 ' OH ' HD12 ' B' ' 44' ' ' ILE . 10.6 p90 -127.36 -145.39 0.31 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.807 -1.183 . . . . 0.0 109.444 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.542 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER -114.91 67.33 0.69 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.139 -0.976 . . . . 0.0 110.213 -179.334 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.725 HD12 ' OH ' ' B' ' 42' ' ' TYR . 0.5 OUTLIER -46.96 145.45 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.706 -1.246 . . . . 0.0 108.108 179.187 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.62 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.0 OUTLIER -105.86 43.05 1.16 Allowed 'General case' 0 C--N 1.295 -1.763 0 O-C-N 120.914 -1.116 . . . . 0.0 109.829 -179.338 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . 0.501 ' HD2' HD12 ' A' ' 30' ' ' ILE . 0.3 OUTLIER -151.02 155.05 38.23 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.366 -0.834 . . . . 0.0 109.477 179.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.944 ' CG2' HG23 ' B' ' 63' ' ' VAL . 15.4 t -150.29 173.42 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 109.456 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.606 ' H ' HG12 ' B' ' 47' ' ' VAL . 20.4 mmt180 -101.59 66.51 1.08 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.982 -1.074 . . . . 0.0 109.942 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.878 ' HG ' HG13 ' A' ' 31' ' ' VAL . 3.8 tp -61.49 89.94 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.268 -0.973 . . . . 0.0 109.121 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' PHE . . . . . 1.077 ' CE1' HD11 ' A' ' 32' ' ' LEU . 7.3 m-30 -79.26 135.32 36.73 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.789 HG22 ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -104.89 -174.94 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.79 -1.194 . . . . 0.0 109.147 179.383 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.533 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.0 OUTLIER -126.48 -162.84 1.18 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.252 -0.905 . . . . 0.0 109.729 -179.687 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.533 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 21.0 mtpt -46.6 -64.74 0.69 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.398 0.618 . . . . 0.0 109.919 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.422 ' O ' ' C ' ' B' ' 55' ' ' ASP . 0.5 OUTLIER -95.38 52.28 1.38 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.793 -179.563 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . 0.644 ' O ' HG21 ' A' ' 13' ' ' VAL . 0.0 OUTLIER 42.72 57.52 3.51 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.351 -0.843 . . . . 0.0 109.654 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . 0.507 ' OD1' ' O ' ' A' ' 10' ' ' GLY . 0.5 OUTLIER -115.6 122.11 44.65 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.412 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.673 HD13 HD11 ' A' ' 8' ' ' LEU . 5.0 mt -60.69 89.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.293 -0.88 . . . . 0.0 110.196 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.72 -28.31 20.62 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . 0.454 ' HB3' ' HB2' ' B' ' 50' ' ' PHE . 4.5 tt0 -105.13 133.02 50.61 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.613 HG22 HG23 ' A' ' 9' ' ' VAL . 58.9 t -89.15 129.11 49.1 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 120.843 -1.161 . . . . 0.0 110.711 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.794 ' HB2' HG11 ' B' ' 47' ' ' VAL . 36.6 Cg_endo -82.64 160.54 16.67 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.632 2.222 . . . . 0.0 109.295 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 3' ' ' THR . 0.0 OUTLIER -150.03 143.14 24.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.906 -1.121 . . . . 0.0 110.062 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.944 HG23 ' CG2' ' B' ' 47' ' ' VAL . 0.9 OUTLIER -111.75 145.16 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.264 0 CA-C-O 117.975 -1.458 . . . . 0.0 109.642 179.895 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 mtm . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.517 ' O ' ' OD2' ' A' ' 23' ' ' ASP . 0.2 OUTLIER -90.18 83.03 5.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 110.231 -179.611 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 24' ' ' LYS . 4.1 p -89.12 -16.53 31.24 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.935 -1.103 . . . . 0.0 108.548 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.541 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.5 mt-10 -112.04 179.23 4.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.422 -0.799 . . . . 0.0 109.336 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.612 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 14.7 m-90 -150.78 47.3 0.44 Allowed Pre-proline 0 C--N 1.298 -1.658 0 O-C-N 121.52 -0.738 . . . . 0.0 109.79 178.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 31.3 Cg_endo -71.18 -25.72 21.95 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 N-CA-C 107.411 -1.803 . . . . 0.0 107.411 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -69.79 -20.32 63.47 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.507 HD13 ' HA ' ' A' ' 16' ' ' ALA . 11.4 mt -83.64 -4.01 58.22 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.496 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.583 ' CG2' ' CG2' ' B' ' 60' ' ' VAL . 22.7 t -55.41 147.78 3.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.106 -0.996 . . . . 0.0 109.833 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.427 ' C ' ' OD1' ' B' ' 56' ' ' ASN . . . 61.65 10.4 23.98 Favored Glycine 0 N--CA 1.481 1.668 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 2.1 tptp -96.12 -144.59 0.28 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.959 -1.318 . . . . 0.0 109.071 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.416 ' CA ' HG12 ' B' ' 57' ' ' ILE . 1.4 m -142.76 165.86 26.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.044 -1.035 . . . . 0.0 109.909 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.682 ' CG2' HG11 ' A' ' 31' ' ' VAL . 76.4 t -50.86 -40.1 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.434 -0.791 . . . . 0.0 109.443 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.536 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 56.7 mt-10 -43.8 -72.1 0.07 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.468 -0.77 . . . . 0.0 109.538 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -56.37 -34.62 66.83 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.081 -1.012 . . . . 0.0 109.734 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.607 ' C ' HD12 ' A' ' 20' ' ' ILE . . . -63.44 -84.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 110.206 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.577 ' HG2' HG23 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -44.74 -34.25 2.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.947 -1.096 . . . . 0.0 109.044 -179.689 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 6.0 ttmt -55.98 -82.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.542 0.687 . . . . 0.0 110.511 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.484 HG12 ' HB3' ' A' ' 23' ' ' ASP . 2.0 t -64.28 -49.9 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.545 -0.722 . . . . 0.0 109.769 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.929 HD13 HD13 ' A' ' 29' ' ' ILE . 77.1 mt -42.54 -54.09 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.364 -0.835 . . . . 0.0 109.47 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 28' ' ' GLN . 4.9 tt -42.1 -45.81 4.08 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.263 -0.898 . . . . 0.0 110.223 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -143.61 54.58 1.33 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.992 -1.068 . . . . 0.0 110.624 -179.188 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.604 ' OD2' ' CZ2' ' A' ' 5' ' ' TRP . 35.0 p-10 -76.23 -28.9 57.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.859 -1.151 . . . . 0.0 108.768 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.779 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -130.72 -83.45 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.055 -1.028 . . . . 0.0 108.692 178.315 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.779 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 42.4 Cg_endo -88.68 -84.93 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.645 0 N-CA-C 108.144 -1.521 . . . . 0.0 108.144 177.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 10.2 mt-10 -162.06 56.3 0.24 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.989 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -88.69 118.12 28.14 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.084 -1.01 . . . . 0.0 109.125 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 1.8 mt-30 -88.19 178.35 6.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 0.0 109.373 -179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.929 HD13 HD13 ' A' ' 20' ' ' ILE . 5.9 tt -147.43 137.67 17.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 C-N-CA 119.204 -0.998 . . . . 0.0 111.011 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.565 HD11 ' HD2' ' B' ' 46' ' ' ARG . 8.3 mt -90.28 117.36 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.944 HG13 ' HG ' ' B' ' 49' ' ' LEU . 5.1 t -99.82 140.98 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.797 -1.189 . . . . 0.0 109.75 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.963 HD21 ' CE1' ' B' ' 50' ' ' PHE . 0.5 OUTLIER -144.08 162.81 38.67 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.264 -0.897 . . . . 0.0 109.536 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.619 ' O ' ' HB ' ' A' ' 34' ' ' VAL . 37.0 Cg_endo -79.83 16.74 1.4 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.542 2.161 . . . . 0.0 111.592 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.619 ' HB ' ' O ' ' A' ' 33' ' ' PRO . 77.1 t 77.33 -70.04 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.972 -0.455 . . . . 0.0 110.236 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.54 ' C ' ' O ' ' A' ' 34' ' ' VAL . . . -18.07 -52.08 0.01 OUTLIER Glycine 0 N--CA 1.501 2.999 0 N-CA-C 112.11 -0.396 . . . . 0.0 112.11 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.556 HG22 ' N ' ' A' ' 37' ' ' ILE . 34.7 m -46.15 -91.73 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.993 -1.298 . . . . 0.0 109.949 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.556 ' N ' HG22 ' A' ' 36' ' ' THR . 10.4 pt 40.44 87.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.684 -0.635 . . . . 0.0 109.912 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.482 ' HB ' ' O ' ' A' ' 37' ' ' ILE . 18.5 t 71.0 -99.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.449 -0.782 . . . . 0.0 110.225 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.464 ' OXT' ' O ' ' A' ' 36' ' ' THR . 7.4 t . . . . . 0 N--CA 1.492 1.653 0 O-C-N 120.722 -1.236 . . . . 0.0 109.864 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . 0.426 ' O ' ' O ' ' B' ' 42' ' ' TYR . 1.2 mp0 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.251 0.548 . . . . 0.0 109.577 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . 0.426 ' O ' ' O ' ' B' ' 41' ' ' GLU . 49.0 p90 -59.15 -157.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.192 -0.942 . . . . 0.0 109.393 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.583 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER -149.76 67.32 0.99 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.113 -0.992 . . . . 0.0 109.757 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.432 ' C ' ' O ' ' B' ' 43' ' ' ARG . 0.7 OUTLIER -48.4 137.1 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.544 -1.347 . . . . 0.0 107.644 179.222 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.647 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 4.3 p-10 -89.62 48.3 1.58 Allowed 'General case' 0 C--N 1.292 -1.896 0 C-N-CA 119.076 -1.05 . . . . 0.0 109.396 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . 0.565 ' HD2' HD11 ' A' ' 30' ' ' ILE . 10.1 ttp180 -151.08 151.68 32.33 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 1.119 ' CG2' HG23 ' B' ' 63' ' ' VAL . 61.4 t -151.43 169.34 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.592 ' HB3' ' CE2' ' B' ' 50' ' ' PHE . 12.6 mmt-85 -100.18 84.46 2.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.631 -1.293 . . . . 0.0 110.709 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.944 ' HG ' HG13 ' A' ' 31' ' ' VAL . 4.2 tp -84.68 97.69 9.79 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 118.933 -1.107 . . . . 0.0 108.62 178.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' PHE . . . . . 0.963 ' CE1' HD21 ' A' ' 32' ' ' LEU . 52.4 m-85 -92.88 131.71 37.66 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 178.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.907 HG22 ' O ' ' A' ' 32' ' ' LEU . 12.9 m -89.08 178.04 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.619 -1.301 . . . . 0.0 110.349 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.511 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.8 OUTLIER -107.89 -151.72 0.47 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.354 -0.841 . . . . 0.0 109.775 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.511 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 1.2 mmtp -74.03 -48.47 29.86 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.478 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.1 OUTLIER -98.99 38.19 1.42 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.39 -0.819 . . . . 0.0 109.503 179.534 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.0 OUTLIER 50.48 67.62 0.89 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.165 -0.96 . . . . 0.0 109.181 -179.413 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . 0.565 ' O ' ' N ' ' B' ' 58' ' ' ALA . 1.2 t30 -133.58 117.35 16.98 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.652 ' CD1' HD11 ' B' ' 49' ' ' LEU . 27.0 mm -46.88 87.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-O 121.384 0.612 . . . . 0.0 109.823 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -89.32 -25.46 21.62 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -105.01 129.42 53.46 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.583 ' CG2' ' CG2' ' A' ' 9' ' ' VAL . 85.3 t -82.56 126.35 73.82 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.054 -1.029 . . . . 0.0 109.989 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.954 ' HB2' HG11 ' B' ' 47' ' ' VAL . 37.0 Cg_endo -81.36 158.91 19.87 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 C-N-CA 122.403 2.068 . . . . 0.0 110.199 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . 0.457 ' NE ' ' HB3' ' A' ' 4' ' ' GLU . 0.3 OUTLIER -150.91 130.62 13.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.054 -1.029 . . . . 0.0 109.839 179.411 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 1.119 HG23 ' CG2' ' B' ' 47' ' ' VAL . 1.1 t -106.18 124.58 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.308 -0.87 . . . . 0.0 108.901 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.881 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 mmt . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.433 ' HD3' ' HA ' ' A' ' 2' ' ' LYS . 3.3 mmtp -85.99 71.53 10.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.062 -1.024 . . . . 0.0 109.604 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.506 HG22 ' O ' ' B' ' 63' ' ' VAL . 2.1 m -99.56 -15.74 18.52 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.382 -0.824 . . . . 0.0 109.475 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.716 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 5.7 mt-10 -102.4 -36.43 8.44 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.112 -0.993 . . . . 0.0 110.026 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.78 ' NE1' HD12 ' A' ' 20' ' ' ILE . 7.8 m-90 56.2 47.33 2.87 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 121.018 -1.051 . . . . 0.0 109.249 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.716 ' HD3' ' HB2' ' A' ' 4' ' ' GLU . 33.4 Cg_endo -74.99 -37.39 2.06 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 N-CA-C 106.789 -2.043 . . . . 0.0 106.789 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -8.62 50.07 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 114.524 -1.216 . . . . 0.0 107.797 177.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.565 ' HG ' HD12 ' B' ' 57' ' ' ILE . 13.2 tp -83.2 -2.03 54.51 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 121.289 -0.882 . . . . 0.0 109.198 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.659 HG22 HG23 ' B' ' 60' ' ' VAL . 17.7 t -57.18 149.54 4.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.021 -1.049 . . . . 0.0 109.459 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 62.56 8.67 21.27 Favored Glycine 0 N--CA 1.481 1.688 0 C-N-CA 119.858 -1.163 . . . . 0.0 110.309 178.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 17.0 tptt -91.1 -145.63 0.19 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.789 -1.418 . . . . 0.0 109.161 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' B' ' 55' ' ' ASP . 0.4 OUTLIER -145.71 160.88 41.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.029 -1.045 . . . . 0.0 109.894 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.859 HG23 HG11 ' B' ' 51' ' ' VAL . 53.7 t -51.89 -32.48 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.339 -0.851 . . . . 0.0 109.19 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.547 ' O ' ' CG ' ' A' ' 18' ' ' LYS . 5.4 mt-10 -43.05 -74.06 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.501 ' HB3' HD11 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -59.97 -37.37 79.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.559 -0.713 . . . . 0.0 109.993 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.604 ' HB3' ' HA ' ' A' ' 13' ' ' VAL . . . -59.44 -80.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 0.0 110.04 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.532 ' HA ' ' CG2' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -47.21 -32.86 4.8 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.469 -1.394 . . . . 0.0 109.347 -179.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.547 ' CG ' ' O ' ' A' ' 14' ' ' GLU . 16.1 mtpt -58.86 -85.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.753 0.787 . . . . 0.0 110.953 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.522 ' O ' ' N ' ' A' ' 23' ' ' ASP . 2.8 t -57.83 -41.33 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.592 -0.692 . . . . 0.0 110.08 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.956 HG21 ' HB ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER -48.73 -52.31 9.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.352 -0.843 . . . . 0.0 109.16 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.461 ' C ' ' O ' ' A' ' 20' ' ' ILE . 0.7 OUTLIER -38.14 -40.86 0.54 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.685 -0.635 . . . . 0.0 110.125 -179.581 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.402 ' HB2' HD23 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -140.38 40.88 1.91 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.112 -0.993 . . . . 0.0 109.765 179.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 19' ' ' VAL . 18.8 p-10 -52.09 -42.93 63.63 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.336 -0.852 . . . . 0.0 109.493 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.782 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -130.75 -78.69 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.444 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.715 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.782 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 40.6 Cg_endo -87.57 -80.79 0.0 OUTLIER 'Trans proline' 0 C--O 1.214 -0.717 0 N-CA-C 107.78 -1.662 . . . . 0.0 107.78 177.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 22.4 mt-10 -161.96 62.08 0.24 Allowed 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.765 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -87.92 121.25 30.11 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.989 -1.069 . . . . 0.0 110.236 -178.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.43 ' O ' HG23 ' B' ' 47' ' ' VAL . 1.1 tp60 -88.59 176.15 7.25 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.057 -1.027 . . . . 0.0 108.242 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.956 ' HB ' HG21 ' A' ' 20' ' ' ILE . 9.4 tt -148.9 137.53 14.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 120.7 -1.25 . . . . 0.0 111.193 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.503 ' O ' ' HB3' ' B' ' 49' ' ' LEU . 0.8 OUTLIER -88.92 152.89 3.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.011 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.705 HG21 HG21 ' A' ' 13' ' ' VAL . 7.6 p -135.02 134.93 53.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 118.813 -1.155 . . . . 0.0 110.298 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.886 HD23 ' N ' ' A' ' 32' ' ' LEU . 0.4 OUTLIER -150.68 149.97 27.14 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.44 -0.787 . . . . 0.0 109.283 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 35' ' ' GLY . 37.9 Cg_endo -78.24 58.62 6.71 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.735 2.29 . . . . 0.0 111.725 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.649 HG23 ' O ' ' B' ' 51' ' ' VAL . 22.0 t 44.16 -93.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.119 -0.988 . . . . 0.0 109.402 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . 43.53 -149.85 0.64 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.7 t -95.36 157.67 15.79 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.31 -1.112 . . . . 0.0 109.38 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.403 HG23 ' N ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -66.85 -36.66 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.288 -0.883 . . . . 0.0 109.484 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.457 ' O ' ' OXT' ' A' ' 39' ' ' THR . 2.5 p -80.1 125.57 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.097 -1.002 . . . . 0.0 109.487 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.457 ' OXT' ' O ' ' A' ' 38' ' ' VAL . 23.3 m . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.322 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . 0.605 ' CE2' ' HA ' ' B' ' 44' ' ' ILE . 15.1 p90 -121.43 -158.13 0.75 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.868 -1.145 . . . . 0.0 109.345 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.533 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 2.0 ptt-85 -91.6 57.02 3.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.204 -0.935 . . . . 0.0 109.929 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.605 ' HA ' ' CE2' ' B' ' 42' ' ' TYR . 0.3 OUTLIER -44.75 142.54 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.893 -1.129 . . . . 0.0 108.458 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.645 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.1 p-10 -102.1 48.67 0.87 Allowed 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.127 -1.029 . . . . 0.0 110.058 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.71 146.34 26.38 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.675 HG12 ' H ' ' B' ' 62' ' ' ARG . 0.0 OUTLIER -150.47 143.7 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 120.968 -1.083 . . . . 0.0 109.317 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -78.67 88.05 4.58 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.99 -1.069 . . . . 0.0 110.796 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.534 ' C ' HD12 ' B' ' 49' ' ' LEU . 2.1 tp -90.41 97.22 11.05 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.141 -1.024 . . . . 0.0 108.657 178.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' PHE . . . . . 0.843 ' CZ ' HD11 ' A' ' 32' ' ' LEU . 16.6 m-85 -92.35 110.72 22.12 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.859 HG11 HG23 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -89.77 172.08 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.906 -1.121 . . . . 0.0 110.947 -178.856 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' B' ' 54' ' ' LEU . 0.7 OUTLIER -94.66 -153.04 0.37 Allowed 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.683 0.754 . . . . 0.0 109.715 -179.233 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.521 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 6.2 mttm -76.84 -47.42 21.46 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.522 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.0 OUTLIER -95.83 39.69 1.13 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.577 -0.702 . . . . 0.0 109.488 179.553 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.0 OUTLIER 47.75 67.29 0.84 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.12 -0.987 . . . . 0.0 109.123 -179.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' B' ' 58' ' ' ALA . 17.8 t-20 -127.33 94.12 3.91 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.658 0.742 . . . . 0.0 109.011 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.575 HD11 ' HB2' ' A' ' 16' ' ' ALA . 4.5 mt -39.68 87.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-O 121.301 0.572 . . . . 0.0 111.066 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -89.48 -19.65 24.82 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -118.19 106.1 12.48 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.659 HG23 HG22 ' A' ' 9' ' ' VAL . 35.4 t -62.52 133.87 94.88 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.227 -0.921 . . . . 0.0 110.345 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.586 ' CB ' HD11 ' A' ' 29' ' ' ILE . 36.2 Cg_endo -79.81 163.38 23.56 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 122.531 2.154 . . . . 0.0 109.398 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . 0.675 ' H ' HG12 ' B' ' 47' ' ' VAL . 0.0 OUTLIER -150.55 128.08 11.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.971 -1.081 . . . . 0.0 110.102 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.765 HG21 ' HB1' ' A' ' 27' ' ' ALA . 1.8 t -106.37 151.34 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.263 -0.898 . . . . 0.0 109.073 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.901 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 mtt . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.296 0.57 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.518 ' HB2' ' HB3' ' A' ' 23' ' ' ASP . 16.7 mmtp -85.11 71.17 10.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.177 -0.952 . . . . 0.0 109.552 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.654 HG23 ' CD ' ' A' ' 24' ' ' LYS . 0.3 OUTLIER -101.23 -24.13 14.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.257 -0.902 . . . . 0.0 109.598 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.586 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 6.9 mt-10 -94.33 -44.56 7.88 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.264 -0.897 . . . . 0.0 109.999 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.62 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 5.5 m-90 64.19 41.83 0.36 Allowed Pre-proline 0 C--N 1.296 -1.724 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.109 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 34.4 Cg_endo -73.14 -30.46 10.6 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 N-CA-C 106.929 -1.989 . . . . 0.0 106.929 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.67 -13.88 62.25 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 177.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.03 HD21 HG21 ' B' ' 57' ' ' ILE . 0.0 OUTLIER -81.89 -5.6 58.4 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.509 ' CG2' ' CG2' ' B' ' 60' ' ' VAL . 25.2 t -53.29 151.94 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.0 -1.063 . . . . 0.0 109.745 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.422 ' HA2' ' OD1' ' B' ' 56' ' ' ASN . . . 62.83 7.27 15.19 Favored Glycine 0 N--CA 1.482 1.716 0 C-N-CA 119.982 -1.104 . . . . 0.0 110.422 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -93.55 -142.56 0.23 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.833 -1.392 . . . . 0.0 109.183 179.646 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -148.73 161.48 41.68 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.994 -1.066 . . . . 0.0 109.89 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.726 ' HA ' HD21 ' B' ' 49' ' ' LEU . 39.9 t -46.39 -35.82 2.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.415 -0.803 . . . . 0.0 109.048 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.538 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 1.5 mt-10 -44.84 -73.88 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.511 -0.743 . . . . 0.0 109.066 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.449 ' O ' HG23 ' A' ' 19' ' ' VAL . 1.9 tm-20 -55.92 -34.5 65.65 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.192 -0.942 . . . . 0.0 109.555 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.685 ' HB1' HD12 ' A' ' 20' ' ' ILE . . . -62.82 -85.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.088 -1.008 . . . . 0.0 110.166 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -42.87 -45.45 4.93 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.837 -1.165 . . . . 0.0 108.914 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 6.1 tptm -42.37 -76.13 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.573 0.702 . . . . 0.0 110.584 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.482 ' O ' ' C ' ' A' ' 20' ' ' ILE . 1.0 OUTLIER -78.16 -52.81 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.459 -0.776 . . . . 0.0 110.402 -178.39 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.685 HD12 ' HB1' ' A' ' 16' ' ' ALA . 60.1 mt -37.98 -34.72 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.394 -0.816 . . . . 0.0 110.004 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.726 HD23 ' HB2' ' A' ' 22' ' ' GLN . 2.4 tt -56.09 -52.98 62.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.081 -1.012 . . . . 0.0 110.357 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.726 ' HB2' HD23 ' A' ' 21' ' ' LEU . 0.4 OUTLIER -128.59 64.21 1.43 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.925 -1.109 . . . . 0.0 111.045 -178.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.518 ' HB3' ' HB2' ' A' ' 2' ' ' LYS . 0.3 OUTLIER -84.42 -50.55 7.67 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.412 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.711 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 10.0 mtpp -101.05 -105.77 0.0 OUTLIER Pre-proline 0 C--N 1.304 -1.381 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.711 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 37.2 Cg_endo -80.16 -70.98 0.01 OUTLIER 'Trans proline' 0 C--O 1.213 -0.738 0 CA-C-N 121.873 1.705 . . . . 0.0 108.059 177.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 25' ' ' PRO . 30.8 mt-10 -162.76 70.2 0.26 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.765 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -88.51 120.48 29.93 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.871 -1.143 . . . . 0.0 109.233 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.82 168.61 11.94 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.193 -0.942 . . . . 0.0 109.642 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.528 ' HB ' HG21 ' A' ' 20' ' ' ILE . 21.4 tt -146.91 140.34 19.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.351 -0.843 . . . . 0.0 109.944 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 1.025 HG22 HD22 ' A' ' 32' ' ' LEU . 1.7 mp -88.97 142.35 13.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.914 ' C ' HD23 ' A' ' 32' ' ' LEU . 4.0 p -105.82 133.04 51.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.47 -0.892 . . . . 0.0 109.491 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.025 HD22 HG22 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -150.73 166.18 15.69 Favored Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.238 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.903 ' O ' HG23 ' A' ' 34' ' ' VAL . 37.4 Cg_endo -78.9 -93.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.301 -1.945 0 C-N-CA 121.703 1.602 . . . . 0.0 111.284 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.903 HG23 ' O ' ' A' ' 33' ' ' PRO . 1.8 t -171.94 -35.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 120.803 -1.186 . . . . 0.0 109.012 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 34' ' ' VAL . . . -38.46 160.06 0.01 OUTLIER Glycine 0 N--CA 1.494 2.557 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -48.65 104.2 0.06 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -1.14 . . . . 0.0 109.534 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.561 HG22 HG13 ' A' ' 38' ' ' VAL . 3.9 mt 50.16 -94.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.249 -0.907 . . . . 0.0 109.621 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.561 HG13 HG22 ' A' ' 37' ' ' ILE . 18.7 m -141.31 167.9 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.013 -1.055 . . . . 0.0 109.679 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.424 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.711 0.767 . . . . 0.0 109.452 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . 0.431 ' O ' ' OXT' ' B' ' 64' ' ' GLY . 28.6 p90 -100.58 -153.53 0.45 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.57 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 2.5 ptt180 -109.57 66.83 0.64 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.711 -1.243 . . . . 0.0 110.296 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.525 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.3 OUTLIER -47.52 142.91 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.82 -1.175 . . . . 0.0 107.955 178.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.651 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.5 p-10 -102.39 44.43 1.01 Allowed 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.004 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . 0.64 ' HG2' HD13 ' A' ' 30' ' ' ILE . 0.8 OUTLIER -151.09 142.69 23.6 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 178.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.536 HG12 ' H ' ' B' ' 62' ' ' ARG . 0.0 OUTLIER -150.59 157.75 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.126 -0.984 . . . . 0.0 109.319 -179.296 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.602 ' HD2' HD11 ' A' ' 32' ' ' LEU . 3.1 mmt180 -92.98 100.96 13.31 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.72 -1.237 . . . . 0.0 110.328 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.726 HD21 ' HA ' ' A' ' 13' ' ' VAL . 0.8 OUTLIER -95.45 96.02 8.82 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.263 -0.975 . . . . 0.0 108.872 178.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' PHE . . . . . 0.951 ' CE1' HD12 ' A' ' 32' ' ' LEU . 24.6 m-85 -93.26 143.53 26.17 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.793 HG22 ' HA ' ' A' ' 33' ' ' PRO . 6.1 m -107.21 -151.57 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.769 -1.207 . . . . 0.0 110.858 -179.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.554 ' N ' HG23 ' B' ' 51' ' ' VAL . 0.2 OUTLIER -141.92 -157.47 0.77 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.426 -0.796 . . . . 0.0 109.68 -179.478 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.532 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 2.8 mtmp? -57.42 -59.02 5.77 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.667 -0.646 . . . . 0.0 109.509 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.428 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 6.7 tp -96.2 42.82 1.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.437 -0.789 . . . . 0.0 109.619 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . 0.498 ' HA ' ' HB ' ' B' ' 51' ' ' VAL . 0.0 OUTLIER 49.2 62.7 2.47 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.101 -0.999 . . . . 0.0 109.567 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . 0.551 ' O ' ' N ' ' B' ' 58' ' ' ALA . 4.0 t30 -122.59 106.19 10.77 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.311 -0.868 . . . . 0.0 108.808 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 1.03 HG21 HD21 ' A' ' 8' ' ' LEU . 28.0 mt -42.06 89.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.496 0.665 . . . . 0.0 110.374 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.48 -17.82 29.54 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -114.92 135.39 54.26 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.509 ' CG2' ' CG2' ' A' ' 9' ' ' VAL . 71.1 t -88.05 128.05 55.23 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.014 -1.054 . . . . 0.0 110.542 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.479 ' O ' ' HD3' ' B' ' 62' ' ' ARG . 36.3 Cg_endo -79.76 158.36 24.69 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.317 2.012 . . . . 0.0 108.41 177.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . 0.536 ' H ' HG12 ' B' ' 47' ' ' VAL . 0.0 OUTLIER -150.54 133.05 15.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.768 -1.208 . . . . 0.0 110.409 -179.612 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.765 HG21 ' HB1' ' A' ' 27' ' ' ALA . 2.1 t -109.06 -25.58 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . 0.511 ' O ' HG21 ' A' ' 3' ' ' THR . . . . . . . . 0 N--CA 1.491 2.348 0 CA-C-O 117.94 -1.478 . . . . 0.0 109.594 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mmt . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.514 ' HB3' ' HB2' ' A' ' 23' ' ' ASP . 3.2 tppt? -84.16 72.73 10.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.064 -1.023 . . . . 0.0 109.969 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.469 ' O ' ' HG3' ' B' ' 62' ' ' ARG . 2.4 m -109.67 6.84 24.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.147 -0.97 . . . . 0.0 109.05 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.619 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 27.7 mt-10 -118.82 -40.8 2.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -0.903 . . . . 0.0 109.914 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.641 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 9.6 m-90 61.7 41.92 0.49 Allowed Pre-proline 0 C--N 1.299 -1.621 0 O-C-N 121.524 -0.735 . . . . 0.0 110.092 -178.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.641 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 32.6 Cg_endo -72.49 -30.34 12.44 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 N-CA-C 106.468 -2.166 . . . . 0.0 106.468 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -16.05 63.17 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.086 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.583 HD11 ' CD1' ' A' ' 5' ' ' TRP . 7.2 mt -81.5 -5.78 58.3 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 121.302 -0.874 . . . . 0.0 109.293 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.653 ' CG2' HG22 ' B' ' 60' ' ' VAL . 23.7 t -57.0 148.04 4.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.148 -0.97 . . . . 0.0 109.81 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.423 ' HA2' ' OD1' ' B' ' 56' ' ' ASN . . . 60.12 10.19 14.1 Favored Glycine 0 N--CA 1.48 1.578 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.472 178.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.765 ' HB3' HD12 ' B' ' 57' ' ' ILE . 0.1 OUTLIER -94.65 -145.43 0.26 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.925 -1.338 . . . . 0.0 109.068 179.693 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 13' ' ' VAL . 0.3 OUTLIER -141.85 161.17 38.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.991 -1.068 . . . . 0.0 110.075 -179.546 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.602 ' HA ' HD11 ' B' ' 49' ' ' LEU . 79.1 t -45.16 -38.5 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.195 -0.941 . . . . 0.0 109.207 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.542 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 2.4 mt-10 -44.41 -75.28 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.413 ' O ' HG23 ' A' ' 19' ' ' VAL . 1.9 tp10 -53.46 -32.69 51.13 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.165 -0.959 . . . . 0.0 109.623 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.835 ' C ' HD12 ' A' ' 20' ' ' ILE . . . -62.58 -85.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 110.578 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.94 -29.45 4.78 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.757 -1.215 . . . . 0.0 109.271 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 16.6 tptm -56.78 -77.95 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.31 0.576 . . . . 0.0 110.749 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 15' ' ' GLU . 1.5 t -69.3 -43.49 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.353 -0.842 . . . . 0.0 109.849 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.835 HD12 ' C ' ' A' ' 16' ' ' ALA . 63.5 mt -48.13 -55.32 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.896 . . . . 0.0 110.003 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.464 ' C ' ' O ' ' A' ' 20' ' ' ILE . 1.2 tt -36.04 -35.84 0.08 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.584 -0.697 . . . . 0.0 110.794 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 20' ' ' ILE . 1.0 OUTLIER -141.91 56.87 1.49 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.02 -1.05 . . . . 0.0 109.718 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.514 ' HB2' ' HB3' ' A' ' 2' ' ' LYS . 26.6 p-10 -70.66 -31.46 68.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.923 . . . . 0.0 109.015 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.707 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -133.84 -97.85 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.702 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.707 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 36.2 Cg_endo -78.63 -68.72 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.716 0 N-CA-C 107.422 -1.799 . . . . 0.0 107.422 176.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.533 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 25.8 mt-10 -163.84 72.26 0.26 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 1.007 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -88.36 114.73 25.27 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 121.068 -1.02 . . . . 0.0 108.875 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.509 ' CB ' ' O ' ' B' ' 45' ' ' ASP . 0.0 OUTLIER -89.06 171.99 9.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.253 -0.904 . . . . 0.0 109.197 -179.6 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.775 HD13 HD13 ' A' ' 20' ' ' ILE . 14.9 tt -149.31 146.58 17.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.823 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.699 HG22 HD22 ' A' ' 32' ' ' LEU . 1.2 mp -89.04 155.78 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 1.035 HG13 HD13 ' B' ' 49' ' ' LEU . 2.0 t -127.91 116.24 42.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 118.555 -1.258 . . . . 0.0 110.956 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.942 HD11 ' CE1' ' B' ' 50' ' ' PHE . 0.7 OUTLIER -141.37 168.03 15.32 Favored Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.1 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.684 ' HD2' ' HB2' ' A' ' 32' ' ' LEU . 37.6 Cg_endo -75.58 -96.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.827 0 C-N-CA 121.187 1.258 . . . . 0.0 109.328 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.567 HG13 ' O ' ' A' ' 33' ' ' PRO . 17.6 m -158.98 13.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 120.86 -1.15 . . . . 0.0 109.518 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -158.32 -79.94 0.03 OUTLIER Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.424 ' O ' ' CG ' ' A' ' 33' ' ' PRO . 7.9 p -95.95 144.47 26.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.376 -1.073 . . . . 0.0 109.593 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.556 ' O ' HG23 ' A' ' 38' ' ' VAL . 11.3 mt -74.36 99.08 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.236 -0.915 . . . . 0.0 109.404 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER 39.8 -97.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.496 -0.752 . . . . 0.0 109.822 -179.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.467 ' N ' ' O ' ' A' ' 37' ' ' ILE . 63.9 p . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.004 -1.06 . . . . 0.0 109.454 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.33 0.586 . . . . 0.0 109.581 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . 0.498 ' O ' ' HA2' ' B' ' 64' ' ' GLY . 2.1 t80 -167.45 135.77 2.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.32 -0.862 . . . . 0.0 108.961 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.576 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 6.6 ptt-85 -122.58 55.14 1.17 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.233 -0.917 . . . . 0.0 109.607 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.606 HG22 ' H ' ' B' ' 64' ' ' GLY . 0.9 OUTLIER -48.05 136.05 4.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 120.622 -1.299 . . . . 0.0 108.132 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.564 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -90.13 38.65 0.94 Allowed 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.446 -0.901 . . . . 0.0 110.282 -178.445 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . 0.566 ' CG ' HD13 ' A' ' 30' ' ' ILE . 0.9 OUTLIER -141.11 146.98 37.79 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.634 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 1.106 ' CG2' HG23 ' B' ' 63' ' ' VAL . 63.5 t -151.59 169.26 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.102 -0.999 . . . . 0.0 109.365 -179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.6 ' N ' HG12 ' B' ' 47' ' ' VAL . 17.0 mmt-85 -99.5 95.52 7.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.718 -1.239 . . . . 0.0 109.57 -179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 1.035 HD13 HG13 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -90.67 82.54 5.77 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 118.954 -1.098 . . . . 0.0 109.293 179.465 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' PHE . . . . . 0.942 ' CE1' HD11 ' A' ' 32' ' ' LEU . 6.5 m-30 -74.46 145.46 43.6 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.513 ' HB ' ' HA ' ' B' ' 55' ' ' ASP . 14.1 m -127.02 176.54 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.573 -1.329 . . . . 0.0 110.742 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.489 ' OD2' ' HG2' ' B' ' 53' ' ' LYS . 0.0 OUTLIER -111.58 -171.76 1.9 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 -179.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.489 ' HG2' ' OD2' ' B' ' 52' ' ' ASP . 1.8 ptmt -51.95 -53.41 41.66 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.965 -1.084 . . . . 0.0 110.781 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.406 ' C ' ' CG ' ' B' ' 55' ' ' ASP . 0.2 OUTLIER -88.96 38.08 0.87 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.964 -1.085 . . . . 0.0 108.797 179.706 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . 0.513 ' HA ' ' HB ' ' B' ' 51' ' ' VAL . 0.0 OUTLIER 51.35 51.42 16.88 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.688 -0.632 . . . . 0.0 109.458 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . 0.514 ' O ' ' N ' ' B' ' 58' ' ' ALA . 30.5 t30 -101.06 112.43 24.89 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.376 -0.827 . . . . 0.0 109.552 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.765 HD12 ' HB3' ' A' ' 11' ' ' LYS . 43.5 mt -51.9 91.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.581 -0.699 . . . . 0.0 109.276 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.514 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.12 -23.78 23.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.578 -0.701 . . . . 0.0 109.11 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.53 126.33 54.87 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.653 HG22 ' CG2' ' A' ' 9' ' ' VAL . 42.2 t -78.67 129.87 72.65 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 120.971 -1.081 . . . . 0.0 109.925 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.887 ' HB2' HG11 ' B' ' 47' ' ' VAL . 36.7 Cg_endo -83.69 159.94 14.3 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.671 2.247 . . . . 0.0 111.189 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . 0.558 ' NH1' ' HB ' ' B' ' 60' ' ' VAL . 0.1 OUTLIER -147.23 146.05 29.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.261 179.036 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 1.106 HG23 ' CG2' ' B' ' 47' ' ' VAL . 1.2 t -117.9 136.97 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.011 -1.056 . . . . 0.0 109.34 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . 0.606 ' H ' HG22 ' B' ' 44' ' ' ILE . . . . . . . . 0 N--CA 1.488 2.154 0 CA-C-O 117.922 -1.488 . . . . 0.0 109.518 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.578 ' O ' HG23 ' A' ' 3' ' ' THR . 9.2 tmm? . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.114 0.483 . . . . 0.0 109.933 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.493 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -50.6 87.7 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.26 -0.9 . . . . 0.0 110.363 -179.57 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 1' ' ' MET . 59.5 p -94.48 -29.16 15.08 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.949 -1.094 . . . . 0.0 108.359 178.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.551 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 4.6 mt-10 -100.78 174.6 5.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.539 -0.725 . . . . 0.0 109.146 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.643 ' CE2' HG12 ' A' ' 20' ' ' ILE . 17.9 m-90 -145.61 46.75 0.59 Allowed Pre-proline 0 C--N 1.298 -1.644 0 O-C-N 121.592 -0.693 . . . . 0.0 109.334 178.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.628 ' HA ' HG21 ' B' ' 60' ' ' VAL . 30.5 Cg_endo -70.31 -27.7 23.51 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 N-CA-C 107.796 -1.655 . . . . 0.0 107.796 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.43 -19.34 62.99 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.793 HD21 HG21 ' B' ' 57' ' ' ILE . 0.0 OUTLIER -87.33 -3.34 59.03 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.657 HG22 ' CG2' ' B' ' 60' ' ' VAL . 41.0 t -53.41 150.34 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 120.929 -1.107 . . . . 0.0 110.016 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.54 0.45 17.62 Favored Glycine 0 N--CA 1.48 1.598 0 C-N-CA 120.092 -1.051 . . . . 0.0 111.032 177.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -93.55 -154.78 0.42 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.625 -1.515 . . . . 0.0 109.321 179.732 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.458 ' O ' HD11 ' B' ' 57' ' ' ILE . 0.6 OUTLIER -134.98 177.88 7.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.113 -0.992 . . . . 0.0 110.197 -179.464 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.77 HG22 HD13 ' B' ' 49' ' ' LEU . 54.0 t -52.98 -43.03 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.526 -0.734 . . . . 0.0 110.199 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.533 ' O ' ' CG ' ' A' ' 18' ' ' LYS . 3.9 mt-10 -41.88 -71.07 0.09 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.387 -0.82 . . . . 0.0 109.41 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -56.62 -36.83 69.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.594 -0.691 . . . . 0.0 110.052 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.685 ' HB2' HD11 ' B' ' 57' ' ' ILE . . . -62.21 -81.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.192 -0.943 . . . . 0.0 110.032 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -46.22 -29.98 1.81 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.655 -1.278 . . . . 0.0 109.168 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 14' ' ' GLU . 4.4 mmtt -62.33 -84.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.628 0.728 . . . . 0.0 110.678 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.55 HG12 ' OD1' ' A' ' 23' ' ' ASP . 2.2 t -56.53 -46.4 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.526 -0.734 . . . . 0.0 109.766 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.943 HG21 ' HB ' ' A' ' 29' ' ' ILE . 87.7 mt -49.44 -58.27 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.238 -0.914 . . . . 0.0 109.386 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.61 HD23 ' HB2' ' A' ' 22' ' ' GLN . 3.3 tt -35.66 -33.97 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.693 -0.629 . . . . 0.0 110.796 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.61 ' HB2' HD23 ' A' ' 21' ' ' LEU . 0.8 OUTLIER -150.48 50.25 0.88 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.993 -1.067 . . . . 0.0 110.509 -179.631 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.55 ' OD1' HG12 ' A' ' 19' ' ' VAL . 2.8 t0 -73.48 -52.81 12.33 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.985 -1.072 . . . . 0.0 108.73 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.875 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.7 OUTLIER -102.38 -92.38 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.366 0 CA-C-O 117.451 -1.261 . . . . 0.0 108.058 178.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.875 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 39.5 Cg_endo -87.05 -74.14 0.0 OUTLIER 'Trans proline' 0 C--O 1.213 -0.727 0 CA-C-N 121.765 1.666 . . . . 0.0 108.229 177.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.509 ' CG ' ' O ' ' A' ' 25' ' ' PRO . 21.2 mt-10 -162.47 56.94 0.22 Allowed 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.645 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -87.93 117.91 27.12 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.192 -0.943 . . . . 0.0 108.845 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.504 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 3.4 tt0 -88.4 -176.87 5.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.324 -0.86 . . . . 0.0 109.786 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.943 ' HB ' HG21 ' A' ' 20' ' ' ILE . 11.6 tt -145.8 145.57 20.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.766 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.486 HG12 ' HG2' ' B' ' 46' ' ' ARG . 7.8 mm -91.41 145.5 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 31' ' ' VAL . 8.0 p -99.05 125.53 52.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 120.814 -1.179 . . . . 0.0 109.775 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.073 HD11 ' CE1' ' B' ' 50' ' ' PHE . 0.5 OUTLIER -143.55 156.51 60.05 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.035 -1.04 . . . . 0.0 110.182 -179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.571 ' HA ' ' CG2' ' B' ' 51' ' ' VAL . 40.5 Cg_endo -81.27 42.22 1.3 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 123.014 2.476 . . . . 0.0 111.125 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.784 HG23 ' CD2' ' B' ' 50' ' ' PHE . 2.4 p 42.23 100.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 121.329 -0.857 . . . . 0.0 109.303 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -141.07 -85.69 0.1 OUTLIER Glycine 0 N--CA 1.487 2.091 0 C-N-CA 119.62 -1.276 . . . . 0.0 110.746 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.58 ' O ' HG22 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -69.39 -78.65 0.07 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.159 -1.2 . . . . 0.0 110.739 -178.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.619 HD12 ' CE2' ' B' ' 50' ' ' PHE . 1.7 tt 86.33 122.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.428 ' O ' ' O ' ' A' ' 37' ' ' ILE . 71.1 t 57.23 106.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.156 -0.965 . . . . 0.0 109.409 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.363 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . 0.603 ' CE2' ' HA ' ' B' ' 44' ' ' ILE . 21.8 p90 -129.53 -158.85 0.92 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 109.845 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.566 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 7.8 ptt-85 -91.88 70.47 5.57 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.421 -0.799 . . . . 0.0 109.834 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.603 ' HA ' ' CE2' ' B' ' 42' ' ' TYR . 0.4 OUTLIER -47.52 144.55 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.573 -1.329 . . . . 0.0 108.256 179.518 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.645 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -103.41 44.57 1.01 Allowed 'General case' 0 C--N 1.296 -1.761 0 C-N-CA 119.053 -1.059 . . . . 0.0 109.419 -179.528 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . 0.486 ' HG2' HG12 ' A' ' 30' ' ' ILE . 7.6 mtt180 -150.32 153.11 35.53 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.673 HG22 ' CG2' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -150.94 -176.97 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.72 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.754 ' HD2' HD22 ' A' ' 32' ' ' LEU . 25.7 mmt180 -111.89 79.8 1.25 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.793 -1.192 . . . . 0.0 110.026 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.77 HD13 HG22 ' A' ' 13' ' ' VAL . 0.5 OUTLIER -62.18 94.74 0.06 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.226 -0.921 . . . . 0.0 109.172 179.456 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' PHE . . . . . 1.073 ' CE1' HD11 ' A' ' 32' ' ' LEU . 1.6 m-30 -80.22 130.47 35.24 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.762 HG22 ' O ' ' A' ' 32' ' ' LEU . 4.4 m -113.52 -176.46 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.593 -1.317 . . . . 0.0 110.741 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.498 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 1.4 p-10 -116.24 -151.07 0.47 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.463 -0.773 . . . . 0.0 109.93 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.498 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 0.9 OUTLIER -70.88 -51.06 28.64 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.407 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.481 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 1.5 tp -100.07 44.6 1.01 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.469 -0.769 . . . . 0.0 109.186 179.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . 0.424 ' CG ' ' C ' ' B' ' 54' ' ' LEU . 0.0 OUTLIER 44.39 67.35 0.7 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.302 -0.874 . . . . 0.0 110.029 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . 0.573 ' O ' ' N ' ' B' ' 58' ' ' ALA . 11.7 t30 -127.4 92.53 3.52 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.793 HG21 HD21 ' A' ' 8' ' ' LEU . 13.6 mt -30.06 86.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-O 121.54 0.686 . . . . 0.0 111.157 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.11 -27.38 21.96 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . 0.525 ' HB3' ' HB2' ' B' ' 50' ' ' PHE . 32.5 tp60 -113.83 130.76 56.43 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.657 ' CG2' HG22 ' A' ' 9' ' ' VAL . 91.2 t -87.29 134.46 36.38 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 120.979 -1.075 . . . . 0.0 110.859 -178.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.46 ' O ' ' HD3' ' B' ' 62' ' ' ARG . 36.8 Cg_endo -79.76 169.45 18.15 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.558 2.172 . . . . 0.0 109.148 178.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . 0.523 ' O ' ' CG1' ' B' ' 47' ' ' VAL . 0.2 OUTLIER -150.18 135.05 17.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.976 -1.078 . . . . 0.0 110.06 -179.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.673 ' CG2' HG22 ' B' ' 47' ' ' VAL . 2.3 t -109.12 150.26 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.328 -0.858 . . . . 0.0 109.316 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.911 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.491 ' HA ' ' HG2' ' A' ' 24' ' ' LYS . 7.1 ptt? . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.266 0.555 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.509 ' HB3' ' HB2' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -86.11 82.61 8.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.212 -0.93 . . . . 0.0 109.739 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.778 HG22 ' CD ' ' A' ' 24' ' ' LYS . 18.6 p -88.66 -12.79 41.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.172 -0.955 . . . . 0.0 109.053 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.526 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 0.6 OUTLIER -110.32 169.6 8.63 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.277 -0.89 . . . . 0.0 108.824 179.244 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.673 ' O ' HG21 ' B' ' 60' ' ' VAL . 15.1 m-90 -150.1 45.05 0.34 Allowed Pre-proline 0 C--N 1.294 -1.826 0 O-C-N 121.57 -0.706 . . . . 0.0 109.26 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 31.2 Cg_endo -69.12 -31.19 23.89 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 N-CA-C 108.232 -1.488 . . . . 0.0 108.232 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -69.66 -19.61 63.6 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 177.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.69 HD12 ' CB ' ' A' ' 11' ' ' LYS . 14.8 tp -84.29 -9.08 58.78 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.493 0.663 . . . . 0.0 109.247 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.479 HG23 HG21 ' B' ' 60' ' ' VAL . 10.4 t -55.69 152.39 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 119.086 -1.045 . . . . 0.0 108.873 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.87 4.16 25.67 Favored Glycine 0 N--CA 1.48 1.61 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.229 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.69 ' CB ' HD12 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -95.76 -143.5 0.27 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.875 -1.368 . . . . 0.0 109.276 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.493 ' CB ' ' OE2' ' A' ' 14' ' ' GLU . 2.2 m -145.02 168.12 21.03 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.068 -1.02 . . . . 0.0 110.192 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.604 HG22 HD11 ' B' ' 49' ' ' LEU . 48.5 t -51.3 -38.6 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.571 -0.706 . . . . 0.0 109.875 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.55 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 0.3 OUTLIER -42.52 -75.75 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.153 -179.615 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.34 -33.34 65.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.34 -0.85 . . . . 0.0 109.682 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 1.042 ' HB2' HD11 ' B' ' 57' ' ' ILE . . . -62.18 -85.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.404 -0.81 . . . . 0.0 110.439 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.527 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -46.75 -31.89 3.27 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.044 -1.035 . . . . 0.0 108.827 -179.331 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.55 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 5.3 tttp -56.41 -83.35 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.425 0 CA-C-O 121.323 0.582 . . . . 0.0 110.549 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.435 ' O ' ' C ' ' A' ' 20' ' ' ILE . 2.4 t -62.53 -48.68 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.507 -0.746 . . . . 0.0 109.842 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.775 HG21 ' HB ' ' A' ' 29' ' ' ILE . 88.9 mt -43.83 -45.17 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.23 -0.919 . . . . 0.0 109.538 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.511 HD23 ' HB2' ' A' ' 22' ' ' GLN . 0.9 OUTLIER -49.26 -44.59 43.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.252 -0.905 . . . . 0.0 111.239 -179.247 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.511 ' HB2' HD23 ' A' ' 21' ' ' LEU . 4.0 mt-30 -137.03 41.17 2.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.693 -1.254 . . . . 0.0 111.413 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.509 ' HB2' ' HB3' ' A' ' 2' ' ' LYS . 1.3 p-10 -67.89 -49.46 61.88 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.778 ' CD ' HG22 ' A' ' 3' ' ' THR . 1.0 OUTLIER -94.6 -116.05 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.476 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 178.314 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.722 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 37.2 Cg_endo -80.79 -66.47 0.02 OUTLIER 'Trans proline' 0 C--O 1.215 -0.664 0 CA-C-N 122.327 1.867 . . . . 0.0 108.035 178.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 18.8 mt-10 -161.29 60.45 0.28 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.611 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -88.25 116.71 26.65 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.034 -1.041 . . . . 0.0 108.197 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.459 ' O ' ' HA ' ' B' ' 46' ' ' ARG . 3.7 tt0 -88.24 176.49 7.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.066 -1.021 . . . . 0.0 110.105 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.775 ' HB ' HG21 ' A' ' 20' ' ' ILE . 19.1 tt -143.66 149.79 17.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 O-C-N 121.183 -0.948 . . . . 0.0 110.67 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.826 HG21 HD11 ' A' ' 37' ' ' ILE . 4.1 mm -97.66 146.44 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.8 HG12 HD12 ' B' ' 49' ' ' LEU . 0.0 OUTLIER -110.51 134.33 53.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.565 -1.334 . . . . 0.0 110.269 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.111 HD11 ' CE1' ' B' ' 50' ' ' PHE . 0.6 OUTLIER -152.67 165.72 16.94 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.756 -0.59 . . . . 0.0 109.509 -179.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.693 ' C ' HG23 ' A' ' 34' ' ' VAL . 38.3 Cg_endo -80.66 24.38 0.67 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.495 2.13 . . . . 0.0 110.804 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.693 HG23 ' C ' ' A' ' 33' ' ' PRO . 2.8 t 81.34 -71.72 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.416 -0.803 . . . . 0.0 109.147 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 34' ' ' VAL . . . -48.23 -104.52 0.01 OUTLIER Glycine 0 N--CA 1.493 2.465 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.47 ' O ' ' HD2' ' A' ' 33' ' ' PRO . 0.3 OUTLIER -77.17 160.93 28.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.141 -1.211 . . . . 0.0 109.394 -179.649 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.826 HD11 HG21 ' A' ' 30' ' ' ILE . 9.6 tt -112.91 -39.69 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 0.0 109.409 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.826 HG13 HG23 ' A' ' 37' ' ' ILE . 26.0 m -103.52 -22.33 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.287 -0.883 . . . . 0.0 109.553 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.476 ' CG2' ' O ' ' A' ' 38' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.823 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' B' ' 42' ' ' TYR . 6.8 mt-10 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.516 -0.549 . . . . 0.0 109.516 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . 0.645 ' CE2' ' HA ' ' B' ' 44' ' ' ILE . 4.0 t80 61.8 157.22 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.087 -1.008 . . . . 0.0 108.856 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.56 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER -96.38 70.45 2.69 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.188 -0.945 . . . . 0.0 110.99 -178.576 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.645 ' HA ' ' CE2' ' B' ' 42' ' ' TYR . 0.3 OUTLIER -50.69 139.92 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 120.274 -1.517 . . . . 0.0 107.438 178.351 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.611 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 2.8 p30 -95.35 45.75 1.1 Allowed 'General case' 0 C--N 1.294 -1.848 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.281 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . 0.541 ' HG2' ' N ' ' B' ' 47' ' ' VAL . 6.0 ttt180 -149.26 156.39 42.05 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.484 -0.76 . . . . 0.0 109.175 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.6 HG22 ' CG2' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -151.75 -173.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.612 ' HD2' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -112.15 69.05 0.68 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.868 -1.145 . . . . 0.0 111.212 -179.187 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.8 HD12 HG12 ' A' ' 31' ' ' VAL . 1.9 tm? -56.49 94.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.005 -1.059 . . . . 0.0 108.253 178.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' PHE . . . . . 1.111 ' CE1' HD11 ' A' ' 32' ' ' LEU . 8.2 m-30 -86.25 143.78 27.76 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.807 HG22 ' O ' ' A' ' 32' ' ' LEU . 15.3 m -122.4 -175.28 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.844 -1.16 . . . . 0.0 109.578 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.499 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.4 OUTLIER -126.91 -154.76 0.65 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.408 -0.808 . . . . 0.0 109.868 -179.69 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.499 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 8.7 mttt -63.45 -54.79 31.06 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.457 0.646 . . . . 0.0 109.262 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.504 ' HA ' HD13 ' B' ' 54' ' ' LEU . 2.9 mm? -98.48 44.07 1.04 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.534 -0.729 . . . . 0.0 109.806 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' B' ' 55' ' ' ASP . 0.0 OUTLIER 48.32 64.17 1.77 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.248 -0.908 . . . . 0.0 109.65 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . 0.536 ' O ' ' N ' ' B' ' 58' ' ' ALA . 0.0 OUTLIER -124.77 98.74 5.84 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.434 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 1.042 HD11 ' HB2' ' A' ' 16' ' ' ALA . 32.1 mt -44.27 91.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 121.491 0.663 . . . . 0.0 109.822 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.3 -20.33 25.56 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -128.23 104.17 7.59 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.673 HG21 ' O ' ' A' ' 5' ' ' TRP . 5.0 t -73.69 134.93 78.39 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.226 -0.921 . . . . 0.0 110.397 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.714 ' HG3' HD11 ' A' ' 29' ' ' ILE . 37.7 Cg_endo -84.04 -175.55 2.27 Favored 'Trans proline' 0 C--N 1.314 -1.251 0 C-N-CA 122.735 2.29 . . . . 0.0 109.677 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . 0.406 ' O ' ' CG1' ' B' ' 47' ' ' VAL . 0.1 OUTLIER -151.09 144.48 24.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.053 -1.029 . . . . 0.0 110.045 179.599 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.6 ' CG2' HG22 ' B' ' 47' ' ' VAL . 1.6 t -110.85 -26.28 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . 0.46 ' N ' ' HB ' ' A' ' 3' ' ' THR . . . . . . . . 0 N--CA 1.489 2.19 0 CA-C-O 118.008 -1.44 . . . . 0.0 109.515 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 mmt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.568 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -67.14 99.14 0.65 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.036 -1.04 . . . . 0.0 109.584 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 1.025 HG22 ' CD ' ' A' ' 24' ' ' LYS . 21.0 p -140.98 -41.12 0.39 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.92 . . . . 0.0 108.53 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.599 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -90.31 -35.93 14.97 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.547 -0.721 . . . . 0.0 109.824 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.995 ' O ' HD12 ' A' ' 8' ' ' LEU . 5.5 m-90 58.49 41.54 0.66 Allowed Pre-proline 0 C--N 1.296 -1.737 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.467 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.636 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 33.7 Cg_endo -72.94 -34.05 6.99 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 N-CA-C 107.119 -1.916 . . . . 0.0 107.119 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -69.44 -9.72 54.87 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.336 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.048 ' O ' HD22 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -80.16 -8.42 59.41 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 121.299 -0.875 . . . . 0.0 109.106 -179.47 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.906 ' N ' HD13 ' A' ' 8' ' ' LEU . 35.4 t -48.66 149.84 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 120.882 -1.136 . . . . 0.0 110.437 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 67.98 2.31 23.57 Favored Glycine 0 N--CA 1.484 1.888 0 C-N-CA 120.142 -1.028 . . . . 0.0 111.138 177.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -93.41 -149.44 0.27 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.745 -1.444 . . . . 0.0 109.601 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.61 164.39 29.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.109 -0.994 . . . . 0.0 110.325 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.726 HG21 HG21 ' A' ' 31' ' ' VAL . 48.1 t -52.23 -34.93 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.461 -0.775 . . . . 0.0 109.062 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.542 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 0.4 OUTLIER -44.36 -66.56 0.37 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.307 -0.871 . . . . 0.0 109.095 179.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.43 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -62.76 -34.04 76.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.093 -1.004 . . . . 0.0 109.303 179.297 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.729 ' HB1' HD12 ' A' ' 20' ' ' ILE . . . -62.11 -82.85 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.125 -0.985 . . . . 0.0 109.604 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.533 ' HG2' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -44.02 -42.07 5.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.951 -1.093 . . . . 0.0 108.905 179.813 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.542 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -47.48 -78.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.588 0.708 . . . . 0.0 110.339 179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.458 ' O ' ' OD1' ' A' ' 23' ' ' ASP . 1.6 t -71.14 -55.27 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.7 -0.625 . . . . 0.0 110.116 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.882 HD13 HD13 ' A' ' 29' ' ' ILE . 95.3 mt -39.53 -34.82 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.524 -0.735 . . . . 0.0 109.872 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.1 tp -48.12 -52.22 21.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.367 -0.833 . . . . 0.0 110.759 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.578 ' O ' ' N ' ' A' ' 24' ' ' LYS . 0.8 OUTLIER -112.32 -66.88 1.04 Allowed 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.672 -1.211 . . . . 0.0 111.492 -178.373 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.559 ' CB ' ' HB3' ' A' ' 2' ' ' LYS . 0.4 OUTLIER 38.78 -92.81 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.41 -0.806 . . . . 0.0 108.875 -179.022 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 1.025 ' CD ' HG22 ' A' ' 3' ' ' THR . 2.8 mtpm? -64.27 -131.72 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.422 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 177.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.728 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 32.5 Cg_endo -74.67 -64.41 0.03 OUTLIER 'Trans proline' 0 C--O 1.215 -0.662 0 CA-C-N 122.084 1.78 . . . . 0.0 108.825 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 9.7 mt-10 -162.17 70.49 0.31 Allowed 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.605 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -88.85 117.47 27.87 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.522 ' CB ' ' O ' ' B' ' 45' ' ' ASP . 1.1 tt0 -87.2 173.55 9.15 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.951 -1.093 . . . . 0.0 109.249 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.882 HD13 HD13 ' A' ' 20' ' ' ILE . 5.4 tt -150.06 128.58 2.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 C-N-CA 118.999 -1.08 . . . . 0.0 110.741 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.636 HG22 HD22 ' A' ' 32' ' ' LEU . 2.9 mm -88.74 141.67 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.726 HG21 HG21 ' A' ' 13' ' ' VAL . 11.8 p -113.94 131.29 66.27 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 120.84 -1.163 . . . . 0.0 110.217 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.945 HD23 ' N ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -143.21 161.98 45.19 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.489 -0.757 . . . . 0.0 109.381 179.444 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.498 ' HD2' ' HB2' ' A' ' 32' ' ' LEU . 36.1 Cg_endo -76.79 142.97 23.14 Favored 'Trans proline' 0 C--N 1.301 -1.936 0 C-N-CA 121.946 1.764 . . . . 0.0 108.528 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.838 HG13 ' O ' ' B' ' 51' ' ' VAL . 17.3 m -67.45 -1.44 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.087 -1.008 . . . . 0.0 110.573 -178.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 34' ' ' VAL . . . -57.11 -157.02 0.01 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -44.74 147.81 0.59 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.091 -1.24 . . . . 0.0 109.94 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.543 HG22 HG23 ' A' ' 38' ' ' VAL . 2.8 mp -117.03 -87.49 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.331 -0.856 . . . . 0.0 109.634 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.543 HG23 HG22 ' A' ' 37' ' ' ILE . 3.7 t -94.12 -52.55 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.065 -1.022 . . . . 0.0 109.612 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.409 ' O ' ' OG1' ' A' ' 39' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.565 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.541 0.686 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . 0.496 ' CD1' ' N ' ' B' ' 42' ' ' TYR . 0.0 OUTLIER -71.18 -110.14 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.519 -0.738 . . . . 0.0 109.552 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.542 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 2.5 ptt180 -113.7 44.87 1.53 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.715 -1.241 . . . . 0.0 109.124 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.532 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.4 OUTLIER -43.03 141.93 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 119.148 -1.021 . . . . 0.0 108.567 -179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.605 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.6 p-10 -102.51 47.01 0.9 Allowed 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 119.188 -1.005 . . . . 0.0 109.819 -178.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . 0.406 ' C ' HG23 ' B' ' 47' ' ' VAL . 3.9 ttm180 -151.9 148.13 27.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.383 -0.823 . . . . 0.0 110.119 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 1.052 ' CG2' HG23 ' B' ' 63' ' ' VAL . 53.7 t -151.41 154.83 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.643 HH11 HD13 ' A' ' 32' ' ' LEU . 10.5 mmt180 -88.06 66.7 8.68 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.601 -1.312 . . . . 0.0 110.372 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 1.065 HD11 HD12 ' B' ' 57' ' ' ILE . 2.5 tp -60.79 90.11 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.089 -1.007 . . . . 0.0 109.383 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' PHE . . . . . 0.778 ' HE1' HD11 ' A' ' 32' ' ' LEU . 3.8 m-30 -76.26 156.06 33.83 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.838 ' O ' HG13 ' A' ' 34' ' ' VAL . 1.8 m -121.31 176.73 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.73 -1.232 . . . . 0.0 109.68 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.492 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.4 OUTLIER -109.22 -154.95 0.55 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.252 -0.905 . . . . 0.0 109.774 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.646 ' HB2' HD22 ' B' ' 54' ' ' LEU . 2.7 mtpt -67.8 -53.97 22.86 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.536 -0.728 . . . . 0.0 109.465 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.763 ' N ' HD22 ' B' ' 54' ' ' LEU . 3.2 mm? -95.88 42.9 1.09 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.0 109.567 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' B' ' 55' ' ' ASP . 0.0 OUTLIER 48.14 65.01 1.43 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.156 -0.965 . . . . 0.0 109.28 -179.727 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' B' ' 58' ' ' ALA . 8.9 t30 -130.01 106.68 8.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.385 -0.822 . . . . 0.0 108.846 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 1.065 HD12 HD11 ' B' ' 49' ' ' LEU . 15.6 mm -39.61 90.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 CA-C-O 121.646 0.736 . . . . 0.0 110.68 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.544 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.09 -27.12 22.15 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -111.79 136.15 51.45 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.626 HG23 HG22 ' A' ' 9' ' ' VAL . 43.1 t -90.01 127.93 51.81 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.837 -1.165 . . . . 0.0 110.609 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.877 ' HB2' HG11 ' B' ' 47' ' ' VAL . 36.5 Cg_endo -79.72 157.04 24.55 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.378 2.052 . . . . 0.0 109.215 177.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . 0.561 ' HD2' ' CA ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -146.12 142.98 29.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.838 -1.164 . . . . 0.0 110.588 -179.396 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 1.052 HG23 ' CG2' ' B' ' 47' ' ' VAL . 0.9 OUTLIER -129.05 114.1 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.446 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.379 0 CA-C-O 117.869 -1.517 . . . . 0.0 109.579 -179.886 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.581 ' N ' ' HG2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -80.85 90.89 5.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.64 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.642 HG23 ' HE3' ' A' ' 24' ' ' LYS . 0.9 OUTLIER -89.4 -46.53 8.66 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.109 -0.994 . . . . 0.0 108.782 179.544 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.575 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 2.6 mp0 -89.78 167.43 12.87 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.349 -0.844 . . . . 0.0 109.361 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.62 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 20.9 m-90 -141.09 46.0 0.82 Allowed Pre-proline 0 C--N 1.294 -1.836 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 5' ' ' TRP . 31.2 Cg_endo -69.6 -27.32 27.36 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 N-CA-C 108.21 -1.496 . . . . 0.0 108.21 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -69.66 -20.03 63.59 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.896 HD21 HG21 ' B' ' 57' ' ' ILE . 0.0 OUTLIER -82.27 -8.66 59.64 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -179.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.63 ' CG2' ' CG2' ' B' ' 60' ' ' VAL . 20.6 t -48.81 154.14 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.095 -1.003 . . . . 0.0 110.004 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.425 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . 65.71 2.43 11.59 Favored Glycine 0 N--CA 1.482 1.717 0 C-N-CA 120.252 -0.975 . . . . 0.0 110.883 178.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -93.69 -143.7 0.23 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.709 -1.465 . . . . 0.0 109.393 179.877 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.458 ' HB3' ' CD ' ' A' ' 14' ' ' GLU . 0.3 OUTLIER -144.46 167.52 22.29 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.964 -1.085 . . . . 0.0 110.121 -179.701 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.587 HG22 HD21 ' B' ' 49' ' ' LEU . 71.6 t -50.82 -40.96 20.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.531 -0.731 . . . . 0.0 109.796 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.544 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -44.68 -69.02 0.15 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.502 -0.749 . . . . 0.0 109.352 -179.763 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.596 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -58.07 -31.13 66.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.176 -0.952 . . . . 0.0 109.415 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.867 ' HB2' HD11 ' B' ' 57' ' ' ILE . . . -64.9 -84.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.045 -1.034 . . . . 0.0 109.954 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -45.2 -34.89 2.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.986 -1.071 . . . . 0.0 109.086 -179.556 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.544 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 20.5 tttp -55.02 -75.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.508 0.671 . . . . 0.0 111.334 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 15' ' ' GLU . 1.5 t -70.28 -46.1 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.486 -0.759 . . . . 0.0 110.968 -177.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.795 HG21 ' HB ' ' A' ' 29' ' ' ILE . 2.6 mt -53.28 -50.55 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.02 -1.05 . . . . 0.0 109.871 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 28' ' ' GLN . 2.3 tt -39.4 -28.08 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.265 -0.897 . . . . 0.0 110.642 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.475 ' N ' ' O ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -149.9 26.82 0.8 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.875 -1.14 . . . . 0.0 110.675 -179.714 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.55 ' OD2' HG12 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -54.49 -64.15 0.92 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.731 -1.23 . . . . 0.0 108.194 179.182 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.748 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 3.5 mtpm? -80.47 -117.58 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.383 0 N-CA-C 106.841 -1.541 . . . . 0.0 106.841 178.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.748 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 36.7 Cg_endo -79.92 -64.2 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.69 0 CA-C-N 122.103 1.787 . . . . 0.0 108.612 178.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 27.2 mt-10 -159.97 60.97 0.36 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.603 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -88.53 117.31 27.39 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.185 -1.006 . . . . 0.0 108.61 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 1.7 tt0 -88.6 169.78 11.41 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.199 -0.938 . . . . 0.0 109.965 -178.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.795 ' HB ' HG21 ' A' ' 20' ' ' ILE . 19.8 tt -140.6 135.14 34.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.51 -0.743 . . . . 0.0 109.52 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.694 HD13 ' CG ' ' B' ' 46' ' ' ARG . 1.2 mp -88.76 128.57 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 1.043 HG22 HD23 ' B' ' 49' ' ' LEU . 25.3 t -94.72 136.3 26.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 118.518 -1.273 . . . . 0.0 110.487 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.07 HD11 ' CE1' ' B' ' 50' ' ' PHE . 0.8 OUTLIER -147.31 156.66 46.18 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.689 -0.632 . . . . 0.0 109.347 179.764 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.566 ' O ' HG23 ' A' ' 34' ' ' VAL . 37.9 Cg_endo -81.71 60.63 7.67 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.779 2.32 . . . . 0.0 109.3 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 33' ' ' PRO . 0.1 OUTLIER 45.75 -90.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.532 -0.73 . . . . 0.0 109.442 -179.055 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 33' ' ' PRO . . . 42.36 -151.59 0.27 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.31 -148.02 0.27 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.214 -1.168 . . . . 0.0 109.174 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.68 HG23 ' H ' ' A' ' 39' ' ' THR . 0.9 OUTLIER -59.76 -172.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.15 -0.969 . . . . 0.0 109.117 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.529 ' O ' HG22 ' A' ' 39' ' ' THR . 7.3 p -42.54 -38.85 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.092 -1.005 . . . . 0.0 109.746 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.68 ' H ' HG23 ' A' ' 37' ' ' ILE . 9.0 t . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 118.085 -0.959 . . . . 0.0 109.745 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . 0.62 ' CE2' ' HA ' ' B' ' 44' ' ' ILE . 10.4 p90 -127.51 -162.58 1.18 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.917 . . . . 0.0 109.337 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.512 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 5.6 ptt180 -92.98 64.46 3.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.027 -1.046 . . . . 0.0 109.907 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.62 ' HA ' ' CE2' ' B' ' 42' ' ' TYR . 0.5 OUTLIER -45.82 146.22 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.946 -1.096 . . . . 0.0 108.73 179.585 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.603 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -110.86 40.91 1.91 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.391 -0.924 . . . . 0.0 109.953 -179.74 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . 0.694 ' CG ' HD13 ' A' ' 30' ' ' ILE . 0.2 OUTLIER -150.23 144.56 25.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.42 -0.8 . . . . 0.0 108.994 179.192 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.55 ' CG2' HG23 ' B' ' 63' ' ' VAL . 0.0 OUTLIER -151.16 164.77 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.087 -1.008 . . . . 0.0 108.857 -179.747 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.614 ' HG3' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -91.9 89.42 7.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.745 -1.222 . . . . 0.0 110.46 -179.241 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 1.043 HD23 HG22 ' A' ' 31' ' ' VAL . 4.0 tp -78.87 91.32 4.76 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' PHE . . . . . 1.07 ' CE1' HD11 ' A' ' 32' ' ' LEU . 4.1 m-30 -77.54 179.74 6.34 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -148.01 -173.58 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.865 -1.147 . . . . 0.0 109.515 179.514 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.54 ' OD2' ' CB ' ' B' ' 56' ' ' ASN . 5.5 p-10 -116.7 -146.43 0.4 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.316 -0.865 . . . . 0.0 109.253 179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.531 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 8.7 mmtp -62.28 -55.62 26.54 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.241 -0.912 . . . . 0.0 110.131 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.551 ' O ' ' CB ' ' B' ' 55' ' ' ASP . 2.4 mp -103.28 17.02 25.04 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.997 -1.065 . . . . 0.0 111.687 -178.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . 0.552 ' HA ' ' CG1' ' B' ' 51' ' ' VAL . 0.2 OUTLIER 91.43 47.87 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.459 0 CA-C-O 122.583 1.182 . . . . 0.0 110.623 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . 0.58 ' O ' ' N ' ' B' ' 58' ' ' ALA . 1.9 t-20 -106.56 97.36 7.16 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.97 -1.081 . . . . 0.0 108.3 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.896 HG21 HD21 ' A' ' 8' ' ' LEU . 43.8 mt -37.28 88.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 121.549 0.69 . . . . 0.0 110.914 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.95 -31.26 18.25 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -99.69 134.94 41.85 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.63 ' CG2' ' CG2' ' A' ' 9' ' ' VAL . 65.1 t -90.12 129.44 45.85 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.092 -1.005 . . . . 0.0 111.21 -178.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.413 ' O ' ' CD ' ' B' ' 62' ' ' ARG . 36.3 Cg_endo -81.84 162.53 18.56 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.308 2.005 . . . . 0.0 108.928 177.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . 0.534 ' O ' ' CG1' ' B' ' 47' ' ' VAL . 0.0 OUTLIER -150.91 132.62 14.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.659 -1.275 . . . . 0.0 110.711 -179.69 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.598 HG21 ' HB1' ' A' ' 27' ' ' ALA . 2.2 t -109.63 130.51 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.468 -0.77 . . . . 0.0 109.044 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.381 0 CA-C-O 117.952 -1.471 . . . . 0.0 109.717 179.74 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpp? . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.622 ' HG3' ' CD1' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -90.94 34.64 0.91 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.162 -0.961 . . . . 0.0 110.083 -179.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.788 HG22 ' HD2' ' A' ' 24' ' ' LYS . 16.1 p -88.48 -20.45 25.13 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.572 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 9.8 mp0 -104.15 -28.98 11.14 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.547 0.689 . . . . 0.0 109.151 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.637 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 8.7 m-90 53.12 42.22 1.15 Allowed Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 119.507 -0.877 . . . . 0.0 108.946 -177.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.637 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 35.1 Cg_endo -73.0 -34.83 5.96 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 N-CA-C 107.447 -1.79 . . . . 0.0 107.447 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.73 -12.0 61.29 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.557 ' HG ' HD12 ' B' ' 57' ' ' ILE . 32.1 tp -81.21 -6.0 58.37 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 121.49 -0.756 . . . . 0.0 109.31 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.594 HG23 HG21 ' B' ' 60' ' ' VAL . 21.0 t -54.37 152.48 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 120.942 -1.099 . . . . 0.0 109.034 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.11 7.14 22.78 Favored Glycine 0 N--CA 1.48 1.601 0 C-N-CA 119.94 -1.124 . . . . 0.0 110.44 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.501 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 5.2 tptt -93.92 -141.26 0.23 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.825 -1.397 . . . . 0.0 109.441 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.545 ' CA ' HG13 ' B' ' 57' ' ' ILE . 48.4 m -149.89 167.17 27.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.939 -1.101 . . . . 0.0 110.454 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.619 ' CG2' HG11 ' B' ' 51' ' ' VAL . 97.1 t -50.35 -34.05 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.49 -0.756 . . . . 0.0 109.814 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.524 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 27.1 mt-10 -45.87 -77.94 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.384 -0.822 . . . . 0.0 109.065 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.407 ' CD ' ' HE2' ' A' ' 11' ' ' LYS . 0.6 OUTLIER -55.69 -31.28 62.3 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.333 -0.854 . . . . 0.0 109.388 179.802 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.722 ' HB2' HD11 ' B' ' 57' ' ' ILE . . . -62.02 -85.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.44 -0.788 . . . . 0.0 110.616 -179.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.491 ' HG2' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -48.26 -29.81 4.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.634 -1.291 . . . . 0.0 108.994 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -57.6 -82.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.413 0.625 . . . . 0.0 111.116 -179.445 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.1 t -64.8 -40.21 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.369 -0.832 . . . . 0.0 110.315 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.8 HG21 ' HB ' ' A' ' 29' ' ' ILE . 98.5 mt -51.8 -56.17 6.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.336 -0.852 . . . . 0.0 109.82 -179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 21' ' ' LEU . 0.4 OUTLIER -36.88 -29.76 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.51 -0.743 . . . . 0.0 110.593 -179.521 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.51 ' N ' ' O ' ' A' ' 20' ' ' ILE . 2.2 mt-30 -148.74 52.53 0.99 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.023 -1.048 . . . . 0.0 109.855 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.516 ' OD2' ' HA ' ' A' ' 3' ' ' THR . 3.8 t0 -53.32 -62.81 1.41 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.985 -1.072 . . . . 0.0 108.409 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.845 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -115.98 -66.8 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 120.748 -1.22 . . . . 0.0 109.201 178.537 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.845 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 42.2 Cg_endo -91.25 -82.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.324 -0.748 0 N-CA-C 108.135 -1.525 . . . . 0.0 108.135 178.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 16.9 mt-10 -161.45 65.46 0.27 Allowed 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.926 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -87.7 115.32 25.06 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.246 -0.982 . . . . 0.0 108.843 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.453 ' CB ' ' O ' ' B' ' 45' ' ' ASP . 1.8 tt0 -87.92 170.27 11.3 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.233 -0.917 . . . . 0.0 108.774 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.8 ' HB ' HG21 ' A' ' 20' ' ' ILE . 12.9 tt -142.3 133.17 24.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 118.719 -1.192 . . . . 0.0 110.576 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.44 ' HA ' HD13 ' A' ' 30' ' ' ILE . 12.1 mm -87.68 107.09 16.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.541 ' HA ' ' HB3' ' B' ' 49' ' ' LEU . 19.5 t -89.0 146.88 5.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.108 -0.995 . . . . 0.0 110.88 -178.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.063 HD11 ' CE1' ' B' ' 50' ' ' PHE . 0.8 OUTLIER -150.33 164.91 18.8 Favored Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.634 ' HA ' HG23 ' B' ' 51' ' ' VAL . 36.4 Cg_endo -77.93 25.18 0.51 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.408 2.072 . . . . 0.0 111.558 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.796 HG23 ' HB3' ' B' ' 50' ' ' PHE . 0.4 OUTLIER 79.72 -11.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.095 -1.003 . . . . 0.0 110.087 179.446 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 36' ' ' THR . . . -55.52 -177.99 0.24 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 35' ' ' GLY . 18.4 p -45.91 169.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -1.162 . . . . 0.0 109.234 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 pp -86.44 -8.36 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.207 -0.933 . . . . 0.0 109.438 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 38' ' ' VAL . 14.2 m -91.05 113.9 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.221 -0.924 . . . . 0.0 109.32 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.541 HG22 ' OXT' ' A' ' 39' ' ' THR . 10.3 m . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.532 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.187 0.518 . . . . 0.0 109.641 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . 0.443 ' O ' ' HA2' ' B' ' 64' ' ' GLY . 27.4 p90 -111.16 -147.4 0.42 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.187 -0.946 . . . . 0.0 109.461 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.527 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER -107.03 55.91 0.65 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.869 -1.144 . . . . 0.0 110.363 -179.151 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.521 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.3 OUTLIER -46.06 139.56 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.648 -1.283 . . . . 0.0 108.356 179.504 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.567 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -99.4 44.86 1.01 Allowed 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.202 -0.936 . . . . 0.0 109.8 -178.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . 0.431 ' C ' HG23 ' B' ' 47' ' ' VAL . 0.2 OUTLIER -149.65 145.59 26.82 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.401 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 1.149 ' CG2' HG23 ' B' ' 63' ' ' VAL . 60.9 t -151.8 169.35 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 109.779 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.605 ' N ' HG12 ' B' ' 47' ' ' VAL . 0.0 OUTLIER -99.12 95.26 6.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.726 -1.234 . . . . 0.0 109.849 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.653 HD11 ' CB ' ' A' ' 16' ' ' ALA . 0.2 OUTLIER -88.21 84.0 6.92 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.015 -1.053 . . . . 0.0 109.277 179.265 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' PHE . . . . . 1.063 ' CE1' HD11 ' A' ' 32' ' ' LEU . 4.4 m-30 -72.43 138.09 46.89 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.949 HG22 ' O ' ' A' ' 32' ' ' LEU . 2.6 m -123.6 -171.18 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.676 -1.265 . . . . 0.0 110.231 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.569 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.0 OUTLIER -129.72 -168.13 1.91 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.893 0.854 . . . . 0.0 110.006 -179.221 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.569 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 13.8 mttm -43.6 -68.95 0.15 Allowed 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.331 0.586 . . . . 0.0 110.071 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.404 ' CG ' ' O ' ' B' ' 54' ' ' LEU . 0.6 OUTLIER -89.96 47.2 1.43 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 0.0 109.742 -179.59 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 47.62 57.39 5.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.294 -0.879 . . . . 0.0 109.828 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . 0.549 ' O ' ' N ' ' B' ' 58' ' ' ALA . 7.0 t30 -106.42 96.42 6.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.139 -0.976 . . . . 0.0 109.055 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.722 HD11 ' HB2' ' A' ' 16' ' ' ALA . 12.2 mt -42.79 91.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 121.5 0.667 . . . . 0.0 109.681 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -87.77 -17.43 31.64 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -129.23 96.9 4.43 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.594 HG21 HG23 ' A' ' 9' ' ' VAL . 1.6 t -56.54 137.02 77.0 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.32 -0.862 . . . . 0.0 109.952 -178.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.799 ' HB2' HG11 ' B' ' 47' ' ' VAL . 36.2 Cg_endo -80.93 160.15 21.09 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.846 2.364 . . . . 0.0 110.22 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . 0.554 ' HD2' ' CB ' ' A' ' 4' ' ' GLU . 0.8 OUTLIER -141.96 134.44 28.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.137 -0.977 . . . . 0.0 109.622 179.798 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 1.149 HG23 ' CG2' ' B' ' 47' ' ' VAL . 1.0 OUTLIER -110.22 147.54 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.209 -0.932 . . . . 0.0 108.996 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' B' ' 42' ' ' TYR . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 mmt . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.511 ' O ' ' CE2' ' A' ' 5' ' ' TRP . 19.0 mmtm -90.01 43.22 1.13 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.161 -0.962 . . . . 0.0 109.786 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.644 HG23 ' CD ' ' A' ' 24' ' ' LYS . 0.2 OUTLIER -90.51 -16.3 29.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.152 -0.967 . . . . 0.0 109.406 179.816 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.607 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 13.7 mt-10 -100.09 -43.14 6.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.323 -0.861 . . . . 0.0 110.289 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.681 ' CE2' HG12 ' A' ' 20' ' ' ILE . 6.7 m-90 61.21 42.47 0.56 Allowed Pre-proline 0 C--N 1.296 -1.717 0 C-N-CA 119.441 -0.904 . . . . 0.0 109.488 -178.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.635 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 32.7 Cg_endo -72.45 -34.07 7.98 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 N-CA-C 106.925 -1.99 . . . . 0.0 106.925 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -69.34 -12.76 61.93 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.988 HD21 ' HB2' ' A' ' 16' ' ' ALA . 21.9 tp -76.62 -6.4 51.87 Favored 'General case' 0 C--N 1.31 -1.138 0 O-C-N 121.506 -0.746 . . . . 0.0 109.462 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.649 HG23 ' CG2' ' B' ' 60' ' ' VAL . 18.3 t -59.7 149.34 6.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 120.81 -1.181 . . . . 0.0 108.482 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 63.42 7.2 18.37 Favored Glycine 0 C--N 1.296 -1.642 0 C-N-CA 119.578 -1.296 . . . . 0.0 110.379 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.542 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -99.63 -154.71 0.48 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.818 -1.401 . . . . 0.0 108.869 179.558 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.445 ' C ' HD11 ' B' ' 57' ' ' ILE . 0.5 OUTLIER -135.48 160.93 36.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.689 -1.257 . . . . 0.0 110.888 -179.124 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.658 HG13 HD23 ' B' ' 49' ' ' LEU . 28.1 t -52.89 -33.08 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.585 -0.697 . . . . 0.0 109.219 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.549 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 52.7 mm-40 -46.28 -67.69 0.26 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.154 -0.966 . . . . 0.0 108.556 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.414 ' O ' HG23 ' A' ' 19' ' ' VAL . 2.5 tp10 -61.62 -30.89 70.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.4 -0.813 . . . . 0.0 109.501 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.988 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -67.54 -82.18 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.177 -0.952 . . . . 0.0 109.751 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -44.36 -40.39 5.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.672 -1.267 . . . . 0.0 108.972 179.64 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.549 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 20.8 tttm -49.92 -72.1 0.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.611 -0.681 . . . . 0.0 110.368 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.516 ' O ' ' N ' ' A' ' 23' ' ' ASP . 2.8 t -72.24 -57.62 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.523 -0.736 . . . . 0.0 109.972 -179.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.944 HG21 ' HB ' ' A' ' 29' ' ' ILE . 5.9 mt -35.93 -53.86 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.588 -0.695 . . . . 0.0 110.211 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.499 ' HB2' ' O ' ' A' ' 17' ' ' LYS . 2.3 tt -37.56 -52.87 1.2 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.615 -0.678 . . . . 0.0 110.003 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.419 ' HG3' ' HA ' ' A' ' 26' ' ' GLU . 1.4 mt-30 -128.56 32.58 4.8 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 109.968 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' VAL . 17.4 p-10 -50.67 -48.88 58.28 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.019 -1.05 . . . . 0.0 108.28 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.708 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 10.4 mtpp -107.24 -106.62 0.0 OUTLIER Pre-proline 0 CA--C 1.561 1.374 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.708 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 37.0 Cg_endo -79.98 -67.74 0.02 OUTLIER 'Trans proline' 0 C--O 1.215 -0.657 0 CA-C-N 121.93 1.725 . . . . 0.0 108.631 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.528 ' CG ' ' O ' ' A' ' 25' ' ' PRO . 27.1 mt-10 -162.02 64.09 0.24 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.789 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -88.86 116.64 27.28 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.022 -1.049 . . . . 0.0 108.916 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.475 ' HG3' ' OD2' ' B' ' 45' ' ' ASP . 0.1 OUTLIER -88.86 165.65 14.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.899 -1.126 . . . . 0.0 109.166 -179.54 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.944 ' HB ' HG21 ' A' ' 20' ' ' ILE . 3.3 tt -139.84 131.99 34.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.158 -0.963 . . . . 0.0 110.276 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.5 mm -88.59 117.95 33.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.478 HG21 HG21 ' A' ' 13' ' ' VAL . 2.5 p -95.93 136.56 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.149 -0.969 . . . . 0.0 109.675 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.954 HD23 ' N ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -143.06 149.58 49.55 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.237 -0.915 . . . . 0.0 109.562 179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.568 ' HA ' ' CG2' ' B' ' 51' ' ' VAL . 37.7 Cg_endo -78.51 67.21 8.4 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.749 2.299 . . . . 0.0 111.197 -178.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.586 ' HA ' ' CD1' ' B' ' 50' ' ' PHE . 91.8 t 41.34 -96.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.455 -0.778 . . . . 0.0 109.094 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.612 ' O ' ' N ' ' A' ' 37' ' ' ILE . . . 40.51 95.22 0.01 OUTLIER Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.47 ' O ' ' C ' ' A' ' 37' ' ' ILE . 1.4 p -36.74 86.68 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.755 -0.85 . . . . 0.0 110.698 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.612 ' N ' ' O ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER 33.36 74.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.827 -0.545 . . . . 0.0 110.446 179.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.3 t -95.3 -68.11 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.164 -0.96 . . . . 0.0 109.216 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 39' ' ' THR . 6.7 m . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.425 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . 0.471 ' O ' ' O ' ' B' ' 42' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . 0.594 ' OH ' HD12 ' B' ' 44' ' ' ILE . 21.7 p90 -57.32 -158.63 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.3 -0.875 . . . . 0.0 109.649 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.547 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER -108.45 81.25 1.44 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.008 -1.057 . . . . 0.0 110.688 -178.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.747 HG23 HG22 ' B' ' 63' ' ' VAL . 0.6 OUTLIER -49.22 145.55 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 120.574 -1.329 . . . . 0.0 108.208 178.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.609 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.3 p-10 -108.46 32.76 4.59 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.07 -1.019 . . . . 0.0 109.888 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . 0.41 ' C ' ' CG2' ' B' ' 47' ' ' VAL . 0.1 OUTLIER -150.57 143.63 24.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.436 -0.79 . . . . 0.0 109.007 179.349 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.869 ' CG2' HG23 ' B' ' 63' ' ' VAL . 1.8 t -149.44 166.43 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -0.908 . . . . 0.0 109.608 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.536 ' HG3' ' CE2' ' B' ' 50' ' ' PHE . 0.0 OUTLIER -95.5 75.56 3.3 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.742 -1.224 . . . . 0.0 110.21 -179.611 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.662 HD22 ' HB1' ' A' ' 16' ' ' ALA . 4.3 tp -76.72 92.97 3.59 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 118.818 -1.153 . . . . 0.0 108.282 178.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' PHE . . . . . 0.839 ' CZ ' HD11 ' A' ' 32' ' ' LEU . 17.8 m-85 -81.52 -177.02 6.34 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.568 ' CG2' ' HA ' ' A' ' 33' ' ' PRO . 6.1 m -144.28 -175.64 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.648 -1.283 . . . . 0.0 110.5 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.533 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.4 OUTLIER -120.0 -154.8 0.59 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.481 -0.762 . . . . 0.0 109.813 -179.616 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.533 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 11.4 mtpt -63.94 -56.78 12.72 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.565 -0.709 . . . . 0.0 109.332 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.64 HD23 ' O ' ' B' ' 54' ' ' LEU . 2.6 tt -97.12 41.87 1.1 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.395 -0.816 . . . . 0.0 109.461 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . 0.405 ' CG ' ' C ' ' B' ' 54' ' ' LEU . 0.0 OUTLIER 49.65 65.06 1.52 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.206 -0.934 . . . . 0.0 109.181 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . 0.553 ' O ' ' N ' ' B' ' 58' ' ' ALA . 17.4 t-20 -123.94 96.44 4.95 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.38 -0.825 . . . . 0.0 108.996 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.607 HD12 ' HG ' ' A' ' 8' ' ' LEU . 4.2 mt -37.45 89.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-O 121.576 0.703 . . . . 0.0 110.88 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.23 -21.56 24.45 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.67 133.79 53.67 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.649 ' CG2' HG23 ' A' ' 9' ' ' VAL . 99.4 t -90.09 128.11 50.94 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 120.999 -1.063 . . . . 0.0 110.59 -179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.533 ' HB2' HG11 ' B' ' 47' ' ' VAL . 37.2 Cg_endo -83.63 165.29 14.01 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.396 2.064 . . . . 0.0 109.43 178.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . 0.541 ' HG3' ' HA ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -148.86 141.15 24.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.168 -0.958 . . . . 0.0 109.749 179.559 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.869 HG23 ' CG2' ' B' ' 47' ' ' VAL . 0.9 OUTLIER -113.12 -18.37 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.261 -0.899 . . . . 0.0 109.084 -179.859 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.935 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.455 ' SD ' ' HB3' ' A' ' 24' ' ' LYS . 2.4 mmt . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.306 0.574 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.572 ' O ' ' CE2' ' A' ' 5' ' ' TRP . 4.1 mmtp -84.79 72.24 10.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.889 . . . . 0.0 109.562 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.537 HG22 ' CD ' ' A' ' 24' ' ' LYS . 70.7 p -88.99 -26.81 21.28 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 109.197 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.589 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 81.2 mt-10 -93.53 -35.46 12.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.336 -0.852 . . . . 0.0 109.958 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.627 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 6.5 m-90 58.34 40.79 0.58 Allowed Pre-proline 0 C--N 1.293 -1.879 0 O-C-N 120.836 -1.165 . . . . 0.0 109.863 -178.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.627 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 34.2 Cg_endo -73.32 -34.92 5.46 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 N-CA-C 107.08 -1.931 . . . . 0.0 107.08 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.9 -11.72 61.08 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 177.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.558 HD21 ' HA ' ' A' ' 16' ' ' ALA . 30.5 tp -79.1 -7.91 58.54 Favored 'General case' 0 C--N 1.309 -1.172 0 O-C-N 121.402 -0.811 . . . . 0.0 109.216 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.613 HG23 ' CG2' ' B' ' 60' ' ' VAL . 19.4 t -54.34 154.22 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 118.994 -1.082 . . . . 0.0 109.151 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.438 ' C ' ' OD1' ' B' ' 56' ' ' ASN . . . 70.37 -0.43 25.29 Favored Glycine 0 C--N 1.297 -1.623 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.629 178.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -96.16 -151.76 0.36 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.665 -1.491 . . . . 0.0 109.584 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.507 ' CB ' ' OE2' ' A' ' 14' ' ' GLU . 1.2 m -139.53 172.8 12.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.138 -0.976 . . . . 0.0 110.535 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.676 ' HA ' HD21 ' B' ' 49' ' ' LEU . 99.2 t -54.72 -37.95 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.586 -0.696 . . . . 0.0 109.916 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.507 ' OE2' ' CB ' ' A' ' 12' ' ' SER . 0.7 OUTLIER -44.05 -74.76 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -0.904 . . . . 0.0 108.855 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.26 -38.23 65.58 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.394 -0.816 . . . . 0.0 109.835 179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.835 ' HB2' HD11 ' B' ' 57' ' ' ILE . . . -59.02 -83.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.237 -0.915 . . . . 0.0 110.308 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.572 ' HA ' HG22 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -46.62 -28.06 1.34 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.586 -1.321 . . . . 0.0 109.617 -179.596 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 10.2 mttt -63.35 -83.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.487 -0.758 . . . . 0.0 110.746 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.468 HG23 ' H ' ' A' ' 19' ' ' VAL . 2.1 t -57.61 -42.34 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.6 -0.688 . . . . 0.0 109.472 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.885 HG21 ' HB ' ' A' ' 29' ' ' ILE . 69.0 mt -50.64 -53.75 11.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.293 -0.879 . . . . 0.0 108.919 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.531 HD12 ' OE1' ' A' ' 28' ' ' GLN . 9.1 tt -34.98 -36.45 0.05 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.788 -0.57 . . . . 0.0 110.642 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 20' ' ' ILE . 3.3 mt-30 -147.36 41.4 1.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.113 -0.992 . . . . 0.0 110.241 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.547 ' OD1' ' HG2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -57.86 -44.85 86.86 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 120.969 -1.082 . . . . 0.0 108.441 179.598 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.837 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -120.71 -88.49 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.241 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.837 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 38.8 Cg_endo -84.07 -81.47 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.655 0 N-CA-C 108.214 -1.494 . . . . 0.0 108.214 177.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 13.9 mt-10 -158.79 57.83 0.43 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 1.035 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -87.67 117.03 26.21 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.178 -0.951 . . . . 0.0 109.303 -179.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.531 ' OE1' HD12 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -88.58 -175.15 4.84 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.129 -0.982 . . . . 0.0 109.549 -179.358 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.885 ' HB ' HG21 ' A' ' 20' ' ' ILE . 14.6 tt -147.62 140.59 19.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.452 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.706 HG22 HD22 ' A' ' 32' ' ' LEU . 2.7 mm -87.51 146.55 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.81 ' C ' HD23 ' A' ' 32' ' ' LEU . 8.7 p -102.37 133.53 45.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 119.071 -1.051 . . . . 0.0 109.734 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.966 HD23 ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -145.68 149.25 39.42 Favored Pre-proline 0 N--CA 1.487 1.401 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.688 ' O ' HG12 ' A' ' 34' ' ' VAL . 36.8 Cg_endo -79.75 21.99 0.75 Allowed 'Trans proline' 0 C--N 1.302 -1.906 0 C-N-CA 122.229 1.953 . . . . 0.0 111.891 -179.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.688 HG12 ' O ' ' A' ' 33' ' ' PRO . 0.4 OUTLIER 78.52 -6.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.989 -1.069 . . . . 0.0 109.891 179.325 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -121.09 -31.74 1.15 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 37' ' ' ILE . 4.7 m -69.55 93.97 0.73 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.23 -1.159 . . . . 0.0 109.559 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.475 HG23 ' O ' ' A' ' 36' ' ' THR . 0.2 OUTLIER -157.77 24.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.244 -0.91 . . . . 0.0 109.478 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.3 t -127.82 111.81 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.259 -0.901 . . . . 0.0 109.452 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.482 179.885 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -118.65 -154.82 0.58 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.225 -0.922 . . . . 0.0 109.46 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.564 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER -122.72 76.94 1.39 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.105 -0.997 . . . . 0.0 109.78 -179.493 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.495 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.3 OUTLIER -48.16 139.37 2.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 120.646 -1.284 . . . . 0.0 108.189 179.334 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.593 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -97.12 45.64 1.04 Allowed 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.331 -179.281 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -150.93 143.28 24.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.403 -0.811 . . . . 0.0 109.133 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 1.097 HG23 HG23 ' B' ' 63' ' ' VAL . 53.5 t -151.0 146.38 16.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.209 -0.932 . . . . 0.0 110.092 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.509 ' HB3' HD11 ' A' ' 32' ' ' LEU . 7.0 mmt180 -71.81 98.24 1.94 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.625 -1.297 . . . . 0.0 110.443 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.846 ' N ' HD21 ' A' ' 32' ' ' LEU . 2.6 tp -84.79 88.37 7.38 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.131 -0.981 . . . . 0.0 108.842 178.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' PHE . . . . . 0.759 ' CE1' HD12 ' A' ' 32' ' ' LEU . 1.8 m-85 -70.13 178.66 2.68 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.672 HG21 ' HA ' ' A' ' 33' ' ' PRO . 6.3 m -139.82 -174.71 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.043 -1.035 . . . . 0.0 109.276 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.687 ' HB3' ' HB2' ' B' ' 58' ' ' ALA . 0.1 OUTLIER -135.94 -158.71 0.89 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.147 -0.97 . . . . 0.0 110.115 -179.996 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.529 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 26.9 mtpt -43.66 -69.81 0.12 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.67 -0.644 . . . . 0.0 110.407 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.481 ' HA ' HD22 ' B' ' 54' ' ' LEU . 0.4 OUTLIER -97.23 52.81 1.15 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.274 -0.891 . . . . 0.0 110.106 -179.138 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . 0.43 ' HA ' ' HB ' ' B' ' 51' ' ' VAL . 0.0 OUTLIER 47.38 58.1 5.22 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.251 -0.906 . . . . 0.0 109.183 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . 0.565 ' O ' ' N ' ' B' ' 58' ' ' ALA . 36.5 t-20 -121.52 113.74 20.25 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.835 HD11 ' HB2' ' A' ' 16' ' ' ALA . 26.4 mt -35.51 88.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-O 121.518 0.675 . . . . 0.0 110.966 -179.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.687 ' HB2' ' HB3' ' B' ' 52' ' ' ASP . . . -89.17 -20.92 23.63 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -109.99 137.99 46.99 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.613 ' CG2' HG23 ' A' ' 9' ' ' VAL . 71.3 t -90.33 129.46 45.31 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.092 -1.005 . . . . 0.0 111.022 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.837 ' CB ' HG11 ' B' ' 47' ' ' VAL . 37.4 Cg_endo -83.46 164.18 14.57 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 122.617 2.212 . . . . 0.0 108.587 178.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -138.97 -43.98 0.47 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.255 -1.528 . . . . 0.0 110.809 -179.65 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 1.097 HG23 HG23 ' B' ' 47' ' ' VAL . 0.5 OUTLIER 77.59 -4.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 O-C-N 121.218 -0.926 . . . . 0.0 109.662 179.677 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.85 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 ptp . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.455 ' O ' ' CE2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -84.49 64.63 8.53 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.283 -0.886 . . . . 0.0 109.686 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.706 HG22 ' CE ' ' A' ' 24' ' ' LYS . 0.6 OUTLIER -89.88 -12.75 38.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.097 -1.002 . . . . 0.0 109.083 179.617 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.569 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 3.9 mt-10 -92.69 -47.22 7.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.387 -0.821 . . . . 0.0 110.336 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.632 ' CE2' HG12 ' A' ' 20' ' ' ILE . 10.9 m-90 62.29 45.15 0.72 Allowed Pre-proline 0 C--N 1.297 -1.703 0 C-N-CA 119.611 -0.836 . . . . 0.0 108.935 -177.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.629 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 33.0 Cg_endo -71.68 -30.85 14.08 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 N-CA-C 107.169 -1.897 . . . . 0.0 107.169 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.29 -15.28 62.87 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.731 HD21 ' HB2' ' A' ' 16' ' ' ALA . 13.4 tp -80.48 -5.81 57.2 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.657 -0.652 . . . . 0.0 109.325 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.551 HG23 HG21 ' B' ' 60' ' ' VAL . 36.9 t -51.68 152.22 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.089 -1.007 . . . . 0.0 109.528 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.459 ' HA2' ' OD1' ' B' ' 56' ' ' ASN . . . 47.42 21.14 1.15 Allowed Glycine 0 N--CA 1.483 1.77 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.516 178.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -96.51 -141.81 0.28 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.862 -1.375 . . . . 0.0 109.143 179.631 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.45 ' N ' HG12 ' B' ' 57' ' ' ILE . 0.6 OUTLIER -146.41 159.42 43.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.911 -1.118 . . . . 0.0 110.008 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.604 ' HA ' HD21 ' B' ' 49' ' ' LEU . 29.8 t -48.15 -36.76 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.409 -0.807 . . . . 0.0 109.649 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.533 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 2.7 mt-10 -45.46 -75.41 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.408 -0.807 . . . . 0.0 109.193 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.4 ' HB3' ' CD1' ' A' ' 8' ' ' LEU . 0.9 OUTLIER -53.88 -32.84 54.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.235 -0.915 . . . . 0.0 109.113 179.489 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.731 ' HB2' HD21 ' A' ' 8' ' ' LEU . . . -64.88 -88.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.404 -0.81 . . . . 0.0 110.309 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.52 ' HA ' ' CG2' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -43.06 -29.02 0.32 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.823 -1.173 . . . . 0.0 109.255 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 3.5 tttt -61.81 -82.89 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.735 -0.603 . . . . 0.0 110.182 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.52 ' O ' ' N ' ' A' ' 23' ' ' ASP . 3.2 t -59.98 -48.36 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.42 -0.8 . . . . 0.0 109.427 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.699 HG21 ' HB ' ' A' ' 29' ' ' ILE . 80.0 mt -48.17 -59.87 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.407 -0.808 . . . . 0.0 110.045 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 27' ' ' ALA . 1.0 OUTLIER -37.74 -33.24 0.07 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.502 -0.749 . . . . 0.0 110.531 -179.327 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.445 ' HB2' HD23 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -149.51 50.47 0.94 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.137 -0.977 . . . . 0.0 109.623 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -66.65 -40.88 88.87 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.176 -0.952 . . . . 0.0 108.639 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.73 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -124.01 -88.53 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.441 0 CA-C-O 117.962 -1.018 . . . . 0.0 108.271 178.078 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.73 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 37.8 Cg_endo -81.34 -79.66 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.659 0 N-CA-C 108.522 -1.376 . . . . 0.0 108.522 177.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 14.5 mt-10 -160.99 66.0 0.3 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.982 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -87.56 116.09 25.44 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.123 -1.031 . . . . 0.0 108.9 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.49 ' CB ' ' O ' ' B' ' 45' ' ' ASP . 0.0 OUTLIER -88.46 161.39 17.05 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.436 -0.79 . . . . 0.0 108.995 -179.543 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.699 ' HB ' HG21 ' A' ' 20' ' ' ILE . 14.4 tt -137.73 136.46 45.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.062 -1.055 . . . . 0.0 110.507 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.528 ' O ' ' HB3' ' B' ' 49' ' ' LEU . 3.9 mm -88.89 155.17 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.502 ' HA ' ' HB3' ' B' ' 49' ' ' LEU . 14.9 p -116.32 137.38 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.77 -1.206 . . . . 0.0 109.752 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.099 HD11 ' CE1' ' B' ' 50' ' ' PHE . 0.9 OUTLIER -150.43 159.99 33.77 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.182 -0.949 . . . . 0.0 110.374 -179.705 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.555 ' HA ' HG23 ' B' ' 51' ' ' VAL . 36.9 Cg_endo -81.18 45.67 2.05 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 123.086 2.524 . . . . 0.0 110.418 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.649 ' N ' HD12 ' A' ' 32' ' ' LEU . 68.9 t 59.87 -90.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.296 -0.878 . . . . 0.0 109.132 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.474 ' N ' HG12 ' A' ' 34' ' ' VAL . . . 53.72 170.99 0.04 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.681 HG23 ' O ' ' A' ' 36' ' ' THR . 10.0 t -99.94 70.64 1.61 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.178 -1.19 . . . . 0.0 109.451 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.756 ' O ' HG22 ' A' ' 37' ' ' ILE . 48.4 mt 47.64 61.59 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.221 -0.925 . . . . 0.0 109.427 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.725 HG23 HG23 ' A' ' 39' ' ' THR . 11.0 m -96.43 -153.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.917 . . . . 0.0 109.325 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.725 HG23 HG23 ' A' ' 38' ' ' VAL . 38.3 p . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.467 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . 0.426 ' N ' ' OXT' ' B' ' 64' ' ' GLY . 5.8 mm-40 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.655 0.741 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . 0.417 ' HD1' ' N ' ' B' ' 43' ' ' ARG . 0.1 OUTLIER -98.72 -123.03 0.14 Allowed 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.583 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 2.0 ptp180 -131.06 56.12 1.81 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.422 -1.424 . . . . 0.0 109.357 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.539 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.5 OUTLIER -42.96 143.14 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.87 -1.144 . . . . 0.0 108.765 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.603 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.1 p-10 -100.99 39.49 1.39 Allowed 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.12 -178.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . 0.459 ' C ' HG23 ' B' ' 47' ' ' VAL . 0.0 OUTLIER -150.79 140.81 22.04 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 1.044 ' CG2' HG23 ' B' ' 63' ' ' VAL . 96.5 t -151.52 152.13 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.999 -1.063 . . . . 0.0 110.323 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.545 ' HG3' HD21 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -78.38 105.2 9.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.083 -1.011 . . . . 0.0 110.139 -179.515 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 1.043 HD11 HD12 ' B' ' 57' ' ' ILE . 2.6 tp -93.27 86.27 5.26 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.304 -0.959 . . . . 0.0 108.505 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' PHE . . . . . 1.099 ' CE1' HD11 ' A' ' 32' ' ' LEU . 5.9 m-30 -69.72 133.28 47.32 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.714 HG22 ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -103.52 -170.54 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.856 -1.153 . . . . 0.0 109.722 179.747 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.527 ' OD2' ' CB ' ' B' ' 56' ' ' ASN . 2.7 p-10 -126.28 -149.72 0.42 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.519 -0.738 . . . . 0.0 109.055 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.519 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 34.4 mttm -56.86 -58.81 6.5 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.317 -0.864 . . . . 0.0 110.233 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.817 HD23 ' O ' ' B' ' 54' ' ' LEU . 0.9 OUTLIER -101.24 15.99 26.97 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.086 -1.009 . . . . 0.0 111.682 -178.587 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . 0.561 ' CB ' ' O ' ' B' ' 54' ' ' LEU . 0.2 OUTLIER 91.71 48.97 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.603 0 CA-C-O 122.621 1.2 . . . . 0.0 110.183 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . 0.527 ' CB ' ' OD2' ' B' ' 52' ' ' ASP . 1.8 t-20 -105.92 123.77 48.51 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.893 -1.129 . . . . 0.0 109.49 179.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 1.043 HD12 HD11 ' B' ' 49' ' ' LEU . 4.3 mm -54.97 88.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.61 -0.681 . . . . 0.0 109.457 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -88.56 -21.5 24.04 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . 0.416 ' O ' ' C ' ' B' ' 60' ' ' VAL . 8.7 mp0 -125.22 85.14 2.36 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.552 ' CG1' ' O ' ' A' ' 4' ' ' GLU . 9.3 t -42.37 130.15 2.82 Favored Pre-proline 0 N--CA 1.487 1.41 0 O-C-N 121.284 -0.885 . . . . 0.0 110.501 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.591 ' HB2' HG11 ' B' ' 47' ' ' VAL . 36.8 Cg_endo -82.56 162.16 16.82 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 122.976 2.451 . . . . 0.0 110.276 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . 0.553 ' N ' HG11 ' B' ' 47' ' ' VAL . 0.1 OUTLIER -139.88 152.81 46.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.065 -1.022 . . . . 0.0 109.514 179.43 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 1.044 HG23 ' CG2' ' B' ' 47' ' ' VAL . 1.2 t -119.24 123.38 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.154 -0.966 . . . . 0.0 109.009 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . 0.426 ' OXT' ' N ' ' B' ' 41' ' ' GLU . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mtt . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.502 ' O ' ' HB2' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -87.86 78.4 8.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 109.741 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.921 HG22 ' CD ' ' A' ' 24' ' ' LYS . 26.4 p -93.49 -14.7 26.35 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.064 -1.022 . . . . 0.0 108.997 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.735 ' HB3' ' HD3' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -105.05 -178.06 3.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.332 -0.855 . . . . 0.0 110.164 -179.575 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.643 ' NE1' HD12 ' A' ' 20' ' ' ILE . 8.0 m-90 -161.65 48.85 0.25 Allowed Pre-proline 0 C--N 1.299 -1.621 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.19 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.735 ' HD3' ' HB3' ' A' ' 4' ' ' GLU . 30.6 Cg_endo -69.24 -25.82 30.63 Favored 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 121.956 1.77 . . . . 0.0 107.586 178.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -67.4 -25.32 65.88 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 177.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.618 ' HB2' ' HB3' ' A' ' 5' ' ' TRP . 0.3 OUTLIER -73.7 -17.08 61.17 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 121.448 0.642 . . . . 0.0 109.445 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.545 HG23 HG21 ' B' ' 60' ' ' VAL . 37.1 t -49.92 149.6 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 C-N-CA 119.555 -0.858 . . . . 0.0 110.02 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.423 ' C ' ' OD1' ' B' ' 56' ' ' ASN . . . 54.39 17.44 8.27 Favored Glycine 0 N--CA 1.48 1.584 0 C-N-CA 120.134 -1.031 . . . . 0.0 110.574 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.566 ' HB3' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -106.89 -143.87 0.38 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.0 -1.294 . . . . 0.0 109.398 179.717 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.502 ' CA ' HG12 ' B' ' 57' ' ' ILE . 0.5 OUTLIER -146.26 168.91 19.9 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.043 -1.035 . . . . 0.0 110.195 -179.465 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.559 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 84.9 t -55.45 -32.77 30.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.436 -0.79 . . . . 0.0 109.586 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.535 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 2.3 mt-10 -45.27 -71.29 0.08 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.135 -0.978 . . . . 0.0 108.837 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.28 -37.7 81.29 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.313 -0.867 . . . . 0.0 109.87 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.663 ' HB1' HD22 ' B' ' 49' ' ' LEU . . . -57.87 -79.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 110.028 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.54 ' HA ' ' CG2' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -50.75 -32.17 18.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.549 -1.344 . . . . 0.0 109.369 179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -56.31 -82.5 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.494 0.664 . . . . 0.0 111.208 -179.192 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.403 HG23 ' H ' ' A' ' 19' ' ' VAL . 2.1 t -61.69 -35.09 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.626 -0.671 . . . . 0.0 110.342 -178.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.999 HG21 ' HB ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER -53.28 -50.25 48.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 O-C-N 121.074 -1.016 . . . . 0.0 109.541 179.873 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.563 HD23 ' HB2' ' A' ' 22' ' ' GLN . 4.2 tt -35.45 -32.2 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.454 -0.779 . . . . 0.0 110.278 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.563 ' HB2' HD23 ' A' ' 21' ' ' LEU . 1.9 tt0 -145.77 56.88 1.21 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.251 -0.905 . . . . 0.0 109.13 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.609 ' OD1' ' HB3' ' A' ' 27' ' ' ALA . 0.4 OUTLIER -65.41 -62.24 1.65 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.671 -0.643 . . . . 0.0 109.537 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.921 ' CD ' HG22 ' A' ' 3' ' ' THR . 0.0 OUTLIER -110.07 -80.95 0.01 OUTLIER Pre-proline 0 C--N 1.301 -1.508 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.551 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.828 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 39.5 Cg_endo -87.92 -71.87 0.01 OUTLIER 'Trans proline' 0 C--O 1.213 -0.732 0 N-CA-C 107.377 -1.817 . . . . 0.0 107.377 176.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.537 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 19.4 mt-10 -165.02 62.3 0.12 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 178.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.609 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -87.53 120.52 28.92 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.069 -1.019 . . . . 0.0 109.345 -178.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.446 ' CB ' ' O ' ' B' ' 45' ' ' ASP . 0.6 OUTLIER -88.36 174.17 8.31 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.416 -0.803 . . . . 0.0 109.143 -179.52 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.999 ' HB ' HG21 ' A' ' 20' ' ' ILE . 18.5 tt -145.74 134.76 17.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.466 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.557 HD12 ' HD2' ' B' ' 46' ' ' ARG . 4.8 mt -88.07 148.27 4.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.438 HG21 HG21 ' A' ' 13' ' ' VAL . 5.8 p -117.07 133.23 64.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 118.811 -1.156 . . . . 0.0 110.858 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.916 HD11 ' HE1' ' B' ' 50' ' ' PHE . 0.2 OUTLIER -147.57 162.24 32.68 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.827 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.897 ' O ' HG13 ' A' ' 34' ' ' VAL . 36.8 Cg_endo -74.03 -85.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 121.634 1.556 . . . . 0.0 110.823 -177.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.897 HG13 ' O ' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -175.13 -34.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.684 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -89.08 -90.24 1.18 Allowed Glycine 0 N--CA 1.486 1.993 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.451 ' H ' HG22 ' A' ' 36' ' ' THR . 0.0 OUTLIER -48.12 125.0 8.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.36 -1.082 . . . . 0.0 109.696 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.3 tt -81.66 163.85 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.0 109.115 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.536 HG22 ' H ' ' A' ' 39' ' ' THR . 2.0 p -76.88 174.09 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.197 -0.939 . . . . 0.0 109.304 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.536 ' H ' HG22 ' A' ' 38' ' ' VAL . 73.2 p . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.526 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . 0.438 ' O ' ' O ' ' B' ' 64' ' ' GLY . 0.1 OUTLIER -98.49 -122.29 0.14 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.299 -0.875 . . . . 0.0 109.554 -179.724 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.57 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.5 OUTLIER -123.34 56.73 1.18 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.556 -1.34 . . . . 0.0 109.552 179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.488 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.3 OUTLIER -44.03 137.22 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.926 -1.109 . . . . 0.0 108.675 179.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.587 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -93.19 45.32 1.17 Allowed 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.419 -0.912 . . . . 0.0 109.689 -178.854 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . 0.557 ' HD2' HD12 ' A' ' 30' ' ' ILE . 14.1 ttp180 -148.04 144.83 28.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.314 -0.867 . . . . 0.0 109.112 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.663 HG22 ' CG2' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -152.2 143.9 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.157 -0.964 . . . . 0.0 109.427 -179.267 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.452 ' HD3' ' HA ' ' B' ' 48' ' ' ARG . 3.3 mmt85 -77.33 115.43 17.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.701 -1.249 . . . . 0.0 109.632 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 1.064 HD11 HD12 ' B' ' 57' ' ' ILE . 1.6 tp -107.89 81.02 1.44 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.987 -1.071 . . . . 0.0 108.843 178.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' PHE . . . . . 0.916 ' HE1' HD11 ' A' ' 32' ' ' LEU . 4.1 m-30 -66.05 -159.86 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.575 HG22 ' HA ' ' A' ' 33' ' ' PRO . 24.1 m -150.42 -171.46 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.74 -1.225 . . . . 0.0 109.574 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.532 ' HB3' ' HB2' ' B' ' 58' ' ' ALA . 1.0 OUTLIER -122.66 -153.14 0.54 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.297 -0.877 . . . . 0.0 109.259 179.434 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.51 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 29.1 mtpt -61.18 -61.48 2.53 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.617 -0.677 . . . . 0.0 109.606 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.415 ' O ' ' C ' ' B' ' 55' ' ' ASP . 3.0 tp -96.09 48.11 1.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.365 -0.834 . . . . 0.0 109.909 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . 0.488 ' HA ' ' HB ' ' B' ' 51' ' ' VAL . 0.0 OUTLIER 45.58 65.31 1.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.061 -1.025 . . . . 0.0 109.28 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . 0.577 ' O ' ' N ' ' B' ' 58' ' ' ALA . 3.5 t30 -133.14 108.71 8.99 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 1.064 HD12 HD11 ' B' ' 49' ' ' LEU . 12.7 mm -32.41 86.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.67 0.748 . . . . 0.0 111.391 -178.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.577 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -90.99 -23.72 20.31 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.04 96.24 5.09 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.607 HG13 ' HB2' ' A' ' 5' ' ' TRP . 3.2 t -57.89 137.44 83.42 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.459 -0.776 . . . . 0.0 110.17 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.457 ' HG3' HD11 ' A' ' 29' ' ' ILE . 35.0 Cg_endo -76.97 172.97 15.24 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 122.438 2.092 . . . . 0.0 109.927 178.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . 0.532 ' O ' ' CG1' ' B' ' 47' ' ' VAL . 0.0 OUTLIER -150.94 135.36 17.01 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.811 -1.181 . . . . 0.0 110.614 -179.601 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.663 ' CG2' HG22 ' B' ' 47' ' ' VAL . 4.6 t -123.77 111.29 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.353 -0.842 . . . . 0.0 108.857 179.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' B' ' 42' ' ' TYR . . . . . . . . 0 N--CA 1.491 2.341 0 CA-C-O 117.93 -1.483 . . . . 0.0 109.729 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ttp . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.247 0.546 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.529 ' CB ' ' OD2' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -89.98 48.21 1.55 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.305 -0.872 . . . . 0.0 109.854 -179.799 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.838 HG22 ' O ' ' B' ' 63' ' ' VAL . 0.2 OUTLIER -89.44 18.81 4.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.213 -0.929 . . . . 0.0 108.499 179.084 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.594 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 37.3 mt-10 -135.33 -40.58 0.73 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.502 -0.749 . . . . 0.0 109.349 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.651 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 6.9 m-90 62.63 40.55 0.37 Allowed Pre-proline 0 C--N 1.299 -1.59 0 O-C-N 121.545 -0.722 . . . . 0.0 109.946 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.651 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 34.7 Cg_endo -72.93 -33.75 7.37 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 N-CA-C 107.462 -1.784 . . . . 0.0 107.462 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -69.57 -10.75 59.47 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 177.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.666 HD21 ' HA ' ' A' ' 16' ' ' ALA . 11.7 tp -81.36 -1.92 47.27 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 121.556 -0.715 . . . . 0.0 109.445 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.58 HG22 HG23 ' B' ' 60' ' ' VAL . 24.1 t -54.71 151.28 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.101 -1.0 . . . . 0.0 109.482 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 64.07 6.18 18.16 Favored Glycine 0 N--CA 1.481 1.677 0 C-N-CA 120.042 -1.075 . . . . 0.0 110.5 178.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -93.13 -145.36 0.23 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.801 -1.411 . . . . 0.0 109.327 179.697 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 m -150.47 179.56 8.05 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.062 -1.023 . . . . 0.0 110.373 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 1.027 HG22 HD21 ' B' ' 49' ' ' LEU . 57.1 t -60.45 -35.3 62.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.487 -0.758 . . . . 0.0 109.724 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' A' ' 18' ' ' LYS . 1.9 pm0 -47.02 -74.46 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.047 -1.033 . . . . 0.0 108.893 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.475 ' HB3' HD11 ' A' ' 8' ' ' LEU . 21.0 tt0 -57.61 -31.38 66.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.219 -0.925 . . . . 0.0 110.084 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.912 ' HB2' HD11 ' B' ' 57' ' ' ILE . . . -66.6 -81.12 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.88 -1.137 . . . . 0.0 109.962 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -45.96 -30.43 1.79 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.758 -1.214 . . . . 0.0 109.056 -179.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 14' ' ' GLU . 0.7 OUTLIER -63.46 -81.44 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.703 -0.623 . . . . 0.0 110.677 -179.501 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.761 HG12 ' HB2' ' A' ' 23' ' ' ASP . 3.3 t -56.18 -50.04 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.204 -0.935 . . . . 0.0 109.613 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.941 HG21 ' HB ' ' A' ' 29' ' ' ILE . 61.8 mt -46.9 -59.49 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.389 -0.819 . . . . 0.0 109.928 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.501 ' C ' ' O ' ' A' ' 20' ' ' ILE . 17.4 tp -29.56 -37.74 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 121.056 0.455 . . . . 0.0 110.659 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.558 ' O ' ' N ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -133.43 -72.67 0.5 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.968 -1.082 . . . . 0.0 109.405 179.096 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.761 ' HB2' HG12 ' A' ' 19' ' ' VAL . 7.6 t0 42.48 -94.84 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.718 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 3.0 mtmp? -66.62 -118.14 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.332 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.718 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 36.5 Cg_endo -79.77 -75.53 0.01 OUTLIER 'Trans proline' 0 C--O 1.214 -0.703 0 CA-C-N 122.309 1.86 . . . . 0.0 108.902 178.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 4.5 mt-10 -156.84 59.88 0.53 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.758 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -89.03 113.01 24.08 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.475 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.549 ' O ' HG23 ' B' ' 47' ' ' VAL . 1.8 mt-30 -87.95 172.21 9.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.065 -1.022 . . . . 0.0 109.175 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.941 ' HB ' HG21 ' A' ' 20' ' ' ILE . 9.4 tt -136.86 142.66 37.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 C-N-CA 118.883 -1.127 . . . . 0.0 110.979 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.802 HG22 HD22 ' A' ' 32' ' ' LEU . 26.9 mm -90.24 122.4 41.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.94 HG22 HD23 ' B' ' 49' ' ' LEU . 32.7 t -96.59 134.09 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.966 -1.084 . . . . 0.0 109.74 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.961 HD23 ' N ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -148.38 170.93 6.9 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 -178.671 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.699 ' O ' HG23 ' A' ' 34' ' ' VAL . 39.9 Cg_endo -75.91 -94.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.299 -2.035 0 O-C-N 123.414 1.218 . . . . 0.0 109.839 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 33' ' ' PRO . 54.8 t -164.74 103.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 178.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -152.42 -115.69 0.64 Allowed Glycine 0 N--CA 1.484 1.849 0 C-N-CA 119.251 -1.452 . . . . 0.0 110.256 -178.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 61.2 m -71.88 96.13 1.63 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.298 -1.119 . . . . 0.0 109.898 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.813 HG22 ' CE2' ' B' ' 50' ' ' PHE . 9.7 pt -94.5 153.54 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.332 -0.855 . . . . 0.0 109.048 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 38' ' ' VAL . 6.0 t 66.61 10.07 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.923 . . . . 0.0 109.526 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 117.917 -1.04 . . . . 0.0 109.425 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . 0.577 ' O ' ' CG ' ' B' ' 42' ' ' TYR . 52.6 mt-10 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . 0.577 ' CG ' ' O ' ' B' ' 41' ' ' GLU . 46.3 p90 40.66 -151.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.649 -0.657 . . . . 0.0 109.408 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.557 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 1.2 ptt180 -123.91 73.15 1.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.841 -1.162 . . . . 0.0 110.086 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.543 HG13 ' N ' ' B' ' 45' ' ' ASP . 0.4 OUTLIER -47.3 144.89 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 120.732 -1.23 . . . . 0.0 107.821 178.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.758 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 1.7 p-10 -106.34 45.7 0.96 Allowed 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 118.798 -1.161 . . . . 0.0 110.243 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . 0.483 ' HG3' HG12 ' A' ' 30' ' ' ILE . 1.4 ttt-85 -152.17 153.07 33.12 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.713 HG22 ' CG2' ' B' ' 63' ' ' VAL . 0.1 OUTLIER -150.59 -172.83 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.098 -1.001 . . . . 0.0 108.56 179.591 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.617 ' HD2' HD11 ' A' ' 32' ' ' LEU . 11.8 mmt85 -119.4 72.25 0.9 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.682 -1.261 . . . . 0.0 110.265 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 1.027 HD21 HG22 ' A' ' 13' ' ' VAL . 3.2 tp -69.21 97.74 0.96 Allowed 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.008 -1.077 . . . . 0.0 108.178 178.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' PHE . . . . . 0.831 ' CE1' HD12 ' A' ' 32' ' ' LEU . 18.1 m-85 -89.37 -162.93 0.92 Allowed 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 33' ' ' PRO . 34.8 m -142.1 175.09 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.769 -1.207 . . . . 0.0 109.363 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.649 ' CB ' ' HB2' ' B' ' 58' ' ' ALA . 0.0 OUTLIER -127.44 -71.9 0.65 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.242 -0.911 . . . . 0.0 108.633 -179.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.548 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 17.9 mmtt -93.21 -75.21 0.5 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.898 -1.126 . . . . 0.0 108.535 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.555 ' O ' ' CB ' ' B' ' 55' ' ' ASP . 0.1 OUTLIER -131.68 51.75 2.12 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 179.088 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . 0.555 ' CB ' ' O ' ' B' ' 54' ' ' LEU . 0.2 OUTLIER 91.33 23.0 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.18 0.514 . . . . 0.0 109.703 -179.344 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . 0.575 ' O ' ' N ' ' B' ' 58' ' ' ALA . 62.4 t30 -88.83 91.87 8.99 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.912 HD11 ' HB2' ' A' ' 16' ' ' ALA . 9.4 mt -38.49 89.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-O 121.687 0.756 . . . . 0.0 110.779 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.649 ' HB2' ' CB ' ' B' ' 52' ' ' ASP . . . -88.13 -25.65 22.87 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -118.2 103.51 9.91 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.581 HG13 ' HD2' ' B' ' 61' ' ' PRO . 63.0 t -62.49 138.21 96.46 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.386 -0.821 . . . . 0.0 110.918 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.581 ' HD2' HG13 ' B' ' 60' ' ' VAL . 36.4 Cg_endo -80.44 170.54 15.85 Favored 'Trans proline' 0 C--N 1.315 -1.199 0 C-N-CA 122.736 2.291 . . . . 0.0 109.294 178.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . 0.545 ' CD ' ' HA ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -149.9 140.39 22.45 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.758 -1.214 . . . . 0.0 110.721 -179.512 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.838 ' O ' HG22 ' A' ' 3' ' ' THR . 1.4 t -119.03 138.75 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.543 -0.723 . . . . 0.0 109.166 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 CA-C-O 117.967 -1.463 . . . . 0.0 109.668 -179.845 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 mmt . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.185 0.516 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.47 ' O ' ' CE2' ' A' ' 5' ' ' TRP . 38.1 mmtm -90.0 45.9 1.31 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.259 -0.901 . . . . 0.0 109.551 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.504 HG23 ' HD2' ' A' ' 24' ' ' LYS . 7.3 m -92.06 -22.56 19.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.229 -0.919 . . . . 0.0 109.708 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.648 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 10.1 mm-40 -105.8 -24.34 12.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.086 -1.009 . . . . 0.0 110.527 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.814 ' NE1' HD12 ' A' ' 20' ' ' ILE . 6.9 m-90 48.24 46.98 4.12 Favored Pre-proline 0 C--N 1.297 -1.709 0 C-N-CA 118.774 -1.17 . . . . 0.0 108.888 -178.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.66 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 31.4 Cg_endo -73.88 -35.44 4.37 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 N-CA-C 106.581 -2.123 . . . . 0.0 106.581 -179.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.84 -12.24 61.47 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 114.318 -1.31 . . . . 0.0 107.666 176.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.579 HD11 ' HB3' ' A' ' 15' ' ' GLU . 19.1 tp -79.68 -7.05 58.34 Favored 'General case' 0 N--CA 1.481 1.105 0 O-C-N 121.476 -0.765 . . . . 0.0 109.454 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.562 HG23 HG21 ' B' ' 60' ' ' VAL . 15.3 t -54.85 151.86 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 120.965 -1.084 . . . . 0.0 108.951 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.451 ' HA2' ' OD1' ' B' ' 56' ' ' ASN . . . 57.1 13.72 9.68 Favored Glycine 0 N--CA 1.481 1.64 0 N-CA-C 110.209 -1.157 . . . . 0.0 110.209 178.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -94.56 -143.52 0.25 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.959 -1.318 . . . . 0.0 109.511 179.843 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.12 170.4 18.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.042 -1.036 . . . . 0.0 110.173 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.551 ' HA ' HD11 ' B' ' 49' ' ' LEU . 78.4 t -53.27 -42.22 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.336 -0.853 . . . . 0.0 109.655 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.528 ' O ' ' CG ' ' A' ' 18' ' ' LYS . 59.0 mm-40 -41.38 -71.64 0.08 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.579 ' HB3' HD11 ' A' ' 8' ' ' LEU . 0.6 OUTLIER -56.09 -38.69 71.04 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.452 -0.78 . . . . 0.0 109.612 179.619 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.758 ' HB2' HD11 ' B' ' 57' ' ' ILE . . . -58.72 -83.85 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.383 -0.823 . . . . 0.0 109.862 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 17' ' ' LYS . 4.3 tptp -45.13 -29.99 1.04 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.563 -1.335 . . . . 0.0 109.39 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' A' ' 14' ' ' GLU . 4.3 mmtt -61.35 -86.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.66 0.743 . . . . 0.0 111.087 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.411 HG23 ' H ' ' A' ' 19' ' ' VAL . 2.4 t -57.89 -38.9 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-O 121.494 0.664 . . . . 0.0 109.824 -178.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.884 HG21 ' HB ' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -53.48 -51.75 38.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.438 -0.789 . . . . 0.0 109.725 -179.645 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 20' ' ' ILE . 45.3 tp -39.25 -23.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.399 -0.813 . . . . 0.0 111.9 -178.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -142.1 13.33 2.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.001 -1.687 . . . . 0.0 112.622 -179.242 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.967 ' OD1' ' HB3' ' A' ' 27' ' ' ALA . 1.2 p-10 -49.29 150.72 1.66 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.729 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.4 OUTLIER 52.81 -131.03 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 -178.809 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.729 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 36.9 Cg_endo -78.17 -83.03 0.0 OUTLIER 'Trans proline' 0 C--O 1.215 -0.635 0 CA-C-N 121.952 1.733 . . . . 0.0 109.346 178.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 3.1 mt-10 -144.69 71.01 1.29 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.417 -0.802 . . . . 0.0 109.046 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.967 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -89.03 118.71 28.95 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.006 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.518 ' O ' HG23 ' B' ' 47' ' ' VAL . 0.0 OUTLIER -88.01 -178.69 6.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.241 -0.912 . . . . 0.0 109.435 -179.313 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.884 ' HB ' HG21 ' A' ' 20' ' ' ILE . 14.0 tt -150.06 152.16 11.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 C-N-CA 119.02 -1.072 . . . . 0.0 111.112 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.424 ' HA ' HD13 ' A' ' 30' ' ' ILE . 16.3 mm -112.16 128.65 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.554 ' HA ' ' HB3' ' B' ' 49' ' ' LEU . 3.0 t -89.56 150.12 3.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 120.824 -1.173 . . . . 0.0 110.173 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.13 HD22 ' CD1' ' B' ' 50' ' ' PHE . 0.0 OUTLIER -130.93 166.21 29.21 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -178.38 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.71 ' O ' HG12 ' A' ' 34' ' ' VAL . 37.9 Cg_endo -81.77 34.87 0.56 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 123.008 2.472 . . . . 0.0 108.934 178.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.966 ' HA ' HD21 ' A' ' 32' ' ' LEU . 0.3 OUTLIER 56.91 3.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 123.549 0.74 . . . . 0.0 111.627 -178.807 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -152.22 -155.58 7.11 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -50.99 129.52 23.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -1.156 . . . . 0.0 109.664 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.991 HD13 ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -57.72 -22.15 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.329 179.874 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' A' ' 39' ' ' THR . 46.0 t -73.08 84.41 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.221 -0.924 . . . . 0.0 109.493 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.408 ' C ' ' O ' ' A' ' 38' ' ' VAL . 23.1 p . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.339 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . 0.577 ' CE2' ' HB ' ' B' ' 44' ' ' ILE . 11.2 p90 -124.98 -140.63 0.29 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.185 -0.947 . . . . 0.0 109.63 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.575 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.2 OUTLIER -130.71 54.97 1.86 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.748 -1.22 . . . . 0.0 110.283 -179.332 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.577 ' HB ' ' CE2' ' B' ' 42' ' ' TYR . 0.2 OUTLIER -45.79 140.17 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.856 -1.152 . . . . 0.0 108.363 179.388 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.624 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.9 OUTLIER -98.92 48.34 0.97 Allowed 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.031 -1.043 . . . . 0.0 109.624 -179.371 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 23.9 ttm180 -150.29 150.4 31.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.459 -0.775 . . . . 0.0 109.03 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.858 HG22 HG23 ' B' ' 63' ' ' VAL . 0.1 OUTLIER -151.36 -172.48 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.181 -0.949 . . . . 0.0 109.343 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . . . . . . . . . 5.1 mmt85 -118.17 71.02 0.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.095 -1.003 . . . . 0.0 110.156 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.572 ' HB2' HG12 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -54.61 103.09 0.08 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.005 -1.059 . . . . 0.0 108.872 179.297 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' PHE . . . . . 1.13 ' CD1' HD22 ' A' ' 32' ' ' LEU . 2.2 m-85 -92.21 119.21 31.62 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.356 -0.84 . . . . 0.0 108.961 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.505 ' O ' ' CG2' ' A' ' 34' ' ' VAL . 1.5 m -108.33 -175.45 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.12 -0.988 . . . . 0.0 109.536 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.545 ' CG ' ' N ' ' B' ' 53' ' ' LYS . 0.0 OUTLIER -129.16 -161.97 1.16 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.291 -0.88 . . . . 0.0 109.619 -179.915 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.545 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 1.8 mttp -49.96 -61.79 1.94 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.589 -0.694 . . . . 0.0 109.934 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . . . . . . . . . 7.6 mp -89.57 48.98 1.67 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.289 -0.882 . . . . 0.0 109.479 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 44.39 49.44 8.11 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.349 -0.844 . . . . 0.0 109.246 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . 0.484 ' HB3' ' CG ' ' B' ' 52' ' ' ASP . 4.9 t30 -107.11 111.17 23.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.31 -0.868 . . . . 0.0 108.873 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.758 HD11 ' HB2' ' A' ' 16' ' ' ALA . 12.5 mt -59.46 90.55 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 121.352 0.596 . . . . 0.0 110.21 -179.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . . . . . . . . . . . -87.94 -19.63 27.0 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . 0.529 ' HB2' ' CB ' ' B' ' 50' ' ' PHE . 1.1 mt-30 -123.12 82.27 1.98 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.567 HG11 ' O ' ' A' ' 5' ' ' TRP . 20.2 t -49.72 137.47 18.21 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.533 -0.73 . . . . 0.0 110.655 -178.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.545 ' HG3' HD11 ' A' ' 29' ' ' ILE . 36.5 Cg_endo -81.23 172.67 12.53 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 123.023 2.482 . . . . 0.0 110.205 179.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . 0.577 ' HG3' ' HA ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -149.53 129.4 13.37 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.229 -0.919 . . . . 0.0 110.009 179.915 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.858 HG23 HG22 ' B' ' 47' ' ' VAL . 0.9 OUTLIER -97.56 119.06 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.217 -0.927 . . . . 0.0 108.906 179.442 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . 0.418 ' OXT' HG22 ' B' ' 44' ' ' ILE . . . . . . . . 0 N--CA 1.491 2.339 0 CA-C-O 118.023 -1.431 . . . . 0.0 109.55 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.6 mtp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.335 0.588 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.47 ' HB3' ' OD2' ' A' ' 23' ' ' ASP . 0.5 OUTLIER -86.05 45.61 1.24 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.335 -0.853 . . . . 0.0 109.492 -179.812 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.552 ' CG2' ' HD2' ' A' ' 24' ' ' LYS . 62.7 p -89.65 33.94 0.83 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.175 -0.953 . . . . 0.0 109.599 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.565 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -135.42 -47.73 0.7 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.183 -0.948 . . . . 0.0 109.83 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.651 ' CE2' HG12 ' A' ' 20' ' ' ILE . 9.3 m-90 58.64 44.96 1.2 Allowed Pre-proline 0 C--N 1.299 -1.604 0 C-N-CA 119.398 -0.921 . . . . 0.0 108.995 -178.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.645 ' HD3' ' N ' ' A' ' 5' ' ' TRP . 33.5 Cg_endo -72.88 -32.09 9.41 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 N-CA-C 107.462 -1.784 . . . . 0.0 107.462 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.56 -12.2 60.97 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.842 HD21 ' HA ' ' A' ' 16' ' ' ALA . 2.7 tp -78.04 -4.32 46.57 Favored 'General case' 0 N--CA 1.483 1.203 0 O-C-N 121.507 -0.746 . . . . 0.0 109.594 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.7 t -52.43 152.39 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 C-N-CA 118.866 -1.133 . . . . 0.0 109.116 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.461 ' HA2' ' OD1' ' B' ' 56' ' ' ASN . . . 45.51 24.08 1.01 Allowed Glycine 0 N--CA 1.481 1.652 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 178.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 1.7 tptm -99.78 -138.93 0.32 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.984 -1.304 . . . . 0.0 109.249 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' B' ' 55' ' ' ASP . 0.3 OUTLIER -150.03 154.83 38.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.809 -1.182 . . . . 0.0 110.744 -179.53 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.633 ' HA ' HD21 ' B' ' 49' ' ' LEU . 54.9 t -52.41 -30.01 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 O-C-N 121.435 -0.79 . . . . 0.0 109.019 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.524 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 14.3 mt-10 -48.91 -74.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.466 -0.771 . . . . 0.0 109.107 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.491 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.6 OUTLIER -57.33 -28.94 63.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.168 -0.958 . . . . 0.0 108.705 179.226 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.89 ' C ' HD12 ' A' ' 20' ' ' ILE . . . -61.08 -86.74 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.4 -0.812 . . . . 0.0 109.959 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.448 ' HD2' ' C ' ' A' ' 17' ' ' LYS . 0.0 OUTLIER -47.46 -35.14 8.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.564 -1.335 . . . . 0.0 108.99 -179.928 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -49.46 -78.82 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.468 0.651 . . . . 0.0 110.869 -179.471 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 15' ' ' GLU . 0.5 OUTLIER -72.76 -44.57 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.425 -0.797 . . . . 0.0 109.677 -178.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.959 HG21 ' HB ' ' A' ' 29' ' ' ILE . 67.2 mt -40.07 -52.91 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.544 -0.722 . . . . 0.0 109.511 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 28' ' ' GLN . 0.5 OUTLIER -38.73 -49.44 1.59 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.563 -0.711 . . . . 0.0 110.483 -179.658 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.464 ' HB2' HD23 ' A' ' 21' ' ' LEU . 1.1 mt-30 -135.06 44.51 2.6 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.099 -1.0 . . . . 0.0 110.506 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.582 ' HB3' ' CE ' ' A' ' 24' ' ' LYS . 4.6 t0 -66.33 -39.85 89.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.866 -1.146 . . . . 0.0 108.488 179.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.824 ' HB2' ' HD3' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -117.42 -99.51 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.444 0 CA-C-O 117.214 -1.374 . . . . 0.0 107.975 178.707 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.824 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 37.3 Cg_endo -82.15 -76.14 0.0 OUTLIER 'Trans proline' 0 C--O 1.213 -0.742 0 CA-C-N 122.374 1.884 . . . . 0.0 108.284 177.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 25' ' ' PRO . 16.3 mt-10 -160.77 56.35 0.31 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.903 ' HB1' HG21 ' B' ' 63' ' ' VAL . . . -88.81 119.15 29.05 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.128 -0.983 . . . . 0.0 109.467 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 21' ' ' LEU . 15.7 mt-30 -89.25 -178.35 5.62 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.224 -0.923 . . . . 0.0 109.326 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.959 ' HB ' HG21 ' A' ' 20' ' ' ILE . 3.6 tt -145.45 127.93 9.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.089 -1.007 . . . . 0.0 110.436 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.823 HD12 ' HD3' ' B' ' 46' ' ' ARG . 33.4 mt -89.0 111.31 22.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.486 HG21 HG21 ' A' ' 13' ' ' VAL . 7.0 p -89.72 146.59 5.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.136 -0.977 . . . . 0.0 110.123 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.161 HD11 ' CE1' ' B' ' 50' ' ' PHE . 0.7 OUTLIER -150.49 161.6 29.99 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.461 -0.775 . . . . 0.0 109.461 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.557 ' HD2' ' HB2' ' A' ' 32' ' ' LEU . 36.9 Cg_endo -78.63 35.5 0.55 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.538 2.159 . . . . 0.0 111.432 -179.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' A' ' 33' ' ' PRO . 4.6 t 73.47 -78.8 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.245 -0.909 . . . . 0.0 109.829 179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.53 168.28 0.58 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.437 ' O ' ' OG1' ' A' ' 36' ' ' THR . 0.5 OUTLIER -88.69 39.22 0.91 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -1.165 . . . . 0.0 109.032 179.724 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 65.95 144.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.324 -0.86 . . . . 0.0 108.951 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.3 t -65.94 137.98 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.104 -0.997 . . . . 0.0 109.542 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.517 -179.88 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.704 0.764 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . 0.581 ' CE2' ' HA ' ' B' ' 44' ' ' ILE . 9.7 p90 -131.63 -152.22 0.49 Allowed 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.74 -0.6 . . . . 0.0 109.419 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.554 ' CG ' ' O ' ' B' ' 43' ' ' ARG . 0.0 OUTLIER -92.72 52.94 1.95 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.154 -0.966 . . . . 0.0 109.597 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.581 ' HA ' ' CE2' ' B' ' 42' ' ' TYR . 0.5 OUTLIER -43.17 145.87 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.99 -1.069 . . . . 0.0 108.262 179.488 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.611 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 2.2 p-10 -106.1 46.44 0.92 Allowed 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 118.962 -1.095 . . . . 0.0 110.756 -178.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . 0.823 ' HD3' HD12 ' A' ' 30' ' ' ILE . 2.3 ptp180 -150.94 153.01 34.43 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.22 -0.925 . . . . 0.0 109.244 178.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 1.091 ' CG2' HG23 ' B' ' 63' ' ' VAL . 31.1 t -150.93 161.66 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.421 -0.799 . . . . 0.0 109.162 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.804 ' HG3' HD21 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -93.38 84.16 4.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.85 -1.156 . . . . 0.0 110.022 -179.453 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.633 HD21 ' HA ' ' A' ' 13' ' ' VAL . 2.5 tp -80.04 83.36 5.94 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 118.985 -1.086 . . . . 0.0 109.17 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' PHE . . . . . 1.161 ' CE1' HD11 ' A' ' 32' ' ' LEU . 3.8 m-30 -66.98 -162.88 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.715 HG12 ' HA ' ' B' ' 55' ' ' ASP . 10.1 m -149.44 160.9 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.834 -1.166 . . . . 0.0 108.702 178.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.715 ' CB ' ' HB2' ' B' ' 58' ' ' ALA . 0.0 OUTLIER -112.37 -70.61 0.8 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.939 -1.1 . . . . 0.0 108.796 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.55 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 9.9 mmmt -92.5 -75.91 0.48 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.848 -1.158 . . . . 0.0 108.49 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.543 ' O ' ' CB ' ' B' ' 55' ' ' ASP . 0.1 OUTLIER -136.85 57.22 1.77 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.056 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . 0.715 ' HA ' HG12 ' B' ' 51' ' ' VAL . 0.2 OUTLIER 91.51 24.13 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.421 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' B' ' 58' ' ' ALA . 31.8 t-20 -88.82 86.79 7.04 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.742 HD11 ' HB2' ' A' ' 16' ' ' ALA . 3.8 mt -37.33 89.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-O 121.511 0.672 . . . . 0.0 111.315 -178.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.715 ' HB2' ' CB ' ' B' ' 52' ' ' ASP . . . -88.81 -17.5 29.62 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . 0.421 ' O ' ' C ' ' B' ' 60' ' ' VAL . 33.9 mt-30 -127.68 84.37 2.25 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.531 ' CG1' ' O ' ' A' ' 4' ' ' GLU . 6.4 t -41.68 136.2 2.01 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.453 -0.779 . . . . 0.0 110.161 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.806 ' HB2' HG11 ' B' ' 47' ' ' VAL . 36.7 Cg_endo -81.95 166.79 16.7 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.751 2.301 . . . . 0.0 110.523 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . 0.621 ' O ' HG13 ' B' ' 47' ' ' VAL . 0.3 OUTLIER -142.72 152.85 42.77 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 109.285 179.416 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 1.091 HG23 ' CG2' ' B' ' 47' ' ' VAL . 1.2 t -116.9 124.73 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.229 -0.919 . . . . 0.0 109.486 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.217 0 CA-C-O 117.957 -1.468 . . . . 0.0 109.599 179.685 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.406 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . 1.5 tmm? . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.312 0.577 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.431 ' HD3' ' HA ' ' A' ' 2' ' ' LYS . 6.0 mmtp -88.92 66.66 7.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.125 -0.984 . . . . 0.0 109.311 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.747 HG22 ' CE ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -103.3 -7.78 20.83 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.307 -0.871 . . . . 0.0 109.063 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.58 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 4.9 mt-10 -99.92 -48.41 4.68 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.993 -1.067 . . . . 0.0 110.878 -178.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.619 ' CE2' HG12 ' A' ' 20' ' ' ILE . 10.4 m-90 60.71 45.76 1.03 Allowed Pre-proline 0 C--N 1.297 -1.711 0 C-N-CA 119.067 -1.053 . . . . 0.0 108.386 -177.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.662 ' HA ' HG21 ' B' ' 60' ' ' VAL . 32.8 Cg_endo -72.31 -31.2 11.93 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 N-CA-C 107.057 -1.94 . . . . 0.0 107.057 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.21 -13.14 62.02 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.763 -1.108 . . . . 0.0 108.525 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.577 HD23 ' HB3' ' A' ' 5' ' ' TRP . 0.3 OUTLIER -71.32 -11.57 60.98 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.204 -0.935 . . . . 0.0 108.987 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.741 HG23 ' CG2' ' B' ' 60' ' ' VAL . 24.4 t -55.9 145.1 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.087 -1.008 . . . . 0.0 109.82 -179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.474 ' HA2' ' OD1' ' B' ' 56' ' ' ASN . . . 59.23 13.65 22.22 Favored Glycine 0 N--CA 1.482 1.726 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.287 177.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 8' ' ' LEU . 1.2 tptp -95.44 -147.11 0.28 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.133 -1.216 . . . . 0.0 109.178 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.84 155.96 44.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.232 -0.917 . . . . 0.0 109.372 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.528 ' CG2' ' CG1' ' B' ' 51' ' ' VAL . 69.0 t -47.17 -37.18 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.834 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.516 ' O ' ' CB ' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -44.81 -76.9 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.211 -0.931 . . . . 0.0 109.317 -179.864 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -54.76 -35.57 63.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.561 -0.712 . . . . 0.0 110.143 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.69 ' C ' HD12 ' A' ' 20' ' ' ILE . . . -63.46 -83.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.827 . . . . 0.0 110.364 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.655 ' HG2' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -45.7 -27.52 0.83 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.142 -0.974 . . . . 0.0 108.884 -179.618 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' A' ' 14' ' ' GLU . 0.1 OUTLIER -67.46 -86.28 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.746 -0.596 . . . . 0.0 111.167 -179.029 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.503 ' O ' ' OD1' ' A' ' 23' ' ' ASP . 4.6 t -46.13 -42.77 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.15 -0.969 . . . . 0.0 109.455 -178.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.995 HG21 ' HB ' ' A' ' 29' ' ' ILE . 46.5 mt -56.63 -44.24 80.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.452 -0.78 . . . . 0.0 109.536 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.44 ' C ' ' O ' ' A' ' 20' ' ' ILE . 4.2 tt -39.15 -25.82 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.222 -0.923 . . . . 0.0 110.588 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.548 ' O ' ' N ' ' A' ' 24' ' ' LYS . 0.6 OUTLIER -144.3 -67.99 0.32 Allowed 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.525 -1.359 . . . . 0.0 111.592 -179.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.516 ' OD1' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER 39.54 -94.51 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.393 -0.817 . . . . 0.0 108.86 -178.549 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.747 ' CE ' HG22 ' A' ' 3' ' ' THR . 10.6 mtpt -64.89 -118.95 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.435 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 178.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.735 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 36.5 Cg_endo -80.56 -73.21 0.01 OUTLIER 'Trans proline' 0 C--O 1.214 -0.71 0 CA-C-N 122.221 1.829 . . . . 0.0 109.006 178.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 5.5 mt-10 -159.29 60.63 0.4 Allowed 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.749 ' HA ' ' HA ' ' B' ' 45' ' ' ASP . . . -88.03 113.99 24.21 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.566 ' O ' HG23 ' B' ' 47' ' ' VAL . 0.2 OUTLIER -86.78 170.57 11.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.144 -0.973 . . . . 0.0 110.517 -177.711 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.995 ' HB ' HG21 ' A' ' 20' ' ' ILE . 19.2 tt -140.21 141.91 32.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.829 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.531 ' O ' ' HB3' ' B' ' 49' ' ' LEU . 1.0 OUTLIER -91.31 163.77 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 179.132 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 1.04 HG13 HD12 ' B' ' 49' ' ' LEU . 64.5 t -135.2 133.39 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.312 -1.492 . . . . 0.0 110.372 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.036 HD21 ' CE1' ' B' ' 50' ' ' PHE . 0.5 OUTLIER -132.19 159.53 71.8 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.503 -0.748 . . . . 0.0 109.113 178.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.541 ' HA ' ' CG2' ' B' ' 51' ' ' VAL . 37.4 Cg_endo -80.73 39.97 0.92 Allowed 'Trans proline' 0 C--N 1.304 -1.774 0 C-N-CA 122.513 2.142 . . . . 0.0 110.652 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.783 HG12 ' N ' ' A' ' 35' ' ' GLY . 14.9 t 50.06 -92.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.102 -0.999 . . . . 0.0 108.708 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.783 ' N ' HG12 ' A' ' 34' ' ' VAL . . . 52.19 -116.53 5.2 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.637 ' O ' HG22 ' A' ' 37' ' ' ILE . 53.4 m -91.2 -101.03 0.11 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.378 -1.072 . . . . 0.0 110.184 -179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.786 ' CG2' HG23 ' A' ' 38' ' ' VAL . 1.5 tp 67.95 173.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.23 -0.919 . . . . 0.0 108.767 -179.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.786 HG23 ' CG2' ' A' ' 37' ' ' ILE . 6.4 t 78.86 -7.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.33 -0.856 . . . . 0.0 109.689 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 38' ' ' VAL . 19.5 p . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.315 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.284 0.564 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . 0.579 ' CE2' ' HA ' ' B' ' 44' ' ' ILE . 53.6 p90 -120.87 -155.72 0.64 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.41 -0.806 . . . . 0.0 109.341 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' ARG . . . . . 0.569 ' HD3' ' CG1' ' B' ' 63' ' ' VAL . 1.6 tpp180 -88.91 75.53 8.04 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.389 -0.819 . . . . 0.0 109.158 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.579 ' HA ' ' CE2' ' B' ' 42' ' ' TYR . 0.4 OUTLIER -52.64 142.74 4.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 179.185 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.749 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -96.54 50.21 1.13 Allowed 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.703 -1.248 . . . . 0.0 110.4 -178.738 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 28' ' ' GLN . 15.0 ttm180 -150.03 150.21 31.44 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.436 -0.79 . . . . 0.0 108.9 178.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.668 HG22 ' CG2' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -151.71 179.9 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.769 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.618 ' HB3' ' CE2' ' B' ' 50' ' ' PHE . 0.9 OUTLIER -107.38 85.21 2.09 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.905 -1.122 . . . . 0.0 111.62 -178.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 1.04 HD12 HG13 ' A' ' 31' ' ' VAL . 2.1 tm? -78.31 93.47 4.67 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' PHE . . . . . 1.036 ' CE1' HD21 ' A' ' 32' ' ' LEU . 50.4 m-85 -89.42 132.95 34.75 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 32' ' ' LEU . 16.7 m -99.77 -169.31 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.842 -1.161 . . . . 0.0 109.538 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' B' ' 55' ' ' ASP . 3.6 p-10 -126.77 -148.89 0.4 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.209 -0.932 . . . . 0.0 109.119 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' LYS . . . . . 0.496 ' N ' ' CG ' ' B' ' 52' ' ' ASP . 4.6 mmmm -76.5 -45.43 30.97 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' LEU . . . . . 0.507 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 1.4 mt -101.15 34.46 2.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.542 -0.724 . . . . 0.0 109.612 179.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . 0.536 ' N ' ' OD1' ' B' ' 52' ' ' ASP . 0.0 OUTLIER 53.77 68.28 0.87 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.016 -1.052 . . . . 0.0 108.179 -178.787 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' B' ' 58' ' ' ALA . 47.1 t-20 -130.93 100.4 5.24 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.678 HD12 HD21 ' B' ' 49' ' ' LEU . 31.2 mm -40.67 88.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.495 0.664 . . . . 0.0 110.624 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' ALA . . . . . 0.563 ' N ' ' O ' ' B' ' 56' ' ' ASN . . . -89.59 -18.46 26.52 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.5 108.33 14.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.48 -0.763 . . . . 0.0 108.998 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.741 ' CG2' HG23 ' A' ' 9' ' ' VAL . 32.8 t -66.27 133.51 94.55 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.304 -0.872 . . . . 0.0 110.236 -179.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.611 ' HB3' HD11 ' A' ' 29' ' ' ILE . 36.5 Cg_endo -81.72 165.17 18.05 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.601 2.201 . . . . 0.0 110.496 179.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' ARG . . . . . 0.567 ' CD ' ' HA ' ' A' ' 4' ' ' GLU . 1.1 tpp180 -150.22 134.85 17.47 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.223 -0.923 . . . . 0.0 110.54 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.668 ' CG2' HG22 ' B' ' 47' ' ' VAL . 1.4 t -118.06 146.96 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 CA-C-O 117.959 -1.467 . . . . 0.0 109.626 179.912 . . . . . . . . 0 0 . 1 stop_ save_